JP2001245666A - New polypeptide - Google Patents
New polypeptideInfo
- Publication number
- JP2001245666A JP2001245666A JP2000060548A JP2000060548A JP2001245666A JP 2001245666 A JP2001245666 A JP 2001245666A JP 2000060548 A JP2000060548 A JP 2000060548A JP 2000060548 A JP2000060548 A JP 2000060548A JP 2001245666 A JP2001245666 A JP 2001245666A
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- dna
- present
- cell
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 837
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 624
- 229920001184 polypeptide Polymers 0.000 title claims abstract description 620
- 238000000034 method Methods 0.000 claims abstract description 297
- 230000036961 partial effect Effects 0.000 claims abstract description 182
- 239000003446 ligand Substances 0.000 claims abstract description 164
- 239000000556 agonist Substances 0.000 claims abstract description 101
- 239000005557 antagonist Substances 0.000 claims abstract description 94
- 238000012216 screening Methods 0.000 claims abstract description 74
- 150000001875 compounds Chemical class 0.000 claims abstract description 62
- 241000282414 Homo sapiens Species 0.000 claims abstract description 49
- 108020004414 DNA Proteins 0.000 claims description 210
- 239000000126 substance Substances 0.000 claims description 186
- 108090000623 proteins and genes Proteins 0.000 claims description 131
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 claims description 123
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 claims description 115
- 238000012360 testing method Methods 0.000 claims description 115
- 230000014509 gene expression Effects 0.000 claims description 71
- 150000001413 amino acids Chemical class 0.000 claims description 70
- 230000000694 effects Effects 0.000 claims description 59
- 150000003839 salts Chemical class 0.000 claims description 56
- 230000027455 binding Effects 0.000 claims description 51
- 239000003607 modifier Substances 0.000 claims description 49
- 108091034117 Oligonucleotide Proteins 0.000 claims description 48
- 239000003814 drug Substances 0.000 claims description 45
- 239000002773 nucleotide Substances 0.000 claims description 44
- 125000003729 nucleotide group Chemical group 0.000 claims description 44
- 241001465754 Metazoa Species 0.000 claims description 43
- 239000013598 vector Substances 0.000 claims description 41
- 210000001103 thalamus Anatomy 0.000 claims description 33
- 238000004519 manufacturing process Methods 0.000 claims description 32
- 206010028980 Neoplasm Diseases 0.000 claims description 25
- 201000011510 cancer Diseases 0.000 claims description 25
- 210000000056 organ Anatomy 0.000 claims description 23
- 108020004511 Recombinant DNA Proteins 0.000 claims description 22
- 210000001638 cerebellum Anatomy 0.000 claims description 20
- 108700008625 Reporter Genes Proteins 0.000 claims description 17
- 238000012258 culturing Methods 0.000 claims description 16
- 230000004064 dysfunction Effects 0.000 claims description 16
- 238000013518 transcription Methods 0.000 claims description 16
- 230000035897 transcription Effects 0.000 claims description 16
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 15
- 229940124597 therapeutic agent Drugs 0.000 claims description 15
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 9
- 238000011002 quantification Methods 0.000 claims description 8
- 238000013519 translation Methods 0.000 claims description 8
- 238000007792 addition Methods 0.000 claims description 7
- 238000012217 deletion Methods 0.000 claims description 7
- 230000037430 deletion Effects 0.000 claims description 7
- 108020004999 messenger RNA Proteins 0.000 claims description 7
- 230000000295 complement effect Effects 0.000 claims description 5
- 238000006467 substitution reaction Methods 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 238000009395 breeding Methods 0.000 claims description 2
- 230000001488 breeding effect Effects 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 3
- 239000002299 complementary DNA Substances 0.000 abstract description 75
- 108091006027 G proteins Proteins 0.000 abstract description 10
- 108091000058 GTP-Binding Proteins 0.000 abstract description 9
- 208000005718 Stomach Neoplasms Diseases 0.000 abstract description 9
- 206010017758 gastric cancer Diseases 0.000 abstract description 9
- 201000011549 stomach cancer Diseases 0.000 abstract description 9
- 238000012163 sequencing technique Methods 0.000 abstract description 8
- 241000124008 Mammalia Species 0.000 abstract description 6
- 230000002950 deficient Effects 0.000 abstract description 4
- 102000030782 GTP binding Human genes 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 description 402
- 239000012528 membrane Substances 0.000 description 57
- 235000002639 sodium chloride Nutrition 0.000 description 54
- 235000018102 proteins Nutrition 0.000 description 43
- 102000004169 proteins and genes Human genes 0.000 description 43
- 230000006870 function Effects 0.000 description 41
- 239000002609 medium Substances 0.000 description 40
- 238000006243 chemical reaction Methods 0.000 description 39
- 230000003834 intracellular effect Effects 0.000 description 38
- 239000002585 base Substances 0.000 description 36
- 241000588724 Escherichia coli Species 0.000 description 32
- 210000000170 cell membrane Anatomy 0.000 description 32
- 238000002360 preparation method Methods 0.000 description 31
- 241000196324 Embryophyta Species 0.000 description 30
- 239000012264 purified product Substances 0.000 description 28
- 102000005962 receptors Human genes 0.000 description 28
- 108020003175 receptors Proteins 0.000 description 28
- 229940023064 escherichia coli Drugs 0.000 description 26
- 239000000284 extract Substances 0.000 description 26
- 244000005700 microbiome Species 0.000 description 26
- XOFLBQFBSOEHOG-UUOKFMHZSA-N γS-GTP Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=S)[C@@H](O)[C@H]1O XOFLBQFBSOEHOG-UUOKFMHZSA-N 0.000 description 24
- 239000000872 buffer Substances 0.000 description 23
- -1 for example Chemical group 0.000 description 23
- 239000006228 supernatant Substances 0.000 description 23
- 229940079593 drug Drugs 0.000 description 22
- 230000035772 mutation Effects 0.000 description 21
- 230000009871 nonspecific binding Effects 0.000 description 21
- 239000000523 sample Substances 0.000 description 21
- 210000001519 tissue Anatomy 0.000 description 21
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 20
- 241000238631 Hexapoda Species 0.000 description 19
- 239000000243 solution Substances 0.000 description 19
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 18
- 230000004913 activation Effects 0.000 description 18
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 18
- 201000010099 disease Diseases 0.000 description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 18
- 102000013446 GTP Phosphohydrolases Human genes 0.000 description 17
- 108091006109 GTPases Proteins 0.000 description 17
- 210000004102 animal cell Anatomy 0.000 description 17
- 210000004556 brain Anatomy 0.000 description 17
- 230000036755 cellular response Effects 0.000 description 15
- 239000012228 culture supernatant Substances 0.000 description 15
- 239000007788 liquid Substances 0.000 description 15
- 239000013612 plasmid Substances 0.000 description 14
- 102000004190 Enzymes Human genes 0.000 description 13
- 108090000790 Enzymes Proteins 0.000 description 13
- 239000013604 expression vector Substances 0.000 description 13
- 238000010369 molecular cloning Methods 0.000 description 12
- 230000002285 radioactive effect Effects 0.000 description 12
- 108010076504 Protein Sorting Signals Proteins 0.000 description 11
- 239000000427 antigen Substances 0.000 description 11
- 108091007433 antigens Proteins 0.000 description 11
- 102000036639 antigens Human genes 0.000 description 11
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 description 11
- 239000012472 biological sample Substances 0.000 description 11
- 229940088598 enzyme Drugs 0.000 description 11
- 230000001965 increasing effect Effects 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- 238000011160 research Methods 0.000 description 11
- 210000002966 serum Anatomy 0.000 description 11
- 241000699666 Mus <mouse, genus> Species 0.000 description 10
- 241000700159 Rattus Species 0.000 description 10
- GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 description 10
- 102000002852 Vasopressins Human genes 0.000 description 10
- 108010004977 Vasopressins Proteins 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 10
- 239000003365 glass fiber Substances 0.000 description 10
- 229940088597 hormone Drugs 0.000 description 10
- 239000005556 hormone Substances 0.000 description 10
- 229960003726 vasopressin Drugs 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 206010035226 Plasma cell myeloma Diseases 0.000 description 9
- 239000002253 acid Substances 0.000 description 9
- 229940114079 arachidonic acid Drugs 0.000 description 9
- 235000021342 arachidonic acid Nutrition 0.000 description 9
- 230000002759 chromosomal effect Effects 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- 239000012634 fragment Substances 0.000 description 9
- 210000004408 hybridoma Anatomy 0.000 description 9
- 210000002752 melanocyte Anatomy 0.000 description 9
- 201000000050 myeloid neoplasm Diseases 0.000 description 9
- 210000000287 oocyte Anatomy 0.000 description 9
- 238000000746 purification Methods 0.000 description 9
- 230000004044 response Effects 0.000 description 9
- 102000034286 G proteins Human genes 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 239000011575 calcium Substances 0.000 description 8
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 8
- 238000007796 conventional method Methods 0.000 description 8
- 230000007423 decrease Effects 0.000 description 8
- 238000001514 detection method Methods 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 8
- 238000009396 hybridization Methods 0.000 description 8
- 238000002347 injection Methods 0.000 description 8
- 239000007924 injection Substances 0.000 description 8
- ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 description 7
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 7
- 206010009944 Colon cancer Diseases 0.000 description 7
- 239000000055 Corticotropin-Releasing Hormone Substances 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 7
- 241000700605 Viruses Species 0.000 description 7
- INAPMGSXUVUWAF-GCVPSNMTSA-N [(2r,3s,5r,6r)-2,3,4,5,6-pentahydroxycyclohexyl] dihydrogen phosphate Chemical compound OC1[C@H](O)[C@@H](O)C(OP(O)(O)=O)[C@H](O)[C@@H]1O INAPMGSXUVUWAF-GCVPSNMTSA-N 0.000 description 7
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 7
- 229960004373 acetylcholine Drugs 0.000 description 7
- 230000002776 aggregation Effects 0.000 description 7
- 238000004220 aggregation Methods 0.000 description 7
- 238000010367 cloning Methods 0.000 description 7
- 238000009792 diffusion process Methods 0.000 description 7
- 150000002148 esters Chemical class 0.000 description 7
- 210000000496 pancreas Anatomy 0.000 description 7
- 239000000049 pigment Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 125000006239 protecting group Chemical group 0.000 description 7
- 230000035945 sensitivity Effects 0.000 description 7
- 231100000331 toxic Toxicity 0.000 description 7
- 230000002588 toxic effect Effects 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 241000283690 Bos taurus Species 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 6
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
- 241001494479 Pecora Species 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 108010071563 Proto-Oncogene Proteins c-fos Proteins 0.000 description 6
- 102000007568 Proto-Oncogene Proteins c-fos Human genes 0.000 description 6
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 6
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 6
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 6
- 230000003491 cAMP production Effects 0.000 description 6
- 239000002775 capsule Substances 0.000 description 6
- 238000004113 cell culture Methods 0.000 description 6
- 210000000349 chromosome Anatomy 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 6
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 239000002858 neurotransmitter agent Substances 0.000 description 6
- 238000010647 peptide synthesis reaction Methods 0.000 description 6
- 230000009822 protein phosphorylation Effects 0.000 description 6
- 238000010188 recombinant method Methods 0.000 description 6
- 230000009870 specific binding Effects 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 241000701447 unidentified baculovirus Species 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
- 244000063299 Bacillus subtilis Species 0.000 description 5
- 235000014469 Bacillus subtilis Nutrition 0.000 description 5
- 241000282693 Cercopithecidae Species 0.000 description 5
- 108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 5
- 238000001042 affinity chromatography Methods 0.000 description 5
- 210000000628 antibody-producing cell Anatomy 0.000 description 5
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 5
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 5
- 238000004520 electroporation Methods 0.000 description 5
- 210000001671 embryonic stem cell Anatomy 0.000 description 5
- 230000002708 enhancing effect Effects 0.000 description 5
- 230000001605 fetal effect Effects 0.000 description 5
- 230000003054 hormonal effect Effects 0.000 description 5
- 238000003018 immunoassay Methods 0.000 description 5
- 150000007524 organic acids Chemical class 0.000 description 5
- 239000008194 pharmaceutical composition Substances 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 241000701161 unidentified adenovirus Species 0.000 description 5
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 108090000932 Calcitonin Gene-Related Peptide Proteins 0.000 description 4
- 102000004414 Calcitonin Gene-Related Peptide Human genes 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 102400000739 Corticotropin Human genes 0.000 description 4
- 101800000414 Corticotropin Proteins 0.000 description 4
- 108010022152 Corticotropin-Releasing Hormone Proteins 0.000 description 4
- 102000012289 Corticotropin-Releasing Hormone Human genes 0.000 description 4
- OHCQJHSOBUTRHG-KGGHGJDLSA-N FORSKOLIN Chemical compound O=C([C@@]12O)C[C@](C)(C=C)O[C@]1(C)[C@@H](OC(=O)C)[C@@H](O)[C@@H]1[C@]2(C)[C@@H](O)CCC1(C)C OHCQJHSOBUTRHG-KGGHGJDLSA-N 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 4
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 4
- 108010010803 Gelatin Proteins 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 4
- 239000000095 Growth Hormone-Releasing Hormone Substances 0.000 description 4
- 241000282412 Homo Species 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 108090001007 Interleukin-8 Proteins 0.000 description 4
- 102400001355 Interleukin-8 Human genes 0.000 description 4
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 4
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 4
- 102000003982 Parathyroid hormone Human genes 0.000 description 4
- 108090000445 Parathyroid hormone Proteins 0.000 description 4
- 239000004698 Polyethylene Substances 0.000 description 4
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 4
- 101710142969 Somatoliberin Proteins 0.000 description 4
- 102100022831 Somatoliberin Human genes 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 108091023040 Transcription factor Proteins 0.000 description 4
- 102000040945 Transcription factor Human genes 0.000 description 4
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 4
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 239000013543 active substance Substances 0.000 description 4
- 125000002252 acyl group Chemical group 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- 229940098773 bovine serum albumin Drugs 0.000 description 4
- 210000004899 c-terminal region Anatomy 0.000 description 4
- 238000010804 cDNA synthesis Methods 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- 208000029742 colonic neoplasm Diseases 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 4
- 229960000258 corticotropin Drugs 0.000 description 4
- 238000012136 culture method Methods 0.000 description 4
- 230000000593 degrading effect Effects 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 239000013613 expression plasmid Substances 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 4
- 102000037865 fusion proteins Human genes 0.000 description 4
- 108020001507 fusion proteins Proteins 0.000 description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 4
- 239000005090 green fluorescent protein Substances 0.000 description 4
- 238000002169 hydrotherapy Methods 0.000 description 4
- 210000003016 hypothalamus Anatomy 0.000 description 4
- 230000003053 immunization Effects 0.000 description 4
- 238000002649 immunization Methods 0.000 description 4
- XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 description 4
- 229940096397 interleukin-8 Drugs 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- 210000003292 kidney cell Anatomy 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 150000007522 mineralic acids Chemical class 0.000 description 4
- 150000007523 nucleic acids Chemical class 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 210000004940 nucleus Anatomy 0.000 description 4
- 235000005985 organic acids Nutrition 0.000 description 4
- 230000002611 ovarian Effects 0.000 description 4
- 210000001672 ovary Anatomy 0.000 description 4
- 239000000199 parathyroid hormone Substances 0.000 description 4
- 229960001319 parathyroid hormone Drugs 0.000 description 4
- 230000001766 physiological effect Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000012521 purified sample Substances 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 230000004936 stimulating effect Effects 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- 210000001550 testis Anatomy 0.000 description 4
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 4
- 239000011534 wash buffer Substances 0.000 description 4
- HWYCFZUSOBOBIN-AQJXLSMYSA-N (2s)-2-[[(2s)-1-[(2s)-5-amino-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]-n-[(2s)-1-[[(2s)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-5-(diaminome Chemical compound C([C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)C1=CC=CC=C1 HWYCFZUSOBOBIN-AQJXLSMYSA-N 0.000 description 3
- LVRVABPNVHYXRT-BQWXUCBYSA-N 52906-92-0 Chemical compound C([C@H](N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O)C(C)C)C1=CC=CC=C1 LVRVABPNVHYXRT-BQWXUCBYSA-N 0.000 description 3
- HFDKKNHCYWNNNQ-YOGANYHLSA-N 75976-10-2 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@@H](NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C1=CC=C(O)C=C1 HFDKKNHCYWNNNQ-YOGANYHLSA-N 0.000 description 3
- LPXQRXLUHJKZIE-UHFFFAOYSA-N 8-azaguanine Chemical compound NC1=NC(O)=C2NN=NC2=N1 LPXQRXLUHJKZIE-UHFFFAOYSA-N 0.000 description 3
- 108010000239 Aequorin Proteins 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
- 102000015427 Angiotensins Human genes 0.000 description 3
- 108010064733 Angiotensins Proteins 0.000 description 3
- 206010003445 Ascites Diseases 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- 241000255789 Bombyx mori Species 0.000 description 3
- 101800004538 Bradykinin Proteins 0.000 description 3
- 102400000967 Bradykinin Human genes 0.000 description 3
- 102100034871 C-C motif chemokine 8 Human genes 0.000 description 3
- 102100039398 C-X-C motif chemokine 2 Human genes 0.000 description 3
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 3
- 108010040471 CC Chemokines Proteins 0.000 description 3
- 102000001902 CC Chemokines Human genes 0.000 description 3
- 108050006947 CXC Chemokine Proteins 0.000 description 3
- 102000019388 CXC chemokine Human genes 0.000 description 3
- 102000055006 Calcitonin Human genes 0.000 description 3
- 108060001064 Calcitonin Proteins 0.000 description 3
- 102000011632 Caseins Human genes 0.000 description 3
- 108010076119 Caseins Proteins 0.000 description 3
- 208000015879 Cerebellar disease Diseases 0.000 description 3
- 102000001326 Chemokine CCL4 Human genes 0.000 description 3
- 108010055165 Chemokine CCL4 Proteins 0.000 description 3
- 101800001982 Cholecystokinin Proteins 0.000 description 3
- 102100025841 Cholecystokinin Human genes 0.000 description 3
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 3
- 241000186226 Corynebacterium glutamicum Species 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 3
- 108050009340 Endothelin Proteins 0.000 description 3
- 102000002045 Endothelin Human genes 0.000 description 3
- 102400001370 Galanin Human genes 0.000 description 3
- 101800002068 Galanin Proteins 0.000 description 3
- 241000287828 Gallus gallus Species 0.000 description 3
- 102000004862 Gastrin releasing peptide Human genes 0.000 description 3
- 108090001053 Gastrin releasing peptide Proteins 0.000 description 3
- 102000051325 Glucagon Human genes 0.000 description 3
- 108060003199 Glucagon Proteins 0.000 description 3
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 3
- 101000946794 Homo sapiens C-C motif chemokine 8 Proteins 0.000 description 3
- 101000889128 Homo sapiens C-X-C motif chemokine 2 Proteins 0.000 description 3
- 101000996727 Homo sapiens Gonadotropin-releasing hormone receptor Proteins 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 101710151321 Melanostatin Proteins 0.000 description 3
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 102000002419 Motilin Human genes 0.000 description 3
- 101800002372 Motilin Proteins 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 102400001095 Neuropeptide FF Human genes 0.000 description 3
- 102400000064 Neuropeptide Y Human genes 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 102000002512 Orexin Human genes 0.000 description 3
- 102400000050 Oxytocin Human genes 0.000 description 3
- 101800000989 Oxytocin Proteins 0.000 description 3
- XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 description 3
- 102000018886 Pancreatic Polypeptide Human genes 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 102100037505 Secretin Human genes 0.000 description 3
- 108010086019 Secretin Proteins 0.000 description 3
- 108010056088 Somatostatin Proteins 0.000 description 3
- 102000005157 Somatostatin Human genes 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 241000282887 Suidae Species 0.000 description 3
- 241000282898 Sus scrofa Species 0.000 description 3
- 101000983124 Sus scrofa Pancreatic prohormone precursor Proteins 0.000 description 3
- 210000001744 T-lymphocyte Anatomy 0.000 description 3
- 102400000336 Thyrotropin-releasing hormone Human genes 0.000 description 3
- 101800004623 Thyrotropin-releasing hormone Proteins 0.000 description 3
- 101800001810 Urotensin-1 Proteins 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- XKMLYUALXHKNFT-RHXYWGNOSA-N [[(2r,3s,4r,5r)-5-(2-amino-6-oxo-3h-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] dihydroxyphosphoryl hydrogen phosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)O[32P](O)(O)=O)[C@@H](O)[C@H]1O XKMLYUALXHKNFT-RHXYWGNOSA-N 0.000 description 3
- 235000011054 acetic acid Nutrition 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 229960005305 adenosine Drugs 0.000 description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 108010005774 beta-Galactosidase Proteins 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 230000000975 bioactive effect Effects 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 3
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 3
- 229960004015 calcitonin Drugs 0.000 description 3
- 239000001506 calcium phosphate Substances 0.000 description 3
- 229910000389 calcium phosphate Inorganic materials 0.000 description 3
- 235000011010 calcium phosphates Nutrition 0.000 description 3
- 229930003827 cannabinoid Natural products 0.000 description 3
- 239000003557 cannabinoid Substances 0.000 description 3
- 150000007942 carboxylates Chemical class 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 230000004663 cell proliferation Effects 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 235000013330 chicken meat Nutrition 0.000 description 3
- 229940107137 cholecystokinin Drugs 0.000 description 3
- 210000004748 cultured cell Anatomy 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 239000003398 denaturant Substances 0.000 description 3
- 229960003638 dopamine Drugs 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 238000005194 fractionation Methods 0.000 description 3
- 239000012737 fresh medium Substances 0.000 description 3
- PUBCCFNQJQKCNC-XKNFJVFFSA-N gastrin-releasingpeptide Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)C1=CNC=N1 PUBCCFNQJQKCNC-XKNFJVFFSA-N 0.000 description 3
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 3
- 229960004666 glucagon Drugs 0.000 description 3
- 229960002743 glutamine Drugs 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 210000001320 hippocampus Anatomy 0.000 description 3
- 229960001340 histamine Drugs 0.000 description 3
- 102000057996 human GNRHR Human genes 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 150000002617 leukotrienes Chemical class 0.000 description 3
- 238000001638 lipofection Methods 0.000 description 3
- 210000002540 macrophage Anatomy 0.000 description 3
- 210000004962 mammalian cell Anatomy 0.000 description 3
- 210000004216 mammary stem cell Anatomy 0.000 description 3
- 229960003987 melatonin Drugs 0.000 description 3
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 3
- SLZIZIJTGAYEKK-CIJSCKBQSA-N molport-023-220-247 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)CN)[C@@H](C)O)C1=CNC=N1 SLZIZIJTGAYEKK-CIJSCKBQSA-N 0.000 description 3
- URPYMXQQVHTUDU-OFGSCBOVSA-N nucleopeptide y Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 URPYMXQQVHTUDU-OFGSCBOVSA-N 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 108060005714 orexin Proteins 0.000 description 3
- XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 description 3
- 229960001723 oxytocin Drugs 0.000 description 3
- 238000007911 parenteral administration Methods 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 108010055752 phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide Proteins 0.000 description 3
- 210000002826 placenta Anatomy 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 102000054765 polymorphisms of proteins Human genes 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000003449 preventive effect Effects 0.000 description 3
- 235000019260 propionic acid Nutrition 0.000 description 3
- 150000003180 prostaglandins Chemical class 0.000 description 3
- 210000002307 prostate Anatomy 0.000 description 3
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 3
- 238000003127 radioimmunoassay Methods 0.000 description 3
- 238000003753 real-time PCR Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 229960002101 secretin Drugs 0.000 description 3
- OWMZNFCDEHGFEP-NFBCVYDUSA-N secretin human Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(N)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)C1=CC=CC=C1 OWMZNFCDEHGFEP-NFBCVYDUSA-N 0.000 description 3
- 239000008159 sesame oil Substances 0.000 description 3
- 235000011803 sesame oil Nutrition 0.000 description 3
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 3
- 210000002027 skeletal muscle Anatomy 0.000 description 3
- NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 description 3
- 229960000553 somatostatin Drugs 0.000 description 3
- 210000004989 spleen cell Anatomy 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 210000003523 substantia nigra Anatomy 0.000 description 3
- 239000000829 suppository Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- RZWIIPASKMUIAC-VQTJNVASSA-N thromboxane Chemical compound CCCCCCCC[C@H]1OCCC[C@@H]1CCCCCCC RZWIIPASKMUIAC-VQTJNVASSA-N 0.000 description 3
- 210000001541 thymus gland Anatomy 0.000 description 3
- 210000001685 thyroid gland Anatomy 0.000 description 3
- 230000005030 transcription termination Effects 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 230000009261 transgenic effect Effects 0.000 description 3
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 3
- 241001430294 unidentified retrovirus Species 0.000 description 3
- PSHRXNWYHPYFQX-OXFOZPMTSA-N urotensin i Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(N)=O)CC1=CC=C(O)C=C1 PSHRXNWYHPYFQX-OXFOZPMTSA-N 0.000 description 3
- 210000004291 uterus Anatomy 0.000 description 3
- 108010071559 vasotocin receptor Proteins 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- PLVPPLCLBIEYEA-WAYWQWQTSA-N (z)-3-(1h-indol-3-yl)prop-2-enoic acid Chemical compound C1=CC=C2C(\C=C/C(=O)O)=CNC2=C1 PLVPPLCLBIEYEA-WAYWQWQTSA-N 0.000 description 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- TVZGACDUOSZQKY-LBPRGKRZSA-N 4-aminofolic acid Chemical compound C1=NC2=NC(N)=NC(N)=C2N=C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 TVZGACDUOSZQKY-LBPRGKRZSA-N 0.000 description 2
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 2
- 229960005508 8-azaguanine Drugs 0.000 description 2
- 102400001318 Adrenomedullin Human genes 0.000 description 2
- 101800004616 Adrenomedullin Proteins 0.000 description 2
- 241000589158 Agrobacterium Species 0.000 description 2
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 241001203868 Autographa californica Species 0.000 description 2
- 210000002237 B-cell of pancreatic islet Anatomy 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- 102000013585 Bombesin Human genes 0.000 description 2
- 108010051479 Bombesin Proteins 0.000 description 2
- 241000186146 Brevibacterium Species 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000701489 Cauliflower mosaic virus Species 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 2
- 102000016950 Chemokine CXCL1 Human genes 0.000 description 2
- 108010014419 Chemokine CXCL1 Proteins 0.000 description 2
- 241000282552 Chlorocebus aethiops Species 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 229920002271 DEAE-Sepharose Polymers 0.000 description 2
- 102000052510 DNA-Binding Proteins Human genes 0.000 description 2
- 101710096438 DNA-binding protein Proteins 0.000 description 2
- SUZLHDUTVMZSEV-UHFFFAOYSA-N Deoxycoleonol Natural products C12C(=O)CC(C)(C=C)OC2(C)C(OC(=O)C)C(O)C2C1(C)C(O)CCC2(C)C SUZLHDUTVMZSEV-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- 108090000204 Dipeptidase 1 Proteins 0.000 description 2
- 241000588722 Escherichia Species 0.000 description 2
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 108010020195 FLAG peptide Proteins 0.000 description 2
- XZWYTXMRWQJBGX-VXBMVYAYSA-N FLAG peptide Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(O)=O)CC1=CC=C(O)C=C1 XZWYTXMRWQJBGX-VXBMVYAYSA-N 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 229930182566 Gentamicin Natural products 0.000 description 2
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 2
- 108010060309 Glucuronidase Proteins 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- 108010070675 Glutathione transferase Proteins 0.000 description 2
- 102000005720 Glutathione transferase Human genes 0.000 description 2
- 239000012981 Hank's balanced salt solution Substances 0.000 description 2
- 101000986765 Homo sapiens Oxytocin receptor Proteins 0.000 description 2
- 101000578940 Homo sapiens PDZ domain-containing protein MAGIX Proteins 0.000 description 2
- 206010062767 Hypophysitis Diseases 0.000 description 2
- 208000026350 Inborn Genetic disease Diseases 0.000 description 2
- 102000036770 Islet Amyloid Polypeptide Human genes 0.000 description 2
- 108010041872 Islet Amyloid Polypeptide Proteins 0.000 description 2
- 108060001084 Luciferase Proteins 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 101710175625 Maltose/maltodextrin-binding periplasmic protein Proteins 0.000 description 2
- 102400001132 Melanin-concentrating hormone Human genes 0.000 description 2
- 101800002739 Melanin-concentrating hormone Proteins 0.000 description 2
- 244000246386 Mentha pulegium Species 0.000 description 2
- 235000016257 Mentha pulegium Nutrition 0.000 description 2
- 235000004357 Mentha x piperita Nutrition 0.000 description 2
- 101100444898 Mus musculus Egr1 gene Proteins 0.000 description 2
- 101100345589 Mus musculus Mical1 gene Proteins 0.000 description 2
- 102400001103 Neurotensin Human genes 0.000 description 2
- 101800001814 Neurotensin Proteins 0.000 description 2
- 244000061176 Nicotiana tabacum Species 0.000 description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 102100028326 PDZ domain-containing protein MAGIX Human genes 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 102000002808 Pituitary adenylate cyclase-activating polypeptide Human genes 0.000 description 2
- 108010004684 Pituitary adenylate cyclase-activating polypeptide Proteins 0.000 description 2
- 102000004211 Platelet factor 4 Human genes 0.000 description 2
- 108090000778 Platelet factor 4 Proteins 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- 239000012980 RPMI-1640 medium Substances 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- 238000002105 Southern blotting Methods 0.000 description 2
- 235000019764 Soybean Meal Nutrition 0.000 description 2
- 241000256248 Spodoptera Species 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 102000002933 Thioredoxin Human genes 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- 101710120037 Toxin CcdB Proteins 0.000 description 2
- 241000255993 Trichoplusia ni Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 108010018369 Urotensin II Proteins 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 2
- 210000004100 adrenal gland Anatomy 0.000 description 2
- ULCUCJFASIJEOE-NPECTJMMSA-N adrenomedullin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)NCC(=O)N[C@@H]1C(N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CSSC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)[C@@H](C)O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 ULCUCJFASIJEOE-NPECTJMMSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 229960003896 aminopterin Drugs 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 230000000692 anti-sense effect Effects 0.000 description 2
- 210000003719 b-lymphocyte Anatomy 0.000 description 2
- 210000003651 basophil Anatomy 0.000 description 2
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 2
- 229940092714 benzenesulfonic acid Drugs 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 102000005936 beta-Galactosidase Human genes 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- DNDCVAGJPBKION-DOPDSADYSA-N bombesin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC=1NC2=CC=CC=C2C=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1NC(=O)CC1)C(C)C)C1=CN=CN1 DNDCVAGJPBKION-DOPDSADYSA-N 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 210000002798 bone marrow cell Anatomy 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 210000001159 caudate nucleus Anatomy 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 210000003710 cerebral cortex Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 210000001612 chondrocyte Anatomy 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 239000013599 cloning vector Substances 0.000 description 2
- OHCQJHSOBUTRHG-UHFFFAOYSA-N colforsin Natural products OC12C(=O)CC(C)(C=C)OC1(C)C(OC(=O)C)C(O)C1C2(C)C(O)CCC1(C)C OHCQJHSOBUTRHG-UHFFFAOYSA-N 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 229940104302 cytosine Drugs 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 229940039227 diagnostic agent Drugs 0.000 description 2
- 239000000032 diagnostic agent Substances 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 210000002889 endothelial cell Anatomy 0.000 description 2
- 210000003979 eosinophil Anatomy 0.000 description 2
- 210000001339 epidermal cell Anatomy 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 239000012894 fetal calf serum Substances 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 210000001652 frontal lobe Anatomy 0.000 description 2
- 239000001530 fumaric acid Substances 0.000 description 2
- 235000011087 fumaric acid Nutrition 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 238000002523 gelfiltration Methods 0.000 description 2
- 208000016361 genetic disease Diseases 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 229960002518 gentamicin Drugs 0.000 description 2
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 210000002149 gonad Anatomy 0.000 description 2
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 210000003494 hepatocyte Anatomy 0.000 description 2
- 210000003630 histaminocyte Anatomy 0.000 description 2
- 235000001050 hortel pimenta Nutrition 0.000 description 2
- 102000052321 human OXTR Human genes 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- 125000002883 imidazolyl group Chemical group 0.000 description 2
- 210000002865 immune cell Anatomy 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- PLVPPLCLBIEYEA-UHFFFAOYSA-N indoleacrylic acid Natural products C1=CC=C2C(C=CC(=O)O)=CNC2=C1 PLVPPLCLBIEYEA-UHFFFAOYSA-N 0.000 description 2
- 125000001041 indolyl group Chemical group 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical group N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 210000001503 joint Anatomy 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 210000001821 langerhans cell Anatomy 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 208000032839 leukemia Diseases 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 210000003593 megakaryocyte Anatomy 0.000 description 2
- ORRDHOMWDPJSNL-UHFFFAOYSA-N melanin concentrating hormone Chemical compound N1C(=O)C(C(C)C)NC(=O)C(CCCNC(N)=N)NC(=O)CNC(=O)C(C(C)C)NC(=O)C(CCSC)NC(=O)C(NC(=O)C(CCCNC(N)=N)NC(=O)C(NC(=O)C(NC(=O)C(N)CC(O)=O)C(C)O)CCSC)CSSCC(C(=O)NC(CC=2C3=CC=CC=C3NC=2)C(=O)NC(CCC(O)=O)C(=O)NC(C(C)C)C(O)=O)NC(=O)C2CCCN2C(=O)C(CCCNC(N)=N)NC(=O)C1CC1=CC=C(O)C=C1 ORRDHOMWDPJSNL-UHFFFAOYSA-N 0.000 description 2
- 210000003584 mesangial cell Anatomy 0.000 description 2
- 229940098779 methanesulfonic acid Drugs 0.000 description 2
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 210000001616 monocyte Anatomy 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000000663 muscle cell Anatomy 0.000 description 2
- 210000000822 natural killer cell Anatomy 0.000 description 2
- 210000004498 neuroglial cell Anatomy 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- PCJGZPGTCUMMOT-ISULXFBGSA-N neurotensin Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 PCJGZPGTCUMMOT-ISULXFBGSA-N 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 210000000440 neutrophil Anatomy 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 210000000869 occipital lobe Anatomy 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 210000000956 olfactory bulb Anatomy 0.000 description 2
- 210000000963 osteoblast Anatomy 0.000 description 2
- 210000002997 osteoclast Anatomy 0.000 description 2
- 210000004409 osteocyte Anatomy 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- 230000020477 pH reduction Effects 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 210000004976 peripheral blood cell Anatomy 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 210000003635 pituitary gland Anatomy 0.000 description 2
- 229920002704 polyhistidine Polymers 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- XNSAINXGIQZQOO-SRVKXCTJSA-N protirelin Chemical compound NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)CC1=CN=CN1 XNSAINXGIQZQOO-SRVKXCTJSA-N 0.000 description 2
- 210000002637 putamen Anatomy 0.000 description 2
- 229940043131 pyroglutamate Drugs 0.000 description 2
- 239000011535 reaction buffer Substances 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 238000005185 salting out Methods 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 229940076279 serotonin Drugs 0.000 description 2
- 230000019491 signal transduction Effects 0.000 description 2
- 238000002741 site-directed mutagenesis Methods 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 239000004455 soybean meal Substances 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 210000000278 spinal cord Anatomy 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 210000002536 stromal cell Anatomy 0.000 description 2
- 238000012916 structural analysis Methods 0.000 description 2
- 210000001913 submandibular gland Anatomy 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 210000002437 synoviocyte Anatomy 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 210000003478 temporal lobe Anatomy 0.000 description 2
- 229940126585 therapeutic drug Drugs 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 108060008226 thioredoxin Proteins 0.000 description 2
- 229940094937 thioredoxin Drugs 0.000 description 2
- 229940035893 uracil Drugs 0.000 description 2
- HFNHAPQMXICKCF-USJMABIRSA-N urotensin-ii Chemical compound N([C@@H](CC(O)=O)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=2C3=CC=CC=C3NC=2)NC(=O)[C@H](CC=2C=CC=CC=2)NC1=O)C(=O)N[C@@H](C(C)C)C(O)=O)C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)CCC(O)=O)[C@@H](C)O HFNHAPQMXICKCF-USJMABIRSA-N 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
- DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical compound NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 description 1
- 125000006526 (C1-C2) alkyl group Chemical group 0.000 description 1
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 description 1
- HLHSUNWAPXINQU-GQCTYLIASA-N (E)-3-(3,4-dihydroxyphenyl)-N-prop-2-ynylprop-2-enamide Chemical compound OC=1C=C(C=CC=1O)/C=C/C(=O)NCC#C HLHSUNWAPXINQU-GQCTYLIASA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-M 4-hydroxybenzoate Chemical compound OC1=CC=C(C([O-])=O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-M 0.000 description 1
- UJBCLAXPPIDQEE-UHFFFAOYSA-N 5-prop-1-ynyl-1h-pyrimidine-2,4-dione Chemical class CC#CC1=CNC(=O)NC1=O UJBCLAXPPIDQEE-UHFFFAOYSA-N 0.000 description 1
- 101710197633 Actin-1 Proteins 0.000 description 1
- 108060003345 Adrenergic Receptor Proteins 0.000 description 1
- 102000017910 Adrenergic receptor Human genes 0.000 description 1
- 239000000275 Adrenocorticotropic Hormone Substances 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- 108020004491 Antisense DNA Proteins 0.000 description 1
- 108020000948 Antisense Oligonucleotides Proteins 0.000 description 1
- 108020005544 Antisense RNA Proteins 0.000 description 1
- 241000256844 Apis mellifera Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- 101000800130 Bos taurus Thyroglobulin Proteins 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 239000012619 Butyl Sepharose® Substances 0.000 description 1
- 102100032367 C-C motif chemokine 5 Human genes 0.000 description 1
- 102100032366 C-C motif chemokine 7 Human genes 0.000 description 1
- 101710155834 C-C motif chemokine 7 Proteins 0.000 description 1
- QLNSPJMIYWEWNF-UHFFFAOYSA-N CC(C)CCCC(C)CCCC(C)CCCC(C)C.CC(C)CCCC(C)CCCC(C)CCCC(C)C Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C.CC(C)CCCC(C)CCCC(C)CCCC(C)C QLNSPJMIYWEWNF-UHFFFAOYSA-N 0.000 description 1
- 101100327917 Caenorhabditis elegans chup-1 gene Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 108090000994 Catalytic RNA Proteins 0.000 description 1
- 102000053642 Catalytic RNA Human genes 0.000 description 1
- 108010055166 Chemokine CCL5 Proteins 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 101100007328 Cocos nucifera COS-1 gene Proteins 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 229940126062 Compound A Drugs 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 241001517047 Corynebacterium acetoacidophilum Species 0.000 description 1
- 241000186145 Corynebacterium ammoniagenes Species 0.000 description 1
- 241000807905 Corynebacterium glutamicum ATCC 14067 Species 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 102000005636 Cyclic AMP Response Element-Binding Protein Human genes 0.000 description 1
- 108010045171 Cyclic AMP Response Element-Binding Protein Proteins 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 238000000018 DNA microarray Methods 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 1
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
- QRLVDLBMBULFAL-UHFFFAOYSA-N Digitonin Natural products CC1CCC2(OC1)OC3C(O)C4C5CCC6CC(OC7OC(CO)C(OC8OC(CO)C(O)C(OC9OCC(O)C(O)C9OC%10OC(CO)C(O)C(OC%11OC(CO)C(O)C(O)C%11O)C%10O)C8O)C(O)C7O)C(O)CC6(C)C5CCC4(C)C3C2C QRLVDLBMBULFAL-UHFFFAOYSA-N 0.000 description 1
- 101100310856 Drosophila melanogaster spri gene Proteins 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241001131785 Escherichia coli HB101 Species 0.000 description 1
- 241001646716 Escherichia coli K-12 Species 0.000 description 1
- 241001302584 Escherichia coli str. K-12 substr. W3110 Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 108091006102 G beta-gamma complex Proteins 0.000 description 1
- 102000034355 G beta-gamma complex Human genes 0.000 description 1
- 108091008664 GR-P Proteins 0.000 description 1
- 108010093031 Galactosidases Proteins 0.000 description 1
- 108010001498 Galectin 1 Proteins 0.000 description 1
- 102100021736 Galectin-1 Human genes 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 102000002068 Glycopeptides Human genes 0.000 description 1
- 108010015899 Glycopeptides Proteins 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- 102000002812 Heat-Shock Proteins Human genes 0.000 description 1
- 108010004889 Heat-Shock Proteins Proteins 0.000 description 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
- 101150102264 IE gene Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 101000668058 Infectious salmon anemia virus (isolate Atlantic salmon/Norway/810/9/99) RNA-directed RNA polymerase catalytic subunit Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 description 1
- 102000008070 Interferon-gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 241000235649 Kluyveromyces Species 0.000 description 1
- 241001138401 Kluyveromyces lactis Species 0.000 description 1
- 102000008192 Lactoglobulins Human genes 0.000 description 1
- 108010060630 Lactoglobulins Proteins 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- GDBQQVLCIARPGH-UHFFFAOYSA-N Leupeptin Natural products CC(C)CC(NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N GDBQQVLCIARPGH-UHFFFAOYSA-N 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 102000009151 Luteinizing Hormone Human genes 0.000 description 1
- 108010073521 Luteinizing Hormone Proteins 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 240000004658 Medicago sativa Species 0.000 description 1
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 1
- 229940096972 Melanin stimulant Drugs 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000003792 Metallothionein Human genes 0.000 description 1
- 108090000157 Metallothionein Proteins 0.000 description 1
- 241001467578 Microbacterium Species 0.000 description 1
- 241000144155 Microbacterium ammoniaphilum Species 0.000 description 1
- 241000713869 Moloney murine leukemia virus Species 0.000 description 1
- 208000035823 Non-specific autoimmune cerebellar ataxia without characteristic antibodies Diseases 0.000 description 1
- 108010079246 OMPA outer membrane proteins Proteins 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 102400000203 Pancreastatin Human genes 0.000 description 1
- 101800005322 Pancreastatin Proteins 0.000 description 1
- 241000237988 Patellidae Species 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- HCBIBCJNVBAKAB-UHFFFAOYSA-N Procaine hydrochloride Chemical compound Cl.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 HCBIBCJNVBAKAB-UHFFFAOYSA-N 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000589774 Pseudomonas sp. Species 0.000 description 1
- 102000009609 Pyrophosphatases Human genes 0.000 description 1
- 108010009413 Pyrophosphatases Proteins 0.000 description 1
- 229910003797 SPO1 Inorganic materials 0.000 description 1
- 229910003798 SPO2 Inorganic materials 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 101100150136 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) SPO1 gene Proteins 0.000 description 1
- 101000741942 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Serine/threonine-protein phosphatase 2B catalytic subunit A2 Proteins 0.000 description 1
- 241000235088 Saccharomyces sp. Species 0.000 description 1
- 241000235346 Schizosaccharomyces Species 0.000 description 1
- 241000235347 Schizosaccharomyces pombe Species 0.000 description 1
- 101100478210 Schizosaccharomyces pombe (strain 972 / ATCC 24843) spo2 gene Proteins 0.000 description 1
- 241000235005 Schwanniomyces occidentalis var. occidentalis Species 0.000 description 1
- 241000209056 Secale Species 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 108091058545 Secretory proteins Proteins 0.000 description 1
- 102000040739 Secretory proteins Human genes 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- 241000881765 Serratia ficaria Species 0.000 description 1
- 241000218654 Serratia fonticola Species 0.000 description 1
- 241000607717 Serratia liquefaciens Species 0.000 description 1
- 241000607715 Serratia marcescens Species 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 108090000787 Subtilisin Proteins 0.000 description 1
- 241001634922 Tausonia pullulans Species 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 108010022394 Threonine synthase Proteins 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 102000004136 Vasopressin Receptors Human genes 0.000 description 1
- 108090000643 Vasopressin Receptors Proteins 0.000 description 1
- 101710087237 Whey acidic protein Proteins 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical group [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 238000003916 acid precipitation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 102000030621 adenylate cyclase Human genes 0.000 description 1
- 108060000200 adenylate cyclase Proteins 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- 238000005571 anion exchange chromatography Methods 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000003816 antisense DNA Substances 0.000 description 1
- 239000000074 antisense oligonucleotide Substances 0.000 description 1
- 238000012230 antisense oligonucleotides Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 108010030518 arginine endopeptidase Proteins 0.000 description 1
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- 230000000035 biogenic effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 229940065144 cannabinoids Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000005277 cation exchange chromatography Methods 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000007910 cell fusion Effects 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000003399 chemotactic effect Effects 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- YDQXYRCYDMRJGD-UHFFFAOYSA-N chloroform;phenol;thiocyanic acid Chemical compound SC#N.ClC(Cl)Cl.OC1=CC=CC=C1 YDQXYRCYDMRJGD-UHFFFAOYSA-N 0.000 description 1
- 238000011098 chromatofocusing Methods 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000037011 constitutive activity Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 238000000432 density-gradient centrifugation Methods 0.000 description 1
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
- 229960003964 deoxycholic acid Drugs 0.000 description 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- UVYVLBIGDKGWPX-KUAJCENISA-N digitonin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)C[C@@H](O)[C@H](O[C@H]5[C@@H]([C@@H](O)[C@@H](O[C@H]6[C@@H]([C@@H](O[C@H]7[C@@H]([C@@H](O)[C@H](O)CO7)O)[C@H](O)[C@@H](CO)O6)O[C@H]6[C@@H]([C@@H](O[C@H]7[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O7)O)[C@@H](O)[C@@H](CO)O6)O)[C@@H](CO)O5)O)C[C@@H]4CC[C@H]3[C@@H]2[C@@H]1O)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 UVYVLBIGDKGWPX-KUAJCENISA-N 0.000 description 1
- UVYVLBIGDKGWPX-UHFFFAOYSA-N digitonine Natural products CC1C(C2(CCC3C4(C)CC(O)C(OC5C(C(O)C(OC6C(C(OC7C(C(O)C(O)CO7)O)C(O)C(CO)O6)OC6C(C(OC7C(C(O)C(O)C(CO)O7)O)C(O)C(CO)O6)O)C(CO)O5)O)CC4CCC3C2C2O)C)C2OC11CCC(C)CO1 UVYVLBIGDKGWPX-UHFFFAOYSA-N 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 229940000406 drug candidate Drugs 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000013210 evaluation model Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000000630 fibrocyte Anatomy 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 125000005519 fluorenylmethyloxycarbonyl group Chemical group 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000012215 gene cloning Methods 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 101150100658 gpr gene Proteins 0.000 description 1
- 239000006451 grace's insect medium Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 108091008039 hormone receptors Proteins 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 210000003917 human chromosome Anatomy 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000006303 immediate early viral mRNA transcription Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940027941 immunoglobulin g Drugs 0.000 description 1
- 238000011532 immunohistochemical staining Methods 0.000 description 1
- 238000012744 immunostaining Methods 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 229960003130 interferon gamma Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 229940125425 inverse agonist Drugs 0.000 description 1
- 239000001573 invertase Substances 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 238000001155 isoelectric focusing Methods 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000000644 isotonic solution Substances 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 1
- GDBQQVLCIARPGH-ULQDDVLXSA-N leupeptin Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCN=C(N)N GDBQQVLCIARPGH-ULQDDVLXSA-N 0.000 description 1
- 108010052968 leupeptin Proteins 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 229940040129 luteinizing hormone Drugs 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 210000003126 m-cell Anatomy 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229940126619 mouse monoclonal antibody Drugs 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 238000011580 nude mouse model Methods 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 108091008880 orphan GPCRs Proteins 0.000 description 1
- 229940116315 oxalic acid Drugs 0.000 description 1
- RYZUEKXRBSXBRH-CTXORKPYSA-N pancreastatin Chemical compound C([C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)CN)CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O)C1=CN=CN1 RYZUEKXRBSXBRH-CTXORKPYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 101150019841 penP gene Proteins 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229950000964 pepstatin Drugs 0.000 description 1
- 108010091212 pepstatin Proteins 0.000 description 1
- FAXGPCHRFPCXOO-LXTPJMTPSA-N pepstatin A Chemical compound OC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)CC(C)C FAXGPCHRFPCXOO-LXTPJMTPSA-N 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000002205 phenol-chloroform extraction Methods 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 150000008300 phosphoramidites Chemical class 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920000771 poly (alkylcyanoacrylate) Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 229960001309 procaine hydrochloride Drugs 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 108091092562 ribozyme Proteins 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 210000003079 salivary gland Anatomy 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229940098362 serratia marcescens Drugs 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000007974 sodium acetate buffer Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000010532 solid phase synthesis reaction Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000007447 staining method Methods 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 239000008174 sterile solution Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- HHLJUSLZGFYWKW-UHFFFAOYSA-N triethanolamine hydrochloride Chemical compound Cl.OCCN(CCO)CCO HHLJUSLZGFYWKW-UHFFFAOYSA-N 0.000 description 1
- MBYLVOKEDDQJDY-UHFFFAOYSA-N tris(2-aminoethyl)amine Chemical compound NCCN(CCN)CCN MBYLVOKEDDQJDY-UHFFFAOYSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 125000000430 tryptophan group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12 0.000 description 1
- 230000002227 vasoactive effect Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 235000021249 α-casein Nutrition 0.000 description 1
- 235000021247 β-casein Nutrition 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、ヒト視床由来の新
規G蛋白質共役型受容体ポリペプチド、該ポリペプチド
の部分ペプチド、該ポリペプチドまたは該部分ペプチド
をコードするDNA、該DNAが組み込まれた組換え体
ベクター、該組換え体ベクターを保有する形質転換体、
該ポリペプチドまたは該部分ペプチドの製造方法、該ポ
リペプチドを認識する抗体、該ポリペプチドまたは該部
分ペプチドを用いた該ポリペプチドのリガンド、アゴニ
スト、アンタゴニストまたは機能修飾物質のスクリーニ
ング方法、該ポリペプチドまたは該部分ペプチドを含有
する該ポリペプチドのリガンド、アゴニスト、アンタゴ
ニストまたは機能修飾物質のスクリーニング用キット、
該スクリーニング方法またはスクリーニング用キットに
よって得られる化合物またはその薬理学的に許容される
塩、該ポリペプチドをコードする遺伝子を欠損または一
部改変した動物とその利用方法に関する。TECHNICAL FIELD The present invention relates to a novel G protein-coupled receptor polypeptide derived from the human thalamus, a partial peptide of the polypeptide, a DNA encoding the polypeptide or the partial peptide, and the DNA incorporated therein. A recombinant vector, a transformant carrying the recombinant vector,
A method for producing the polypeptide or the partial peptide, an antibody recognizing the polypeptide, a method for screening a ligand, agonist, antagonist or functional modifier of the polypeptide using the polypeptide or the partial peptide, the polypeptide or A kit for screening a ligand, agonist, antagonist or functional modifier of the polypeptide containing the partial peptide,
The present invention relates to a compound obtained by the screening method or the screening kit or a pharmacologically acceptable salt thereof, an animal deficient or partially modified in a gene encoding the polypeptide, and a method of using the same.
【0002】[0002]
【従来の技術】G蛋白質共役型受容体(以下、GPCR
と略すこともある)は、生体の細胞や臓器の各機能細胞
表面に存在し、生体の細胞や臓器の機能を調節する分
子、例えばホルモン、神経伝達物質および生理活性物質
等の受容体として機能することで、生理学的または病態
学的に非常に重要な役割を担っている。GPCRは、
光、味物質、匂い物質などの受容体としても機能してい
る。GPCRの具体的なリガンドとしては、蛋白質、ペ
プチド、生体アミン、脂質メディエータ、光子、カルシ
ウム、糖、核酸など多種多様のものが知られている。ヘ
テロ三量体(Gα、Gβγ)のG蛋白質(guanine nucl
eotide-binding protein)と共役し、G蛋白質の活性化
を通して細胞内にシグナルを伝達する。GPCRは7個
の膜貫通領域を有することから、7回膜貫通型受容体と
も呼ばれる。2. Description of the Related Art G protein-coupled receptors (hereinafter, GPCRs)
Is sometimes present on the surface of each functional cell in living cells and organs and functions as a receptor for molecules that regulate the function of living cells and organs, such as hormones, neurotransmitters, and biologically active substances. In doing so, it plays a very important role physiologically or pathologically. GPCRs are
It also functions as a receptor for light, taste substances, and odor substances. As specific ligands for GPCRs, a wide variety of proteins, peptides, biogenic amines, lipid mediators, photons, calcium, sugars, nucleic acids and the like are known. Heterotrimeric (G α, G βγ) G protein (guanine nucl
EOtide-binding protein) and transmits a signal into cells through activation of G protein. GPCRs are also called seven transmembrane receptors because they have seven transmembrane domains.
【0003】GPCRは創薬ターゲットとして非常にす
ぐれており、これまでにGPCRの天然リガンド、アゴ
ニストまたはアンタゴニストが薬となっている。現在上
市されている薬の約60%はGPCRをターゲットにし
たものである。GPCRは遺伝病の原因にもなってお
り、遺伝病の診断や治療においても重要なターゲットで
ある〔Trends in Pharmacological Science, 18, 430
(1984)〕。[0003] GPCRs are excellent targets for drug discovery, and natural ligands, agonists or antagonists of GPCRs have been used as drugs so far. Approximately 60% of currently marketed drugs target GPCRs. GPCRs also cause genetic diseases and are important targets in the diagnosis and treatment of genetic diseases [Trends in Pharmacological Science, 18 , 430
(1984)].
【0004】したがって、新規なGPCRを取得し、そ
の機能解析を行うことは、その機能と密接に関連した医
薬品開発を行う上で、非常に有用な手段を提供する。例
えば、脳などの中枢神経系の器官においては、多くのホ
ルモン、ホルモン様物質、神経伝達物質あるいは生理活
性物質などによって、脳の生理的な機能が調節されてい
るが、脳内には未知のホルモン、ホルモン様物質、神経
伝達物質あるいは生理活性物質が存在すると考えられ
る。胃、腸、膵臓などの器官の生理機能も、多くのホル
モン、ホルモン様物質、神経伝達物質あるいは生理活性
物質などによって調節されていることが知られており、
胃、腸、膵臓などの器官には未知のホルモン、ホルモン
様物質、神経伝達物質あるいは生理活性物質が存在する
と考えられる。脳、胃、腸、膵臓などの器官において
は、上記のホルモン、ホルモン様物質、神経伝達物質あ
るいは生理活性物質に対応する受容体(例えばGPC
R)が存在していることも知られているが、これらの器
官には未知の受容体(例えばGPCR)も存在すると考
えられる。既知GPCRについても、新たなサブタイプ
が存在する可能性もある。Therefore, obtaining a novel GPCR and analyzing its function provides a very useful means for developing a drug closely related to its function. For example, in the central nervous system organs such as the brain, the physiological functions of the brain are regulated by many hormones, hormone-like substances, neurotransmitters or biologically active substances, but unknown in the brain. It is thought that hormones, hormone-like substances, neurotransmitters or bioactive substances are present. It is known that the physiological functions of organs such as the stomach, intestine, and pancreas are also regulated by many hormones, hormone-like substances, neurotransmitters or bioactive substances,
It is thought that unknown hormones, hormone-like substances, neurotransmitters or biologically active substances exist in organs such as the stomach, intestine and pancreas. In organs such as the brain, stomach, intestine, and pancreas, receptors (eg, GPC) corresponding to the above hormones, hormone-like substances, neurotransmitters or bioactive substances
R) is also known to be present, but it is likely that unknown receptors (eg, GPCRs) also exist in these organs. New subtypes may also exist for known GPCRs.
【0005】脳、胃、腸、膵臓において発現している新
規なGPCR遺伝子を取得できれば、該GPCRのアミ
ノ酸配列と既知GPCRのアミノ酸配列とを比較した
り、該GPCR遺伝子の転写物の発現分布を調べること
により、該GPCRの機能を推定し、医薬品開発に有用
な情報を得ることができる。また、新規GPCR遺伝子
が取得できれば、該GPCRに対する天然リガンド、ア
ゴニスト、またはアンタゴニストを効率よくスクリーニ
ングすることが可能になる。該天然リガンド、アゴニス
ト、またはアンタゴニストは医薬品として期待される。[0005] If a novel GPCR gene expressed in the brain, stomach, intestine, and pancreas can be obtained, the amino acid sequence of the GPCR can be compared with the amino acid sequence of a known GPCR, and the expression distribution of the transcript of the GPCR gene can be determined. By investigating, the function of the GPCR can be estimated and useful information for drug development can be obtained. In addition, if a new GPCR gene can be obtained, a natural ligand, agonist or antagonist for the GPCR can be efficiently screened. The natural ligand, agonist or antagonist is expected as a pharmaceutical.
【0006】[0006]
【発明が解決しようとする課題】これまで知られていな
いG蛋白質共役型受容体ポリペプチドおよび該ポリペプ
チドをコードするDNAが得られれば、該ポリペプチド
のリガンド、アゴニスト、アンタゴニストまたは機能修
飾物質のスクリーニングが可能になり、該スクリーニン
グによって得られる物質は医薬品として有用である。If a G protein-coupled receptor polypeptide and a DNA encoding the polypeptide, which have not been known, can be obtained, a ligand, an agonist, an antagonist or a function modifying substance of the polypeptide may be obtained. Screening becomes possible, and substances obtained by the screening are useful as pharmaceuticals.
【0007】本発明は、ヒト視床由来の新規G蛋白質共
役型受容体ポリペプチドまたはその部分ペプチド、該ポ
リペプチドまたは該部分ペプチドをコードするDNA、
該DNAを含有する組換えベクター、該組換えベクター
を保持する形質転換体、該ポリペプチドまたは該部分ペ
プチドの製造方法、該ポリペプチドに対するリガンド、
アゴニスト、アンタゴニストまたは機能修飾物質のスク
リーニング方法およびスクリーニング用キット、該スク
リーニング方法および該スクリーニングキットを用いて
得られるリガンド、アゴニスト、アンタゴニストまたは
機能修飾物質と該リガンド、アゴニスト、アンタゴニス
トまたは機能修飾物質を含有する医薬、および該ポリペ
プチドまたはその部分ペプチドに対する抗体などを提供
することを目的としている。The present invention relates to a novel G protein-coupled receptor polypeptide derived from the human thalamus or a partial peptide thereof, a DNA encoding the polypeptide or the partial peptide,
A recombinant vector containing the DNA, a transformant carrying the recombinant vector, a method for producing the polypeptide or the partial peptide, a ligand for the polypeptide,
Screening method and screening kit for agonist, antagonist or function modifying substance, containing the screening method and ligand, agonist, antagonist or function modifying substance obtained by using the screening kit and said ligand, agonist, antagonist or function modifying substance It is intended to provide a drug, an antibody against the polypeptide or a partial peptide thereof, and the like.
【0008】[0008]
【課題を解決するための手段】本発明者らは、鋭意研究
を重ねた結果、ヒト胃癌細胞株 KATOIII由来のcDNA
ライブラリーの各cDNAクローンの配列をランダムに
シークエンスすることにより、これまでに知られていな
かった新規なGPCRの一部をコードするcDNAを単
離することに成功した。該cDNAはC末端部分を欠失
していたため、該新規GPCRポリペプチド全長をコー
ドするcDNAをヒト視床より取得し、全塩基配列を決
定・解析することにより、本発明を完成するに至った。Means for Solving the Problems The present inventors have conducted intensive studies and found that cDNA derived from human gastric cancer cell line KATOIII was used.
By randomly sequencing the sequence of each cDNA clone in the library, a cDNA encoding a portion of a novel GPCR that was previously unknown was successfully isolated. Since the cDNA lacked the C-terminal portion, the present invention was completed by obtaining a cDNA encoding the full length of the novel GPCR polypeptide from the human thalamus and determining and analyzing the entire nucleotide sequence.
【0009】本発明は、以下の(1)〜(35)に関す
る。 (1) 配列番号1に記載のアミノ酸配列を有するG蛋
白質共役型受容体ポリペプチド。 (2) 配列番号1に記載のポリペプチドのアミノ酸配
列において、1個以上のアミノ酸が欠失、置換若しくは
付加したアミノ酸配列を有するポリペプチドであり、か
つ(1)に記載のポリペプチドと実質的に同一の活性を
有するポリペプチド。 (3) (1)または(2)に記載のG蛋白質共役型受
容体ポリペプチドの部分ペプチドであり、かつ該ポリペ
プチドのリガンド、アゴニスト、アンタゴニストまたは
機能修飾物質との結合能を有する部分ペプチド。 (4) (1)または(2)に記載のG蛋白質共役型受
容体ポリペプチドをコードするDNA。 (5) 配列番号2に記載のDNA中において、塩基番
号175〜1287番で表される塩基配列を有するDN
A。 (6) (4)または(5)に記載のDNAから選ばれ
るDNAとストリンジェントな条件下でハイブリダイズ
するDNAであり、かつ(1)に記載のG蛋白質共役型
受容体ポリペプチドと実質的に同一の活性を有するポリ
ペプチドをコードするDNA。 (7) (3)に記載のG蛋白質共役型受容体ポリペプ
チドの部分ペプチドをコードするDNA。 (8) (6)に記載のDNAにコードされるポリペプ
チドの部分ペプチドをコードするDNAであり、かつ
(1)または(2)に記載のポリペプチドのリガンド、
アゴニスト、アンタゴニストまたは機能修飾物質との結
合能を有する部分ペプチドをコードするDNA。 (9) (4)〜(8)のいずれか1つに記載のDNA
をベクターに組込んで得られる組換え体DNA。 (10) (9)に記載の組換え体DNAを保有する形
質転換細胞、形質転換植物または形質転換非ヒト動物。 (11) (10)に記載の形質転換細胞、形質転換植
物または形質転換非ヒト動物を用い、(i)該形質転換
細胞を培地中で培養し該培養物中に、(ii)該形質転換
植物を栽培し該植物中に、または(iii)該形質転換非
ヒト動物を飼育し該動物中に、(1)または(2)に記
載のポリペプチドまたは(3)に記載の部分ペプチドを
生成蓄積させ、該培養物、該植物または該動物から該ポ
リペプチドまたは該部分ペプチドを採取することを特徴
とする、(1)または(2)に記載のポリペプチドまた
は(3)に記載のペプチドの製造方法。 (12) (1)または(2)に記載のポリペプチド、
または(3)に記載の部分ペプチドを認識する抗体。 (13) (12)に記載の抗体を用いる(1)または
(2)に記載のポリペプチド、または(3)に記載の部
分ペプチドの免疫学的定量方法。 (14) (13)に記載の定量方法を用いる癌、ある
いは視床または小脳の機能異常症の判定方法。 (15) (1)または(2)に記載のポリぺプチドを
コードするmRNA量を測定することによる癌、あるい
は視床または小脳の機能異常症の判定方法。 (16) (1)または(2)に記載のポリぺプチドを
コードする遺伝子の欠失、置換または付加を検出するこ
とによる癌、あるいは視床または小脳の機能異常症の判
定方法。 (17) (1)または(2)に記載のポリペプチド、
または(3)に記載の部分ペプチドと、被験試料とを接
触させ、被験試料より(1)または(2)に記載のポリ
ペプチドのリガンド、アゴニスト、アンタゴニストまた
は機能修飾物質を選択することを特徴とする、(1)ま
たは(2)に記載のポリペプチドのリガンド、アゴニス
ト、アンタゴニストまたは機能修飾物質のスクリーニン
グ方法。 (18) (1)または(2)に記載のポリペプチド、
または(3)に記載の部分ペプチドを発現する細胞と、
被験試料とを接触させ、被験試料より(1)または
(2)に記載のポリペプチドのリガンド、アゴニスト、
アンタゴニストまたは機能修飾物質を選択することを特
徴とする、(1)または(2)に記載のポリペプチドの
リガンド、アゴニスト、アンタゴニストまたは機能修飾
物質のスクリーニング方法。 (19) (i)(1)または(2)に記載のポリペプ
チド、または(3)に記載の部分ペプチドと、リガンド
とを接触させた場合と(ii)(1)または(2)に記載
のポリペプチド、または(3)に記載の部分ペプチド
と、リガンドおよび被験試料とを接触させた場合とを比
較し、被験試料より(1)または(2)に記載のポリペ
プチドのアゴニスト、アンタゴニストまたは機能修飾物
質を選択することを特徴とする、(1)または(2)に
記載のポリペプチドのアゴニスト、アンタゴニストまた
は機能修飾物質のスクリーニング方法。 (20) (i)(1)または(2)に記載のポリペプ
チド、または(3)に記載の部分ペプチドを発現する細
胞と、リガンドとを接触させた場合と(ii)(1)また
は(2)に記載のポリペプチド、または(3)に記載の
部分ペプチドを発現する細胞と、リガンドおよび被験試
料とを接触させた場合とを比較し、被験試料より(1)
または(2)に記載のポリペプチドのアゴニスト、アン
タゴニストまたは機能修飾物質を選択することを特徴と
する、(1)または(2)に記載のポリペプチドのアゴ
ニスト、アンタゴニストまたは機能修飾物質のスクリー
ニング方法。 (21) (1)または(2)に記載のポリペプチド、
または(3)に記載の部分ペプチドを含有することを特
徴とする、(1)または(2)に記載のポリペプチドの
リガンド、アゴニスト、アンタゴニストまたは機能修飾
物質のスクリーニング用キット。 (22) (17)〜(20)に記載のスクリーニング
方法、または(21)に記載のスクリーニング用キット
を用いて得られる、(1)または(2)に記載のポリペ
プチドのリガンド、アゴニスト、アンタゴニストまたは
機能修飾物質、またはその薬理学的に許容される塩。 (23) (12)に記載の抗体、(22)に記載のリ
ガンド、アゴニスト、アンタゴニストおよび機能修飾物
質から選ばれる物質、またはその薬理学的に許容される
塩を含有する、癌、あるいは視床または小脳の機能異常
症の治療薬。 (24) (i)(1)または(2)に記載のポリペプ
チドを発現する細胞と、(ii)(1)または(2)に記
載のポリペプチドを発現する細胞と被験試料とを接触さ
せた場合とを比較し、被験試料より(1)または(2)
に記載のポリペプチドをコードする遺伝子の発現を変動
させる化合物を選択することを特徴とする、(1)また
は(2)に記載のポリペプチドをコードするDNAの発
現量を変動させる化合物のスクリーニング方法。 (25) 発現量の変動を、(13)に記載の方法、ま
たは(1)または(2)に記載のポリペプチドをコード
するmRNA量を定量する方法で測定することを特徴と
する、(24)に記載のスクリーニング方法。 (26) (1)または(2)に記載のポリペプチドを
コードする遺伝子の転写を制御する領域の下流にレポー
ター遺伝子の連結されたDNAを含有する形質転換体と
被験試料とを接触させ、被験試料より(1)または
(2)に記載のポリペプチドをコードするDNAの発現
量を変動させる化合物を選択することを特徴とする、
(1)または(2)に記載のポリペプチドをコードする
遺伝子の発現量を変動させる化合物のスクリーニング方
法。 (27) 転写を制御する領域が、配列番号15の20
202〜25202番目の塩基配列で表わされるDNA
中の連続する50〜5000bpの塩基配列を有するD
NAで規定される領域である、(26)に記載のスクリ
ーニング方法。 (28) (24)〜(27)のいずれか1つに記載の
スクリーニング方法によって得られる化合物またはその
薬理学的に許容される塩。 (29) (28)に記載の化合物またはその薬理学的
に許容される塩を含有する、癌、あるいは視床または小
脳の機能異常症の治療薬。 (30) (4)〜(6)に記載のDNAおよび配列番
号2に記載のDNAから選ばれるDNAの塩基配列中の
連続した5〜60塩基と同じ配列を有するオリゴヌクレ
オチド、該オリゴヌクレオチドと相補的な配列を有する
オリゴヌクレオチド、およびこれらオリゴヌクレオチド
のオリゴヌクレオチド誘導体から選ばれるDNA。 (31) (4)〜(6)および(30)に記載のDN
Aから選ばれるDNAを用い、(1)または(2)に記
載のポリペプチドをコードするDNAの転写またはmR
NAの翻訳を抑制する方法。 (32) (1)または(2)に記載のポリペプチドを
コードするDNAを含む遺伝子の全部または一部が欠損
または置換し、(1)または(2)に記載のポリペプチ
ドの発現量が変化した遺伝子欠失または置換非ヒト動
物。 (33) (32)に記載の動物に被験試料を接種、ま
たは該動物の臓器、組織あるいは細胞と、被験試料とを
接触させ、被験試料より、癌、あるいは視床または小脳
の機能異常症の治療薬を選択することを特徴とする、
癌、あるいは視床または小脳の機能異常症の治療薬のス
クリーニング方法。 (34) (33)に記載のスクリーニング方法で得ら
れる化合物またはその薬理学的に許容される塩。 (35) (34)に記載の化合物またはその薬理学的
に許容される塩を含有する、癌、あるいは視床または小
脳の機能異常症の治療薬。The present invention relates to the following (1) to (35). (1) A G protein-coupled receptor polypeptide having the amino acid sequence of SEQ ID NO: 1. (2) a polypeptide having an amino acid sequence in which one or more amino acids have been deleted, substituted or added in the amino acid sequence of the polypeptide described in SEQ ID NO: 1, and substantially the same as the polypeptide described in (1) A polypeptide having the same activity as (3) A partial peptide which is a partial peptide of the G protein-coupled receptor polypeptide according to (1) or (2), and has a binding ability to a ligand, agonist, antagonist or functional modifier of the polypeptide. (4) A DNA encoding the G protein-coupled receptor polypeptide according to (1) or (2). (5) DN having a base sequence represented by base numbers 175 to 1287 in the DNA set forth in SEQ ID NO: 2.
A. (6) A DNA that hybridizes under stringent conditions with a DNA selected from the DNAs of (4) or (5), and substantially the same as the G protein-coupled receptor polypeptide of (1). DNA encoding a polypeptide having the same activity as the above. (7) A DNA encoding a partial peptide of the G protein-coupled receptor polypeptide according to (3). (8) a DNA encoding a partial peptide of the polypeptide encoded by the DNA according to (6), and the ligand of the polypeptide according to (1) or (2);
DNA encoding a partial peptide capable of binding to an agonist, antagonist, or function modifying substance. (9) The DNA according to any one of (4) to (8)
And a recombinant DNA obtained by incorporating the DNA into a vector. (10) A transformed cell, transformed plant or transformed non-human animal having the recombinant DNA according to (9). (11) Using the transformed cell, transformed plant or transformed non-human animal according to (10), (i) culturing the transformed cell in a medium, and (ii) performing the transformation in the culture. Cultivating a plant, and (iii) breeding the transformed non-human animal to produce the polypeptide according to (1) or (2) or the partial peptide according to (3) in the animal Collecting the polypeptide or the partial peptide from the culture, the plant or the animal, and collecting the polypeptide or the peptide according to (1) or (2). Production method. (12) The polypeptide according to (1) or (2),
Or an antibody that recognizes the partial peptide according to (3). (13) The method for immunologically quantifying the polypeptide according to (1) or (2) or the partial peptide according to (3) using the antibody according to (12). (14) A method for determining cancer or dysfunction of the thalamus or cerebellum using the quantification method according to (13). (15) A method for determining cancer or dysfunction of the thalamus or cerebellum by measuring the amount of mRNA encoding the polypeptide according to (1) or (2). (16) A method for determining cancer, or dysfunction of the thalamus or cerebellum by detecting deletion, substitution or addition of the gene encoding the polypeptide according to (1) or (2). (17) the polypeptide according to (1) or (2),
Alternatively, the partial peptide according to (3) is brought into contact with a test sample, and a ligand, agonist, antagonist or function-modifying substance of the polypeptide according to (1) or (2) is selected from the test sample. A method for screening for a ligand, agonist, antagonist or function modifying substance of the polypeptide according to (1) or (2). (18) the polypeptide according to (1) or (2),
Or a cell expressing the partial peptide according to (3),
A test sample is brought into contact with the test sample, and a ligand, an agonist of the polypeptide according to (1) or (2),
A method for screening for a ligand, agonist, antagonist or function-modifying substance of a polypeptide according to (1) or (2), which comprises selecting an antagonist or a function-modifying substance. (19) (i) The polypeptide according to (1) or (2) or the partial peptide according to (3) is brought into contact with a ligand and (ii) the polypeptide according to (1) or (2). Or the partial peptide described in (3) is compared with the case where the ligand and the test sample are brought into contact with each other, and the agonist, antagonist, or antagonist of the polypeptide described in (1) or (2) is compared with the test sample. A method for screening a polypeptide agonist, antagonist or function-modifying substance according to (1) or (2), which comprises selecting a function-modifying substance. (20) (i) contacting a cell that expresses the polypeptide according to (1) or (2) or the partial peptide according to (3) with a ligand; and (ii) (1) or ( A cell expressing the polypeptide according to 2) or the partial peptide according to (3) is compared with a case where a ligand and a test sample are brought into contact with each other.
Alternatively, the method for screening for an agonist, antagonist or function modifying substance of the polypeptide according to (1) or (2), comprising selecting an agonist, antagonist or function modifying substance for the polypeptide according to (2). (21) the polypeptide according to (1) or (2),
Or a kit for screening a ligand, agonist, antagonist or function-modifying substance of the polypeptide according to (1) or (2), which comprises the partial peptide according to (3). (22) A ligand, agonist, or antagonist of the polypeptide according to (1) or (2), which is obtained by using the screening method according to (17) to (20) or the screening kit according to (21). Or a function modifier, or a pharmacologically acceptable salt thereof. (23) A cancer or a thalamus containing a substance selected from the antibody according to (12), the ligand, agonist, antagonist and function-modifying substance according to (22), or a pharmacologically acceptable salt thereof. Drugs for cerebellar dysfunction. (24) (i) Contacting a cell expressing the polypeptide of (1) or (2) with (ii) a cell expressing the polypeptide of (1) or (2) and a test sample. (1) or (2) from the test sample
A method for screening a compound that changes the expression level of a DNA encoding the polypeptide according to (1) or (2), which comprises selecting a compound that alters the expression of the gene encoding the polypeptide according to (1). . (25) The method according to (24), wherein the variation in the expression level is measured by the method described in (13) or the method for quantifying the amount of mRNA encoding the polypeptide according to (1) or (2). ). (26) A test sample is brought into contact with a transformant containing a reporter gene-linked DNA downstream of a region controlling transcription of the gene encoding the polypeptide according to (1) or (2), and Selecting from the sample a compound that changes the expression level of the DNA encoding the polypeptide according to (1) or (2),
A method for screening a compound that changes the expression level of a gene encoding the polypeptide according to (1) or (2). (27) The region controlling transcription is 20 of SEQ ID NO: 15.
DNA represented by nucleotide sequence from position 202 to position 25202
Having a continuous base sequence of 50 to 5000 bp
The screening method according to (26), which is a region defined by NA. (28) A compound obtained by the screening method according to any one of (24) to (27) or a pharmacologically acceptable salt thereof. (29) A therapeutic agent for cancer or dysfunction of the thalamus or cerebellum, comprising the compound according to (28) or a pharmacologically acceptable salt thereof. (30) an oligonucleotide having the same sequence as 5 to 60 consecutive bases in the base sequence of a DNA selected from the DNA of (4) and (6) and the DNA of SEQ ID NO: 2, complementary to the oligonucleotide; Selected from oligonucleotides having specific sequences and oligonucleotide derivatives of these oligonucleotides. (31) DN according to (4) to (6) and (30)
Transcription of DNA encoding the polypeptide according to (1) or (2) or mR using a DNA selected from A
A method to suppress translation of NA. (32) All or a part of a gene containing a DNA encoding the polypeptide according to (1) or (2) is deleted or replaced, and the expression level of the polypeptide according to (1) or (2) is changed A non-human animal with a deleted or substituted gene. (33) The animal according to (32) is inoculated with a test sample, or the test sample is brought into contact with an organ, tissue or cell of the animal, and the test sample is used to treat cancer or thalamus or cerebellar dysfunction. Characterized by choosing a drug,
A method for screening a therapeutic agent for cancer or dysfunction of the thalamus or cerebellum. (34) A compound obtained by the screening method according to (33) or a pharmacologically acceptable salt thereof. (35) A therapeutic agent for cancer or dysfunction of the thalamus or cerebellum, comprising the compound according to (34) or a pharmacologically acceptable salt thereof.
【0010】[0010]
【発明の実施の形態】(1)本発明のG蛋白質共役型受
容体ポリペプチドまたはその部分ペプチド 本発明のポリペプチドは、G蛋白質共役型受容体ポリペ
プチドであり、例えば、配列番号1で表わされるアミノ
酸配列を有するポリペプチドまたは該ポリペプチドのア
ミノ酸配列において1個以上のアミノ酸が欠失、置換若
しくは付加されたアミノ酸配列を有するポリペプチドで
あり、かつ配列番号1で表されるアミノ酸配列を有する
ポリペプチドと実質的に同一な活性を有するポリペプチ
ドをあげることができる。BEST MODE FOR CARRYING OUT THE INVENTION (1) G protein-coupled receptor polypeptide of the present invention or a partial peptide thereof The polypeptide of the present invention is a G protein-coupled receptor polypeptide, for example, represented by SEQ ID NO: 1. Or a polypeptide having an amino acid sequence in which one or more amino acids have been deleted, substituted or added in the amino acid sequence of the polypeptide, and having the amino acid sequence represented by SEQ ID NO: 1. A polypeptide having substantially the same activity as the polypeptide can be mentioned.
【0011】本発明のポリペプチドの由来は特に限定さ
れるものではなく、その由来として例えば、ヒトや哺乳
動物(例えば、モルモット、ラット、マウス、ニワト
リ、ウサギ、ブタ、ヒツジ、ウシ、サルなど)の細胞、
あるいは該細胞の存在する組織をあげることができる。The origin of the polypeptide of the present invention is not particularly limited. Examples of the origin include humans and mammals (eg, guinea pig, rat, mouse, chicken, rabbit, pig, sheep, cow, monkey, etc.). Cells,
Alternatively, a tissue in which the cell exists can be mentioned.
【0012】該細胞の具体例としては、脾細胞、神経細
胞、グリア細胞、膵臓β細胞、骨髄細胞、メサンギウム
細胞、ランゲルハンス細胞、表皮細胞、上皮細胞、内皮
細胞、繊維芽細胞、繊維細胞、筋細胞、脂肪細胞、免疫
細胞(例、マクロファージ、T細胞、B細胞、ナチュラ
ルキラー細胞、肥満細胞、好中球、好塩基球、好酸球、
単球)、巨核球、滑膜細胞、軟骨細胞、骨細胞、骨芽細
胞、破骨細胞、乳腺細胞、肝細胞もしくは間質細胞、ま
たはこれら細胞の前駆細胞、幹細胞もしくはガン細胞な
どをあげることができる。また該組織の具体例として
は、脳、脳の各部位(例、嗅球、扁頭核、大脳基底球、
海馬、視床、視床下部、視床下核、大脳皮質、延髄、小
脳、後頭葉、前頭葉、側頭葉、被殻、尾状核、脳染、黒
質)、脊髄、下垂体、胃、膵臓、腎臓、肝臓、生殖腺、
甲状腺、胆のう、骨髄、副腎、皮膚、筋肉、肺、消化
管、血管、心臓、胸腺、脾臓、顎下腺、末梢血、末梢血
球、腸管、前立腺、睾丸、精巣、卵巣、胎盤、子宮、
骨、関節、小腸、大腸、骨格筋などをあげることができ
る。特に、脳や脳の各部位は組織として好ましい。Specific examples of the cells include spleen cells, nerve cells, glial cells, pancreatic β cells, bone marrow cells, mesangial cells, Langerhans cells, epidermal cells, epithelial cells, endothelial cells, fibroblasts, fiber cells, muscle cells Cells, fat cells, immune cells (eg, macrophages, T cells, B cells, natural killer cells, mast cells, neutrophils, basophils, eosinophils,
Monocytes), megakaryocytes, synovial cells, chondrocytes, osteocytes, osteoblasts, osteoclasts, mammary cells, hepatocytes or stromal cells, or precursors, stem cells or cancer cells of these cells Can be. Specific examples of the tissue include the brain, various parts of the brain (eg, olfactory bulb, nucleus pulposus, basal sphere
Hippocampus, thalamus, hypothalamus, hypothalamus nucleus, cerebral cortex, medulla, cerebellum, occipital lobe, frontal lobe, temporal lobe, putamen, caudate nucleus, brain stain, substantia nigra), spinal cord, pituitary gland, stomach, pancreas, Kidneys, liver, gonads,
Thyroid, gall bladder, bone marrow, adrenal gland, skin, muscle, lung, gastrointestinal tract, blood vessels, heart, thymus, spleen, submandibular gland, peripheral blood, peripheral blood cells, intestinal tract, prostate, testicle, testis, ovary, placenta, uterus,
Examples include bones, joints, small intestine, large intestine, and skeletal muscle. In particular, the brain and each part of the brain are preferable as tissues.
【0013】また本発明のポリペプチドは、化学合成に
よって合成されたポリペプチドであってもよい。The polypeptide of the present invention may be a polypeptide synthesized by chemical synthesis.
【0014】上記の1個以上のアミノ酸の欠失、置換若
しくは付加されたアミノ酸配列からなり、かつ配列番号
1で表されるアミノ酸配列を有するポリペプチドと実質
的に同一な活性を有するポリペプチドは、Molecular cl
oning, A laboratory manual, Second Edition.(1989)
(以下、モレキュラー・クローニング第2版と略す)、
Current Protocols in Molecular Biology, John and W
ily & Sons (1987-1997)(以下、カレント・プロトコー
ルズ・イン・モレキュラー・バイオロジーと略す)、Nu
cleic Acids Research, 10, 6487 (1982)、Proc. Natl.
Acad. Sci. USA, 79, 6409 (1982)、Gene, 34, 315 (1
985)、Nucleic Acids Research, 13, 4431 (1985)、Pro
c. Natl. Acad. Sci. USA, 82, 488 (1985)等に記載の
部位特異的変異導入法によりを用いて、例えば配列番号
1で表されるアミノ酸配列を有するポリペプチドをコー
ドするDNAに部位特異的変異を導入することにより取
得することができる。欠失、置換若しくは付加されるア
ミノ酸の数は特に限定されないが、上記の部位特異的変
異法等の周知の方法により欠失、置換若しくは付加でき
る程度の数であり、1〜数十個程度、好ましくは1〜2
0個程度、より好ましくは1〜10個さらに好ましくは
1〜5個である。A polypeptide comprising an amino acid sequence in which one or more amino acids are deleted, substituted or added, and having substantially the same activity as the polypeptide having the amino acid sequence represented by SEQ ID NO: 1 , Molecular cl
oning, A laboratory manual, Second Edition. (1989)
(Hereinafter abbreviated as Molecular Cloning 2nd Edition),
Current Protocols in Molecular Biology, John and W
ily & Sons (1987-1997) (hereinafter abbreviated as Current Protocols in Molecular Biology), Nu
cleic Acids Research, 10 , 6487 (1982), Proc. Natl.
Acad. Sci. USA, 79 , 6409 (1982), Gene, 34 , 315 (1
985), Nucleic Acids Research, 13 , 4431 (1985), Pro
c. Natl. Acad. Sci. USA, 82 , 488 (1985), etc., using a site-directed mutagenesis method, for example, to DNA encoding a polypeptide having the amino acid sequence represented by SEQ ID NO: 1. It can be obtained by introducing a site-specific mutation. The number of amino acids to be deleted, substituted or added is not particularly limited, but is a number that can be deleted, substituted or added by a known method such as the above-described site-directed mutagenesis, and is about 1 to several tens, Preferably 1-2
The number is about 0, more preferably 1 to 10, and still more preferably 1 to 5.
【0015】また、該アミノ酸の欠失、置換若しくは付
加されたアミノ酸配列を有するポリペプチドが配列番号
1に記載のポリペプチドと実質的に同一な活性を有する
には、BLAST〔J. Mol. Biol., 215, 403 (1990)、Nucle
ic acids Research, 25, 3389 (1997)〕、FASTA〔Metho
d in Enzymology, 183, 63 (1990)、Proc. Natl. Acad.
Sci. USA, 85, 2444 (1988)〕等の解析ソフトを用いて
計算したときに、配列番号1で表わされるアミノ酸配列
と約70%以上、好ましくは約80%以上、さらに好ま
しくは約90%以上の相同性を有するアミノ酸配列を有
することが好ましい。In order for a polypeptide having an amino acid sequence in which the amino acid has been deleted, substituted or added to have substantially the same activity as the polypeptide shown in SEQ ID NO: 1, BLAST [J. Mol. Biol. ., 215 , 403 (1990), Nucle
ic acids Research, 25 , 3389 (1997)), FASTA (Metho
d in Enzymology, 183 , 63 (1990), Proc. Natl. Acad.
Sci. USA, 85 , 2444 (1988)], the amino acid sequence represented by SEQ ID NO: 1 is about 70% or more, preferably about 80% or more, more preferably about 90%. It is preferable to have an amino acid sequence having the above homology.
【0016】上記の実質的に同一の活性としては、例え
ば、配列番号1に記載のアミノ酸配列で表されるペプチ
ドの有するリガンド結合活性、シグナル情報伝達作用な
どが挙げられる。実質的に同一とは、それらの活性が性
質的に同一であることを示す。したがって、リガンド結
合活性やシグナル情報伝達作用の程度、蛋白質の分子量
などの量的要素は異なっていてもよい。The above-mentioned substantially identical activities include, for example, a ligand binding activity and a signal information transmitting activity of the peptide represented by the amino acid sequence of SEQ ID NO: 1. Substantially identical indicates that their activities are identical in nature. Therefore, the quantitative factors such as the ligand binding activity, the degree of signal transduction, and the molecular weight of the protein may be different.
【0017】本発明のポリペプチドとして、さらに上記
ポリペプチドにおいて、N末端のメチオニン残基のアミ
ノ基が保護基(例えば、ホルミル基、アセチル基などの
C1-6アシル基など)で保護されているもの、N端側が
生体内で切断され生成したグルタミル基がピログルタミ
ン化したもの、分子内のアミノ酸の側鎖上の置換基(例
えば、−OH、−COOH、アミノ基、イミダゾール
基、インドール基、グアニジノ基など)が適当な保護基
(例えば、ホルミル基、アセチル基などのC1-6アシル
基など)で保護されているもの、あるいは糖鎖が結合し
たいわゆる糖蛋白質などの複合蛋白質なども含まれる。
また、上記ポリペプチドのC末端がアミド(−CONH
2)またはエステル(−COOR)のもの本発明のポリ
ペプチドである。ここでエステル基のRとしては、メチ
ル、エチル、n−プロピル、イソプロピルもしくはn−
ブチルなどのC1-6アルキル基、例えば、シクロペンチ
ル、シクロヘキシルなどのC3-8シクロアルキル基、例
えば、フェニル、α−ナフチルなどのなどのC6-12アリ
ール基、例えば、ベンジル、フェネチルなどのフェニル
−C1-2アルキル基もしくはα−ナフチルメチルなどの
α−ナフチル−C1-2アルキル基などのC7-14アラルキ
ル基のほか、経口用エステルとして汎用されるピバロイ
ルオキシメチルエステルなどであってもよい。本発明の
ポリペプチドがC末端以外にカルボキシル基(またはカ
ルボキシレート)を有している場合、カルボキシル基が
アミド化またはエステル化されているものも本発明のポ
リペプチドに含まれる。この時のエステルとしては、例
えば上記のC末端のエステルなどをあげることができ
る。As the polypeptide of the present invention, further, in the above-mentioned polypeptide, the amino group of the N-terminal methionine residue is protected with a protecting group (for example, a C1-6 acyl group such as a formyl group and an acetyl group). , A glutamyl group formed by cleavage of the N-terminal side in vivo and a pyroglutamate, a substituent on the side chain of an amino acid in the molecule (for example, -OH, -COOH, an amino group, an imidazole group, an indole group, Guanidino group) protected with an appropriate protecting group (eg, a C1-6 acyl group such as a formyl group or an acetyl group), or a complex protein such as a so-called glycoprotein to which a sugar chain is bound. .
Further, the C-terminus of the polypeptide is an amide (-CONH
2 ) or an ester (-COOR) is the polypeptide of the present invention. Here, R of the ester group is methyl, ethyl, n-propyl, isopropyl or n-
C1-6 alkyl groups such as butyl, for example, C3-8 cycloalkyl groups such as cyclopentyl and cyclohexyl, for example, C6-12 aryl groups such as phenyl, α-naphthyl, etc., for example, phenyl-C1 such as benzyl, phenethyl and the like. In addition to a C7-14 aralkyl group such as an -2 alkyl group or an α-naphthyl-C1-2 alkyl group such as α-naphthylmethyl, a pivaloyloxymethyl ester generally used as an oral ester may be used. When the polypeptide of the present invention has a carboxyl group (or carboxylate) other than at the C-terminus, those in which the carboxyl group is amidated or esterified are also included in the polypeptide of the present invention. Examples of the ester at this time include the above-mentioned C-terminal ester and the like.
【0018】本発明のポリペプチドの塩としては、とり
わけ生理学的に許容される酸付加塩が好ましい。この様
な塩としては、例えば無機酸(例えば、塩酸、リン酸、
臭化水素酸、硫酸)との塩、あるいは有機酸(例えば、
酢酸、ギ酸、プロピオン酸、フマル酸、マレイン酸、コ
ハク酸、酒石酸、クエン酸、リンゴ酸、蓚酸、安息香
酸、メタンスルホン酸、ベンゼンスルホン酸)との塩な
どが用いられる。As the salt of the polypeptide of the present invention, a physiologically acceptable acid addition salt is particularly preferable. Such salts include, for example, inorganic acids (eg, hydrochloric acid, phosphoric acid,
Salts with hydrobromic acid, sulfuric acid, or organic acids (for example,
Examples thereof include salts with acetic acid, formic acid, propionic acid, fumaric acid, maleic acid, succinic acid, tartaric acid, citric acid, malic acid, oxalic acid, benzoic acid, methanesulfonic acid, and benzenesulfonic acid.
【0019】本発明の部分ペプチドとは、本発明のポリ
ペプチドの部分ペプチドであり、かつ本発明のポリペプ
チドのリガンド、アゴニスト、アンタゴニストまたは機
能修飾物質との結合能を有するペプチドである。GPC
Rのリガンド結合領域は、細胞外領域、膜貫通領域、あ
るいは細胞外領域と膜貫通領域の両方であることが知ら
れている〔Current Opinion of Cell Biology, 6, 191
(1994)、EMBO J., 18,1723 (1999)〕。したがって、本
発明のポリペプチドのリガンド、アゴニスト、アンタゴ
ニストまたは機能修飾物質との結合能を有する本発明の
部分ペプチドとしては、例えば、該ポリペプチドを発現
している細胞において、該細胞の膜の外に露出している
部分(細胞外領域部分)、あるいは膜結合領域部分を含
む部分ペプチドなどをあげることができる。また、本発
明の部分ペプチドは、個々のドメインを個別に含むペプ
チドでも良いし、複数のドメインを同時に含む部分ペプ
チドでも良い。The partial peptide of the present invention is a partial peptide of the polypeptide of the present invention and a peptide capable of binding to the ligand, agonist, antagonist or functional modifier of the polypeptide of the present invention. GPC
It is known that the ligand binding region of R is an extracellular region, a transmembrane region, or both an extracellular region and a transmembrane region [Current Opinion of Cell Biology, 6 , 191
(1994), EMBO J., 18 , 1723 (1999)]. Therefore, examples of the partial peptide of the present invention having the ability to bind to the ligand, agonist, antagonist, or function-modifying substance of the polypeptide of the present invention include, for example, in the cell expressing the polypeptide, the outside of the cell membrane. (Extracellular region) or a partial peptide containing a membrane-bound region. Further, the partial peptide of the present invention may be a peptide individually containing each domain or a partial peptide containing a plurality of domains simultaneously.
【0020】任意のGPCRの膜結合領域は、既知のG
PCRとのホモロジーを基に予測することができる〔EM
BO J., 12, 1693 (1993)〕。したがって、該方法で予測
した膜結合領域を基に、任意のGPCRの細胞外領域と
細胞内領域を予測することができる。また、ハイドロパ
シー解析(アロカ社より購入した解析ソフトMacMolly3.
5を使用)や膜結合領域予測解析(三井情報開発より購
入した解析ソフトSOSUI system ver1.0/10を使用)を行
うことによっても、任意のGPCRの膜結合領域、細胞
外領域、および細胞内領域を予測することができる。[0020] The membrane-binding region of any GPCR may be a known GPCR.
It can be predicted based on homology with PCR [EM
BO J., 12 , 1693 (1993)]. Therefore, the extracellular region and intracellular region of any GPCR can be predicted based on the membrane-bound region predicted by the method. Hydropathy analysis (analysis software MacMolly3.
5) and the membrane-bound region prediction analysis (using the analysis software SOSUI system ver1.0 / 10 purchased from Mitsui Informational Development) can also be used to determine the membrane-bound region, extracellular region, and intracellular region of any GPCR. The region can be predicted.
【0021】したがって、本発明のポリペプチドに関し
て上記解析を行うことにより、具体的な細胞外領域(親
水性部位)、膜結合領域(疎水性領域)、および細胞内
領域(親水性領域)を予測することができる。Therefore, by performing the above analysis on the polypeptide of the present invention, specific extracellular regions (hydrophilic regions), membrane-bound regions (hydrophobic regions), and intracellular regions (hydrophilic regions) can be predicted. can do.
【0022】具体的には、例えば、配列番号1で表され
るアミノ酸配列を有する本発明のポリペプチドにおいて
は、細胞外領域としては、配列番号1で表わされるアミ
ノ酸配列の第1番目〜第49番目、第107番目〜第1
21番目、第187番目〜第208番目または第298
番目〜第309番目のアミノ酸配列で表される領域をあ
げることができ、また、膜結合領域としては、配列番号
1で表わされるアミノ酸配列の第50番目〜第75番
目、第81番目〜第106番目、第122番目〜第14
7番目、第161番目〜第186番目、第209番目〜
第234番目、第272番目〜第297番目または第3
10番目〜第335番目のアミノ酸配列をで表される領
域をあげることができる。Specifically, for example, in the polypeptide of the present invention having the amino acid sequence represented by SEQ ID NO: 1, the extracellular region includes the first to 49th amino acids of the amino acid sequence represented by SEQ ID NO: 1. , 107th to 1st
21st, 187th to 208th or 298th
And the region represented by the amino acid sequence at positions 50-75 and 81-106 of the amino acid sequence represented by SEQ ID NO: 1. Th, 122nd to 14th
7th, 161st to 186th, 209th to
234th, 272nd to 297th or 3rd
The region represented by the 10th to 335th amino acid sequences can be exemplified.
【0023】本発明の部分ペプチドとして、さらに上記
の部分ペプチドにおいて、N末端のメチオニン残基のア
ミノ基が保護基(例えば、ホルミル基、アセチル基など
のC1-6アシル基など)で保護されているもの、N端側
が生体内で切断され生成したグルタミル基がピログルタ
ミン化したもの、分子内のアミノ酸の側鎖上の置換基
(例えば、−OH、−COOH、アミノ基、イミダゾー
ル基、インドール基、グアニジノ基など)が適当な保護
基(例えば、ホルミル基、アセチル基などのC1-6アシ
ル基など)で保護されているもの、あるいは糖鎖が結合
したいわゆる糖ペプチドなどの複合ペプチドなども含ま
れる。また、上記部分ペプチドのC末端に存在するカル
ボキシル基(−COOH)またはカルボキシレート(−
COO-)が、上記した本発明のポリペプチドと同様、
アミドまたはエステル化されていてもよい。また、本発
明の部分ペプチドがC末端以外にカルボキシル基(また
はカルボキシレート)を有している場合、カルボキシル
基がアミド化またはエステル化されているものも本発明
の部分ペプチドに含まれる。この時のエステルとして
は、例えば上記のC末端のエステルなどがあげれる。本
発明の部分ペプチドの塩としては、とりわけ生理学的に
許容される酸付加塩が好ましい。この様な塩としては、
例えば無機酸(例えば、塩酸、リン酸、臭化水素酸、硫
酸)との塩、あるいは有機酸(例えば、酢酸、ギ酸、プ
ロピオン酸、フマル酸、マレイン酸、コハク酸、酒石
酸、クエン酸、リンゴ酸、蓚酸、安息香酸、メタンスル
ホン酸、ベンゼンスルホン酸)との塩などがあげられ
る。 (2)本発明のG蛋白質共役型受容体ポリペプチドまた
はその部分ペプチドをコードするDNA 本発明のポリペプチドをコードするDNAは、本発明の
ポリペプチドをコードするDNAであればいかなるDN
Aでもよく、具体例として、(a)配列番号2に記載の
塩基配列において塩基番号175〜1287番で表され
る塩基配列を有するDNA、(b)(a)に記載のDN
Aとストリンジェントな条件でハイブリダイズし、かつ
配列番号1に記載のアミノ酸配列を有するポリペプチド
と実質的に同一の活性を有するポリペプチドをコードす
るDNAなどをあげることができる。As the partial peptide of the present invention, further, in the above partial peptide, the amino group of the N-terminal methionine residue is protected by a protecting group (for example, a C1-6 acyl group such as a formyl group or an acetyl group). , A glutamyl group formed by cleavage of the N-terminal side in vivo and a pyroglutamate, a substituent on the side chain of an amino acid in the molecule (for example, -OH, -COOH, an amino group, an imidazole group, an indole group) , A guanidino group or the like) protected with a suitable protecting group (eg, a C1-6 acyl group such as a formyl group or an acetyl group), or a complex peptide such as a so-called glycopeptide having a sugar chain bonded thereto. It is. Further, a carboxyl group (-COOH) or a carboxylate (-
COO -) is, as with the polypeptides of the present invention described above,
It may be amide or esterified. When the partial peptide of the present invention has a carboxyl group (or carboxylate) other than the C-terminus, those in which the carboxyl group is amidated or esterified are also included in the partial peptide of the present invention. Examples of the ester at this time include the above-mentioned C-terminal ester and the like. As the salt of the partial peptide of the present invention, a physiologically acceptable acid addition salt is particularly preferable. Such salts include:
For example, salts with inorganic acids (eg, hydrochloric acid, phosphoric acid, hydrobromic acid, sulfuric acid) or organic acids (eg, acetic acid, formic acid, propionic acid, fumaric acid, maleic acid, succinic acid, tartaric acid, citric acid, apple) Acid, oxalic acid, benzoic acid, methanesulfonic acid, benzenesulfonic acid) and the like. (2) DNA encoding the G protein-coupled receptor polypeptide of the present invention or a partial peptide thereof The DNA encoding the polypeptide of the present invention may be any DNA as long as it encodes the polypeptide of the present invention.
A, and specific examples thereof include (a) DNA having a base sequence represented by base numbers 175 to 1287 in the base sequence represented by SEQ ID NO: 2, and (b) DN having the base sequence represented by (a).
DNA that hybridizes with A under stringent conditions and encodes a polypeptide having substantially the same activity as the polypeptide having the amino acid sequence of SEQ ID NO: 1 can be mentioned.
【0024】上記のストリンジェントな条件下でハイブ
リダイズし、かつ配列番号1に記載のアミノ酸配列を有
するポリペプチドと実質的に同一の活性を有するポリペ
プチドをコードするDNAとは、上記(a)に記載のD
NAをプローブとして、コロニー・ハイブリダイゼーシ
ョン法、プラーク・ハイブリダイゼーション法あるいは
サザンブロットハイブリダイゼーション法等を用いるこ
とにより得られるDNAを意味し、具体的には、コロニ
ーあるいはプラーク由来のDNAを固定化したフィルタ
ーを用いて、0.7〜1.0 mol/LのNaCl存在
下、42〜65℃でハイブリダイゼーションを行った
後、0.1〜2倍濃度のSSC(saline-sodium citrat
e)溶液(1倍濃度のSSC溶液の組成は、150mmol
/L 塩化ナトリウム、15mmol/L クエン酸ナトリウ
ムよりなる)を用い、42〜65℃条件下でフィルター
を洗浄することにより同定できるDNAをあげることが
できる。ハイブリダイゼーションは、モレキュラー・ク
ローニング第2版、カレント・プロトコールズ・イン・
モレキュラー・バイオロジー、DNA Cloning 1: Core Te
chniques, A Practical Approach,Second Edition, Oxf
ord University Press (1995)等に記載されている方法
に準じて行うことができる。ハイブリダイズ可能なDN
Aとしては、具体的にはBLAST、FASTA等の解析ソフトを
用いて計算したときに、上記の(a)に記載のDNAと
少なくとも60%以上の相同性を有するDNA、好まし
くは80%以上の相同性を有するDNA、より好ましく
は95%以上の相同性を有するDNAをあげることがで
きる。The DNA that hybridizes under the above-mentioned stringent conditions and encodes a polypeptide having substantially the same activity as the polypeptide having the amino acid sequence of SEQ ID NO: 1 is the above-mentioned (a). D described in
A DNA obtained by using a colony hybridization method, a plaque hybridization method, a Southern blot hybridization method, or the like with NA as a probe. After hybridization at 42-65 ° C. in the presence of 0.7-1.0 mol / L NaCl, and then 0.1- to 2-fold concentration of SSC (saline-sodium citrat).
e) Solution (The composition of a 1-fold concentration SSC solution is 150 mmol
/ L sodium chloride and 15 mmol / L sodium citrate) and washing the filter under the conditions of 42 to 65 ° C. Hybridization is performed using Molecular Cloning 2nd Edition, Current Protocols in
Molecular biology, DNA Cloning 1: Core Te
chniques, A Practical Approach, Second Edition, Oxf
It can be performed according to the method described in ord University Press (1995) and the like. Hybridizable DN
As A, specifically, a DNA having at least 60% or more homology with the DNA described in (a) above, and preferably 80% or more when calculated using analysis software such as BLAST or FASTA. DNAs having homology, more preferably DNAs having homology of 95% or more can be mentioned.
【0025】本発明の部分ペプチドをコードするDNA
としては、本発明の部分ペプチドをコードするDNAで
あればいかなるものであってもく、具体例として(a)
配列番号2に記載の塩基配列において塩基番号175〜
1287番で表される塩基配列から選ばれる部分塩基配
列を有するDNAであり、かつ配列番号1に記載のアミ
ノ酸配列を有するポリペプチドのリガンド、アゴニス
ト、アンタゴニストまたは機能修飾物質との結合能を有
する部分ペプチドをコードするDNA、(b)本発明の
ポリペプチドをコードするDNAとストリンジェントな
条件でハイブリダイズするDNAを表す塩基配列から選
ばれる部分塩基配列を有するDNAであり、かつ配列番
号1に記載のアミノ酸配列を有するポリペプチドのリガ
ンド、アゴニスト、アンタゴニストまたは機能修飾物質
との結合能を有するペプチドをコードするDNA、をあ
げることができる。DNA encoding the partial peptide of the present invention
May be any DNA as long as it encodes the partial peptide of the present invention, and specific examples thereof include (a)
In the nucleotide sequence of SEQ ID NO: 2,
A DNA having a partial nucleotide sequence selected from the nucleotide sequence represented by No. 1287, and a portion having a binding ability to a ligand, agonist, antagonist or function modifying substance of the polypeptide having the amino acid sequence of SEQ ID NO: 1 A DNA encoding a peptide, (b) a DNA having a partial nucleotide sequence selected from a nucleotide sequence representing a DNA that hybridizes under stringent conditions with a DNA encoding the polypeptide of the present invention, and described in SEQ ID NO: 1. And DNA encoding a peptide capable of binding to a ligand, agonist, antagonist, or function-modifying substance of a polypeptide having the following amino acid sequence.
【0026】本発明の部分ペプチドをコードするDNA
とは、本発明のポリペプチドのリガンド、アゴニスト、
アンタゴニストまたは機能修飾物質との結合能を有す
る、本発明のポリペプチドの部分ペプチドをコードする
DNAであり、例えば、上記(1)に記載の方法で予測
した細胞外領域または膜結合領域を含む部分ペプチドを
コードするDNAをあげることができる。具体的には配
列番号1で表わされるアミノ酸配列の第1番目〜第49
番目、第107番目〜第121番目、第187番目〜第
208番目または第298番目〜第309番目のアミノ
酸配列を有する部分ペプチドをコードするDNAであ
る、配列番号2で表わされる塩基配列の第175番目〜
第321番目、第493番目〜第537番目、第733
番目〜第798番目または第1066番目〜第1101
番目の塩基配列を有するDNAをあげることができる。
また、配列番号1で表わされるアミノ酸配列の第50番
目〜第75番目、第81番目〜第106番目、第122
番目〜第147番目、第161番目〜第186番目、第
209番目〜第234番目、第272番目〜第297番
目または第310番目〜第335番目のアミノ酸配列を
有する部分ペプチドをコードするDNAである、配列番
号2で表される塩基配列の第322番目〜第399番
目、第415番目〜第492番目、第538番目〜第6
15番目、第655番目〜第732番目、第799番目
〜第876番目、第988番目〜第1065番目または
第1102番目〜第1179番目の塩基配列をあげるこ
とができる。また、本発明の部分ペプチドをコードする
DNAは、個々の部分ペプチドを個別にコードするDN
Aであっても良いし、個々の部分ペプチドをコードする
DNAを同時に複数含むDNAであっても良い。DNA encoding the partial peptide of the present invention
Is a ligand, an agonist of the polypeptide of the present invention,
DNA encoding a partial peptide of the polypeptide of the present invention, which is capable of binding to an antagonist or a function-modifying substance, for example, a portion containing an extracellular region or a membrane-bound region predicted by the method described in (1) above. Examples include DNA encoding a peptide. Specifically, the first to 49th amino acid sequences represented by SEQ ID NO: 1
No. 175 of the nucleotide sequence represented by SEQ ID NO: 2, which is a DNA encoding a partial peptide having an amino acid sequence of the 107th to the 121st, the 187th to the 208th or the 298th to the 309th amino acid Th ~
321nd, 493rd to 537th, 733rd
Th to 798 th or 1066 th to 1101 th
And a DNA having the second base sequence.
In addition, the 50th to 75th, the 81st to the 106th, and the 122nd of the amino acid sequence represented by SEQ ID NO: 1.
Is a DNA encoding a partial peptide having an amino acid sequence at positions 147th, 161st to 186th, 209th to 234th, 272th to 297th, or 310th to 335th. No. 322 to No. 399, No. 415 to No. 492, No. 538 to No. 6 of the nucleotide sequence represented by SEQ ID NO: 2.
The 15th, 655th to 732rd, 799th to 876th, 988th to 1065th or 1102th to 1179th base sequences can be mentioned. Further, the DNA encoding the partial peptide of the present invention may be a DNA encoding each partial peptide individually.
A or a DNA containing a plurality of DNAs encoding individual partial peptides at the same time.
【0027】(3)本発明のポリペプチドをコードする
DNAの取得、ならびに該DNAおよびオリゴヌクレオ
チドの製造 本発明のポリペプチドをコードするDNAは、例えば、
ヒトや哺乳動物(例えば、モルモット、ラット、マウ
ス、ニワトリ、ウサギ、ブタ、ヒツジ、ウシ、サルな
ど)のあらゆる細胞(例えば、脾細胞、神経細胞、グリ
ア細胞、膵臓β細胞、骨髄細胞、メサンギウム細胞、ラ
ンゲルハンス細胞、表皮細胞、上皮細胞、内皮細胞、繊
維芽細胞、繊維細胞、筋細胞、脂肪細胞、免疫細胞
(例、マクロファージ、T細胞、B細胞、ナチュラルキ
ラー細胞、肥満細胞、好中球、好塩基球、好酸球、単
球)、巨核球、滑膜細胞、軟骨細胞、骨細胞、骨芽細
胞、破骨細胞、乳腺細胞、肝細胞もしくは間質細胞、ま
たはこれら細胞の前駆細胞、幹細胞もしくはガン細胞な
ど)、またはそれらの細胞が存在するあらゆる組織、例
えば、脳、脳の各部位(例、嗅球、扁頭核、大脳基底
球、海馬、視床、視床下部、視床下核、大脳皮質、延
髄、小脳、後頭葉、前頭葉、側頭葉、被殻、尾状核、脳
染、黒質)、脊髄、下垂体、胃、膵臓、腎臓、肝臓、生
殖腺、甲状腺、胆のう、骨髄、副腎、皮膚、筋肉、肺、
消化管、血管、心臓、胸腺、脾臓、顎下腺、末梢血、末
梢血球、腸管、前立腺、睾丸、精巣、卵巣、胎盤、子
宮、骨、関節、小腸、大腸、骨格筋など(特に、脳や脳
の各部位)に由来するゲノムDNA、ゲノムDNAライ
ブラリー、上記の細胞や組織由来のcDNA、またはc
DNAライブラリー等から選ばれる各々のゲノムDNA
またはcDNAをランダムにシーケンシングして得るこ
とができる。(3) Obtaining the DNA encoding the polypeptide of the present invention, and producing the DNA and the oligonucleotide The DNA encoding the polypeptide of the present invention may be, for example,
All cells of humans and mammals (eg, guinea pig, rat, mouse, chicken, rabbit, pig, sheep, cow, monkey, etc.) (eg, spleen cells, nerve cells, glial cells, pancreatic β cells, bone marrow cells, mesangial cells) , Langerhans cells, epidermal cells, epithelial cells, endothelial cells, fibroblasts, fibrocytes, muscle cells, adipocytes, immune cells (eg, macrophages, T cells, B cells, natural killer cells, mast cells, neutrophils, Basophils, eosinophils, monocytes), megakaryocytes, synovial cells, chondrocytes, osteocytes, osteoblasts, osteoclasts, mammary cells, hepatocytes or stromal cells, or precursor cells of these cells, Stem cells or cancer cells), or any tissue in which these cells are present, for example, the brain, various parts of the brain (eg, olfactory bulb, nucleus pulposus, basal sphere, hippocampus, thalamus, hypothalamus, thalamus Nucleus, cerebral cortex, medulla, cerebellum, occipital lobe, frontal lobe, temporal lobe, putamen, caudate nucleus, brain stain, substantia nigra), spinal cord, pituitary, stomach, pancreas, kidney, liver, gonad, thyroid, gall bladder , Bone marrow, adrenal gland, skin, muscle, lungs,
Gastrointestinal tract, blood vessels, heart, thymus, spleen, submandibular gland, peripheral blood, peripheral blood cells, intestinal tract, prostate, testes, testis, ovaries, placenta, uterus, bones, joints, small intestine, large intestine, skeletal muscle, etc. Genomic DNA, genomic DNA library, cDNA derived from the above cells or tissues, or c
Each genomic DNA selected from a DNA library etc.
Alternatively, it can be obtained by randomly sequencing cDNA.
【0028】ゲノムDNAの調製、ゲノムDNAライブ
ラリーの作製は、例えば上記各種細胞、器官または組織
を用いて常法に従い行うことができる。具体的な方法と
してはモレキュラー・クローニング第2版やカレント・
プロトコールズ・イン・モレキュラー・バイオロジーに
記載された方法をあげることができる。Preparation of genomic DNA and preparation of a genomic DNA library can be carried out, for example, using the above-mentioned various cells, organs or tissues in accordance with a conventional method. Specific methods include Molecular Cloning 2nd Edition and Current Cloning
Examples include the methods described in Protocols in Molecular Biology.
【0029】cDNAおよびcDNAライブラリーの作
製は、例えば、上記各種細胞、器官または組織由来のm
RNAを用いて、常法により作製できる。具体的には、
モレキュラー・クローニング第2版やカレント・プロト
コールズ・イン・モレキュラー・バイオロジー、DNA
Cloning 1: Core Techniques, A Practical Approach,
Second Edition, Oxford University Press (1995)等
に記載された方法、完全長cDNA作製法〔Methods in
Enzymology, 303, 19 (1999)、Gene, 138, 171 (199
4)〕、あるいは市販のキット、例えばスーパースクリプ
ト・プラスミド・システム・フォー・cDNA・シンセ
シス・アンド・プラスミド・クローニング〔SuperScrip
t Plasmid System for cDNA Synthesis and Plasmid Cl
oning;ギブコBRL(Gibco BRL)社製〕やザップ−c
DNA ・シンセシス・キット〔ZAP-cDNA Synthesis Ki
t、ストラタジーン社製〕を用いて作製できる。The preparation of cDNAs and cDNA libraries can be performed, for example, by using m-cells, organs, or tissues derived from
It can be prepared by an ordinary method using RNA. In particular,
Molecular cloning 2nd edition, Current Protocols in Molecular Biology, DNA
Cloning 1: Core Techniques, A Practical Approach,
Second Edition, Oxford University Press (1995), etc., a method for preparing full-length cDNA [Methods in
Enzymology, 303 , 19 (1999), Gene, 138 , 171 (199
4)] or a commercially available kit such as Superscript Plasmid System for cDNA Synthesis and Plasmid Cloning [SuperScrip
t Plasmid System for cDNA Synthesis and Plasmid Cl
oning; Gibco BRL) or Zap-c
DNA Synthesis Kit [ZAP-cDNA Synthesis Ki
t, manufactured by Stratagene).
【0030】ライブラリーを作製するためのクローニン
グベクターとしては、大腸菌K12株中で自立複製でき
るものであれば、ファージベクター、プラスミドベクタ
ー等いずれでも使用できる。具体的には、ZAP Express
〔ストラタジーン社製、Strategies, 5, 58 (1992)〕、
pBluescript II SK(+)〔Nucleic Acids Research, 17,9
494 (1989)〕、λzap II(ストラタジーン社製)、
λgt10 、λgt11〔DNA Cloning, A Practical
Approach, 1, 49 (1985)〕、λTriplEx(クローンテッ
ク社製)、λExCell(ファルマシア社製)、pT7T
318U (ファルマシア社製)、pcD2〔Mol. Cell. Bi
ol., 3, 280 (1983)〕、pUC18 〔Gene, 33, 103
(1985)〕、pAMo〔J. Biol. Chem., 268, 22782-227
87 (1993)、別名pAMoPRC3Sc(特開平05-336963)〕、p
AMo−d(実施例1参照)等をあげることができる。As a cloning vector for preparing a library, any phage vector, plasmid vector, or the like can be used as long as it can replicate autonomously in E. coli K12 strain. Specifically, ZAP Express
(Strategies, 5 , 58 (1992), manufactured by Stratagene)
pBluescript II SK (+) (Nucleic Acids Research, 17 , 9
494 (1989)], λzap II (manufactured by Stratagene),
λgt10, λgt11 [DNA Cloning, A Practical
Approach, 1 , 49 (1985)], λTriplEx (Clontech), λExCell (Pharmacia), pT7T
318U (Pharmacia), pcD2 [Mol. Cell. Bi
ol., 3 , 280 (1983)], pUC18 [Gene, 33 , 103
(1985)], pAMo [J. Biol. Chem., 268 , 22782-227.
87 (1993), also known as pAMoPRC3Sc (Japanese Patent Laid-Open No. 05-336963), p
AMo-d (see Example 1) and the like.
【0031】ライブラリーの作製に用いる宿主微生物と
しては、大腸菌に属する微生物であればいずれでも用い
ることができる。具体的には、Escherichia coli XL1-B
lueMRF'〔ストラタジーン社製、Strategies, 5, 81 (19
92)〕、Escherichia coli C600〔Genetics, 39, 440 (1
954)〕、Escherichia coli Y1088〔Science, 222, 778
(1983)〕 、Escherichia coli Y1090〔Science, 222, 7
78 (1983)〕、Escherichia coli NM522 〔J. Mol. Bio
l., 166, 1 (1983)〕、Escherichia coli K802〔J. Mo
l. Biol., 16, 118 (1966)〕、Escherichia coli JM10
5 〔Gene, 38, 275 (1985)〕、Escherichia coli SOLR
TM Strain(ストラタジーン社より市販)およびE. coli
LE392(モレキュラー・クローニング第2版)等を用い
ることができる。As the host microorganism used for preparing the library, any microorganism belonging to Escherichia coli can be used. Specifically, Escherichia coli XL1-B
lueMRF '[Stratagies, 5 , 81 (19
92)), Escherichia coli C600 [Genetics, 39 , 440 (1
954)), Escherichia coli Y1088 (Science, 222 , 778
(1983)), Escherichia coli Y1090 (Science, 222 , 7
78 (1983)), Escherichia coli NM522 (J. Mol. Bio
l., 166 , 1 (1983)], Escherichia coli K802 (J. Mo.
l. Biol., 16 , 118 (1966)], Escherichia coli JM10
5 (Gene, 38 , 275 (1985)), Escherichia coli SOLR
TM Strain (commercially available from Stratagene) and E. coli
LE392 (Molecular Cloning 2nd Edition) or the like can be used.
【0032】より具体的なcDNAライブラリーの作製
方法としては以下の方法があげられる。More specific methods for preparing a cDNA library include the following methods.
【0033】ヒト胃癌細胞KATOIIIから、モレキュラー
・クローニング第2版記載の方法に準じてmRNAを抽
出し、オリゴキャップ法〔Gene, 138, 171 (1994)〕に
よりcDNAを合成する。次に、蛋白質 核酸 酵素,
41, 197 (1996)、Gene, 138,171 (1994)記載の方法によ
り第一鎖cDNAを合成した後、該cDNAの5’末端
側と3’末端側に設計したプライマーを用いてpolymera
se chain reaction〔モレキュラー・クローニング第2
版およびPCR Protocols Academic Press(1990)、以
下PCRと略す)により2本鎖cDNAに変換する。該
cDNAは制限酵素SfiIで切断し、DraIで切断
したクローニングベクター pME18SFL3(GenBank AB00986
4, Expression vector, 3392bp)に連結することで、c
DNAライブラリーを作製できる。MRNA is extracted from human gastric cancer cells KATOIII according to the method described in Molecular Cloning, Second Edition, and cDNA is synthesized by the oligocap method [Gene, 138 , 171 (1994)]. Next, protein nucleic acid enzyme,
41 , 197 (1996) and Gene, 138 , 171 (1994). After synthesizing a first-strand cDNA, using a primer designed on the 5 'end and 3' end of the cDNA,
se chain reaction [Molecular Cloning 2
Plate and PCR Protocols Academic Press (1990), hereinafter abbreviated as PCR). The cDNA was cleaved with restriction enzyme Sfi I, cloning vector pME18SFL3 (GenBank AB00986 cut with Dra I
4, Expression vector, 3392bp)
A DNA library can be prepared.
【0034】cDNAの塩基配列は、cDNAライブラ
リーを構成する各大腸菌クローンをランダムに選び、該
クローンよりプラスミドDNAを調製し、該プラスミド
に含有されるcDNAの両末端側の塩基配列を、通常用
いられる塩基配列解析方法、例えばサンガー(Sanger)ら
のジデオキシ法〔Proc. Natl. Acad. Sci. USA, 74,546
3 (1977)〕あるいは373A・DNAシークエンサー
(Perkin Elmer社製)等の塩基配列分析装置を用いて決
定することができる。For the nucleotide sequence of cDNA, each E. coli clone constituting a cDNA library is randomly selected, a plasmid DNA is prepared from the clone, and the nucleotide sequences at both ends of the cDNA contained in the plasmid are usually used. Nucleotide sequence analysis method, for example, the dideoxy method of Sanger et al. [Proc. Natl. Acad. Sci. USA, 74 , 546].
3 (1977)] or a nucleotide sequence analyzer such as a 373A DNA sequencer (manufactured by Perkin Elmer).
【0035】このようにして得られた塩基配列と相同性
のある遺伝子、あるいは該塩基配列がコードするアミノ
酸配列と相同性を有する蛋白質の存在をデータベース検
索により調べる。検索には、Blast、FrameSearch法(Co
mpugen社製)等のプログラムを利用することができる。
データベースとしては、GenBank等の公的なデータベー
スを利用することもできるし、私的なデータベースも利
用できる。該検索により、塩基レベルまたはアミノ酸レ
ベルで既知のGPCRと相同性を示したcDNAに関し
ては、全塩基配列を決定し、該cDNAにコードされる
ポリペプチドの全アミノ酸配列を明らかにする。The presence of the thus obtained gene having homology to the base sequence or a protein having homology to the amino acid sequence encoded by the base sequence is examined by database search. Blast, FrameSearch method (Co
mpugen) can be used.
As the database, a public database such as GenBank can be used, or a private database can also be used. As a result of the search, the entire nucleotide sequence of a cDNA showing homology with a known GPCR at the base or amino acid level is determined, and the entire amino acid sequence of the polypeptide encoded by the cDNA is determined.
【0036】該cDNAが完全長のポリペプチドをコー
ドしていない場合は、以下のようにして完全長のポリペ
プチドをコードするcDNAを得ることができる。When the cDNA does not encode a full-length polypeptide, a cDNA encoding the full-length polypeptide can be obtained as follows.
【0037】各種臓器または各種細胞から調製した一本
鎖cDNAライブラリーまたは上記記載の方法で作製で
きるcDNAライブラリーを鋳型にして、該cDNAに
特異的なプライマーセットを用いてPCRを行うことに
より、該cDNAに対応する遺伝子を発現する臓器や細
胞を特定し、特定された臓器あるいは細胞由来のcDN
Aライブラリーに対し、該cDNAをプローブにしてコ
ロニーハイブリダイゼーション法(モレキュラー・クロ
ーニング第2版)を行うことにより新ためて該cDNA
の全長を含むcDNAをcDNAライブラリーから選択
することができる。Using a single-stranded cDNA library prepared from various organs or cells or a cDNA library prepared by the method described above as a template, PCR is performed using a primer set specific to the cDNA, An organ or cell expressing the gene corresponding to the cDNA is specified, and cDN derived from the specified organ or cell is identified.
The library A was newly subjected to a colony hybridization method (molecular cloning, second edition) using the cDNA as a probe to newly obtain the cDNA.
Can be selected from a cDNA library.
【0038】また、該cDNAに対応する遺伝子が発現
している臓器または細胞由来の一本鎖cDNAライブラ
リーまたはcDNAライブラリーを鋳型として、5' RAC
E法と3' RACE法〔Proc. Natl. Acad. Sci. USA, 85, 89
98 (1988)〕を行うことにより、該cDNAの5'末端側
の断片と3'末端側の断片を取得し、両断片を連結するこ
とにより、全長cDNAを取得することもできる。ま
た、市販のキット(例えばベーリンガー社製の5'/3' RA
CE kit)を用いて、5' RACE法と3' RACE法を行うことも
できる。Further, using a single-stranded cDNA library or a cDNA library derived from an organ or a cell expressing the gene corresponding to the cDNA as a template, 5 ′ RAC
E method and 3 'RACE method (Proc. Natl. Acad. Sci. USA, 85 , 89
98 (1988)], a 5′-end fragment and a 3′-end fragment of the cDNA are obtained, and by linking both fragments, a full-length cDNA can be obtained. In addition, commercially available kits (for example, Boehringer's 5 '/ 3' RA
The 5 'RACE method and the 3' RACE method can also be performed using a CE kit.
【0039】各種臓器または各種細胞由来の一本鎖cD
NAライブラリーは、常法または市販されているキット
に従って作製することができるが、例えば以下に示すよ
うな方法で作製できる。Single chain cD derived from various organs or cells
The NA library can be prepared by a conventional method or a commercially available kit. For example, the NA library can be prepared by the following method.
【0040】各種臓器または各種細胞からグアニジウム
チオシアネート フェノール−クロロホルム法〔Anal.
Biochem., 162, 156 (1987)〕により全RNAを抽出
する。必要に応じて、全RNAをデオキシリボヌクレア
ーゼI(Life Technologies社製)で処理し、混入の可
能性がある染色体DNAを分解する。得られた全RNA
各々について、オリゴ(dT)プライマーまたはランダ
ムプライマーを用いてSUPERSCRIPTTM Preamplification
System for First Strand cDNA System(LifeTechnolo
gies社)により一本鎖cDNAライブラリーを作製でき
る。上記のようにして作製した一本鎖cDNAライブラ
リーとしては、例えばヒト視床から作製した一本鎖cD
NAライブラリーをあげることができる。From various organs or various cells, a guanidium thiocyanate phenol-chloroform method [Anal.
Biochem., 162 , 156 (1987)]. If necessary, the total RNA is treated with deoxyribonuclease I (manufactured by Life Technologies) to degrade chromosomal DNA that may be contaminated. Total RNA obtained
For each, SUPERSCRIPT ™ Preamplification using oligo (dT) or random primers
System for First Strand cDNA System (LifeTechnolo
gies) to produce a single-stranded cDNA library. The single-stranded cDNA library prepared as described above includes, for example, a single-stranded cDNA prepared from the human thalamus.
NA libraries can be given.
【0041】上記のようにして取得した完全長のポリペ
プチドをコードするcDNAの全塩基配列を決定し、該
ポリペプチドのアミノ酸配列について、再度上記と同様
にしてデータベース検索を行い、既知のGPCRとの相
同性を調べることができる。また、該ポリペプチドのア
ミノ酸配列を用いて疎水性プロット解析を行い、該ポリ
ペプチドがGPCRに共通する7回膜貫通領域を有する
かを調べ、該ポリペプチドが7回膜貫通領域を有し、か
つ既知のGPCRと相同性を示せば、該ポリペプチドは
GPCRであると考えることができる。該ポリペプチド
が既知GPCRとは異なる場合、該ポリペプチドは新規
GPCRであると考えることができる。The entire nucleotide sequence of the cDNA encoding the full-length polypeptide obtained as described above is determined, and the amino acid sequence of the polypeptide is again searched in the database in the same manner as described above, and the known GPCR and Can be examined for homology. Further, a hydrophobicity plot analysis is performed using the amino acid sequence of the polypeptide, and it is determined whether the polypeptide has a seven-transmembrane region common to GPCRs. The polypeptide has a seven-transmembrane region, If the polypeptide shows homology with a known GPCR, the polypeptide can be considered to be a GPCR. If the polypeptide is different from the known GPCR, the polypeptide can be considered a novel GPCR.
【0042】また、決定された新規ポリペプチドのアミ
ノ酸配列に基づいて、該ポリペプチドをコードするDN
Aを化学合成することによっても目的のDNAを調製す
ることができる。DNAを化学合成は、チオホスファイ
ト法を利用した島津製作所社製のDNA合成機、フォス
フォアミダイト法を利用したパーキン・エルマー社製の
DNA合成機 model392等を用いて行うことが
できる。Further, based on the determined amino acid sequence of the novel polypeptide, DN encoding the polypeptide is
The target DNA can also be prepared by chemically synthesizing A. Chemical synthesis of DNA can be performed using a DNA synthesizer manufactured by Shimadzu Corporation using a thiophosphite method, a DNA synthesizer model 392 manufactured by Perkin-Elmer Inc. using a phosphoramidite method, or the like.
【0043】後述のオリゴヌクレオチドをセンスプライ
マーおよびアンチセンスプライマーとして用い、これら
DNAに相補的なmRNAを発現している細胞のmRN
Aから調製したcDNAを鋳型として、PCRを行うこ
とによっても、目的とするDNAを調製することができ
る。Using the oligonucleotides described below as sense primers and antisense primers, the mRN of cells expressing mRNA complementary to these DNAs was used.
The target DNA can also be prepared by performing PCR using the cDNA prepared from A as a template.
【0044】上記の方法により取得される新規G蛋白質
共役型受容体ポリペプチドをコードするDNAとして、
例えば、配列番号1で表されるポリペプチドをコードす
るDNA等をあげることができ、具体的には、配列番号
2に記載の塩基配列において塩基番号175〜1287
番で表される塩基配列を有するDNA等をあげることが
できる。配列番号2に記載の塩基配列において塩基番号
175〜1287番で表される塩基配列を有するDNA
がコードするポリペプチドは、ハイドロパシー解析、膜
結合領域予測解析解析方法、および ENBO J., 12, 1693
(1993)記載の方法により、以下の構造からなると予想
される(図1、および図2〜10参照)。N末端の細胞
外領域(49アミノ酸)、第一膜貫通領域(26アミノ
酸)、第一細胞内ループ(5アミノ酸)、第二膜貫通領
域(26アミノ酸)、第一細胞外ループ(15アミノ
酸)、第三膜貫通領域(26アミノ酸)、第二細胞内ル
ープ(13アミノ酸)、第四膜貫通領域(26アミノ
酸)、第二細胞外ループ(22アミノ酸)、第五膜貫通
領域(26アミノ酸)、第三細胞内ループ(37アミノ
酸)、第六膜貫通領域(26アミノ酸)、第三細胞外ル
ープ(12アミノ酸)、第七膜貫通領域(26アミノ
酸)、C末端の細胞内領域(36アミノ酸)。As the DNA encoding the novel G protein-coupled receptor polypeptide obtained by the above method,
For example, a DNA encoding the polypeptide represented by SEQ ID NO: 1 and the like can be mentioned. Specifically, in the nucleotide sequence of SEQ ID NO: 2, base numbers 175 to 1287
And the like having a base sequence represented by No. DNA having a nucleotide sequence represented by nucleotide numbers 175 to 1287 in the nucleotide sequence of SEQ ID NO: 2
Is encoded by hydropathy analysis, membrane-bound region prediction analysis method, and ENBO J., 12 , 1693
According to the method described in (1993), the following structure is expected (see FIGS. 1 and 2 to 10). N-terminal extracellular domain (49 amino acids), first transmembrane domain (26 amino acids), first intracellular loop (5 amino acids), second transmembrane domain (26 amino acids), first extracellular loop (15 amino acids) , Third transmembrane domain (26 amino acids), second intracellular loop (13 amino acids), fourth transmembrane domain (26 amino acids), second extracellular loop (22 amino acids), fifth transmembrane domain (26 amino acids) , Third intracellular loop (37 amino acids), sixth transmembrane region (26 amino acids), third extracellular loop (12 amino acids), seventh transmembrane region (26 amino acids), C-terminal intracellular region (36 amino acids) ).
【0045】アミノ酸配列のハイドロパシー解析によ
り、該ポリペプチドはシグナルペプチドを有していない
と考えられる(図1参照)。From the hydropathic analysis of the amino acid sequence, it is considered that the polypeptide does not have a signal peptide (see FIG. 1).
【0046】配列番号2に記載の塩基配列を有するDN
Aを含むプラスミドとしては、例えば、pBS−KAT
O06734Lをあげることができる。 pBS−KA
TO06734Lを保有する大腸菌 Escherichia coli
DH5α/pBS−KATO06734LはFERM B
P−6967として平成11年12月8日付けで工業技
術院生命工学工業技術研究所、日本国茨城県つくば市東
1丁目1番3号(郵便番号305−8566)に寄託さ
れている。DN having the nucleotide sequence of SEQ ID NO: 2
Examples of the plasmid containing A include pBS-KAT
O6734L. pBS-KA
Escherichia coli harboring TO0673L
DH5α / pBS-KATO0673L is FERM B
P-6967 has been deposited with the Institute of Biotechnology and Industrial Technology, Institute of Industrial Science and Technology, 1-3-1 Higashi, Tsukuba, Ibaraki, Japan (Postal Code 305-8566) on December 8, 1999.
【0047】上記の方法で取得した本発明のDNAおよ
びDNA断片を用いて、モレキュラー・クローニング第
2版等に記載の常法により、あるいは該DNAの塩基配
列情報を用いてDNA合成機により、本発明のDNAの
一部の配列を有するアンチセンス・オリゴヌクレオチ
ド、センス・オリゴヌクレオチド等のオリゴヌクレオチ
ドを調製することができる。Using the DNA and DNA fragment of the present invention obtained by the above-mentioned method, the DNA is synthesized by a conventional method described in Molecular Cloning, 2nd edition, etc., or by a DNA synthesizer using the nucleotide sequence information of the DNA. Oligonucleotides such as antisense oligonucleotides and sense oligonucleotides having a partial sequence of the DNA of the present invention can be prepared.
【0048】該オリゴヌクレオチドとしては、本発明の
DNAの塩基配列中の連続した5〜60塩基と同じ塩基
配列を有するDNAまたは該DNAと相補的な配列を有
するDNAをあげることができ、具体的には、配列番号
2に記載のDNAの塩基配列中の連続した5〜60塩基
と同じ配列を有するDNAまたは該DNAと相補的な配
列を有するDNAをあげることができる。センスプライ
マーおよびアンチセンスプライマーとして用いる場合に
は、両者の融解温度(Tm)および塩基数が極端に変わ
ないオリゴヌクレオチドを選択することが好ましい。具
体的には、例えば配列番号11および配列番号12で表
される塩基配列を有するオリゴヌクレオチドのプライマ
ーセット、配列番号11および配列番号17で表される
塩基配列を有するオリゴヌクレオチドのプライマーセッ
ト、または配列番号13および配列番号14で表される
塩基配列を有するオリゴヌクレオチドのプライマーセッ
トをあげることができる。Examples of the oligonucleotide include a DNA having the same base sequence as 5 to 60 consecutive bases in the base sequence of the DNA of the present invention or a DNA having a sequence complementary to the DNA. Examples of the DNA include a DNA having the same sequence as 5 to 60 consecutive nucleotides in the base sequence of the DNA described in SEQ ID NO: 2 or a DNA having a sequence complementary to the DNA. When used as a sense primer and an antisense primer, it is preferable to select an oligonucleotide whose melting temperature (Tm) and the number of bases of both do not extremely change. Specifically, for example, a primer set of an oligonucleotide having the nucleotide sequence represented by SEQ ID NO: 11 and SEQ ID NO: 12, a primer set of an oligonucleotide having the nucleotide sequence represented by SEQ ID NO: 11 and SEQ ID NO: 17, or And primer sets of oligonucleotides having the nucleotide sequences represented by SEQ ID NOs: 13 and 14.
【0049】更に、これらオリゴヌクレオチドの誘導体
(以下、オリゴヌクレオチド誘導体という)も本発明の
オリゴヌクレオチドとして利用することができる。該オ
リゴヌクレオチド誘導体としては、オリゴヌクレオチド
中のリン酸ジエステル結合がホスフォロチオエート結合
に変換されたオリゴヌクレオチド誘導体、オリゴヌクレ
オチド中のリン酸ジエステル結合がN3’−P5’ホス
フォアミデート結合に変換されたオリゴヌクレオチド誘
導体、オリゴヌクレオチド中のリボースとリン酸ジエス
テル結合がペプチド核酸結合に変換されたオリゴヌクレ
オチド誘導体、オリゴヌクレオチド中のウラシルがC−
5プロピニルウラシルで置換されたオリゴヌクレオチド
誘導体、オリゴヌクレオチド中のウラシルがC−5チア
ゾールウラシルで置換されたオリゴヌクレオチド誘導
体、オリゴヌクレオチド中のシトシンがC−5プロピニ
ルシトシンで置換されたオリゴヌクレオチド誘導体、オ
リゴヌクレオチド中のシトシンがフェノキサジン修飾シ
トシン( phenoxazine - modified cytosine)で置換され
たオリゴヌクレオチド誘導体、オリゴヌクレオチド中の
リボースが2’−O−プロピルリボースで置換されたオ
リゴヌクレオチド誘導体、あるいはオリゴヌクレオチド
中のリボースが2’−メトキシエトキシリボースで置換
されたオリゴヌクレオチド誘導体等をあげることができ
る〔細胞工学,16, 1463 (1997)〕。 (4)本発明のポリペプチドおよび部分ペプチドの製造
法 本発明のポリペプチドまたはその塩は、前述したヒトや
哺乳動物の細胞または組織から公知の蛋白質の精製方法
によって製造することもできるし、後述する本発明のポ
リペプチドをコードするDNAを含有する形質転換体を
用いても製造することができる。また、後述のペプチド
合成法に準じて製造することもできる。ヒトや哺乳動物
の組織または細胞から製造する場合、例えばヒトや哺乳
動物の組織または細胞をホモジナイズした後、酸などで
抽出を行ない、該抽出液を逆相クロマトグラフィー、イ
オン交換クロマトグラフィーなどのクロマトグラフィー
を組み合わせることにより単離・精製することができ
る。Further, derivatives of these oligonucleotides (hereinafter referred to as oligonucleotide derivatives) can also be used as the oligonucleotide of the present invention. Examples of the oligonucleotide derivative include an oligonucleotide derivative in which a phosphodiester bond in an oligonucleotide is converted to a phosphorothioate bond, and a phosphodiester bond in an oligonucleotide converted to an N3′-P5 ′ phosphoramidate bond. Oligonucleotide derivative, the ribose and the phosphodiester bond in the oligonucleotide are converted to a peptide nucleic acid bond, the uracil in the oligonucleotide is C-
Oligonucleotide derivatives substituted with 5-propynyluracil, oligonucleotide derivatives in which uracil in the oligonucleotide is substituted with C-5 thiazoleuracil, oligonucleotide derivatives in which cytosine in the oligonucleotide is substituted with C-5 propynylcytosine, oligo Oligonucleotide derivative in which cytosine in nucleotide is replaced by phenoxazine-modified cytosine, oligonucleotide derivative in which ribose in oligonucleotide is replaced by 2′-O-propyl ribose, or ribose in oligonucleotide Can be exemplified by oligonucleotide derivatives substituted with 2'-methoxyethoxyribose [Cell Engineering, 16 , 1463 (1997)]. (4) Method for Producing Polypeptide and Partial Peptide of the Present Invention The polypeptide of the present invention or a salt thereof can be produced from the above-mentioned method for purifying a protein from human or mammalian cells or tissues, and will be described later. It can also be produced using a transformant containing a DNA encoding the polypeptide of the present invention. Further, it can also be produced according to the peptide synthesis method described later. When producing from human or mammalian tissues or cells, for example, after homogenizing human or mammalian tissues or cells, extraction is performed with an acid or the like, and the extract is subjected to chromatography such as reverse phase chromatography or ion exchange chromatography. Isolation and purification can be performed by combining the chromatography.
【0050】本発明の部分ペプチドまたはその塩は、公
知のペプチドの合成法に従って合成することもできる
し、あるいは本発明のG蛋白質共役型受容体ポリペプチ
ドを適当なペプチダーゼで切断することによっても製造
することができる。ペプチドの合成法としては、例え
ば、固相合成法、液相合成法のいずれによっても良い。
すなわち、本発明の部分ペプチドを構成し得る部分ペプ
チドもしくはアミノ酸と残余部分とを縮合させ、生成物
が保護基を有する場合は保護基を脱離することにより目
的のペプチドを製造することができる。公知の縮合方法
や保護基の脱離としては、例えば、以下の(a)〜
(e)に記載された方法が挙げられる。 (a)M. Bodanszky および M.A. Ondetti、ペプチド
シンセシス (Peptide Synthesis), Interscience Publi
shers, New York (1966年) (b)SchroederおよびLuebke、ザ ペプチド(The Pepti
de), Academic Press, New York (1965年) (c)泉屋信夫他、ペプチド合成の基礎と実験、 丸善
(株) (1975年) (d)矢島治明 および榊原俊平、生化学実験講座 1、
タンパク質の化学IV、 205、(1977年) (e)矢島治明監修、続医薬品の開発 第14巻 ペプチド
合成 広川書店 また、反応後は通常の精製法、例えば、溶媒抽出・蒸留
・カラムクロマトグラフィー・液体クロマトグラフィー
・再結晶などを組み合わせて本発明の部分ペプチドを精
製単離することができる。上記方法で得られる部分ペプ
チドが遊離体である場合は、公知の方法によって適当な
塩に変換することができるし、逆に塩で得られた場合
は、公知の方法によって遊離体に変換することができ
る。The partial peptide of the present invention or a salt thereof can be synthesized according to a known peptide synthesis method, or can be produced by cleaving the G protein-coupled receptor polypeptide of the present invention with an appropriate peptidase. can do. As a method for synthesizing a peptide, for example, any of a solid phase synthesis method and a liquid phase synthesis method may be used.
That is, the target peptide can be produced by condensing a partial peptide or amino acid capable of constituting the partial peptide of the present invention with the remaining portion, and removing the protective group when the product has a protective group. Known condensation methods and elimination of protecting groups include, for example, the following (a) to
The method described in (e) is mentioned. (A) M. Bodanszky and MA Ondetti, peptide
Synthesis (Peptide Synthesis), Interscience Publi
shers, New York (1966) (b) Schroeder and Luebke, The Pepti
de), Academic Press, New York (1965) (c) Nobuo Izumiya et al., Fundamentals and experiments of peptide synthesis, Maruzen
(1975) (d) Haruaki Yajima and Shunpei Sakakibara, Laboratory of Biochemical Experiments 1,
Protein Chemistry IV, 205, (1977) (e) Supervised by Haruaki Yajima, Development of Continuing Drugs Volume 14 Peptide Synthesis Hirokawa Shoten Also, after the reaction, conventional purification methods such as solvent extraction, distillation, and column chromatography -The partial peptide of the present invention can be purified and isolated by a combination of liquid chromatography, recrystallization and the like. When the partial peptide obtained by the above method is a free form, it can be converted to an appropriate salt by a known method, and conversely, when it is obtained by a salt, it can be converted to a free form by a known method. Can be.
【0051】また上記方法以外にも上記(3)で得られ
た本発明のDNAを宿主細胞中で発現させることによ
り、本発明のポリペプチドまたは部分ペプチドを製造す
ることができる。In addition to the above method, the polypeptide or partial peptide of the present invention can be produced by expressing the DNA of the present invention obtained in the above (3) in a host cell.
【0052】即ち、本発明のDNAを適当な発現ベクタ
ーのプロモーター下流に挿入した組換え体DNAを造成
し、該組換え体DNAを宿主細胞に導入することによ
り、本発明のポリペプチドまたは部分ペプチドを発現す
る形質転換体を取得し、該形質転換体を培養することに
より、本発明のポリペプチドまたは部分ペプチドを製造
することができる。That is, a recombinant DNA in which the DNA of the present invention is inserted downstream of a promoter of an appropriate expression vector is constructed, and the recombinant DNA is introduced into a host cell, whereby the polypeptide or partial peptide of the present invention is obtained. A polypeptide or partial peptide of the present invention can be produced by obtaining a transformant that expresses and then culturing the transformant.
【0053】宿主細胞としては、原核細胞、酵母、動物
細胞、昆虫細胞、植物細胞等、目的とする遺伝子を発現
できるものであればいずれも用いることができる。ま
た、動物個体や植物個体を用いることもできる。As the host cell, any prokaryotic cell, yeast, animal cell, insect cell, plant cell, or the like can be used as long as it can express the gene of interest. Moreover, an animal individual or a plant individual can also be used.
【0054】発現ベクターとしては、上記宿主細胞にお
いて自立複製が可能、または染色体中への組込みが可能
で、本発明のDNAの転写に適した位置にプロモーター
を含有しているものを用いることができる。As the expression vector, those which can replicate autonomously in the above-mentioned host cells or can be integrated into a chromosome and which contain a promoter at a position suitable for transcription of the DNA of the present invention can be used. .
【0055】細菌等の原核生物を宿主細胞として用いる
場合、本発明のDNAの発現ベクターは、原核生物中で
自立複製可能であると同時に、プロモーター、リボソー
ム結合配列、新規受容体遺伝子、転写終結配列、より構
成されていることが好ましい。プロモーターを制御する
遺伝子が含まれていてもよい。When a prokaryote such as a bacterium is used as a host cell, the DNA expression vector of the present invention is capable of autonomous replication in a prokaryote, and has a promoter, a ribosome binding sequence, a novel receptor gene, a transcription termination sequence. , It is preferable to be constituted. A gene that controls the promoter may be included.
【0056】発現ベクターとしては、例えば、pBTr
p2、pBTac1、pBTac2(いずれもベーリン
ガーマンハイム社より市販)、pSE280(インビト
ロジェン社製)、pGEMEX−1(Promega社製)、
pQE−8(QIAGEN社製)、pKYP10( 特開昭58
−110600)、pKYP200〔Agric. Biol. Che
m., 48, 669 (1984)〕、pLSA1〔Agric. Biol. Che
m., 53, 277 (1989)〕、pGEL1〔Proc. Natl. Aca
d. Sci., USA, 82, 4306 (1985)〕、pBluescript II SK
(-)(STRATAGENE社)、pTrs30(FERM BP
−5407)、pTrs32(FERM BP−540
8)、pGHA2(FERM BP−400)、pGK
A2(FERM B−6798)、pTerm2(特開
平3−22979、US4686191、US4939
094、US5160735)、pKK233−2(Ph
armacia社製)、pGEX(Pharmacia社製)、pETシ
ステム(Novagen社製)、pSupex、pUB11
0、pTP5、pC194、pTrxFus(Invitrog
en社)、pMAL−c2(New England Biolabs社)等
をあげることができる。As an expression vector, for example, pBTr
p2, pBTac1, pBTac2 (all commercially available from Boehringer Mannheim), pSE280 (Invitrogen), pGEMEX-1 (Promega),
pQE-8 (manufactured by QIAGEN), pKYP10 (JP-A-58
-110600), pKYP200 [Agric. Biol. Che
m., 48 , 669 (1984)], pLSA1 [Agric. Biol. Che.
m., 53 , 277 (1989)], pGEL1 [Proc. Natl. Aca
d. Sci., USA, 82 , 4306 (1985)], pBluescript II SK
(-) (STRATAGENE), pTrs30 (FERM BP)
-5407), pTrs32 (FERM BP-540)
8), pGHA2 (FERM BP-400), pGK
A2 (FERM B-6798), pTerm2 (JP-A-3-22979, US4686191, US4939)
094, US5160735), pKK233-2 (Ph
armacia), pGEX (Pharmacia), pET system (Novagen), pSuex, pUB11
0, pTP5, pC194, pTrxFus (Invitrog
en company), pMAL-c2 (New England Biolabs) and the like.
【0057】プロモーターとしては、大腸菌等の宿主細
胞中で発現できるものであればいかなるものでもよい。
例えば、trpプロモーター(Ptrp)、lacプロモーター
(Plac)、PLプロモーター、PRプロモーター等の、
大腸菌やファージ等に由来するプロモーター、SPO1
プロモーター、SPO2プロモーター、penPプロモ
ーター等をあげることができる。またPtrpを2つ直列
させたプロモーター(Ptrp x2)、tacプロモータ
ー、lacT7プロモーター、let Iプロモーターのように人
為的に設計改変されたプロモーター等も用いることがで
きる。The promoter may be any promoter as long as it can be expressed in host cells such as E. coli.
For example, trp promoter (P trp), lac promoter (P lac), P L promoter, such as P R promoter,
Promoters derived from E. coli, phage, etc., SPO1
Promoter, SPO2 promoter, penP promoter and the like can be mentioned. In addition, artificially designed and modified promoters such as a promoter in which two Ptrps are connected in series (P trp x2), a tac promoter, a lacT7 promoter, and a let I promoter can also be used.
【0058】リボソーム結合配列としては、シャイン−
ダルガノ(Shine-Dalgarno)配列と開始コドンとの間を
適当な距離(例えば6〜18塩基)に調節したプラスミ
ドを用いることが好ましい。As the ribosome binding sequence, Shine-
It is preferable to use a plasmid in which the distance between the Shine-Dalgarno sequence and the initiation codon is adjusted to an appropriate distance (for example, 6 to 18 bases).
【0059】本発明のDNAの発現には転写終結配列は
必ずしも必要ではないが、好適には構造遺伝子直下に転
写終結配列を配置することが望ましい。Although a transcription termination sequence is not always necessary for expression of the DNA of the present invention, it is preferable to arrange a transcription termination sequence immediately below a structural gene.
【0060】宿主細胞としては、エシェリヒア属、セラ
チア属、バチルス属、ブレビバクテリウム属、コリネバ
クテリウム属、ミクロバクテリウム属、シュードモナス
属等に属する微生物、例えば、Escherichia coli XL1-B
lue、Escherichia coli XL2-Blue、Escherichia coli D
H1、Escherichia coli MC1000、Escherichia coli KY32
76、Escherichia coli W1485、Escherichia coli JM10
9、Escherichia coli HB101、Escherichia coli No.4
9、Escherichia coli W3110、Escherichia coli NY49、
Escherichia coli BL21(DE3)、Escherichia coli BL21
(DE3)pLysS、Escherichia coli HMS174(DE3)、Escheric
hia coli HMS174(DE3)pLysS、Serratia ficaria、Serra
tia fonticola、Serratia liquefaciens、Serratia mar
cescens、Bacillus subtilis、Bacillus amyloliquefac
iens、Corynebacterium ammoniagenes、Brevibacterium
immariophilum ATCC14068、Brevibacterium saccharol
yticumATCC14066、Corynebacterium glutamicum ATCC13
032、Corynebacterium glutamicum ATCC14067、Coryneb
acterium glutamicum ATCC13869、Corynebacterium ace
toacidophilum ATCC13870、Microbacterium ammoniaphi
lum ATCC15354、Pseudomonas sp. D-0110等をあげるこ
とができる。As the host cell, microorganisms belonging to the genus Escherichia, Serratia, Bacillus, Brevibacterium, Corynebacterium, Microbacterium, Pseudomonas, etc., for example, Escherichia coli XL1-B
lue, Escherichia coli XL2-Blue, Escherichia coli D
H1, Escherichia coli MC1000, Escherichia coli KY32
76, Escherichia coli W1485, Escherichia coli JM10
9, Escherichia coli HB101, Escherichia coli No.4
9, Escherichia coli W3110, Escherichia coli NY49,
Escherichia coli BL21 (DE3), Escherichia coli BL21
(DE3) pLysS, Escherichia coli HMS174 (DE3), Escheric
hia coli HMS174 (DE3) pLysS, Serratia ficaria , Serra
tia fonticola , Serratia liquefaciens , Serratia mar
cescens , Bacillus subtilis , Bacillus amyloliquefac
iens , Corynebacterium ammoniagenes , Brevibacterium
immariophilum ATCC14068, Brevibacterium saccharol
yticum ATCC14066, Corynebacterium glutamicum ATCC13
032, Corynebacterium glutamicum ATCC14067, Coryneb
acterium glutamicum ATCC13869, Corynebacterium ace
toacidophilum ATCC13870, Microbacterium ammoniaphi
lum ATCC15354, Pseudomonas sp. D-0110 and the like.
【0061】組換えベクターの導入方法としては、上記
宿主細胞へDNAを導入する方法であればいずれも用い
ることができ、例えば、エレクトロポレーション法〔Nu
cleic Acids Res., 16, 6127 (1988)〕、カルシウムイ
オンを用いる方法〔Proc. Natl. Acad. Sci. USA, 69,
2110 (1972)〕、プロトプラスト法(特開昭63-24839
4)、Gene, 17, 107 (1982)やMolecular & General Gen
etics, 168, 111 (1979)に記載の方法等をあげることが
できる。As a method for introducing a recombinant vector, any method for introducing DNA into the above host cells can be used. For example, electroporation [Nu
cleic Acids Res., 16 , 6127 (1988)], a method using calcium ions [Proc. Natl. Acad. Sci. USA, 69 ,
2110 (1972)], the protoplast method (JP-A-63-24839).
4), Gene, 17 , 107 (1982) and Molecular & General Gen
etics, 168 , 111 (1979).
【0062】酵母菌株を宿主細胞として用いる場合に
は、発現ベクターとして、例えば、YEp13(ATCC37
115)、YEp24(ATCC37051)、YCp50(ATCC37
419)、pHS19、pHS15等を例示することがで
きる。プロモーターとしては、酵母菌株中で発現できる
ものであればいかなるものでもよく、例えば、PHO5
プロモーター、PGKプロモーター、GAPプロモータ
ー、ADHプロモーター、gal 1プロモーター、g
al 10プロモーター、ヒートショック蛋白質プロモ
ーター、MFα1プロモーター、CUP 1プロモータ
ー等のプロモーターをあげることができる。When a yeast strain is used as a host cell, as an expression vector, for example, YEp13 (ATCC37)
115), YEp24 (ATCC37051), YCp50 (ATCC37
419), pHS19, pHS15 and the like. Any promoter can be used as long as it can be expressed in yeast strains.
Promoter, PGK promoter, GAP promoter, ADH promoter, gal 1 promoter, g
Examples of the promoter include an al10 promoter, a heat shock protein promoter, a MFα1 promoter, and a CUP1 promoter.
【0063】宿主細胞としては、サッカロマイセス属、
シゾサッカロマイセス属、クルイベロミセス属、トリコ
スポロン属、シワニオミセス属等に属する酵母菌株をあ
げることができ、具体的には、Saccharomyces cerevisi
ae、Schizosaccharomyces pombe、Kluyveromyces lacti
s、Trichosporon pullulans、Schwanniomyces alluvius
等をあげることができる。またGPCRの発現に適した
変異株を用いることもできる〔Trends in Biotechnolog
y, 15, 487 (1997)、Mol. Cell. Biol., 15, 6188 (199
5)、Mol. Cell. Biol., 16, 4700 (1996)〕。As the host cell, Saccharomyces sp.
Yeast strains belonging to the genus Schizosaccharomyces, Kluyveromyces, Trichosporone, Siwaniomyces and the like can be mentioned, and specifically, Saccharomyces cerevisi
ae , Schizosaccharomyces pombe , Kluyveromyces lacti
s , Trichosporon pullulans , Schwanniomyces alluvius
Etc. can be given. Alternatively, a mutant suitable for GPCR expression can be used [Trends in Biotechnolog
y, 15 , 487 (1997), Mol.Cell.Biol., 15 , 6188 (199
5), Mol. Cell. Biol., 16 , 4700 (1996)].
【0064】組換えベクターの導入方法としては、酵母
にDNAを導入する方法であればいずれも用いることが
でき、例えば、エレクトロポレーション法〔Methods. i
n Enzymol., 194, 182 (1990)〕、スフェロプラスト法
〔Proc. Natl. Acad. Sci. USA, 84, 1929 (1978)〕、
酢酸リチウム法〔J. Bacteriol., 153, 163 (1983)〕、
Proc. Natl. Acad. Sci. USA, 75, 1929 (1978)記載の
方法等をあげることができる。As a method for introducing a recombinant vector, any method for introducing DNA into yeast can be used. For example, an electroporation method [Methods.
n Enzymol., 194 , 182 (1990)), spheroplast method (Proc. Natl. Acad. Sci. USA, 84 , 1929 (1978)),
Lithium acetate method (J. Bacteriol., 153 , 163 (1983)),
Natl. Acad. Sci. USA, 75 , 1929 (1978).
【0065】動物細胞を宿主細胞として用いる場合に
は、発現ベクターとして、例えば、pcDNAI/Am
p、pcDNAI、pCDM8、pAGE107、pR
EP4、pAGE103、pAMo、pAMoA、pA
Mo−d(実施例1参照)、pAS3−3等を例示する
ことができる。When an animal cell is used as a host cell, pcDNAI / Am may be used as an expression vector.
p, pcDNAI, pCDM8, pAGE107, pR
EP4, pAGE103, pAMo, pAMoA, pA
Mod-d (see Example 1), pAS3-3 and the like can be exemplified.
【0066】プロモーターとしては、動物細胞中で発現
できるものであればいずれも用いることができ、例え
ば、サイトメガロウイルス(ヒトCMV)のIE(imme
diateearly)遺伝子のプロモーター、SV40の初期プ
ロモーター、モロニー・ミュリン・ロイケミア・ウイル
ス(Moloney Murine Leukemia Virus)のロング・ター
ミナル・リピート・プロモーター(Long Terminal Repe
at Promoter)、レトロウイルスのプロモーター、ヒー
トショックプロモーター、SRαプロモーター、あるい
はメタロチオネインのプロモーター等をあげることがで
きる。また、ヒトCMVのIE遺伝子のエンハンサーを
プロモーターと共に用いてもよい。Any promoter can be used as long as it can be expressed in animal cells. For example, the IE (imme) of cytomegalovirus (human CMV) can be used.
diateearly) promoter, early promoter of SV40, long terminal repeat promoter of Moloney Murine Leukemia Virus
at promoter, a retrovirus promoter, a heat shock promoter, an SRα promoter, a metallothionein promoter, and the like. Further, an enhancer of the IE gene of human CMV may be used together with the promoter.
【0067】宿主細胞としては、マウス・ミエローマ細
胞、ラット・ミエローマ細胞、マウス・ハイブリドーマ
細胞、CHO細胞、BHK細胞、アフリカミドリザル腎臓細
胞、Namalwa細胞、Namalwa KJM-1細胞、ヒト胎児腎臓細
胞、ヒト白血病細胞、HBT5637(特開昭63−299)、ヒト
大腸癌細胞株、カエルの卵母細胞およびカエルのメラニ
ン細胞等をあげることができる。As host cells, mouse myeloma cells, rat myeloma cells, mouse hybridoma cells, CHO cells, BHK cells, African green monkey kidney cells, Namalwa cells, Namalwa KJM-1 cells, human fetal kidney cells, human leukemia Cell, HBT5637 (JP-A-63-299), human colon cancer cell line, frog oocytes, frog melanocytes and the like.
【0068】さらにマウス・ミエローマ細胞としては、
SP2/0、NSO等、ラット・ミエローマ細胞としてはYB2/0
等、ヒト胎児腎臓細胞としてはHEK293等、ヒト白血病細
胞としてはBALL-1等、アフリカミドリザル腎臓細胞とし
てはCOS-1、COS-7、ヒト大腸癌細胞株としてはHCT-15等
をあげることができる。Further, as mouse / myeloma cells,
YB2 / 0 for rat myeloma cells such as SP2 / 0 and NSO
HEK293 etc. as human fetal kidney cells, BALL-1 etc. as human leukemia cells, COS-1 and COS-7 as African green monkey kidney cells, HCT-15 etc. as human colon cancer cell line. it can.
【0069】組換えベクターの導入方法としては、動物
細胞にDNAを導入する方法であればいずれも用いるこ
とができ、例えば、エレクトロポレーション法〔Cytote
chnology, 3, 133 (1990)〕、リン酸カルシウム法(特
開平2-227075)、リポフェクション法〔Proc. Natl. Ac
ad. Sci. USA, 84, 7413 (1987)〕、Virology, 52, 456
(1973)に記載の方法等をあげることができる。形質転
換体の取得および培養は、特開平2−227075号公
報あるいは特開平2−257891号公報に記載されて
いる方法に準じて行なうことができる。As a method for introducing a recombinant vector, any method for introducing DNA into animal cells can be used. For example, an electroporation method [Cytote
chnology, 3 , 133 (1990)], calcium phosphate method (Japanese Patent Laid-Open No. 2-227075), lipofection method [Proc. Natl. Ac
ad. Sci. USA, 84 , 7413 (1987)], Virology, 52 , 456.
(1973). Obtaining and culturing the transformant can be performed according to the method described in JP-A-2-227075 or JP-A-2-25791.
【0070】昆虫細胞を宿主として用いる場合には、例
えば、バキュロウイルス・イクスプレッション・ベクタ
ーズ ア・ラボラトリー・マニュアル〔Baculovirus Exp
ression Vectors, A Laboratory Manual, W. H. Freema
n and Company, New York (1992)〕、モレキュラー・バ
イオロジー ア・ラボラトリー・マニュアル(Molecular
Biology, A Laboratory Manual)、カレント・プロト
コールズ・イン・モレキュラー・バイオロジー 、Bio/T
echnology, 6, 47 (1988)等に記載された方法によっ
て、ポリペプチドを発現することができる。When an insect cell is used as a host, for example, baculovirus expression vectors, a laboratory manual [Baculovirus Exp.
ression Vectors, A Laboratory Manual, WH Freema
n and Company, New York (1992)], Molecular Biology A Laboratory Manual (Molecular
Biology, A Laboratory Manual), Current Protocols in Molecular Biology, Bio / T
The polypeptide can be expressed by the method described in Echinology, 6 , 47 (1988) and the like.
【0071】即ち、組換え遺伝子導入ベクターおよびバ
キュロウイルスを昆虫細胞に共導入して昆虫細胞培養上
清中に組換えウイルスを得た後、さらに組換えウイルス
を昆虫細胞に感染させ、ポリペプチドを発現させること
ができる。That is, after a recombinant gene transfer vector and a baculovirus are co-transfected into insect cells to obtain a recombinant virus in the culture supernatant of insect cells, the recombinant virus is further infected into insect cells, and the polypeptide is transferred to the insect cells. Can be expressed.
【0072】該方法において用いられる遺伝子導入ベク
ターとしては、例えば、pVL1392、pVL1393、pBlueBacII
I(すべてインビトロジェン社製)等をあげることがで
きる。The gene transfer vector used in the method includes, for example, pVL1392, pVL1393, pBlueBacII
I (all manufactured by Invitrogen) and the like.
【0073】バキュロウイルスとしては、例えば、夜盗
蛾科昆虫に感染するウイルスであるアウトグラファ・カ
リフォルニカ・ヌクレアー・ポリヘドロシス・ウイルス
(Autographa californica nuclear polyhedrosis viru
s) 等を用いることができる。Examples of the baculovirus include, for example, Autographa californica nuclea polyhedrosis virus, which is a virus that infects night moth insects
(Autographa californica nuclear polyhedrosis viru
s) etc. can be used.
【0074】昆虫細胞としては、Spodoptera frugiperd
aの卵巣細胞、Trichoplusia niの卵巣細胞、カイコ卵巣
由来の培養細胞等を用いることができる。Spodoptera f
rugiperdaの卵巣細胞としてはSf9、Sf21(バキュロウイ
ルス・イクスプレッション・ベクターズ ア・ラボラト
リー・マニュアル)等、Trichoplusia niの卵巣細胞と
してはHigh 5、BTI-TN-5B1-4(インビトロジェン社製)
等、カイコ卵巣由来の培養細胞としてはBombyx mori N4
等をあげることができる。As insect cells, Spodoptera frugiperd
a ovarian cells, ovarian cells of Trichoplusia ni, can be used cultured cells derived from silkworm ovary. Spodoptera f
The ovarian cells of rugiperda include Sf9 and Sf21 (Baculovirus Expression Vectors A Laboratory Manual) and the like. The ovarian cells of Trichoplusia ni are High 5, BTI-TN-5B1-4 (manufactured by Invitrogen)
Bombyx mori N4 is a cultured cell derived from silkworm ovary.
Etc. can be given.
【0075】組換えウイルスを調製するための、昆虫細
胞への上記組換え遺伝子導入ベクターと上記バキュロウ
イルスの共導入方法としては、例えば、リン酸カルシウ
ム法(特開平2-227075)、リポフェクション法〔Proc.
Natl. Acad. Sci. USA, 84,7413 (1987)〕等をあげるこ
とができる。As a method for co-transferring the above-mentioned recombinant gene transfer vector and the above baculovirus into insect cells for preparing a recombinant virus, for example, a calcium phosphate method (Japanese Patent Laid-Open No. 2-227075), a lipofection method [Proc.
Natl. Acad. Sci. USA, 84 , 7413 (1987)].
【0076】また、動物細胞にDNAを導入する方法と
同様の方法を用いて、昆虫細胞にDNAを導入すること
もでき、例えば、エレクトロポレーション法〔Cytotech
nology, 3, 133 (1990)〕、リン酸カルシウム法(特開
平2-227075)、リポフェクション法〔Proc. Natl. Aca
d. Sci. USA, 84, 7413 (1987)〕等をあげることができ
る。In addition, DNA can be introduced into insect cells using the same method as that for introducing DNA into animal cells. For example, electroporation [Cytotech.
nology, 3 , 133 (1990)], calcium phosphate method (Japanese Patent Laid-Open No. 2-227075), lipofection method [Proc. Natl. Aca
d. Sci. USA, 84 , 7413 (1987)].
【0077】植物細胞または植物個体を宿主として用い
る場合には、公知の方法〔組織培養, 20 (1994)、組織
培養, 21 (1995)、Trends in Biotechnology, 15, 45(1
997)〕に準じてポリペプチドを生産することができる。When a plant cell or a plant individual is used as a host, a known method [tissue culture, 20 (1994), tissue culture, 21 (1995), Trends in Biotechnology, 15 , 45 (1)
997)].
【0078】遺伝子発現に用いるプロモーターとして
は、植物細胞中で発現できるものであればいずれも用い
ることができ、例えば、カリフラワーモザイクウイルス
(CaMV)の35Sプロモーター、イネアクチン1プロモー
ター等をあげることができる。また、プロモーターと発
現させる遺伝子の間に、トウモロコシのアルコール脱水
素酵素遺伝子のイントロン1等を挿入することにより、
遺伝子の発現効率をあげることもできる。As the promoter used for gene expression, any promoter can be used as long as it can be expressed in plant cells. Examples thereof include the cauliflower mosaic virus (CaMV) 35S promoter and the rice actin 1 promoter. Further, by inserting intron 1 and the like of a maize alcohol dehydrogenase gene between the promoter and the gene to be expressed,
Gene expression efficiency can also be increased.
【0079】宿主細胞としては、ジャガイモ、タバコ、
トウモロコシ、イネ、アブラナ、大豆、トマト、小麦、
大麦、ライ麦、アルファルファ、亜麻等の植物細胞等を
あげることができる。The host cells include potato, tobacco,
Corn, rice, rape, soy, tomato, wheat,
Plant cells such as barley, rye, alfalfa, flax and the like can be mentioned.
【0080】組換えベクターの導入方法としては、植物
細胞にDNAを導入する方法であればいずれも用いるこ
とができ、例えば、アグロバクテリウム(Agrobacteriu
m)(特開昭59-140885、特開昭60-70080、WO94/0097
7)、エレクトロポレーション法〔Cytotechnology, 3,
133 (1990)、特開昭60-251887〕、パーティクルガン
(遺伝子銃)を用いる方法(特許第2606856、特許第251
7813)等をあげることができる。[0080] Introduction of the recombinant vector can be carried by any of the methods for introducing DNA into plant cells, for example, Agrobacterium (Agrobacterium
m ) (JP-A-59-140885, JP-A-60-70080, WO94 / 0097)
7), electroporation [Cytotechnology, 3 ,
133 (1990), JP-A-60-251887], a method using a particle gun (gene gun) (Patent Nos. 2606856, 251
7813).
【0081】遺伝子を導入した植物の細胞や器官は、ジ
ャーファーメンターを用いて大量培養することができ
る。また、遺伝子導入した植物細胞を再分化させること
により、遺伝子が導入された植物個体(トランスジェニ
ック植物)を造成することもできる。The cells or organs of the plant into which the gene has been introduced can be cultured in large quantities using a jar fermenter. Further, a plant individual (transgenic plant) into which the gene has been introduced can also be created by redifferentiating the plant cell into which the gene has been introduced.
【0082】動物個体を用いて本発明のポリペプチドを
生産することもできる。例えば、公知の方法〔American
Journal of Clinical Nutrition, 63, 639S (1996)、A
merican Journal of Clinical Nutrition, 63, 627S (1
996)、Bio/Technology, 9, 830 (1991)〕に準じて、遺
伝子を導入した動物中に本発明のポリペプチドを生産す
ることができる。The polypeptide of the present invention can be produced using an animal individual. For example, known methods [American
Journal of Clinical Nutrition, 63 , 639S (1996), A
American Journal of Clinical Nutrition, 63 , 627S (1
996), Bio / Technology, 9 , 830 (1991)], and the polypeptide of the present invention can be produced in an animal into which a gene has been introduced.
【0083】プロモーターとしては、動物で発現できる
ものであればいずれも用いることができるが、例えば、
乳腺細胞特異的なプロモーターであるαカゼインプロモ
ーター、βカゼインプロモーター、βラクトグロブリン
プロモーター、ホエー酸性プロテインプロモーター等が
好適に用いられる。As the promoter, any promoter that can be expressed in animals can be used.
Mammary cell-specific promoters such as α-casein promoter, β-casein promoter, β-lactoglobulin promoter, whey acidic protein promoter and the like are preferably used.
【0084】本発明のポリペプチドまたは部分ペプチド
をコードするDNAを組み込んだ組換え体DNAを保有
する微生物、動物細胞、あるいは植物細胞由来の形質転
換体を、通常の培養方法に従って培養し、該ポリペプチ
ドを生成蓄積させ、該培養物より該ポリペプチドを採取
することにより、該ポリペプチドを製造することができ
る。A transformant derived from a microorganism, animal cell, or plant cell having a recombinant DNA into which DNA encoding the polypeptide or partial peptide of the present invention has been incorporated is cultured according to a conventional culture method. The polypeptide can be produced by producing and accumulating the peptide and collecting the polypeptide from the culture.
【0085】形質転換体が動物個体または植物個体の場
合は、通常の方法に従って、飼育または栽培し、該ポリ
ペプチドを生成・蓄積させ、該動物個体または植物個体
より該ポリペプチドを採取することにより、該ポリペプ
チドを製造することができる。When the transformant is an individual animal or plant, the animal is bred or cultivated according to a usual method to produce and accumulate the polypeptide, and the polypeptide is collected from the individual animal or plant. And the polypeptide can be produced.
【0086】即ち、動物個体の場合、例えば、本発明の
DNAを保有する非ヒトトランスジェニック動物を飼育
し、該組換え体DNAのコードする本発明のポリペプチ
ドまたは部分ペプチドを該動物中に生成・蓄積させ、該
動物中より該ポリペプチドまたは部分ペプチドを採取す
ることにより、本発明のポリペプチドまたは部分ペプチ
ドを製造することができる。該動物中の生成・蓄積場所
としては、例えば、各種細胞の細胞膜画分、該動物のミ
ルク、卵等をあげることができる。That is, in the case of an animal individual, for example, a non-human transgenic animal having the DNA of the present invention is bred and the polypeptide or partial peptide of the present invention encoded by the recombinant DNA is produced in the animal. -The polypeptide or partial peptide of the present invention can be produced by accumulating and collecting the polypeptide or partial peptide from the animal. Examples of the production / accumulation site in the animal include cell membrane fractions of various cells, milk, eggs, and the like of the animal.
【0087】植物個体の場合、例えば、本発明のDNA
を保有するトランスジェニック植物を栽培し、該組換え
体DNAのコードする本発明のポリペプチドまたは部分
ペプチドを該植物中に生成・蓄積させ、該植物中より該
ポリペプチドまたは部分ペプチドを採取することによ
り、本発明のポリペプチドまたは部分ペプチドを製造す
ることができる。In the case of a plant individual, for example, the DNA of the present invention
Cultivating a transgenic plant carrying the recombinant DNA, producing and accumulating the polypeptide or partial peptide of the present invention encoded by the recombinant DNA in the plant, and collecting the polypeptide or partial peptide from the plant. Thus, the polypeptide or partial peptide of the present invention can be produced.
【0088】本発明のポリペプチドまたは部分ペプチド
の製造用形質転換体が大腸菌等の原核生物、酵母菌等の
真核生物である場合、これら生物を培養する培地は、該
生物が資化し得る炭素源、窒素源、無機塩類等を含有
し、形質転換体の培養を効率的に行える培地であれば天
然培地、合成培地のいずれでもよい。When the transformant for producing the polypeptide or partial peptide of the present invention is a prokaryote such as Escherichia coli, or a eukaryote such as yeast, the medium for culturing these organisms may be a carbon-containing medium capable of assimilating the organism. Any of a natural medium and a synthetic medium may be used as long as the medium contains a source, a nitrogen source, inorganic salts, and the like, and can efficiently culture the transformant.
【0089】炭素源としては、該形質転換体が資化し得
るものであればよく、グルコース、フラクトース、スク
ロース、これらを含有する糖蜜、デンプンあるいはデン
プン加水分解物等の炭水化物、酢酸、プロピオン酸等の
有機酸、エタノール、プロパノール等のアルコール類が
用いられる。The carbon source may be any as long as the transformant can assimilate, such as glucose, fructose, sucrose, molasses containing these, carbohydrates such as starch or starch hydrolysate, acetic acid, propionic acid and the like. Alcohols such as organic acids, ethanol, and propanol are used.
【0090】窒素源としては、アンモニア、塩化アンモ
ニウム、硫酸アンモニウム、酢酸アンモニウム、リン酸
アンモニウム等の各種無機酸や有機酸のアンモニウム
塩、その他含窒素化合物、並びに、ペプトン、肉エキ
ス、酵母エキス、コーンスチープリカー、カゼイン加水
分解物、大豆粕および大豆粕加水分解物、各種発酵菌体
およびその消化物等がを用いることができる。Examples of the nitrogen source include ammonium salts of various inorganic and organic acids such as ammonia, ammonium chloride, ammonium sulfate, ammonium acetate, and ammonium phosphate, other nitrogen-containing compounds, peptone, meat extract, yeast extract, and corn steep. Liquor, casein hydrolyzate, soybean meal and soybean meal hydrolyzate, various fermented cells and digested products thereof can be used.
【0091】無機塩としては、リン酸第一カリウム、リ
ン酸第二カリウム、リン酸マグネシウム、硫酸マグネシ
ウム、塩化ナトリウム、硫酸第一鉄、硫酸マンガン、硫
酸銅、炭酸カルシウム等を用いることができる。As the inorganic salt, potassium (II) phosphate, potassium (II) phosphate, magnesium phosphate, magnesium sulfate, sodium chloride, ferrous sulfate, manganese sulfate, copper sulfate, calcium carbonate and the like can be used.
【0092】培養は、振盪培養または深部通気攪拌培養
等の好気的条件下で行う。培養温度は15〜40℃がよ
く、培養時間は、通常16〜96時間である。培養中p
Hは、3.0〜9.0に保持する。pHの調整は、無機
あるいは有機の酸、アルカリ溶液、尿素、炭酸カルシウ
ム、アンモニア等を用いて行う。The cultivation is performed under aerobic conditions such as shaking culture or deep aeration stirring culture. The culturing temperature is preferably 15 to 40 ° C, and the culturing time is usually 16 to 96 hours. During culture
H is kept between 3.0 and 9.0. The pH is adjusted using an inorganic or organic acid, an alkali solution, urea, calcium carbonate, ammonia, or the like.
【0093】また培養中必要に応じて、アンピシリンや
テトラサイクリン等の抗生物質を培地に添加してもよ
い。[0093] If necessary, an antibiotic such as ampicillin or tetracycline may be added to the medium during the culture.
【0094】プロモーターとして誘導性のプロモーター
を用いた発現ベクターで形質転換した微生物を培養する
ときには、必要に応じてインデューサーを培地に添加し
てもよい。例えば、lacプロモーターを用いた発現ベク
ターで形質転換した微生物を培養するときにはイソプロ
ピル−β−D−チオガラクトピラノシド(IPTG)等
を、trpプロモーターを用いた発現ベクターで形質転換
した微生物を培養するときにはインドールアクリル酸
(IAA)等を培地に添加してもよい。When a microorganism transformed with an expression vector using an inducible promoter is cultured, an inducer may be added to the medium, if necessary. For example, when culturing a microorganism transformed with an expression vector using a lac promoter, culturing a microorganism transformed with an expression vector using a trp promoter such as isopropyl-β-D-thiogalactopyranoside (IPTG). At times, indole acrylic acid (IAA) or the like may be added to the medium.
【0095】本発明のポリペプチドまたは部分ペプチド
の製造用形質転換体が動物細胞である場合、該細胞を培
養する培地は、一般に使用されているRPMI1640
培地〔The Journal of the American Medical Associat
ion, 199, 519 (1967)〕、EagleのMEM培地〔Sc
ience, 122, 501 (1952)〕、DMEM培地〔Virology,
8, 396 (1959)〕、199培地〔Proceeding of the Soc
iety for the Biological Medicine, 73, 1 (1950)〕ま
たはこれら培地に牛胎児血清等を添加した培地等を用い
ることができる。When the transformant for producing the polypeptide or the partial peptide of the present invention is an animal cell, the culture medium for culturing the cell may be a commonly used RPMI1640 medium.
Medium (The Journal of the American Medical Associat
ion, 199 , 519 (1967)], Eagle's MEM medium [Sc
ience, 122 , 501 (1952)), DMEM medium (Virology,
8 , 396 (1959)), 199 medium (Proceeding of the Soc
Society for the Biological Medicine, 73 , 1 (1950)], or a medium obtained by adding fetal bovine serum or the like to such a medium.
【0096】培養は、通常pH6〜8、30〜40℃、
5%CO2存在下等の条件下で1〜7日間行う。The cultivation is usually carried out at pH 6-8, 30-40 ° C.
This is performed for 1 to 7 days under conditions such as the presence of 5% CO 2 .
【0097】また培養中必要に応じて、カナマイシン、
ペニシリン等の抗生物質を培地に添加してもよい。During the culturing, kanamycin,
An antibiotic such as penicillin may be added to the medium.
【0098】昆虫細胞を宿主細胞として得られた形質転
換体を培養する培地としては、一般に使用されているT
NM−FH培地(Pharmingen社製)、Sf-900 II SFM培
地(ギブコBRL社製)、ExCell400 、Ex
Cell405(JRH Biosciences社製)、Grace's Ins
ect Medium〔Nature, 195, 788 (1962)〕等を用いるこ
とができる。As a medium for culturing a transformant obtained by using an insect cell as a host cell, a commonly used medium is used.
NM-FH medium (Pharmingen), Sf-900 II SFM medium (Gibco BRL), ExCell400, Ex
Cell 405 (manufactured by JRH Biosciences), Grace's Ins
ect Medium [Nature, 195 , 788 (1962)] and the like can be used.
【0099】培養条件はpH6〜7、培養温度は25〜
30℃、培養時間は通常1〜5日間が好ましい。また、
培養中必要に応じて、ゲンタマイシン等の抗生物質を培
地に添加してもよい。The culture conditions are pH 6-7, and the culture temperature is 25-
Preferably, the cultivation time is usually 1 to 5 days at 30 ° C. Also,
If necessary, an antibiotic such as gentamicin may be added to the medium during the culture.
【0100】本発明のポリペプチドまたは部分ペプチド
は、直接発現させる以外に、モレキュラー・クローニン
グ第2版に記載されている方法等に準じて、分泌タンパ
ク質または融合タンパク質として発現させることもでき
る。融合させるタンパク質としては、β-ガラクトシダ
ーゼ、プロテインA、プロテインAのIgG結合領域、
クロラムフェニコール・アセチルトランスフェラーゼ、
ポリ(Arg)、ポリ(Glu)、プロテインG、マル
トース結合タンパク質、グルタチオンS-トランスフェ
ラーゼ、ポリヒスチジン鎖(His-tag)、Sペプチド、
DNA結合タンパク質ドメイン、Tac抗原、チオレド
キシン、グリーン・フルオレッセント・プロテイン、F
LAGペプチド、および任意の抗体のエピトープなどが
あげられる〔山川彰夫,実験医学,13, 469-474 (199
5)〕。The polypeptide or partial peptide of the present invention can be expressed as a secretory protein or a fusion protein in accordance with the method described in Molecular Cloning, 2nd edition, in addition to direct expression. Examples of proteins to be fused include β-galactosidase, protein A, an IgG binding region of protein A,
Chloramphenicol acetyltransferase,
Poly (Arg), poly (Glu), protein G, maltose binding protein, glutathione S-transferase, polyhistidine chain (His-tag), S peptide,
DNA binding protein domain, Tac antigen, thioredoxin, green fluorescent protein, F
LAG peptide and epitopes of any antibodies [Akio Yamakawa, Experimental Medicine, 13 , 469-474 (199)
Five)〕.
【0101】本発明のポリペプチドまたは部分ペプチド
の生産方法としては、宿主細胞内に生産させる方法、宿
主細胞外に分泌させる方法、あるいは宿主細胞膜上に生
産させる方法があり、使用する宿主細胞や、生産させる
ポリペプチドの構造を変えることにより、該方法を選択
することができる。The polypeptide or partial peptide of the present invention can be produced in a host cell, secreted out of the host cell, or produced on the host cell membrane. The method can be selected by changing the structure of the polypeptide to be produced.
【0102】宿主細胞外へ分泌発現させる場合、あるい
は宿主細胞膜上に発現させる場合は、必要に応じて宿主
に合ったシグナル配列を、本発明のポリペプチドまたは
部分ペプチドのN端末側に付加する。該ポリペプチドま
たは部分ペプチドのN末端を一部欠失させた上で、上記
分泌シグナルを付加した方がよい場合もある。宿主がエ
シェリヒア属菌である場合は、アルカリフォスファター
ゼ・シグナル配列、OmpA・シグナル配列などが、宿主
がバチルス属菌である場合は、α−アミラーゼ・シグナ
ル配列、サブチリシン・シグナル配列などが、宿主が酵
母である場合は、メイテイングファクターα・シグナル
配列、インベルターゼ・シグナル配列など、宿主が動物
細胞である場合には、インシュリン・シグナル配列、α
−インターフェロン・シグナル配列、抗体分子・シグナ
ル配列などがそれぞれ利用できる。In the case of secretory expression outside the host cell or expression on the host cell membrane, a signal sequence suitable for the host is added to the N-terminal side of the polypeptide or partial peptide of the present invention, if necessary. In some cases, it is better to add the above-mentioned secretion signal after partially deleting the N-terminus of the polypeptide or partial peptide. When the host is a bacterium belonging to the genus Escherichia, an alkaline phosphatase signal sequence, an OmpA signal sequence, or the like is used. When the host is a bacterium belonging to the genus Bacillus, an α-amylase signal sequence, a subtilisin signal sequence, or the like is used. If the host is an animal cell, an insulin signal sequence, an α signal sequence, an invertase signal sequence, etc.
-Interferon signal sequence, antibody molecule / signal sequence, etc. can be used.
【0103】本発明のポリペプチドまたは部分ペプチド
に、精製または検出用のタグを付加して発現することが
できる。タグは任意の場所に付加することができるが、
哺乳動物細胞で発現させる場合、上述した細胞外領域ま
たは細胞内領域に付加するのが好ましい。The polypeptide or partial peptide of the present invention can be expressed by adding a tag for purification or detection. Tags can be added anywhere,
When expressed in mammalian cells, it is preferable to add the gene to the extracellular region or intracellular region described above.
【0104】精製・検出用のタグとしては、β-ガラク
トシダーゼ、プロテインA、プロテインAのIgG結合
領域、クロラムフェニコール・アセチルトランスフェラ
ーゼ、ポリ(Arg)、ポリ(Glu)、プロテイン
G、マルトース結合タンパク質、グルタチオンS-トラ
ンスフェラーゼ、ポリヒスチジン鎖(His-tag)、Sペ
プチド、DNA結合タンパク質ドメイン、Tac抗原、
チオレドキシン、グリーン・フルオレッセント・プロテ
イン、FLAGペプチド、および任意の抗体のエピトー
プなどがあげられる〔山川彰夫,実験医学,13, 469-47
4 (1995)〕。Examples of tags for purification and detection include β-galactosidase, protein A, an IgG binding region of protein A, chloramphenicol acetyltransferase, poly (Arg), poly (Glu), protein G, and maltose binding protein. , Glutathione S-transferase, polyhistidine chain (His-tag), S peptide, DNA binding protein domain, Tac antigen,
Examples include thioredoxin, green fluorescent protein, FLAG peptide, and an epitope of any antibody [Akio Yamakawa, Experimental Medicine, 13 , 469-47.
4 (1995)].
【0105】また、特開平2−227075に記載され
ている方法に準じて、ジヒドロ葉酸還元酵素遺伝子等を
用いた遺伝子増幅系を利用して生産量を上昇させること
もできる。Further, according to the method described in Japanese Patent Application Laid-Open No. 2-227075, the production amount can be increased by utilizing a gene amplification system using a dihydrofolate reductase gene or the like.
【0106】本発明のポリペプチドまたは部分ペプチド
の製造用形質転換体の培養物から、本発明のポリペプチ
ドを単離・精製するには、通常のポリペプチドの単離・
精製法を用いることができる。In order to isolate and purify the polypeptide of the present invention from the culture of the transformant for producing the polypeptide or the partial peptide of the present invention, a usual method for isolating and purifying the polypeptide is used.
Purification methods can be used.
【0107】例えば、本発明のポリペプチドまたは部分
ペプチドが本発明のポリペプチドまたは部分ペプチド製
造用の形質転換体の細胞内に溶解状態で蓄積する場合に
は、培養物を遠心分離することにより、培養物中の細胞
を集め、該細胞を洗浄した後に、超音波破砕機、フレン
チプレス、マントンガウリンホモゲナイザー、ダイノミ
ル等により細胞を破砕し、無細胞抽出液を得る。For example, when the polypeptide or partial peptide of the present invention accumulates in a lysed state in the cells of the transformant for producing the polypeptide or partial peptide of the present invention, the culture is centrifuged. After collecting the cells in the culture and washing the cells, the cells are crushed by an ultrasonic crusher, a French press, a Manton-Gaurin homogenizer, a Dynomill or the like to obtain a cell-free extract.
【0108】該無細胞抽出液を遠心分離することにより
得られた上清から、溶媒抽出法、硫安等による塩析法脱
塩法、有機溶媒による沈殿法、ジエチルアミノエチル
(DEAE)−セファロース、DIAION HPA-75 (三菱化
成社製)等レジンを用いた陰イオン交換クロマトグラフ
ィー法、S-Sepharose FF(ファルマシア社製)等のレジ
ンを用いた陽イオン交換クロマトグラフィー法、ブチル
セファロース、フェニルセファロース等のレジンを用い
た疎水性クロマトグラフィー法、分子篩を用いたゲルろ
過法、アフィニティークロマトグラフィー法、クロマト
フォーカシング法、等電点電気泳動等の電気泳動法等の
手法を用い、精製標品を得ることができる。The supernatant obtained by centrifuging the cell-free extract was subjected to a solvent extraction method, a salting-out method using ammonium sulfate, a desalting method, a precipitation method using an organic solvent, diethylaminoethyl (DEAE) -Sepharose, DIAION. Anion exchange chromatography using a resin such as HPA-75 (Mitsubishi Kasei), cation exchange chromatography using a resin such as S-Sepharose FF (Pharmacia), butyl sepharose, phenyl sepharose, etc. Purified samples can be obtained using techniques such as hydrophobic chromatography using resins, gel filtration using molecular sieves, affinity chromatography, chromatofocusing, and electrophoresis such as isoelectric focusing. it can.
【0109】本発明のポリペプチドまたは部分ペプチド
が本発明のポリペプチドまたは部分ペプチドの製造用の
形質転換体の細胞膜上に蓄積する場合には、同様に細胞
を回収後破砕し、遠心分離やろ過により膜画分を得たの
ち、トリトンX−100などの界面活性剤を用いて該ポ
リペプチドまたは該部分ペプチドを膜から可溶化した
後、上記と同様の単離・精製法により精製標品を得るこ
とができる。When the polypeptide or partial peptide of the present invention accumulates on the cell membrane of the transformant for producing the polypeptide or partial peptide of the present invention, the cells are similarly recovered, crushed, centrifuged or filtered. , And the polypeptide or the partial peptide is solubilized from the membrane using a surfactant such as Triton X-100, and then the purified sample is isolated and purified in the same manner as described above. Obtainable.
【0110】また、該ポリペプチドまたは該部分ペプチ
ドが細胞内に不溶体を形成して発現した場合は、同様に
細胞を回収後破砕し、遠心分離を行うことにより得られ
た沈殿画分より、通常の方法により該ポリペプチドまた
は該ペプチドを回収後、該ポリペプチドまたは該部分ペ
プチドの不溶体を変性剤で可溶化する。該可溶化液を、
変性剤を含まないあるいは変性剤の濃度がポリペプチド
または該部分ペプチドが変性しない程度に希薄な溶液に
希釈、あるいは透析し、該ポリペプチドまたは該部分ペ
プチドを正常な立体構造に構成させた後、上記と同様の
単離・精製法により精製標品を得ることができる。When the polypeptide or the partial peptide is expressed by forming an insoluble substance in the cells, the cells are similarly collected, crushed, and centrifuged to obtain a precipitate fraction. After recovering the polypeptide or the peptide by an ordinary method, the insoluble form of the polypeptide or the partial peptide is solubilized with a denaturant. The lysate is
After the denaturant is not contained or the concentration of the denaturant is diluted to a dilute solution such that the polypeptide or the partial peptide is not denatured, or dialyzed to form the polypeptide or the partial peptide into a normal three-dimensional structure. A purified sample can be obtained by the same isolation and purification method as described above.
【0111】細胞外に該ポリペプチドまたは該部分ペプ
チドが分泌される場合には、該培養物を遠心分離等の手
法により処理し、可溶性画分を取得する。該可溶性画分
から、上記無細胞抽出液上清からの単離・精製法と同様
の手法により、該ポリペプチドまたは該部分ペプチドの
精製標品を得ることができる。When the polypeptide or the partial peptide is secreted extracellularly, the culture is treated by a technique such as centrifugation to obtain a soluble fraction. From the soluble fraction, a purified sample of the polypeptide or the partial peptide can be obtained by the same method as the above-mentioned isolation and purification method from the cell-free extract supernatant.
【0112】また、本発明のポリペプチドまたは該部分
ペプチドを他のタンパク質との融合タンパク質として生
産し、融合したタンパク質に親和性をもつ物質を用いた
アフィニティークロマトグラフィーを利用して精製する
こともできる〔山川彰夫,実験医学,13, 469-474 (199
5)〕。例えば、ロウらの方法〔Proc. Natl. Acad. Sci.
USA, 86, 8227 (1989)、Genes Develop., 4, 1288 (1
990)〕、特開平05-336963、WO94/23201に記載の方法に
準じて、本発明のポリペプチドまたは部分ペプチドをプ
ロテインAとの融合タンパク質として生産し、イムノグ
ロブリンGを用いるアフィニティークロマトグラフィー
により精製することができる。また、本発明のポリペプ
チドまたは部分ペプチドをFLAGペプチドとの融合タ
ンパク質として生産し、抗FLAG抗体を用いるアフィ
ニティークロマトグラフィーにより精製することができ
る〔Proc. Natl. Acad. Sci. USA, 86, 8227 (1989)、G
enes Develop., 4, 1288 (1990)〕。Further, the polypeptide of the present invention or the partial peptide can be produced as a fusion protein with another protein, and purified by affinity chromatography using a substance having an affinity for the fused protein. [Akio Yamakawa, Experimental Medicine, 13 , 469-474 (199
Five)〕. For example, the method of Lowe et al. [Proc. Natl. Acad. Sci.
USA, 86 , 8227 (1989), Genes Develop., 4 , 1288 (1
990)], the polypeptide or partial peptide of the present invention is produced as a fusion protein with protein A, and purified by affinity chromatography using immunoglobulin G according to the method described in JP-A-05-336963 and WO94 / 23201. can do. Further, the polypeptide or partial peptide of the present invention can be produced as a fusion protein with a FLAG peptide and purified by affinity chromatography using an anti-FLAG antibody [Proc. Natl. Acad. Sci. USA, 86 , 8227 ( 1989), G
enes Develop., 4 , 1288 (1990)].
【0113】更に、本発明のポリペプチドまたは部分ペ
プチド自身に対する抗体を用いたアフィニティークロマ
トグラフィーで精製することもできる。Further, it can be purified by affinity chromatography using an antibody against the polypeptide of the present invention or the partial peptide itself.
【0114】また、公知の方法〔J. Biomolecular NMR,
6, 129、Science, 242, 1162 (1988)、J. Biochem., 1
10, 166 (1991)〕に準じて、in vitro転写・翻訳系を
用いて本発明のポリペプチドまたは部分ペプチドを生産
することもできる。Further, a known method [J. Biomolecular NMR,
6 , 129, Science, 242 , 1162 (1988), J. Biochem., 1
10 , 166 (1991)], the polypeptide or partial peptide of the present invention can be produced using an in vitro transcription / translation system.
【0115】更に、本発明のポリペプチドまたは部分ペ
プチドは、Fmoc法(フルオレニルメチルオキシカル
ボニル法)、tBoc法(t−ブチルオキシカルボニル
法)等の化学合成法によっても製造することができる。
また、Advanced ChemTech 社、パーキン・エルマー社、
ファルマシアバイオテク社、Protein Technology Instr
ument社、Synthecell−Vega社、PerSeptive社、島津製
作所等のペプチド合成機を利用し化学合成することもで
きる。Further, the polypeptide or the partial peptide of the present invention can also be produced by a chemical synthesis method such as the Fmoc method (fluorenylmethyloxycarbonyl method) and the tBoc method (t-butyloxycarbonyl method).
Advanced ChemTech, Perkin-Elmer,
Pharmacia Biotech, Protein Technology Instr
Chemical synthesis can also be carried out using a peptide synthesizer such as ument, Synthecell-Vega, PerSeptive, Shimadzu Corporation.
【0116】精製した本発明のポリペプチドの構造解析
は、蛋白質化学で通常用いられる方法、例えば遺伝子ク
ローニングのためのタンパク質構造解析(平野久著、東
京化学同人発行、1993年)に記載の方法により実施
可能である。The structural analysis of the purified polypeptide of the present invention is carried out by a method usually used in protein chemistry, for example, a method described in Protein Structural Analysis for Gene Cloning (Hisashi Hirano, Tokyo Chemical Dojin, 1993). It is feasible.
【0117】上記の方法で得られる本発明のポリペプチ
ドまたは部分ペプチドが遊離体で得られた場合には、公
知の方法あるいはそれに準じる方法によって塩に変換す
ることができ、逆に塩で得られた場合には公知の方法あ
るいはそれに準じる方法により、遊離体または他の塩に
変換することができる。なお、本発明のポリペプチドま
たは部分ペプチドを、適当な蛋白修飾酵素を作用させる
ことにより、任意に修飾を加えたり、ポリペプチドを部
分的に除去することもできる。蛋白修飾酵素としては、
例えば、トリプシン、キモトリプシン、アルギニルエン
ドペプチダーゼ、プロテインキナーゼ、グリコシダーゼ
などが用いられる。When the polypeptide or partial peptide of the present invention obtained by the above method is obtained in a free form, it can be converted into a salt by a known method or a method analogous thereto, and conversely, can be obtained by a salt. In this case, it can be converted to a free form or another salt by a known method or a method analogous thereto. The polypeptide or partial peptide of the present invention can be arbitrarily modified or partially removed by the action of an appropriate protein modifying enzyme. As protein modifying enzymes,
For example, trypsin, chymotrypsin, arginyl endopeptidase, protein kinase, glycosidase and the like are used.
【0118】上記方法で製造できる本発明のポリペプチ
ドまたは部分ペプチド、若しくはそれらの塩の活性は、
標識したリガンドとの結合実験および特異抗体を用いた
エンザイムイムノアッセイなどにより測定することがで
きる。 (5)本発明のポリペプチドを認識する抗体 (5−1)本発明のポリペプチドを認識する抗体の生産 (I)ポリクローナル抗体の作製 上記(4)に記載の方法により取得したポリペプチドま
たは部分ペプチドを抗原として用い、動物に投与するこ
とによりポリクローナル抗体を作製することができる。The activity of the polypeptide or partial peptide of the present invention or the salt thereof which can be produced by the above method is as follows.
It can be measured by a binding experiment with a labeled ligand, an enzyme immunoassay using a specific antibody, or the like. (5) Antibody recognizing the polypeptide of the present invention (5-1) Production of antibody recognizing the polypeptide of the present invention (I) Preparation of polyclonal antibody Polypeptide or portion obtained by the method described in (4) above A polyclonal antibody can be prepared by using a peptide as an antigen and administering it to an animal.
【0119】該抗原を投与する動物としては、ウサギ、
ヤギ、3〜20週令のラット、マウス、ハムスター等を
あげることができる。該抗原の投与量は動物1匹当たり
50〜100μgが好ましい。抗原としてペプチドを用
いる場合は、ペプチドをスカシガイヘモシアニン(keyh
ole limpet haemocyanin)や牛チログロブリンなどのキ
ャリア蛋白に共有結合させたものを用いることができ
る。抗原とするペプチドは、ペプチド合成機によっても
合成することができる。The animals to which the antigen is administered include rabbits,
Goats, rats, mice, hamsters, etc., 3 to 20 weeks old can be mentioned. The dose of the antigen is preferably 50 to 100 μg per animal. When a peptide is used as an antigen, the peptide is used as keyhole limpet hemocyanin
(ole limpet haemocyanin) or bovine thyroglobulin, which is covalently bonded to a carrier protein. A peptide serving as an antigen can also be synthesized by a peptide synthesizer.
【0120】該抗原の投与は、1 回目の投与の後1〜2
週間おきに3〜10回行う。各投与後、3〜7日目に眼
底静脈叢より採血し、該血清が免疫に用いた抗原と反応
することを酵素免疫測定法〔酵素免疫測定法(ELIS
A法):医学書院刊1976年、Antibodies-A Laborat
ory Manual, Cold Spring Harbor Laboratory (1988)〕
等で確認する。The administration of the antigen is performed 1-2 times after the first administration.
Perform 3 to 10 times every week. Blood is collected from the fundus venous plexus 3 to 7 days after each administration, and the reaction of the serum with the antigen used for immunization is determined by enzyme immunoassay [enzyme immunoassay (ELIS)].
A method): 1976, published by Medical Shoin, Antibodies-A Laborat
ory Manual, Cold Spring Harbor Laboratory (1988))
Confirm with etc.
【0121】免疫に用いた抗原に対し、その血清が充分
な抗体価を示した上記動物より血清を取得し、該血清を
分離、精製することによりポリクローナル抗体を取得す
ることができる。[0121] A polyclonal antibody can be obtained by obtaining serum from the above animal whose serum shows a sufficient antibody titer against the antigen used for immunization, and separating and purifying the serum.
【0122】分離、精製する方法としては、遠心分離、
40〜50%飽和硫酸アンモニウムによる塩析、カプリ
ル酸沈殿〔Antibodies,A Laboratory manual,Cold Spri
ng Harbor Laboratory, (1988)〕、またはDEAE−セ
ファロースカラム、陰イオン交換カラム、プロテインA
またはG−カラムあるいはゲル濾過カラム等を用いるク
ロマトグラフィー等を、単独または組み合わせて処理す
る方法があげられる。 (II)モノクローナル抗体の作製 (a)抗体産性細胞の調製 免疫に用いた本発明のポリペプチドの部分ペプチドに対
し、その血清が十分な抗体価を示した上記動物を抗体産
生細胞の供給源として供することができる。Methods for separation and purification include centrifugation,
Salting out with 40-50% saturated ammonium sulfate, caprylic acid precipitation [Antibodies, A Laboratory manual, Cold Spri
ng Harbor Laboratory, (1988)] or DEAE-Sepharose column, anion exchange column, protein A
Alternatively, there is a method in which chromatography using a G-column or a gel filtration column or the like is performed alone or in combination. (II) Preparation of Monoclonal Antibody (a) Preparation of Antibody-Producing Cells The above animal whose serum showed a sufficient antibody titer against the partial peptide of the polypeptide of the present invention used for immunization was used as a source of antibody-producing cells. Can be served as
【0123】該抗体価を示した上記動物に抗原物質を最
終投与した後3〜7日目に、脾臓を摘出する。該脾臓を
MEM培地(日水製薬社製)中で細断し、ピンセットで
ほぐし、1,200rpmで5分間遠心分離した後、上
清を捨てる。得られた沈殿画分の脾細胞をトリス−塩化
アンモニウム緩衝液(pH7.65)で1〜2分間処理
し赤血球を除去した後、MEM培地で3回洗浄し、得ら
れた脾細胞を抗体産生細胞として用いる。 (b)骨髄腫細胞の調製 骨髄腫細胞としては、マウスまたはラットから取得した
株化細胞を使用する。The spleen is excised 3 to 7 days after the last administration of the antigenic substance to the above animal showing the antibody titer. The spleen is shredded in a MEM medium (manufactured by Nissui Pharmaceutical Co., Ltd.), loosened with forceps, centrifuged at 1,200 rpm for 5 minutes, and the supernatant is discarded. The spleen cells in the obtained precipitate fraction are treated with a Tris-ammonium chloride buffer (pH 7.65) for 1 to 2 minutes to remove erythrocytes, and then washed three times with a MEM medium. Use as cells. (b) Preparation of myeloma cells As myeloma cells, cell lines obtained from mice or rats are used.
【0124】例えば、8−アザグアニン耐性マウス(BA
LB/c由来)骨髄腫細胞株P3-X63Ag8-U1(以下、P3−U
1と略す)〔Curr. Topics. Microbiol. Immunol., 81,
1 (1978)、Europ. J. Immunol., 6, 511 (1976)〕、SP2
/0-Ag14(SP-2)〔Nature, 276,269 (1978)〕、P3-X63-Ag
8653(653)〔J. Immunol., 123, 1548 (1979)]、P3-X63
-Ag8(X63)〔Nature, 256, 495 (1975)〕等を用いること
ができる。For example, 8-azaguanine-resistant mice (BA
LB / c-derived) myeloma cell line P3-X63Ag8-U1 (hereinafter P3-U
1) [Curr. Topics. Microbiol. Immunol., 81 ,
1 (1978), Europ. J. Immunol., 6 , 511 (1976)), SP2
/ 0-Ag14 (SP-2 ) [Nature, 276, 269 (1978)], P3-X63-Ag
8653 (653) [J. Immunol., 123 , 1548 (1979)], P3-X63
-Ag8 (X63) [Nature, 256 , 495 (1975)] or the like can be used.
【0125】これらの細胞株は、8−アザグアニン培地
〔RPMI−1640培地にグルタミン(1.5 mmol
/L)、2−メルカプトエタノール(5×10-5 mmol/
L)、ジェンタマイシン(10μg/ml)および牛胎
児血清(FCS)(CSL社製、10%)を加えた培地
(以下、正常培地という)に、さらに8−アザグアニン
(15μg/ml)を加えた培地〕で継代するが、細胞
融合の3〜4日前に正常培地で培養し、融合には該細胞
を2×107個以上用いる。 (c)ハイブリドーマの作製 (a)で取得した抗体産生細胞と(b)で取得した骨髄腫細胞
をMEM培地またはPBS(リン酸二ナトリウム 1.
83g、リン酸一カリウム 0.21g、食塩7.65
g、蒸留水 1リットル、pH7.2)でよく洗浄し、
細胞数が、抗体産生細胞:骨髄腫細胞=5〜10:1に
なるよう混合し、1,200rpmで5分間遠心分離し
た後、上清を捨てる。These cell lines were prepared in an 8-azaguanine medium [glutamine (1.5 mmol) in an RPMI-1640 medium.
/ L), 2-mercaptoethanol (5 × 10 −5 mmol /
L), gentamicin (10 μg / ml) and fetal calf serum (FCS) (manufactured by CSL, 10%) (8% azaguanine (15 μg / ml) were further added to a medium (hereinafter referred to as a normal medium). Medium), and cultured in a normal medium 3 to 4 days before cell fusion, and use 2 × 10 7 or more of the cells for fusion. (c) Preparation of hybridoma The antibody-producing cells obtained in (a) and the myeloma cells obtained in (b) were cultured in MEM medium or PBS (disodium phosphate 1.
83 g, monopotassium phosphate 0.21 g, salt 7.65
g, 1 liter of distilled water, pH 7.2)
The cells are mixed so that the number of cells becomes antibody-producing cells: myeloma cells = 5 to 10: 1, centrifuged at 1,200 rpm for 5 minutes, and the supernatant is discarded.
【0126】得られた沈澱画分の細胞群をよくほぐし、
該細胞群に、攪拌しながら、37℃で、108抗体産生
細胞あたり、ポリエチレングライコール−1000(P
EG−1000) 2g、MEM 2mlおよびジメチル
スルホキシド(DMSO)0.7mlを混合した溶液を
0.2〜1ml添加し、更に1〜2分間毎にMEM培地
1〜2mlを数回添加する。添加後、MEM培地を加え
て全量が50mlになるように調製する。[0126] The cells of the obtained precipitate fraction were loosened well,
To the cell group, while stirring, at 37 ° C., 10 8 antibody-producing cells per polyethylene of glycol -1000 (P
EG-1000), 0.2 to 1 ml of a mixed solution of 2 g of MEM, 2 ml of MEM and 0.7 ml of dimethylsulfoxide (DMSO) is added, and 1-2 ml of MEM medium is added several times every 1 to 2 minutes. After the addition, a MEM medium is added to adjust the total volume to 50 ml.
【0127】該調製液を900rpmで5分間遠心分離
後、上清を捨てる。得られた沈殿画分の細胞を、ゆるや
かにほぐした後、メスピペットによる吸込み、吹出しで
ゆるやかにHAT培地〔正常培地にヒポキサンチン(1
0-4 mmol/L)、チミジン(1.5×10-5 mmol/L)
およびアミノプテリン(4×10-7M)を加えた培地〕
100ml中に懸濁する。[0127] After centrifuging the prepared solution at 900 rpm for 5 minutes, the supernatant is discarded. The cells of the obtained precipitate fraction are loosened loosely, and then slowly sucked and blown out with a mesipette into a HAT medium [hypoxanthine (1 in normal medium).
0 -4 mmol / L), thymidine (1.5 × 10 -5 mmol / L)
Medium supplemented with aminopterin (4 × 10 −7 M)
Suspend in 100 ml.
【0128】該懸濁液を96穴培養用プレートに100
μl/穴ずつ分注し、5% CO2インキュベーター中、
37℃で7〜14日間培養する。培養後、培養上清の一
部をとりアンチボディイズ〔Antibodies, A Laboratory
manual, Cold Spring Harbor Laboratory, Chapter 14
(1988)〕等に記載されている 酵素免疫測定法により、
本発明のポリペプチドの部分ペプチドに特異的に反応す
るハイブリドーマを選択する。The suspension was added to a 96-well culture plate in an amount of 100
aliquots per well, in a 5% CO 2 incubator,
Incubate at 37 ° C for 7-14 days. After culturing, a part of the culture supernatant is removed and used for antibodies (Antibodies, A Laboratory
manual, Cold Spring Harbor Laboratory, Chapter 14
(1988)).
A hybridoma that specifically reacts with a partial peptide of the polypeptide of the present invention is selected.
【0129】酵素免疫測定法の具体的例として、以下の
方法をあげることができる 免疫の際、抗原に用いた本発明のポリペプチドの部分ペ
プチドを適当なプレートにコートし、ハイブリドーマ培
養上清もしくは後述の(d)で得られる精製抗体を第一抗
体として反応させ、さらに第二抗体としてビオチン、酵
素、化学発光物質あるいは放射線化合物等で標識した抗
ラットまたは抗マウスイムノグロブリン抗体を反応させ
た後に標識物質に応じた反応を行ない、本発明のポリペ
プチドに特異的に反応するものを本発明のポリペプチド
に対するモノクローナル抗体を生産するハイブリドーマ
として選択する。Specific examples of the enzyme immunoassay include the following methods. In the case of immunization, a partial peptide of the polypeptide of the present invention used as an antigen is coated on an appropriate plate, and the hybridoma culture supernatant or After reacting the purified antibody obtained in (d) below as a first antibody, and further reacting an anti-rat or anti-mouse immunoglobulin antibody labeled with biotin, an enzyme, a chemiluminescent substance or a radioactive compound as a second antibody A reaction according to the labeling substance is performed, and a substance that specifically reacts with the polypeptide of the present invention is selected as a hybridoma that produces a monoclonal antibody against the polypeptide of the present invention.
【0130】該ハイブリドーマを用いて、限界希釈法に
よりクローニングを2回繰り返し〔1回目は、HT培地
(HAT培地からアミノプテリンを除いた培地)、2回
目は、正常培地を使用する〕、安定して強い抗体価の認
められたものを本発明のポリペプチドの抗ポリペプチド
抗体産生ハイブリドーマ株として選択する。 (d)モノクローナル抗体の調製 プリスタン処理〔2,6,10,14−テトラメチルペ
ンタデカン(Pristane)0.5mlを腹腔内投
与し、2週間飼育する〕した8〜10週令のマウスまた
はヌードマウスに、(c)で取得した本発明のポリペプチ
ドモノクローナル抗体産生ハイブリドーマ細胞5〜20
×106細胞/匹を腹腔内に注射する。10〜21日間
でハイブリドーマは腹水癌化する。Using the hybridoma, cloning was repeated twice by the limiting dilution method (the first time, an HT medium (a medium obtained by removing aminopterin from the HAT medium), and the second time, a normal medium was used). Those having a strong antibody titer are selected as hybridoma strains producing anti-polypeptide antibodies of the polypeptide of the present invention. (d) Preparation of Monoclonal Antibody To a mouse or a nude mouse of 8 to 10 weeks old, which was treated with pristane (0.5 ml of 2,6,10,14-tetramethylpentadecane (Pristane) was intraperitoneally administered and bred for 2 weeks). , 5-20 hybridoma cells producing the polypeptide monoclonal antibody of the present invention obtained in (c)
× 10 6 cells / mouse are injected intraperitoneally. In 10 to 21 days, the hybridoma becomes ascites cancer.
【0131】該腹水癌化したマウスから腹水を採取し、
3,000rpmで5分間遠心分離して固形分を除去す
る。得られた上清より、ポリクローナルで用いた方法と
同様の方法でモノクローナル抗体を精製、取得すること
ができる。[0131] Ascites was collected from the mouse with ascites cancer,
Centrifuge at 3,000 rpm for 5 minutes to remove solids. From the obtained supernatant, a monoclonal antibody can be purified and obtained by a method similar to the method used for polyclonal.
【0132】抗体のサブクラスの決定は、マウスモノク
ローナル抗体タイピングキットまたはラットモノクロー
ナル抗体タイピングキットを用いて行う。蛋白質量は、
ローリー法あるいは280nmでの吸光度より算出す
る。 (5−2)本発明の抗体の利用 (a)本発明の抗体を用いる本発明のポリペプチドの免
疫学的検出および定量本発明のポリペプチドの免疫学的
検出法としては、マイクロタイタープレートを用いるE
LISA法、蛍光抗体法、ウェスタンブロット法、免疫
組織染色法〔別冊 実験医学, ザ・プロトコールシリー
ズ, 免疫染色・in situハイブリダイゼーション, 羊土
社 (1997)、Journal of Immunological Methods, 150,
5, (1992)〕等をあげることができる。The subclass of the antibody is determined using a mouse monoclonal antibody typing kit or a rat monoclonal antibody typing kit. The protein content is
It is calculated from the Lowry method or the absorbance at 280 nm. (5-2) Use of the Antibody of the Present Invention (a) Immunological Detection and Quantification of the Polypeptide of the Present Invention Using the Antibody of the Present Invention As an immunological detection method of the polypeptide of the present invention, a microtiter plate is used. E used
LISA method, fluorescent antibody method, Western blot method, immunohistological staining method [Separate volume Experimental Medicine, The Protocol Series, Immunostaining / in situ Hybridization, Yodosha (1997), Journal of Immunological Methods, 150 ,
5, (1992)].
【0133】免疫学的定量法としては、液相中で本発明
のポリペプチドと反応する抗体のうちエピトープが異な
る2種類のモノクローナル抗体を用いたサンドイッチE
LISA法、126I等の放射性同位体で標識した本発明の
ポリペプチドと本発明のポリペプチドを認識する抗体と
を用いるラジオイムノアッセイ法等をあげることができ
る。As an immunoassay, a sandwich E using two kinds of monoclonal antibodies having different epitopes among antibodies reacting with the polypeptide of the present invention in the liquid phase is used.
LISA, radioimmunoassay using the polypeptide of the present invention labeled with a radioisotope such as 126 I, and an antibody recognizing the polypeptide of the present invention, and the like.
【0134】上記検出あるいは定量法は、大腸癌、胃癌
等の診断に利用することができる。また、上記検出ある
いは定量法を用いて本発明のポリペプチドを発現する細
胞や細胞株を同定することができる。本発明のポリペプ
チドを発現する細胞や細胞株は、該ポリペプチドのリガ
ンド、アゴニストまたはアンタゴニストの探索や該ポリ
ペプチドの機能解析に有用である。 (b)本発明の抗体を含有する医薬 本発明の抗体は、医薬、例えば視床または小脳の異常
症、大腸癌、胃癌等の疾患の治療薬として用いることが
できる。The above detection or quantification method can be used for diagnosis of colorectal cancer, gastric cancer and the like. In addition, cells or cell lines that express the polypeptide of the present invention can be identified using the above detection or quantification methods. Cells or cell lines that express the polypeptide of the present invention are useful for searching for a ligand, agonist or antagonist of the polypeptide, and for analyzing the function of the polypeptide. (B) Medicine containing the antibody of the present invention The antibody of the present invention can be used as a medicine, for example, a therapeutic agent for diseases such as abnormalities of the thalamus or cerebellum, colon cancer, and gastric cancer.
【0135】本発明の抗体を含有する医薬は、治療薬と
して該化合物単独で投与することも可能ではあるが、通
常は薬理学的に許容される一つあるいはそれ以上の担体
と一緒に混合し、製剤学の技術分野においてよく知られ
る任意の方法により製造した医薬製剤として提供するの
が望ましい。Although the drug containing the antibody of the present invention can be administered alone as a therapeutic agent, it is usually mixed with one or more pharmacologically acceptable carriers. It is desirable to provide it as a pharmaceutical preparation manufactured by any method well known in the field of pharmaceutical science.
【0136】投与経路は、治療に際して最も効果的なも
のを使用するのが望ましく、経口投与、または口腔内、
気道内、直腸内、皮下、筋肉内および静脈内等の非経口
投与をあげることができる。投与形態としては、噴霧
剤、カプセル剤、錠剤、顆粒剤、シロップ剤、乳剤、座
剤、注射剤、軟膏、テープ剤等があげられる。It is desirable to use the most effective route for treatment.
Parenteral administration, such as in the respiratory tract, rectally, subcutaneously, intramuscularly and intravenously, can be mentioned. Administration forms include sprays, capsules, tablets, granules, syrups, emulsions, suppositories, injections, ointments, tapes and the like.
【0137】経口投与に適当な製剤としては、乳剤、シ
ロップ剤、カプセル剤、錠剤、散剤、顆粒剤等があげら
れる。例えば乳剤およびシロップ剤のような液体調製物
は、水、ショ糖、ソルビトール、果糖等の糖類、ポリエ
チレングリコール、プロピレングリコール等のグリコー
ル類、ごま油、オリーブ油、大豆油等の油類、p−ヒド
ロキシ安息香酸エステル類等の防腐剤、ストロベリーフ
レーバー、ペパーミント等のフレーバー類等を添加剤と
して用いて製造できる。カプセル剤、錠剤、散剤、顆粒
剤等は、乳糖、ブドウ糖、ショ糖、マンニトール等の賦
形剤、デンプン、アルギン酸ナトリウム等の崩壊剤、ス
テアリン酸マグネシウム、タルク等の滑沢剤、ポリビニ
ルアルコール、ヒドロキシプロピルセルロース、ゼラチ
ン等の結合剤、脂肪酸エステル等の界面活性剤、グリセ
リン等の可塑剤等を添加剤として用いて製造できる。Formulations suitable for oral administration include emulsions, syrups, capsules, tablets, powders, granules and the like. Liquid preparations such as emulsions and syrups include water, sugars such as sucrose, sorbitol, fructose, glycols such as polyethylene glycol, propylene glycol, oils such as sesame oil, olive oil, soybean oil, p-hydroxybenzoate. It can be produced using preservatives such as acid esters and flavors such as strawberry flavor and peppermint as additives. Capsules, tablets, powders, granules, etc. are excipients such as lactose, glucose, sucrose, mannitol, disintegrants such as starch, sodium alginate, lubricants such as magnesium stearate, talc, polyvinyl alcohol, hydroxy It can be produced using a binder such as propylcellulose and gelatin, a surfactant such as fatty acid ester, and a plasticizer such as glycerin as additives.
【0138】非経口投与に適当な製剤としては、注射
剤、座剤、噴霧剤等があげられる。例えば、注射剤は、
塩溶液、ブドウ糖溶液、あるいは両者の混合物からなる
担体等を用いて調製する。座剤はカカオ脂、水素化脂肪
またはカルボン酸等の担体を用いて調製される。また、
噴霧剤は該化合物そのもの、ないしは受容者の口腔およ
び気道粘膜を刺激せず、かつ該化合物を微細な粒子とし
て分散させ吸収を容易にさせる担体等を用いて調製す
る。担体として具体的には乳糖、グリセリン等が例示さ
れる。該化合物および用いる担体の性質により、エアロ
ゾル、ドライパウダー等の製剤が可能である。また、こ
れらの非経口剤においても経口剤で添加剤として例示し
た成分を添加することもできる。Preparations suitable for parenteral administration include injections, suppositories, sprays and the like. For example, injections
It is prepared using a carrier comprising a salt solution, a glucose solution, or a mixture of both. Suppositories are prepared using carriers such as cocoa butter, hydrogenated fats or carboxylic acids. Also,
Sprays are prepared using the compound itself or a carrier which does not irritate the oral and respiratory tract mucosa of the recipient and which disperses the compound as fine particles to facilitate absorption. Specific examples of the carrier include lactose and glycerin. Formulations such as aerosols and dry powders are possible depending on the properties of the compound and the carrier used. Also, in these parenteral preparations, the components exemplified as additives in the oral preparation can be added.
【0139】投与量または投与回数は、目的とする治療
効果、投与方法、治療期間、年齢、体重等により異なる
が、通常成人1日当たり10μg/kg〜8mg/kg
である。 (6)本発明のポリペプチドまたは本発明の部分ペプチ
ドの利用 (6−1)本発明のG蛋白質共役型受容体ポリペプチド
に対するリガンドのスクリーニング方法 本発明のポリペプチドまたは本発明の部分ペプチドを用
いて、本発明のポリペプチドに対するリガンドを探索、
決定できる。The dose or the number of administrations varies depending on the intended therapeutic effect, administration method, treatment period, age, body weight, etc., but is usually 10 μg / kg to 8 mg / kg per day for an adult.
It is. (6) Use of polypeptide of the present invention or partial peptide of the present invention (6-1) Method for screening ligand for G protein-coupled receptor polypeptide of the present invention Using polypeptide of the present invention or partial peptide of the present invention Searching for a ligand for the polypeptide of the present invention,
Can decide.
【0140】該リガンドを探索または決定する方法とし
ては、例えば本発明のポリペプチドまたは部分ペプチド
もしくはそれらの塩と、試験物質とを接触させ、試験物
質より本発明のポリペプチドに対するリガンドを選択す
る方法、または本発明のポリペプチドまたは部分ペプチ
ドを発現する細胞や該細胞の膜画分と、試験物質とを接
触させ、試験物質より本発明のポリペプチドに対するリ
ガンドを選択する方法等をあげることができる。As a method of searching for or determining the ligand, for example, a method of contacting a polypeptide or a partial peptide of the present invention or a salt thereof with a test substance and selecting a ligand for the polypeptide of the present invention from the test substance. Or a method of contacting a cell expressing the polypeptide or partial peptide of the present invention or a membrane fraction of the cell with a test substance, and selecting a ligand for the polypeptide of the present invention from the test substance. .
【0141】試験物質としては、公知のリガンド〔例え
ば、アンギオテンシン、ボンベシン、カナビノイド、コ
レシストキニン、グルタミン、セロトニン、メラトニ
ン、ニューロペプチドY、オピオイド、プリン、バソプ
レッシン、オキシトシン、PACAP(ピチュイタリ
アデニレートシクラーゼ アクティベイティング プロテ
イン)、セクレチン、グルカゴン、カルシトニン、アド
レノメジュリン、ソマトスタチン、GHRH(グロース
ホルモン リリーシング ホルモン)、CRF(コルチコ
トロピン リリーシング ファクター)、ACTH(アド
レノコルチコトロピック ホルモン)、メラニンスティ
ミュレーションホルモン、GRP(ガストリン リリー
シング ペプチド)、PTH(パラチロイド ホルモ
ン)、VIP(バソアクティブ インテスティナル アン
ド リレイテッド ポリペプチド)、ドーパミン、モチリ
ン、アミリン、ブラジキニン、CGRP(カルシトニン
ジーンリレーティッド ペプチド)、ロイコトリエン、
パンクレアスタチン、プロスタグランジン、トロンボキ
サン、アデノシン、アドレナリン、αおよびβ−ケモカ
イン〔例えば、IL−8(インターロイキン−8)、G
ROα(グロース リレーティッド ジーンα)、GRO
β、GROγ、NAP−2(ニューロナル カルモジュ
リン バインディング プロテイン−2)、ENA−78
(エピセリアルセル−デライブド ニュトロフィル−ア
クティベーティング プロテイン−78)、PF4(プ
レートレット ファクター4)、IP10(インターフ
ェロンγ インデューシブル プロテイン オブ 10k
d)、GCP−2(グラニュロサイト ケモタクティッ
ク プロテイン−2)、MCP−1(モノサイト ケモア
トラクタント プロテイン−1)、HC14、MCP−
3、I−309、MIP1α(マクロファージ インフ
ラマトリ プロテイン1α)、MIP−1β、RANT
ES(レギュレーティッド オン アクチベーション、ノ
ーマル Tセル エクスプレスドアンド セクレーテッ
ド)など〕、エンドセリン、エンテロガストリン、ヒス
タミン、ニューロテンシン、TRH、パンクレアティッ
クポリペプタイド、ガラニン、ウロテンシンIおよびI
I、ニューロペプチドFF、オレキシンおよびメラニン
コンセントレーティングホルモンなど〕の他に、例え
ば、ヒトまたは哺乳動物(例えば、マウス、ラット、ブ
タ、ウシ、ヒツジ、サルなど)の組織抽出物や該抽出物
由来の精製物、細胞培養上清や該上清由来の精製物など
の生体試料や、既知蛋白質、組換え技術を用いて生産さ
れた組換え蛋白質、微生物の菌体抽出液や該抽出液由来
の精製物、微生物培養上清や該上清由来の精製物、既知
化合物、コンビナトリアルケミストリーを用いて合成さ
れた化合物などがあげられる。As test substances, known ligands [for example, angiotensin, bombesin, cannabinoid, cholecystokinin, glutamine, serotonin, melatonin, neuropeptide Y, opioid, purine, vasopressin, oxytocin, PACAP (Pichuitari)
Adenylate cyclase activating protein), secretin, glucagon, calcitonin, adrenomedullin, somatostatin, GHRH (growth hormone-releasing hormone), CRF (corticotropin-releasing factor), ACTH (adrenocorticotropic hormone), melanin stimulant Ration hormone, GRP (gastrin-releasing peptide), PTH (parathyroid hormone), VIP (vasoactive intestinal and reduced polypeptide), dopamine, motilin, amylin, bradykinin, CGRP (calcitonin gene-related peptide), leukotriene,
Pancreatastatin, prostaglandin, thromboxane, adenosine, adrenaline, α and β-chemokines [eg, IL-8 (interleukin-8), G
ROα (Growth Relayed Gene α), GRO
β, GROγ, NAP-2 (neural calmodulin binding protein-2), ENA-78
(Epserial Cell-Derived Neutrofil-Activating Protein-78), PF4 (Platelet Factor 4), IP10 (Interferon-γ Inducible Protein of 10k)
d), GCP-2 (granulosite chemotactic protein-2), MCP-1 (monosite chemoretractant protein-1), HC14, MCP-
3, I-309, MIP1α (macrophage inflammatri protein 1α), MIP-1β, RANT
ES (Regulated on Activation, Normal T Cell Expressed and Secreted), endothelin, enterogastrin, histamine, neurotensin, TRH, pancreatic polypeptide, galanin, urotensin I and I
I, neuropeptide FF, orexin and melanin concentrating hormone, etc.], as well as, for example, tissue extracts of humans or mammals (eg, mice, rats, pigs, cows, sheep, monkeys, etc.) and those derived from the extracts. Biological samples such as purified products, cell culture supernatants and purified products derived from the supernatants, known proteins, recombinant proteins produced using recombinant techniques, microbial cell extracts and purifications derived from the extracts Products, microbial culture supernatants, purified products derived from the supernatants, known compounds, compounds synthesized using combinatorial chemistry, and the like.
【0142】具体的な本発明のポリペプチドに対するリ
ガンドの探索または決定方法としては、本発明のポリペ
プチドまたは部分ペプチド、若しくはその塩、あるいは
本発明のポリペプチドまたは部分ペプチドを発現する細
胞に対して試験物質を作用させ、本発明のポリペプチド
または部分ペプチド、若しくはその塩に対する試験物質
の結合量を測定する、あるいは本発明のポリペプチドを
発現する細胞の応答を検出する方法をあげることができ
る。As a specific method for searching for or determining a ligand for the polypeptide of the present invention, a method for searching for a polypeptide or a partial peptide of the present invention or a salt thereof, or a cell expressing the polypeptide or partial peptide of the present invention may be used. Examples of the method include a method of measuring the amount of a test substance bound to a polypeptide or a partial peptide of the present invention or a salt thereof, or detecting a response of a cell expressing the polypeptide of the present invention.
【0143】より具体的には、(a)標識した試験物質
を、本発明のポリペプチドまたは部分ペプチドもしくは
それらの塩に接触させた場合における、標識した試験物
質の該ポリペプチドまたは部分ペプチド若しくはそれら
の塩に対する結合量を測定し、該試験物質から本発明の
ポリペプチドまたはその塩に対するリガンドを選択する
ことを特徴とする、本発明のポリペプチドに対するリガ
ンドの決定方法、(b)標識した試験物質を、本発明の
ポリペプチドまたは部分ペプチドを含有する細胞または
該細胞の膜画分に接触させた場合における、標識した試
験物質の該細胞または該膜画分に対する結合量を測定
し、該試験物質から本発明のポリペプチドに対するリガ
ンドを選択することを特徴とする、本発明のポリペプチ
ドに対するリガンドの決定方法、(c)試験物質を、本
発明のポリペプチドを含有する細胞または該細胞の膜画
分に接触させた場合における、標識したGTPγSのG
α蛋白質への結合量を測定し、試験物質から本発明のポ
リペプチドに対するリガンドを選択することを特徴とす
る、本発明のポリペプチドに対するリガンドの決定方
法、(d)試験物質を、本発明のポリペプチドを含有す
る細胞または該細胞の膜画分に接触させた場合における
GTPase活性を測定し、試験物質より本発明のペプ
チドに対するリガンドを選択することを特徴とする、本
発明のポリペプチドに対するリガンドの決定方法、
(e)試験物質を、本発明のポリペプチドを含有する細
胞に接触させた場合における、ポリペプチドを介した細
胞刺激活性(例えば、アラキドン酸遊離、アセチルコリ
ン遊離、細胞内Ca2+遊離、細胞内cAMP生成、細胞
内cGMP生成、イノシトールリン酸産生、細胞膜電位
変動、細胞内蛋白質のリン酸化、c−fos活性化、p
Hの低下、細胞増殖活性、メラニン色素の凝集または拡
散、またはレポーター遺伝子の発現量などを促進する活
性または抑制する活性など)を測定し、試験物質より本
発明のポリペプチドに対するリガンドを選択することを
特徴とする、本発明のポリペプチドに対するリガンドの
決定方法、をあげることができる。More specifically, (a) when the labeled test substance is brought into contact with the polypeptide or partial peptide of the present invention or a salt thereof, the polypeptide or partial peptide of the labeled test substance or their salts (B) a method for determining a ligand for the polypeptide of the present invention, which comprises measuring the amount of binding to a salt of the present invention and selecting a ligand for the polypeptide of the present invention or a salt thereof from the test substance; Is contacted with a cell containing the polypeptide or partial peptide of the present invention or a membrane fraction of the cell, the amount of the labeled test substance bound to the cell or the membrane fraction is measured, and the test substance Selecting a ligand for the polypeptide of the present invention from a ligand for the polypeptide of the present invention. Determination method, (c) a test substance, when in contact with the membrane fraction of the cell or the cell containing the polypeptide of the present invention, the labeled GTPyS G
A method for determining a ligand for the polypeptide of the present invention, which comprises measuring the amount of binding to the α protein and selecting a ligand for the polypeptide of the present invention from the test substance. A ligand for the polypeptide of the present invention, which comprises measuring the GTPase activity when the cell is contacted with a cell containing the polypeptide or a membrane fraction of the cell, and selecting a ligand for the peptide of the present invention from a test substance. How to determine
(E) polypeptide-mediated cell stimulating activity (eg, arachidonic acid release, acetylcholine release, intracellular Ca 2+ release, intracellular) when a test substance is brought into contact with a cell containing the polypeptide of the present invention. cAMP production, intracellular cGMP production, inositol phosphate production, cell membrane potential fluctuation, intracellular protein phosphorylation, c-fos activation, p
H decrease, cell proliferation activity, aggregation or diffusion of melanin pigment, or activity to promote or suppress reporter gene expression, etc.) and select a ligand for the polypeptide of the present invention from the test substance. And a method for determining a ligand for the polypeptide of the present invention.
【0144】以下に、本発明のリガンドを探索、または
決定する方法をより詳細に説明する。 (I)試験物質の結合量を測定する方法 上記(a)および(b)に示したように、本発明のポリ
ペプチドまたは部分ペプチド若しくはその塩、あるいは
本発明のポリペプチドまたは部分ペプチドを発現する細
胞に対して標識した試験物質を作用させ、本発明のポリ
ペプチドに対する試験物質の結合量を測定し、試験物質
より本発明のポリペプチドに対するリガンド選択するこ
とにより、本発明のポリペプチドに対するリガンドを探
索または決定することができる。Hereinafter, the method for searching for or determining the ligand of the present invention will be described in more detail. (I) Method for Measuring the Amount of Test Substance to be Bound As shown in (a) and (b) above, the polypeptide or partial peptide of the present invention or a salt thereof, or the polypeptide or partial peptide of the present invention is expressed. The labeled test substance is allowed to act on the cells, the amount of the test substance bound to the polypeptide of the present invention is measured, and the ligand for the polypeptide of the present invention is selected from the test substance, whereby the ligand for the polypeptide of the present invention is obtained. Can be searched or determined.
【0145】試験物質としては、例えば、3H、14C、
125I、35S、32P等の放射性同位元素で標識した公知
のGPCRのリガンド〔アンギオテンシン、ボンベシ
ン、カナビノイド、コレシストキニン、グルタミン、セ
ロトニン、メラトニン、ニューロペプチドY、オピオイ
ド、プリン、バソプレッシン、オキシトシン、PACA
P、セクレチン、グルカゴン、カルシトニン、アドレノ
メジュリン、ソマトスタチン、GHRH、CRF、AC
TH、メラニンスティミュレーションホルモン、GR
P、PTH、VIP、ドーパミン、モチリン、アミリ
ン、ブラジキニン、CGRP、ロイコトリエン、パンク
レアスタチン、プロスタグランジン、トロンボキサン、
アデノシン、アドレナリン、αおよびβ−ケモカイン
(例えば、IL−8、GROα、GROβ、GROγ、
NAP−2、ENA−78、PF4、IP10、GCP
−2、MCP−1、HC14、MCP−3、I−30
9、MIP1α、MIP−1β、RANTESなど)、
エンドセリン、エンテロガストリン、ヒスタミン、ニュ
ーロテンシン、TRH、パンクレアティックポリペプタ
イド、ガラニン、ウロテンシンIおよびII、ニューロ
ペプチドFF、オレキシンおよびメラニンコンセントレ
ーティングホルモンなど〕を用いることができる。ま
た、 3H、14C、125I、35S、32P等の放射性同位元素
で標識した任意の蛋白質、ペプチドまたは化合物を用い
ることもできる。As test substances, for example,ThreeH,14C,
125I,35S,32Known labeling with radioactive isotopes such as P
GPCR ligands [angiotensin, Bombesi
, Cannabinoids, cholecystokinin, glutamine,
Rotonin, melatonin, neuropeptide Y, opioid
Do, pudding, vasopressin, oxytocin, PACA
P, secretin, glucagon, calcitonin, adreno
Medulin, somatostatin, GHRH, CRF, AC
TH, melanin stimulation hormone, GR
P, PTH, VIP, dopamine, motilin, amiri
, Bradykinin, CGRP, leukotriene, punk
Reastatin, prostaglandin, thromboxane,
Adenosine, adrenaline, α and β-chemokines
(For example, IL-8, GROα, GROβ, GROγ,
NAP-2, ENA-78, PF4, IP10, GCP
-2, MCP-1, HC14, MCP-3, I-30
9, MIP1α, MIP-1β, RANTES, etc.),
Endothelin, enterogastrine, histamine,
-Rotensin, TRH, pancreatic polypeptide
Id, galanin, urotensin I and II, neuro
Peptide FF, orexin and melanin concentrate
And other hormones). Ma
Was ThreeH,14C,125I,35S,32Radioactive isotopes such as P
Using any protein, peptide or compound labeled with
You can also.
【0146】上記方法において、本発明のポリペプチド
または部分ペプチドとして、該ポリペプチドまたは部分
ペプチドを直接用いることもできるが、該ポリペプチド
または部分ペプチドを含有する細胞そのもの、またはそ
の細胞膜画分を用いることもできる。細胞膜画分を用い
る際の部分ペプチドとしては、リガンド結合能を有する
親水性部位と細胞膜貫通領域である疎水性部位の両方を
有する部分ペプチドが好ましい。該ポリペプチドまたは
部分ペプチドを含有する細胞を用いる場合、該細胞をグ
ルタルアルデヒド、ホルマリンなどで固定化してもよ
い。In the above method, the polypeptide or the partial peptide of the present invention can be used directly as the polypeptide or the partial peptide, but the cell itself containing the polypeptide or the partial peptide or the cell membrane fraction thereof is used. You can also. As the partial peptide when the cell membrane fraction is used, a partial peptide having both a hydrophilic site capable of binding ligand and a hydrophobic site that is a cell transmembrane region is preferable. When cells containing the polypeptide or partial peptide are used, the cells may be immobilized with glutaraldehyde, formalin, or the like.
【0147】また、本発明のポリペプチドまたは部分ペ
プチドとして、天然に存在するポリペプチドまたは部分
ペプチド、あるいは遺伝子組換えの手法を用いて作製し
た組換えポリペプチドまたは組換え部分ペプチドのいず
れも用いることができる。本発明のポリペプチドとし
て、(3)に記載の方法により、配列番号2で表される
塩基配列を有するDNAに変異を導入して得られる変異
DNAにコードされるポリペプチドのうち、構成的に活
性型となった変異型ポリペプチドは特に有用である。As the polypeptide or partial peptide of the present invention, any of a naturally occurring polypeptide or partial peptide, and a recombinant polypeptide or a recombinant partial peptide prepared by using a gene recombination technique may be used. Can be. As the polypeptide of the present invention, among the polypeptides encoded by the mutant DNA obtained by introducing a mutation into the DNA having the base sequence represented by SEQ ID NO: 2 by the method described in (3), The activated mutant polypeptide is particularly useful.
【0148】G蛋白質共役型受容体(GPCR)の中に
は、GPCRポリペプチドを細胞に過剰に発現させた際
に、リガンドが存在しなくてもシグナルを流すものが存
在し、これらは構成活性型GPCRと呼ばれる。また、
もともとは構成活性型ではないGPCRにおいても、ア
ミノ酸の置換、欠失などの変異を導入することにより構
成活性型になることが知られている。構成活性型に変化
した変異GPCRでは、アゴニストとの親和性が増加す
る場合があることが知られていることから、構成活性型
の変異GPCRはリガンドの探索において有用と考えら
れる〔Journalof Pharmacology and Experimental Ther
apeutics, 275, 1274 (1995)、Endocrinology, 137, 39
36 (1996)、J. Biol. Chem., 272, 1822 (1997)〕。Among G protein-coupled receptors (GPCRs), there are those that, when a GPCR polypeptide is overexpressed in a cell, pass a signal even in the absence of a ligand. It is called a type GPCR. Also,
It is known that even GPCRs that are not originally constitutively active become constitutively active by introducing mutations such as amino acid substitutions and deletions. Since it is known that a mutant GPCR changed to a constitutively active form may have an increased affinity for an agonist, a constitutively active mutant GPCR is considered to be useful in the search for a ligand [Journal of Pharmacology and Experimental Ther
apeutics, 275 , 1274 (1995), Endocrinology, 137 , 39
36 (1996), J. Biol. Chem., 272 , 1822 (1997)].
【0149】該構成活性型GPCRは既知の方法に従っ
て取得することができる〔J. Biol.Chem., 271, 1857
(1996)、Science, 268, 98 (1995) 、Journal of Pharm
acology and Experimental Therapeutics, 275, 1274
(1995)、J. Biol. Chem., 272, 1822 (1997)、Journal
of Receptor and Signal Transduction Research, 17,5
7 (1997)、WO98/46995〕。The constitutively active GPCR can be obtained according to a known method [J. Biol. Chem., 271 , 1857].
(1996), Science, 268 , 98 (1995), Journal of Pharm
acology and Experimental Therapeutics, 275 , 1274
(1995), J. Biol. Chem., 272 , 1822 (1997), Journal
of Receptor and Signal Transduction Research, 17 , 5
7 (1997), WO98 / 46995].
【0150】上記の細胞膜画分とは、細胞を破砕した
後、それ自体公知の方法で得られる細胞膜が多く含まれ
る画分のことをいう。細胞の破砕方法としては、Potter
−Elvehjem型ホモジナイザーで細胞を押し潰す方法、ワ
ーリングブレンダーやポリトロン(Kinematica社製)に
よる破砕、超音波による破砕、フレンチプレスなどで加
圧しながら細胞を細いノズルから噴出させることによる
破砕などが挙げられる。細胞膜の分画には、分画遠心分
離法や密度勾配遠心分離法などの遠心力による分画法が
主として用いられる。例えば、細胞破砕液を低速(50
0〜3000rpm)で短時間(通常、約1〜10分
間)遠心分離し、上清をさらに高速(15000〜30
000rpm)で通常30分〜2時間遠心分離し、得ら
れる沈澱を膜画分とする。該膜画分中には、発現した受
容体蛋白質と細胞由来のリン脂質や膜蛋白質などの膜成
分が多く含まれる。The above-mentioned cell membrane fraction refers to a fraction containing a large amount of cell membranes obtained by disrupting cells and then obtaining the cell membrane by a method known per se. Potter
-A method of crushing cells with an Elvehjem-type homogenizer, crushing with a Waring blender or a polytron (manufactured by Kinematica), crushing with ultrasonic waves, crushing by ejecting cells from a thin nozzle while applying pressure with a French press, and the like. For the fractionation of cell membranes, fractionation by centrifugal force such as fractionation centrifugation or density gradient centrifugation is mainly used. For example, the cell lysate is slowed (50
(3000 rpm) for a short period of time (usually about 1-10 minutes), and the supernatant is further centrifuged (15000-30)
000 rpm) for 30 minutes to 2 hours, and the resulting precipitate is used as a membrane fraction. The membrane fraction is rich in the expressed receptor protein and membrane components such as cell-derived phospholipids and membrane proteins.
【0151】本発明のポリペプチドを発現する細胞とし
ては、上記(4)に記載したように、該ポリペプチドを
コードするDNAを含む組換え体DNAを適当な宿主細
胞に導入して得られる形質転換細胞のように大量に該ポ
リペプチドを発現している細胞を用いることもできる。
大腸菌、枯草菌、酵母などの微生物の他、昆虫細胞、カ
エルの卵母細胞、カエルのメラニン細胞、動物細胞、植
物細胞などがあげられるが、該形質転換体が生産する本
発明のポリペプチドが高次構造を保ち、リガンドとの結
合性を保持するためには、酵母、昆虫細胞、カエルの卵
母細胞、カエルのメラニン細胞、動物細胞、植物細胞な
どで発現させるのが好ましい。As the cells expressing the polypeptide of the present invention, as described in the above (4), a plasmid obtained by introducing a recombinant DNA containing a DNA encoding the polypeptide into an appropriate host cell can be used. Cells expressing the polypeptide in large amounts, such as transformed cells, can also be used.
In addition to microorganisms such as Escherichia coli, Bacillus subtilis, and yeast, insect cells, frog oocytes, frog melanocytes, animal cells, plant cells, and the like can be mentioned, and the polypeptide of the present invention produced by the transformant can be used. In order to maintain the higher-order structure and maintain the binding property to the ligand, it is preferable to express in yeast, insect cells, frog oocytes, frog melanocytes, animal cells, plant cells and the like.
【0152】本発明のポリペプチドまたは部分ペプチド
を含有する細胞やその細胞膜画分中のポリペプチドまた
は部分ペプチドの量は、例えば1細胞当たり103〜108分
子であるのが好ましく、105〜107分子であるのが好適で
ある。なお、発現量が多いほど膜画分当たりのリガンド
結合活性(比活性)が高くなり、高感度なスクリーニン
グ系の構築が可能になるばかりでなく、同一ロットで大
量の試料を測定できるようになる。The amount of the polypeptide or the partial peptide in the cell containing the polypeptide or the partial peptide of the present invention or the cell membrane fraction thereof is preferably, for example, 10 3 to 10 8 molecules per cell, and preferably 10 5 to 10 5 molecules. Preferably it is 10 7 molecules. The higher the expression level, the higher the ligand binding activity (specific activity) per membrane fraction, which makes it possible not only to construct a highly sensitive screening system, but also to measure a large number of samples in the same lot. .
【0153】以下、具体例を示す。Hereinafter, specific examples will be described.
【0154】本発明のポリペプチドまたは部分ペプチド
を含有する細胞または該細胞の細胞膜画分を、適当なバ
ッファーに懸濁することにより本発明のポリペプチドの
標品を調製する。バッファーは、リガンドと本発明のポ
リペプチドとの結合を阻害しないバッファーであればい
ずれでもよく、例えばpH4〜10(望ましくはpH6〜8)
のリン酸バッファーやTris-HClバッファーなどが用いら
れる。また、非特異的結合を低減させる目的で、CHA
PS、Tween−80、ジギトニン、デオキシコール
酸などの界面活性剤やウシ血清アルブミンやゼラチンな
どの各種蛋白質をバッファーに加えることもできる。さ
らに、プロテアーゼによる本発明のポリペプチドやリガ
ンドの分解を抑える目的でPMSF、ロイペプチン、E
−64、ペプスタチンなどのプロテアーゼ阻害剤を添加
することもできる。10μl〜10 mlの該ポリペプチド標
品に、放射性同位元素(3H、125I、14C、35S、32Pな
ど)で標識した一定の放射能量の試験物質を共存させ
る。非特異的結合量(NSB)を知るために大過剰の未
標識の試験物質を加えた反応チューブも用意する。反応
は約0〜50℃、望ましくは約4〜37℃で、約20分
〜24時間、望ましくは約30分〜3時間行なう。反応
後、ガラス繊維濾紙等で濾過し、適量の同バッファーで
洗浄した後、ガラス繊維濾紙に残存する放射活性を液体
シンチレーションカウンターあるいはγ−カウンターで
計測する。全結合量(B)から非特異的結合量(NS
B)を引いたカウント(B−NSB)が0cpmを越え
る試験物質を本発明のポリペプチドに結合する物質とし
て選択することができる。これらの内、本発明のポリペ
プチドを含有する細胞または該細胞の細胞膜画分への結
合活性が強く、かつ本発明のポリペプチドを含有しない
細胞または該細胞の細胞膜画分への結合活性が弱い物質
を、本発明のポリペプチドのリガンドとして選択するこ
とができる。A sample of the polypeptide of the present invention is prepared by suspending a cell containing the polypeptide or the partial peptide of the present invention or a cell membrane fraction of the cell in an appropriate buffer. The buffer may be any buffer as long as it does not inhibit the binding between the ligand and the polypeptide of the present invention, for example, pH 4 to 10 (preferably pH 6 to 8).
Phosphate buffer or Tris-HCl buffer. In addition, CHA was used for the purpose of reducing non-specific binding.
Surfactants such as PS, Tween-80, digitonin, deoxycholic acid and various proteins such as bovine serum albumin and gelatin can also be added to the buffer. In addition, PMSF, leupeptin, E
Protease inhibitors such as -64 and pepstatin can also be added. 10 μl to 10 ml of the polypeptide preparation is allowed to coexist with a radioactive test substance labeled with a radioisotope ( 3 H, 125 I, 14 C, 35 S, 32 P, etc.). A reaction tube containing a large excess of unlabeled test substance is also prepared to determine the amount of non-specific binding (NSB). The reaction is carried out at about 0 to 50 ° C, preferably about 4 to 37 ° C, for about 20 minutes to 24 hours, preferably for about 30 minutes to 3 hours. After the reaction, the mixture is filtered with a glass fiber filter or the like, washed with an appropriate amount of the same buffer, and the radioactivity remaining on the glass fiber filter is measured with a liquid scintillation counter or a γ-counter. From the total binding amount (B) to the non-specific binding amount (NS
A test substance having a count (B-NSB) less than 0 cpm minus B) can be selected as a substance that binds to the polypeptide of the present invention. Among them, the binding activity to the cell containing the polypeptide of the present invention or the cell membrane fraction of the cell is strong, and the binding activity to the cell not containing the polypeptide of the present invention or the cell membrane fraction of the cell is weak. Substances can be selected as ligands for the polypeptide of the invention.
【0155】上記方法において、本発明のポリペプチド
または部分ペプチドを含有する細胞として、本発明のポ
リペプチドを発現しない宿主細胞に該ポリペプチドまた
は該部分ペプチドをコードするDNAをベクターDNA
に組み込んだ組換え体DNAを導入して得られる該ポリ
ペプチドまたは該部分ペプチド発現細胞を用い、本発明
のポリペプチドを含有しない細胞として、同宿主細胞に
ベクターのみを導入することによって作製した該ポリペ
プチドを発現しないコントロール細胞を用いることによ
り、リガンドの判定をより正確に行うことができる。 (II)GTPγSのGα蛋白質への結合量を測定する方
法 上記(c)に示したように、本発明のポリペプチドを含
有する細胞または細胞の膜画分に試験物質を接触させ、
標識したGTPγSのGα蛋白質(膜画分)への結合量
を測定することにより、該ポリペプチドのリガンドを探
索または決定することができる〔Molecular Pharmacolo
gy, 47, 848 (1995)、WO98/46995〕。In the above method, as a cell containing the polypeptide or the partial peptide of the present invention, a host cell not expressing the polypeptide of the present invention is transformed into a vector DNA by encoding a DNA encoding the polypeptide or the partial peptide.
Using the polypeptide or the partial peptide-expressing cells obtained by introducing the recombinant DNA incorporated into the host cell as a cell not containing the polypeptide of the present invention, by introducing only a vector into the host cell. By using control cells that do not express the polypeptide, the ligand can be more accurately determined. (II) Method for measuring the amount of GTPγS bound to Gα protein As shown in (c) above, a test substance is brought into contact with a cell containing the polypeptide of the present invention or a membrane fraction of the cell,
By measuring the amount of labeled GTPγS bound to Gα protein (membrane fraction), the ligand of the polypeptide can be searched or determined [Molecular Pharmacolo
gy, 47 , 848 (1995), WO98 / 46995].
【0156】試験物質としてはいかなる物質も使用でき
るが、例えば、既知ペプチド、既知GPCRリガンド、
既知蛋白質、組換え技術を用いて生産された組換え蛋白
質、細胞抽出液や該抽出液由来の精製物、細胞培養上清
や該上清由来の精製物、血清などの生体試料や該生体試
料由来の精製物、微生物の菌体抽出液や該抽出液由来の
精製物、微生物培養上清や該上清由来の精製物、既知化
合物、コンビナトリアルケミストリーを用いて合成され
た化合物などを使用することができる。標識したGTP
γSとしては、例えば35Sで標識したGTPγSを用い
ることができる。As the test substance, any substance can be used. For example, a known peptide, a known GPCR ligand,
Biological samples and biological samples such as known proteins, recombinant proteins produced using recombinant techniques, cell extracts and purified products derived from the extracted solutions, cell culture supernatants and purified products derived from the supernatants, serum and the like Use of a purified product derived from a microorganism, a cell extract of a microorganism, a purified product derived from the extract, a microorganism culture supernatant or a purified product derived from the supernatant, a known compound, a compound synthesized using combinatorial chemistry, or the like. Can be. GTP labeled
As γS, for example, GTPγS labeled with 35 S can be used.
【0157】本発明のポリペプチドを含有する細胞また
は該細胞の膜画分としては、上記(I)に記載したもの
を使用することができる。As the cells containing the polypeptide of the present invention or the membrane fraction of the cells, those described in the above (I) can be used.
【0158】以下、具体例を示す。Hereinafter, specific examples will be described.
【0159】本発明のポリペプチドを含有する細胞また
は細胞膜画分標品を、上記(I)に記載した方法により
調製する。10μl〜10 mlの該ポリペプチド標品に、試
験化合物、放射性同位元素(35Sなど)で標識した一定
の放射能量のGTPγS、およびGDPを共存させる。
非特異的結合量(NSB)を知る必要がある場合は、大
過剰の未標識のGTPγSを加えた反応チューブを用意
する。全結合量(B)から非特異的結合量(NSB)を
引いたカウント(B−NSB)が特異的結合量である。
反応は約0〜50℃、望ましくは約4〜37℃で、約2
0分〜24時間、望ましくは約30分〜3時間行なう。
反応後、ガラス繊維濾紙等で濾過し、適量の同バッファ
ーで洗浄した後、ガラス繊維濾紙に残存する放射活性を
液体シンチレーションカウンターで計測する。同様の操
作を本発明のポリペプチドを発現しない細胞または細胞
膜画分を用いて行い、放射活性を測定する。A cell or cell membrane fraction preparation containing the polypeptide of the present invention is prepared by the method described in the above (I). A test compound, a radioactive amount of GTPγS labeled with a radioisotope (such as 35 S), and GDP are allowed to coexist with 10 μl to 10 ml of the polypeptide preparation.
If it is necessary to know the amount of non-specific binding (NSB), prepare a reaction tube to which a large excess of unlabeled GTPγS has been added. The count (B-NSB) obtained by subtracting the non-specific binding amount (NSB) from the total binding amount (B) is the specific binding amount.
The reaction is carried out at about 0 to 50 ° C, preferably about 4 to 37 ° C, for about 2 hours.
The reaction is performed for 0 minute to 24 hours, preferably for about 30 minutes to 3 hours.
After the reaction, the mixture is filtered with a glass fiber filter or the like, washed with an appropriate amount of the same buffer, and the radioactivity remaining on the glass fiber filter is measured with a liquid scintillation counter. The same operation is performed using cells or cell membrane fractions that do not express the polypeptide of the present invention, and the radioactivity is measured.
【0160】本発明のポリペプチドを含有する細胞また
は該細胞の膜画分を用いた際のGTPγSの細胞または
該細胞の膜画分への結合活性と、本発明のポリペプチド
を発現していない細胞また該細胞の膜画分を用いた際
の、GTPγSの細胞または細胞膜画分への結合活性を
比較し、試験試料より、本発明のポリペプチドを含有す
る細胞または該細胞の膜画分を用いた際にGTPγSの
膜画分への結合を増強する活性が強い物質を、本発明の
ポリペプチドのリガンドとして選択することができる。When a cell containing the polypeptide of the present invention or a membrane fraction of the cell is used, GTPγS binds to the cell or the membrane fraction of the cell, and does not express the polypeptide of the present invention. The binding activity of GTPγS to a cell or a cell membrane fraction when using a cell or a membrane fraction of the cell is compared, and a cell containing the polypeptide of the present invention or a membrane fraction of the cell is determined from a test sample. A substance having a strong activity of enhancing the binding of GTPγS to the membrane fraction when used can be selected as a ligand of the polypeptide of the present invention.
【0161】上記方法において、本発明のポリペプチド
を含有する細胞として、本発明のポリペプチドを発現し
ない宿主細胞に該ポリペプチドをコードするDNAをベ
クターに組み込んだ組換え体DNAを導入して得られ
る、本発明のポリペプチドを発現する細胞を用い、本発
明のポリペプチドを含有しない細胞として、同宿主細胞
にベクターのみを導入することによって作製した、本発
明のポリペプチドを発現しないコントロール細胞を用い
ることにより、リガンドの判定をより正確に行うことが
できる。 (III)GTPase活性を測定する方法 上記(d)に示したように、本発明のポリペプチドを含
有する細胞または細胞の膜画分に試験物質を接触させ、
GTPase活性を測定することにより、本発明のポリ
ペプチドのリガンドを探索または決定することができる
〔J. Biol. Chem., 271, 1857 (1996)、J. Biol. Che
m., 271, 1857 (1996)、WO98/46995〕。In the above method, as a cell containing the polypeptide of the present invention, a host cell that does not express the polypeptide of the present invention is obtained by introducing a recombinant DNA obtained by incorporating a DNA encoding the polypeptide into a vector. A control cell that does not express the polypeptide of the present invention prepared by introducing only a vector into the host cell as a cell that does not contain the polypeptide of the present invention, using a cell that expresses the polypeptide of the present invention as a cell that does not contain the polypeptide of the present invention. By using this, the ligand can be determined more accurately. (III) Method for measuring GTPase activity As shown in the above (d), a test substance is brought into contact with a cell containing the polypeptide of the present invention or a membrane fraction of the cell,
By measuring GTPase activity, the ligand of the polypeptide of the present invention can be searched or determined [J. Biol. Chem., 271 , 1857 (1996), J. Biol. Che.
m., 271 , 1857 (1996), WO98 / 46995].
【0162】試験物質としては、上記(II)に記載した
物質を使用することができる。As the test substance, the substances described in the above (II) can be used.
【0163】本発明のポリペプチドを含有する細胞また
は該細胞の膜画分としては、上記(I)に記載したもの
を使用することができる。As the cells containing the polypeptide of the present invention or the membrane fraction of the cells, those described in the above (I) can be used.
【0164】以下、具体例を示す。The following is a specific example.
【0165】本発明のポリペプチドを含有する細胞また
は細胞膜画分標品を、上記(I)に記載した方法により
調製する。10μl〜10mlの該ポリペプチド標品に、試験
化合物、放射性同位元素(32Pなど)で標識した一定の
放射能量のGTP(例えば[γ32P]GTP)を共存さ
せる。反応は約0〜50℃、望ましくは約4〜37℃
で、約20分〜24時間、望ましくは約30分〜3時間
行なう。反応後、反応液の上清を回収し、遊離した[γ
32P]Piの放射活性を液体シンチレーションカウンタ
ーで計測する。反応液をガラス繊維濾紙等で濾過し、適
量の同バッファーで洗浄した後、濾過液中の放射活性を
液体シンチレーションカウンターで計測してもよい。同
様に、本発明のポリペプチドを含有しない細胞または細
胞膜画分についても、濾過液中の放射活性を測定する。A cell or cell membrane fraction preparation containing the polypeptide of the present invention is prepared by the method described in the above (I). To the polypeptide preparation of 10Myueru~10ml, test compounds, coexisting GTP radioactive isotopes (such as 32 P) constant amount of radioactivity labeled with (e.g. [γ 32 P] GTP). The reaction is carried out at about 0-50 ° C, preferably about 4-37 ° C.
For about 20 minutes to 24 hours, preferably for about 30 minutes to 3 hours. After the reaction, the supernatant of the reaction solution was recovered and released [γ
The radioactivity of < 32 > P] Pi is measured with a liquid scintillation counter. After filtering the reaction solution with a glass fiber filter or the like and washing with an appropriate amount of the same buffer, the radioactivity in the filtrate may be measured with a liquid scintillation counter. Similarly, the radioactivity in the filtrate is measured for cells or cell membrane fractions that do not contain the polypeptide of the present invention.
【0166】本発明のポリペプチドを含有する細胞また
は該細胞の膜画分を用いた際のGTPase活性と、本
発明のポリペプチドを発現していない細胞または該細胞
の膜画分を用いた際のGTPase活性を比較し、試験
化合物中より、本発明のポリペプチドを含有する細胞ま
たは該細胞の膜画分を用いた際にGTPase活性を増
強する活性が強い化合物を本発明のポリペプチドのリガ
ンドとして選択することができる。GTPase activity when cells containing the polypeptide of the present invention or a membrane fraction of the cells were used, and GTPase activity when cells not expressing the polypeptide of the present invention or a membrane fraction of the cells were used. The GTPase activity of the polypeptide of the present invention is compared with a compound having a strong activity of enhancing GTPase activity when a cell containing the polypeptide of the present invention or a membrane fraction of the cell is used. Can be selected as
【0167】上記方法において、本発明のポリペプチド
を含有する細胞として、本発明のポリペプチドを発現し
ない宿主細胞に該ポリペプチドをコードするDNAをベ
クターに組み込んだ組換え体DNAを導入して得られ
る、本発明のポリペプチドを発現する細胞を用い、本発
明のポリペプチドを含有しない細胞として、同宿主細胞
にベクターのみを導入することによって作製した、本発
明のポリペプチドを発現しないコントロール細胞を用い
ることにより、リガンドの判定をより正確に行うことが
できる。 (IV)細胞の応答を検出する方法 上記(e)に示したように、本発明のポリペプチドを発
現する細胞に試験物質を接触させ、該ポリペプチドの活
性化を細胞の応答を指標として検出することにより、該
ポリペプチドのリガンドを探索または決定することがで
きる。細胞の応答としては、例えば、アラキドン酸遊
離、アセチルコリン遊離、細胞内Ca2+遊離、細胞内c
AMP生成、細胞内cAMP減少、細胞内cGMP生
成、イノシトールリン酸産生、細胞膜電位変動、細胞内
蛋白質のリン酸化、c−fos活性化、pHの低下、細
胞増殖活性、メラニン色素の凝集または拡散、またはレ
ポーター遺伝子の発現量などをあげることができる〔J.
Biol. Chem., 271, 1857 (1996)、Science, 268, 98
(1995) 、Journal of Pharmacology and Experimental
Therapeutics, 275, 1274 (1995)、J. Biol. Chem., 27
2, 1822 (1997)、 Journal of Receptor and Signal Tr
ansduction Research, 17, 57 (1997)、Endocrinology
138, 1400 (1997)、Endocrinology 138, 1471 (1997)、
Nat. Biotechnol., 16, 1334 (1998)、Biochem. Bioph
ys. Res. Commun., 251, 471 (1998)、Brit. J. Pharma
col., 125, 1387 (1998)、Trends Biotechnol., 15, 48
7 (1997)、Anal. Biochem., 252, 115 (1997)、Nature,
358, 325 (1992)、Nature, 393, 272 (1998)、Cell, 9
2, 573 (1998)、J. Biol. Chem., 272, 27497 (1997)、
Trends Pharmacol. Sci., 18, 430 (1997)、Trends Pha
rmacol. Sci., 20, 370 (1999)、WO98/46995〕。In the above method, the cells containing the polypeptide of the present invention may be obtained by introducing a recombinant DNA having a DNA encoding the polypeptide into a vector into a host cell that does not express the polypeptide of the present invention. A control cell that does not express the polypeptide of the present invention prepared by introducing only a vector into the host cell as a cell that does not contain the polypeptide of the present invention, using a cell that expresses the polypeptide of the present invention as a cell that does not contain the polypeptide of the present invention. By using this, the ligand can be determined more accurately. (IV) Method for Detecting Cell Response As shown in (e) above, a test substance is brought into contact with a cell expressing the polypeptide of the present invention, and the activation of the polypeptide is detected using the cell response as an index. By doing so, the ligand of the polypeptide can be searched or determined. Cell responses include, for example, arachidonic acid release, acetylcholine release, intracellular Ca 2+ release, intracellular c
AMP production, intracellular cAMP reduction, intracellular cGMP production, inositol phosphate production, cell membrane potential fluctuation, intracellular protein phosphorylation, c-fos activation, pH decrease, cell growth activity, melanin pigment aggregation or diffusion, Or the expression level of a reporter gene can be raised (J.
Biol. Chem., 271 , 1857 (1996), Science, 268 , 98.
(1995), Journal of Pharmacology and Experimental
Therapeutics, 275 , 1274 (1995), J. Biol. Chem., 27
2 , 1822 (1997), Journal of Receptor and Signal Tr
ansduction Research, 17 , 57 (1997), Endocrinology
138 , 1400 (1997), Endocrinology 138 , 1471 (1997),
Nat. Biotechnol., 16 , 1334 (1998), Biochem. Bioph.
ys. Res. Commun., 251 , 471 (1998); Brit. J. Pharma.
col., 125 , 1387 (1998), Trends Biotechnol., 15 , 48
7 (1997), Anal. Biochem., 252 , 115 (1997), Nature,
358 , 325 (1992), Nature, 393 , 272 (1998), Cell, 9
2 , 573 (1998), J. Biol. Chem., 272 , 27497 (1997),
Trends Pharmacol. Sci., 18 , 430 (1997), Trends Pha
rmacol. Sci., 20 , 370 (1999), WO98 / 46995].
【0168】レポーター系を用いて細胞の応答をモニタ
ーする場合は、例えば、本発明のポリペプチドを発現す
る細胞に、該ポリペプチドの活性化により発現が誘導さ
れる遺伝子のプロモーター配列の下流に適当なレポータ
ー遺伝子を連結したDNAを導入することにより、該ポ
リペプチドの活性化をレポーター遺伝子の発現で測定す
ることができる。該プロモーターとしては、例えばIC
AM−1遺伝子のプロモーター、c−fosのプロモー
ター、Krox−24のプロモーター〔Biochem. J., 3
20, 145 (1996)〕などが利用できる。また、該プロモー
ターは、適当な転写因子の結合配列と基本プロモーター
からなる人工プロモーターでもよい。転写因子の結合配
列としては、例えばCRE(CREB binding element)、
TRE(TPA responsive element)、SRE(serum re
sponsive element)などが利用できる。レポーター遺伝
子としては、クロラムフェニコール・アセチルトランス
フェラーゼ遺伝子、β−グルクロニダーゼ遺伝子、β−
ガラクトシダーゼ遺伝子、β-ラクタマーゼ遺伝子、エ
クオリン遺伝子、ルシフェラーゼ遺伝子およびグリーン
・フルオレッセント・プロテイン遺伝子などが利用でき
る。When the response of a cell is monitored using a reporter system, for example, a cell expressing the polypeptide of the present invention may be appropriately placed downstream of a promoter sequence of a gene whose expression is induced by activation of the polypeptide. By introducing a DNA linked to any reporter gene, the activation of the polypeptide can be measured by the expression of the reporter gene. As the promoter, for example, IC
AM-1 gene promoter, c-fos promoter, Krox-24 promoter [Biochem. J., 3
20 , 145 (1996)]. Further, the promoter may be an artificial promoter consisting of a binding sequence of an appropriate transcription factor and a basic promoter. Examples of transcription factor binding sequences include CRE (CREB binding element),
TRE (TPA responsive element), SRE (serum re
sponsive element) can be used. Reporter genes include chloramphenicol acetyltransferase gene, β-glucuronidase gene,
The galactosidase gene, β-lactamase gene, aequorin gene, luciferase gene, green fluorescent protein gene and the like can be used.
【0169】上記方法で用いられる本発明のポリペプチ
ドを含有する細胞としては、上記(I)に記載したもの
を使用することができる。As the cells containing the polypeptide of the present invention used in the above method, those described in the above (I) can be used.
【0170】本発明のポリペプチドを発現する細胞とし
ては、上記(4)に記載したように、該ポリペプチドを
コードするDNAを含む組換え体DNAを適当な宿主細
胞に導入して得られる形質転換細胞のように大量に該ポ
リペプチドを発現している細胞を用いることもできる。
宿主細胞としては、大腸菌、枯草菌、酵母などの微生物
の他、昆虫細胞、カエルの卵母細胞、カエルのメラニン
細胞、動物細胞、植物細胞などを用いることができる
が、該形質転換細胞が発現する該ポリペプチドが高次構
造を保ち、リガンドとの結合性や機能性を保持するため
には、酵母、昆虫細胞、カエルの卵母細胞、カエルのメ
ラニン細胞、動物細胞、植物細胞などで発現させるのが
好ましい。また酵母の変異株や改変Gα蛋白質を発現さ
せた酵母などを宿主として利用することもできる〔Tren
ds in Biotechnology, 15, 487 (1997)、Mol. Cell. Bi
ol., 15, 6188 (1995)、Mol. Cell. Biol., 16, 4700
(1996)〕。As the cells expressing the polypeptide of the present invention, as described in the above (4), a plasmid obtained by introducing a recombinant DNA containing a DNA encoding the polypeptide into an appropriate host cell can be used. Cells expressing the polypeptide in large amounts, such as transformed cells, can also be used.
Examples of the host cell include microorganisms such as Escherichia coli, Bacillus subtilis, and yeast, as well as insect cells, frog oocytes, frog melanocytes, animal cells, plant cells, and the like. In order for the polypeptide to retain its higher-order structure and retain its binding property and functionality with a ligand, it is expressed in yeast, insect cells, frog oocytes, frog melanocytes, animal cells, plant cells, etc. It is preferred that Further, a mutant strain of yeast, a yeast expressing the modified Gα protein, or the like can also be used as a host [Tren
ds in Biotechnology, 15 , 487 (1997), Mol. Cell. Bi
ol., 15 , 6188 (1995), Mol. Cell. Biol., 16 , 4700.
(1996)].
【0171】試験物質としては、上記(II)に記載した
物質を使用することができる。As the test substance, the substances described in the above (II) can be used.
【0172】以下具体例を示す。Specific examples are shown below.
【0173】本発明のポリペプチドを発現する細胞をマ
ルチウェルプレート等に培養する。培養後、必要に応じ
て新鮮な培地あるいは細胞に毒性を示さない適当なバッ
ファーに交換し、試験化合物を添加して一定時間インキ
ュベートする。その後、細胞の応答(例えば、アラキド
ン酸遊離、アセチルコリン遊離、細胞内Ca2+遊離、細
胞内cAMP生成、細胞内cGMP生成、イノシトール
リン酸産生、細胞膜電位変動、細胞内蛋白質のリン酸
化、c−fos活性化、pHの低下、細胞増殖活性、メ
ラニン色素の凝集または拡散、またはレポーター遺伝子
の発現量などを促進する活性または抑制する活性など)
を測定する。例えば、上記細胞の抽出液や上清を用い
て、該細胞の応答により生成した産物を常法に従って定
量する。細胞刺激活性の指標とする物質(例えば、アラ
キドン酸など)の生成が、細胞が含有する分解酵素によ
って検定困難な場合は、該分解酵素に対する阻害剤を添
加して定量してもよい。また、cAMP産生抑制などの
活性については、フォルスコリンなどで細胞のcAMP
産生量を増大させておいた細胞に対する産生抑制作用と
して検出することができる。The cells expressing the polypeptide of the present invention are cultured in a multiwell plate or the like. After the culture, the medium is replaced with a fresh medium or an appropriate buffer that is not toxic to cells, if necessary, and the test compound is added thereto and incubated for a certain period of time. Thereafter, cellular responses (eg, arachidonic acid release, acetylcholine release, intracellular Ca 2+ release, intracellular cAMP production, intracellular cGMP production, inositol phosphate production, cell membrane potential fluctuation, intracellular protein phosphorylation, c- fos activation, pH lowering, cell growth activity, aggregation or diffusion of melanin pigment, activity to promote or suppress reporter gene expression, etc.)
Is measured. For example, using the cell extract or supernatant, the product produced by the response of the cells is quantified according to a conventional method. When production of a substance (for example, arachidonic acid or the like) as an indicator of cell stimulating activity is difficult to be assayed by a degrading enzyme contained in a cell, an inhibitor for the degrading enzyme may be added for quantification. In addition, for activities such as cAMP production inhibition, cells are cAMP-expressed with forskolin or the like.
It can be detected as a production inhibitory effect on cells whose production amount has been increased.
【0174】同様の操作を、本発明のペプチドを発現し
ない細胞についても行い、上記の細胞の応答を測定す
る。The same operation is performed for cells that do not express the peptide of the present invention, and the response of the cells is measured.
【0175】本発明のポリペプチドを含有する細胞を用
いた際の細胞の応答と、本発明のポリペプチドを発現し
ていない細胞を用いた際の細胞の応答を比較し、試験物
質より、本発明のポリペプチドを含有する細胞を用いた
際に細胞の応答が強く検出される物質を、本発明のポリ
ペプチドのリガンドとして選択することができる。The response of the cell when using the cell containing the polypeptide of the present invention was compared with the response of the cell when using the cell not expressing the polypeptide of the present invention. Substances that strongly detect cellular responses when cells containing the polypeptide of the present invention are used can be selected as ligands for the polypeptide of the present invention.
【0176】上記方法において、本発明のポリペプチド
を含有する細胞として、本発明のポリペプチドを発現し
ない宿主細胞に該ポリペプチドをコードするDNAをベ
クターに組み込んだ組換え体DNAを導入して得られ
る、本発明のポリペプチドを発現する細胞を用い、本発
明のポリペプチドを含有しない細胞として、同宿主細胞
にベクターのみを導入することによって作製した、本発
明のポリペプチドを発現しないコントロール細胞を用い
ることにより、リガンドの判定をより正確に行うことが
できる。 (6−2)本発明のG蛋白質共役型受容体ポリペプチド
に対するリガンドのスクリーニング用キット 本発明のポリペプチドまたはその塩に結合するリガンド
のスクリーニング用キットは、本発明のポリペプチドま
たは本発明の部分ペプチドもしくはそれらの塩、本発明
のポリペプチドまたは本発明の部分ペプチドを含有する
細胞、または該細胞の膜画分などを含有する。本発明の
リガンドのスクリーニング用キットの例としては、次の
ものがあげられる。 (a)リガンドスクリーニング用試薬 測定用緩衝液および洗浄用緩衝液 Hanks' Balanced Salt Solution(ギブコ社製)に、0.
05%のウシ血清アルブミン(シグマ社製)を加えたも
の。孔径0.45μmのフィルターで濾過滅菌し、4℃
で保存するか、あるいは用時調製しても良い。 本発明のポリペプチドまたは部分ペプチド標品 本発明のポリペプチドまたは部分ペプチドを発現させた
CHO細胞を、12穴プレートに5×105個/穴で継
代し、5%CO2 、95%air インキュベーター
中、37℃で2日間培養したもの。 標識試験化合物 市販の〔3H〕、〔125I〕、〔14C〕、〔35S〕などで
標識した化合物、または適当な方法で標識化した化合
物。該化合物の水溶液状態のものを4℃あるいは−20
℃にて保存し、用時に測定用緩衝液にて1μmol/Lに希
釈する。水に難溶性を示す試験化合物については、ジメ
チルホルムアミド、DMSO、メタノール等に溶解す
る。 非標識試験化合物 標識化合物の100〜1000倍濃度に調製した非標識
化合物。 (b)測定法 12穴組織培養用プレートを用いて培養した本発明の
ポリペプチドを発現するCHO細胞を、測定用緩衝液1
mlで2回洗浄した後、490μlの測定用緩衝液を各
穴に加える。 標識試験化合物を5μl加え、室温で1時間反応させ
る。非特異的結合量を知るために非標識試験化合物を5
μl加えておいたものを準備してもよい。 反応液を除去し、1mlの洗浄用緩衝液で3回洗浄す
る。細胞に結合した標識試験化合物を溶解液(0.2m
ol/L NaOH、1%SDS)で溶解し、4mlの
液体シンチレーターA(和光純薬製)と混合する。 液体シンチレーションカウンター(ベックマン社製)
を用いて放射活性を測定する。In the above method, the cells containing the polypeptide of the present invention may be obtained by introducing a recombinant DNA having a DNA encoding the polypeptide into a vector into a host cell that does not express the polypeptide of the present invention. A control cell that does not express the polypeptide of the present invention prepared by introducing only a vector into the host cell as a cell that does not contain the polypeptide of the present invention, using a cell that expresses the polypeptide of the present invention as a cell that does not contain the polypeptide of the present invention. By using this, the ligand can be determined more accurately. (6-2) Kit for screening ligand for G protein-coupled receptor polypeptide of the present invention Kit for screening ligand binding to polypeptide of the present invention or a salt thereof comprises polypeptide of the present invention or a part of the present invention It contains a peptide or a salt thereof, a cell containing the polypeptide of the present invention or the partial peptide of the present invention, or a membrane fraction of the cell. Examples of the kit for screening a ligand of the present invention include the following. (A) Ligand screening reagent Measurement buffer and washing buffer Hanks' Balanced Salt Solution (Gibco)
One containing 05% bovine serum albumin (manufactured by Sigma). Sterilized by filtration through a 0.45 μm filter, 4 ° C
Or may be prepared at the time of use. Preparation of polypeptide or partial peptide of the present invention CHO cells expressing the polypeptide or partial peptide of the present invention were subcultured on a 12-well plate at 5 × 10 5 cells / well, and 5% CO 2 , 95% air Cultured at 37 ° C. for 2 days in an incubator. Labeled test compound A compound labeled with commercially available [ 3 H], [ 125 I], [ 14 C], [ 35 S], or the like, or a compound labeled by an appropriate method. An aqueous solution of the compound at 4 ° C or -20
Store at ℃ and dilute to 1 μmol / L with a measuring buffer before use. Test compounds that are poorly soluble in water are dissolved in dimethylformamide, DMSO, methanol and the like. Unlabeled test compound An unlabeled compound prepared at a concentration of 100 to 1000 times that of the labeled compound. (B) Measuring method CHO cells expressing the polypeptide of the present invention, which were cultured using a 12-well tissue culture plate, were placed in a measuring buffer 1
After washing twice with ml, 490 μl of measurement buffer is added to each well. 5 μl of the labeled test compound is added and reacted at room temperature for 1 hour. In order to know the amount of non-specific binding, 5
What has been added may be prepared. Remove the reaction solution and wash 3 times with 1 ml of washing buffer. The labeled test compound bound to the cells is dissolved in a lysis solution (0.2 m
ol / L NaOH, 1% SDS) and mixed with 4 ml of liquid scintillator A (manufactured by Wako Pure Chemical Industries). Liquid scintillation counter (Beckman)
The radioactivity is measured using.
【0177】本発明のポリペプチドのリガンドとして
は、例えば、脳、視床下部、下垂体、膵臓などに存在す
る物質などが挙げられるが、本発明のリガンドには、既
知のリガンドは含まれない。既知のリガンドとしては、
アンギオテンシン、ボンベシン、カナビノイド、コレシ
ストキニン、グルタミン、セロトニン、メラトニン、ニ
ューロペプチドY、オピオイド、プリン、バソプレッシ
ン、オキシトシン、PACAP、セクレチン、グルカゴ
ン、カルシトニン、アドレノメジュリン、ソマトスタチ
ン、GHRH、CRF、ACTH、メラニンスティミュ
レーションホルモン、GRP、PTH、VIP、ドーパ
ミン、モチリン、アミリン、ブラジキニン、CGRP、
ロイコトリエン、パンクレアスタチン、プロスタグラン
ジン、トロンボキサン、アデノシン、アドレナリン、α
およびβ−ケモカイン(例えば、IL−8、GROα、
GROβ、GROγ、NAP−2、ENA−78、PF
4、IP10、GCP−2、MCP−1、HC14、M
CP−3、I−309、MIP1α、MIP−1β、R
ANTESなど)、エンドセリン、エンテロガストリ
ン、ヒスタミン、ニューロテンシン、TRH、パンクレ
アティックポリペプタイド、ガラニン、ウロテンシンI
およびII、ニューロペプチドFF、オレキシンおよび
メラニンコンセントレーティングホルモンなどがあげら
れる。 (6−3)本発明のG蛋白質共役型受容体ポリペプチド
に対するリガンドの定量法 本発明のポリペプチドまたはその部分ペプチドもしくは
それらの塩は、リガンドに対して結合性を有しているの
で、生体内におけるリガンド濃度を感度良く定量するこ
とができる。本発明の定量法は、例えば、競合法と組み
合わせることによって用いることができる。すなわち、
被検体を本発明のポリペプチドまたはその部分ペプチド
もしくはそれらの塩と接触させることによって、被検体
中のリガンド濃度を測定することができる。具体的に
は、例えば、既知の方法〔入江寛編「ラジオイムノアッ
セイ」(講談社、昭和49年発行)、入江寛編「続ラジ
オイムノアッセイ」(講談社、昭和54年発行)〕ある
いはそれに準じる方法に従って行うことができる。 (6−4)本発明のG蛋白質共役型受容体ポリペプチド
のアゴニスト、アンタゴニストまたは機能修飾物質のス
クリーニング方法 本発明のポリペプチドまたはその部分ペプチドもしくは
それらの塩、あるいは本発明のポリペプチドまたは部分
ペプチドを発現する細胞や該細胞の膜画分は、本発明の
ポリペプチドに対するアゴニスト、アンタゴニストまた
は機能修飾物質を選択するための試薬として有用であ
る。The ligand of the polypeptide of the present invention includes, for example, substances present in the brain, hypothalamus, pituitary gland, pancreas and the like, but the ligand of the present invention does not include known ligands. Known ligands include:
Angiotensin, bombesin, cannabinoid, cholecystokinin, glutamine, serotonin, melatonin, neuropeptide Y, opioid, purine, vasopressin, oxytocin, PACAP, secretin, glucagon, calcitonin, adrenomedullin, somatostatin, GHRH, CRF, ACTH, ACTH Simulation hormone, GRP, PTH, VIP, dopamine, motilin, amylin, bradykinin, CGRP,
Leukotriene, pancreastatin, prostaglandin, thromboxane, adenosine, adrenaline, α
And β-chemokines (eg, IL-8, GROα,
GROβ, GROγ, NAP-2, ENA-78, PF
4, IP10, GCP-2, MCP-1, HC14, M
CP-3, I-309, MIP1α, MIP-1β, R
ANTES, etc.), endothelin, enterogastrin, histamine, neurotensin, TRH, pancreatic polypeptide, galanin, urotensin I
And II, neuropeptide FF, orexin and melanin concentrating hormone. (6-3) Method for Quantifying Ligands for G Protein-Coupled Receptor Polypeptides of the Present Invention Since the polypeptides of the present invention or partial peptides thereof or salts thereof have binding properties to ligands, Ligand concentration in the body can be quantified with high sensitivity. The quantification method of the present invention can be used, for example, by combining it with a competition method. That is,
The ligand concentration in the subject can be measured by contacting the subject with the polypeptide of the present invention or a partial peptide thereof or a salt thereof. Specifically, for example, it is carried out according to a known method ("Radio Immunoassay" edited by Hiroshi Irie (Kodansha, published in 1974), "Radio Immunoassay" (edited by Hiroshi Irie) (published in Kodansha, 1974) or a method according thereto. be able to. (6-4) Method of Screening for Agonist, Antagonist or Functional Modifier of G Protein-Coupled Receptor Polypeptide of the Present Invention Polypeptide of the present invention or a partial peptide thereof or a salt thereof, or polypeptide or partial peptide of the present invention The cells that express E. coli and the membrane fraction of these cells are useful as reagents for selecting agonists, antagonists or functional modifiers for the polypeptide of the present invention.
【0178】本発明のポリペプチドのアゴニスト、アン
タゴニストまたは機能修飾物質のスクリーニング方法と
しては、例えば、(A) 本発明のポリペプチドまた
はその部分ペプチドもしくはそれらの塩と、リガンドと
を接触させた場合と、本発明のポリペプチドまたはそ
の部分ペプチドもしくはそれらの塩と、リガンドおよび
試験物質とを接触させた場合との比較を行ない、試験物
質より本発明のポリペプチドのアゴニスト、アンタゴニ
ストまたは機能修飾物質を選択することを特徴とする方
法、(B) 本発明のポリペプチドまたはその部分ペ
プチドを発現する細胞または該細胞膜画分と、リガンド
とを接触させた場合と、本発明のポリペプチドまたは
その部分ペプチドを発現する細胞または該細胞膜画分
と、リガンドおよび試験物質とを接触させた場合との比
較を行ない、試験物質より本発明のポリペプチドのアゴ
ニスト、アンタゴニストまたは機能修飾物質を選択する
ことを特徴とする方法、(C) 上記(6−1)の
(a)〜(d)に記載した本発明のポリペプチドのリガ
ンドの探索法と同じ方法を用いることを特徴とする方
法、をあげることができる。As a method for screening for agonists, antagonists or functional modifiers of the polypeptide of the present invention, for example, (A) a method in which the polypeptide of the present invention or its partial peptide or a salt thereof is contacted with a ligand; Comparison between the case where the polypeptide of the present invention or a partial peptide thereof or a salt thereof is brought into contact with a ligand and a test substance is carried out, and an agonist, an antagonist or a function modifying substance of the polypeptide of the present invention is selected from the test substance. (B) a cell expressing the polypeptide of the present invention or a partial peptide thereof, or a cell membrane fraction thereof, and a ligand, and the polypeptide of the present invention or a partial peptide thereof. Expressing cells or the cell membrane fraction, ligand and test substance (C) a method characterized by comparing with the case of contacting and selecting an agonist, antagonist or function modifying substance of the polypeptide of the present invention from the test substance; A method characterized by using the same method as the method for searching for the ligand of the polypeptide of the present invention described in (d).
【0179】また、上記(6−1)の(a)〜(d)に
記載した本発明のポリペプチドのリガンドの探索法にお
いては(6−1)に記載した構成活性型の変異ポリペプ
チドを用いることを特徴とする、本発明のポリペプチド
のアゴニスト、アンタゴニストまたは機能修飾物質のス
クリーニング方法もあげることができる。In the method for searching for a ligand of the polypeptide of the present invention described in (a) to (d) of (6-1), the constitutively active mutant polypeptide described in (6-1) is used. A screening method for an agonist, antagonist or functional modifier of the polypeptide of the present invention, which is characterized in that it is used, can also be mentioned.
【0180】より具体的には、(a) 標識したリガ
ンドを、本発明のポリペプチドまたは部分ペプチドもし
くはそれらの塩に接触させた場合と、標識したリガン
ドおよび試験物質を本発明のポリペプチドまたはその部
分ペプチドもしくはそれらの塩に接触させた場合におけ
る、標識したリガンドの該ポリペプチドまたはその部分
ペプチドもしくはそれらの塩に対する結合量を測定して
比較し、標識したリガンドより本発明のポリペプチドの
アゴニスト、アンタゴニストまたは機能修飾物質を選択
することを特徴とする、本発明のポリペプチドのアゴニ
スト、アンタゴニストまたは機能修飾物質のスクリーニ
ング方法、(b) 標識したリガンドを、本発明のポ
リペプチドまたは部分ペプチドを含有する細胞または該
細胞の膜画分に接触させた場合と、標識したリガンド
および試験物質を本発明のポリペプチドまたは部分ペプ
チドを含有する細胞または該細胞の膜画分に接触させた
場合における、標識したリガンドの該細胞または該膜画
分に対する結合量を測定して比較し、標識したリガンド
より本発明のポリペプチドのアゴニスト、アンタゴニス
トまたは機能修飾物質を選択することを特徴とする、本
発明のポリペプチドのアゴニスト、アンタゴニストまた
は機能修飾物質のスクリーニング方法、(c) リガ
ンドを本発明のポリペプチドを含有する細胞または該細
胞の膜画分に接触させた場合と、リガンドと試験物質
を本発明のポリペプチドを含有する細胞または該細胞の
膜画分に接触させた場合における、標識したGTPγS
のGα蛋白質(膜画分)への結合量を測定して比較し、
試験物質より本発明のポリペプチドのアゴニスト、アン
タゴニストまたは機能修飾物質を選択するを特徴とする
本発明のポリペプチドのアゴニスト、アンタゴニストま
たは機能修飾物質のスクリーニング方法、(d) リ
ガンドを本発明のポリペプチドを含有する細胞または該
細胞の膜画分に接触させた場合と、リガンドと試験物
質を本発明の受容体蛋白質を含有する細胞または該細胞
の膜画分に接触させた場合におけるGTPase活性を
測定して比較し、試験物質より本発明のポリペプチドの
アゴニスト、アンタゴニストまたは機能修飾物質を選択
することを特徴とする、本発明のポリペプチドのアゴニ
スト、アンタゴニストまたは機能修飾物質のスクリーニ
ング方法、(e) リガンドを本発明のポリペプチド
を含有する細胞または該細胞の膜画分に接触させた場合
と、リガンドと試験物質を本発明のポリペプチドまた
は部分ペプチドを含有する細胞または該細胞の膜画分に
接触させた場合における本発明のポリペプチドを介した
細胞刺激活性(例えば、アラキドン酸遊離、アセチルコ
リン遊離、細胞内Ca2+遊離、細胞内cAMP生成、細
胞内cGMP生成、イノシトールリン酸産生、細胞膜電
位変動、細胞内蛋白質のリン酸化、c−fos活性化、
pHの低下、細胞増殖活性、メラニン色素の凝集または
拡散、またはレポーター遺伝子の発現量などを促進する
活性または抑制する活性など)を測定して比較し、試験
物質より本発明のポリペプチドのアゴニスト、アンタゴ
ニストまたは機能修飾物質を選択することを特徴とす
る、本発明の受容体蛋白質のアゴニスト、アンタゴニス
トまたは機能修飾物質のスクリーニング方法、(f)試
験物質を本発明のポリペプチドを含有する細胞または該
細胞の膜画分に接触させた場合における、標識したGT
PγSのGα蛋白質(膜画分)への結合量を測定し、試
験物質より本発明のポリペプチドのアゴニストまたは機
能修飾物質を選択することを特徴とする、本発明のポリ
ペプチドのアゴニストまたは機能修飾物質のスクリーニ
ング方法、(g)試験物質を本発明のポリペプチドを含
有する細胞または該細胞の膜画分に接触させた場合にお
けるGTPase活性を測定し、試験物質より本発明の
ポリペプチドのアゴニストまたは機能修飾物質を選択す
ることを特徴とする本発明のポリペプチドのアゴニスト
または機能修飾物質のスクリーニング方法、(h)試験
物質を、本発明のポリペプチドを含有する細胞に接触さ
せた場合における、本発明のポリペプチドまたは部分ペ
プチドを介した細胞刺激活性(例えば、アラキドン酸遊
離、アセチルコリン遊離、細胞内Ca2+遊離、細胞内c
AMP生成、細胞内cGMP生成、イノシトールリン酸
産生、細胞膜電位変動、細胞内蛋白質のリン酸化、c−
fos活性化、pHの低下、メラニン色素の凝集または
拡散、またはレポーター遺伝子の発現量などを促進する
活性または抑制する活性など)を測定し、試験物質より
本発明のポリペプチドのアゴニストまたは機能修飾物質
を選択することを特徴とする、本発明のポリペプチドの
アゴニストまたは機能修飾物質のスクリーニング方法、
(i)上記(a)〜(h)において、本発明のポリペプ
チドとして構成活性型に変異させたポリペプチドを使用
することを特徴とする本発明のポリペプチドのアゴニス
ト、アンタゴニストまたは機能修飾物質のスクリーニン
グ方法、をあげることができる。More specifically, (a) the case where the labeled ligand is brought into contact with the polypeptide of the present invention or the partial peptide or a salt thereof, and the case where the labeled ligand and the test substance are brought into contact with the polypeptide of the present invention or the same. When contacted with a partial peptide or a salt thereof, the amount of the labeled ligand bound to the polypeptide or the partial peptide or a salt thereof is measured and compared, and an agonist of the polypeptide of the present invention is obtained from the labeled ligand; A method for screening for an agonist, antagonist or function-modifying substance of the polypeptide of the present invention, which comprises selecting an antagonist or a function-modifying substance; and (b) a labeled ligand containing the polypeptide or partial peptide of the present invention. Contacted with cells or membrane fraction of the cells When the labeled ligand and the test substance are brought into contact with the cell or the membrane fraction of the cell containing the polypeptide or partial peptide of the present invention, the amount of the labeled ligand bound to the cell or the membrane fraction Measuring and comparing the agonist, antagonist or function modifier of the polypeptide of the present invention from the labeled ligand, screening method of agonist, antagonist or function modifier of the polypeptide of the present invention, (C) When the ligand is brought into contact with the cell containing the polypeptide of the present invention or the membrane fraction of the cell, and when the ligand and the test substance are brought into contact with the cell containing the polypeptide of the present invention or the membrane fraction of the cell. Labeled GTPγS when contacted
Is measured and compared to the Gα protein (membrane fraction),
A method of screening for an agonist, antagonist or function-modifying substance of the polypeptide of the present invention, which comprises selecting an agonist, antagonist or function-modifying substance of the polypeptide of the present invention from a test substance; GTPase activity was measured in the case of contacting with a cell containing the or a membrane fraction of the cell, and in the case of contacting a ligand and a test substance with a cell containing the receptor protein of the present invention or a membrane fraction of the cell. (E) a method of screening for an agonist, antagonist or function-modifying substance of the polypeptide of the present invention, which comprises selecting an agonist, antagonist or function-modifying substance of the polypeptide of the present invention from the test substance. Ligand is added to a cell containing the polypeptide of the present invention or the cell. A cell containing the polypeptide or partial peptide of the present invention or a cell mediated by the polypeptide of the present invention in a case where the ligand and the test substance are brought into contact with the membrane fraction of the cell. Stimulation activity (eg, arachidonic acid release, acetylcholine release, intracellular Ca 2+ release, intracellular cAMP production, intracellular cGMP production, inositol phosphate production, cell membrane potential fluctuation, intracellular protein phosphorylation, c-fos activation ,
pH decrease, cell proliferation activity, aggregation or diffusion of melanin pigment, or activity to promote or suppress the expression level of a reporter gene, etc.). A method for screening for an agonist, antagonist or function-modifying substance of the receptor protein of the present invention, which comprises selecting an antagonist or a function-modifying substance; (f) a cell containing the polypeptide of the present invention as a test substance or the cell; GT in contact with the membrane fraction of
Measuring the amount of binding of PγS to Gα protein (membrane fraction) and selecting an agonist or functional modifier of the polypeptide of the present invention from the test substance; A method for screening a substance, (g) measuring the GTPase activity when a test substance is brought into contact with a cell containing the polypeptide of the present invention or a membrane fraction of the cell, and determining whether an agonist of the polypeptide of the present invention or A method for screening for an agonist or a function-modifying substance of the polypeptide of the present invention, which comprises selecting a function-modifying substance; and (h) a method for contacting a test substance with a cell containing the polypeptide of the present invention. Cell stimulating activity via the polypeptides or partial peptides of the invention (eg, arachidonic acid release, acetylcholine Release, intracellular Ca 2+ release, intracellular c
AMP production, intracellular cGMP production, inositol phosphate production, cell membrane potential fluctuation, intracellular protein phosphorylation, c-
fos activation, pH reduction, melanin pigment aggregation or diffusion, or activity to promote or suppress reporter gene expression, etc.) is measured, and an agonist or functional modifier of the polypeptide of the present invention is determined from the test substance. A method of screening for an agonist or a function modifier of the polypeptide of the present invention, characterized by selecting
(I) In the above (a) to (h), an agonist, antagonist or function-modifying substance of the polypeptide of the present invention, characterized in that a polypeptide mutated to a constitutively active form is used as the polypeptide of the present invention. Screening methods.
【0181】上記(a)および(b)で選択された物質
は、上記(c)〜(i)の方法を用いて、アゴニスト、
アンタゴニストまたは機能修飾物質かを区別することが
できる。一方、上記(a)〜(i)の方法で選択された
物質の中には、本発明のポリペプチドのアゴニストやア
ンタゴニストではないが、本発明のポリペプチドの機能
を修飾できる物質(機能修飾物質)も含まれる。例え
ば、(a)〜(i)の方法で選択された物質の中には、
本発明のポリペプチドとG蛋白質の共役を阻害したり増
強したりする物質も含まれると考えられる。また、
(c)〜(i)の方法で選択された物質の中には、本発
明のポリペプチドより下流のシグナルを阻害したり増強
する物質も含まれると考えられる。これら機能修飾物質
も医薬品の候補として有用である。The substances selected in the above (a) and (b) can be obtained by using the above methods (c) to (i)
It is possible to distinguish between antagonists or functional modifiers. On the other hand, among the substances selected by the above methods (a) to (i), substances which are not agonists or antagonists of the polypeptide of the present invention but which can modify the function of the polypeptide of the present invention (function modifying substances) ) Is also included. For example, among the substances selected by the methods (a) to (i),
It is considered that a substance that inhibits or enhances coupling between the polypeptide of the present invention and a G protein is also included. Also,
It is considered that the substances selected by the methods (c) to (i) include substances that inhibit or enhance signals downstream of the polypeptide of the present invention. These functional modifiers are also useful as drug candidates.
【0182】上記方法による本発明のポリペプチドのア
ゴニスト、アンタゴニストまたは機能修飾物質のスクリ
ーニング方法の詳細な説明を以下にする。 (I)リガンドの結合量を測定する方法 上記(a)および(b)に示したように、本発明のポリ
ペプチドまたは部分ペプチド若しくはそれらの塩、ある
いは本発明のポリペプチドまたは部分ペプチドを発現す
る細胞に対して試験物質と標識したリガンドを作用さ
せ、本発明のポリペプチドまたは部分ペプチド若しくは
その塩に対するリガンドの結合量を測定することによ
り、本発明のポリペプチドに対するアゴニスト、アンタ
ゴニストまたは機能修飾物質のスクリーニングを行うこ
とができる。A detailed description of the method for screening for an agonist, antagonist or functional modifier of the polypeptide of the present invention by the above method will be given below. (I) Method for Measuring the Amount of Ligand Binding As shown in (a) and (b) above, the polypeptide or partial peptide of the present invention or a salt thereof, or the polypeptide or partial peptide of the present invention is expressed. A test substance and a labeled ligand are allowed to act on cells, and the amount of the ligand bound to the polypeptide or partial peptide of the present invention or a salt thereof is measured. Screening can be performed.
【0183】標識したリガンドとしては、標識したリガ
ンド、標識したリガンドアナログ化合物などを用いるこ
とができる。例えば〔3H〕、〔125I〕、〔14C〕、〔
35S〕などで標識されたリガンドなどを用いることがで
きる。As the labeled ligand, a labeled ligand, a labeled ligand analog compound and the like can be used. For example, [ 3 H], [ 125 I], [ 14 C], [
35 S] or the like.
【0184】試験物質としてはいかなる物質も使用でき
るが、例えば、既知ペプチド、既知GPCRリガンド、
既知蛋白質、組換え技術を用いて生産された組換え蛋白
質、細胞抽出液や該抽出液由来の精製物、細胞培養上清
や該上清由来の精製物、血清などの生体試料や該生体試
料由来の精製物、微生物の菌体抽出液や該抽出液由来の
精製物、微生物培養上清や該上清由来の精製物、既知化
合物、コンビナトリアルケミストリーを用いて合成され
た化合物などを使用することができる。As a test substance, any substance can be used. For example, a known peptide, a known GPCR ligand,
Biological samples and biological samples such as known proteins, recombinant proteins produced using recombinant techniques, cell extracts and purified products derived from the extracted solutions, cell culture supernatants and purified products derived from the supernatants, serum and the like Use of a purified product derived from a microorganism, a cell extract of a microorganism, a purified product derived from the extract, a microorganism culture supernatant or a purified product derived from the supernatant, a known compound, a compound synthesized using combinatorial chemistry, or the like. Can be.
【0185】本方法に用いる本発明のポリペプチドまた
は部分ペプチドとしては、該ポリペプチドまたは部分ペ
プチドを含有するものであれば何れのものであってもよ
く、該ポリペプチドまたは部分ペプチドを含有する細胞
から精製した該ポリペプチドまたは部分ペプチドでもよ
いし、該ポリペプチドまたは部分ペプチドを含有する細
胞そのものまたはその細胞膜画分を用いてもよい。該ポ
リペプチドまたは部分ペプチドを含有する細胞を用いる
場合、該細胞をグルタルアルデヒド、ホルマリンなどで
固定化してもよい。The polypeptide or partial peptide of the present invention used in the present method may be any as long as it contains the polypeptide or partial peptide, and may be a cell containing the polypeptide or partial peptide. The polypeptide or the partial peptide purified from the above may be used, or a cell containing the polypeptide or the partial peptide itself or a cell membrane fraction thereof may be used. When cells containing the polypeptide or partial peptide are used, the cells may be immobilized with glutaraldehyde, formalin, or the like.
【0186】また、本発明のポリペプチドまたは部分ペ
プチドとしては、天然に存在するポリペプチドまたは部
分ペプチド、あるいは遺伝子組換えの手法を用いて作製
した組換えポリペプチドまたは組換え部分ペプチドのい
ずれでもよいが、(3)に記載の方法により、配列番号
2で表される塩基配列を有するDNAに変異を導入して
得られる変異DNAにコードされるポリペプチドのう
ち、構成的に活性型となった変異型ポリペプチドは特に
有用である。[0186] The polypeptide or partial peptide of the present invention may be a naturally occurring polypeptide or partial peptide, or a recombinant polypeptide or a recombinant partial peptide prepared using a gene recombination technique. Was constitutively active in the polypeptide encoded by the mutated DNA obtained by introducing a mutation into the DNA having the base sequence represented by SEQ ID NO: 2 by the method described in (3). Variant polypeptides are particularly useful.
【0187】構成活性型に変異したGPCRについては
(6−1)に記載したように、該変異GPCRでは、ア
ゴニストとの親和性が増加する場合があることが知られ
ていることから、構成活性型の変異GPCRはアゴニス
トの探索において有用である。アンタゴニストの探索に
は、普通はリガンドを使用する必要があるが、リガンド
が不明のGPCR(オーファンGPCRと呼ばれる)の
場合はリガンドを使用することができない。しかし、天
然型または変異型の構成活性型GPCRを用いれば、リ
ガンドがなくてもアンタゴニストの探索が可能になる。
例えば、構成活性型GPCRポリペプチドを細胞に過剰
に発現させた際に流れるシグナルやG蛋白質の活性化を
抑制する物質を探索することにより、アンタゴニストを
選択することが可能である。この際、アンタゴニストと
ともにGPCRの機能修飾物質も選択されうる。また、
構成活性型GPCRポリペプチドを細胞に過剰に発現さ
せた際に流れるシグナルやG蛋白質の活性化を増強する
物質を探索することにより、アゴニストや機能修飾物質
も選択することができる。As described in (6-1), regarding the GPCR mutated to the constitutively active form, it is known that the mutant GPCR may have an increased affinity for agonists. Mutant GPCRs of the type are useful in the search for agonists. Searching for an antagonist usually requires the use of a ligand, but in the case of a GPCR whose ligand is unknown (called an orphan GPCR), the ligand cannot be used. However, if a natural or mutant constitutively active GPCR is used, it is possible to search for an antagonist without a ligand.
For example, an antagonist can be selected by searching for a signal that flows when a constitutively active GPCR polypeptide is overexpressed in a cell or a substance that suppresses activation of a G protein. At this time, a GPCR function modifier may be selected together with the antagonist. Also,
By searching for a signal that flows when the constitutively active GPCR polypeptide is overexpressed in cells and a substance that enhances the activation of G protein, an agonist or a function modifying substance can also be selected.
【0188】GPCRに変異が生じて構成活性型に変化
したことが原因で起こる疾患が多数知られている〔日本
臨床, 56, 1658 (1998)、日本臨床, 56, 1843 (1998)、
日本臨床, 56, 1856 (1998)、日本臨床, 56, 1931 (199
8)、Trends in Endocrinology and Metabolism, 9, 27
(1998)、Endocrinology, 137, 3936 (1996)〕。これら
の構成活性型変異GPCRの活性を抑制できるアンタゴ
ニスト(インバースアゴニストと呼ばれる)は、構成活
性型変異GPCRが原因で起こる疾患の治療に有用であ
る。アンタゴニストは、ニュートラルアンタゴニストと
インバースアゴニストに分類される。インバースアゴニ
ストは構成活性型GPCRの活性を抑制することができ
るが、ニュートラルアンタゴニストは構成的活性を抑制
することができない。構成活性型変異GPCRは、イン
バースアゴニストの探索に有用である。A number of diseases caused by mutations in GPCRs and changes to constitutively active forms have been known [Japanese clinical practice, 56 , 1658 (1998), Japanese clinical practice, 56 , 1843 (1998),
Japanese clinical, 56 , 1856 (1998), Japanese clinical, 56 , 1931 (199)
8), Trends in Endocrinology and Metabolism, 9 , 27
(1998), Endocrinology, 137 , 3936 (1996)]. Antagonists capable of suppressing the activity of these constitutively active mutant GPCRs (called inverse agonists) are useful for treating diseases caused by constitutively active mutant GPCRs. Antagonists are classified into neutral antagonists and inverse agonists. Inverse agonists can suppress the activity of constitutively active GPCRs, whereas neutral antagonists cannot suppress constitutive activity. The constitutively active mutant GPCR is useful for searching for an inverse agonist.
【0189】上記方法に用いられる細胞膜画分は、上記
(6−1)に記載した方法により調製することができ
る。The cell membrane fraction used in the above method can be prepared by the method described in the above (6-1).
【0190】本発明のポリペプチドまたは部分ペプチド
を発現する細胞としては、上記(4)に記載したよう
に、該ポリペプチドをコードするDNAを含む組換え体
DNAを適当な宿主細胞に導入して得られる形質転換細
胞のように大量に該ポリペプチドを発現している細胞を
用いることもできる。宿主細胞としては大腸菌、枯草
菌、酵母などの微生物の他、昆虫細胞、カエルの卵母細
胞、カエルのメラニン細胞、動物細胞、植物細胞などが
用いられる。該形質転換細胞が発現する本発明のポリペ
プチドが高次構造を保ち、リガンドとの結合性を保持す
るためには、酵母、昆虫細胞、カエルの卵母細胞、カエ
ルのメラニン細胞、動物細胞、植物細胞などで発現させ
るのが好ましい。酵母の変異株や改変Gα蛋白質を発現
させた酵母などを宿主として利用することもできる〔Tr
ends in Biotechnology, 15, 487 (1997)、Mol. Cell.
Biol., 15, 6188 (1995)、Mol. Cell. Biol., 16, 4700
(1996)〕。As the cells expressing the polypeptide or partial peptide of the present invention, as described in the above (4), a recombinant DNA containing the DNA encoding the polypeptide is introduced into an appropriate host cell. Cells expressing the polypeptide in large amounts, such as the resulting transformed cells, can also be used. Examples of the host cell include microorganisms such as Escherichia coli, Bacillus subtilis, and yeast, as well as insect cells, frog oocytes, frog melanocytes, animal cells, and plant cells. In order that the polypeptide of the present invention expressed by the transformed cell retains a higher-order structure and retains binding with a ligand, yeast, insect cells, frog oocytes, frog melanocytes, animal cells, It is preferably expressed in plant cells and the like. A mutant strain of yeast or a yeast expressing the modified Gα protein can also be used as a host [Tr
ends in Biotechnology, 15 , 487 (1997), Mol. Cell.
Biol., 15 , 6188 (1995), Mol. Cell. Biol., 16 , 4700.
(1996)].
【0191】本発明のポリペプチドまたは部分ペプチド
を含有する細胞やその細胞膜画分中のGPCRの量は、
1細胞当たり103〜108分子であるのが好ましく、105〜1
07分子であるのが好適である。なお、発現量が多いほど
膜画分当たりのリガンド結合活性(比活性)が高くな
り、高感度なスクリーニング系の構築が可能になるばか
りでなく、同一ロットで大量の試料を測定できるように
なる。The amount of GPCR in cells containing the polypeptide or partial peptide of the present invention or in the cell membrane fraction thereof is as follows:
It is preferably 10 3 to 10 8 molecules per cell, preferably 10 5 to 1 molecule.
0 7 a molecule of is preferable. The higher the expression level, the higher the ligand binding activity (specific activity) per membrane fraction, which makes it possible not only to construct a highly sensitive screening system, but also to measure a large number of samples in the same lot. .
【0192】以下、具体例を示す。Hereinafter, specific examples will be described.
【0193】本発明のポリペプチドまたは部分ペプチド
の標品を、上記(6−1)に記載した方法により調製す
る。10μl〜10mlの該ポリペプチドまたは部分ペプチド
標品に、試験物質と放射性同位元素(3H、125I、14C、
35S、32Pなど)で標識した一定の放射能量のリガンドを
共存させる。非特異的結合量(NSB)を知るために大
過剰の未標識のリガンドを加えた反応チューブも用意す
る。反応は約0〜50℃、望ましくは約4〜37℃で、
約20分〜24時間、望ましくは約30分〜3時間行な
う。反応後、ガラス繊維濾紙等で濾過し、適量の同バッ
ファーで洗浄した後、ガラス繊維濾紙に残存する放射活
性を液体シンチレーションカウンターあるいはγ−カウ
ンターで計測する。全結合量(B)から非特異的結合量
(NSB)を引いたカウント(B−NSB)が特異的結
合量である。試験物質非存在下におけるリガンドの特異
的結合量と、試験物質存在下におけるリガンドの特異的
結合量を比較して、リガンドの特異的結合量を減少させ
る物質を本発明の受容体蛋白質のアゴニスト、アンタゴ
ニストまたは機能修飾物質として選択することができ
る。A preparation of the polypeptide or the partial peptide of the present invention is prepared by the method described in the above (6-1). To the polypeptide or partial peptide preparations of 10Myueru~10ml, the test substance and radioactive isotopes (3 H, 125 I, 14 C,
35 S, 32 P, etc.) and coexist with a certain amount of radioactive ligand. A reaction tube containing a large excess of unlabeled ligand is also prepared to determine the amount of non-specific binding (NSB). The reaction is carried out at about 0 to 50 ° C, preferably about 4 to 37 ° C,
The reaction is performed for about 20 minutes to 24 hours, preferably for about 30 minutes to 3 hours. After the reaction, the mixture is filtered with a glass fiber filter or the like, washed with an appropriate amount of the same buffer, and the radioactivity remaining on the glass fiber filter is measured with a liquid scintillation counter or a γ-counter. The count (B-NSB) obtained by subtracting the non-specific binding amount (NSB) from the total binding amount (B) is the specific binding amount. A specific binding amount of the ligand in the absence of the test substance, and comparing the specific binding amount of the ligand in the presence of the test substance, a substance that decreases the specific binding amount of the ligand, an agonist of the receptor protein of the present invention, It can be selected as an antagonist or a function modifier.
【0194】上記方法において、本発明のポリペプチド
または部分ペプチドを含有する細胞として、本発明のポ
リペプチドを発現しない宿主細胞に該ポリペプチドまた
は該部分ペプチドをコードするDNAをベクターDNA
に組み込んだ組換え体DNAを導入して得られる該ポリ
ペプチドまたは該部分ペプチドの大量発現細胞を用いる
ことにより、本発明の受容体蛋白質のアゴニスト、アン
タゴニストまたは機能修飾物質をより感度良く選択する
ことができる。また、同宿主細胞にベクターのみを導入
することによって得られる該ポリペプチドを発現しない
細胞や、同宿主細胞に他のG蛋白質共役型受容体ポリペ
プチドの発現プラスミドを導入することによって得られ
る他のG蛋白質共役型受容体ポリペプチドの発現細胞を
用いて同様の実験を行うことにより、取得したアゴニス
ト、アンタゴニストまたは機能修飾物質の本発明のG蛋
白質共役型受容体ポリペプチドに対する特異性を調べる
ことができる。 (II)GTPγSのGα蛋白質への結合量を測定する方
法 上記(c)に示したように、本発明のポリペプチドを含
有する細胞の膜画分に試験物質とリガンドを接触させ、
標識したGTPγSのGα蛋白質(膜画分)への結合量
を測定することにより、該GPCRのアゴニスト、アン
タゴニストまたは機能修飾物質をスクリーニングするこ
とができる〔Molecular Pharmacology,47, 848-854 (19
95)、WO98/46995〕。In the above method, as a cell containing the polypeptide or the partial peptide of the present invention, a host cell that does not express the polypeptide of the present invention is transformed into a vector DNA by encoding the DNA encoding the polypeptide or the partial peptide.
By using cells expressing a large amount of the polypeptide or the partial peptide obtained by introducing the recombinant DNA incorporated into the receptor, the agonist, antagonist or functional modifier of the receptor protein of the present invention can be selected with higher sensitivity. Can be. In addition, cells that do not express the polypeptide obtained by introducing only the vector into the same host cell, and other cells that are obtained by introducing an expression plasmid of another G protein-coupled receptor polypeptide into the same host cell. By performing similar experiments using cells expressing the G protein-coupled receptor polypeptide, it is possible to examine the specificity of the obtained agonist, antagonist or functional modifier for the G protein-coupled receptor polypeptide of the present invention. it can. (II) Method for measuring the amount of GTPγS bound to Gα protein As shown in (c) above, a test substance and a ligand are brought into contact with the membrane fraction of a cell containing the polypeptide of the present invention,
By measuring the amount of labeled GTPγS bound to the Gα protein (membrane fraction), it is possible to screen for agonists, antagonists or functional modifiers of the GPCR [Molecular Pharmacology, 47 , 848-854 (19)
95), WO98 / 46995].
【0195】また、上記(f)に示したように、本発明
のポリペプチドを含有する細胞の膜画分に試験物質を接
触させ、標識したGTPγSのGα蛋白質(膜画分)へ
の結合量を測定することにより、該ポリペプチドのアゴ
ニストまたは機能修飾物質をスクリーニングすることが
できる〔Molecular Pharmacology, 47, 848-854 (199
5)、WO98/46995〕。Further, as shown in (f) above, the test substance was brought into contact with the membrane fraction of the cells containing the polypeptide of the present invention, and the amount of labeled GTPγS bound to the Gα protein (membrane fraction). By measuring the molecular weight, an agonist or a functional modifier of the polypeptide can be screened [Molecular Pharmacology, 47 , 848-854 (1992).
5), WO98 / 46995].
【0196】試験物質としてはいかなる物質も使用でき
るが、例えば、既知ペプチド、既知GPCRリガンド、
既知蛋白質、組換え技術を用いて生産された組換え蛋白
質、細胞抽出液や該抽出液由来の精製物、細胞培養上清
や該上清由来の精製物、血清などの生体試料や該生体試
料由来の精製物、微生物の菌体抽出液や該抽出液由来の
精製物、微生物培養上清や該上清由来の精製物、既知化
合物、コンビナトリアルケミストリーを用いて合成され
た化合物などを使用することができる。標識したGTP
γSとしては、例えば35Sで標識したGTPγSを用い
ることができる。As a test substance, any substance can be used. For example, a known peptide, a known GPCR ligand,
Biological samples and biological samples such as known proteins, recombinant proteins produced using recombinant techniques, cell extracts and purified products derived from the extracted solutions, cell culture supernatants and purified products derived from the supernatants, serum and the like Use of a purified product derived from a microorganism, a cell extract of a microorganism, a purified product derived from the extract, a microorganism culture supernatant or a purified product derived from the supernatant, a known compound, a compound synthesized using combinatorial chemistry, or the like. Can be. GTP labeled
As γS, for example, GTPγS labeled with 35 S can be used.
【0197】本発明のポリペプチドを含有する細胞また
は該細胞の膜画分としては、上記(I)に記載したもの
を使用することができる。As the cells containing the polypeptide of the present invention or the membrane fraction of the cells, those described in the above (I) can be used.
【0198】以下、具体例を示す。Hereinafter, specific examples will be described.
【0199】本発明のポリペプチド標品を、上記(6−
1)に記載した方法により調製する。The polypeptide preparation of the present invention was prepared using the above (6-
Prepared by the method described in 1).
【0200】アゴニストのスクリーニングの際には、10
μl〜10mlの該ポリペプチド標品に、試験物質、放射性
同位元素(35Sなど)で標識した一定の放射能量のGT
PγS、およびGDPを共存させる。非特異的結合量
(NSB)を知る必要がある場合には、大過剰の未標識
のGTPγSを加えた反応チューブを用意する。全結合
量(B)から非特異的結合量(NSB)を引いたカウン
ト(B−NSB)が特異的結合量である。反応は約0〜
50℃、望ましくは約4〜37℃で、約20分〜24時
間、望ましくは約30分〜3時間行なう。反応後、ガラ
ス繊維濾紙等で濾過し、適量の同バッファーで洗浄した
後、ガラス繊維濾紙に残存する放射活性を液体シンチレ
ーションカウンターで計測する。GTPγSの膜画分へ
の結合を増強する活性を有する物質を、本発明のポリペ
プチドのアゴニストまたは機能修飾物質として選択する
ことができる。When screening for agonists, 10
A test substance, a radioactive isotope (such as 35 S) -labeled GT with a certain amount of radioactivity
PγS and GDP coexist. If it is necessary to know the non-specific binding amount (NSB), prepare a reaction tube to which a large excess of unlabeled GTPγS has been added. The count (B-NSB) obtained by subtracting the non-specific binding amount (NSB) from the total binding amount (B) is the specific binding amount. The reaction is about 0
The reaction is carried out at 50 ° C., preferably about 4-37 ° C., for about 20 minutes to 24 hours, preferably for about 30 minutes to 3 hours. After the reaction, the mixture is filtered with a glass fiber filter or the like, washed with an appropriate amount of the same buffer, and the radioactivity remaining on the glass fiber filter is measured with a liquid scintillation counter. A substance having an activity of enhancing the binding of GTPγS to the membrane fraction can be selected as an agonist or a function modifier of the polypeptide of the present invention.
【0201】アンタゴニストや機能修飾物質のスクリー
ニングの際には、10μl〜10 mlの上記ポリペプチド標
品に、リガンド、試験物質、放射性同位元素(35Sな
ど)で標識した一定の放射能量のGTPγS、およびG
DPを共存させて同様の実験を行う。試験物質非存在下
におけるGTPγSの結合量と、試験物質存在下におけ
るリガンドの結合量を比較して、GTPγSの結合量を
減少させる物質を本発明のポリペプチドのアンタゴニス
トまたは機能修飾物質として選択することができる。一
方、GTPγSの結合量を増加させる物質を本発明のポ
リペプチドの機能修飾物質またはアゴニストとして選択
することができる。When screening for antagonists or functional modifiers, a ligand, a test substance, a radioactive isotope (such as 35 S) -labeled GTPγS, And G
A similar experiment is performed in the presence of DP. Comparing the amount of GTPγS binding in the absence of the test substance with the amount of ligand binding in the presence of the test substance, and selecting a substance that reduces the amount of GTPγS binding as an antagonist or a functional modifier of the polypeptide of the present invention. Can be. On the other hand, a substance that increases the amount of GTPγS bound can be selected as a function-modifying substance or an agonist of the polypeptide of the present invention.
【0202】本発明のポリペプチドを含有する細胞とし
て、本発明のポリペプチドを発現しない宿主細胞に該ポ
リペプチドをコードするDNAをベクターに組み込んだ
組換え体DNAを導入して得られる該ポリペプチドの大
量発現細胞を用いることにより、本発明の受容体蛋白質
のアゴニスト、アンタゴニストまたは機能修飾物質をよ
り感度良く選択することができる。また、同宿主細胞に
ベクターのみを導入することによって得られる該ポリペ
プチドを発現しない細胞や、同宿主細胞に他のG蛋白質
共役型受容体ポリペプチドの発現プラスミドを導入する
ことによって作製した他のG蛋白質共役型受容体ポリペ
プチドの発現細胞を用いて同様の実験を行うことによ
り、取得したアゴニスト、アンタゴニストまたは機能修
飾物質の本発明のG蛋白質共役型受容体ポリペプチドに
対する特異性を調べることができる。 (III)GTPase活性を測定する方法 上記(d)に示したように、本発明のポリペプチドを含
有する細胞の膜画分にリガンドと試験物質を接触させ、
GTPase活性を測定することにより、該ポリペプチ
ドのアゴニスト、アンタゴニストまたは機能修飾物質を
スクリーニングすることができる〔J. Biol. Che., 27
1, 1857-1860 (1996)、WO98/46995〕。As a cell containing the polypeptide of the present invention, a polypeptide obtained by introducing a recombinant DNA obtained by incorporating a DNA encoding the polypeptide into a vector into a host cell that does not express the polypeptide of the present invention. By using cells expressing a large amount of the above, an agonist, an antagonist or a functional modifier of the receptor protein of the present invention can be selected with higher sensitivity. In addition, cells that do not express the polypeptide obtained by introducing only the vector into the same host cell, and other cells that are produced by introducing an expression plasmid for another G protein-coupled receptor polypeptide into the same host cell. By performing the same experiment using cells expressing the G protein-coupled receptor polypeptide, it is possible to examine the specificity of the obtained agonist, antagonist or functional modifier for the G protein-coupled receptor polypeptide of the present invention. it can. (III) Method for measuring GTPase activity As shown in (d) above, a ligand and a test substance are brought into contact with a membrane fraction of a cell containing the polypeptide of the present invention,
By measuring the GTPase activity, an agonist, antagonist or functional modifier of the polypeptide can be screened [J. Biol. Che., 27
1 , 1857-1860 (1996), WO98 / 46995].
【0203】また、上記(e)に示したように、本発明
のポリペプチドを含有する細胞の膜画分に試験物質を接
触させ、GTPase活性を測定することにより、該ポ
リペプチドのアゴニストまたは機能修飾物質をスクリー
ニングすることができる〔J.Biol. Che., 271, 1857-18
60 (1996)、WO98/46995〕。Further, as shown in the above (e), the test substance is brought into contact with the membrane fraction of the cell containing the polypeptide of the present invention, and the GTPase activity is measured to determine the agonist or function of the polypeptide. Modifiers can be screened [J. Biol. Che., 271 , 1857-18.
60 (1996), WO 98/46995].
【0204】試験物質としてはいかなる物質も使用でき
るが、例えば、既知ペプチド、既知GPCRリガンド、
既知蛋白質、組換え技術を用いて生産された組換え蛋白
質、細胞抽出液や該抽出液由来の精製物、細胞培養上清
や該上清由来の精製物、血清などの生体試料や該生体試
料由来の精製物、微生物の菌体抽出液や該抽出液由来の
精製物、微生物培養上清や該上清由来の精製物、既知化
合物、コンビナトリアルケミストリーを用いて合成され
た化合物などを使用することができる。As the test substance, any substance can be used. For example, a known peptide, a known GPCR ligand,
Biological samples and biological samples such as known proteins, recombinant proteins produced using recombinant techniques, cell extracts and purified products derived from the extracted solutions, cell culture supernatants and purified products derived from the supernatants, serum and the like Use of a purified product derived from a microorganism, a cell extract of a microorganism, a purified product derived from the extract, a microorganism culture supernatant or a purified product derived from the supernatant, a known compound, a compound synthesized using combinatorial chemistry, or the like. Can be.
【0205】本発明のポリペプチドを含有する細胞また
は該細胞の膜画分としては、上記(I)に記載したもの
を使用することができる。As the cells containing the polypeptide of the present invention or the membrane fraction of the cells, those described in the above (I) can be used.
【0206】以下、具体例を示す。Hereinafter, specific examples will be described.
【0207】本発明のポリペプチド標品を、上記(6−
1)に記載した方法により調製する。The polypeptide preparation of the present invention was prepared using the above (6-)
Prepared by the method described in 1).
【0208】アゴニストのスクリーニングの際には、10
μl〜10 mlの該ポリペプチド標品に、試験化合物、放
射性同位元素(32Pなど)で標識した一定の放射能量の
GTP(例えば[γ32P]GTP)を共存させる。反応
は約0〜50℃、望ましくは約4〜37℃で、約20分
〜24時間、望ましくは約30分〜3時間行なう。反応
後、反応液の上清を回収し、放出された[γ32P]Pi
の放射活性を液体シンチレーションカウンターで計測す
る。反応液をガラス繊維濾紙等で濾過し、適量の同バッ
ファーで洗浄した後、濾過液中の放射活性を液体シンチ
レーションカウンターで計測してもよい。GTPase
活性を増強する活性を有する物質を、本発明のポリペプ
チドのアゴニストまたは機能修飾物質として選択するこ
とができる。When screening for agonists, 10
the Myueru~10 ml of the polypeptide preparation, test compound coexist GTP radioactive isotopes (such as 32 P) constant amount of radioactivity labeled with (e.g. [γ 32 P] GTP). The reaction is carried out at about 0 to 50 ° C, preferably about 4 to 37 ° C, for about 20 minutes to 24 hours, preferably for about 30 minutes to 3 hours. After the reaction, the supernatant of the reaction solution was recovered, and the released [γ 32 P] Pi
Is measured with a liquid scintillation counter. After filtering the reaction solution with a glass fiber filter or the like and washing with an appropriate amount of the same buffer, the radioactivity in the filtrate may be measured with a liquid scintillation counter. GTPase
A substance having an activity of enhancing the activity can be selected as an agonist or a function modifier of the polypeptide of the present invention.
【0209】アンタゴニストや機能修飾物質のスクリー
ニングの際には、10μl〜10 mlの該ポリペプチド標品
に、リガンド、試験化合物、放射性同位元素(32Pな
ど)で標識した一定の放射能量のGTP(例えば[γ32
P]GTP)を共存させて同様の実験を行う。試験物質
非存在下におけるGTPase活性と、試験物質存在下
におけるGTPase活性を比較して、GTPase活
性を減少させる物質を本発明のポリペプチドのアンタゴ
ニストまたは機能修飾物質として選択することができ
る。一方、GTPase活性を増加させる物質を本発明
のポリペプチドの機能修飾物質またはアゴニストとして
選択することができる。When screening for antagonists or functional modifiers, 10 μl to 10 ml of the polypeptide preparation is added to a ligand, a test compound, a radioactive isotope (such as 32 P), and a certain amount of radioactive GTP ( For example, [γ 32
P] GTP) is used in the same experiment. By comparing the GTPase activity in the absence of the test substance with the GTPase activity in the presence of the test substance, a substance that decreases the GTPase activity can be selected as an antagonist or a function modifier of the polypeptide of the present invention. On the other hand, a substance that increases GTPase activity can be selected as a function modifier or an agonist of the polypeptide of the present invention.
【0210】本発明のポリペプチドを含有する細胞とし
て、本発明のポリペプチドを発現しない宿主細胞に該ポ
リペプチドをコードするDNAをベクターに組み込んだ
組換え体DNAを導入することによって得られる該ポリ
ペプチドの大量発現細胞を用いることにより、本発明の
受容体蛋白質のアゴニスト、アンタゴニストまたは機能
修飾物質をより感度良く選択することができる。また、
同宿主細胞にベクターのみを導入することによって得ら
れる該ポリペプチドを発現しない細胞や、同宿主細胞に
他のG蛋白質共役型受容体ポリペプチドの発現プラスミ
ドを導入することによって得られる他のG蛋白質共役型
受容体ポリペプチドの発現細胞を用いて同様の実験を行
うことにより、取得したアゴニスト、アンタゴニストま
たは機能修飾物質の本発明のG蛋白質共役型受容体ポリ
ペプチドに対する特異性を調べることができる。 (IV)細胞の応答を検出する方法 上記(e)に示したように、本発明のポリペプチドを発
現する細胞にリガンドと試験物質を接触させ、該ポリペ
プチドの活性化を細胞の応答を指標として検出すること
により、該ポリペプチドのアゴニスト、アンタゴニスト
または機能修飾物質をスクリーニングすることができ
る。As a cell containing the polypeptide of the present invention, a recombinant DNA obtained by introducing a DNA encoding the polypeptide into a vector is introduced into a host cell that does not express the polypeptide of the present invention. By using cells expressing a large amount of the peptide, the agonist, antagonist or functional modifier of the receptor protein of the present invention can be selected with higher sensitivity. Also,
A cell that does not express the polypeptide obtained by introducing only a vector into the host cell, or another G protein that is obtained by introducing an expression plasmid for another G protein-coupled receptor polypeptide into the host cell By performing a similar experiment using cells expressing the conjugated receptor polypeptide, the specificity of the obtained agonist, antagonist, or function modifying substance for the G protein-coupled receptor polypeptide of the present invention can be examined. (IV) Method of Detecting Cell Response As shown in (e) above, a cell expressing the polypeptide of the present invention is brought into contact with a ligand and a test substance, and the activation of the polypeptide is used as an indicator of the cell response. As a result, an agonist, antagonist or functional modifier of the polypeptide can be screened.
【0211】また、上記(h)に示したように、本発明
のポリペプチドを発現する細胞に試験物質を接触させ、
該ポリペプチドの活性化を細胞の応答を指標として検出
することにより、該ポリペプチドのアゴニストまたは機
能修飾物質をスクリーニングすることができる。[0211] As shown in the above (h), a test substance is brought into contact with cells expressing the polypeptide of the present invention.
By detecting the activation of the polypeptide using the response of the cell as an index, an agonist or a functional modifier of the polypeptide can be screened.
【0212】細胞の応答としては、例えば、アラキドン
酸遊離、アセチルコリン遊離、細胞内Ca2+遊離、細胞
内cAMP生成、細胞内cAMP減少、細胞内cGMP
生成、イノシトールリン酸産生、細胞膜電位変動、細胞
内蛋白質のリン酸化、c−fos活性化、pHの低下、
細胞増殖活性、メラニン色素の凝集または拡散などを測
定する。また、レポーター系を用いて細胞の応答をモニ
ターすることもできる。例えば、機能的な本発明のポリ
ペプチドを発現する細胞に、該ポリペプチドの活性化に
より発現が誘導される遺伝子のプロモーター配列の下流
に適当なレポーター遺伝子を連結したDNAを導入する
ことにより、該ポリペプチドの活性化をレポーター遺伝
子の発現で測定することができる。該プロモーターとし
ては、例えばICAM−1遺伝子のプロモーター、c−
fosのプロモーター、Krox−24のプロモーター
などが利用できる。また、該プロモーターは、適当な転
写因子の結合配列と基本プロモーターからなる人工プロ
モーターでもよい。転写因子の結合配列としては、例え
ばCRE、TRE、SRE、などが利用できる。レポー
ター遺伝子としては、クロラムフェニコール・アセチル
トランスフェラーゼ遺伝子、β−グルクロニダーゼ遺伝
子、β−ガラクトシダーゼ遺伝子、β-ラクタマーゼ遺
伝子、ルシフェラーゼ遺伝子、エクオリン遺伝子および
グリーン・フルオレッセント・プロテイン遺伝子などが
利用できる。The cell response includes, for example, arachidonic acid release, acetylcholine release, intracellular Ca 2+ release, intracellular cAMP generation, intracellular cAMP reduction, intracellular cGMP
Production, inositol phosphate production, cell membrane potential fluctuations, phosphorylation of intracellular proteins, c-fos activation, pH reduction,
Cell proliferation activity, melanin pigment aggregation or diffusion, etc. are measured. The response of cells can also be monitored using a reporter system. For example, by introducing into a cell that expresses a functional polypeptide of the present invention, a DNA linked with an appropriate reporter gene downstream of the promoter sequence of a gene whose expression is induced by activation of the polypeptide, Activation of the polypeptide can be measured by expression of the reporter gene. Examples of the promoter include a promoter of ICAM-1 gene, c-
A fos promoter, a Krox-24 promoter and the like can be used. Further, the promoter may be an artificial promoter consisting of a binding sequence of an appropriate transcription factor and a basic promoter. As the binding sequence of the transcription factor, for example, CRE, TRE, SRE and the like can be used. Examples of the reporter gene include a chloramphenicol acetyltransferase gene, a β-glucuronidase gene, a β-galactosidase gene, a β-lactamase gene, a luciferase gene, an aequorin gene, and a green fluorescent protein gene.
【0213】本発明のポリペプチドを発現する細胞とし
ては、上記(4)に記載したように、該ポリペプチドを
コードするDNAを含む組換え体DNAを適当な宿主細
胞に導入して得られる形質転換細胞のように、大量に該
ポリペプチドを発現している細胞を用いることもでき
る。該宿主細胞としては、大腸菌、枯草菌、酵母などの
微生物の他、昆虫細胞、カエルの卵母細胞、カエルのメ
ラニン細胞、動物細胞、植物細胞などが用いられる。該
形質転換細胞が発現する本発明のポリペプチドが高次構
造を保持し、リガンドとの結合性や機能性を保持するた
めには、酵母、昆虫細胞、カエルの卵母細胞、カエルの
メラニン細胞、動物細胞、植物細胞などで発現させるの
が好ましい。酵母の変異株や改変Gα蛋白質を発現させ
た酵母などを宿主として利用することもできる。As the cells expressing the polypeptide of the present invention, as described in (4) above, a trait obtained by introducing a recombinant DNA containing a DNA encoding the polypeptide into an appropriate host cell. Cells expressing the polypeptide in large amounts, such as transformed cells, can also be used. Examples of the host cell include microorganisms such as Escherichia coli, Bacillus subtilis, and yeast, as well as insect cells, frog oocytes, frog melanocytes, animal cells, and plant cells. In order that the polypeptide of the present invention expressed by the transformed cell retains a higher-order structure and retains binding and functionality with a ligand, yeast, insect cells, frog oocytes, and frog melanocytes It is preferably expressed in animal cells, plant cells and the like. A yeast mutant or a yeast expressing the modified Gα protein can also be used as a host.
【0214】試験物質としてはいかなる物質も使用でき
るが、例えば、既知ペプチド、既知GPCRリガンド、
既知蛋白質、組換え技術を用いて生産された組換え蛋白
質、細胞抽出液や該抽出液由来の精製物、細胞培養上清
や該上清由来の精製物、血清などの生体試料や該生体試
料由来の精製物、微生物の菌体抽出液や該抽出液由来の
精製物、微生物培養上清や該上清由来の精製物、既知化
合物、コンビナトリアルケミストリーを用いて合成され
た化合物などを使用することができる。As the test substance, any substance can be used. For example, a known peptide, a known GPCR ligand,
Biological samples and biological samples such as known proteins, recombinant proteins produced using recombinant techniques, cell extracts and purified products derived from the extracted solutions, cell culture supernatants and purified products derived from the supernatants, serum and the like Use of a purified product derived from a microorganism, a cell extract of a microorganism, a purified product derived from the extract, a microorganism culture supernatant or a purified product derived from the supernatant, a known compound, a compound synthesized using combinatorial chemistry, or the like. Can be.
【0215】以下具体例を示す。 アゴニストのスクリーニング方法 本発明のポリペプチドを発現する細胞をマルチウェルプ
レート等に培養する。必要に応じて新鮮な培地あるいは
細胞に毒性を示さない適当なバッファーに交換し、試験
物質を添加して一定時間インキュベートする。その後、
細胞の応答(例えば、アラキドン酸遊離、アセチルコリ
ン遊離、細胞内Ca2+遊離、細胞内cAMP生成、細胞
内cGMP生成、イノシトールリン酸産生、細胞膜電位
変動、細胞内蛋白質のリン酸化、c−fos活性化、p
Hの低下、メラニン色素の凝集または拡散、またはレポ
ーター遺伝子の発現量などを促進する活性または抑制す
る活性など)を測定する。例えば、細胞の抽出液や上清
を用いて、細胞の応答により生成した産物を常法に従っ
て定量する。細胞刺激活性の指標とする物質(例えば、
アラキドン酸など)の生成が、細胞が含有する分解酵素
によって検定困難な場合は、該分解酵素に対する阻害剤
を添加して定量してもよい。また、cAMP産生抑制な
どの活性については、フォルスコリンなどで細胞のcA
MP産生量を増大させておいた細胞に対する産生抑制作
用として検出することができる。細胞の応答を増強する
活性を有する物質を、本発明のポリペプチドのアゴニス
トまたは機能修飾物質として選択することができる。 アンタゴニストまたは機能修飾物質のスクリーニン
グ 本発明のポリペプチドを発現する細胞をマルチウェルプ
レート等に培養する。必要に応じて新鮮な培地あるいは
細胞に毒性を示さない適当なバッファーに交換し、リガ
ンドと試験物質を添加して一定時間インキュベートす
る。その後、上記と同様の方法により細胞の応答を測定
する。試験物質非存在下における細胞応答と、試験物質
存在下における細胞応答を比較して、細胞応答を減少さ
せる物質を本発明のポリペプチドのアンタゴニストまた
は機能修飾物質として選択することができる。一方、細
胞応答を増加させる物質を本発明のポリペプチドの機能
修飾物質またはアゴニストとして選択することができ
る。Specific examples will be described below. Agonist screening method Cells expressing the polypeptide of the present invention are cultured in a multiwell plate or the like. If necessary, replace with a fresh medium or an appropriate buffer that is not toxic to cells, add the test substance, and incubate for a certain period of time. afterwards,
Cell response (eg, arachidonic acid release, acetylcholine release, intracellular Ca 2+ release, intracellular cAMP production, intracellular cGMP production, inositol phosphate production, cell membrane potential fluctuation, intracellular protein phosphorylation, c-fos activity , P
H reduction, melanin pigment aggregation or diffusion, or the activity of promoting or suppressing the expression level of a reporter gene, etc.). For example, using a cell extract or supernatant, a product produced by the cell response is quantified according to a conventional method. Substance as an indicator of cell stimulating activity (for example,
When the production of arachidonic acid or the like is difficult to be assayed by a degrading enzyme contained in cells, an inhibitor for the degrading enzyme may be added for quantification. As for activities such as cAMP production inhibition, cells were cAA-expressed with forskolin or the like.
It can be detected as a production inhibitory effect on cells whose MP production has been increased. A substance having an activity of enhancing a cellular response can be selected as an agonist or a function modifier of the polypeptide of the present invention. Screening for antagonists or functional modifiers Cells expressing the polypeptide of the present invention are cultured in a multiwell plate or the like. If necessary, replace the medium with a fresh medium or an appropriate buffer that is not toxic to cells, add the ligand and the test substance, and incubate for a certain period of time. Thereafter, the response of the cells is measured by the same method as described above. By comparing the cellular response in the absence of the test substance with the cellular response in the presence of the test substance, a substance that reduces the cellular response can be selected as an antagonist or a functional modifier of the polypeptide of the present invention. On the other hand, substances that increase the cellular response can be selected as functional modifiers or agonists of the polypeptide of the present invention.
【0216】本発明のポリペプチドを含有する細胞とし
て、本発明のポリペプチドを発現しない宿主細胞に該ポ
リペプチドをコードするDNAをベクターに組み込んだ
組換え体DNAを導入して得られる該ポリペプチドの大
量発現細胞を用いることにより、本発明の受容体蛋白質
のアゴニスト、アンタゴニストまたは機能修飾物質をよ
り感度良く選択することができる。また、同宿主細胞に
ベクターのみを導入することによって得られる該ポリペ
プチドを発現しない細胞や、同宿主細胞に他のG蛋白質
共役型受容体ポリペプチドの発現プラスミドを導入する
ことによって得られる他のG蛋白質共役型受容体ポリペ
プチドの発現細胞を用いて同様の実験を行うことによ
り、取得したアゴニスト、アンタゴニストまたは機能修
飾物質の本発明のG蛋白質共役型受容体ポリペプチドに
対する特異性を調べることができる。 (6−5)本発明のG蛋白質共役型受容体ポリペプチド
のアゴニスト、アンタゴニストまたは機能修飾物質のス
クリーニング用キット 本発明のポリペプチドのアゴニスト、アンタゴニストま
たは機能修飾物質のスクリーニング用キットは、本発明
のポリペプチドまたはその部分ペプチドもしくはそれら
の塩、または本発明のポリペプチドまたはその部分ペプ
チドを含有する細胞または該細胞の膜画分を含有するも
のなどである。本発明のスクリーニング用キットとし
て、たとえば下記の試薬と測定法をあげることができ
る。 (a)スクリーニング用試薬 測定用緩衝液および洗浄用緩衝液 Hanks' Balanced Salt Solution(ギブコ社製)に、0.
05%のウシ血清アルブミン(シグマ社製)を加えたも
の。孔径0.45μmのフィルターで濾過滅菌し、4℃
で保存するか、あるいは用時調製しても良い。 本発明のポリペプチド標品 本発明のポリペプチドを発現させたCHO細胞を、12
穴プレートに5×10 5個/穴で継代し、5%CO2、9
5%air インキュベーター中、37℃で2日間培養
したもの。 標識リガンド 市販の〔3H〕、〔125I〕、〔14C〕、〔35S〕などで
標識したリガンド。水溶液の状態のものを4℃あるいは
−20℃にて保存し、用時に測定用緩衝液にて1μmol/
Lに希釈する。 リガンド標準液 リガンドを0.1%ウシ血清アルブミン(シグマ社製)
を含むPBSで1mmol/Lとなるように溶解し、−20℃
で保存する。 (b)測定法 12穴組織培養用プレートにて培養した本発明のポリ
ペプチド発現CHO細胞を、測定用緩衝液1mlで2回
洗浄した後、490μlの測定用緩衝液を各穴に加え
る。 10-3〜10-10 mol/Lの試験物質溶液を5μl加え
た後、標識リガンドを5μl加え、室温にて1時間反応
させる。非特異的結合量を知るためには試験物質のかわ
りに10-3 mol/Lのリガンドを5μl加えておく。 反応液を除去し、1mlの洗浄用緩衝液で3回洗浄す
る。細胞に結合した標識リガンドを溶解液(0.2mol/L
NaOH、1%SDS)で溶解し、4mlの液体シン
チレーターA(和光純薬製)と混合する。 液体シンチレーションカウンター(ベックマン社製)
を用いて放射活性を測定し、Percent Maximum Binding
(PMB)を下記式で求める。 PBM=(B−NSB)÷B0×100 PMB:Percent Maximum Binding B:検体を加えた時の値 NSB:Non-specific Binding(非特異的結合量) B0:最大結合量 上記(6−4)のスクリーニング方法または本スクリー
ニング用キットを用いて得られる物質またはその塩は、
本発明のポリペプチドのアゴニスト、アンタゴニストま
たは機能修飾物質である。該物質としては、ペプチド、
タンパク、非ペプチド性化合物、合成化合物、発酵生産
物などが挙げられ、これら物質は新規な物質であっても
よいし、公知の物質であってもよいが、該公知物質は、
本発明のアゴニスト、アンタゴニストまたは機能修飾物
質には含まれない。本発明のポリペプチドに対するアゴ
ニストは、本発明のポリペプチドに対するリガンドが有
する生理活性と同様の作用を有しているので、該リガン
ド活性に応じて安全で低毒性な医薬組成物として有用で
ある。逆に、本発明のポリペプチドに対するアンタゴニ
ストは、本発明のポリペプチドに対するリガンドが有す
る生理活性を抑制することができるので、該リガンド活
性を抑制する安全で低毒性な医薬組成物として有用であ
る。また、本発明のポリペプチドの機能修飾物質は、本
発明のポリペプチドに対するリガンドが有する生理活性
を増強または抑制することができるので、該リガンド活
性を増強または抑制する安全で低毒性な医薬組成物とし
て有用である。The cells containing the polypeptide of the present invention
Host cells that do not express the polypeptide of the present invention.
DNA encoding the repeptide was incorporated into the vector
The size of the polypeptide obtained by introducing the recombinant DNA
The receptor protein of the present invention is obtained by using
Agonists, antagonists or functional modifiers
Can be selected with high sensitivity. In addition, the host cell
The polypeptide obtained by introducing only the vector
Cells that do not express the peptide or host cells that contain other G proteins
Introduce an expression plasmid for a coupled receptor polypeptide
G protein-coupled receptor polypeptide obtained by the method
Similar experiments were performed using peptide-expressing cells.
Acquired agonists, antagonists or functional
G protein-coupled receptor polypeptide of the present invention as a decorating substance
The specificity can be determined. (6-5) G protein-coupled receptor polypeptide of the present invention
Of agonists, antagonists or functional modifiers
Cleaning Kit Agonists, antagonists and the like of the polypeptide of the present invention.
Or a kit for screening for a functional modifier
Or a partial peptide thereof or
Or a polypeptide of the present invention or a partial peptide thereof.
A cell containing a tide-containing cell or a membrane fraction of the cell.
And so on. The screening kit of the present invention
For example, the following reagents and measurement methods can be used.
You. (A) Screening reagent Measurement buffer and washing buffer Hanks' Balanced Salt Solution (Gibco)
05% bovine serum albumin (Sigma) was added.
of. Sterilized by filtration through a 0.45 μm filter, 4 ° C
Or may be prepared at the time of use. Polypeptide preparation of the present invention CHO cells expressing the polypeptide of the present invention
5 × 10 on hole plate FivePassage by individual / hole, 5% COTwo, 9
Cultured at 37 ° C for 2 days in a 5% air incubator
What you did. Labeled ligandThreeH], [125I], [14C], [35S]
Labeled ligand. Aqueous solution at 4 ° C or
Store at −20 ° C., and use 1 μmol /
Dilute to L. Ligand standard solution 0.1% bovine serum albumin (Sigma)
And dissolved at 1 mmol / L in PBS containing -20 ° C.
To save. (B) Measuring method The poly of the present invention cultured on a 12-well tissue culture plate
Peptide-expressing CHO cells were washed twice with 1 ml of measurement buffer.
After washing, 490 μl of measurement buffer was added to each well.
You. 10-3-10-Ten Add 5 μl of mol / L test substance solution
After adding 5 μl of labeled ligand, react for 1 hour at room temperature
Let it. To know the amount of non-specific binding
10-3 Add 5 μl of mol / L ligand. Remove the reaction solution and wash 3 times with 1 ml of washing buffer
You. The labeled ligand bound to the cells is lysed (0.2 mol / L)
NaOH, 1% SDS).
Mix with Chilator A (manufactured by Wako Pure Chemical Industries). Liquid scintillation counter (Beckman)
Radioactivity was measured using Percent Maximum Binding
(PMB) is calculated by the following equation. PBM = (B−NSB) ÷ B0 × 100 PMB: Percent Maximum Binding B: Value when a sample is added NSB: Non-specific Binding (Non-specific binding amount) B0: Maximum binding amount The above (6-4) Screening method or this screen
The substance or its salt obtained using the kit for
Agonists, antagonists and the like of the polypeptide of the present invention.
Or a functional modifier. Such substances include peptides,
Protein, non-peptide compound, synthetic compound, fermentation production
Substances, and even if these substances are new substances,
Or a known substance, but the known substance is
Agonist, antagonist or functionally modified product of the present invention
Not included in quality. Jaw for the polypeptide of the present invention
Nists have ligands for the polypeptides of the invention.
Has the same effect as the physiological activity of
It is useful as a safe and low toxic pharmaceutical composition
is there. Conversely, antagonies to the polypeptides of the invention
The strike has a ligand for the polypeptide of the present invention.
Biological activity can be suppressed,
It is useful as a safe and low toxic pharmaceutical composition
You. In addition, the functional modifier of the polypeptide of the present invention
Physiological activity of the ligand for the polypeptide of the invention
Can be enhanced or suppressed.
Safe and low toxic pharmaceutical composition to enhance or suppress
And useful.
【0217】上記(6−4)のスクリーニング方法また
は本スクリーニング用キットを用いて得られる化合物ま
たはその塩を上記の医薬組成物として使用する場合、常
法に従って製剤化することができる。例えば、必要に応
じて糖衣を施した錠剤、カプセル剤、エリキシル剤、マ
イクロカプセル剤などとして経口的に、あるいは水もし
くはそれ以外の薬学的に許容し得る液との無菌性溶液、
または懸濁液剤などの注射剤の形で非経口的に使用でき
る。例えば、該化合物またはその塩を生理学的に認めら
れる担体、香味剤、賦形剤、ベヒクル、防腐剤、安定
剤、結合剤などとともに一般に認められた製薬実施に要
求される単位用量形態で混和することによって製造する
ことができる。これら製剤における有効成分量は指示さ
れた範囲の適当な容量が得られるようにするものであ
る。錠剤、カプセル剤などに混和することができる添加
剤としては、例えば、ゼラチン、コーンスターチ、トラ
ガント、アラビアゴムのような結合剤、結晶性セルロー
スのような賦形剤、コーンスターチ、ゼラチン、アルギ
ン酸などのような膨化剤、ステアリン酸マグネシウムの
ような潤滑剤、ショ糖、乳糖またはサッカリンのような
甘味剤、ペパーミント、アカモノ油またはチェリーのよ
うな香味剤などが用いられる。調剤単位形態がカプセル
である場合には、前記タイプの材料にさらに油脂のよう
な液状担体を含有することができる。注射のための無菌
組成物は注射用水のようなベヒクル中の活性物質、胡麻
油、椰子油などのような天然産出植物油などを溶解また
は懸濁させるなどの通常の製剤実施にしたがって処方す
ることができる。When the compound or its salt obtained by using the screening method of (6-4) or this screening kit is used as the above pharmaceutical composition, it can be formulated according to a conventional method. For example, sugar-coated tablets as needed, capsules, elixirs, orally as microcapsules, or a sterile solution with water or other pharmaceutically acceptable liquid,
Alternatively, it can be used parenterally in the form of injections such as suspensions. For example, the compound or a salt thereof is mixed with physiologically acceptable carriers, flavors, excipients, vehicles, preservatives, stabilizers, binders and the like in a unit dosage form required for generally accepted pharmaceutical practice. Can be manufactured. The amount of the active ingredient in these preparations is such that an appropriate dose in the specified range can be obtained. Examples of additives that can be mixed with tablets, capsules, and the like include binders such as gelatin, corn starch, tragacanth, and acacia, excipients such as crystalline cellulose, corn starch, gelatin, and alginic acid. Useful bulking agents, lubricants such as magnesium stearate, sweeteners such as sucrose, lactose or saccharin, flavoring agents such as peppermint, reddish oil or cherry and the like are used. When the preparation unit form is a capsule, a liquid carrier such as oil and fat can be further contained in the above-mentioned type of material. Sterile compositions for injection can be formulated according to normal pharmaceutical practice such as dissolving or suspending the active substance in vehicles such as water for injection, naturally occurring vegetable oils such as sesame oil, coconut oil and the like. .
【0218】注射用の水性液としては、例えば、生理食
塩水、ブドウ糖やその他の補助薬を含む等張液(例え
ば、D−ソルビトール、D−マンニトール、塩化ナトリ
ウムなど)などが用いられ、適当な溶解補助剤、例え
ば、アルコール(例えば、エタノール)、ポリアルコー
ル(例えば、プロピレングリコール、ポリエチレングリ
コール)、非イオン性界面活性剤(例えば、ポリソルベ
ート80(TM)、HCO−50)などと併用してもよ
い。油性液としては、例えば、ゴマ油、大豆油などが用
いられ、溶解補助剤である安息香酸ベンジル、ベンジル
アルコールなどと併用してもよい。また、緩衝剤(例え
ば、リン酸塩緩衝液、酢酸ナトリウム緩衝液)、無痛化
剤(例えば、塩化ベンザルコニウム、塩酸プロカインな
ど)、安定剤(例えば、ヒト血清アルブミン、ポリエチ
レングリコールなど)、保存剤(例えば、ベンジルアル
コール、フェノールなど)、酸化防止剤などと配合して
もよい。調整された注射液は通常、適当なアンプルに充
填される。このようにして得られる製剤は安全で低毒性
であるので、例えば、ヒトや哺乳動物(例えば、ラッ
ト、ウサギ、ヒツジ、ブタ、ウシ、ネコ、イヌ、サルな
ど)に対して投与することができる。該化合物またはそ
の塩の投与量は、投与対象、対象臓器、症状、投与方法
などにより差異はあるが、経口投与の場合、一般的に成
人(60kgとして)においては、一日につき約0.1
〜100mg、好ましくは約1.0〜50mg、より好
ましくは約1.0〜20mgである。非経口的に投与す
る場合は、その1回投与量は投与対象、対象臓器、症
状、投与方法などによっても異なるが、例えば、注射剤
の形では通常成人(60kgとして)においては、一日
につき約0.01〜30mg程度、好ましくは約0.1
〜20mg程度、より好ましくは約0.1〜10mg程
度を静脈注射により投与するのが好都合である。他の動
物の場合も、60kg当たりに換算した量を投与するこ
とができる。 (7)本発明のDNAまたはオリゴヌクレオチドの利用 (7−1)本発明のポリペプチドをコードする染色体遺
伝子の取得および該遺伝子の利用 (I)本発明のポリペプチドをコードする染色体遺伝子
の取得 本発明のDNAまたはオリゴヌクレオチドをプローブと
して、公知の方法〔東京大学医科学研究所 制癌研究部
編、新細胞工学実験プロトコール、秀潤社 (1993
年)〕を用いて、本発明のポリペプチドをコードする染
色体遺伝子および該遺伝子の発現制御領域を取得するこ
とが可能である。As the aqueous solution for injection, for example, physiological saline, isotonic solution containing glucose and other adjuvants (eg, D-sorbitol, D-mannitol, sodium chloride, etc.) and the like are used. It may be used in combination with a solubilizing agent, for example, an alcohol (eg, ethanol), a polyalcohol (eg, propylene glycol, polyethylene glycol), a nonionic surfactant (eg, polysorbate 80 (TM), HCO-50). Good. As the oily liquid, for example, sesame oil, soybean oil and the like are used, and may be used in combination with solubilizers such as benzyl benzoate and benzyl alcohol. In addition, buffers (eg, phosphate buffer, sodium acetate buffer), soothing agents (eg, benzalkonium chloride, procaine hydrochloride, etc.), stabilizers (eg, human serum albumin, polyethylene glycol, etc.), storage Agents (eg, benzyl alcohol, phenol, etc.), antioxidants and the like. The prepared injection is usually filled in a suitable ampoule. Since the thus obtained preparation is safe and has low toxicity, it can be administered to, for example, humans and mammals (eg, rats, rabbits, sheep, pigs, cows, cats, dogs, monkeys, etc.). . The dose of the compound or a salt thereof varies depending on the administration subject, the target organ, the condition, the administration method, and the like. However, in the case of oral administration, generally, in an adult (60 kg), about 0.1 per day is used.
-100 mg, preferably about 1.0-50 mg, more preferably about 1.0-20 mg. In the case of parenteral administration, the single dose varies depending on the administration subject, target organ, symptoms, administration method and the like. About 0.01 to 30 mg, preferably about 0.1
Conveniently, about 20 mg, more preferably about 0.1 to 10 mg is administered by intravenous injection. In the case of other animals, the dose can be administered in terms of 60 kg. (7) Use of DNA or oligonucleotide of the present invention (7-1) Obtaining chromosomal gene encoding polypeptide of the present invention and use of the gene (I) Obtaining chromosomal gene encoding polypeptide of the present invention Using the DNA or oligonucleotide of the invention as a probe, a known method [New Cell Engineering Experimental Protocol, edited by Cancer Research Division, Institute of Medical Science, The University of Tokyo, Shujunsha (1993)
Year)] can be used to obtain a chromosomal gene encoding the polypeptide of the present invention and an expression control region of the gene.
【0219】また、本発明のポリペプチドをコードする
ヒトcDNAの配列と、公開されているデータベースに
登録されてるヒト染色体遺伝子の配列とを比較すること
により、本発明のポリペプチドをコードするヒト染色体
遺伝子を同定し、その構造を明らかにできる可能性があ
る。cDNAの配列と一致する染色体遺伝子配列が登録
されていれば、本発明のDNAの配列と染色体遺伝子の
配列を比較することにより、本発明のポリペプチドをコ
ードする染色体遺伝子のエクソンおよびイントロン構
造、ならびに該染色体遺伝子の発現制御領域(例えばプ
ロモーター領域など)を決定することができる。By comparing the sequence of the human cDNA encoding the polypeptide of the present invention with the sequence of the human chromosomal gene registered in a public database, the human chromosome encoding the polypeptide of the present invention can be compared. It may be possible to identify genes and elucidate their structure. If a chromosomal gene sequence that matches the cDNA sequence is registered, the exon and intron structures of the chromosomal gene encoding the polypeptide of the present invention are compared by comparing the sequence of the chromosomal gene with the sequence of the DNA of the present invention, and The expression control region (eg, promoter region, etc.) of the chromosomal gene can be determined.
【0220】プロモーター領域としては、哺乳動物細胞
において本発明のポリペプチドをコードする遺伝子の転
写に関与するすべてのプロモーター領域があげられる。
具体的には、例えば、ヒトの視床、小脳、全脳、海馬、
黒質、胎児脳、胎児腎、胎児肝臓、心臓、肝臓、乳腺、
胎盤、前立腺、唾液腺、骨格筋、胸腺、甲状腺、子宮、
ヒト大腸癌細胞、またはヒト胃癌細胞において、本発明
のポリペプチドをコードする遺伝子の転写に関与するプ
ロモーター領域をあげることができる。Examples of the promoter region include all promoter regions involved in transcription of a gene encoding the polypeptide of the present invention in mammalian cells.
Specifically, for example, the human thalamus, cerebellum, whole brain, hippocampus,
Substantia nigra, fetal brain, fetal kidney, fetal liver, heart, liver, mammary gland,
Placenta, prostate, salivary glands, skeletal muscle, thymus, thyroid, uterus,
In human colorectal cancer cells or human gastric cancer cells, a promoter region involved in transcription of a gene encoding the polypeptide of the present invention can be mentioned.
【0221】上記プロモーター領域の具体的例として
は、配列番号15に記載の塩基配列において塩基番号2
0202〜25202番で表される塩基配列を有するD
NA中、50〜5000bpの連続した塩基配列を有す
るDNAをあげることができる。 (II)本発明のポリペプチドをコードする染色体遺伝子
および該遺伝子の利用方法 下記(8)で示すように、該プロモーター領域は本発明
のポリペプチドをコードする遺伝子の転写を制御する物
質のスクリーニングに有用である。また、該プロモータ
ー領域の配列情報を用いて、本発明のポリペプチドをコ
ードする遺伝子の転写を抑制するためのデコイDNA
〔Nippon Rinsho - Japanese Journal ofClinical Medi
cine, 56, 563 (1998)、Circulation Research, 82, 10
23 (1998)、Experimental Nephrology, 5, 429 (199
7)、Nippon Rinsho - Japanese Journal of Clinical M
edicine, 54, 2583 (1996)〕を作製することができる。 (7−2)本発明のG蛋白質共役型受容体ポリペプチド
をコードする遺伝子の転写産物量の測定 ノーザンハイブリダイゼーション法(モレキュラー・ク
ローニング第2版)、PCR法〔PCR Protocols, Acade
mic Press (1990)〕、定量的PCR法〔Proc.Natl. Aca
d. Sci. USA, 87, 2725 (1990)〕、Real Time PCR法〔J
unko Stevens,実験医学(増刊), 15, 46 (1997)〕等の
方法により、本発明のポリペプチドをコードする遺伝子
の転写産物量を測定することができる。特に、定量的P
CR法やReal Time PCR法は定量性に優れている点で好
ましい方法である。該転写産物を定量することにより、
本発明のポリペプチドの発現異常に基づく疾患の診断が
可能である。したがって、本発明のDNAまたはオリゴ
ヌクレオチドは、本発明のポリペプチドをコードする遺
伝子の転写産物を定量するための遺伝子診断剤として有
用である。 (7−3)本発明のG蛋白質共役型受容体ポリペプチド
をコードする遺伝子の変異および多型の検出 GPCR遺伝子またはGPCR遺伝子の発現制御領域に
は変異や多型が存在することが知られている。例えば、
GPCR遺伝子の変異によりGPCRの機能が不活性化
または活性化し、各種の疾患が起こることが知られてい
る〔日本臨床,56, 1658 (1998)、日本臨床, 56, 1836
(1998)、日本臨床, 56, 1843 (1998)、日本臨床, 56, 1
848 (1998)、日本臨床, 56, 1856 (1998)、日本臨床, 5
6, 1871(1998)、日本臨床, 56, 1876 (1998)、日本臨
床, 56, 1931 (1998)、Trends inEndocrinology and Me
tabolism, 9, 27 (1998)〕。また、GPCR遺伝子また
はGPCR遺伝子の発現制御領域の変異によりGPCR
の発現量が増加または低下し、各種の疾患が起こる場合
もある。したがって、本発明のポリペプチドをコードす
る遺伝子または該遺伝子の発現制御領域の変異を調べる
ことにより、本発明の受容体蛋白質の機能の不活性化ま
たは活性化、あるいは本発明のポリペプチドの発現の増
加または低下に基づく疾患の診断を行うことができる。As a specific example of the promoter region, the base sequence shown in SEQ ID NO: 15
D having the nucleotide sequence represented by Nos. 0202 to 25202
A DNA having a continuous base sequence of 50 to 5000 bp in NA can be mentioned. (II) Chromosomal gene encoding polypeptide of the present invention and method of using the gene As shown in (8) below, the promoter region is used for screening for a substance that controls transcription of the gene encoding the polypeptide of the present invention. Useful. Further, a decoy DNA for suppressing transcription of a gene encoding the polypeptide of the present invention using the sequence information of the promoter region.
(Nippon Rinsho-Japanese Journal of Clinical Medi
cine, 56 , 563 (1998), Circulation Research, 82 , 10
23 (1998), Experimental Nephrology, 5 , 429 (199
7), Nippon Rinsho-Japanese Journal of Clinical M
edicine, 54 , 2583 (1996)]. (7-2) Measurement of Transcript Amount of Gene Encoding G Protein-Coupled Receptor Polypeptide of the Present Invention Northern Hybridization Method (Molecular Cloning 2nd Edition), PCR Method [PCR Protocols, Acade
mic Press (1990)], quantitative PCR (Proc. Natl. Aca
d. Sci. USA, 87 , 2725 (1990)], Real Time PCR (J
Unko Stevens, Experimental Medicine (extra edition), 15 , 46 (1997)] and the like can measure the amount of the transcript of the gene encoding the polypeptide of the present invention. In particular, the quantitative P
The CR method and the Real Time PCR method are preferred methods in that they have excellent quantitative properties. By quantifying the transcript,
Diagnosis of diseases based on abnormal expression of the polypeptide of the present invention is possible. Therefore, the DNA or oligonucleotide of the present invention is useful as a genetic diagnostic agent for quantifying a transcript of a gene encoding the polypeptide of the present invention. (7-3) Detection of Mutations and Polymorphisms in the Gene Encoding the G Protein-Coupled Receptor Polypeptide of the Present Invention It is known that mutations and polymorphisms exist in the GPCR gene or the expression control region of the GPCR gene. I have. For example,
It is known that the mutation of the GPCR gene inactivates or activates the function of the GPCR and causes various diseases [Japanese clinical, 56 , 1658 (1998), Japanese clinical, 56 , 1836.
(1998), Japanese clinical practice, 56 , 1843 (1998), Japanese clinical practice, 56 , 1
848 (1998), Japanese clinical study, 56 , 1856 (1998), Japanese clinical study, 5
6 , 1871 (1998), Japanese clinical practice, 56 , 1876 (1998), Japanese clinical practice, 56 , 1931 (1998), Trends in Endocrinology and Me
tabolism, 9 , 27 (1998)]. In addition, GPCR gene or GPCR gene expression control region mutation
Expression level increases or decreases, and various diseases may occur. Therefore, by examining the mutation of the gene encoding the polypeptide of the present invention or the expression control region of the gene, inactivation or activation of the function of the receptor protein of the present invention, or expression of the polypeptide of the present invention, Diagnosis of a disease based on an increase or decrease can be made.
【0222】また、GPCR遺伝子やGPCR遺伝子の
発現制御領域の多型により、GPCRの性質やGPCR
の発現量が変化し、疾患の発症率や進展速度が異なるこ
とが知られている〔Cancer. Res., 59, 3561 (1999)、A
nnu. Rev. Immunol., 17, 657 (1999)、日本臨床, 56,
1871 (1998)〕。例えば、β3アドレナリン受容体の64
番目のトリプトファンがアルギニンに置換した該変異受
容体蛋白質を有する人では、肥満や糖尿病の発症率が高
いことが知られている。したがって、本発明のG蛋白質
共役型受容体ポリペプチドをコードする遺伝子または該
遺伝子の発現制御領域の変異を調べることにより、本発
明のポリペプチドの性質や発現量の変化に基づく疾患の
発症率や進展速度の予測を行うことができる。Further, the properties of the GPCRs and the GPCR
It is known that the expression level of the disease changes, and the disease incidence rate and progression rate differ (Cancer. Res., 59 , 3561 (1999), A
nnu. Rev. Immunol., 17 , 657 (1999), Japanese clinical practice, 56 ,
1871 (1998)]. For example, the beta 3 adrenergic receptor 64
It is known that a person having the mutant receptor protein in which the second tryptophan is substituted with arginine has a high incidence of obesity and diabetes. Therefore, by examining the mutation of the gene encoding the G protein-coupled receptor polypeptide of the present invention or the expression control region of the gene, the disease incidence rate based on changes in the properties and expression level of the polypeptide of the present invention can be improved. A prediction of the speed of progress can be made.
【0223】また、現在使用されている薬剤の多くはG
PCRをターゲットとしたものであるが、GPCR遺伝
子やGPCR遺伝子の発現制御領域の多型により、GP
CRの性質やGPCRの発現量が変化し、薬剤への感受
性が変化することが知られている〔Journal of Pharmac
olgy and Experimental Therapeutics, 275, 1274 (199
5)、J. Bilo. Chem., 272, 1822 (1997)、Pharmacogene
tics, 5, 318 (1995)、J. Bilo. Chem., 274, 12670 (1
999)、Proc. Natl. Acad. Sci. USA, 95, 9608 (199
8)、Science, 286, 487 (1999)〕。したがって、本発明
のポリペプチドをコードする遺伝子または該遺伝子の発
現制御領域の変異を調べることにより、本発明のポリペ
プチドの性質や発現量の変化に基づく薬剤の感受性の予
測を行うことができる。Most of the drugs currently used are G
Although it is targeted for PCR, the GPR gene and the polymorphism of the expression control region of the GPCR gene may cause
It is known that the properties of CR and the expression level of GPCR change, and the sensitivity to drugs changes [Journal of Pharmac.
olgy and Experimental Therapeutics, 275 , 1274 (199
5), J. Bilo. Chem., 272 , 1822 (1997), Pharmacogene
tics, 5 , 318 (1995), J. Bilo. Chem., 274 , 12670 (1
Natl. Acad. Sci. USA, 95 , 9608 (199).
8), Science, 286 , 487 (1999)]. Therefore, by examining the mutation of the gene encoding the polypeptide of the present invention or the expression control region of the gene, it is possible to predict drug sensitivity based on changes in the properties and expression level of the polypeptide of the present invention.
【0224】本発明のポリペプチドをコードする遺伝子
または該遺伝子の発現制御領域の変異または多型の検出
は、該遺伝子または該制御領域の塩基配列情報を用いて
行うことができる。具体的には、サザンブロット法、ダ
イレクトシークエンス法、PCR法、DNAチップ法な
どを用いて遺伝子の変異や多型を検出することができる
〔臨床検査, 42, 1507-1517 (1998)、臨床検査, 42, 15
65-1570 (1998)〕。Detection of a mutation or polymorphism in the gene encoding the polypeptide of the present invention or the expression control region of the gene can be performed using the nucleotide sequence information of the gene or the control region. Specifically, gene mutations and polymorphisms can be detected by Southern blotting, direct sequencing, PCR, DNA chip method, etc. [Clinical test, 42 , 1507-1517 (1998), clinical test , 42 , 15
65-1570 (1998)].
【0225】本発明のポリペプチドまたはその部分ペプ
チドをコードするDNA、および本発明のポリペプチド
をコードする遺伝子の発現制御領域中の塩基配列を有す
るDNAを、プローブまたはプライマーとして使用する
ことにより、ヒトまたは哺乳動物(例えば、ラット、ウ
サギ、ヒツジ、ブタ、ウシ、ネコ、イヌ、サルなど)に
おける本発明のポリペプチドをコードする遺伝子ならび
に該遺伝子の発現制御領域の変異や多型を検出すること
ができる。したがって、本発明のポリペプチドまたはそ
の部分ペプチドをコードするDNA、および本発明のポ
リペプチドをコードする遺伝子の発現制御領域中の塩基
配列を有するDNAは、上記変異や多型を検出するため
の遺伝子診断剤として有用である。 (7−4)本発明のG蛋白質共役型受容体ポリペプチド
の発現量または機能が亢進した疾患の治療剤 アンチセンスRNA/DNA技術〔バイオサイエンスと
インダストリー, 50,322 (1992)、化学, 46, 681 (199
1)、Biotechnology, 9, 358 (1992)、Trends in Biotec
hnology, 10, 87 (1992) 、Trends in Biotechnology,
10, 152 (1992)、細胞工学, 16, 1463 (1997)〕、トリ
プル・ヘリックス技術〔Trends in Biotechnology, 10,
132 (1992)〕、リボザイム技術〔Current Opinion in
ChemicalBiology, 3, 274 (1999)、FEMS Microbiology
Reviews, 23, 257 (1999)、Frontiers in Bioscience,
4, D497 (1999)、Chemistry & Biology, 6, R33 (199
9)、Nucleic Acids Research, 26, 5237 (1998)、Trend
s In Biotechnology, 16, 438 (1998)〕、あるいはデコ
イDNA法〔Nippon Rinsho - Japanese Journal ofCli
nical Medicine, 56, 563 (1998)、Circulation Resear
ch, 82, 1023 (1998)、Experimental Nephrology, 5, 4
29 (1997)、Nippon Rinsho - Japanese Journal of Cli
nical Medicine, 54, 2583 (1996)〕を用いて任意の遺
伝子の発現を抑制することができる。By using a DNA encoding the polypeptide of the present invention or a partial peptide thereof and a DNA having a nucleotide sequence in the expression control region of a gene encoding the polypeptide of the present invention as a probe or a primer, Alternatively, it is possible to detect a gene encoding the polypeptide of the present invention in a mammal (eg, rat, rabbit, sheep, pig, cow, cat, dog, monkey, etc.) and a mutation or polymorphism in the expression control region of the gene. it can. Therefore, a DNA encoding the polypeptide of the present invention or a partial peptide thereof, and a DNA having a nucleotide sequence in the expression control region of the gene encoding the polypeptide of the present invention may be a gene for detecting the above mutation or polymorphism. Useful as a diagnostic agent. (7-4) A therapeutic agent for a disease in which the expression level or function of the G protein-coupled receptor polypeptide of the present invention is enhanced. Antisense RNA / DNA technology [Bioscience and Industry, 50 , 322 (1992), Chemistry, 46 , 681 (199
1), Biotechnology, 9 , 358 (1992), Trends in Biotec
hnology, 10 , 87 (1992), Trends in Biotechnology,
10 , 152 (1992), Cell Engineering, 16 , 1463 (1997)), Triple Helix Technology (Trends in Biotechnology, 10 ,
132 (1992)), ribozyme technology (Current Opinion in
ChemicalBiology, 3 , 274 (1999), FEMS Microbiology
Reviews, 23 , 257 (1999), Frontiers in Bioscience,
4 , D497 (1999), Chemistry & Biology, 6 , R33 (199
9), Nucleic Acids Research, 26 , 5237 (1998), Trend
s In Biotechnology, 16 , 438 (1998)) or decoy DNA method [Nippon Rinsho-Japanese Journal of Cli
nical Medicine, 56 , 563 (1998), Circulation Resear
ch, 82 , 1023 (1998), Experimental Nephrology, 5 , 4
29 (1997), Nippon Rinsho-Japanese Journal of Cli
nical Medicine, 54 , 2583 (1996)].
【0226】例えば、上記(2)に記載の本発明のDN
A、オリゴヌクレオチドまたはその誘導体を用いて、本
発明のポリペプチドをコードするDNAの転写の抑制、
あるいは本発明のポリペプチドをコードする転写産物の
翻訳の抑制を行うことが可能である。すなわち、本発明
のDNA、オリゴヌクレオチドまたはその誘導体を投与
することにより、本発明のポリペプチドの生産を抑制す
ることができる。For example, the DN of the present invention described in the above (2)
A, using an oligonucleotide or a derivative thereof, suppresses transcription of a DNA encoding the polypeptide of the present invention;
Alternatively, translation of a transcript encoding the polypeptide of the present invention can be suppressed. That is, by administering the DNA, oligonucleotide or derivative thereof of the present invention, production of the polypeptide of the present invention can be suppressed.
【0227】例えば、本発明のポリペプチドの発現増加
または該ポリペプチドのリガンドの発現増加が原因で受
容体を介した生理作用が亢進している患者がいる場合、
本発明のDNA、オリゴヌクレオチドまたはその誘導体
を患者に投与することにより、該生理作用を抑制するこ
とができる。すなわち、本発明のDNA、オリゴヌクレ
オチドまたはその誘導体は、本発明のポリペプチドの発
現量または機能が亢進した疾患の治療剤として有用であ
る。For example, when there is a patient whose physiological activity via a receptor is enhanced due to increased expression of the polypeptide of the present invention or increased expression of a ligand of the polypeptide,
The physiological action can be suppressed by administering the DNA, oligonucleotide or derivative thereof of the present invention to a patient. That is, the DNA, oligonucleotide, or derivative thereof of the present invention is useful as a therapeutic agent for a disease in which the expression level or function of the polypeptide of the present invention is enhanced.
【0228】本発明のDNA、オリゴヌクレオチドまた
はその誘導体を上記治療剤として使用する場合は、本発
明のDNA、オリゴヌクレオチドまたはその誘導体を単
独あるいはレトロウイルスベクター、アデノウイルスベ
クター、アデノウイルスアソシエーテッドウイルスベク
ターなどの適当なベクターに挿入した後、上記(6−
5)に記載した常法に従って製剤化、処方および投与す
ることができる。 (7−5)本発明のG蛋白質共役型受容体ポリペプチド
の発現量または機能が低下した疾患の遺伝子予防・治療
剤 本発明のポリペプチドをコードするDNAは、本発明の
ポリペプチドの発現量または機能が低下した疾患の遺伝
子予防・治療剤などの医薬として使用することができ
る。例えば、本発明のポリペプチドの発現低下や変異の
ためにリガンドの生理作用が期待できない患者がいる場
合に、(i)本発明のポリペプチドをコードするDNA
を該患者に投与し発現させることによって、あるいは
(ii)対象となる細胞に本発明のポリペプチドをコード
するDNAを挿入し発現させた後に、該細胞を該患者に
移植することなどによって、患者の体内における本発明
のポリペプチドの量を増加させ、リガンドの作用を充分
に発揮させることができる。したがって、本発明のポリ
ペプチドをコードするDNAは、本発明のポリペプチド
の発現量または機能が低下した疾患に対して安全で低毒
性な遺伝子予防・治療剤として有用である。When the DNA, oligonucleotide or derivative thereof of the present invention is used as the above therapeutic agent, the DNA, oligonucleotide or derivative thereof of the present invention may be used alone or in a retrovirus vector, adenovirus vector, adenovirus associated virus vector. After insertion into an appropriate vector such as
It can be formulated, formulated and administered according to the usual method described in 5). (7-5) Gene preventive / therapeutic agent for a disease in which the expression level or function of the G protein-coupled receptor polypeptide of the present invention is reduced, DNA encoding the polypeptide of the present invention, the expression level of the polypeptide of the present invention Alternatively, it can be used as a medicament such as an agent for preventing or treating a disease with reduced function. For example, when there is a patient who cannot expect the physiological action of the ligand due to a decrease in the expression or mutation of the polypeptide of the present invention, (i) DNA encoding the polypeptide of the present invention
Is administered to the patient and expressed, or (ii) after inserting and expressing the DNA encoding the polypeptide of the present invention in cells of interest and transplanting the cells into the patient, etc. Can increase the amount of the polypeptide of the present invention in the body of the subject and sufficiently exert the action of the ligand. Therefore, the DNA encoding the polypeptide of the present invention is useful as a safe and low-toxic gene preventive / therapeutic agent for diseases in which the expression level or function of the polypeptide of the present invention is reduced.
【0229】本発明のポリペプチドをコードするDNA
を上記予防・治療剤として使用する場合は、本発明のD
NAを単独あるいはレトロウイルスベクター、アデノウ
イルスベクター、アデノウイルスアソシエーテッドウイ
ルスベクターなどの適当なベクターに挿入した後、上記
(7−4)に記載した常法に従って製剤化、処方および
投与することができる。 (7−6)本発明のG蛋白質共役型受容体ポリペプチド
をコードする遺伝子の転写または翻訳を制御する物質の
スクリーニング方法 本発明のポリペプチドをコードする遺伝子の転写過程、
あるいは転写産物からタンパク質への翻訳過程を促進ま
たは抑制する化合物は、該ポリペプチドの発現を制御す
ることにより、該ポリペプチドを介して発揮される細胞
機能を制御することが可能である。したがって、本発明
のポリペプチドをコードする遺伝子の転写過程、あるい
は転写産物からタンパク質への翻訳過程を促進または抑
制する化合物は、本発明のポリペプチドに対するリガン
ドが有する生理活性を増強または抑制することができる
ので、該リガンドの活性を増強または抑制する安全で低
毒性な医薬組成物として有用である。DNA encoding the polypeptide of the present invention
When used as the above prophylactic / therapeutic agent, the D of the present invention
After inserting NA alone or into an appropriate vector such as a retrovirus vector, an adenovirus vector, an adenovirus associated virus vector, etc., it can be formulated, formulated and administered according to the conventional method described in the above (7-4). . (7-6) Screening method for substance controlling transcription or translation of gene encoding G protein-coupled receptor polypeptide of the present invention Transcription process of gene encoding polypeptide of the present invention
Alternatively, a compound that promotes or suppresses the process of translating a transcript into a protein can control cell functions exerted through the polypeptide by controlling the expression of the polypeptide. Therefore, a compound that promotes or suppresses the transcription process of a gene encoding the polypeptide of the present invention or the translation process from a transcript to a protein can enhance or suppress the physiological activity of the ligand for the polypeptide of the present invention. Therefore, it is useful as a safe and low toxic pharmaceutical composition that enhances or suppresses the activity of the ligand.
【0230】該化合物は、以下(a)〜(c)に示す方
法により取得できる。 (a)[i]本発明のポリペプチドを発現する細胞と、
[ii]試験物質の存在下、本発明のポリペプチドを発現
する細胞を、上記(4)に記載の培養法で2時間から1
週間培養後、細胞中の該ポリペプチド量を、上記(5)
で記載した本発明の抗体を用いて測定、比較し、該ポリ
ペプチド量を増加または低下させる活性を有する化合物
を選択し取得する方法。The compound can be obtained by the following methods (a) to (c). (A) [i] a cell expressing the polypeptide of the present invention;
[Ii] In the presence of a test substance, cells expressing the polypeptide of the present invention are cultured for 2 hours to 1 hour by the culture method described in (4) above.
After culturing for a week, the amount of the polypeptide in the cells is determined according to the above (5).
A method for measuring and comparing using the antibody of the present invention described in the above, and selecting and obtaining a compound having an activity of increasing or decreasing the amount of the polypeptide.
【0231】本発明の抗体を用いた測定法としては、例
えば、マイクロタイタープレートを用いるELISA
法、蛍光抗体法、ウェスタンブロット法、免疫組織染色
等を用いた検出法をあげることができる。 (b)[i]本発明のポリペプチドを発現する細胞と、
[ii]試験物質の存在下、本発明のポリペプチドを発現
する細胞を、上記(4)で記載の培養法で2時間から1
週間培養後、細胞中の該ポリペプチドをコードするDN
Aの転写産物量を、上記(7−2)で記載したノーザン
ハイブリダイゼーション法またはPCR法等の方法を用
いて測定、比較し、該転写産物量を増加または低下させ
る活性を有する化合物を選択し取得する方法。 (c)上記(7−2)で取得したプロモーターの下流に
レポーター遺伝子を連結したDNAを組み込んだプラス
ミドを公知の方法により作製し、上記(5)に記載の方
法に準じて動物細胞に導入し、形質転換体を取得する。
[i]該形質転換体と、[ii]試験物質の存在下、該形
質転換体を、上記(5)に記載の培養法で2時間から1
週間培養し、細胞中のレポーター遺伝子の発現量を公知
の方法〔東京大学医科学研究所 制癌研究部編, 新細胞
工学実験プロトコール, 秀潤社 (1993),Biotechniques,
20, 914 (1996)、J. Antibiotics, 49, 453 (1996) 、
Trends in Biochemical Sciences, 20, 448 (1995)、細
胞工学, 16, 581 (1997)〕を用いて測定、比較し、該発
現量を増加または低下させる活性を有する化合物を選択
・取得する方法。As a measurement method using the antibody of the present invention, for example, an ELISA using a microtiter plate is used.
Method, fluorescent antibody method, Western blot method, immunohistochemical staining and the like. (B) [i] cells expressing the polypeptide of the present invention;
[Ii] In the presence of a test substance, cells expressing the polypeptide of the present invention are cultured for 2 hours to 1 hour by the culture method described in (4) above.
After weekly culture, DN encoding the polypeptide in the cells
The transcript amount of A is measured and compared using a method such as the Northern hybridization method or the PCR method described in the above (7-2), and a compound having an activity of increasing or decreasing the transcript amount is selected. How to get. (C) A plasmid in which a reporter gene-linked DNA is incorporated downstream of the promoter obtained in the above (7-2) is prepared by a known method, and introduced into animal cells according to the method described in the above (5). , To obtain a transformant.
[I] In the presence of the transformant and [ii] a test substance, the transformant is cultured for 2 hours to 1 hour by the culture method described in the above (5).
After culturing for a week, the expression level of the reporter gene in the cells can be determined by a known method (New Cancer Engineering Protocol, Shujunsha (1993), Biotechniques, Ed.
20 , 914 (1996), J. Antibiotics, 49 , 453 (1996),
A method for selecting and obtaining a compound having an activity of increasing or decreasing the expression level by measuring and comparing the results using Trends in Biochemical Sciences, 20 , 448 (1995), Cell Engineering, 16 , 581 (1997)].
【0232】レポーター遺伝子としては、例えば、クロ
ラムフェニコール・アセチルトランスフェラーゼ遺伝
子、β−グルクロニダーゼ遺伝子、β−ガラクトシダー
ゼ遺伝子、β−ラクタマーゼ遺伝子、ルシフェラーゼ遺
伝子、エクオリン遺伝子またはグリーン・フルオレッセ
ント・プロテイン(GFP)遺伝子等をあげることがで
きる。 (7−7)本発明のDNAが欠損または置換した動物の
作製 本発明のDNAが欠損または置換した動物は、本発明の
DNAを含む遺伝子の全部または一部が欠損または置換
しており、本発明のポリペプチドの発現量が変化した動
物である。該動物、または該動物の臓器、組織または細
胞は、上記の方法により取得される医薬、例えば、大腸
癌、胃癌または視床、小脳の機能異常等の疾患の治療薬
の評価に用いることができ、薬剤評価モデル動物、臓
器、組織または細胞として有用である。Examples of the reporter gene include chloramphenicol acetyltransferase gene, β-glucuronidase gene, β-galactosidase gene, β-lactamase gene, luciferase gene, aequorin gene, and green fluorescent protein (GFP). Genes and the like can be mentioned. (7-7) Preparation of animal deficient or substituted for DNA of the present invention An animal deficient or substituted for the DNA of the present invention has all or a part of the gene containing the DNA of the present invention deleted or substituted. An animal in which the expression level of the polypeptide of the present invention has changed. The animal, or an organ, a tissue or a cell of the animal, can be used for evaluation of a medicament obtained by the above method, for example, a therapeutic drug for a disease such as colorectal cancer, gastric cancer or thalamus, cerebellar dysfunction, etc. It is useful as a drug evaluation model animal, organ, tissue or cell.
【0233】該動物は、本発明のDNAを含むベクター
を用い、目的とする動物、例えばウシ、ヒツジ、ヤギ、
ブタ、ウマ、ニワトリ、マウス等の非ヒト哺乳動物の胚
性幹細胞(embryonic stem cell)において染色体上の本
発明のポリペプチドをコードするDNAを公知の相同組
換えの手法〔例えば、Nature, 326, 295 (1987)、Cell,
51, 3, 503 (1987)等〕により不活化または任意の配列
と置換した変異胚性幹細胞クローンを作成することがで
きる〔Nature, 350, 243 (1991)〕。As the animal, a vector containing the DNA of the present invention is used, and the desired animal, for example, cow, sheep, goat,
Pigs, horses, chickens, embryonic stem cells of non-human mammals such as mice (embryonic stem cells), a DNA encoding the polypeptide of the present invention on the chromosome in a known homologous recombination technique (for example, Nature, 326 , 295 (1987), Cell,
51 , 3, 503 (1987), etc.] to produce a mutant embryonic stem cell clone inactivated or substituted with an arbitrary sequence [Nature, 350 , 243 (1991)].
【0234】このようにして作成した胚性幹細胞クロー
ンを用い、動物の受精卵の胚盤胞(blastcyst)への注入
キメラ法または集合キメラ法等の手法により胚性幹細胞
クローンと正常細胞からなるキメラ個体を作成すること
ができる。このキメラ個体と正常個体の掛け合わせによ
り、全身の細胞の染色体上の本発明のポリペプチドをコ
ードするDNAに任意の変異を有する個体を得ることが
でき、さらにその個体の掛け合わせにより相同染色体の
双方に変異が入った、ホモ個体(ノックアウト動物)を
得ることができる。Using the embryonic stem cell clone thus prepared, a chimera comprising an embryonic stem cell clone and normal cells by a technique such as injection chimera method or assembly chimera method of injecting a fertilized egg of an animal into a blastcyst. Individuals can be created. By crossing the chimeric individual with a normal individual, it is possible to obtain an individual having an arbitrary mutation in the DNA encoding the polypeptide of the present invention on the chromosome of whole body cells. A homozygous individual (knockout animal) having both mutations can be obtained.
【0235】このようにして動物個体において、染色体
上の本発明のポリペプチドをコードするDNAの任意の
位置へ変異の導入が可能である。例えば染色体上の本発
明のポリペプチドをコードするDNAの翻訳領域中への
塩基の欠失、置換若しくは付加等の変異を導入すること
により、その産物の活性を変化させることができる。Thus, in an animal individual, a mutation can be introduced into the chromosome at any position of the DNA encoding the polypeptide of the present invention. For example, by introducing a mutation such as deletion, substitution or addition of a base into the translation region of the DNA encoding the polypeptide of the present invention on the chromosome, the activity of the product can be changed.
【0236】またその発現制御領域への同様な変異の導
入により、発現の程度、時期、組織特異性等を改変させ
ることも可能である。さらにCre-loxP系との組合せによ
り、より積極的に発現時期、発現部位、発現量等を制御
することも可能である。By introducing similar mutations into the expression control region, it is also possible to modify the degree, timing, tissue specificity, etc. of the expression. Furthermore, by combining with the Cre-loxP system, the expression timing, expression site, expression amount, and the like can be more positively controlled.
【0237】このような例としては脳のある特定の領域
で発現されるプロモータを利用して、その領域でのみ目
的遺伝子を欠失させた例〔Cell, 87, 1317 (1996)〕やC
reを発現するアデノウィルスを用いて、目的の時期に、
臓器特異的に目的遺伝子を欠失させた例〔Science, 27
8, 5335 (1997)〕が知られている。[0237] Examples of such a case include the use of a promoter expressed in a specific region of the brain and deletion of the target gene only in that region [Cell, 87 , 1317 (1996)] and C
Using adenovirus expressing re, at the desired time,
An organ-specific deletion of a target gene [Science, 27
8 , 5335 (1997)].
【0238】従って染色体上の本発明のポリペプチドを
コードするDNAについてもこのように任意の時期や組
織で発現を制御できる、または任意の塩基の欠失、置換
若しくは付加をその翻訳領域や、発現制御領域に有する
動物個体を作成することが可能である。Accordingly, the expression of the DNA encoding the polypeptide of the present invention on the chromosome can be controlled at any time and in any tissue, or the deletion, substitution or addition of any base can be controlled by its translation region or expression. It is possible to create an animal individual having the control region.
【0239】このような動物は任意の時期、任意の程度
または任意の部位で、本発明のポリペプチドに起因する
種々の疾患、例えば、癌や視床または小脳の機能異常等
の症状を誘導することができる。Such an animal may induce, at any time, at any degree, or at any site, various diseases caused by the polypeptide of the present invention, for example, cancer, dysfunction of the thalamus or cerebellum. Can be.
【0240】従って、本発明のノックアウト動物は、本
発明のポリペプチドに起因する種々の疾患、例えば、癌
や視床または小脳の機能異常等の治療や予防において極
めて有用な動物モデルとなる。特にその治療薬、予防
薬、また機能性食品、健康食品等の評価用モデルとして
非常に有用である。Therefore, the knockout animal of the present invention becomes an extremely useful animal model in the treatment and prevention of various diseases caused by the polypeptide of the present invention, for example, cancer and dysfunction of the thalamus or cerebellum. In particular, it is very useful as a therapeutic drug, a preventive drug, and a model for evaluating functional foods, health foods and the like.
【0241】[0241]
【実施例】以下の実施例中に記載の方法については、と
くに断らない限り、モレキュラー・クローニング第二版
記載の方法に従って行った。 実施例1 新規G蛋白質共役型受容体(KAT0673
4Lポリペプチド)をコードするcDNAのクローン化 (1)KATOIII細胞由来cDNAライブラリーの作製 ヒト胃癌組織細胞株 KATOIIIから、mRNAを抽出し、精製
した。それぞれのpolyA(+)RNAよりオリゴキャプ法〔Gen
e, 138, 171 (1994)〕によりcDNAライブラリーを作成し
た。Oligo-cap linker(配列番号3で表される塩基配列
を有するDNA)およびOligo dT primer(配列番号4
で表される塩基配列を有するDNA)を用いて、蛋白質
核酸 酵素, 41, 197 (1996)、Gene, 200, 149 (1997)
記載の方法に従ってBAP(Bacterial Alkaline Phosphat
ase)処理、TAP(Tobacco Acid Pyrophosphatase)処
理、RNAライゲーション、第一鎖cDNAの合成とRN
Aの除去を行った。次いで、配列番号5で表される塩基
配列を有するDNA(5'末端側)と配列番号6で表さ
れる塩基配列を有するDNA(3'末端側)をプライマ
ーセットとして用いたPCRにより2本鎖cDNAに変
換した後、制限酵素SfiIで切断した。該cDNAを
DraIIIで切断したベクター pME18SFL3(GenBank acc
esion no. AB009864, Expression vector, 3392 bp)に
組み込み、cDNAライブラリーを作製した。上記方法
により、cDNAは発現が可能なように一方向に組み込
まれる。 (2)ランダムシークエンス 上記(1)で調製したcDNAライブラリーの各大腸菌
クローンから常法に従ってプラスミドDNAを取得し、
各プラスミドが含有するcDNAの5'末端側の塩基配列
を決定した。塩基配列の決定は、Dye Terminator Cycle
Sequencing FSReady Reaction Kit, dRhodamine Termi
nator Cycle Sequencing FS Ready Reaction Kitまたは
BigDye Terminator Cycle Sequencing FS Ready Reacti
on Kit(PE Biosystems社製)とDNAシークエンサー・
ABI PRISM 377(PE Biosystems社製)を用いて行った。
塩基配列決定用のプライマーとしては、配列番号7およ
び8で表される塩基配列を有するDNAを使用した。EXAMPLES The methods described in the following examples were carried out according to the method described in Molecular Cloning, Second Edition, unless otherwise specified. Example 1 Novel G protein-coupled receptor (KAT0673)
Cloning of cDNA Encoding 4L Polypeptide) (1) Preparation of KATOIII Cell-Derived cDNA Library mRNA was extracted and purified from human gastric cancer tissue cell line KATOIII. The oligocap method (Gen
e, 138 , 171 (1994)]. Oligo-cap linker (DNA having the base sequence represented by SEQ ID NO: 3) and Oligo dT primer (SEQ ID NO: 4
Using a DNA having a base sequence represented by the following formula: protein nucleic acid enzyme, 41 , 197 (1996), Gene, 200 , 149 (1997)
BAP (Bacterial Alkaline Phosphat)
ase) treatment, TAP (Tobacco Acid Pyrophosphatase) treatment, RNA ligation, first-strand cDNA synthesis and RN
A was removed. Next, double-stranded DNA was obtained by PCR using the DNA having the nucleotide sequence represented by SEQ ID NO: 5 (5 'end) and the DNA having the nucleotide sequence represented by SEQ ID NO: 6 (3' end) as a primer set. After converting into cDNA, it was cut with restriction enzyme SfiI . The cDNA
The vector pME18SFL3 (GenBank acc.
esion no. AB009864, Expression vector, 3392 bp) to prepare a cDNA library. By the above method, the cDNA is unidirectionally integrated so that expression is possible. (2) Random sequence Plasmid DNA was obtained from each E. coli clone of the cDNA library prepared in (1) according to a conventional method,
The nucleotide sequence at the 5 'end of the cDNA contained in each plasmid was determined. The nucleotide sequence is determined by the Dye Terminator Cycle
Sequencing FSReady Reaction Kit, dRhodamine Termi
nator Cycle Sequencing FS Ready Reaction Kit or
BigDye Terminator Cycle Sequencing FS Ready Reacti
on Kit (PE Biosystems) and DNA sequencer
This was performed using ABI PRISM 377 (manufactured by PE Biosystems).
DNAs having the nucleotide sequences represented by SEQ ID NOS: 7 and 8 were used as primers for nucleotide sequence determination.
【0242】得られた塩基配列についてはBlast、Fast
a、FrameSearch等のプログラムを利用して、相同性のあ
る遺伝子や蛋白質の解析を行った。その結果、pME−
KAT06734と名づけたプラスミドが含有するcD
NA(KAT06734 cDNAと呼ぶ)は、ヒトバ
ソプレッシン受容体やヒト黄体形成ホルモン放出ホルモ
ン受容体と相同性を有する蛋白質をコードしていること
がわかった。 (3)KAT06734 cDNAの全塩基配列の決定 上記(2)で得られたpME−KAT06734が含有
するcDNA(KAT06734 cDNA)の3'末端
側の塩基配列も決定し、該cDNAの全塩基配列を決定
した。塩基配列の決定には、パーキンエルマー社のDN
Aシークエンサー377とApplied Biosystems社製の反
応キット(ABI PrismTM BigDyeTM Terminator Cycle Se
quencing Ready Reaction kit)を使用した。[0242] The obtained base sequence was determined by Blast and Fast.
a) Analysis of homologous genes and proteins was performed using programs such as FrameSearch. As a result, pME-
CD contained in a plasmid named KAT06734
NA (referred to as KAT06734 cDNA) was found to encode a protein having homology to human vasopressin receptor and human luteinizing hormone releasing hormone receptor. (3) Determination of the entire nucleotide sequence of KAT06734 cDNA The nucleotide sequence at the 3 ′ end of the cDNA (KAT06734 cDNA) contained in pME-KAT06734 obtained in (2) above was also determined, and the entire nucleotide sequence of the cDNA was determined. did. To determine the nucleotide sequence, use PerkinElmer's DN
A Sequencer 377 and Applied Biosystems' reaction kit (ABI Prism ™ BigDye ™ Terminator Cycle Se
quencing Ready Reaction kit) was used.
【0243】KAT06734 cDNAは880bp
で、143アミノ酸からなるポリペプチドをコードして
いた(配列番号19)。相同性解析およびハイドロパシ
ー解析から、本cDNAのコードする蛋白質は、C末端
を欠失した新規GPCRであると考えられた。 (4)ヒト視床からの完全長cDNA(KAT0673
4L cDNA)の取得 ヒト胃癌細胞株KATOIIIおよび大腸癌細胞株Colo205由来
の全RNAを鋳型として3'-RACE法を行うことによ
り、KAT06734 cDNAで欠失していた3'末端
側のcDNA断片を取得した。3'-RACE法には、5'/
3' RACE キット(ベーリンガー社製)を用い、配列番号
9で表される塩基配列を有するDNA(図7の06734-5-
1)をKAT06734 cDNA特異的プライマーと
して用いた。3'-RACE法で取得したcDNA断片の
配列を決定し、KAT06734cDNAの配列と連結
した配列(KAT06734−3')を作成した(図11
〜13参照)。本配列においては、途中でOpen Reading
Frameがずれてしまうことから、再度PCRにより全長
cDNAの取得を試みることとした。その際、癌細胞株
ではスプライシング異常がある可能性が考えられたた
め、cDNAソースとしてはヒト正常組織(ヒト視床)
を用いた。The KAT06734 cDNA is 880 bp.
Encoded a polypeptide consisting of 143 amino acids (SEQ ID NO: 19). From the homology analysis and the hydropathy analysis, the protein encoded by the present cDNA was considered to be a novel GPCR lacking the C-terminus. (4) Full-length cDNA from human thalamus (KAT0673)
Acquisition of 4L cDNA) The 3'-RACE method was performed using total RNA from human gastric cancer cell line KATOIII and colon cancer cell line Colo205 as a template to obtain a 3'-terminal cDNA fragment deleted in KAT06734 cDNA. did. The 3'-RACE method includes 5 '/
Using a 3 'RACE kit (Boehringer), a DNA having the nucleotide sequence of SEQ ID NO: 9 (06734-5-
1) was used as a KAT06734 cDNA specific primer. The sequence of the cDNA fragment obtained by the 3′-RACE method was determined, and a sequence (KAT06733-1 ′) linked to the sequence of the KAT06734 cDNA was prepared (FIG. 11).
To 13). In this array, Open Reading
Since the frame was shifted, it was decided to try to obtain the full-length cDNA again by PCR. At that time, it was thought that there was a possibility of splicing abnormality in the cancer cell line.
Was used.
【0244】下記の実施例4の方法で調製したヒト視床
由来の1本鎖cDNAを鋳型として、配列番号11で表
される塩基配列を有するDNA(図7の06734SP5)と配
列番号12で表される塩基配列を有するDNA(図10
の06734-3-3)をプライマーセットとして用いてPCR
を行い、新たなcDNA断片を取得した。PCR反応
は、実施例4の(a)で合成したヒト視床由来の一本鎖
cDNA(6.25μl)に、Forwardプライマ
ー(配列番号11に記載のDNA)を10pmol、Re
verseプライマー(配列番号12に記載のDNA)を
10pmol、2.5mmol/L dNTP混合液を2.5
μl 、5単位/μlのTaKaRa Ex TaqTM (Takar
a社製)を0.1μl、10×反応緩衝液( Takar
a社製)を2.5μl添加し、滅菌水を加えて全量を2
5μlに調製した。サーマルサイクラーDNA eng
ine(MJ Research社製)を用い、95℃
5分間の熱処理によりDNAを変性させた後、96℃で
15秒間、68℃で1分48秒間からなる反応を35サ
イクル行った。その後、さらに72℃で10分間反応を
行った。Using the single-stranded cDNA derived from the human thalamus prepared by the method of Example 4 below as a template, a DNA having the nucleotide sequence of SEQ ID NO: 11 (06734SP5 in FIG. 7) and a DNA represented by SEQ ID NO: 12 DNA (see FIG. 10)
PCR using 06734-3-3) as a primer set
Was performed to obtain a new cDNA fragment. In the PCR reaction, 10 pmol of a forward primer (DNA of SEQ ID NO: 11) was added to the single-stranded cDNA (6.25 μl) derived from the human thalamus synthesized in (a) of Example 4 and
10 pmol of the reverse primer (DNA of SEQ ID NO: 12) and 2.5 mmol / L dNTP mixed solution
μl, 5 units / μl of TaKaRa Ex Taq ™ (Takar
a) (0.1 μl, 10 × reaction buffer (Takar)
a) was added and sterilized water was added to make a total amount of 2 μl.
It was adjusted to 5 μl. Thermal cycler DNA eng
ine (manufactured by MJ Research) at 95 ° C
After denaturing the DNA by heat treatment for 5 minutes, 35 cycles of a reaction consisting of 96 ° C. for 15 seconds and 68 ° C. for 1 minute and 48 seconds were performed. Thereafter, the reaction was further performed at 72 ° C. for 10 minutes.
【0245】上記PCRで増幅したcDNA断片の配列
を、ABI PrismTM BigDyeTM Terminator Cycle Sequenci
ng Ready Reaction Kit(PE Applied Biosystems社製)
を用いたダイレクトシークエンスにより決定した。プラ
イマーとしては、配列番号9、11、12で表される塩
基配列を有するDNA、および配列番号18で表される
塩基配列を有するDNA(図9の06734-3-2)を使用し
た。決定した塩基配列と、KAT06734 cDNA
の5'末端側配列およびKAT06734−3'の3'末端側
配列とを連結した配列を作成した(図7〜10参照)。
本合成配列を有するcDNAをKAT06734L c
DNAと呼び、その塩基配列を配列番号2に示す。本c
DNAは371アミノ酸の蛋白質をコードしていた(図
7〜10参照)。該アミノ酸配列を有するポリペプチド
をKAT06734Lポリペプチドと呼び、そのアミノ
酸配列を配列番号1に示した。The sequence of the cDNA fragment amplified by the above PCR was compared with ABI Prism ™ BigDye ™ Terminator Cycle Sequenci.
ng Ready Reaction Kit (PE Applied Biosystems)
Was determined by direct sequencing using As the primer, a DNA having the nucleotide sequence represented by SEQ ID NO: 9, 11, or 12, and a DNA having the nucleotide sequence represented by SEQ ID NO: 18 (06734-3-2 in FIG. 9) were used. Determined nucleotide sequence and KAT06734 cDNA
5'-terminal sequence and the 3'-terminal sequence of KAT0673-3-3 'were prepared (see FIGS. 7 to 10).
The cDNA having the synthetic sequence was designated as KAT0673Lc
It is called DNA, and its base sequence is shown in SEQ ID NO: 2. Book c
The DNA encoded a protein of 371 amino acids (see FIGS. 7-10). The polypeptide having the amino acid sequence is called KAT0673L polypeptide, and the amino acid sequence is shown in SEQ ID NO: 1.
【0246】ハイドロパシープロフィールから、該ポリ
ペプチドは7つの膜結合領域を有すると考えられた(図
1)。膜結合領域部分の具体的な予測はEMBO J., 12, 1
693(1993)に記載の方法に従って行った。From the hydropathy profile, the polypeptide was considered to have seven membrane-bound regions (FIG. 1). EMBO J., 12 , 1
693 (1993).
【0247】該ポリペプチドは、アミノ酸レベルで既知
のG蛋白質共役型受容体と相同性を有していたが、中で
もヒトバソプレッシン1A受容体、ヒトバソプレッシン
1B受容体、ヒトバソプレッシン2受容体、ヒトオキシ
トシン受容体、ヒト黄体形成ホルモン放出ホルモン受容
体、ホワイトサッカーのバソトシン受容体と高い相同性
を示した。KAT06734Lポリペプチドと上記既知
G蛋白質共役型受容体のアミノ酸配列を用いて作成した
デンドログラムを図14に示す。デンドログラムは、CL
USTAL X Multiple Sequence Alignment Program(ftp:/
/ftp-igbmc.u-strasbg.fr/pub/ClustalX/)を用いて作
成した。同プログラムを用いて、KAT06734Lポ
リペプチドと上記既知GPCRのアミノ酸配列をアライ
ンメントした結果を図2〜6に示す。KAT06734
Lポリペプチド中の予想される7つの膜貫通領域(TM
1〜TM7)を下線で示してある。The polypeptide had homology at the amino acid level to known G protein-coupled receptors. It showed high homology with the receptor, human luteinizing hormone-releasing hormone receptor, and vasotocin receptor in white soccer. FIG. 14 shows a dendrogram created using the KAT0673L polypeptide and the amino acid sequence of the known G protein-coupled receptor. Dendrogram CL
USTAL X Multiple Sequence Alignment Program ( ftp: /
/ftp-igbmc.u-strasbg.fr/pub/ClustalX/ ). FIGS. 2 to 6 show the results of aligning the KAT0673L polypeptide and the amino acid sequence of the known GPCR using the same program. KAT06734
The seven predicted transmembrane regions in the L polypeptide (TM
1 to TM7) are underlined.
【0248】KAT06734Lポリペプチドはアミノ
酸レベルで、ヒトバソプレッシン1A受容体と24.8
%、マウスバソプレッシン1A受容体と26.4%、ヒ
トバソプレッシン1B受容体と27.8%、ヒトバソプ
レッシン2受容体と22.9%、ヒトオキシトシン受容
体と25.6%、ヒト黄体形成ホルモン放出ホルモン受
容体と19.0%、ホワイトサッカーのバソトシン受容
体と26.7%の相同性を示した。At the amino acid level, KAT0673L polypeptide interacts with human vasopressin 1A receptor by 24.8.
%, Mouse vasopressin 1A receptor 26.4%, human vasopressin 1B receptor 27.8%, human vasopressin 2 receptor 22.9%, human oxytocin receptor 25.6%, human luteinizing hormone release It showed 19.0% homology with the hormone receptor and 26.7% with white soccer vasotocin receptor.
【0249】以上の結果から、該ポリペプチドは新規な
G蛋白質共役型受容体であることが明らかになった。ヒ
トおよびマウスのバソプレッシン1A受容体、ヒトバソ
プレッシン1B受容体、ヒトバソプレッシン2受容体、
ヒトオキシトシン受容体、ヒト黄体形成ホルモン放出ホ
ルモン受容体、ホワイトサッカーのバソトシン受容体の
天然リガンドはいずれもペプチドであることから、該新
規G蛋白質共役型受容体のリガンドもペプチドであると
推定された。また、該新規G蛋白質共役型受容体は上記
既知G蛋白質共役型受容体と19.0〜27.8%の相
同性を示すことから、該新規G蛋白質共役型受容体のリ
ガンドは、上記既知G蛋白質共役型受容体のリガンドと
は異なると推定された。 実施例2 KAT06734Lポリペプチドのヒト培養
細胞株における発現 (1)pBS−KAT06734Lの造成 下記の実施例4の方法で調製したヒト視床由来の1本鎖
cDNAを鋳型として、配列番号13で表される塩基配
列を有するDNA(図7の 06734-F)と配列番号14で
表される塩基配列を有するDNA(図9の 06734-R)を
プライマーセットとして用いてPCRを行い、KAT0
6734LポリペプチドをコードするcDNA断片を取
得した。PCR反応は、後述の実施例4の(a)で合成
したヒト視床由来の一本鎖cDNA(6.25μl)
に、Forwardプライマー(配列番号13で表され
る塩基配列を有するDNA)を10pmol、Reve
rseプライマー(配列番号14で表される塩基配列を
有するDNA)を10pmol、2.5mmol/L dNTP
混合液を2.5μl 、5単位/μlのTaKaRa Ex TaqT M
(Takara社製)を0.1μl、10×反応緩衝液
( Takara社製)を2.5μl添加し、滅菌水を加
えて全量を25μlに調製した。サーマルサイクラーD
NA engine(MJ Research社製)を
用い、95℃で5分間、熱処理によりDNAを変性させ
た後、94℃で30秒間、65℃で1分間、72℃で2
分間からなる反応を1サイクルとして、35サイクル行
った。その後、さらに72℃で10分間反応を行った。From the above results, it was revealed that the polypeptide is a novel G protein-coupled receptor. Human and mouse vasopressin 1A receptor, human vasopressin 1B receptor, human vasopressin 2 receptor,
Since natural ligands of human oxytocin receptor, human luteinizing hormone-releasing hormone receptor, and white soccer vasotocin receptor are all peptides, it is estimated that the ligand of the novel G protein-coupled receptor is also a peptide. . In addition, since the novel G protein-coupled receptor shows 19.0 to 27.8% homology with the known G protein-coupled receptor, the ligand of the novel G protein-coupled receptor is It was presumed to be different from the ligand of the G protein-coupled receptor. Example 2 Expression of KAT0673L polypeptide in a human cultured cell line (1) Construction of pBS-KAT0673L L Using the single-stranded cDNA derived from the human thalamus prepared by the method of Example 4 below as a template, represented by SEQ ID NO: 13 PCR was performed using a DNA having a base sequence (06734-F in FIG. 7) and a DNA having a base sequence represented by SEQ ID NO: 14 (06734-R in FIG. 9) as a primer set, and KAT0 was obtained.
A cDNA fragment encoding the 6734L polypeptide was obtained. The PCR reaction was performed using the human thalamus-derived single-stranded cDNA (6.25 μl) synthesized in Example 4 (a) described below.
10 pmol of a Forward primer (DNA having the base sequence represented by SEQ ID NO: 13) in Rev
rse primer (DNA having the base sequence represented by SEQ ID NO: 14) at 10 pmol, 2.5 mmol / L dNTP
2.5 μl of the mixture, 5 units / μl of TaKaRa Ex Taq T M
0.1 μl (manufactured by Takara) and 2.5 μl of 10 × reaction buffer (manufactured by Takara) were added, and sterilized water was added to adjust the total volume to 25 μl. Thermal cycler D
The DNA was denatured by heat treatment at 95 ° C. for 5 minutes using NA engine (manufactured by MJ Research), and then denatured at 94 ° C. for 30 seconds, 65 ° C. for 1 minute, and 72 ° C. for 2 minutes.
One cycle of the reaction was performed for 35 minutes, and 35 cycles were performed. Thereafter, the reaction was further performed at 72 ° C. for 10 minutes.
【0250】該cDNA断片を制限酵素HindIII
とXbaIで切断後、1.1kbのHindIII−X
baI断片を取得した。また、pBluescript II SK
(+)を制限酵素HindIIIとXbaIで切断後、
3.0kbのHindIII−XbaI断片を取得し
た。上記2断片を結合することにより、pBS−KAT
06734Lを造成した。PCR増幅断片にエラーのな
いことはシークエンスにより確認した。pBS−KAT
06734Lを含む大腸菌であるEscherichia coli DH5
α/pBS-KAT06734Lは、平成11年12月8日付で工業技
術院生命工学工業技術研究所にFERM BP−696
7として寄託されている。 (2)KAT06734Lポリペプチド発現用プラスミ
ドpAMo−KAT06734Lの造成 上記(1)で造成したpBS−KAT06734Lを制
限酵素HindIIIとNotIで切断後、1.1kb
のHindIII−NotI断片を取得した。また、p
AMo〔 J. Biol. Chem., 268, 22782 (1993)、別名p
AMoPRC3Sc(特開平05-336963)〕を制限酵素
HindIIIとNotIで切断後、8.7kbのHi
ndIII−NotI断片を取得した。上記2断片を結
合することにより、pAMo−KAT06734Lを造
成した。 (3)KAT06734Lポリペプチドのヒト培養細胞
株における発現 コントロールプラスミド(pAMo)およびKAT06
734Lポリペプチド発現用プラスミド(pAMo−K
AT06734L)を、それぞれ1μg/μlになるよ
うにTEに溶解した後、エレクトロポレーション法〔Cy
totechnology,3, 133 (1990)〕によりNamalwa KJM-1細
胞〔Cytotechnology, 1, 151(1988)〕に導入し、形質転
換細胞を得た。[0250] limit the cDNA fragment enzyme Hin dIII
After the cut with Xba I, Hin of 1.1kb dIII- X
The ba I fragment was obtained. Also, pBluescript II SK
(+) After cleavage with restriction enzymes Hin dIII and Xba I,
It has acquired the Hin dIII- Xba I fragment of 3.0kb. By combining the above two fragments, pBS-KAT
0673L was produced. The absence of errors in the PCR amplified fragment was confirmed by sequencing. pBS-KAT
Escherichia coli DH5, which is Escherichia coli containing 06734L
α / pBS-KAT06734L was submitted to FERM BP-696 on December 8, 1999 by
No. 7 has been deposited. (2) KAT06734L was cleaved with polypeptide limit pBS-KAT06734L which was constructed with the expression plasmid pAMo-KAT06734L of Construction (1) enzyme Hin dIII and Not I, 1.1 kb
It has acquired the Hin dIII- Not I fragment. Also, p
AMo [J. Biol. Chem., 268 , 22782 (1993), aka p
AMoPRC3Sc (Japanese Unexamined Patent Publication No. 05-336963)]
After the cut with Hin dIII and Not I, of 8.7kb Hi
n dIII- Not acquired the I fragment. By combining the above two fragments, pAMo-KAT0673L was constructed. (3) Expression of KAT0673L polypeptide in human cultured cell lines Control plasmid (pAMo) and KAT06
734L polypeptide expression plasmid (pAMo-K
AT0673L) was dissolved in TE at a concentration of 1 μg / μl, and then electroporation [Cy
totechnology, 3 , 133 (1990)] to transform the cells into Namalwa KJM-1 cells [Cytotechnology, 1 , 151 (1988)].
【0251】1.6×106細胞あたり4μgのプラスミ
ドを導入した後、8ml のRPMI1640・ITPSG
培地[7.5% NaHCO3 を1/40量、 200mmol/L L-グルタミ
ン溶液 (GIBCO 社製) を3%、ペニシリン・ストレプトマ
イシン溶液 (GIBCO 社製、5000 units/ml ペニシリン、
5000μg/ml ストレプトマイシン) を0.5%、10mmol/LN
−2−ヒドロキシエチルピペラジン−N’−2−エタン
スルフォニック・アシッド(N-2-hydroxyethylpiperazi
ne-N'-2-hydroxypropane-3-sulfonic acid; HEPES )、
3 μg/ml インシュリン、5 μg/ml トランスフェリン、
5mmol/L ピルビン酸ナトリウム、125nmol/L 亜セレン酸
ナトリウム、1mg/ml ガラクトースを添加したRPMI
1640培地(日水製薬社製)]に懸濁し、CO2イン
キュベーターで37℃で24時間培養した。その後、G418
(ギブコ社製)を0.5mg/mlになるように添加し、さらに
14日間培養して安定形質転換株を取得した。該形質転
換株は、0.5mg/mlのG418を含むRPMI1640・IT
PSG培地で継代した。After introducing 4 μg of plasmid per 1.6 × 10 6 cells, 8 ml of RPMI1640 · ITPSG was introduced.
Medium [7.5% NaHCO 3 1/40 volume, 200 mmol / L L-glutamine solution (GIBCO) 3%, penicillin-streptomycin solution (GIBCO, 5000 units / ml penicillin,
(5000μg / ml streptomycin) 0.5%, 10mmol / LN
-2-Hydroxyethylpiperazine-N'-2-ethanesulfonic acid (N-2-hydroxyethylpiperazi
ne-N'-2-hydroxypropane-3-sulfonic acid; HEPES),
3 μg / ml insulin, 5 μg / ml transferrin,
RPMI supplemented with 5 mmol / L sodium pyruvate, 125 nmol / L sodium selenite, and 1 mg / ml galactose
1640 medium (manufactured by Nissui Pharmaceutical Co., Ltd.)] and cultured at 37 ° C. for 24 hours in a CO 2 incubator. Then G418
(Manufactured by Gibco) was added to a concentration of 0.5 mg / ml, and the mixture was further cultured for 14 days to obtain a stable transformant. The transformant was RPMI1640.IT containing 0.5 mg / ml G418.
Passaged in PSG medium.
【0252】該安定形質転換株またはその膜画分は、上
記(6−1)に記載した方法に準じて、KAT0673
4Lポリペプチド(新規G蛋白質受容体)のリガンド、
アゴニスト、アンタゴニストまたは機能修飾物質の探索
にも利用することができる。 実施例3 KAT06734L染色体遺伝子の構造解析 本発明のKAT06734L cDNAの配列と、デー
タベースに登録されてるヒト染色体遺伝子の配列とを比
較することにより、本発明のKAT06734Lポリペ
プチドをコードするヒト染色体遺伝子(KAT0673
4L染色体遺伝子と呼ぶ)を同定し、そのプロモーター
領域、エクソンおよびイントロン構造を下記の方法によ
り決定した。The stable transformant or the membrane fraction thereof was obtained according to the method described in the above (6-1), using KAT0673.
A ligand for a 4L polypeptide (a novel G protein receptor),
It can also be used to search for agonists, antagonists or functional modifiers. Example 3 Structural Analysis of KAT06734L Chromosome Gene By comparing the sequence of the KAT06734L cDNA of the present invention with the sequence of the human chromosome gene registered in the database, the human chromosomal gene encoding the KAT06734L polypeptide of the present invention (KAT0673L) was compared.
4L chromosome gene) and its promoter region, exon and intron structure were determined by the following method.
【0253】KAT06734L cDNAの塩基配列
(配列番号2)とGenBank〔インターネット上のNationa
l Center for Biotechnology Information (NCBI) のホ
ームページ(http://www.ncbi.nlm.nih.gov/)からアク
セスできる〕に登録されている配列とを比較した結果、
登録番号AC005493、AC005680、AC005174、AC005862、AC
005853のヒト染色体DNA配列の一部が、KAT067
34L cDNAの塩基配列の一部と一致することが判
明した。解析の結果、KAT06734L染色体遺伝子
は9個のエクソンと8個のイントロンから構成される非
常に大きな遺伝子であることが明らかとなった。AC0054
93とAC005680の配列はつながり、エクソン1とエクソン
2を含んでいた(配列番号15で表される塩基配列を有
するDNA)。AC005174、AC005862、およびAC005853の
配列はつながり、エクソン3〜9を含んでいた(配列番
号16で表される塩基配列を有するDNA)。エクソン
1の上流配列(1〜5kb)は、KAT06734L染
色体遺伝子のプロモーター領域(転写制御領域を含む)
と考えられた。登録番号AC005680の配列は、ヒト染色体
7p14-15に位置することから、KAT06734L染色
体遺伝子はヒト染色体7p14-15に位置することが判明し
た。KAT06734L染色体遺伝子の染色体上の位置
と構造(プロモーター領域、エクソン領域、イントロン
領域)は、本研究によってKAT06734L cDN
Aの構造が明らかになることにより、初めて特定できた
ものである。The base sequence of KAT0673L cDNA (SEQ ID NO: 2) and GenBank [Nationa on the Internet
l Accessible from the Center for Biotechnology Information (NCBI) homepage (http://www.ncbi.nlm.nih.gov/).
Registration numbers AC005493, AC005680, AC005174, AC005862, AC
Part of the human chromosomal DNA sequence of 005853 is KAT067
It turned out that it matched a part of base sequence of 34L cDNA. As a result of the analysis, it was revealed that the KAT0673L chromosome gene is a very large gene composed of 9 exons and 8 introns. AC0054
The sequence of 93 and AC005680 were linked, and contained exon 1 and exon 2 (DNA having the nucleotide sequence represented by SEQ ID NO: 15). The sequences of AC005174, AC005862, and AC005853 were linked and included exons 3 to 9 (DNA having the nucleotide sequence represented by SEQ ID NO: 16). The exon 1 upstream sequence (1 to 5 kb) corresponds to the promoter region of the KAT0673L chromosome gene (including the transcription control region).
It was considered. The sequence with accession number AC005680 is a human chromosome.
Since it is located at 7p14-15, it was found that the KAT0673L chromosome gene was located at human chromosome 7p14-15. The location and structure of the KAT0673L chromosome gene on the chromosome (promoter region, exon region, intron region) were determined by the present study to be KAT06734L cDN.
This was the first time that the structure of A was identified.
【0254】エクソン1の上流配列(5kb)につい
て、配列解析ソフトGENETYX-MAC 10.1のTranscription
Factor Database 〔Nucleic Acids Research 18, 1749
(1990)、Trends in Biochemical Sciences 16, 455(199
1)、Nucleic Acids Research 20S, 2091 (1992)、Nucle
ic Acids Research 21S, 3117 (1993)〕をもとに作成さ
れたMotif Search Programを用いて、転写因子の結合配
列のコンセンサス配列の存在について解析した結果、該
配列はプロモーター領域を有する配列であると判断され
た。About the upstream sequence (5 kb) of exon 1, Transcription of sequence analysis software GENETYX-MAC 10.1
Factor Database (Nucleic Acids Research 18 , 1749
(1990), Trends in Biochemical Sciences 16 , 455 (199
1), Nucleic Acids Research 20S , 2091 (1992), Nucleic Acids Research
ic Acids Research 21S , 3117 (1993)], the Motif Search Program was used to analyze the presence of a consensus sequence of transcription factor binding sequences, and found that the sequence had a promoter region. It was judged.
【0255】KAT06734L cDNA、KAT0
6734 cDNA、およびKAT06734L-3'の
塩基配列、ならびにKAT06734L染色体遺伝子を
比較した結果、KAT06734 cDNAと KAT0III
細胞から3'-RACE法で取得したDNA断片は、スプ
ライシングの異常によって生じたバリアントと考えられ
た。 実施例4 KAT06734L染色体遺伝子からの転写
産物のヒト各種細胞における発現量の検討 KAT06734L染色体遺伝子からの転写産物(KA
T06734L転写産物と呼ぶ)の定量は、常法〔PCR
Protocols, Academic Press(1990)〕にしたがって半定
量的PCR法により行った。KAT06734L cDNA, KAT0
As a result of comparing the base sequences of KAT06734L-3 ′ and KAT06734L chromosomal gene, KAT07634 cDNA and KAT0III
The DNA fragment obtained from the cells by the 3'-RACE method was considered to be a variant generated by splicing abnormality. Example 4 Examination of Expression Level of Transcripts from KAT06734L Chromosomal Gene in Various Human Cells Transcripts from KAT06734L chromosomal gene (KA
Quantification of T0673L transcript) is performed by a conventional method [PCR
Protocols, Academic Press (1990)].
【0256】また、どの細胞でも同程度発現していると
考えられるβ−アクチンの転写産物の定量も同時に行
い、細胞間でのmRNA量の違いや、サンプル間での逆
転写酵素によるmRNAから一本鎖cDNAへの変換効
率に大差ないことを確認した。Also, the transcript of β-actin, which is considered to be expressed to the same extent in any cell, was simultaneously determined, and the amount of mRNA between cells and the difference in mRNA between samples by reverse transcriptase were determined. It was confirmed that there was not much difference in the conversion efficiency to the main-strand cDNA.
【0257】β−アクチン転写産物の定量は、常法〔Pr
oc. Natl. Acad. Sci. USA, 87, 2725 (1990)、J. Bio
l. Chem., 269, 14730 (1994)、特開平06-181759 〕に
したがって定量的PCR法により行った。 (a)各種細胞および細胞株由来の一本鎖cDNAの合
成 ヒト細胞株としては、 T細胞株(Jurkat、Molt-3、Mol
t-4、HUT78)、 B細胞株(Namalwa KJM-1、Daudi、 Ra
ji)、顆粒球/単球系細胞株(HL-60、U-937、 THP-
1)、血管内皮細胞株(IVEC、HUVEC)、メラノーマ細胞
株(WM266-4、WM115)、神経芽細胞腫細胞株SK-N-MC、
肺癌細胞株(PC-9、 HLC-1、QG90)、前立腺癌細胞株PC
-3、胃癌細胞株KATOIII、膵臓癌細胞株(Capan-1、Capa
n-2)、大腸癌細胞株(Colo205、SW1116、LS180)を用
いた。 Jurkat、QG90およびSW1116は愛知癌センターよ
り入手した。HLC-1は大阪大学癌研究所より入手した。K
ATOIIIおよびPC-9は免疫生物研究所より入手した。HUVE
C(human umbelical vascular endothelial cell)はク
ラボ社より入手した。IVEC〔J. Cell. Physiol., 157,
41 (1993) 〕はN.T.L.FRANCE社より入手し
た。Molt-4、DaudiはJapanese Collection of Research
Bioresources(JCRB)cell bank 〔インターネッ
トアドレスhttp://cellbank.nihs.go.jp/〕より入手し
た。それ以外の細胞は、アメリカン・タイプ・カルチャ
ー・コレクション (American Type Culture Collectio
n) より入手した。The quantification of the β-actin transcript was carried out by a conventional method [Pr
oc. Natl. Acad. Sci. USA, 87 , 2725 (1990), J. Bio
l. Chem., 269 , 14730 (1994), JP-A-06-181759], and a quantitative PCR method. (A) Synthesis of single-stranded cDNA derived from various cells and cell lines As human cell lines, T cell lines (Jurkat, Molt-3, Mol
t-4, HUT78), B cell line (Namalwa KJM-1, Daudi, Ra
ji), granulocyte / monocyte cell lines (HL-60, U-937, THP-
1), vascular endothelial cell lines (IVEC, HUVEC), melanoma cell lines (WM266-4, WM115), neuroblastoma cell line SK-N-MC,
Lung cancer cell line (PC-9, HLC-1, QG90), prostate cancer cell line PC
-3, gastric cancer cell line KATOIII, pancreatic cancer cell line (Capan-1, Capa
n-2), colon cancer cell lines (Colo205, SW1116, LS180). Jurkat, QG90 and SW1116 were obtained from Aichi Cancer Center. HLC-1 was obtained from Osaka University Cancer Institute. K
ATOIII and PC-9 were obtained from the Institute for Immunobiology. HUVE
C (human umbelical vascular endothelial cell) was obtained from Kurabo. IVEC [J. Cell. Physiol., 157 ,
41 (1993)]. T. L. Obtained from FRANCE. Molt-4 and Daudi are Japanese Collection of Research
Bioresources (JCRB) cell bank [Internet address http://cellbank.nihs.go.jp/] Other cells are from the American Type Culture Collection (American Type Culture Collection).
n) Obtained from
【0258】また、健康な成人の末梢血よりPolymorphp
repTM(Nycomed Pharma社製)を用いて多形核白血球と
単核球を分離取得した。次いで、取得した単核球からNy
ronFiber(和光純薬社製)を用いてT細胞を取得した。
方法はNyron Fiberの説明書に従った。J. Immunol., 15
0, 1122 (1993)に記載の方法に従って、取得したT細胞
を以下の3種の条件で培養し、活性化T細胞を取得し
た。 10%FCSを含むRPMI1640培地を用いて1
×106細胞/mlでシードしたT細胞に、50ng/
mlのインターロイキン2(IL-2)、1μg/mlのph
ytohemagglutinin-P (PHA-P)、および5ng/mlのト
ランスフォーミング・グロース・ファクターβ(TGF-
β)を添加し、2日間、4日間、6日間、または8日間
培養後、細胞を回収した。 10%FCSを含むRPMI1640培地を用いて1
×106細胞/mlでシードしたT細胞に、50ng/
mlのIL-2と1μg/mlのPHA-Pを添加し、4日間、
6日間、または8日間培養後、細胞を回収した。 抗CD3抗体をコートした培養容器に、10%FCS
を含むRPMI1640培地を用いて1×106細胞/
mlでT細胞をシードし、50ng/mlのIL-2の存在
下、2日間、4日間、6日間、または8日間培養後、細
胞を回収した。In addition, polymorphp from peripheral blood of healthy adults
Polymorphonuclear leukocytes and mononuclear cells were separated and obtained using rep TM (manufactured by Nycomed Pharma). Next, Ny was obtained from the obtained mononuclear cells.
T cells were obtained using ronFiber (manufactured by Wako Pure Chemical Industries, Ltd.).
The method followed the instructions of Nyron Fiber. J. Immunol., 15
0 , 1122 (1993), the obtained T cells were cultured under the following three conditions to obtain activated T cells. Using RPMI 1640 medium containing 10% FCS,
50 ng / T cells seeded at × 10 6 cells / ml
ml of interleukin 2 (IL-2), 1 μg / ml ph
ytohemagglutinin-P (PHA-P) and 5 ng / ml transforming growth factor β (TGF-P
β) was added, and the cells were collected after culturing for 2, 4, 6, or 8 days. Using RPMI 1640 medium containing 10% FCS,
50 ng / T cells seeded at × 10 6 cells / ml
ml of IL-2 and 1 μg / ml of PHA-P were added and
After culturing for 6 days or 8 days, the cells were collected. 10% FCS in culture vessel coated with anti-CD3 antibody
1 × 10 6 cells / RPMI1640 medium containing
T cells were seeded in ml and cultured for 2, 4, 6, or 8 days in the presence of 50 ng / ml IL-2, and the cells were collected.
【0259】各細胞の全RNAは常法〔Biochemistry,
18, 5294 (1977)〕にしたがって調製した。全RNAか
ら一本鎖cDNAの合成はキット(SUPERSCRIPTTM Prea
mplification System;BRL社製)を用いて行った。
細胞株については5μgの全RNAから一本鎖cDNA
を合成し、それぞれ水で50倍希釈してPCRの鋳型と
して使用した。プライマーとしては、オリゴ(dT)プ
ライマーを用いた。The total RNA of each cell was determined by a conventional method [Biochemistry,
18 , 5294 (1977)]. Synthesis of single-stranded cDNA from total RNA is performed using a kit (SUPERSCRIPT ™ Prea
mplification System; manufactured by BRL).
For cell lines, 5 μg of total RNA to single-stranded cDNA
Was synthesized, diluted 50-fold with water, and used as a template for PCR. As a primer, an oligo (dT) primer was used.
【0260】また、ヒト各種臓器由来のmRNA(Clon
tech社製)から同様にして一本鎖cDNAを合成した。
1μgのmRNAから一本鎖cDNAを合成し、水で2
40倍希釈してPCRの鋳型として使用した。プライマ
ーとしては、オリゴ(dT)プライマーを用いた。mR
NAとしては、以下の35種類の臓器由来のmRNAを
使用した。1副腎、2脳、3尾状核、4海馬、5黒質、
6視床、7腎、8膵臓、9脳下垂体、10小腸、11骨
髄、12扁桃体、13小脳、14脳梁、15胎児脳、1
6胎児腎、17胎児肝臓、18胎児肺、19心臓、20
肝臓、21肺、22リンパ節、23乳腺、24胎盤、2
5前立腺、26唾液腺、27骨格筋、28脊髄、29脾
臓、30胃、31精巣、32胸腺、33甲状腺、34気
管、35子宮。 (b)定量的PCR用のスタンダードおよび内部コント
ロールの調製 pBS−KAT06734LをcDNA部分を切り出す
制限酵素HindIIIとNotIで切断して直鎖状DNA
に変換した後、酵母のトランスファーRNAを1μg/
mlで含む水で段階的に希釈して、定量用のスタンダー
ドとして用いた。In addition, mRNA derived from various human organs (Clon
tech) was synthesized in the same manner.
Single-stranded cDNA was synthesized from 1 μg of mRNA, and
A 40-fold dilution was used as a template for PCR. As a primer, an oligo (dT) primer was used. mR
As NA, mRNA derived from the following 35 kinds of organs was used. 1 adrenal gland, 2 brains, 3 caudate nuclei, 4 hippocampus, 5 substantia nigra,
6 thalamus, 7 kidneys, 8 pancreas, 9 pituitary gland, 10 small intestine, 11 bone marrow, 12 amygdala, 13 cerebellum, 14 corpus callosum, 15 fetal brain, 1
6 fetal kidney, 17 fetal liver, 18 fetal lung, 19 heart, 20
Liver, 21 lungs, 22 lymph nodes, 23 mammary glands, 24 placentas, 2
5 prostate, 26 salivary glands, 27 skeletal muscle, 28 spinal cord, 29 spleen, 30 stomach, 31 testis, 32 thymus, 33 thyroid, 34 trachea, 35 uterus. (B) Quantitative PCR for Standard and preparation pBS-KAT06734L internal control cutting out the cDNA partial restriction enzyme Hin dIII and Not was cut with I linear DNA of
After converting to 1 μg /
It was serially diluted with ml of water and used as a standard for quantification.
【0261】また、β−アクチンをコードするcDNA
を含有するpUC119−ACT、およびβ−アクチン
をコードするcDNAの一部を欠損させたcDNAを含
有するpUC119−ACTdのそれぞれのcDNA部
分を制限酵素HindIIIとAsp718で切断して直
鎖状DNAに変換した後、酵母のトランスファーRNA
を1μg/mlで含む水で段階的に希釈して、それぞれ
β−アクチンの転写産物定量用のスタンダードおよび内
部コントロールとして用いた〔J. Biol. Chem., 269, 1
4730 (1994)、特開平06-181759〕。 (c)PCR法を用いたKAT06734L転写産物の
定量 (a)で調製した各種組織および細胞株由来の一
本鎖cDNAを鋳型としてPCRを行った。PCRに
は、配列番号9(図7の0634-5')および配列番号17
(図8の06734-3')で表される塩基配列を有するDNA
をプライマーセットとして用いた。また、上記(b)で
作製したスタンダードを鋳型として同様にPCRを行う
ことにより検量線を作製した。Also, cDNA encoding β-actin
Containing pUC119-ACT, and β- actin containing cDNA were missing part of the cDNA encoding pUC119-ACTD respective cDNA portion was cut with restriction enzymes Hin dIII and Asp 718 linear DNA of After conversion to yeast transfer RNA
Was serially diluted with water containing 1 μg / ml and used as a standard and an internal control, respectively, for quantifying β-actin transcripts [J. Biol. Chem., 269 , 1].
4730 (1994), JP-A-06-181759]. (C) Quantification of KAT0673L transcript using PCR method PCR was performed using single-stranded cDNAs derived from various tissues and cell lines prepared in (a) as templates. In the PCR, SEQ ID NO: 9 (0634-5 ′ in FIG. 7) and SEQ ID NO: 17
DNA having the nucleotide sequence represented by (06734-3 ′ in FIG. 8)
Was used as a primer set. In addition, a calibration curve was prepared by similarly performing PCR using the standard prepared in (b) above as a template.
【0262】PCR反応は、(a)で合成した一本鎖c
DNA(5μl)に、Forwardプライマー(配列
番号9に記載のDNA)を10pmol、Revers
eプライマー(配列番号17に記載のDNA)を10pm
ol、2.5mmol/L dNTP混合液を1.6μl、ジメ
チルスルフォキシドを1μl、5単位/μlのRecombin
ant Taq DNA Polymerase (Takara社製)を0.1
μl、10×反応緩衝液( Takara社製)を2μl
添加し、滅菌水を加えて全量を20μlに調製した。サ
ーマルサイクラーDNA engine(MJ Res
earch社製)を用い、94℃で3分間の熱処理によ
りDNAを変性させ後、94℃で1分間、60℃で1分
間、72℃で1分間からなる反応を1サイクルとして2
5〜35サイクル行った。該反応液の一部(8μl)を
アガロースゲル電気泳動に供した後、ゲルをSYBR Green
I nucleic acid stain(Molecular Probes社)で染色
した。増幅されたDNA断片のパターンをフルオロイメ
ージャー(FluorImager SI; Molecular Dynamics社製)
で解析することにより、増幅されたDNA断片の量を測
定した。より正確な転写産物の定量を行なうため、PC
Rのサイクル数を変えて同様のPCRを行った。スタン
ダードの量はPCRのサイクル数に応じて変化させた。The PCR reaction was carried out using the single-stranded c synthesized in (a).
10 pmol of the forward primer (DNA of SEQ ID NO: 9) was added to DNA (5 μl),
e primer (DNA of SEQ ID NO: 17) at 10 pm
ol, 2.5 mmol / L dNTP mixture 1.6 μl, dimethyl sulfoxide 1 μl, 5 units / μl Recombin
ant Taq DNA Polymerase (Takara) 0.1
2 μl of 10 μl reaction buffer (Takara)
Then, sterile water was added to adjust the total volume to 20 μl. Thermal cycler DNA engine (MJ Res
DNA, denatured by heat treatment at 94 ° C for 3 minutes, and 2 cycles of a reaction consisting of 94 ° C for 1 minute, 60 ° C for 1 minute, and 72 ° C for 1 minute.
Five to 35 cycles were performed. After subjecting a part (8 μl) of the reaction solution to agarose gel electrophoresis, the gel was subjected to SYBR Green
The cells were stained with I nucleic acid stain (Molecular Probes). The pattern of the amplified DNA fragment is converted to a fluoro imager (FluorImager SI; manufactured by Molecular Dynamics).
The amount of the amplified DNA fragment was measured by the analysis described in (1). For more accurate transcript quantification, PC
The same PCR was performed by changing the number of cycles of R. The amount of the standard was changed according to the number of PCR cycles.
【0263】β−アクチンの転写産物の定量については
J. Biol. Chem., 269, 14730 (1994)および特開平06-1
81759に記載の方法と同様に行った。For quantification of the transcript of β-actin,
J. Biol. Chem., 269 , 14730 (1994) and JP-A-06-1
It carried out similarly to the method of 81759.
【0264】KAT06734L転写産物は、ヒト正常
組織では視床と小脳で比較的多く発現していた。全脳、
海馬、黒質、胎児脳、胎児腎、胎児肝臓、心臓、肝臓、
乳腺、胎盤、前立腺、唾液腺、骨格筋、胸腺、甲状腺、
子宮でも発現が見られた(図15)。KAT06734
Lポリペプチドは、上記発現組織において重要な生理学
的機能を果たしていると推定される。The KAT0673L transcript was relatively frequently expressed in the thalamus and cerebellum in normal human tissues. The whole brain,
Hippocampus, substantia nigra, fetal brain, fetal kidney, fetal liver, heart, liver,
Mammary gland, placenta, prostate, salivary gland, skeletal muscle, thymus, thyroid,
Expression was also seen in the uterus (FIG. 15). KAT06734
The L polypeptide is presumed to perform important physiological functions in the expression tissues.
【0265】ヒト培養細胞株では、大腸癌細胞株(LS-1
80、Colo205)および胃癌細胞株(KATOIII)でKAT0
6734L転写産物の発現がみられた。その他の細胞株
では発現はみられなかった(図16)。KAT06734
L転写産物が発現している上記細胞株は、上記(6−
1)に記載した方法に準じてKAT06734Lポリペ
プチドのリガンド、アゴニスト、アンタゴニストまたは
機能修飾物質の探索に利用することができる。In the human cultured cell line, a colon cancer cell line (LS-1
80, Colo205) and KATO in gastric cancer cell line (KATOIII).
Expression of the 6734L transcript was observed. No expression was observed in other cell lines (FIG. 16). KAT06734
The cell line expressing the L transcript is (6-
According to the method described in 1), it can be used for searching for ligands, agonists, antagonists or functional modifiers of the KAT0673L polypeptide.
【0266】[0266]
配列番号3−人工配列の説明:合成DNA 配列番号4−人工配列の説明:合成DNA 配列番号5−人工配列の説明:合成DNA 配列番号6−人工配列の説明:合成DNA 配列番号7−人工配列の説明:合成DNA 配列番号8−人工配列の説明:合成DNA 配列番号9−人工配列の説明:合成DNA 配列番号10−人工配列の説明:合成DNA 配列番号11−人工配列の説明:合成DNA 配列番号12−人工配列の説明:合成DNA 配列番号13−人工配列の説明:合成DNA 配列番号14−人工配列の説明:合成DNA 配列番号17−人工配列の説明:合成DNA 配列番号18−人工配列の説明:合成DNA SEQ ID NO: 3-Description of Artificial Sequence: Synthetic DNA SEQ ID NO: 4-Description of Artificial Sequence: Synthetic DNA SEQ ID NO: 5-Description of Artificial Sequence: Synthetic DNA SEQ ID NO: 6-Description of Artificial Sequence: Synthetic DNA SEQ ID NO: 7-Artificial Sequence Description: Synthetic DNA SEQ ID NO: 8-Description of Artificial Sequence: Synthetic DNA SEQ ID NO: 9-Description of Artificial Sequence: Synthetic DNA SEQ ID NO: 10-Description of Artificial Sequence: Synthetic DNA SEQ ID NO: 11-Description of Artificial Sequence: Synthetic DNA Sequence No. 12—Description of Artificial Sequence: Synthetic DNA SEQ ID No. 13—Description of Artificial Sequence: Synthetic DNA SEQ ID No. 14—Description of Artificial Sequence: Synthetic DNA SEQ ID No. 17—Description of Artificial Sequence: Synthetic DNA SEQ ID No. 18—Description of Artificial Sequence Description: Synthetic DNA
【0267】[0267]
【配列表】 SEQUENCE LISTING <110> KYOWA HAKKO KOGYO CO., LTD <120> Novel Polypeptides <130> H11-1931A4 <140> <141> <160> 18 <170> PatentIn Ver. 2.0 <210> 1 <211> 371 <212> PRT <213> Homo sapiens <400> 1 Met Pro Ala Asn Phe Thr Glu Gly Ser Phe Asp Ser Ser Gly Thr Gly 1 5 10 15 Gln Thr Leu Asp Ser Ser Pro Val Ala Cys Thr Glu Thr Val Thr Phe 20 25 30 Thr Glu Val Val Glu Gly Lys Glu Trp Gly Ser Phe Tyr Tyr Ser Phe 35 40 45 Lys Thr Glu Gln Leu Ile Thr Leu Trp Val Leu Phe Val Phe Thr Ile 50 55 60 Val Gly Asn Ser Val Val Leu Phe Ser Thr Trp Arg Arg Lys Lys Lys 65 70 75 80 Ser Arg Met Thr Phe Phe Val Thr Gln Leu Ala Ile Thr Asp Ser Phe 85 90 95 Thr Gly Leu Val Asn Ile Leu Thr Asp Ile Asn Trp Arg Phe Thr Gly 100 105 110 Asp Phe Thr Ala Pro Asp Leu Val Cys Arg Val Val Arg Tyr Leu Gln 115 120 125 Val Val Leu Leu Tyr Ala Ser Thr Tyr Val Leu Val Ser Leu Ser Ile 130 135 140 Asp Arg Tyr His Ala Ile Val Tyr Pro Met Lys Phe Leu Gln Gly Glu 145 150 155 160 Lys Gln Ala Arg Val Leu Ile Val Ile Ala Trp Ser Leu Ser Phe Leu 165 170 175 Phe Ser Ile Pro Thr Leu Ile Ile Phe Gly Lys Arg Thr Leu Ser Asn 180 185 190 Gly Glu Val Gln Cys Trp Ala Leu Trp Pro Asp Asp Ser Tyr Trp Thr 195 200 205 Pro Tyr Met Thr Ile Val Ala Phe Leu Val Tyr Phe Ile Pro Leu Thr 210 215 220 Ile Ile Ser Ile Met Tyr Gly Ile Val Ile Arg Thr Ile Trp Ile Lys 225 230 235 240 Ser Lys Thr Tyr Glu Thr Val Ile Ser Asn Cys Ser Asp Gly Lys Leu 245 250 255 Cys Ser Ser Tyr Asn Arg Gly Leu Ile Ser Lys Ala Lys Ile Lys Ala 260 265 270 Ile Lys Tyr Ser Ile Ile Ile Ile Leu Ala Phe Ile Cys Cys Trp Ser 275 280 285 Pro Tyr Phe Leu Phe Asp Ile Leu Asp Asn Phe Asn Leu Leu Pro Asp 290 295 300 Thr Gln Glu Arg Phe Tyr Ala Ser Val Ile Ile Gln Asn Leu Pro Ala 305 310 315 320 Leu Asn Ser Ala Ile Asn Pro Leu Ile Tyr Cys Val Phe Ser Ser Ser 325 330 335 Ile Ser Phe Pro Cys Arg Glu Gln Arg Ser Gln Asp Ser Arg Met Thr 340 345 350 Phe Arg Glu Arg Thr Glu Arg His Glu Met Gln Ile Leu Ser Lys Pro 355 360 365 Glu Phe Ile 370 <210> 2 <211> 1714 <212> DNA <213> Homo sapiens <400> 2 agcacgtaga tcctccctgt catcaggcag agctcttcag tgaggtgggc tcagggaggg 60 ctctgtgcct ccgttcagca gagctgcagc tgctgcccag ctctcaggag gcaagctgga 120 ctccctcact cggctgcagg agcaaggaca gtgaggctca accccgcctg agcc atg 177 Met 1 cca gcc aac ttc aca gag ggc agc ttc gat tcc agt ggg acc ggg cag 225 Pro Ala Asn Phe Thr Glu Gly Ser Phe Asp Ser Ser Gly Thr Gly Gln 5 10 15 acg ctg gat tct tcc cca gtg gct tgc act gaa aca gtg act ttt act 273 Thr Leu Asp Ser Ser Pro Val Ala Cys Thr Glu Thr Val Thr Phe Thr 20 25 30 gaa gtg gtg gaa gga aag gaa tgg ggt tcc ttc tac tac tcc ttt aag 321 Glu Val Val Glu Gly Lys Glu Trp Gly Ser Phe Tyr Tyr Ser Phe Lys 35 40 45 act gag caa ttg ata act ctg tgg gtc ctc ttt gtt ttt acc att gtt 369 Thr Glu Gln Leu Ile Thr Leu Trp Val Leu Phe Val Phe Thr Ile Val 50 55 60 65 gga aac tcc gtt gtg ctt ttt tcc aca tgg agg aga aag aag aag tca 417 Gly Asn Ser Val Val Leu Phe Ser Thr Trp Arg Arg Lys Lys Lys Ser 70 75 80 aga atg acc ttc ttt gtg act cag ctg gcc atc aca gat tct ttc aca 465 Arg Met Thr Phe Phe Val Thr Gln Leu Ala Ile Thr Asp Ser Phe Thr 85 90 95 gga ctg gtc aac atc ttg aca gat att aat tgg cga ttc act gga gac 513 Gly Leu Val Asn Ile Leu Thr Asp Ile Asn Trp Arg Phe Thr Gly Asp 100 105 110 ttc acg gca cct gac ctg gtt tgc cga gtg gtc cgc tat ttg cag gtt 561 Phe Thr Ala Pro Asp Leu Val Cys Arg Val Val Arg Tyr Leu Gln Val 115 120 125 gtg ctg ctc tac gcc tct acc tac gtc ctg gtg tcc ctc agc ata gac 609 Val Leu Leu Tyr Ala Ser Thr Tyr Val Leu Val Ser Leu Ser Ile Asp 130 135 140 145 aga tac cat gcc atc gtc tac ccc atg aag ttc ctt caa gga gaa aag 657 Arg Tyr His Ala Ile Val Tyr Pro Met Lys Phe Leu Gln Gly Glu Lys 150 155 160 caa gcc agg gtc ctc att gtg atc gcc tgg agc ctg tct ttt ctg ttc 705 Gln Ala Arg Val Leu Ile Val Ile Ala Trp Ser Leu Ser Phe Leu Phe 165 170 175 tcc att ccc acc ctg atc ata ttt ggg aag agg aca ctg tcc aac ggt 753 Ser Ile Pro Thr Leu Ile Ile Phe Gly Lys Arg Thr Leu Ser Asn Gly 180 185 190 gaa gtg cag tgc tgg gcc ctg tgg cct gac gac tcc tac tgg acc cca 801 Glu Val Gln Cys Trp Ala Leu Trp Pro Asp Asp Ser Tyr Trp Thr Pro 195 200 205 tac atg acc atc gtg gcc ttc ctg gtg tac ttc atc cct ctg aca atc 849 Tyr Met Thr Ile Val Ala Phe Leu Val Tyr Phe Ile Pro Leu Thr Ile 210 215 220 225 atc agc atc atg tat ggc att gtg atc cga act att tgg att aaa agc 897 Ile Ser Ile Met Tyr Gly Ile Val Ile Arg Thr Ile Trp Ile Lys Ser 230 235 240 aaa acc tac gaa aca gtg att tcc aac tgc tca gat ggg aaa ctg tgc 945 Lys Thr Tyr Glu Thr Val Ile Ser Asn Cys Ser Asp Gly Lys Leu Cys 245 250 255 agc agc tat aac cga gga ctc atc tca aag gca aaa atc aag gct atc 993 Ser Ser Tyr Asn Arg Gly Leu Ile Ser Lys Ala Lys Ile Lys Ala Ile 260 265 270 aag tat agc atc atc atc att ctt gcc ttc atc tgc tgt tgg agt cca 1041 Lys Tyr Ser Ile Ile Ile Ile Leu Ala Phe Ile Cys Cys Trp Ser Pro 275 280 285 tac ttc ctg ttt gac att ttg gac aat ttc aac ctc ctt cca gac acc 1089 Tyr Phe Leu Phe Asp Ile Leu Asp Asn Phe Asn Leu Leu Pro Asp Thr 290 295 300 305 cag gag cgt ttc tat gcc tct gtg atc att cag aac ctg cca gca ttg 1137 Gln Glu Arg Phe Tyr Ala Ser Val Ile Ile Gln Asn Leu Pro Ala Leu 310 315 320 aat agt gcc atc aac ccc ctc atc tac tgt gtc ttc agc agc tcc atc 1185 Asn Ser Ala Ile Asn Pro Leu Ile Tyr Cys Val Phe Ser Ser Ser Ile 325 330 335 tct ttc ccc tgc agg gag caa aga tca cag gat tcc aga atg acg ttc 1233 Ser Phe Pro Cys Arg Glu Gln Arg Ser Gln Asp Ser Arg Met Thr Phe 340 345 350 cgg gag aga act gag agg cat gag atg cag att ctg tcc aag cca gaa 1281 Arg Glu Arg Thr Glu Arg His Glu Met Gln Ile Leu Ser Lys Pro Glu 355 360 365 ttc atc tagaccctag ggcagtgcca gtgctaggct gagcaccatc agctctccca 1337 Phe Ile 370 ggtccttgtc acctgcttgg gcacgtgcat ggaacccgag ccaacttcac cccaccctcg 1397 tcattacctg ggagatgcac aagacaaatg ttctaatgac tgcatgcact gcttaagtat 1457 tggccaacac gaactcccca gttattcatg ccagccagga aggaaacgcc ttccttcccc 1517 accattccca gccctccttc ccactggcca gcacctgaac ccagtgaaca caggcatcag 1577 tggtccaggg tcctggcttg gagccagtga gtagacaggc aagcagaggg gacaaaggta 1637 gctgggttat acatgaatat tctcattaca ataggagaaa ataaaagact taattaagcc 1697 caaaaaaaaa aaaaaaa 1714 <210> 3 <211> 30 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: synthetic DNA <400> 3 agcaucgagu cggccuuguu ggccuacugg 30 <210> 4 <211> 42 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: synthetic DNA <400> 4 gcggctgaag acggcctatg tggccttttt tttttttttt tt 42 <210> 5 <211> 21 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: synthetic DNA <400> 5 agcatcgagt cggccttgtt g 21 <210> 6 <211> 21 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: synthetic DNA <400> 6 gcggctgaag acggcctatg t 21 <210> 7 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: synthetic DNA <400> 7 cttctgctct aaaagctgcg 20 <210> 8 <211> 30 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: synthetic DNA <400> 8 tgtgggaggt tttttctcta 20 <210> 9 <211> 23 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: synthetic DNA <400> 9 agagggcagc ttcgattcca gtg 23 <210> 10 <211> 24 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: synthetic DNA <400> 10 gaatggggtt ccttctacta ctcc 24 <210> 11 <211> 22 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: synthetic DNA <400> 11 ggctgcagga gcaaggacag tg 22 <210> 12 <211> 23 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: synthetic DNA <400> 12 aacccagcta cctttgtccc ctc 23 <210> 13 <211> 33 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: synthetic DNA <400> 13 tgacaagctt accccgcctg agccatgcca gcc 33 <210> 14 <211> 33 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: synthetic DNA <400> 14 tagtgcggcc gctggcactg ccctagggtc tag 33 <210> 15 <211> 80578 <212> DNA <213> Homo sapiens <220> <221> exon <222> (25203)..(25523) <220> <221> exon <222> (51516)..(51648) <400> 15 gatctttgac aaacctgaca aaaacaagaa atggggaaag gattccctat ttaataaatg 60 gtgctgggaa aactggctag ccatatgtag aaagctgaaa ctggatccct tccttacacc 120 ttatataaaa attaattcaa gatggattaa agacttaaac gttagaccta aaaccataaa 180 aaccctagaa gaaaatctag gcaataccat tcaggacata ggcatgggca aggacttcat 240 gtctaaaaca ccaaaagcaa tggcaacaaa agccaaaatt gacaaatggg atctaatcaa 300 actaaagagc ttctgcacag caaaagaaac taccatcaga gtgaacaggc aacctacaga 360 atgggagaaa agttttgcaa tctactcatc tgacaaaggg ctaatatcca gaatctacaa 420 tgaactccaa caaatttaca agaaaaaaac aaacaacccc atcaacaagt gggcaaagga 480 catgaacaga cacttctcaa aagaagacat ttatgcagcc aaaagacaca tgaaaaaatg 540 ctcatcatca atggccatca aagaaatgca aatcaaaact acaatgagat accatctcac 600 accagttaga atggcaatca ttaaaaagtc aggaaacaac aggtgctgga gaggatgtgg 660 agaaatagga acacttttac actgttggtg ggactgtaaa ctagttcaac cattgtggaa 720 gtcagtgtgg cgattcctca gggatctaga actagaaata ccatttgacc cagcaatccc 780 attactgggt atacacccaa aggattataa atcaagctgc tataaagaca catgcacatg 840 tatgtttatt gtggcactat tcacgatagc aaagacttgg aaccaaccca aatctccaac 900 aatggtagac tggattaaga aaatgtggta catatacacc atggaatact atgcagccat 960 aaaaaatgat gagttcatgc cctttgtagg gacacggatg aagatggaaa ccatcactct 1020 cagcaaacta tcgcaaggac aaaaatccaa acactgtatg ttctcactca taggtgggaa 1080 ttgaacaatg agaacacatg gacacaggaa ggggaacatc acacacaggg gcctgttgtg 1140 gggtgtgggg aggtggggag ggatagcatt tggagatata cctaatgtta aatgacgagt 1200 tactgggtgc agcacaccaa catggcatat gtatacatat gtaactaacc tgcacattgt 1260 gcacatgtac cctaaaactt aaagtataat aaataacaaa aaaaaaaaaa gaaaaggaac 1320 aaacaaatcc tctgagaaat atagaactat gtgaaaagac caaatctacg tttgatgggt 1380 gtacctgaaa gtgatgggga gaatggaacc aagttggaaa acattcttca ggatatgatc 1440 caggagaact tccccaacct actaagacag gccaatattc aaattcagga agtacatgga 1500 acaccacaaa gatactcctc gagaagagca accccaaaac acataatcat cagattcacc 1560 aagtttgaaa tgaaggaaaa aatattaaca gcagctagag agaaaggtcg ggttacccac 1620 aaaagggagc ctatcagact aacagtggat ctctctgcag aaaccctaca agccagaaga 1680 gagtaggggc caatattcaa cattcttaaa gaaaataatt ttcaacccag aatttcatat 1740 ccagtcatac taagcttcat aagcaaagga gaaacaaaat cctttacaga caagcaaatg 1800 ctgagagatt ttgtcaccac cagacctgac ttaaaagagc tcctgaagga agcactaaat 1860 atgaaaagga aaaacccata ctagccactg caaaaacata ccaaattgta aagaccatca 1920 acactatgaa gaaactgcat caactaatga gcaaaataac cagctagcat cacaatgaca 1980 ggatcaaatt cacactaaca atattaacct caaatgtaaa caaactaaat gccccaatta 2040 aaagacacag actggcaaat tggataagca gtgaagaacc actggtgtgc tgtattcagg 2100 agacccatct cacagacaaa gacatacaca ggctcaaaat gaagggatgg aggagaattt 2160 accaagaaaa tggaaagcaa aaaaaagcag gggttgcaat cctagtctct gataaaacag 2220 actttaaacc aacaaagatc aaaaaagaca aagaagagca ttacataatg gtaaagggat 2280 caaagcaaca agaagagcta actatcctaa atatatatgc acccaataca ggagcaccca 2340 gattcataaa gcaagttctt agagaactac aaagagactt agaatctcac acaataatag 2400 tgggagactt taacaaccca ctgtcaatat tagacagatc aacaagacag aaaattaaca 2460 aggatattca ggacttgaac tcagctctgg attgagcaga cctaatagac atctccaccc 2520 caaattaaca gaatatacct tcttctcagc acctcatggc acttattcta aaattgacca 2580 cataattgga agtgaaacac tcctcagcaa atgcaaaaga acggaaatca taacagtctc 2640 tcagaccaca gtgcaatcaa attagaaccc aagattaaga aactcattca aaactgcaca 2700 accacaagga aactgaacaa cctgcccctg aatgactact gggtacataa tgaaatcaag 2760 gcagaaataa ataagttctt tgaaaccaat gagaacaaag acacagtgta ccagaatctc 2820 tgggacacag ctaaagcagt gtttagagga aaatttatag cactaaatgc ccacaggaga 2880 aagtagaaaa gatctaaaat caacacccta acatcagaat taaaagaact agagaagcaa 2940 gggcaaagaa attcaaaagc tagcagaagg caagaaataa ctaagatcag agcagaactg 3000 aaggagatag agacatgaaa aacccttaaa aatatcaacg aacccaggag ctggtgtttt 3060 gaaaagatta acaaaataga tagaccgcta gccagactaa taaagaagaa aatagagaaa 3120 aatcaaatag acacaataaa aaatgataaa gggataccat cactgatccc acagaaagac 3180 aaaccaccat cagagaatac tataaacatc tctatgcaaa taaactagaa catctagaag 3240 aaatggataa attcctggac acatacacac tcccaagacc aaaccaggaa gaagttgatc 3300 cctgaataga ccagtaacaa gttctgaaat tgaggcagta attaatagcc taccaaccaa 3360 aaaaaccaca ggaccagatg gattcactgc caaattctac cagaggtaca aagaggagct 3420 ggtactattc cttctgaaat ttttccaaac aacaaaaaaa gagggactcc tccctaactc 3480 attttaagag accagcatca tcctgatact aaaacctggc agagacacaa caaaaaaaga 3540 aattttaggc caatatccct gatgaacatc aatgtgaaaa tcctcaataa aatactggca 3600 aaccaaatcc agcagcacat caaatagctt atccaccaca atcaagttgg cttcatacct 3660 gggctgcaag gctagtttaa cttatggaaa tcaataaacg taatccatca cataaacaga 3720 accaatgaca gaaaccacat gattatctca atagatgcag aaaaggcctt tgacaaaatt 3780 caacacccct tcatgctaaa aactctcaat aaactaggta ttgatggaac atatctcaaa 3840 ataataagag ctatttatga caaacccaca gccagtatca cactgaacgg gcaaaagctg 3900 gaagcattcc ctttgaaaac cagcacaaga caaggatgcc ctctctctcc actcctattc 3960 aacatagaat tggaagttct ggccagggca atcaggcaag agaaagaaat aaagcgtatt 4020 caaaaagaaa ggaaatccaa ctgtctctgt ttgcagatga catgactgta tacctagaaa 4080 accccattgt ctcagcccaa aatctccttc agctgataag caacttcagc caagtctcag 4140 gatacaaaat caatgtgcaa aaatcagaag aattcctatg caccaatcat acacaaaaag 4200 agagaaagat tatgagtgaa ctcccattca caatggctac aagagaataa atacctagga 4260 atccaactta cttacaaggg atgtgaagga cctcttcaag aactacaaac cactgctcaa 4320 ggaaataaaa gaggacacaa acacatggaa aaacattcca tgctcatgga taggaagaat 4380 caatatcgtg aaaatggcca tactgcccaa agtaatttag agattcaatg ctatccccat 4440 caagctacca ttaactttct tcacagaatt agaaaaaaac tactttaaat ttgatacgga 4500 accaaaaatg aggctgtata gccaagaaaa tcctaagcaa aaataacaaa gctggaggca 4560 tcacactacc tgacttcaaa ctatactaca aacagcatgg tactggtacc aagacagata 4620 tatagaccaa tggaacagaa cagaggcctc agaaataatg acatatatct acaatcatct 4680 gatctttgac aaacctgaca aaacaagcaa tgaggaaagg attccctgtt taataaatgg 4740 tgctgggcaa actggctagc catatgcaaa aaacacagaa actggacccc ttccttacac 4800 cttatacaaa aattaagcca agatggatta aagacttaag tgtaagacct aaagccataa 4860 aaaccctaga agaaaacctg ggcaatacca ttcaggacat aggcatgggc aaagacttca 4920 tgactaaaac accaaaagca aaggcaacaa aagccaaaat tgacaaatgg gatctaatta 4980 aactaaagag cttctgcaca gcaaaataaa ctatcatcag agtaaacagg caacctacag 5040 aatgggaaaa aaattttgca aactattcat ctgaaaaagg gctaatatcc agaatctaca 5100 aagaacttaa agaaatttac aagaaaaaaa atcccatcaa aaagtgggtg aaggatatga 5160 atagacactt ctcaaaagaa gatatttatg tggtcaaaaa acatatgaaa aaaagctcat 5220 catcactggt cattagagaa atgcagatca aaaccacaat gagataccgt ctcatgccag 5280 ttagaatggc gatcattaca aagtcaggaa acaacagatg ctggagagga tgtggagaaa 5340 taggaaagct tttacactac tggtgggagt gtaaattagt tcaaccattg tggaagacag 5400 tgtggcgatt cctcaaggat ctagaaccag aaataccatt tgacccagcc atcccattac 5460 tgggtatata cccaaaggat tataaatcat tctactataa agatgcatgc atacgtaggt 5520 ttattgcagc actagtcaca atagtaaaca cttggaacca acccaaatgc ccatcagtaa 5580 tagactggat aaagcaaatg tggcacatat acaccatggg atactatgca cctataaaaa 5640 aggatgggtt catgtccttt gcagggatgt gaatgaagct ggaaaccatc attctcagca 5700 aactaacaca gaaacagaaa accaaacact gcatgttctc actcataagt gggagttgaa 5760 caatgagaac agatggacac agggaggaca tcacacacca tggcctgcca gggggttaga 5820 ggctagggga gagatagcat tcaagaaata cctaatgtag atgacaggtt gatgggtgca 5880 gcaaaccaac atggcatgtc catacctatg taacaaacct gcacattctg cacatgtatc 5940 ccagaactta aagtataatt ttaaaaaagt aggttggaga ttcatattta aagtgaaact 6000 aagccaaaat ttgtattatt tttcttaata atttccaaaa tgcaatctaa gttttacctt 6060 ttaagccaat ctgatcaact tctcatggca ctaccttgag aaaaactcta aggtatacta 6120 agacacagtg gttctcagtg ccataatcca tcagtgaatg tggggacagg cagcaggcac 6180 agagagtggg gagtgtgccc agctctgaca taaagaacaa caatatgttg atgcaacatc 6240 aagaagttgc ttctctcctg ggcttccttg tagccgttat cagctattac ccaactcagc 6300 tactctacag tcattttcaa cacttttctt cctttctgtg tcccattgcc aagtctttaa 6360 aagccaggca ctcatttttc aagacccctt tcataaggcc aggggttgct gtataaccta 6420 gttattgcca gtaggatgta aagagataat tgtcatcatc ttcataagca tcatgaaaat 6480 attttcctct ctgaacagag aaacagatga agaagaatgt cttcctctac caccagcatc 6540 ctcccccacc ctccgaccta ttttgttgtt gttgattttt gtttcttgtt tgagacggag 6600 tctcgctctg tcgcccaggc tggagtgcag tggcgcaatc ttggctcact gcaacctctg 6660 cctcccaggt tcaagcgatt ctcctgcctc agcctcccga gtagttggga ttacaggcac 6720 cctgccccca cgcctggcta atttttgtat ttttagtaga gatgaggttt caccatgttg 6780 gccaggctgg tctcctaacc tcaagtgatc ctcttaacct caagtgatct gcctgtcttg 6840 gcctcccaaa gtgctgggat tatatgcatg agccaccacg cctagcctcc tccccgcctt 6900 tttttaaacc cattaccatc cttgctttct gatttggact ggcattgaag atatgattat 6960 taggaatctg actgccaact tgtgatcgtg aaggaagaca ttggcaacat gataaaaata 7020 gcatagagga ggatgaaagg agtctggatg tcctggggac ttgttgagct accaaaccca 7080 ccctgatact gcccagcttc tgttctttgt ggtataaaca atacatggct tggcggtttc 7140 atctactgtg agttaagtct tctgctcctt gctatcgagt gtatcctaaa accaatacac 7200 cagcaaatga gatgcaagaa taactgcctg tttgctctgt catttttgca atgtagacac 7260 cacctagaac aagaaaatta ctgaatctct gaatgacatt tttgtaaagc catagaagca 7320 aaaacacaag tttaaaagac ctagatttta attattagag tcagattctt gagaaaattt 7380 ctgatggcct tgaagccagc agtttataca gtgaggcagg acaaggagaa atctatttga 7440 gtgttgtttc ctccccgcac acagataaaa tcagaacatt ttctagagag gattgggaat 7500 ggagaagaca gcagatgcta atgttgggct ctgcttcctg gctttccctt cctacagggt 7560 tgacccattg atggggtgga taaaataggc ttggagatct gaatgtagaa aggacttgcc 7620 ccacacttcc tgcctcgaac tcagagagga gatggccttc aagaatgcct tgcagcaacg 7680 tgggtagaca gcattgggct cagaataggg gcacagcata gcaaaaccaa ctcatctcag 7740 gtcttggaag agacttcaaa aagctcccaa gcttccccca aaaaggagct caaaggacag 7800 cagagaatga agagctggaa tgcatcagga attcacatcc gcatatcaga gactcagaaa 7860 gtgattatgt cagataaatg gaagaaaaat aagtagaaag agaatcattc aggcagacta 7920 aattttaaaa taaattactc tgaaatgaga agttaagagt cttttgggtc ttgtcccata 7980 tagaacaaaa gagctatgtt aatttatctt gtaaagaaag ttttgtttca tgcatccgag 8040 ttgataatgt aaaatttaaa gttgcttcag ataatgtgac aaccctggag tataatacat 8100 taggactcat ctctctgaac gaacagcaac tttgcaaaag aggaaacggg gctgcctgtt 8160 ctgttactgt cacatctgat ttttatttgt atatgacttg accagccttt atagctctca 8220 ccacacagca cttccatgtt ccataatgga cctgttcaaa ggaagccata tcactccact 8280 tgatttgctt ctgataccag ttccaggggt attgatctgt cttgagtaat gtgttattgt 8340 tgacagagag gtttcttgac tcactgtagg tgacttttta tgccctttaa agttctgaaa 8400 agcccataaa gataatgttt aaattacaag tcatacacaa cagaagagag tctggagcag 8460 ccacacaggc aactgcatag taccagaagg actgtggaca tggaatcaga ctacacagtt 8520 ccatagctga ctgggtatat tactctttcc tcaatttcct catatgtgaa atggtaaggc 8580 taatatctac ctagcatagt tttctgaaga ttttataaga gatcacatat ataaagcacc 8640 taaccttgtt aatccataga agaaatgtaa taaatatcag aaaaagaaga gatttttttt 8700 ctcccttctt ttgttatttc atgctataaa ttttaccatt ttctgggttt aagtacaatg 8760 cgtttatgct aaggtttaac acggtggctt catcttttag tcattctaat taatttcagc 8820 attgactgaa cccagtggcc cctgtagata aaaacaggac caaccactaa acattaaact 8880 ctcaagcacc cacctgtaat cacttaaaca gctagaggtg gctccactga tacttattaa 8940 acagatgttc actctgtaac aaaagtgtac caatctcatc ctgaagccca gaaaatagaa 9000 aagaagatag gacagcctct gttaccaatg gcagaaatat gacagggcta tatgaggcta 9060 agataaagga tatcaaactc aaaaccaaga gtgataagca aggagactgt gttagactgt 9120 ttcaataatt aaggtgagaa atgatggcag cctgaagtgt gattttcatg atggagatgg 9180 ggagaaatag atagtttaaa aactgttaaa aaggagcatt ggcagaactc attaattgaa 9240 cagatgcaga tagcaggtag gctgggggag ggaggtgtta catatgacaa catgacatat 9300 tctgttaata ctaattgaag gcctctatgg tggaatcact tacttaggtg acttgggaat 9360 acagggaggt aaagtcacat tcctggctcc caagaaatgt atagtacatt taaagggata 9420 agacataaca acatcttttt agtatctgct ctagtttatt attttatttt ttagggccct 9480 attctgttct caaaaaaaaa aaaaaaaaaa gtagtaagga tgaaaagggg tagggcatct 9540 ggaaaaaact ttggagaagc ctcaggaaca tcccgcttga aacctccagc caattatttc 9600 agtcttatag agagagtgga ttaaatgaat aggttgtgtc actatttttg agaagcctga 9660 gtgcctcttc taagagctat tctcatttcc acaaaaagga agggaaattg cggtatctaa 9720 aagtagtgtt tgaaagtcac ttcttaagaa ttatatcgag tcaaaacact ttcatttaaa 9780 gcccttaata tttgaacatt gttatttatt tttgctgttt ggatttttat gtgtgtgttt 9840 gtgtacctat gaaaaactat tcatgtctca aatgaaataa aagaaggtgg ctgtgatgta 9900 ttagtatagg ttctcaattt ctgtcctagg taagatgaaa agcatgaaga tgcctccttc 9960 aatcccgtca tggccacagt ctccttgtca tacccatata ggctctacct caagttgtgg 10020 gcaaacttct ttacccacct gtcatgaaac tgtgcttttt ctatgctatc tctagggccc 10080 caagactgta tggatagctg cagaccacca cattcaggaa gaggggccag atccattagg 10140 gagtatattt ggcattgagc tgatagagaa taaaggagaa aaacttcctg agtagctcca 10200 gtcttaccaa cccagcttct gtttcaaagt gagttcatga tcaacggtgg tctcgcctgg 10260 agtcattagt ccagagaaca tcccaacaaa gaaggtgtag gaagttttcc taaacctaat 10320 ttttaggtca aaaaaacaag acagagagag aacaagatta ggaaataaat gggaagttgg 10380 aggagcccgg atcaagcaga agtaagccca agaatgcaag ggaaaggtct gaggtataat 10440 ggtataggtc tgagacagga agagctacgg aataagcaga gcaagaaagt gcagagggca 10500 ataaggaatc ctttcagatg cttttcttct actccaaccc caattagata cacatgggca 10560 ttggtaattt tgccttctga atctctggga taatacatca accacgtcat ttgccctggg 10620 gagagggtct ttgaaattag cacaatagct ctgatttcct gccaaatggt taatcagaag 10680 gggacctaat acataaagag caggaatcta ttgttttcat agactcctta tgccttgggt 10740 aagacataat tctaacttgc tattaccccc ttctctgatt ttacactaac tagggatata 10800 acagccacct caaatgtccc cagatagtcc acatcccagc aacagccgac ttcgccaaat 10860 tggggcagcg atttcacctt catctcacag agttcaatga gtatgttgcc aagggacatt 10920 ttgagtgcca attcactaat tttacagaaa ctctgtaatt ggttggaatt gctaaggtca 10980 gggattgtac atttcttgtc accttccttc agagggctaa tttctgtttt ctctctcgga 11040 tgcattctat agctcaaaca gcagatgcat tctcttgcag tggtgaataa aggccattct 11100 tggacaggcc caattgctct actaagttag aaggaacctc ctttttagct gacatataat 11160 caatcagcat gcattcggtt tagagcaatg aatcttctgt aagtgacaag agactggatt 11220 tgttaatttt gctttcagca aatgtacctt aatatggata tttctaagat tcttggcagc 11280 aatataattt aaaacatggt ttagtgtgac aatacaagag catgatgttc tgattctgat 11340 aaaattttgt cacatatgag agaaggaaga aaaaaaaggt tagtagttca gataagagaa 11400 aataattggc tgaaaagctt ttatatttga gaatgatata aaagtggaaa gtgaaatcat 11460 tgacatgaac tgagaacttt gacggacctt tactctggaa ccgcaattgc ccagctgtgc 11520 ctgacatgat cccatttgaa gtcaggggtc atgatataaa cctctcatct ctgattttcc 11580 cctaaccagg gctccaatgg acatctcaga attcctcaga acccccacac tctccaacag 11640 ctgactttga tagtttgcct gttacgaatc agggcagcaa tttgatcact tctcatatgg 11700 tccaatacat atgttgtcaa gtaaagtaaa aagatagcac aagaaatttt tactagatat 11760 aattgcattt gaatcacatc caactatgca tgaaaacagc atagatatca cctaagactc 11820 ttactaacga aagttcccca caaaatatct tagtgcagtg attctcaaag ttgtggtata 11880 tatcggaatc accaggggga acttgttaaa atgcagaagc ccaggctttt gtctacttga 11940 tgaatctgag cccctattct ttattaactc ccccaggtaa ttctaaaaca cttctgagtt 12000 tgagaaccac tgatgtagtg ttatagaaag taagtagaga aaaggatgag ctatagataa 12060 gagggcaaca ctttctgccc cttttcccac tgcatgtagg acatgttgag gagtggttta 12120 gctggatggg aaagcaagtg tcttttttca tcacttttca ctgagcaggc agtttctcaa 12180 ttgcagcgcc ttctccctct gactccatgc ccatacacac attatgaatc cgagggccgg 12240 tgcccatgca gccatacaat agagacaagg accaatttac ttgccaacta aacatgtagg 12300 gacatgctgt ctatcctcaa cacagataaa acctgcaggt gctcttcctt tgttgagccc 12360 agtgcttctc aaccttggtt gcacattaca attgaagaat gtttcaaact ccccattgcc 12420 caagctgtaa cacagtctag ttacagctaa attgggagga gagcacaggt tttggtggtt 12480 tataaggctt cccaggtgat tcaacatcta accaaaattg aaaacaactg tctctaattc 12540 agattctcac gaatgaggca gattcatcct gcatttaaga gagcaacctg taactctaag 12600 gttacttctt ctattgtata gtctcatgat ttggtatcag attaagtagt ttaaaatatg 12660 agaaaatgtg cacgaagaaa agtcccagag atctgattgc ccattccttc tcctttccta 12720 cagtcttcag tctaggtgac aatgcaaata taaacctgct cttttcagga agaaaatacc 12780 caccacacca acatatggaa atagaaagac tgtgtaaacc tgattctttt ataaggcgtg 12840 taaagagaga aatgagaaca gcacatttga aattcagatt taatcaagaa gtcttaaact 12900 caataaaaag acaactcaat ttttaaatgg acagaagatt ttagtagata tttttatcaa 12960 agaagatata caaataacta ataagcacct gaaaaaaagc tcaacattat tggctattag 13020 gaaatgcaaa tcaaaaccac atgaaataac acttactcat cactgaaatg gctataatca 13080 aaaaaacaga caataaaagt gatgtcaatg atgtggaaaa actaaaacgc tcattaatac 13140 attgctggtg ggaatgtaaa atggtgtggc cactttggaa agcagtatgc caatttctta 13200 aaaattaaac acaaagttac catgcaaatc agcaattcta ctcctagtag tctctccaag 13260 agagatgaaa atgaaagatg gccacacaaa gacttgtatg tgaatgttta ttatggataa 13320 tacccccaaa gtggaaacaa cgcaaatgtc tttcaactgg taaatggata aacaaaatgt 13380 gatatagcca caaaatggaa taatttacaa caataaaaag taatacagta ctgatatagg 13440 ccacactatg catgaacttc agaaaattat gctgcacaaa agaaatccaa cacaaagtcc 13500 acatatttta tgatttaatt tctacaaaat gtctagaaaa gataaatctg cagagacaaa 13560 aagctgatta gtggttgccg gggactggag tggatataaa gaatgactac aaatgggcct 13620 gagagatact atttgcgtga gagaaatgtt ctaaaattgg attgtggcga tggttgcaca 13680 actctgtaaa tttactagaa gttaattaag ttgtgtactt aaaatgggtg aattttatga 13740 tatatatatt ataataaagc tatttagaaa aacatgtaga attgacttta caattctgca 13800 aaaataatgt aaaaatttaa gtagatataa catgcaaaaa taaagcttat tactttggaa 13860 aaaattactt caaaaatatg aaaatagttt aagctgcagg aattttttta aaaaaacaaa 13920 ctctaaaatg ataatattga gcattgacta tattccaggc attattctaa gtgctttata 13980 tcattttgtc ctataaatga gcctctaagt ttgatgttat gttccattgt actagtattg 14040 aaactgaggt ctaactagag ataaaagact gatgctagaa taagaagaca gattaaaagg 14100 aagatggtag tactaaagaa ataatttgag taatttatag tgcgtttgca taattgtaac 14160 tggtattaaa aagaatgaaa aagagaatag agacccaaat ctagtgttga tcagatgaag 14220 attaaagaca tcacagacaa tgcagagaaa aaggagaaag agattaaggt gatcagagaa 14280 tagatgatag atagatacag atgacataaa atgaggaaca gagtagggat aattagtgtt 14340 cttggggtgc agaggagaat caacataaaa atattaaaga tattatttaa aatgtctttt 14400 tagctgaaga gaattctaaa cataaataat actatcatta gcaagaataa atatcaggca 14460 ataatgtacc acaactgcac tgagcacaca tcagctcctt gaaccatcac aacaacccta 14520 ggaagcatga actataattt ccattttaca aaggatccct agagctaaga tgactagata 14580 tcttgtttgc ttaggacaat tctggtttac tgcatgtaaa ctacctaaaa tacccatttt 14640 attctcaaat ttatgagtct ggacaataaa ttacatgatc accctatttt gagtctaaga 14700 actacaggtg gtaaactgca gaaccaaaac ttattggaga agtctccaaa gcctttgttc 14760 ttaaccattt tgttatacta aatctgcaga gctaaagtgt tcatcacaaa gcgacacaac 14820 ttgtaaaaaa taagtgatta taccaagaaa ttctgcattt caaagataaa taaacaactc 14880 tatatgcatt cagtagaagt aagtcattta aaaaggaaaa agatattaat taatttcata 14940 agtaaatgaa aaatagtacc ctggatttct tctttacaac attaaatgcc agaaaacaat 15000 gtctacaaag tcaagttaga attaatggaa gctctcaaat atacaagtag ctaagaatca 15060 agaagtcaag caactactta aagacattgt ccagctaatt taggtagaaa tcaaaattta 15120 gacttcacaa acacataagt aagatacaga agtacttata gtgggcaatg aatccacttt 15180 aatatcaaat tatgtaacag ttgatctggt aaatatcatg tctagacaaa gtatacatgt 15240 gatatttctt ggaagacaat atgcaccata tctaacttcg atcctgcatc aaaaattcca 15300 ctggtttgag aagaggccga gggagcagtg tgggaagaaa tgcatatgag ctgcttttcc 15360 cattttcaca aggggaatcc aataaataat gtcttattcc tgttgttgat aaactagcag 15420 tctgaaattt agtcaaaatt tttaagttgt aaaaatatac atcagtagag caaaaaaaat 15480 tgtattatct ttcatgttgc agaagaaaat agaattaaag aaaaccttag aaagataaca 15540 taaagaaaaa atgcaaaggt aatactaaaa ctaaagaaaa tattttaaat agcagtaaaa 15600 gacagaaaac aaaggtaaaa atcaggaagt atatagagag accaaacaca ggatgtttaa 15660 tactaaatac aaatggttaa atcactctct tattaaaaga aagatagcct catattaaac 15720 aaaacaataa gtaaaatata tttacaagag acaccaaatg ccaatgatta cagaatgtag 15780 agaataaaag aatcagtaaa gatatgcaaa agaaactaaa atataataca aatttaaaaa 15840 tacagtataa cagctattta cctagcattt acattgtatt taattaatct agagatgatt 15900 ttaagtatat gtaaggatat gcataggtta tatgcaaata ctacaccgtt ttatataagc 15960 gacttgagca tcttggattt ggcatccacg ggagtcttac aacaaatcct ccatgcatac 16020 caagggattt gtctgcttat ctgacttact taaagaatcc tgattttata gagcgtgacc 16080 atattctcag cctcccttgc aaataggaga agctatgtga ctaagttctg accagtgaaa 16140 tataagtgga agttactggg agggcttcca ggaaaattcc tttaaaaaga gctgagctcc 16200 cttttgtctt tcccctttcc ttcttccatt ggctggaatg caaacacgat gaagctgaaa 16260 tgtatatctt acaaccatat ggtgacctta aagatggaag cacttcatca aggaaaacag 16320 agcaagaaga tacgatgagc ctgggtcact aatgatatcc tggaaccact tcaccacccc 16380 ttgattcatg ttaccactaa ttccccattg ctttcctaca ttaattcaaa cttgactttg 16440 taaaaattat tttctggcat ataatgttgt aaagaaaaaa ttcaagatac tgttttttta 16500 tttacttact aaattaatat agtatttctt tattagtgac tcacttttac tgaatgcatg 16560 taaaacttgt ttatccttga aatacaggat tccttggtac aaccactttt ttttctaaaa 16620 ctagtttgtt tctttatgat gaacactata atagctctgc agatttagtg taataaaagg 16680 gttaagaaca atagctttgg agacttccat gactgaaagt tttggttctg caacttacca 16740 actctagttc ttaggcccaa agtaaggtga tcatgttatt taccttgtgt cttcaccaca 16800 ataccttgac tctatctttc ttgagggaaa gacaaacaag cattctgttt tgttcaaatt 16860 gctctttttt taagatctct gtacttggac taaaaagcaa ttattaactg atatcagcac 16920 ataaaattag tttataacaa atcaaaatcc aaggtgaaaa aattatatga gagtcttttt 16980 acttgatggt tgacaaattc aacataatca cgtgtgtcat gaatcttttt atgacaacaa 17040 tacagcatca aaatgtacag tgtagaccta gaggaaatac aaagagaaac acagggcccc 17100 aataataatg gaaaacataa acaaaccttt ctgtgccttt gacaaattag gtagacaaaa 17160 gctaaaaggt aaagaaatga gattctagag acttcagtag aactaagagt acctaataaa 17220 atgcttctaa aaatatgtgt gtgtgcgtgc gcacatgtgc acacacacag gcatttgtga 17280 aattatctta taaatagaat tccaggtatt ttttcaaaaa ctgaacatat atatataatg 17340 ttttaaaata tttcaaaaga tagaacttgc cttcaaaata taattcaaga aataaacaaa 17400 acttgaaatt aaactgaaca aaaatataaa catttagaag tcacttccaa gtaattcttt 17460 ggtctaagaa gaaatcagac acacattgta tttattgtag aaaataatga aaatgaaaat 17520 accacatatc agactctcca ggtcacagct aaaagcagat tcagaggaaa attcgttgcc 17580 ttaaatgctt caattataaa tatgaatgaa tgaaaataaa cgttaagtat ttaatccaag 17640 cattcagatt ttttaaagac agcaaaatta agaaagaaaa agaaggaatt gatgaagatg 17700 tagtaatagc aattgtactt caataaaata ttttgaggaa ataatcagac aagagctcaa 17760 gaatgtttgt tcggtgctgt ttctggaaac tcagaaaaaa ctttaatctt tattataggg 17820 atgattgaat aaatcataac acatttcatg ttagcagaac aaagagacac taaaatatat 17880 accttaatac aaaaatctac aacaagtgga attaaaaagc agaatgcaga gctgaatata 17940 agaatcacaa ttgggcactg aggaatacat tagcagttaa tataagttgt gtctttacat 18000 cttcaggtat ttatttaaag gaactacagt ttggtgttat aattagaaaa atacaaccct 18060 aaaagtatgg actgtgaaat catatttatt ctagtgtcct cctttaagta gaacattgca 18120 ttccatttct ttagggactg tatttcttaa tcattgtaac aggtataacc tcttgtaccc 18180 attacagcaa gcaattacta aatataatat accacatttg tcttttctgc aggatcccaa 18240 gaatttctct gccctcaaag caattttctg tttaatgcta tgctgaggat actcttattt 18300 catactaatg atttagaacc ctcaccacca tatcagaatt ccaagccaaa actaaggtac 18360 tatgaaaagt taactggtgt ggaaagtcaa tggtcatttc ttatcttatt tctctacttg 18420 aagagttatt ccttaccaag agctctccgc accttcacta tggggaaata tgcacctact 18480 ttaaggaaat attatgggaa ttaaatgttg tgacatcttt caggcaccca gcacagtggt 18540 gagatggagt tcccccttta ccttctccca tattctttcc tgatcctatc tgagtaatta 18600 caactcttcc aaccaatcca cttttacaca gtttttttta tagaataaac atccaaatgc 18660 agcatctgtg atatatctga attaaatagt gggtgcaaca acatggctat ttcaagctta 18720 aatgtcagct aatttttttg aaagcaaagt catgggagtg agtgtctgtt tacacctaat 18780 gctgagaaat ttaatctctg caggctgtga cacattctga tatcagagga tcaaaatccc 18840 actggtggaa gttaatttcc tttgctctac aatccacact taccattctg cactcaggtg 18900 ggaaaataaa acttgtgttc ttcatccaaa gttactaaaa acacccaagc ccaaatttaa 18960 acctcaaaac tatgagctct gcttccttgg aactcaaaag aataattctc tttgctactc 19020 agagattaat cacactgcct ttatcaccta ctatgcttgt gttattttac tcttcttttg 19080 ttatttaact gagagcattt gtgtctattc tacccaacca aaccatgaat ttgcatgtgt 19140 cagggaagct ctggcaaaat ctgatacaac ttattcctca tatattaatt gcttaataca 19200 gtttttgtga ttgaattttg agctaataac atattttaat tcaatacagc atgcattttt 19260 aaacactctg agaatgtcca aaaacaattt ggcacttagg taagaagaga ctttattcag 19320 gctgggtgcg gtgggtggct cacgcctgta atcccagccc ttcgggaggc cgaggcgggc 19380 ggatcacaag gtcaagaaat cgagaccatc ctggacaaaa tggtgaaacc cagtctctac 19440 taaaaataca aaaattagct gggcgtggtg ccatgggcct gtagtcccag ctactgggga 19500 ggctgagaca ggagaattcc ttgaacccgg gaggcggaga ttgcaataag ctgagatcac 19560 gccagtgcac tccagcctgg caacagagca agactccatc ttaaaataga ataaaataaa 19620 ataaagagac tttattcgaa aggattagtg caagagggag actggaccat tacagtaagg 19680 agaaaggggc tgttgtagtt tggagaacat tcttatcatg agatctggaa gtatctcaag 19740 ggttaggaaa aaagagattc tctttcatag gaaagaatag acaaggctag aaagaaccag 19800 gtgtggagaa gtaccatgac aggagtgaca cgatctgcca gtagatgagg gaatatttta 19860 ccctgaactc tgcagcgtac tccagggaga ggctgtggag gaggagctgt gtgctggctg 19920 aggctgaggg cgggacaaag ttcagcctag gagaagcaaa gaatcttaac caaagttggt 19980 ttagcctgca tttttttctg attgatcagt ggggacaaaa cagcttagct aatatcattt 20040 atgagacaaa caaaaggaat ttagagggtc tgcgtctggc cttgttataa gtgttgatgg 20100 ctatttactc tgtgttgcta caaaaatata tgtgaaattg ggtaatttaa aaagaacaga 20160 ggttcatttg gttcacagtt ctgcaggctg tacaagaagc atagtgtcag catttgcttc 20220 tggtgagggc cttgggaagc ttacaatcat ggcagaaggc aaagtaggaa caggcacgcc 20280 acatggcaag agagggagca agagagaaag gaggaggtgc caggctcttt gaacaaccag 20340 atctcatgag aactaaaatc aagaactcac tcattactgc aagaacagca ccaagccctt 20400 catgagggat ccacccccat gatcgaaaca cctcccacca ggccccacct ccaacattag 20460 aggtcacatt tcaacatgag atttgaaggg gacaaaacat ttgaaccata tcaatgccca 20520 caaggcagca ttggtgaatc tgatttaagt cacatgggga ataatggtta gctgcacaaa 20580 gccctttctg gaacacaaag cagtgggggc atttattaac cttttctgtt ttccaggatc 20640 acagggttct ggtaaagttc aaacttgtca gaggatacaa ggagaaaagg tgcagtgtct 20700 ccattcagga atttggagac taaagaaaga gtcaaggaaa aattgttcac atttttaaaa 20760 atagtaacga ttaagcagaa gacaagaagg aagacaatta gatctcattt gatttccaat 20820 accttcatga tgcaggcacc acagtctctc agttaacaga tgagaagaaa gaggcttaga 20880 actgttaagt aaataatcca gggactcaca gacaggacat agcagagcca agtttgaatc 20940 cagatcattt tgacagccca gggcacagtt catatatgaa aaggccaact aacaaaatgt 21000 tagctaacaa atgcatcact gtggacagtc aggaaatacc tgcaagctcc agaactttct 21060 catttacata gcactaacag aaacttttgg actttccctg caatgaggca gagtgtcaat 21120 ccctactgag atggacccca ataaccatta aaaatacata tataaaaaac aagtttaaat 21180 attttgccta taacttttat tccaaagctt atgaactctt ctcttttagc attacaggaa 21240 aatgatgtat ttgttcaagg atataaaaat tgtggccagg gctcccatag tgaatgtatg 21300 aagcaggaag ctggggggat ccatggaacc ttgagcattc tcttccagaa ctctccatcc 21360 ctgctaaagc taaaatgcct gtatcatggg caaagcttgt cacactagaa aggtcaaaac 21420 ttaaaaatgt tcttaccaag tatctcccag tagtatgtgg ctgatatgag actgaggcaa 21480 agcttctcct agcagaaaag aagggactca gtaacctggg aaaggtgacc ttcatctaga 21540 aaaggaagag acagaatttc tacaaatgag ttcaggtaag aatgtgtatt agagttctcc 21600 agagaaacag aaatagaact aataggaggg gtgtgtgtgt gtgtgtgtgt gtgtgtgtgt 21660 gtgtgtgtgt gtagggaggg gggagagaga gaaacagaga gagaaattta ttatagggaa 21720 tacaatatga aataatcatt cacacaatta atagagacta agaagtccca agatctgcaa 21780 gcagcaagtg tcaggcctct gagcccaagc caagccatcg catcccctgt gacttgcacg 21840 tatacgccca gatggcctga agtaactgaa gaatcacaag agaagtgaaa aggccctgcc 21900 ccgccttaac tgatgacatt ccaccattgt gatttgttcc tgccccaccc taactgatca 21960 aggtactttg taatctcccc cacccttaag aaggttcttt gtaattctcc ccacccttga 22020 gaatgtactt tgtgagatcc acccctgccc gcaaaacatt gctcttaact tcaccgccta 22080 tcccaaaacg tataagaact aatgataatc caccaccctt tgctgactct cttttcagac 22140 tcagcccacc tgcacccagg tgaaataaac agccatgttg ctcacacaaa gcctgtttgg 22200 tgctctcttc acacggacgc gcatgaaagc aagctggaga cccaggagag ctgatgtgta 22260 gttccagtct gagtatgaag gcctgagaac caggagagcc aatggtgtag ttccagtctg 22320 aaagctggca ggcttgagac ccaggaagaa ctgatgtttc agttcaagcc caaaagccag 22380 aaaaaaaaca atgtcccagc tcaaagaagt caggcaagag gagttccccg cttttcacag 22440 aagaattagc ctatttattc tattcaggcc tttaattgaa tggatgagag ccattcacat 22500 tagggagggc aatctgcttt actcagtctg ccaattcaaa tgctaatctc atccagagcc 22560 acctcacaga cacacccaga ataatgttta actatttggg cactccatgg cccagtcaaa 22620 ctgacacata cagttaatca ttataccatg ttagtttgtc ttcttgtcca ctcaactttc 22680 ttctaactac tgtatagtat tccattgtgt tatatacatg cacagttata ctttataaag 22740 atgaaagggc tgggcacagt ggctcacacc tgtaatccca gcactttggg aggccgaggc 22800 aggtggatca cgaggtcagg agatcaagac catcctggct aacatggtga aaccctgtct 22860 ctactaaaaa tacaaaaaat tagccaggcg tggtggcagg cgcctgtagt cccagctact 22920 tgggaggttg aggcaggaga atggcgtgaa cccaggaggc agaacttgca gtaagccgag 22980 atcgtgccat tgcactccag cctgggcaac agaaaaagac tccatctcaa aaaaaaaaaa 23040 aaaaaaaaag gaaacaacca tatttattat tttgcttaat attatgtttg taagttccat 23100 ttatgttatt tttggctaca gatcattttc ttattgctat atagtatttc attgtgtgac 23160 tacatgaaaa tttattcatc cagttgatgg acatttgggt ggtttccagt ttgggatgat 23220 tcattgattt tgacatcatg aatatttagg ttgcttctga tacgtttctt taatactttg 23280 cgaaggcatc attttgcatg actgcttgta tagatacata aatgtttctc ttgggtggcc 23340 acaggttaaa caatggtcta tctggatcat gaatggagag aaaaggaaac aaccagaaag 23400 ctctctctcc ccacctattc tctgtccatg gcatctgcca ctttctctca ctctgcccct 23460 accacactgt gacctaacca gcttctacct tctcccagga gttcctcaca gattttgtct 23520 tataaacatt ttcttgaagt aaaacatacc tacagaaaag tgcatatgtt ttaagtatgt 23580 agtgcaaaga atttatgtga attgagcata tgtaagtaac ccagatagag atgaaaaatt 23640 attagcatct agaaatggaa caatgcatta gaggatatgt aattccagct ttactaaata 23700 ctgctgaatt gcttttcaaa aattaccaca tcaactaact ctcaccagaa gtaaagatgt 23760 acacccgttt cccttcaatc ttgtcagcac ttggggatag ccacacgcta gctttcacta 23820 taataatagg taaacattct tactggtttt agttattttc cttaattttt aatatggttg 23880 agcctatctt catactcatt tgttagttgg aatatgctgc acttgttttg ctattgagtt 23940 gttgtcctgt tttgaacctt tccttaagag tccacagctt atccagtttt ctacacaact 24000 cacttctgtt tgctgccctt cattatagac tcaatgcctt ctcattgcta gagcactgtg 24060 ccctccttgg ggctcgatgg tttataataa agcttcccca ggagatctca tgggggccag 24120 gttctttagt ggtggccact aaagctacta cctcttattc caggtgccat aaaccagtgg 24180 ctggacctgg ttggttcaca gagtgttctc aatgtgagga atcaggtatt gtgcttggtt 24240 gtcatataag cagcttagtt cccattgttt tatacctggc ctgctaccct cattcatgtt 24300 accttcatgc cccatagaca tttgagattt gatgcaaacc agtctgttac agtaaaagca 24360 ccactgtcta ggaagttctg gagatgggtt atcagctcat ttacatcagc agctgcggga 24420 tcttgggcaa gtcatttcac ctattggagc cactctctgc tagcataaag gagaacataa 24480 agataccttc cctgcctatc tcacaaggtt gtttgggaaa ctgaatgaaa gaacgtgtaa 24540 atgtgctttg caggtttttt gtgaaacagg aatagctgtt agtattctcg cctagccctg 24600 tctgtggtgc ccaggatgct gcattacctc ctttctaccc tcgccctgag tattggtcct 24660 aggtagaagc tgaggtgaat atactgaaag cagtaagaat cttcaccagg cccctcccag 24720 tcatatcaca aggtgttgta gcttattgac aaacacagac ctcatgtttc tctgagaacc 24780 gccctgtgaa cacctagata gaactaaggg tgtgaaatac aaacgtacta tttgcctaca 24840 cttacggaaa taagagcaca tgacacagta gatggcaagg tgaggcttta agtcagaaag 24900 caacctcagc tgaaacaaat gcataattat aatttgattt cagaagtgga aacatgaccc 24960 gaattcatgc acctactgat tagtccaaat tcctttattg ttgaagctgg agcagaagtg 25020 ggggtccacc gtggaagtaa ggaaaagcaa aacagaacag gggtctcatc cagggagcca 25080 tgtcgatggc tatggggagc tccaccttgc tcttggggtg gggccctggc cctgggtggg 25140 actgtggggt gatgagggtt gtgctatgct ggctacctgg tggtaattgc caaggagaga 25200 gcagcacgta gatcctccct gtcatcaggc agagctcttc agtgaggtgg gctcagggag 25260 ggctctgtgc ctccgttcag cagagctgca gctgctgccc agctctcagg aggcaagctg 25320 gactccctca ctcagctgca ggagcaagga cagtgaggct caaccccgcc tgagccatgc 25380 cagccaactt cacagagggc agcttcgatt ccagtgggac cgggcagacg ctggattctt 25440 ccccagtggc ttgcactgaa acagtgactt ttactgaagt ggtggaagga aaggaatggg 25500 gttccttcta ctactccttt aaggtaagtt tcttgcctgc gactctgaac actgacttat 25560 aacaatgaga ctgctggaac ttaagagtgt caattgaagt atcatagcca gtattgtgaa 25620 tgagtgttat tttctttact aaaaaggatt tttaaaagtc tgaagtgcta aaacaacaag 25680 ctgtagtgtg cagagaccta gattgtagtt tcttaggaat acaggtgacg tttttctttc 25740 tgatgctgct ggaaatgtgt gaatcgtgag taacatttat gagtggatga tttttacttt 25800 ccccctttcc ttaggtgaaa gcacttttaa ttaatcctat agcagtactt gaaatgtctg 25860 tttctagtag gggttagagc tatgagtttt ttgctaggaa caccagagat gcggaaagct 25920 cacaatcccc aggacagtga ctgatatgat gagaaacaac attgaataag gcaggaagga 25980 cgacactttc tttgatgatc cttttcatta aacatcagtg aggaatatat ttctttgagg 26040 gtagttgatg atgccaccat ttgcaacaaa ttacctccta gaacaaatga aggacagaga 26100 gtttggtgag tttcaccttc aaagtatcca agggccacac tgaggaagga tcttcattaa 26160 gctaatactg tattgtttct tattccgcaa caagatcttg tggacagaaa tgaaccgcac 26220 atttgggaaa agaacagttt cctgcttctt gcctcagaat gctgggttgt caggttattt 26280 cacacctgtc taacgatatg tttagtcatt gcaataattc acaggtctca aactggtcct 26340 ttccactgaa gaaaaaatac ttcaaaaaga ttctagttgt tgctttgttg ggttttgttg 26400 ttgttgttgt tgttaatcct ctgtatgttc ttgaaatgat ttggttttta cacaatgaga 26460 tagcattact gtaacatcca cctccctact ggaagttcac ttcttttgca aatattcaga 26520 ataaaacttt cagcagggtg ctgtcccagg agtcagactt aaacttccag ggccctaatg 26580 atcctgcagc aaagcagaac ctgagcaaac tactcctcca ctggcttcag tgaaaccctg 26640 tcccttggaa tcacctccta atgcatatgc acatacgcag cccagctgca cagctccacg 26700 atgtagctta gaaagtaaaa ttagagtttg ttgccactta atgtcgactg aataatcccc 26760 tttatgaaat cagcctgcag acccagagag tctgtcttgg caggctgtgt gcacccagga 26820 agcacaggac tccactcagt attgctgcct gtgtagcctc tttgatattc ttagaacatg 26880 atagcaagca gaatgaagag aggccctcca ttgcaaaggg aataaaatca gcaataaggt 26940 ggttattctg agactctggc aagaatcaat ctcagctgaa atctcatttg ccattttttg 27000 aatatagcac ctacagggat atttggaata tgtgaagaaa caaatcccac cttgctctct 27060 atgagtgttt gtcctctcta tcctagcaac atcatcgcca gacactaaag agaatcacag 27120 catctctagc tgattcctat tgatatgttt gcagcaaaac ggctggacca ctggacaagg 27180 agaaaagcag aaagacagga attgtgtttg gccaggagct tagaatgctc agattcatta 27240 tttgagagat acgtgtattg actaaaaccc tgtgattttt agttacacag tgattactgg 27300 tggtatttgt gagaacttag cttatatttc ttagtgtaac tttttttcta tgatcccctt 27360 tgggcacaag caattctaat gcattgttga tacagaaata gttccaatgc aagcccttgt 27420 tcactgcaat tcattttatc tgacatactt ctagagaaga aattcgaaac catgctccct 27480 ttactgtctc ccagatgtat cccctttaat ccccattgcc ttcatcaaaa gcagtaaaaa 27540 aaatagcatg aaaataaaaa tagcagcagc agtaaaagtc acagaaataa cagcaacaac 27600 catacgtctc atttactttg ggcattcttg gtgccaagag tcatagcaag actcacttag 27660 caagtgactt ctgtgaagta tctcatttaa ttctcacaat ccatggtgta tctttccttc 27720 cggtcctgcc ttccatcttc atctgtttat ctcaatttta cccagtctat aaagctcagc 27780 ttgggttgct tcctccatga agccctcctt gactcatccc tccctgactc atccctccct 27840 gagcttcatt agtgtcacgg actgtacctc tcttcttgcc acttaatgca gttctgtctt 27900 aaactgctat ttccatatgt gttggctgaa tgtgttacag tcctcaagct ccttgagtaa 27960 aatgaatgcc ttatatttgt ttcatatttt ctcccaggac ctaccactat gttagtcata 28020 ctcaataaac attgactgca taaacaaatt gtgatgtgtt ttttcttcca attaccaaca 28080 ttttgtcaaa taagcaacag aaagcatgta ttccctgtga cagaggtggg tgggggctct 28140 cattaaccaa gtttccaccc atcagcccct accctgcctg gtctctatac tcacccaggt 28200 ccctttctgc aagcatgttc agcttgtccc tattccattt ctaagccaat gagaccaaag 28260 tcggttctag attccagtgg gtggggtatg gaattagctg aggcaccatg agctggtacc 28320 aagtacctgg tccagccctg gggaatccat ctctattgca tggcagcctt acctagtctc 28380 agctgtcttg ctccgtccac ttacctaggc tcctgacttc gtttcccatc tcacattcta 28440 gttcttatcc tctgaactcc aaagctcttt caggaggaga caaagcaccc cgtctagatc 28500 ttactggcac ttccttcaca ggcttagagt ctgttccttc ctcccacctc cacccttgaa 28560 ttctggcttc tgcttccacc cctctaacct actctacctt cctaagcatg tgaggctctt 28620 ggaaatgagc agggaggtct agggtgggtt cacccatccc atcttccacc atgggccttg 28680 tgtaactaac cctacgtggt cttgggttca agattctcag ctcagaccct ggctcccttc 28740 acagtttcca gttttgtgtg cttttaagat cacatccagc tcacctcttc aagacctagg 28800 tcttggcact aaggaattat atgcgtttca agaatctacc agaagttttc aaggggaaat 28860 gggaaccagc tcatcagaaa ataaatgagg tatctgaata taaggctgtc caaatgcaaa 28920 acaaatacaa aactcttcac acagaaagcc cttaattttg ctggtgaatt caccagcaat 28980 gtttcctgaa tctctgatac ttaatgagaa acctaattag aagtaactgg gagggagacc 29040 tgtcttgatt agtgaattat ctaaattata aaataatgta aatgaaactt agttttatta 29100 ctcataggtg agcacagaaa catgaactaa gactgctaaa tatcacctaa taacaatctt 29160 ttattgcgcc tccttcggtg gatagttaca agtgatacac aattagtcta ttgtttatat 29220 gtaaatggtt gcttctaagt gcttgagggt gatttgacac agtttgttcc ctttgtttgt 29280 acaccctccc tgccacgctg ccttactgtt aattttctta acacactctt cctccattaa 29340 tataacaaaa gcaaatttca actcaacgca tgtcccaatt atctcacgct atgcttttgc 29400 aagggagctc cttcctgccc tggccccagg acagtgtcag ggatgtcctt cctggaatcc 29460 agaatccctc atgtcccaac ccccaaatgt atctcctgca atttgtaacg agaggtcttg 29520 catttacatc atgcattttt tattcttttc taattagtct cgctcagtat gttcaatttg 29580 agtttctaca gttgaatact gtggctgctc ctaaggaaat tactaccagt tttgctcggt 29640 taaatcatta ttaaacatat tattccttcc tgccagttct gctacccaga cctagtgctc 29700 tgctttccaa tccctgaccc tgggtaaact ctaccgtgca gtgtgtccaa tttcacttca 29760 cacaaatgag aaaggctgag gatggcacac aatttccaaa ctatagacgc tagtatttga 29820 aaaggaaatc ttcctcagct aaatttctct ttgcattact aatacatttg atggcaggaa 29880 gcataatctt agctaattca gaataaacct agtcattgca gagcttttca gcccaggaag 29940 agttttcaca ttttctggct tcgggaaggc atctaactcc aggggcagtg cttctgtagt 30000 gcatttctct ctctctctct ctctctctct ctgtgtgtgt gtgtgtatgt gtgtgtggcg 30060 ggggggagtg ggggtagagg atggatggtg aagagagtct gatctactga gggatctgag 30120 caagttggca tcagctgaaa caagacctgt ctgtccctca gatgtggtca tcctcgttct 30180 ggactttcat ctgggttccc atccgacctg tgtcaggccc acattgcttt ctggggtaat 30240 gtcccttggc cacattctct cctggtacag ggtgcttgaa tccctgtctc tcaatcccag 30300 cgataatttc tgcctccttc ctaagaatag aaagtttgac tgctaccaac tttgggctgc 30360 agaaaacaaa atggagcatc tctggccctc tctcatccca catagccacc tacgctatac 30420 aacttccacc tcatgataga tgggaaaatc tgggagactg tacttccctg gtccctacac 30480 agtaagtgga cctcagcgcc cttccaatcc tgtgctcccc aaatgtagca aatgttctct 30540 cttcctccgc tttttcctgc taacccttgg aggggggcaa tccaataccc tcttgtcatt 30600 gtctcagttg cctcgcatct ccccagcatc tgacaccact gctgcgccat caaactcttc 30660 catcgccctc agcgaccccc ctgtcatggg gaaattgatg acacagtgtt cttccgaatt 30720 tattattcca ggctctctgt tctgaatgct caaaagtcac accctcttgc aacagaaaaa 30780 acccatttct cttccagctg tttaagatat cctcactgag gtattttgaa agcccagtgc 30840 tgacttgttt ctgtccatct gcattgataa agagtgcagt ctgaggacag tggggctgcc 30900 tgggctggtg gacagtgtat caaagaagtg gaaagaagca catccattca tgcttgacaa 30960 tgtcattctg ccatccttca aataatttcc tgttgatgaa gtaagaatgt ttcaagccat 31020 gcactcaggt agataagaaa tctaacacta tttttcttaa ataaactgag cttctctctg 31080 gacctctcag tcccccaagt aaactcaggc ttttgagctt tctccatcat ttcaatgagg 31140 cagtgtggct cagagagcag gctttagagc cagacttctg gggtcaaatc ccagtgccac 31200 accatctagc agagtgactt tgggcacttt acttccaccg gtgtctcagt ttcctcatcc 31260 aacaaacaaa gctaataatt gcatgtcctg tagagagttg ttgtgaatag ttaagtgaga 31320 gaatgcttgt atagccttaa agaacagcaa gcggccccca ggagtgttca ttattcataa 31380 ttagagtccc aggaattcgt cattccactc ttttctcaag acaactactg agaggtgagg 31440 aggcagcatt agctgtaagg aagaagtttc ggaagatgct gagagagacc actgcaggtg 31500 gaagcacttc aggacagctt cgatatgcag gtggtcctca aacaatggtc atgaattaag 31560 ctgtttcttt tctttttttt aaaaaaaaaa aatgagacca tgaaaatgta gaataagata 31620 tagatataga gggaaaattt ccatttctta ctttgtcatc ctgatattat gtctagctat 31680 tatctaagca aacttaatgg cccactacat gaaaggctat ttgcagaaag agcaaattat 31740 gccctatctg gagaaagaaa gaaatggctt cttctctgct gtgaagattt tccaggccac 31800 agatggcaaa atcacccaag gtcatgagga agttgtaagg aataatcaag tttcttgttt 31860 tcccacttag gcaatattga tggctgccta aaaatgatag atctattact cttgtcagca 31920 ctttacagtt tgcaatatga tttcacaata tcacctttga acctcccatc agctctaggg 31980 ggatttaaaa tagcattctt tttctttgag cagatatgaa actaaagtct gagggaagtt 32040 aaaggtgtaa acttcctaaa agttaagata aggtaaaaat aaaataagaa agaaaagaaa 32100 gagaattctg agctgatttt ggtctggata ggttaagctc tccaacagta aaaaacaaac 32160 cctaaatctc cgtgatttaa cacaccagag gtttattgtt ccctcatatc acagtagcaa 32220 acaggtcaac ttgtagctac accttctaga acaagtggct tccaggggtg atggtaaatt 32280 ttctcttgct gtctttggcc tgaaatgaca catgactttg actgaattcc attggcaaga 32340 attaattacc tcaataggca acagaaacgc ccccagggtc gagggtataa tgcatggctt 32400 taaagatttg atccttacct tctggcagat aaaacccaaa tccttgggcc tggcctactg 32460 gcctttcaca ttctgaccca atcaccttct ctactcctct cttcacatcc tggaccacgt 32520 tgtactgact gtcttaccat agtctgagga tacagggtcc tgtttacctt ttctggatat 32580 gcctttctca cacctttttc ttctgatatc acgctaacct caattgcctt ctcttctagg 32640 aaggcttcag aattgttcag tagtccagca tcatcacatc actacccttc tgctcctaaa 32700 gcacttagaa tctctgtgca atatggttcc tctcttgaca tgcatgttca cctacataca 32760 cacacacaca cgcatacaca cacacccatg agcacataca catggacaca tacaaataca 32820 cagtgacaga cacacatgcc cacacacaca cagactagat gtcagttatt tagggacacc 32880 tttagatcct actattccta gtacagtgac tgacacacag cagataaaag gtcagtaaat 32940 attttgttga gtgaaagagt atatcaagaa ataatctgta aaacaagttt actgctaata 33000 tctcaataag ctcatgtgaa tgaatttggg tagataaagt cttaatcctt attcaccaac 33060 catttggctt gaatttatag gtgtcataat ttgggaggga ttcgtgacat cacagtaagc 33120 catgttctat attatttagt aatgatgagg aataatgatg atgctatcgg attttgggaa 33180 aaatccgtag gattggtgag tagaggcact acacaagcct ggaaaaggga aaggaaaaga 33240 gaacaggttt ctgtaaccca ggatgacatt tggttgaaac aatacttagt ttcaacctcc 33300 tcctcacttt cccagctaag tactcactct cctagtctcc cttgcagtta aaggtagcac 33360 agtttgggaa gcttaattgg aagtctctga gatttctaat aaagattttt ccttttctga 33420 tgaaagcgga aagatattgc tggcattctg atgtccccct gacttgaatt cagacataat 33480 gcatggagcc gcagcagcca ttttgtgacc acaggaaaaa aaagccaagg gaatcttagc 33540 aaattgagtt cagcagcaac atatcttcag atttcttatt atatgaaaaa aaataaatct 33600 ttgtttaagc cactgctaag ctgaatactt tcctaattga tataaatact aagtgtaata 33660 cgacattgac agtattgaag ccaagatctt aaaacatggc ccccagagag tcaagcagac 33720 attgcattat tacacatttg gagggtacag aggctggatc tgcccatggt ttttgtcttg 33780 ttattatcta cattacaaag agattgaata gattcttata aaaactgatt cagactagat 33840 tgtatggttt tgagtaacca agaaagtaaa agtttctccc cctcctcaaa gaaaagggcc 33900 ttacattttt caaatgattc tctacattcc agataataac aatgccattc acttatgtaa 33960 ttctatgaaa aaatactaaa accattctga aaacatcagc tcaaaaaact acccaaaaca 34020 tttgctcatt ttttcatgat ggctcaataa gaagattttt ttattctcct ccaaaaagca 34080 taaggaatca catcctttcc tgacagctta aaacatccaa gcaaaatgtg agctggagcc 34140 atgggctctg gacctggcag gcaggtgtgg accttcagca caccacaggg ctgctctagc 34200 cccaggcatt tctgccctgg gtacagaaca ataaccacca tccctgcctg gatggtgaag 34260 taggaatgga gccagttctc atgtgggagg aagagttttg agagacagga gaaagggggg 34320 tagtcatgga ggagttctgc ttactaatct gtgacaatcc tctccaagcc cagagaaggt 34380 gggaggtagg ggaggaccga tgctcttccc catcaaaggc cagcctccta gactctccat 34440 tcatccagct tcttcaccct cctggcctct ccactttccc cgcctttcca cttactcaga 34500 ttctccacct ttccagacac tccatcctca aagactctcc acccacccag gctagtcatg 34560 cattgctaaa gataaataaa aaagaaactt cctgggactc tttcctcctt ctaaagacag 34620 gagtaggtgg ttggaaagga ataagatgca atcataactt tgacaagact cacaagaacc 34680 ctcatgaaga ttccctgccc tctcacaagc ctctcttttc ccagccttaa ctgcttgccc 34740 tcatccttac cagggcattc agcttggact ttgcacgctc agtttttaaa aaacagttct 34800 gtctccccct ttctcaccat ccctctttta tctcatcaga acttctttct tcaataaact 34860 gattccaagt attagcaaaa aaaaccattc taagtaaaag agttctgagt tccatccctc 34920 aagtgtctct tcttataacc cccctaacat atgttagggg ggttaatatt aatgtaaaat 34980 aaactcttac tcctcatgcc ctctggacag agtctaaagg attcttggag ttccttaaag 35040 aagccaaaac tcttttgctg ggctacagcc acgattcacc caggcctctg aatcagaccc 35100 aagatatccc cacagcactc agaattccat tcacataaag atattgaacg aaggtgttca 35160 cacaaggagc attattcaca agtcataatt taataaaaaa tgtcagggaa tattgtgagt 35220 gctcaaatgc aggtttctca tctttcacgt attattgtag actctaaccc ttagcaacac 35280 agagcaaccc atgcagatag aagatattct tttggctaag aatacattta ttccttttcc 35340 aatgtattta gtcccttttc aggatttttg gtctaggtta agattaaaat gcaaagagta 35400 ttcaagaaca cagaaactat cagcctaaaa taaaacttag aataatgtaa tgaatgcaat 35460 tctatcaggc cactcagtct tttctattga tcatttcatt catcaatcag gttaagcaag 35520 cttatgctga ggaaacaaat aactggatat tctcagtggg ttaaaatcat aatattttaa 35580 tgtttgtttc ctactcatgt cccatgtcca tcacaggtta acagggtgac tccgtgtatt 35640 gtaatctctc agggaaccag ttgatggaag ccccatgtca acaaaggctt ccataatact 35700 gaagtcagaa gagcaagagc tagagagata cagagtaacg aaccttgccc tggctctcat 35760 aagcttctgc ccagaaataa cacatatgac ttccactcac tattcattgg ccaaagtaag 35820 ttcatggtca cgtctggtat cagtggagca gagaaatgta atcctcctgc tcggaaaggc 35880 agggaatctt ggtgctcggt aatgtctaat gcaactccta aagctctgag acaggcatta 35940 tcctctttga tttagagaga agaaaagtga ggctctgaga agataagttc acataatagt 36000 taataatcca aaaactttta cccagatatt ggttaaaatt ataacccaga taaggcgcat 36060 gctctttcca ccatatcaga acttcccaaa agttgttcca cagaactcta attatgagag 36120 ttcttaagca gttgtcaggg gaatatgaaa taaagaattt tggaagcacc acatattata 36180 caccattata tacttagagg atgcattcac catttaactc tctgagaagt cttacagtaa 36240 ggaaacttgt ttatggtggc tcacgcctgt aatcccagca ctttgggaga tcaaagcggg 36300 tggatcattt gaggtcagga gtttgagacc agcctggcca acatgataaa accccatctc 36360 tactaaaaat acaaaaatta gccaggcgtg gtggcaggtg cctgcagtcc cagccactca 36420 ggaggctgag gctgaggcag gagaattgct tgatcccggg aggcagagga tgcagtgagc 36480 caagatcaca ccattacact ccagcctggg cgacagagcg agactctgtt tcaaaaaaaa 36540 aaaaagaaag aaagaaaaga aacttgttta attctttaat atgcattttc caagtctatt 36600 tgaccacaga gcattacaat attacctcta ataatgacca ctggcacaca cttcagaaaa 36660 cactctgtta tgtgttttcc tgaaagagcc taccagacaa ccaaacagaa ctagctcttt 36720 gagcagatga ggcccagaga agtaaagtga ccttcccaag gttacatagc tggtagatgg 36780 tagagtcagg acaagaactg caatctctaa ctatccaagt tggagcttct gctcagctgt 36840 cgagaggatc gtgaaaaaac gagagtgttt tataaactgg aaagcgctat tcgaatttaa 36900 gatagcatta attctctagg tgaagcatta ctgaaatata tagaatacat ggaaggacat 36960 gaggtgcttc aagataggat gattaaattt ggtgaagatg tcaattctcc ccaaattagc 37020 atataatgtt tgaaataatt ttaatcaaaa cttcaatgtg attgttttaa attgattaaa 37080 taatttgaaa tttttattta aaaaataggt gagaaaagct cagaaatttg aacacaaaca 37140 actatgggga agaaagatgt ttccctatta gttattaata aatgtatatc cacagtaagc 37200 aaaacattac agaactagca aaataattga cagatggatc aataataaga aatattttgc 37260 actgaaaata aagtcctggt acatatatga acttaatgtt acaaagaaac taccacagtt 37320 agtaaaaaag gaactagtat ttttgcaaca aaagtagtgg gtgaataatg gttcttatat 37380 aaagttgtaa atctcagcta gattgcggaa ctaaattttt acaaaatagc tagaaaaatt 37440 atataatgat gacactaatt tcaggactag caagcattat tcaagcctaa aaacaaaaat 37500 ttaaagggaa acaacaaact aagaaaatta tttgcaataa aaataaatat ataatattat 37560 agctaatagt atatacatta attatataaa aatataacat ggttaaagtc cttaatatgt 37620 aaagagccct tgagggaaaa taaataatat ttctaatgga aaagtgggca tgggaaataa 37680 aaacaatttt agattaaata cagagttaaa agaatgtgtg aaaaaatatt gtttattagt 37740 ggtctgaaca atacaaactc aataattcac cataatatga gatatatcaa ataaagatca 37800 aagcaaaata atatataaag cacagaacag ttctgtaaaa ctgtttgtgg gagagtaaat 37860 cagaacaact taacccaatt tttctggaga acaatttagt aatatacagc aaacttaaat 37920 gatgtattca ggcactgctt agtaattcta cttgtaggat tataccataa gtatactaaa 37980 gaaacattca aagacagaaa caaagactgc attaagttgt tttattaaaa agtaagtttc 38040 tagcaatgga ataataaaat tgtgatataa ccatagaatg gaatattaag gaatattatg 38100 caactataat aaccatttct ctttgtgcaa tgttaaaggt ttttaaaagc acaataaata 38160 taatatattt caagttttat atacactcat aaaatataga agaaacaaat accaagatgg 38220 aaaagtaaga aattctctct gaaagttact ttgcagatgg tttttatttt atctttgtgt 38280 aaaagcttac tgtattttct agagtgagca catattatat ttattattct aaacgacaaa 38340 ataaccatgt aagatacacc atgccacctc tcaaataaat tgtgtgcatt gtatttccat 38400 gacagtaaat aggaagaatc tatttactct gcagaagccc agaaatgaac ccaagcaagc 38460 gaggcttgca tgacccagag agcacattaa aggatccaga aatgcaggca agggaacaag 38520 acagccaatg aaaaccaagg cagatgactg gctgtatgaa ttgagtgcac accaactcat 38580 tagcctttta cattttgcta cccaaccacc caacttagat gcacagaaaa caaagcttgc 38640 aagagtagca attccagact ctgtagcagg aatccttctg ctgagcctct ctcatgcccc 38700 ctcccctact gttctcatct cccaggatgt tcaaatccat tccctggtcc ttacatctgc 38760 ttctgcccat gcatgtgttc gctcctcctg gtttcttttg gctacttgat tttgagtctc 38820 ccggatggat tttaaatacc aggtccaagc caaagtgggc cctccagggg aaagtttctc 38880 agacactttc cctttttatt agcacctcca gaacagaaaa caaattcctg aaggtttatt 38940 attttaatta cgtggatcat caggaataat acattctggg tatttttatt atatagtaat 39000 tactttggtt cctacgacat tgtagagatt tggacttaat ttgctcaaat gttagttttc 39060 catatttcaa gagtctagtg cttaaatagc aatttaaatg ttaatctcag ttcttgttat 39120 gtagctgaca tttcattcgt ttattcagca aatattaatt actacataga cttgaagccc 39180 agtgggtttc caaatgattt ctaacatctg tggtttgcta tattatggga attcagatgg 39240 aatctcagaa tttaattgtt tcaaagcttt caatacatgc tattagtggt taatttggaa 39300 gtcctcttgc gatccaagaa caaattgcaa gaagagattc acgttaaaat gattgcagaa 39360 cattggcatt tctgtttctg gtgaaattca aggattcacc agtaaccaga aaactgaatt 39420 cgaaagtaac gcaagtgcag tcccacatgc caagccctga tcgaaatgag aacgtttagg 39480 atgtgggaga ttaacattgt taataaagca tgatctacgg cccatggtac tgatgataaa 39540 aactccaaac caatgactat gtctttctgg tcagagtaga aatgactaat gcagttattc 39600 aacatgtcct ggagactaaa ctaagaaatc aatgtcaggc agtaatccag agtccactga 39660 atcactttcc tgtacagtcc cagtctgaag gtgctagtat tacattctgt cacttgtaat 39720 catggtgttg agaggtaagg caaaggcaat tcaggtgaag acaactgagg aagatcgcag 39780 atggacaaga atctctcctc ctgacagcag attcttctaa ctccggacaa tgacacaggc 39840 cctggacctt gtcccattat tgaaataatt ggctttcaga ccgagctcca gcttgctcat 39900 tgtaaacctt tctctgctgt tactacctca aaagtgcctg aatggccact atctgtcctc 39960 actaacctgc agttctcact ctctgccttc acttacgctg ttgccaggca ccctacttct 40020 tagcttggct acttctactc attgtttcag actcagctca cataacagtc tctctaggct 40080 atacctgctg accaaccatg accagctcct ccccaggttc tattacatgt tccttatttg 40140 ggtttctaca acatctttat catagaagtt cacattgaaa attctggttg acgtacctgc 40200 ctccaccatc agactataag ctccttgtct tcgcctccct tttatcccca aagtatgttg 40260 aactttgata ctagattctc agaaatgttt atggaatttg attgtacaga ttacaaacca 40320 gtataatcat gtctccagct ccatgatttt caggagagtt tcccacttcc ggcctgagtg 40380 tcatttctac accaacatgt aagccaaggc tctctcctct ggataaatgc ctttccctct 40440 gccatactac atgggagttc acagaatgac tctcagttca caactacttg gaacaatcgt 40500 ggtccacagc cccactctcc aattcaacag gcctaggctt caactgcacc tcccatccca 40560 ttcacattcc ctattcttca tgaagaaggc ctctgtcagc ttgtcttgcc agtctccaga 40620 caagtctaga ggcattgcag agggtgtaat ctctctccat ccctgttcta gacccttgtt 40680 aaagtgatat gagaagcctt acaaaggtat taaaacttga gctaacaacc acatttatat 40740 gtagctgtat acagatttct tacttttttg tgaatattta aaaaatttta tcatacatat 40800 tttcataatt gagtgttgta actgatgaca atcctgggta atccaggata gaatccccat 40860 agttcatggt aaagcagtta gaaaacgtaa atgccaacag gaggtcgtga tgacaataat 40920 tcaactgtat ttgcaagcag gcctcccagt tgggttactc aggggttgat agcaggggag 40980 tggaggagag acagatttta aaaaggggca tcatcggaag gagatggctg tcagggagaa 41040 aaatggcagg ccctcctgaa ctagcccagt cctagcttca ggcctccttg ttgaccttga 41100 ctggttattg accacctggc attgcttctg tagcagcagg tagggtgaga tgtgggaaga 41160 agttgggatg acctcctgaa tgacagatta ccaactgtcc agctactgcc caggggtcac 41220 cacatcctca cattgtgtct cattctccaa gtctaattaa gcagcttcag gaacacagaa 41280 ctttgctatc tgctcctacc tgtttcactt aaaatcaggt gcccatgtat gtctctgtgt 41340 tacactgtga ctgatcccta ataaaattag agattttcaa tctttgcact tgatattgcc 41400 aactcaccta agcaaattaa tgaggctttg agtaggcctc agagcctggt gctgtgaatg 41460 atggaagcca cacaagtctc agggacaggg cagtagaatt tcattgtctt ctcactgaga 41520 agtgacacca aatcattgaa accttttttc ttatacttta tttcctgtat tggaaaatgg 41580 cagatatttg ctccttcctg tgttagagat attcatcttc aacatcacat acataacaac 41640 cttcctaaaa caaaccctga aaacatgagg ggcacggaaa gctttgtgac tcccaggaca 41700 gctgatgtag ctgcatcttg tgtgacattt atcactactg ttgtgtggag gccacatgtt 41760 gccatagagt ccctccattc ctccaatgca tggaccttat gctcagtcct gagggagaca 41820 gtcatgaatc caacccagcc ccagaaaccc agcttcaggc aagttttggc tcagaaagaa 41880 aatgaagatt tgtctccccc ttgaaaattg aaagtaaatg aggcaacttt cactatctta 41940 aaccaaaatt ggggcagaaa actactagag taagcagggc atggtctttc cagttaagca 42000 aaactacatg caaatcccag ctgcatcacc taatgagcca gtaacccagg taagtaactt 42060 ctctgagctt catttcctta cctataagat tgaggacagt gataactcgt tggtcaggtt 42120 gttatggtta agtgagcaat atgtaagcct tcttaaatga tgcttggcac atggcaatca 42180 atcaaaaata tttattgtgc acctactaca tacattacaa actcagtaag ccatgtactg 42240 gattaatgtg attcactcaa attatttcat tccctttcac cctataattg ttaaagatac 42300 ttaggctttt tgtcttccag ttttcagcac ctaactgaaa aaggagatca ctattccttg 42360 gatctggata aatccagact agcctgacag atccagaatc aactagagta actaatgtct 42420 tgtatttcct gagataattc ccatttcaaa tgaccttttc tgtgattctt gtaagtagct 42480 ttgcacttgt catcaaccaa gtttccatct gacagagatt tattaagcac cttctacggg 42540 ccagacagat gccaggggtg gagttgtgac ccaggcttag tgcctgccag catgggcatc 42600 cttttggctc tggaagcatg gctcatggag ccacatccca gctatcagcc ctgtggcagc 42660 atcaccatca tcaaaggaac cctgcaattc atctttctaa atcccaattt gcaattctct 42720 aagtctgcag aaaactgatg tcactgtgta gcctgactaa cttgaggtga aaagccaatc 42780 agtcatgtgc cagcaaccat gtaattgagc tgagaacagg ccaatcttta gttattgaaa 42840 cattttaaat acatttctta tttccactca gtattggacc atctggctgg aattttgcct 42900 cacatcacca ctagggggca ttttatgccc aactatattc tgcaatagtt tgggggttgt 42960 gttgggacac catcagcaca gtgtggtggg gggtgggtag ggagaatgct tcttaggctt 43020 agtgaaattc cgatagactg gtaccgaaaa tagggtgaac agggtgaatt caagcatcac 43080 tctgaaaagg cagtgagtta gttatcaccc ctcaaatgta catatgtagt ccacaaacct 43140 aagggaggag ataaaccaat ttttattgca tatctactat gtaacaggca ctgagctaaa 43200 aatctccatc ttcatcatct tatctaccca tcacaactat cctgagatag gttttgtctt 43260 catcctcatt ttacaaataa gaggtcagag aggttatcac ttacaaccta tcacacatcc 43320 agcaagtagc aaaaactgag tccaggtcag gttgctttca aagcctatca acttttcgtc 43380 cacgaggctc acctagttgt gatattctca ctcctctgaa attgtttcct cagtccccat 43440 taccatgact ctccagatta tcctgggatt tgtgtgtgtc tctgtgtgcc tgtgggtggg 43500 gagggggaca tgcacgcata atacggctgc gaataaagga gcaagcagct gagtgttttc 43560 atacttaatg acccttgtac tagtcagtga aacaggattt aaatttgact gagtataact 43620 tacacactct acctgtttta ttctcttgta gcaccaacgc cttacactgt gtctggcata 43680 gagtaggaaa ttaatagatg ttagatgaat tcataaacag ataaatcaac atggctctta 43740 ggaagacccc aaaagcattt gcccggggag gcttcctatg tctggaagtg ttctgaagcc 43800 tatgaagtaa ggtgagatta tcttccaaca gaaaactcca aaagatgtgg aggtggggag 43860 ggtttgattt ataggatttg ctcagcctgc cctagagaca tcagccaatc aaaggaaaat 43920 agactccaac ctgtttacag agctcctcgg acttaccatc ccaaagcata gtccaagaac 43980 aaaagcccag tccaagggat cactgactca ccagcccctg ggaatgattt ccaattcact 44040 gatacatcaa accagggtga tttgatatgc agtgtttgtc actctgaact tccaacaatg 44100 cagatctgag ccccgggact actttgaaaa gactggatcc cttggctcgg attgtactct 44160 acaaagatga agaaggcagc cattttctgc ccactgggga ccagaagcct cttccattag 44220 gcagaaactt catttctgga aatgtgaact ttgctgccag agtcatcaat gccgacgctc 44280 tatgtgaaaa gcagaccatt tactcacttc agcattgatt ttctggaaac atggcctgcc 44340 tgtatttata tgaggaaagg agaacatgaa agagagatat agtctgaaaa tgtaacgttg 44400 acttccaatg caaaactacc ctgagttcac tgattttatt ctcttcctct ttccaattct 44460 catccaaaag gctatcagaa tgtaatttca gttgaaaagg cttccatatc agaagtagaa 44520 aatagggaag gtcgatgact tccctattcc cttccacctg ctggaaaact ggaggaatgc 44580 ccacaaggtg tagagtaggt aagacattct gagggagggg ccaacagatt cgtctgctct 44640 ctgacaggaa gtaaaggcct tcctggggag gtcagtagag aagagaccag ccccagggga 44700 ttccactcct cagagtccat ccactgaggc tggggccatc tccagtgagc aaatttctgt 44760 gggaggttta ctgaatgctg cagacctcac aaaaaaggat tttggccagt gccttctccc 44820 agctaaagga gtgtggacag ctggctaagt aaaacttggg cgaggccatg gatggtgcca 44880 gtgaagacag agcctcagta aggaaaacag tcctgtatct actatcttcc tcacattcca 44940 cccttgcctc cttctttggc tgctcccaga cattgttctc acctctccca ccatggagac 45000 gtggatttct gatctggcaa agaaacatca caagtgcttt aacttttctc ttccttcttc 45060 atccaagaat gaaagttcaa cagagaccaa tacagttctg gacaagtgca agaaataaac 45120 catcccccag caccatccag gctcagaaaa aatgctggat atgatacaag gctttgcaat 45180 tctttttttt tttttttttt ttttttgaca gagtctcatt ctatctccag gctggagtgc 45240 agtggcgcca tctcagctca ctgcaacctc cgcctcccgg gttcaagcga ttctcctggc 45300 tcagcctccc gagtagctgg gactacaagc acgcaccacc acgaccagct aattgcaatt 45360 tttaaagaag aaattgcttt aaggcattaa catgcttctc tttatgaaac agatccccta 45420 aaagaaacag gagtaaatct tggaaaatct cttacttgta ttctcagcag agcttgaaag 45480 gacattgcat taagaaaagg gacacagtgg ccgggcgcgg tggctcacat ctgtaatctc 45540 agcactttgg gaggcccagg agggtggatc atgaggtcag gagatcgaga ccatcttggc 45600 taacacagtg aaaccccgtc tctactaaaa atacaaaaaa ttagctgggc atggtggtgg 45660 ttgcctgcag tcccatctac tcgggaggct gaggcaggag aatggcgtga acccggcagg 45720 cggagcttgc agtgagccga gattgcgcca ctgcactcca gcctgggtga cagaactaga 45780 ctctgtctca aaaaaaagaa aaaagaaaaa aaaaagaaat tcttataaac ttcactgtaa 45840 acaatggaaa gcagaatatg atctcccgaa aagagaagta tgttatacta gaatatgcta 45900 ataatctaaa ttttaaaatc acagattatt ttaacagaac ctggggttgg ggaaataaaa 45960 tagttttaaa gcctcttaat taattttatt tctcagtgtg aagtcaaatt tgaatgattt 46020 ttaatggtta cttaaaaatt aagcattcaa tgtcttaaat tttttaaagt taacatgcga 46080 taaaagagaa taactgtttc aaattactag tgaacaaatt aaaataaaaa cacaaatgac 46140 aaagaaaata tttttaaagt acaaaaacaa actttaaaaa ccttgtaaga tcttacatat 46200 cagttacaca ataaattaca atgaatcagt gtcattatta aaaatagact gtcagtttaa 46260 gtcaaaaaca aaaattatat tctacttaca ggagaaatac ttggtagcaa atgaaacaac 46320 atagttagaa atatatagat aaacaaagat ataccattaa aatagaaata tgattcaatc 46380 aagtatggca aaattaatat taggaaatag ttcaaggcaa aaagagttat gaaagaaaag 46440 aacagtaagc cctcacttat catccgagtg ttttgataag ttctcggaaa ctgtgacttt 46500 aagcgaaact acatataata aaaccagtga tttttctttt tcttatcaat ggcataatgt 46560 tgaaggaaat gatgttattc tgggcctgct agttcgtttc acttaaagtc acagtttcca 46620 agaacctatt gatgatgata agtgaggact tactgtaagt tatgtaattg aagatgaaat 46680 agacataaaa tcacaagcca aataaaaata tttcattaaa atgtgtaaac aaaaattatt 46740 agtaataaaa ggtaaacttt aaaattagta tagaaatcat ttaaataata atatgcaaca 46800 gttttattta taagtataaa ctgaaatggt gctactacta gttagaaata aactaatcct 46860 aatactaaat acaaaatgtt aaaattgatc acaaatgaga taaaaaatat caaaaattga 46920 tcttatctag ataattcatc aacagtataa aaataattgc agaaatgtta tgtaaagaat 46980 tgcatagcaa atatttacaa agctcacatg atatgaccat aatagataaa ccaccagaga 47040 aaaccttatt gattttatgc ataacaagaa tgccttctat catattataa cctcatcatt 47100 gttctgaaac ttctaaccaa tgcaaaaaaa tgggaaatat aaataatctt tgaaagtcgg 47160 aaagaaaatt atttgccatt gatatgataa tctccactaa aaatacaaaa gacttaatga 47220 aatgacaatt aagattagtg aaacaattta tatcttggct ggcttcaaag tacatatatg 47280 aaagtaagtt atttttatat aaaccaacat tacccagtta gagaaataca atggtgtaaa 47340 tgaaatatgt catttaaaat agaaatttta aaatataaaa cacttaggaa taaaaaatgt 47400 gaagaaaact gtaaagctac ccagaaccac taaagagagc atcatggcat atcctagtca 47460 agtttaagat ttgtttctcc catgtcccag catttccata cctagaatat gtactagaga 47520 aaaaaagtac ggtaccctat agcattgttt ctgatagctt caaactggaa accacccaac 47580 tgtctatcaa atacatgaga tcaataaatc gcagcatagt cacaccatgg agtactatat 47640 aggaataaaa atgaaaaacc tgcagctctt tgcaatcaca agaacgaata ttgcaatcat 47700 aaaccaaaga gtcaagacaa aagaaacaca tagcataaaa ctactctata aagctggaaa 47760 acaggcagca ctctttttgg atgcatgtat aagtggtaac agtaaatatt aaataagtag 47820 aaatcaggtt agaggtaatt tctagaagag acagaataga gttttacatg gggcacagga 47880 agggctttct ggtgttgata aaggtttttt ttttttttaa tgatgttggt aataattata 47940 tgggctttta ctctatgatt actaagtaat gtgtatgtat atatattgtg cactttttat 48000 gttgtatatt ttgtgtcagg cagatcgtct gcatagtcct aaactcttga tttcttccac 48060 ttcttgacac aatcctttgg gaccctttca gctcttcatt ctgtaggctc aagttctgcc 48120 ctgcctccat ccccagacca agtcccaacc tgagggagag ctgggtctca atcttccctt 48180 tactaggatg ggaaatgcca acattctttt tggttaccca ttcctggagg atggttccag 48240 ctggcagggg ccatagaaga ttgatgcaca gctgtatttt cctgtcattt tgggcacagg 48300 ggtgaggatg gaactttgcc cctttgacag ttttagctcc agtcaactgc tgttaacttt 48360 gacctcagga cacccttcac cctacatcca tgaacatgtt gcaacatcag gcaactacaa 48420 ggtaagtaga ggtatgcagg gccttgtgga ttcagtttct tctcccacgt ggatgaacag 48480 cagcagcgga agagatagat agcacctctt ttccagctgg atagtgtgct gaaacacttc 48540 ctcagcctcc tagcagtgcc aaagacatgt agggtggcct tagccagaaa ggtgaggcca 48600 tcccagcctc cagcatgggg ttgcggaagt agatataggt gacccactag agctgtgaac 48660 tcctttaact ctagcgttga agtgccatat tcaatgagca cagttctgga aaggtctcca 48720 gggaccccat atcacatcat gaactaaccc aaacctctaa atcccctaaa tctttcaaag 48780 ctgagagaga gagagagaga gtaattcacc tttagggatt gatatagact gggctatgat 48840 attttgagcc cactcactgg gaaccatgga tagggtgatt atataattga ctatccaacc 48900 aaagacactt tttgagagag aaagggcaat ttaaataatt atcttgggac agcagttgac 48960 aactaggact atcctaggca aaccaggtta cataattacc ctagccatgg accatacttt 49020 gagaagcact ttccaaaggc ctctgccatg tgcagctgct catagccaag ctcatgctac 49080 acaggtggaa aagcttctgg aaaattgggg tgcttcccta gaagactcag aatgttaaca 49140 aggaataggg aagaaagaga actactgaag agcttggcac aggagggctg gcccagaacc 49200 tgtgtcacag cactgccctg ggccattcac accaaagctc attccagaga ctgaaagtat 49260 ttgatggcct tctgtcatac cttacctgcc aggccacctg cttgatgggc tctttcctga 49320 acctagacac ccccagggca ccatcgtcct ccctgataga atattatatt agaacaattt 49380 gaggaacata gacacattat ccccaaccct gtccctcaac tgtttcatct gtcagcacca 49440 tggtgtcagt gagaccttct gatggagact tccaagccac ctggctgctt aggttagtct 49500 gcaagttgtt ccagtgtttt ttaagagagg tcctccaaat tcaaatcact tgtttatgtc 49560 ccactgctgg cacaccacct gaatgggaag tgtcagtcta cgacatcaaa ggcctctcct 49620 gctgtgtctg ctactgacag cactgttgtc catctatctc aaatgggaga attctcttac 49680 aaaaactcac tccctccact cagtacggtc ctttgcataa caattagttt ttattcttga 49740 tgctttatca cccatttcaa gactgctaga gaaatgagtt atgcaggata tgacccctct 49800 agtcatcaaa gaaccagaga aaaagtgtgt ggcttgaagc tgagcaaaga tgctgcctcc 49860 aagtgggaag tgacatatgt atgctggaca cgatatatct gcagagctct ccaaccctgt 49920 catcctccca ctctagttgt acagccctca tcctcccccc acatcaccac aatgcctatc 49980 ctcatttcca cagttctgca gttccaaggc cctgacctcc acctaggatc tcagaaactg 50040 atctgtaaat ccaggatgga gagcctaaat atcagattga taaagtgtag gactcatgaa 50100 gatgctcata aaaaatttct tagaaggcca ggtgcggtgg ctcacaccta taatcccagc 50160 actttgggag gctgaggcag gtggatcact aggtcaggag attgagacca tcctggctaa 50220 cacggtgaaa ccctgtgtct actaaaaaat acaaaaaaaa attcgccggg cgtggtggtg 50280 ggtgcctgta gtcccagcta cttgggaggc tgaggcagga gaatggcatg aacctgggag 50340 gcagagcttg cagtgagcta aggtcatgcc actgcactcc agcctgggtg acagagtgag 50400 actctgtcac aaaaaaaaaa aaaatatttc ttagaaggac tgtcagattc atagcattct 50460 cgcttttttc ttttttacta attaatcatt tatcttaatc tgtttcatgc tgctatgaca 50520 gaatacccaa gactgagtaa tttataaaga aaagtaattt atttctacag tgccagggtc 50580 tgggaaggtg ctggtatctg gtgagggctt tcttgctgca tcattccatg gcagaaagtg 50640 agagggtgag agagggacaa gggaggggaa ctgaactcat tcctttatca gtaacccact 50700 cctgcaataa ctaatccact cccacaataa caacattaat ctattcatga gggcacagcc 50760 ttcatgacct agtcacttct taaaggttct accttaactc cattgctttg gggattaaat 50820 ttcaacatat aaacccttgg aggacacatt caaaccacag aaacattctt cagtagaact 50880 ttaatattac tgtcttataa aattctgtca aatgaacaaa agataaccca taattacacc 50940 ctaatatgac tgcttttaac attttactgt atttcagcct ttttgctatg tatataattt 51000 tacagagttg taatcatacc cagtatatga ttttatcatg ttttcccact taccattata 51060 ggtattttta atattgctac atagtcttca tggttgtcat tgttaatagc tatgctgtaa 51120 tagttcactg aattgaagtg ctttatttac ttagctaccc tattatcttt aaacaatttc 51180 taatttcttt ttataataaa catggacata tttctgacag gggtgttctt tttcacatct 51240 tgacctactt ttcacatagt gttacaatta cctgaccaaa gaatacaaac tttttgtctc 51300 ttgacgtata tttccaaaag atttttaaaa ggtgcattaa tttactctgc agctggtgta 51360 aatgaagacc attttgtcat tgttttcttg agagtagagc ttccaaaagt agggatatgt 51420 ggctaggagg aagaaatcca gcctggggca ggcattctgt aaagaactcc agttctcact 51480 ggtacactgg ttttattttt ctctgtttct tgcagactga gcaattgata actctgtggg 51540 tcctctttgt ttttaccatt gttggaaact ccgttgtgct tttttccaca tggaggagaa 51600 agaagaagtc aagaatgacc ttctttgtga ctcagctggc catcacaggt aagtaactat 51660 gcaagtgaga ggcaggaagc tatatgtgaa gtccctatgg cttcctgctt ttaatgaatt 51720 ttatcaaaaa aaaaaaaatg taacgcatcg gtcaatttgg gaataatttc tgaaagaata 51780 taaaacctat atttgaatat ttcctctggc atacttaaca catatgaatg cctctaagat 51840 ttcattataa aagtaactca ctacactaat ggaaatatca ttatcagtat caccaaatgg 51900 ttctataggg tttccctgtt tttatacaca gtagcctcca tagttcacta aggtgatatt 51960 accatatcat cctgcattat aagcttaagg aatacatccc agaaaatgta ccagcactat 52020 ctctattaaa ttattaatgt taagtcttga gtactttgca gattaaagcc tgtggacatt 52080 gcttttgaaa tgcaaatgat gtgtaacacc actactgggg gtagtataat gaagtaatat 52140 aatctcaagg atcgggatgc ttaagtgtag actttggaaa tgaccattca gtagaagagt 52200 gagcacagca cacctagtag aggaatggtg aaatattctc aaggaagaaa atgatctgtg 52260 aaagttaggg ccccaaagac atgagtagag ctcatgttca aaaggaaaag aaaaacacaa 52320 ccagggaaag agtcctgttc tacaggccag aaagaaagtg agaaaatgag attcacagaa 52380 ggtccagcat aagccacact tggagtccta agctctggga gcaagatggc tgttatatta 52440 gcttaatttg gatcagacta tagaaaaaaa aatgcaaaag gaaaaattta aatattaaat 52500 gcttacaagg agtgacggca aatgactttc agaaagggct atttggtaca tttcaacctg 52560 tactgttatc tcagctgtag taatggtagt ggagctcttt agaatttagt cttgagccat 52620 aatatttcaa aaatttatga cactgtaact tacaagagaa tcttagccat acattgttag 52680 taacctgaaa ttcccctttt tctttctaac aaagtataac aagcccacct gcttgagctg 52740 ggctgcagtg gccagggtaa acatccaagg caccagtgaa aaatacagag aaggtaaaag 52800 gagcaagagt tctgaagatg gaacctggga tgggggaaag tttcttcaat ctttcctacc 52860 aacaagaact ccaatttttc actcctataa ccgtagaagt agaggtaatt aggatcatcc 52920 agcaaatgct tagaggcaaa tatccctgga tgaggatgcc acagcttatt ttcattatat 52980 ttcttcgatt acagtgtggt aatgcatgtt gtatggaact acatattctt tcagaatgaa 53040 aggatttaga ggtggcaaga atatcagctt gaaatttaaa gttttttcat aaacaataaa 53100 caaatgataa ttgaaaattc actacatatt atcaaagaca aaagttgtat gttctaattc 53160 atcatcgttg tattaatctg ggcttaattt catgtacatc tcctggacag tgtttttatt 53220 tgttaattgt ttctagaaaa actctagggg tcaggtcaga agcattttaa atgaagaatt 53280 cctgaaatga aaaacattgc caaaggtcta agactgaagc tcaatggtct gagattgaat 53340 ttatatatta ttgaaatttc cttcatacac attttagcat gatcacagat cctttggtaa 53400 aggaggtgag aatacatacc tgagtcttga gtatgcatat agaagttacc caggcatcaa 53460 ctgaggggcc ctgtgctttg agacatatat aaaaatgtgg tttgagtccc ccatcatatg 53520 tcaatgtcct ccttaagatt tcttcaaatt ctgtggaatt tatattttta cttctctttt 53580 gcttcttgct tcctccttcc actaaattct tgctctctct caccagtatc tcatctttct 53640 gagctcctct ttttttgcgg ttgtttcatg ctgtccctaa cgaggcactc aaagcaccct 53700 cctttccttt attttcttta aaatcatcca caaaagtatg actttctttg tttaaaggac 53760 ttttctgaat atttcaggta atataatgat attgtatcac agaaaagtaa atatcttaag 53820 agcaaatatt tcattttctc agaacattca gctgacatca gaaatgtttc attttgatca 53880 tgccactgca ctccagcctg ggcgacagag tgagactccg tctcaaaaaa aaaaaaaaaa 53940 aaaaagaaat gtctcagttt taccttgctt cagcctcact attctgctct ctcttctaaa 54000 tgtctagtat cttgtgccaa aaaattttaa tactttcctc tgtttttgtt ttgctttgtt 54060 cttaccacta ccaaaccgtg atctcagaga ccccacaact tccaaaaaac aagtatcagg 54120 cttttttttt ttttaacaaa ggaagttgct ccctaaaaaa gaaccctgga actagttaca 54180 atgataaaca gacaaagaaa aatacacatt catatttata gttacatatg tcatggctaa 54240 aaataaatta ttctaaattg tataaaacca taagatatac agtgataact caatagtatg 54300 ttgtattagt ctgttctcac actgctatga agaaattctc gagactgggt aatttataaa 54360 ggaaagaggt ttagttgact cagagttctg cattgctagg gagacctgag gaaacttatt 54420 aatacaatca tggcagaagg caaaggagaa gcaggtacct tcttcacaag gcagcaaggt 54480 ggagtgaggg caagcagggg gaatgccaga tgcttataaa acatcagatc ttgtgagact 54540 cactcattat cacaacaaca gcatagggaa accgccctca tgatccaatt acctccacct 54600 ggtcctgccc ttgacacatg ggggttatta caattcaagg tgagttttgg gtggggacat 54660 agagtcaaac catatcatat attatgtgct gtgcttgcaa aaattttgaa gtggttttag 54720 gccaatacgc ctacctacaa taattagaaa agctggacaa aatttaaaca tttgttagaa 54780 ggtatcacat agctgccaaa gacaattaag acttgagggg ccaagatttc atagagcaga 54840 aaattttatg agataaatac attatttgac accactatcc ccttaaagta ttagctgatt 54900 taaaagcaga aactggaagg ctgaaaacct gagtagagct ttgggcagtt tcactggact 54960 gatggggcaa aaattaattt gccaaagcat actggctttg ataaacattc cagggtttcc 55020 attggtactg ctgaaaagat acaacctaca agtaagagtg aactaaaaat ggatcagccc 55080 tcaccaaaaa attaaataca acccaaaacc tgaatgaaat cagatgatct acctctgcat 55140 gcacacaaac catctgccag tgcaaaaata aatcttcttt ggaggaagaa ggcattatcc 55200 catcatcaaa ttaactataa ttttccatgc acaacgttca gcacttgatt aaaaaataac 55260 caggaaggca acaatacaat aattgatgaa aaacgaggag aaaaatagat aacgaagagt 55320 tgcacaagag atccatctat tggcattatc aagatacaga atttataact gttgctcatc 55380 tgtttagaag ctacaaaata agattgaagg ttgaatgtcc tatctccagg cttttggtgc 55440 acctgccccc ttaacagtgg agcttgagca cacaaagaac tccctttcca cacaaagaac 55500 ttggtgtagt ggcagttcct ccactccaca cctggatgta attccagcca tttaacacac 55560 ctgccccaat ggactaggag tttgagccac ctcttcctcc catgcaaaga ccttgtggct 55620 gcagtttctc tgctctttcc ccagacatat cacccaactc gaggtgcacc tgctcctcca 55680 gatcaggagc ttgagctact cctacattcc ccaggaaaac tttgtggcag tagtggtctc 55740 tctccacctt gctggggcat atttccaggc atttgacaca cctgattgtc taaattagaa 55800 gcatgacctg cccctccgtg cagagatctt ggtagagcaa agctctctgc actcgatgcc 55860 cagacatatt tccaggcatt tgaagcacca actcttctag attaggaatt taagcttccc 55920 ccacttcctg tgcagagaac ttgggacagt ggaggtttcc agactctatg cctaggcaca 55980 tctccaggca cttggcagct gcccaccaga ccctgcctca gagctaatgc ttctgcctgc 56040 cattgggaga actgtaggag agcttgctta gtctagccca cccatcttgg cccccactcc 56100 agaactaagc agggagctca gaccactgtg catttcacag atcagcccat tgcccaagtc 56160 agcagaactt ctcccagtaa acaagaatca agtatatatc catttgagtc agctgcagct 56220 gaactttatc cataagcttc acctactggc ctggaggttg aactgcacaa tacaataaga 56280 aatctggggc caggcacagt ggctcacgcc tgtaatccca gcactttggg aggccaaggc 56340 gggcagatca caaggtcagg agatcgagac catcctggct aatacggtga tacccggttt 56400 ctactaaaaa tgcaaaaaat tagctgggtg tggtggtgga cgcctgtagt cacagctact 56460 cgggaggctg aggcaggaga atggcatgac cccaggaggt ggagcttgca gtgagccgag 56520 attgtgccac tgcactccag cctggatgac agagccagac tctgtctcaa aaaaaaaaaa 56580 aaaaaaaaaa aaaaaaaaga aaagaaaaga aagaaagaaa tctaggcagg gcatggtggt 56640 ttatgcctgt agtcccagca ctttgggatg ctaaggccgg caaatcactt gagcttagga 56700 attcgtaacc aacctgggca acatagtgag acccccatct ctgcaaaaaa tttttaaaat 56760 tagccaggca tggtgatgca cacctgtagt cccagttgcc agggaggctg aggtgggaga 56820 attattggtg cccagaaggt caaggcagca gtgagccaag atcatgccac tgcactccca 56880 tctgggtaac aaagtgggac cctgtctcta aaaaaaatta aaaaaaaaaa aaggaaaaga 56940 aaagaaatct gatgacataa ctgcacagca ctggaaaatg taataagcct cctgagacct 57000 ctgccaccca gccttatagg aggcagtgag cctcctcaca tacccagtac acggctacta 57060 caaccagcat ttgggaaagc caccatacaa agactaccca ttaccaagaa acgcttatac 57120 agactcgttg ccactgaaag cacccagaac caaatccaaa ggaccttaca caacataaac 57180 tatagacatc tcctcagatg aggaaaaaag tcacatccaa ataaaagcaa atttaaaaaa 57240 aaataagaag agatagctta tctggatgag aaggaaccag agaaataact cggaatgtat 57300 gaataaaata gagtgctaca acacccccaa aggatcacac taactctcca gtaatggatt 57360 ctaaccaaga tgaaatattt gaaatatcag gtaaagagct caaaatattg atttttaaaa 57420 agctcaatga gatccaagaa aaaattgaaa accaacacaa agaaaacaat tcaggacatg 57480 caagaagaga tagataccac taaaataaaa gaaacggaca tttaaaaatt attgaaggaa 57540 aaacaaaata aaagtgaaag cttcaacaat aggctagacc aagtggaaga aagactttca 57600 gaactagaag acatcttttg aattaaacca gtaagaaaaa tatacagaaa aatgaatttt 57660 aagaaatgcc tagtgccttt gataaatacg ggattatgta aagcacccaa acctacaatt 57720 tataggtatt tcaaagggtg aagaagaaaa agtatggaaa acctatttga ggaaataatt 57780 cagaaaagct tctttggttt tgggagagat ttagaaaccc agatacaaga aactcaaaaa 57840 actcctagaa gacacatcgt gagaagaaca tcaccaagac gtatagtcat cagactatcc 57900 aaagtcaaca tgaaggaaaa aatcctaaga gtgcccagag agaagtgtct aatcacctat 57960 aaaggaaatt tcataagact aatagtggac ttctcagcag aaaccctaca tgccagaaga 58020 gatcaggggc ctatttttag cctccttaaa gaacaaatgt gccagccaag attttcacat 58080 cctgccatgc taagctttat aaatgaagaa gaaatcaagt cttaaccaga caaataaatg 58140 ctaagggaat ttgtcaatac tagaccagac ttacaagata tgctcaaagg agttctaaac 58200 atggaaacaa aagaacaata ctcatcatca taaaaggaca cacagataca aagctcacag 58260 atcctgtaaa ccaacaacac aattgaaact ccaagtaaca acactgtgac aggaacacaa 58320 cctcacatat taatattaat cttgaatgca aatggcctaa atattccact taaaatatag 58380 agtggaaaat tggattaaaa agagactcaa ctatctgcta cctacaagat atccacttac 58440 tgactaaaga cagctataga ctcaaagtaa aggggtggga aaatatatat catgcaaatg 58500 ggaaaaaaag caagcaggag tagccattct tatattagat aaaacagaca tcaaaccacc 58560 aacaataaaa aaacaagaca aagaatggca tcatataatg ataaaaggtt caaacgacaa 58620 gaagattgaa ctattgtaaa gtatacacga ccaacactgg agagcccaga tttacaaaaa 58680 ttacgactac atataagaac aaagatgaat agaaaaaaaa tagtggtctt caatactcca 58740 ctgacatcag tagacagatc atcaaggcag gaaatcaaca aaaaatctct ggacttattc 58800 tgggtacagt aactgactct tgtaatccca gcactttgag gggctgaggt ggtaggattg 58860 tttgaggcca gttgttcaag accagcttgg gcaatatact gagacccaat tccacaaaat 58920 aaataaatga ataaataaat aaaaattaat taagcatagt agcacatgcc tgtagtctaa 58980 gcaacttgca aggctgagct ggaaggattg tgtgagtgca ggagtttgag gttacagtaa 59040 gcaccactgc aatccagcct gggcaaaaga gtgagaccct gtctcctaaa aaaacaaaac 59100 aaaacgaaac aaaataaaaa gaaagaaaga aactctggac ttaaactata tatagaccaa 59160 atggacctaa tagacattta tagaacattt catttaataa ctgtaaaata tacattcttc 59220 tcatctgtac atggaacatt ctcccaaatt gactttattc ttagccataa agcaattctc 59280 aataaattaa aaaaaactga aatcatatca agtgttttct taaaccacag tggaataaaa 59340 ttataaatca aaccaacggg caccttcaaa aatacacaag aacatgaaaa ctaagcaatt 59400 tgctcctgaa tggccttttg gtaaacaata aaattaagac aaaaataaaa aacatttcaa 59460 aatgaatgaa agtagagata caacatacca aaacctctgg gatatagtga aaacagttct 59520 aagagaaaag tttatagaat tcaatgctta cactaaaaga tagaaagatt tcaaattaac 59580 aacctaacat tacacctcta aggaacaagg aaagcgagaa caagccaaat ccaaagtaag 59640 cagaaaaaaa agaaatataa taacaaagat cagagcacaa tgacatgaga ttgagattta 59700 aaaaaagata caaaaagtca acaaaacaaa atgttggatc tttgaaaaga taaatgaaat 59760 tggcagcctt ctagctagat gaaacaagaa acaggagaga tgattcaatt aagtacaatc 59820 agaaatgata aagatgattg acatagtttg gatgtgtgtc ctagaccaaa tcgcatgttg 59880 aaatacaatc cccccgtgtt ggaggtaggg cctggtggaa agtgattata tcatggaggc 59940 agatttctca ttaatggttt aggaccatcc cccttgggca ccagcctact gccctcatga 60000 tagtgaatga gcttttgtga gatctggtgt tgcacccccc tgctctctct ctcttgattc 60060 ttctctggcc atgtgatgtg cctgctccct cttcgctttg ccttccatta tgattgtaag 60120 cttcctgagc ccctccaaga agccaagcag atgccagcat catacttcct gcacagcctg 60180 cagaactatg agccaattaa acctcttttc tttataaatt acccagtctc agttacttct 60240 ttatagcctt gtgagaatgg actaatgcag tgaaattaca actgatacta tagaaataaa 60300 aaaaaatcat cagagatgac tatgaacacc tctgtgcaca caaactagaa aacctggagg 60360 aaatggataa atcccagaaa catacaaccc cctaagattg aaccaggaaa gagtagaaat 60420 cctgaataga ccaatagcaa gtaataaaat cacatcagta ataaaaaatc ttccaacaaa 60480 aaaaatctca agaccagaca gattcacagc tgaattttat cagatgtaca aagaaaagct 60540 ggtaccaatc ttactgaatc tattccaaaa catgaatgtg aagcaattcc taactgttcc 60600 tataaaacca gtatcaccct gataccaaaa tcatacaagg acacaacaac aacaatacaa 60660 aaaaacccac tacaggccaa taaccctgat ggacatagtt gcaaaatttc tcatcaagat 60720 accagcaaac caaatccaac agcatgttaa aaagataata catcacaatc aagtgagttt 60780 tattccatgg atgcaaggat gattcaacat atgcaaatca ataaaatcaa tagacatgat 60840 tcaccacatt aacaaaacta aaaacaaaaa ccatatgatc atctcaatac aataaggcgt 60900 caataaaatc caacatcttt tgataataaa aaccctcaac aaattaggca tctaaggaac 60960 atacctcaaa ataagagcca tctattacaa acctacagcc aacattatac tgaatgagga 61020 aaaattgaaa gcattatccc taaaaactgg aacacaatga ggatgtccac attcaccact 61080 cctattcaac atagcactga aagtcctagc tagagcaatc aggcaagaaa aagaaatgaa 61140 aggaatccac actagaaaaa aaagtcaaat taccaaatta tctctgttca gtaatgacat 61200 gactgtatac ttagaaaaca ctctacagac tccaaaagac tcctagactt aacaaacaac 61260 ttcaataaat tttcaggata caaaatcaac atataaaaat cagtagcatg tctatacacc 61320 agtagtcttc aggctgagaa ccaaatcaag aacttgatct taacaatagc cacaaaaaat 61380 aaaataaaat aaaataataa aacacctagg aatactttta accaaggaga tgaaatatct 61440 ctacaaggac aactacaaaa agtgatgaaa gaaattgtag ataacacaca tgactggaaa 61500 aacatcccat gctcatggat tggaaaattt aatatcatta aaatgaccat acttcccaaa 61560 gcaatctaca gattcaacac aatccctatc atattacaaa tgccattttt cagagaatta 61620 gtaaaacaag attaaagttt atatagaatt ttaaaagacc ctgaatagcc aaagtaattc 61680 ttttcttttt ttgaaatgga gtctcgctct gtcaccaggc tggagtgcat tggcacgatc 61740 ttggctcact gcaacctaca cctcctgggt tcaagagatt ctcctgcctc agcctcctga 61800 gtagctggga ctacaggtgc gcatcaccat gcccagctaa tttttgtatt tttagtagag 61860 acggggtttc accatgttgg ccaggatggt cttgatctct tgaccttgtg atctgccagc 61920 ctcagcctct caaagtgctg ggattacagg tgtgaaccac cgtgcctagc atagccaaag 61980 taattctaag caaaagaaaa aatccagagg caccacattg cctgacttta tacaacaagg 62040 ctgtagtaac taaaacagca tgatactggt acaaaaatag acacacagat caatgaaaca 62100 gaatagagaa agcagttaaa atgccacata cctgcaacca acccatcttt aacaaagctg 62160 acaaaaataa acaatatgga aaggacacct tattcaataa atggtgctgg gaaaattggc 62220 tagccatatg cagaagaatg aaaccctacc tatgacaata tacaaacatt aactcaagat 62280 agatcaaaga cttaaatgta agatctgaaa ctaaaaatct tagggaaaaa aacctgggaa 62340 aactctactg gacattagac taggcaaaga atttatgaca aagaccccca aaacaaatgg 62400 aacagaaaca aaaataggca agtggaactt atttaaatta aaaagcttct gtacaacaaa 62460 agaaataatc aacaaataga cagcctattt ggagaggaag tatttgcaga ttatttctcc 62520 aacaaatgac taatatccaa aatatacaag gaactaagac aaatcaacaa gaaagaacaa 62580 acaaccccat taaaaactgg gcaaaagaca tgaacagaca tttctcaaaa ttagaaatac 62640 tagcagccaa caaacacatg aaaaaaggct caatatcact aatcatcaga gaaattaaaa 62700 gtaataccac aatgagatat catcttacac cagtcagaat ggctattatt aaaaaatcaa 62760 aaaacaatag atgctggcaa ggctgtgaag aaaagggtag acttacacac ttttgaggga 62820 atgtaaatta gttcaaccac tatagaaaac agtatagaga tttctcagaa gacttgaaac 62880 agatcttcca tttcaccaag caatctcact actgagtatc tacccaaagg aaatgaaatc 62940 actatataaa aaagacattt gccctcatat gttcattgca gcactattca cactagcaaa 63000 gtcaggcaat gaagctcagt ctccagcaat ggttgatttg ataaaaaaaa aaaaaaaaaa 63060 aactgcggta tatatacacc atagaatact atgcagctat aaaaaagaat gaaatcatgt 63120 cctttacaga aacatagata aagctagaag ccattatact aagtaaaata actcagaagc 63180 aaataaaata acatatgttc tccttcataa gggggagcta aatatccatc catagataaa 63240 aagatggaaa taatagacac tagggactcc aaaagagaga aaggtgggag gtgaataaga 63300 gttgaaaagt tacctattgg ttacagtgtt cactatttag gtaatgggta cactggaatc 63360 acaatctcca ctagttacaa tatgttacaa tacacctgtg tattacaata tgcctgtgta 63420 aaaaactgca cacatatgcc tggaatctaa aattttaaaa taatgaagat tgaatgtcct 63480 agaaaggaat aaaacaaaac atttaggaac tgacaattac aactgaagct tacaatacaa 63540 tagttaaact tagcggcaaa ttaaatgtag ctaaagaaga aatcattgaa ctggaatata 63600 ggtccaaaga aaataattag attgaagcat gaaaaaagaa aggacaaaaa atacaaaaag 63660 aaaataaaaa gcatatggaa gtagtgaaaa ggactcccag aaaaagataa agcccagact 63720 ggatagaaac aacacttata gtggccaata attttcccaa actctttaaa gacatcaaaa 63780 cacaaataca taaagcacca taaaggacaa cagcaagcaa acaaacaaat ataaagagaa 63840 ttaaaacaca tgaaatgata agactaagta aaagccccat aatcttgaat ttgaaatgaa 63900 aatatttatg ctagctcatg atgtatttta tgcttcagga gtttttaagg atacatacca 63960 aaatgtttat aggtaaactg ataacatgtc tgggatttac ttcaaaataa tttgaggctg 64020 ggggtgggtt gagatgtata gatgtacaaa attgatattg ataactgttg gaggttggtg 64080 gtgagtacat tggattcttt atttttttta tactattctc tctactttta tgtaagttta 64140 agattttttt cataataaaa ttcaaaacaa aattatgcat gattataatg aaacaaaata 64200 aagagatctg ggtagttaaa gatgttaaag tccttggatt gcctggatgt agtaaaagta 64260 ctaatttcta ttagatttta atgtcaagga ggtgtgttaa aatctctaaa gtaatcctcc 64320 caaattatga aaactgacat tactagcaag ctaaagaagg tataaaatgc agtatttgaa 64380 tatgcaaata tatatgttta tatatagagt tattccccag tatccatgga ggattagttc 64440 cagaatcccc tgccaataca aaaattcgag gatgcttaag tcccttacat aaaatagata 64500 gtatttgcat ataacctaca tacaccctcc tgtatacttt aagtcatctc taaattactt 64560 ataatttcta atgcaatgta aattctatat aaaaattttt atactatatt cttaaaattt 64620 gtatcatttt attattgtat tgttatttta tactttctta atatttttaa tctgcagttg 64680 atagaatcca tggatgtgga acccacagat aaaaagggcc aattataata catacatatt 64740 atataaaatc aatctaagtt aagacaggag agaaaaaata ttagaattat tagaacaagt 64800 aagaagaata ggccagtaca cttaacctca aatgtatcag taattgcatt aattgtaaat 64860 ggactaaata ttcccattaa aataacaaga ttgtcagagt agatttttaa attacctatt 64920 ttaatttgtt tataaaaggt gtacaccata aataaaatga tgcaggttaa aattaaaagg 64980 aaaaggatgg taaagtaaaa tgataaaaaa taatgaaaca aaacaaaaca caaagtaaaa 65040 gtaagccaat gcagctacat atgtgtatca aaagtttata aatttgctgt gattcttgga 65100 atcacttgta gctttatctg tgtcttagaa tttgctttga aaggaataca aagacaggag 65160 ggcttctaaa gctagtaatg ttctatttct tgatcttgct tgtagttacg tgggcgtgtt 65220 cctcttgtaa taattcacca aattatatac ttatgatttt gtatactttt ctttatgtgt 65280 tttatttcaa tacaaagttt atttacaaaa tatatcacat taatccaggg caggggttgc 65340 aatctcaaat ggctttagga atcaagcagg caatgaatgt aaacatgtaa aagagccaag 65400 gggaagagac agaatgaaaa cagagataaa aaccagagaa tgaatgccct gcctaaagac 65460 attaaaatca atttttgtca aacactgtgc tgatcaaaca aatcacacat gcaggccaga 65520 tttgacccaa gggtgacttt cttacaacaa ctgatatata aaatttaaac atcagaattt 65580 gaaaagtgtg ccactataaa attctagccc acctctgaag tatgaaccca ccttcaattt 65640 gtgaggtaga atattaatct ttactggtgg attgtgagaa gtgaggccaa gaagttgggg 65700 aggttaacat ttacaatggt ttagacaaat catatgtttg acaaggttta aaatcccttc 65760 tgttcaaaga atatcttata ttaggatttt cttctcctaa tgtgtttatt attgttttta 65820 ttagtataat ttttaaagaa atctgaacta ttgcacgcct cagagaccat aacagtgaga 65880 acaaaaatat aaaggaaaat tttcaaatga tggaaagtgt aacccatata acccgaaatc 65940 ttcatgattt tcagatgacc atctgattaa ggagaaaagt caagataagc acatattcat 66000 atctgcttat ttctagaatt gttctatcag aagaccatga attggtcata tgaggggaag 66060 aaacactgac atgatactgg ctctattagg atgatattaa aagaggctgc tggctcaagc 66120 ttagcatgga tgagttgttc tcacataaag atgctgttat tgaccaggtg tggtggctca 66180 cgcctataat cccagcactt tgggaggctt tggtgagtag atcccctgtg tccaggagtt 66240 caagaccagc ctgagcaaca tagtgagacc ctgtctctac taaaaaattt tttaaattaa 66300 aagttaaaaa attaaatgat gttgctattg ttaatgcatt cctgcaatgc taacatgctt 66360 tcataaatat acttatgatt ttataggtgt tttcctctta gcctcaagaa gggagatgtt 66420 ttagtctagg gactgtcata acaaaataat ataaactgtg tggctcaaac aacagaaatt 66480 tatttcctcg cagtcctgta ggctgaaagt ttaacattag ggtgccagca tggtgtggct 66540 ctcttcctgg gttgcagatg tcaccgtctc actgcatcct catgtggcct ttgtgcaatg 66600 cctctgcaca aagagagaga aacagcaagt tatgtgccgt ctcttcttgt aggctcacta 66660 atcctatgga atcagggccc cacccttgtt aaccttaatt atttccacag aggtcatatg 66720 ttcaaataca gtcacattgg gagttagaga ttcaacatat aaattttagg ggaatacaaa 66780 ccttcagtct gtaacaggga acagaggtgc tagaagaaat gtagtagtag caaaaggtgg 66840 ggtggggaga taataggagc ttcatatgtc ttgctaagaa gttcaggctt tgcttttagc 66900 acagcccctc ttctgctagc tttgttcagg ccaccatcac ctttgatgca gattactaca 66960 aaagccaccc aaggtgtatg aaatgagaaa acacatactt aaattaaccc atggccaggt 67020 tttgctggta acttgggaac acagtaaggg aaggaaaata actttgttgt ggagagggca 67080 aaccaaggaa ggtcagaaag acatagagac agtggaagct caaggaaccg gaggttgtcc 67140 caaagtcata aggcggatgt aacgagagca ccagaacaac agagctggaa ggaaggaagg 67200 aaggaaggat atgtttagaa agcaagatgt tcccagatga atactgcaga ggtagtataa 67260 ctcagtgcaa cgattgtact gggtaggcaa ggtagggtgg cagggaaagt cactagcaaa 67320 catggccaca ataatggaaa ctaaactttg tgtttaccat gcaccaggct ctgtgctaca 67380 tgctttctgt agatcatctc atttaatcct cacacaggga tttaagcctg aagttttttt 67440 cagagaagac atacaaatcc caagtaagag catgaaaaga tgttcattag cattagtcat 67500 tagaggaaat gcaaatccaa agatcaggga gatacgactt cacaccttca agaatggcta 67560 ttcccctata aaataatata ctaaatcact ctttgaaaca taacattttc cacaaactca 67620 cctctttgaa ttcacatttt gctttgccag tgttttatgt tattcagaca tgagtttgaa 67680 tctcagcatt tctacttctg agccctatga cctatgaaaa gtgacaattt ctctgaatat 67740 caatttccca atccaaaaaa tgggaatacc tcttggagtt gtggtgagga ttaaataaga 67800 taatgaatat aaagtgccta gtatagtaag aggcatatta ttgttcaata aatgctagct 67860 gtgaatgcta ctgctatagt tatttcattc actgtagaaa tgattaattt aaactccttc 67920 aagtaactta ctaaagagtg aaagttctcc aaaaggcttg aatttcactg caaacctctt 67980 tccttgtttt gctcttttat tcaggacaat acactttgct caggtgtgtc tttgactctc 68040 aagcattgct ttaaagaatg accagacttt gtcatatacc attcttaaag gagttcagga 68100 catgccaccc caaaatatgc tgctttcata tattgattat tttgagctga tagcacttca 68160 acagcaaatg caagagagac tttttcggaa ctcagctgcc taaaaacaga tcctccaaaa 68220 gaaattcaat tgccatatat cctctccctg ggagttttat taatcagcaa agatacactt 68280 ttatcacaaa acaggaaact ggaagtcaac accacctaca gaaaaacttt ttcataaact 68340 gttatatctc ccattgattc ttctaaaaac ccattcatct ttccccagaa tcatttactc 68400 caccctaagt gacttacatc acccctcccc atcccctgtt aacacagtat gtaagctctc 68460 aaatctcttt taggagtatt cattattttc ctgtggcacc ccatgaacat aatattaaaa 68520 tgaatatgcc ttctctctta ttaatctgcc tgttgtcagt ttatttcata gacacagcta 68580 tcgaacctag gagagtacag ggaaattctt tcctccccta tatgcttaaa tcataagatt 68640 caactgacat cagcaatgaa acaaacattc agaaaactaa attcagagac attatatctg 68700 gcttttctga gggagaataa taagaactaa taggcattgt caggtaaggc aatacagatg 68760 tttttaatta aatgatgttt tttcaccatg acccacatct tgaaaacacc ttcctaatta 68820 aagaccagta gtcttgagtg attctttgaa gaacattttt acttccattt ggtcttttct 68880 ttattgagtt gatgaatctg ctggaattag attcagcgca cataacataa aatccaaata 68940 atgctggctt aagttcataa ggatttattt ttatcttatg taaagaagtc cggacgtagg 69000 taatccaggg ctcgtgctgc attttcttac cattgggaac ccaggctcct ctgtatttct 69060 actgtattaa aggactgtca ccctcaagtt cagctcatgg tacagatggc ggttggttca 69120 agatgactgc tagaacatct gtcatcatgc ccaaattcta gccagcagga aggaagaagg 69180 gaggaaggac agaggggctc atatcagctc tttgtcctcc tcttaattgg cattgccaga 69240 attcccaccc attagttttt ccttgcatct caatggtaac gtctaagtga aaaaaagcct 69300 gggaaatatt ttcatttatt attatttttt taacccaggc ccattggcca gaataaaacc 69360 agcttccttt tcctaaggaa gaaggagaaa tagaattaag gaacagtctc tggcatagct 69420 tgttctccat acttttactt ccatccagaa ctgagaagtt tagacaacaa atctcttttt 69480 gtccacccat tgcctgcttt gagaatgctt cttccagagt gctacgctct cttctaatga 69540 cttattatct tggcagactg cacttttcac accctccata ggctgcagtg atccattgga 69600 tgattgtccc attatgtaga taagttccta ttgctggctg tttatgcttt tctcccattt 69660 ttaggctatt agcaatcctg caataaacat tctcataatt aaatttgtat gagaattctg 69720 tattatttat ttagaaaaag tttatagaag tggacttact gcatcaaaga aaggcacttt 69780 tgtggctttt gaattggcta atgtcttttt tggttaccca agttaaaaga tgatggaaaa 69840 tgtcggggga caaatgctct agaacccgct agcatagacc tacactaagt cttattcaaa 69900 aaggtccctg taaacaaaac cctagttgac ttgcagtagc tacagaatca taactggttt 69960 tttgagagca gagattctct ccgttcctcc cttagtgata cttagccagc tactggtaat 70020 ttgcttatta tcaaaaggag cggccaggcg cggtggctca tgcctgtaat cccaccactt 70080 tgggaggcca aggcgggcgg atcacgaggt caggagatcg agaccatcct ggctaacacg 70140 gtgaaacccc gtctctacta aaaatacaaa aaatcagcca ggcgtggtgg cgggcgcgat 70200 ggcaggcgcc tgtagtccca gctactccag aggctgaggc gggagaatgg cgtgaacccg 70260 ggaagcggag ctcgcagtga gccgagatcg cgccactgcc ctccagcctg ggtgacagag 70320 caagactccg tctcaaaata aataaataaa taaataaata aataaataaa gcattttttt 70380 tttcacttta gccagcgcat cagagaagaa cccacacttg attgtcttat ttttccccct 70440 acaatgccca gagcagtatt cacacattca tgaaaagaaa acacatcact tagaacattc 70500 gaatagagca cgtgttttta ttttgctctt ctatgtttta cctccacttc tccacaattt 70560 tgatcccttc aaaaaaaaat cttaactaat tattctctat atattctatt aggaatcttg 70620 gctgtagact taatcttgag gttagaaaga aaatagatct tgaagccact attttggcac 70680 attctgtaat tcttagaatt tccattctaa caattttctg gatgaattta ataaccgttt 70740 atattttatg agctaaagtg ccaattaaaa ttattcattt accatcttta agacttactt 70800 gtctgtttta ttcaaatgca ataaaaatgc ggaactaata agagtaactc ccgatgagtg 70860 ttcaacaaag aaaagaaaga aaacatattt tttggcgcac attcaaatca tttccttttt 70920 ctggtagggc caaatcttct catattggga aaggaaatta gctttgcttc aaagcacttt 70980 ctgaagagca atttactaat gagcttagga attctctgcc ctcataaccc tcctatacat 71040 tacctgaacg cagagaaact tgagacgttc agcaagggag gtaaggccag gagtgttgag 71100 gcgtccaggt ccgtctgtgg agttcactgc caccttcctg tgtggatttc agtccttgtt 71160 ttcctggatt ttgagttgca ttctcaatac attattttta tttttattca tagtgaaaat 71220 attgaagact gaattttttc tgaattcata caatttatat gacatgttat tttttatttt 71280 ctaaatattt tactgttgaa gtagttcctc tttcacccaa aaaaactaat agtttttgct 71340 gtcttttttt aatttctacg tgaccatttc tttaatattt tgtaattcac atttaatttt 71400 attgccttgt agtcaaggaa tatttctgaa aggacttctg ctctttggaa cttattaaga 71460 gtgtctttga ggtttaatat gtaattatta tcttaaaaat atttaatgta tactaaaatg 71520 taagacacaa tttattgctg tggaattaaa caaagaccat ccaaatgaga acaagcaatg 71580 gctatttact cagagtttgg gagtcagccc acagtttctt gtgttgacag agactcaaaa 71640 ggctgagtgg aaaagctttg caagggggaa aaaaaggcag ggtctcagct atgccctgat 71700 tggaggctgc tggcctaggg aagttgacct gaagcacagc atcttatcgg attgcttaag 71760 ggtgcatatt tacctttctc ctattggtcc taagttagaa gcaagggaaa caattaaagg 71820 agctatcagt tatgaaccaa gttctgggtt tgttgggcta attgctatgg tggtattgtt 71880 tggcttcctg agctggttgc tgcaggttgt ggataagagt tctattttat gtatatggtc 71940 tggccattgt ctatatgttc agtctctcaa tgcattattt gtacttattc ttttgaattt 72000 gcctttacta attatggtct ctatattgtc tctttttata tacatatttt ttgcctgttt 72060 aacgtatgat agatgactaa aagtgctatt aaaaactttc acacttttgg ttggacgtgg 72120 tggctcatgc ttgtaatccc agcactttgg gaggctgagg cgggcagatc actggaggtc 72180 aggagttcaa gatcagcctg gtcaatatgg tgaaaccccg tctctattaa aaatataaaa 72240 atcagttggg catgatggtg cacgcccgta ataccagcta ctcaggaggc tgaggtggga 72300 ggatcgcttg aatccaggag gtggaggttg cagtgagcag ggatcacgcc actgcactcc 72360 tgcactccag cctgggcagc agaatgagac tccatatcaa aaaaaaaaaa aaaaaagaga 72420 gaaaagaaaa gcctttcaca ctttctctca tcttttagta tttttgatca atgtttgttt 72480 tatacatttc aatggtttat tatttggttc ctaaaggctc ctgattagca tatctttaat 72540 gtatgtttgt gtatgtatgt tgatctctct ctctctctct ctctctctca tacacacaca 72600 taagtctttt catttattag ctttgcttta aactttgcta atgtgatatt aatattatgt 72660 ttatctatct tctttttatt gcacttgttt gccaagcacc gaactaagca ttttaaataa 72720 tatcacattt ttgtaactgt tttggcattt atcttcttca ttgtgacttt acttgaaata 72780 attatcaatg tgtatttcta tatttgagtg tttcaatact tatcaagagt tttcttcccc 72840 attcttggtt cctgtgtttc gacacagctc tcaactttct gtagtacttt gggtagtatt 72900 ttttttttca agaagtcatt ggataagatt ataaacacct ggcatttctt tatgagcctt 72960 tttcttcact ccacaacaat aatgatttag atgggtatag aaatcttgaa ttcataactc 73020 aaatctccat agatgttgct ccatttaatt ctggtatttt gtgttaccaa aaaaaaatct 73080 aaagtcagtc caagatttct ttcttgatag gttatccaat tttgtctttt gtttctgatt 73140 tttttttttt tagatttcat gctttcacca ggttatgtct attttttggt cgtctgttat 73200 gtgagttctc tgagctgcca tatgctcttt tgatctgctg attaatgtga attcgtaggt 73260 tattttcttt atgtctttga atacagatta cttaccattt attttaatct tatcttcagg 73320 aactctaact gtctgtctat atgttagtaa ttttggcctt tctgtcatca tttaaatatc 73380 ttggtcctat tcttctacgt gggaagaata atttatactt tattaatcaa taatttgatt 73440 ttgattcaat gattagcagt gctaattcta ctttttattg tttctgaagt atcttaaagg 73500 ttgctttgtc tatgaaaagt tttaaaacat tcttcctttg tattatctgg tgccttttta 73560 tttctgtcag cttcttggtg tttcccttct cacaacctat ctaatgtctt attatctcgt 73620 ctttcacctt taattccata ctgtcaaagt gtccccaaaa tgtaaaaaga atgcaaaata 73680 tgcgctaaaa tttcagggtt tcttgagcta aagttttttt gaatatatat tctttttctg 73740 atatttttgt gctcttttta actcaatgct aggaaatctc tctctgtctc atatgtttca 73800 cccatctact gaaagttttt taattggcta acatctgaat aaatgcacat atcttttatt 73860 tggattattc ctacactagc tgcacaatgc catcattgtt tcctccacca agaagagctg 73920 ggtgggccat gttcattgag aaaatcagtt tctctcaaac aggagaaaaa atggcattgt 73980 cctatcgcta tgtgaataat tcaactaaaa agaataactg ttctcccagt aaagcttttt 74040 ctttcttaga aaaattgggt ttctttatat tccatgcctt tgcttcagag cacaatatgt 74100 gacctgggaa aggcatttac ccttgttaaa ccttcatttt ctcatttcta aaattacaag 74160 ggttatctcc atgatcttta ggaagccaga actgatctgg ttctaatggt cctttgattc 74220 taattagaaa tttccaactg caaaagttga gggggattct tacatcttca gaagccaact 74280 aattaaacaa cttttgctgt aatgagtgtc agtcaccttt atgaatcagc ttgtcactta 74340 ataatagaaa tagctggctt ctggcccatg cagaaggaat gtagaaaata gactatagta 74400 acaagctgac tcccattctc ctgttgttcc ctgcctcact cagtttccac agtcaactta 74460 ggacaattcc atactgtgat tatttactcc tgctttgctt tcgtaattca acaaacagta 74520 ttaaccactt actatggcga ggcatggttc caggtgctaa ggacccacag tggatttgat 74580 tacaaattac aggtaaaata ataaagcaat aaaaaggata attttgcttt catcatcgaa 74640 agctcagtga tagagtaagc tttagacttt atttgcctca gcaatgcagc agtggtagag 74700 ggcagaggag aagtctcatc ctaagccttg ctcccaaggc tggttatagg atgctgtatt 74760 agtttgctgg gactgccgta acaaatacca aagattgggc agcttaaaca acagaaattt 74820 actttctcac agttctagaa gctagaagtc ctctatcaaa gtgttggcta attttatttt 74880 gaggcctttc tcattggatt gtagatggct gtcttctccg tttttttcac atggcttttt 74940 ttctgtccat gtctgtatcc taatcttctc ttcttatgag gacaccacca gttatactgg 75000 attagggccc acccagaatt acctcatctt tttttcttca ttatctcttt aaagtcccta 75060 tctctaagca tgtcacattg tgaaggactg gaggttagga ctttaacata tgaatttagg 75120 ggagatgcaa ttcagcccat aacaaatgcc tgctagtaac tcatgggaac tctcttccac 75180 atgcaaagag ataaaatgtg atttctgcaa gttttattag aaatatagga aggaaccctt 75240 cccagcaggg cttgacaagc ctgtgcatgt gcctcactga cataactaag ttatagggtc 75300 atatttgaac taatccatgg aacaagacat gcaattacac tgatgagctt aggctgaagt 75360 caaatgtctc actcctgaaa attcagactt ccccaaaaca catgggctga acaggtaaga 75420 tggatacttc aactgaaagc cagggtactt aacaaaagca ggagaaatag atgctgggga 75480 ggtaatccca acgtccagtg caaatgctat gagggaaaac gacagagtcc caaacatgct 75540 ggagcttata gttagaggaa ggaaaaatta gatttttctc agggctttgg gattggggca 75600 cctggcagtc agcgcctaga ttccaaagca ggtcagaaga tgcctctgcc caagtattgg 75660 aaaccttttg aatatctttg agtattaaaa acattttaac actgcctgag aaaagtagta 75720 gttatgaagt tatacattta gcctatccca ttcaactcag gggattgtac acagatcaaa 75780 taaattgcaa ttgtgtttcc ctccctgata ttcacatagg aaggtgagtg gtgagcagta 75840 aacttcagga cctttaaagt tatcattgct ttcacccttg caccagcttt ttgaggtaaa 75900 tattcccatt ttctaggaga ggataatgag gctcagagag ggtaagtggc ctccccaggg 75960 tcttctagct gaattgtaac cagcttgatc ttccttttga attccaccat cttgcctgtg 76020 agggaaaaag gaataaggag ccaggagttg cagggtcatt cttctcctca agaggcttga 76080 gagtaactaa gtatctgttc aaaacacttt tgagaatttg gcggcctcat tacgtttctc 76140 aggagtccct gggggaggtt acacttttag gatccccagg aatagagtga caaaatacag 76200 ctaccacaac ttggtcctgt gcaactgtgc ccttgctcag caattactga ctccattctg 76260 actgaactct gccaaaaact cttaacatta ataattatta cctgttctca attttaataa 76320 ttaagagttt tacaacttcc agtgactctt aattcaggtt tctttggctt actgttcttg 76380 gacaataaca gtatggtcac tgttgcacag acagaagcta gacatagtct gtatagctaa 76440 ctccctcatg tccttcaaat ctttcttcaa atgtcagttt cttttggggc cttctgtgac 76500 caacctgatg aatagagccc accagcccca gaccacagcg ttcctgactt cctttactct 76560 gcttcacttt tccctttttc acagcaattg tcacattcta ttctactata acttacttat 76620 ttattgaatt taccactgat tgtttgccta acctcactat aagacaggga tctttgtttt 76680 attctccaag aacttagaac agtagttatt caattaatat ttgttgaagc aatgaatgaa 76740 ccaaatgaat gaatgaaaga tgaatataaa aatatttata tgtcctaaca ctctactaag 76800 cattatgaca gaatatccac caaaaaaaaa agatgagaag gagaaaccat tattcttctg 76860 tagcagggct aacagaacat gagcagatgg caaacgtgag attatcagca ccttctgggc 76920 tagttcctgg aaatcagctg atttcctgct gcttccaaaa attcttaaag ctttcagact 76980 cctgagcaag ctcctgcaaa acacctattt tggtgctgca agcacctgca gtagctctct 77040 agtcattcag gtacttgttg accttaggaa ctcaagccat agcttccacg attttcaatc 77100 cctgatccct cttcagtctc aaattgctgt atccaaaacc cttcctactt gcaatatatt 77160 agaaaggcca ccttctgacc aaatctgaaa agttgggtag gtttgtagag gatgagtttt 77220 tggattattc ccaattcttt tgatcctcac cccaacctcc taagactaaa gctacagtgg 77280 cctcccttta gggaagaaag cagaggaaag gagcagagga attattttct gtgaattaac 77340 tgtttctaga ttctaatatt agtgactaaa ctgccatttg tacttcctat attcctgttt 77400 tagcaagagc taaaagagtt tcaaagaagg taaattgtat tctaagaaga gaattcagaa 77460 agtcctttcc agaatagatg aatcttaaat gatgggcagg tttcccacag agataggtgg 77520 ggaagccatt ctaacctaga aaacaggatg cctagaagta tgcagtgttt tcagaaaatg 77580 gcagacacag gcttccttgg ctagagaaca aagacttcat acaggagtag gttcataaat 77640 acaagcacaa gagaccttta tagcattggg gtctagtgat tctcaattat tctgcctata 77700 agcatcaact gcaagaatag ttaaaattct attgaagaga agaaatgttt cctgctgtgc 77760 cagaaaccct taagaaaaag caaaggaatt tcacagagct gaagatcaag cacctgagaa 77820 acaagtttgc ctcaagagat gcttccaaag gcaagttgga agcttattga tgaaaaagtg 77880 aaacactatc acaaggagta caggcagatg ggacagaact gaaattcaaa tggctaggat 77940 ggcaagaaaa gctgaccact tctatgtacc tgcagaacgc aaattggcat ttgtcatcag 78000 gatcagagat atcaatgatg tgagcccaaa ggtccaaaag gtgttgtagc ttcttcgcct 78060 ttgtcagatc ttcaatggaa gctttgttaa gctcaacaag cttagcatgc tgaggattgt 78120 agaaccatat attgcacgag ggtacccaaa cctgaagtca ttaaatgaac taatctacaa 78180 gcattgttat ggcaagatca ataagaagag aactgccatg atagatacca atttgattgc 78240 ttgatctggc ttcatctgcg tggaggatct gattcatgaa atttgtactg ctggaaacac 78300 ttcaaagaag caaataactt cctgtacccc ttcaaattat cctctctatg agatggaatg 78360 aagagaaaaa ccactcattt tatagaggtg gagatgttgg caacagggaa gaccagatta 78420 atgggctcat tagaaggata aaataaggtg tctgccatga ttatttttgt aatcttgtca 78480 gttaataaac agtgactgct ttcgatttga aaaaaaaata catagttaaa atacacctac 78540 acattcacac caaagattct gatttaattg gtatgaagcc aaaccaagac attagtactt 78600 ttccagagct tcccaggtga ttttaatttg cagccagtgc tgagaaacac tgagacgatg 78660 cacataaaat gcctagccca gagcctgctc aagaaatgtt agctgttgct ctctactgtc 78720 actgtttggg tggttgagac ttgtgcccag gcttcctagg ggagtgttcc tcccattgcc 78780 ccacagttcc ctgtaagtgg tggaaaagga gaccctatag cagcacttct caacaccggc 78840 tacacatttg aatcaataga ggagccttgc caaggtttgc aaaagatggc tgggtctgtc 78900 tctaaccaat tagaatctct gaaggtggga cccaggtatc cccattattt actttcccca 78960 ttaactattc cacaaatatc ctcatatgat ctgatctcta tttccccata atgattgact 79020 ggtatttctc tttgccattt cagtattcac aatctgcttt gtattaaagc tgcttattta 79080 cgttatctct cccactgtga accactgcag atcagggact ggatttgttt tgttttgttt 79140 tagtttttat acaattgctt tccccttgca ctcagcatac agcaaagctc taacacatga 79200 tatatactta cataatatta atttaattaa ttgtcagaaa ccatagatac tcaactataa 79260 gactttcctg ccttctccac tctacttttc catttttcat gttttctttg ttgttgtgct 79320 tttctatgcc ttcttcacac tgtagccaaa gttattttat tcaaaattca aattaattta 79380 attatggaag ctgggtaatg agcctaataa tataaacaca gtggtgcagt gagcatgcag 79440 ttagttacaa tgttccatct atttttctgt tgtgtgaagg catccacaat ttataaagta 79500 cctggtgatt caaaaattaa gaaccactat tctaagagta ggtggaggcc agactatgga 79560 atcttccaac aaccaggagc aggagttgga atggaataaa ttagagcact ggatcatccc 79620 tgaaatccct gagcagagga acaaccgaaa cagagatgta tttaagctta taagtctaaa 79680 taaaagttgg gggtttaaaa aggctactta attacttctg agaaaaaata ttttattcat 79740 ttctcactgg gcttctataa tcacctcagc tctgtctgca gtttcctttc ttctgtaatt 79800 atttttctct ccattttctt gccctgatag ccacgtgctc atttgggtat ccatcaaaag 79860 actacatttc agtatattaa ttctctcact ggatggtaca gcttgaattt ccttctgcta 79920 gtttcattaa aatctaaatg gggggaaaag tcctctacat tatctaggag atccatgtga 79980 gctgcccagc tccattagct gttgtctgtt agaggtggat tacaagcagg tgtaatctta 80040 aggacaccgc ccttctgtga ttgttaagaa ggaacacaga ctgagcagag cggctactgt 80100 tctgatcagg agccaccacc actggttcct acagtataca gaatttcaat tgtcagatct 80160 gtcctggagg aacaatagaa tacaactgtg aattaaataa tttagaaacc aaggacataa 80220 tctcactttt ctaaatgagt ttgcctcttt taggagtcag tatattcgta gttttgctag 80280 cacagtcctg tgatgtagga ggaaaatgcc caaaaatatt ctagaaaaaa cattgagaat 80340 tcaagttaaa atgtcagatg gagcagcctc tagaattcct cctttgtagg ccatcagtaa 80400 tctcactgaa aattagacat gtattattta taaataataa tataatatta tgcatatttt 80460 aaatattaat gatttaggtc aaacgcagaa ggtgaaattt gtaggtgtca gaaatgaagg 80520 ccaaatcttt agtgggaagg ctgtgggagc tgaagctctg cagagcacag tggggatc 80578 <210> 16 <211> 112190 <212> DNA <213> Homo sapiens <220> <221> exon <222> (31560)..(31663) <220> <221> exon <222> (64868)..(64961) <220> <221> exon <222> (80499)..(80700) <220> <221> exon <222> (87482)..(87558) <220> <221> exon <222> (97994)..(98080) <220> <221> exon <222> (101581)..(101761) <220> <221> exon <222> (102663)..(103161) <400> 16 gatcacgagg tcaagagatc gagaccattc tggccaacgt ggtgaaaccc cgtgtctatt 60 aaaaatacaa aaattagctg tgcatggtgg aacgcacctg cagtcctagc tactcaggag 120 actgaggcag gggagtcact tgaacctggg aggtggaggt tgcagtgagc cgagactgcg 180 ccactgcact ccagcctggc gacagagcaa gactccacca aaaaaacaaa aaaaaaaaaa 240 aaaaagaggc atttctaaga gagagacctt aaccctaagg cagacactga agaggatttg 300 gggcatgaaa taggagctgc aggttggaga acatcacaag caagggcatc tgtaacccac 360 cctacccact ttctcaagag acagtccaga gagcgagtaa ggcacagggg ccctcttctg 420 catattgaaa gtgagaagaa atgcctatgc gagtgtctag gcagagagct tgaaacagcc 480 acttgtgggt ctctgcacct gcagcctggt gcagggatca gaagaatgta cttattctgt 540 gcaacaagag ccatgccttt gtgacaaagc ccgtggccca agaaggccct gcatttggaa 600 caaggaggca ccactttgat ctgctgacag ctaagtgcaa ggtggaatca gagatatctt 660 aatagatgtc aatgataaca gatgatacca agaaccaggc atcttagaca cacacacaca 720 tacacacaca cacacacgtg cacgagcacc cacgcacgca tgtgactgga taccgcatga 780 gttttctaaa gcttaaagat gactacaagg acaaagagta aacacttaat tgactgcaat 840 taagtttttg atatccagca gagtaggagt ttttactagc aattaacttc agttttagaa 900 cacgacaaat cttattttta ttatacaact acaaacaaat atataatgaa tgctcagatt 960 ccaggaccct atacctgggg tgatgggtgg gacgagttaa agaagggatc tggacactgc 1020 tgcctctctg ccttctttat atggggaccg tatcacaaat gaggctcact gtgcctccag 1080 tcatgtttac tgtgcagcaa ggcttttggc cagagaacat aattgacatg cacagagctg 1140 gagctcttgc cagctcacag caaaagggcc tctaattcag agaaaaagga gttggacctc 1200 tgccagtcat gtacctgtta tgctttcata taggcatcag ttagaccctg atctcagtct 1260 gacaaaccag aaaatataaa accatcagga tcaaggcata ctttttactg ggagtgttag 1320 cctggtaatg gagaggaatg ttattgctct aagcattcgc ataatatcta ttgatcaaac 1380 ctctgtgaag ctgctattct tcatgccagc gtctggcggc aagggaggac tatttcaggt 1440 ctcaccatca cagccacttc acactcaggc catgccacag tcaccagcac agcttgggat 1500 tggggcagga agtccccagg gtgaccagac agaaagcagc ctcaggacgg ggccagagca 1560 tgagactagg ggtggtggca gctgggtttt atttactctg ggctgtgtga ccttgggcaa 1620 gctgccagcc cattctgttc ctctctgcat gccatacaac cgggaattcc tacattactg 1680 agtcactcct gggccaaggt ttgatgtccc tattaaaatg ctgttgagag agtaagtggc 1740 ttcagtcact agccctggag aatgagttca ccagtttgat ttgtttacaa ctgagaactc 1800 tttcagtttg tgtgcgtgag gtgctggggg agcaggtgga agaggctttg ctggagtggg 1860 ggaaatatcc tgcctgggag tgggattggc ggaagggggc atatttgtca atcacaatag 1920 aatcctagac acttatgtct gggaggcata gcataggcca ttgcattcat cttcccccca 1980 gtacctgaat ctgtgaccaa tggaactgag gatctttact taacaacctc tagtgatggg 2040 ataatcacct ccttctaagg caagctactt ggaaactcta agatattact gagaaaagac 2100 cctgagccca gccttgaatt agtccaaagt ctaatgcttc tcccaggtga cagcccttga 2160 aagagtgtgt gacaggcgcc atgccccctg aatggtctct tctcccaaat aaataatacc 2220 tgattctccc tctgcaatgt tcatgaccca aacaaagctg agcctctgtg tggccactct 2280 cagtttgatg ttgtacccca aaccttcaac ctcagtctta atgcctggga atgggggaat 2340 gtgtggaaaa aggcatgaaa cacagtacac agcaaaatgt cttaacattt ctcttgattc 2400 tctagctcct tatccctttt cctaaaaatc tctttctaaa tctttcaagg ataaagggaa 2460 gggggtagaa aggggaagtg aggagaggta aaggaagatg ttcattattg ggagcctata 2520 atgttccaaa cacgtgggac atttaatctt cacaaagtaa gtatacccac cctaatttta 2580 taaggtagaa actaagaccc aagatatcta agtaagttgc ccaaagtcac aaagcaatta 2640 cctggcaaac aatggattca gataatgact atatcatagg ccaagcccaa ttacactcaa 2700 aataattcac atcttcctaa gaggcaagcc ctgggggccc aagagggggt tgttgagtaa 2760 gggcagaaag tacaagggag acaagttgcc aatcacagct tggccctgat tattgtaata 2820 actgacacaa ttaaagttca atttcgtatc cttagaaggt ttccgtcata ttccaaggct 2880 gatgagaaat ttccattcta agaatgggga tctgttgaat gttttaaatt caggcactta 2940 attaaatctt ttaagatgac tctttctgtg tttgccctta gtcttttatt tctatccaat 3000 attgttcctg gaccaaatag ggtcgggctg ctgtttcttg tagcccaata atgagatgca 3060 gatgaactgg ggaggaagag agtttttttt ttaagtatat aaaaacattt attcattaga 3120 aaacaaggag actggcaaac atatattcca aagtgaaagc agctcaatgc agttcagtta 3180 ggctaattta agagaaaggc cttgcatttt aaagatcgtg tatgtatttt tttttttttt 3240 caaaaaagga gacaggcaaa tattctacaa ggggaacaga attagaattc taggtcaccc 3300 tacaagttac cctgcacagg gaggaaagga acaggcaaga tgacttctca ggatctgtgc 3360 ctgcgagctg atgctctgag aatgggggtt attttcttgg gtgtcctgtc ttctgtcatc 3420 taggctaaaa aatcttcctc acttgactca tcacttgaga agacaacttt tggtttcttt 3480 tcggaagctc gctgctgggt gttcggatgc cgatgggtag tacgacgggg ctctggtgtg 3540 acgaagtcat tgtctgaggc tgcagaagcc agaggctggt gcctacaaac agtggatggt 3600 ttcttggctg ttggggctct ctggctacct gcttggttaa tctcaagctc ctcaatccca 3660 tccaaacctc tggcatgaca ggcctgaagc ttttgctcaa attcatctat tatagccttg 3720 ccctcaggct tggccccatg ttgtagcttg cccataactg acaaaaaaga actgaagatg 3780 gactcatctg acagtttatc tccaaaacag tcaaaattgc caagcatctt gcaagggcct 3840 tgctctgtga ggggcagctg tgacacacag taggccaggt cctgctgcac ctgctcagtt 3900 taggctgtgt ggaaccgctg acacagcttt tccaccaggc tttgtctgct tgtctttggt 3960 gatgatgtag gagaagaact gcttcataat ggtgtgaaaa ggcacttcct ccacccccag 4020 ctcggggtct gacaggtggc tgatgatatc tggaaggaga ctatagattg cattgccctt 4080 gtggaagagc tcattgaaga acttcttggc cagggcagca atttgagact cagggttgat 4140 gagcagcatg gccatctcac tcacctgccc ctttaccttc accatgtcct tgaggatcag 4200 gtggagtcat caccagcccc actgttttcc acactggctg agcagggtcc tgaaggtgag 4260 catatagatg aggagtccag gggtccacca gattgggaaa gtggatggcc agatccccag 4320 tggcaacgat gagattagac cggacaatgg gaagtggaga cttttctagc atggtgaaca 4380 gaagatgagg ctgggagttg cagaaagtgg tactgatcat gcagaacttg ccaagggtag 4440 gtgaagcagc tgcagagagg tctgggttgc tatagaggcc tgagttgttg tagactttaa 4500 gcaagagtgg aacaaaggca gccagtgtct gtttgccatc caacagttcc atcttgcaga 4560 agccgcggat tagttctgcc tccgtgtcat ctgctgcccc aaccagcccc agctcctcct 4620 ccatagtggt ctcgaaactt gtattcttct ccttgggatc tttggtcttg tgctcctgtt 4680 cttcccggag aactcggcgc tgacagagct ctccactcac tgcctgctcc aagtggacca 4740 gctgctgcag agccacatcc ccagccaggg acaagaggtt catcaacagg aaagtgggga 4800 gcattgtggg agactccttc gggtccccct gactggttct cttctcttct agcttctcca 4860 gggcctgttt tgcacagccc tgccatatct gggcacagat cactgtggga ctctctgcca 4920 gttggtaaat gagggtcact gccacctctt tgaatgggat ccagagtggg tctggtggac 4980 aaagcctttc gggaccgtct cccgcagtca ctcaaacaac ttgtgttcct gaggcaactg 5040 gaagtggggg tgacgtttgc ccagagaagt ctttctactg tcagagatgt tggcgatggc 5100 atggcacacc tgctgggcca gccggtagtc ctgtggaaac ttcggaagag agttttattt 5160 tctgcaaccg gtgacgggga gaaggcctgg aaattattgc cagaccaact taaaattaca 5220 aagttttcca gagcttatat accttccaaa ctatatgtct acgtgtaagg tatgcattca 5280 tctaaagatg taaatggtta acttctttta atctataacc aaggtctgag tcctaaatac 5340 cttcctctgg agcctcagta aatttactta atctaaatgg gtccaggtgc tggggggatt 5400 acccttatct tgtctcctgc taaattacag aggttttggg agttccttca gacctccaat 5460 aaacttgttt gtggaggcct aaggagtttc cttagacccc cagtgaaact tgtttaatcc 5520 taaatgggtc ctgttaagaa ttcctttgtt attttgtcat gccttaagtc ccaggaaagg 5580 cctaggtaaa actcttgatg ggcttttgtt acattccagc cttcgtacag gggcactggc 5640 ttttaatatt taacttaacc actcagtcag tactgaaaga gttgtcagtg acacctggcc 5700 tgccacaatt atgagtgtcc agaattttac tagatgtttg ggggaagggg aatgagaagc 5760 ctgaattagg aatattctcc acgagtctct cacaatctag ttggaaagac tagtaaactc 5820 aatgacatat taaatgataa gtaaatgaca acctgtggtc cttacttcat gcctttgcac 5880 acactgctct ctctacctgg atgcccttct ctcacctgat ctctccagca aagcactact 5940 cattcctcaa gacacaaagc tgaacaggca ctctgtgaag cctgcctagt ccgcttgctt 6000 ccttcccaga agattttgcc aatcatccct cttttggaca aatatcgtgc aacactgtat 6060 tttaattatt tcccaactcc ctgaaacact agaatgtgag caatttgaag ataggaatgg 6120 agtttccttc cttgcattct cagcacatag cattgtgtct gaaaccaaat agtcagcaat 6180 caatagtaat tgatgagtgt ttaaagaagc actacaggaa gtggcaaaaa tcagggtcct 6240 ccagggcaac acgatgggga cttcacagag tgggtggagc ttgtattggg ccttagagga 6300 tgactaacat ttggagatgc tgatgctgcc aaaagtagaa agatcaggag gaataaaagc 6360 ccagaaatac gagactgtct tccccagtgt tttatggtgg tcctagattc aaatatccca 6420 tcatgtcaca actttgaaat gaggaaaata ctttcaccaa gaagttgaat gctattctga 6480 attacaaacc caggtgagtg ctcatcaaga acagaagacc agccaggtgt ggtggtgcac 6540 gcctgtagtc ccagctattc aggaggctga ggtgggagta tcacttgagc ccaggagctc 6600 atagtgcgct atgtggatcg gatgtttgta ctaagtttgg catcagtatg gttaccccta 6660 tcccaggagc aggtgaccac tagattgcct aaggaagcat gaaccagccc aagttggaaa 6720 cagagcaagt caaaattccc atgctgatca gcagtgggat tatgccagtg aacagccact 6780 gcactacaat gtgagcaaca taaagagacg cccctgtcca aaaaaacaaa gaaggaaacc 6840 tgcaatccga gcactttggg aggctgggga aggaggattg cttgaagcca ggagtccaag 6900 accagccagg gcaacatggc gagaccctgt ctctacaaaa ataaaaataa gttaaacata 6960 aataaaaaat tctaaatgaa ttttaaaaag aaagaaaaaa taatagaagg ctttggggat 7020 cagggcagcc caaagggatt cctggagttt caaacacaaa atagacatga gagacttaat 7080 ctggatgtca gaccagcact agaagaaaac ctggacattt tgaagccctt aaattcataa 7140 aactttgaca gtttcatgaa catttgttga aaccttgcca tgtccaagaa ggtcacctag 7200 gatcagaact tccacccatc tcctcttctc cccctgtcct tttctgaggt ctacaccccc 7260 tttgtagtag gtggtcaact ggacacagga ctaggtttat caaaacttgc tctcgggaaa 7320 taaaaataag acaagaaata caatatacac aagaacacat gttcttgtac ctcagtctct 7380 gaatagcctg tctctagact ctgtttgatg taagagtggt tgcttctgaa aaaagaactg 7440 agtgactaac aatggttgga gaagggtgcc tttcttaatt ttagttttta ttatttttat 7500 tgaagtatga agttcaatcc ggtgcacgca agtatcagct gatgaatttt cacaaacaga 7560 agataccagt gtaactagca cccaaatcaa gaaatgttac catctgcctc tatgccccct 7620 cctaccaatt cccagtacca cctcttcccc ccaccaagag taagccctga ggcccagaca 7680 ggcttcacct aattttatat tttatttttt ctttttatga acagctttat taaaatattc 7740 acataacaat acagttcacc cattaaaagt ataaaactga gtggctttta atatattcac 7800 agatatgtat aaccatcacc aaagtcaatt ttaaaatatt ttcatcacct caaaaagaag 7860 gcaaatacct tttagctata actcccacct cacatcctcc gtaaccctag ccaactgcca 7920 atctacttcc tatgtctatg aaattgccag ttctccacat ttcatataaa tggaatcatg 7980 taatatatta tcttttgtga ctggtttatt tcacttaaca ctttcaaggt tcatttttgt 8040 tgtagcacgt atccatattt cattttttat ggctaaataa tattctatca tatggatata 8100 gcacattttg tttatccgtt catcagttga tgattatttc agtggttttt accttttggc 8160 tcttaggaat aaaatgctgc tataaacatt catgtacaac tttctgtgtg gacagttttt 8220 tctcttgggt atgtaactag aagcagaatt gctgggtcat atggtaacac tgtggttagc 8280 attctaagca actacagttt tatattccca ccagcagtgt acaaaggttt caattcctcc 8340 tcatcctcac caacatttgt tgtttgggga ttgttcatta caaatacatg aaacagtggt 8400 taccagagtc agtcagggtg ggagggagga atgcagagat ttaggtcaag gatacaaagt 8460 agcaaatacg tagaatgatt taattcttta cataaataga accttacagt atgtgtgctt 8520 ttgtttctga cttcttttgc tcagcattag attcaggaga ttcatcaaca ttgctgcgta 8580 tagttgcaga cagtttacta tccttattga atggtgttct actgtgtgaa catactacag 8640 ttgctttttt cattccacta gtggtgggca tttgggtcat ttccagttta gggctactat 8700 gaatactgct gccttgaaca gtccaggata catcattttg tgagctgctt atttttatta 8760 tttgtgctac ctgaattttg tattatgtgc aggtattact ttttttaaat gtcctaaaaa 8820 cacctttaag ggcttttaaa ctaggatcag aaacttagct ccttccctac tgacaagcag 8880 gcagaaaaaa aaaataatag taatagctag tatttactga atgctcattg agccacctct 8940 ttagggaaaa aaatcttttc atatatgttt gcttttaatc ctccaaatta ctcaaagcca 9000 taggtattct cattatgccc atgttagacc tgcagaaact gagaccgaag gaggttaaat 9060 aacttgtgca aaaccataca actagcaagt agggaatcac agtacaaata caggtctctg 9120 aatataaagc ctgtgcattc accctccaat tacacagcct ctgattacac tcagctggga 9180 gttcagggag cctgctagac atggggagga gaagctgaaa tgagagcacc tgaaactgcc 9240 agctcagtcc agctcaacag ctcggattgt tctccccacc gcccccctac ttcctgtcct 9300 aattaatcaa atgctcttga acatgaaaga gagtgagatt ggatttttgt taagatgaaa 9360 gaaaggaatc tgttcccatc tggcaccttc aaaactctcc tattcaagcc agcagggagc 9420 atttatgcaa cctacatggc agtttaataa ttccccaaga atgccaggag attaagcaat 9480 gtcacaaccg atctggatcc accggcactt gagaataatg gaaagagcag gggtctaagg 9540 tctaggacag gggtcaacca aatttctctg taaaggccca gatattaaat attttaggct 9600 ttgcaggtcc tatgatctct gtgtcaacta cccaactctg gcattgtaac atgaaagcag 9660 ccatgagcaa acaggcatgg ctgtgtaact aaaacttctt ttatggcaca gatatttgaa 9720 tttcatataa ttttcatgtg cctgggcata tatttctttt ttaaaaaata ttttctaacc 9780 agtaaaatat gtaaaagtta ttcttagttt gaaagctgca caaaaatgga ggacaaagtc 9840 tagcgacctg aattcaaatc ctctctctgc catttgttat ttctgtggct ttcgacatat 9900 tacttacatt cactaagctt catttctctc ttgagaaaat gagcagagca ggtgccatgc 9960 attcagggcc tcccttgtgg ctggcactga gccacatgct ttatatgctt tactgaatta 10020 aatcctacaa taaccacaaa aggctgaaat tatatgattg ccttcttcag atagttacga 10080 tgattaagaa attatgtcta taattgtgcc tgagctggcc tccatagttc attgagtttg 10140 atgcttcctg ttgtacgcaa aaattgccat gttggttcga tgagagcatg cctgcttttt 10200 ctactacctg tggtgttttg agtacctata tttgtattgc acttacagtg aaaattatct 10260 aattatatta ttctatttaa ttacaattgc atcaagctcc aataaacaat ccaaatttca 10320 ctgaactgaa agttgagtgc acactttgaa tagtcactcc ttctgttagg ttggtgcaaa 10380 agtaattgcc attactttta gtagcaaaaa cagcaattac tttcgcacca acctaatata 10440 tatgtgcaca gtaggcagtt tggctcaggt acacttattc aaaacattgc attaagtaag 10500 ataatacatg ttaaatacct agcacacagc ctgggatgca ggtgtcggcc agtgtttgtt 10560 ccccacttcc ttagtgacaa agattaggct tagctacttt ttgggaaagg tgagtgccac 10620 cagaaagatg aggccaaggc cttatcagac acactggaac acagccttcc caaggaataa 10680 atccagaata ttttgtgtat gagttctggc tctgaagccc agcctgttct tacactgacc 10740 ccccagtttc tgccttgatc agccacccac taggctgggc attgcttcct ctcactctgc 10800 tatctagtga cccaacctcg gcccaaccct ccagctttct tctggccatg cgactgttct 10860 gctagtctgc tccgcatatc tgctcctacc ttccgatgcc tcctctgagc tttggctcca 10920 ctccccactc agcacaaaca acttactttg ccccagtatg gggtacaaca gctcagactc 10980 ttctagaggt ctaatcctgg acacctcgtt tgctttataa gcacaatctg gaaagaagag 11040 tttcattgct cagagcccct caggaagcag aagaggagag tggtgaagag agcattcatc 11100 ctctggaatg accataactg gtgtttcaat cccagctccc ctccatacta atacttgggt 11160 gagttactca ccaggtctat gcttcagttt cttcatctgt aaaatggagg ttgtaaaaat 11220 atcatctacc ccatagggtt atggtgatga ttaaattagt tcttctatag aaagtgcctg 11280 cagcagtggt tagcatgtgg taggcacttt gtatgtgtta tctgttatgt ctgtttgctc 11340 ttactaacat ctatatttct gagtcctaga cctccccaga gagtgtgaag ttcatggtgt 11400 ttcatgggaa cagatgtaag cccacttgct gaatctctct ctgagctaat aattaacaaa 11460 tacattgcac agtagcttac caggaaagcc tatactggtc tgaacaagaa gaaacttgct 11520 gaacaattct aaagctcact tctcaatata acagcagccc ttgctcaaca tgttgcccat 11580 atcttcagta ccgtgcagag gtcacagcca tcatattctg ccagctcttc ccctatgggt 11640 tgagcaacca tatgtgtctt cccaaccagg acatttttca tttttagctt cttgttttga 11700 cataatttca ggtttacaga aaatcttcaa gagtagtaca aataccccca tgtaccctgt 11760 acacatattc ctgaaatgtt aatatttttc atatttgctt tatcatttcc tctatcagtc 11820 tatctataat acctacctat ctacctatcc atccatctaa aaatgtccca ggtaatcagc 11880 aaacctgctt taaatgtcac caattatccc aagaacatcc tttttagcac aaaaaacccc 11940 gaatcatgta ttgtattcag ttgccatgta cgtttagtgt tctttaactt agaacagttc 12000 cttggtcttt ctttgtatct tatgacatca acatttttaa atagcatagg ttagatattt 12060 tgtggagttt ctctcacttt gggtttgtgt gatgtttcct tctgaataga ttaaggttat 12120 gtgcttttga gagttataca ccaggaatga tgctatgttc ctcttagtat atagtatcag 12180 cagacacagt atatcaattt gtcccattac tagtgatgtt attgtcagat ttctccactg 12240 taaagatact atttttcctt ttgcaactga caagtatttt aagagtacat agccatcctg 12300 atactcctta aactttcact cacagcactt accatacagt gtagattcct gtctgaatca 12360 atgctataaa ggtttccaaa tgatgatttt ctaatttcat tatttcttct atacttatta 12420 gcagtctctc tactttaagg aagaaatttc ccttctctcc catttttaaa tttacatcat 12480 aggttcttct tttattctgt gggttataat ttgttgccat agttatttct ttttatgcct 12540 agattgctga ctggggtcag caagagccct acaatttggt gcgtgtttct gttgacatgt 12600 ttctcagcat ttttgggcat gtcctcactt gccagcacaa catgatgttc caggcttatc 12660 ttgtcctttt cccagcccca ggccaggaat cagccatctc caatgagcca agtaaaacca 12720 tggcatattt aagagaaagg gccacaggca taatcatggc gggtataaac tgaaactgac 12780 ctagaaatgc tgggtcatat tcccaatcta ccactagatg tccttccaca cctcaatagt 12840 tcttcacagg aagcagtcct ggggcatttg gaaatggtgg gatatttgga gttatcacaa 12900 agactggggc agcaggggtt acttctggca tttagtaagc acagcccagg catgccaaat 12960 ttcctgcaca ggaccatcta tcctaacaca gaattgcccc ataagtagca atcctgttaa 13020 taaatagtgg cccaatccct gaactaatct atcttgtgtt ctagtctctc aaggattggc 13080 ttagttcttt tcaccttatc cgccatcagt taatttaatc accactgttt ccatagtgag 13140 aatctaatat attagactga tcaagtgtgt taatcaaata tattggatta gctggcatgc 13200 attatagcaa ataaaatagc cagtcttcat tttagatcta gtttaaagaa agcctctact 13260 tcttatgtgt caatttttgc agaaaacatt attctagcaa gttggcaagg agtctaggac 13320 ttatgttaag acacaccatc tcatccccag ttcttgcagc tctctgtcta gttattggcc 13380 ctattcattg catcagcacc aacaacagct acccaggttt tatagggcaa gcattttact 13440 aaacatttta cataaactat ctcatttaac cttcacagta gccctataaa tcaggcattc 13500 ttattacaat tttacaaaga gccctggatt ccgtgtggtc agtagcaagc ccaagatagc 13560 acagctgtca tgtagcagag ccaacattca aaatcccaca gtcgggctcc agtagccatg 13620 ctgtgtactg cccatgcatg taagaacata cccaacacaa tgaaaaataa gaaatgaaat 13680 agaaagggca tggaaaatat caaatcataa ctgcagagga aaaaagtcaa atttaagctt 13740 agagttactg caaagttact gcaacccatc atattttatt ttgtgcttcc tagttagtgg 13800 ctaaaactaa gggcaaaact gactaaatat aatttgttgt aatcttgagg gaaatgcaca 13860 gcaagatgtt tcttgatcaa gaaaactgat actacggagc tttatattca gtactttgat 13920 gaaacagcac taaaatgtcc tcaataacat ctctacaaag aatcagtgat tcttagacct 13980 ctaagaggag ccagtgtgat gcctaaacat aggcatgtag gctacttgac agacagactc 14040 agcatagcag tcatcatcac gtagtaattt ctagcatcct agtagctttc tcactggctt 14100 tagttttgaa taaatgggat ttttgctaag atcttacatt atgcaacaga ggcaaccaca 14160 aagaccaccc ctagaaaatg aaatgatctt gggccccttc ctcccttacc tcctgcttca 14220 cactgcattc tttgggaagc ggatgctgaa acagagtcag gtatacaaaa atctggggag 14280 aagtcactcc tgtgaaagca aagggaagaa gtaagattgg gctggaggac ccatcagagc 14340 ctgacattaa cctgacagtc tctggcagct caggaatcct ttaggatttc catgttgggt 14400 ataaatgatt agactcttct actataactt agtcattggt agaggttgta ccaagaatag 14460 catgatccca gctaaaaagc tgaggcaaac cctgaggaat ctaacagctg gaggatgtca 14520 gcaaaccata tacctcacag ctggacagca aggtctttct tgaaggggga tctgagcagc 14580 atatctctat gtctgcctca tttccctatg tacaagcgtg tacctgattg cagcagaatg 14640 agatgagaaa caaatatttt tttgttacaa tttaccactt ccatctcagc ctgctacccc 14700 ttagctctcc ttgggcaaag ggaaaaagac atttgaagag cctgcctctt ggataagtga 14760 aaatggaact ctcctctcct tctcttggat ttctaaacat cccagatcat ttctgtgaat 14820 tctttttatt aggaaaatag catcctttaa aagagaaaac aagttgtcta tgtcttatat 14880 tcagagtcag tttgagcccc atgttgtgca atgatcttgt gcaatgataa ttacatgcta 14940 ccatgcctca agaaatttcc ccttaagtgg agtgaggagg agaaatagtg gaggctcaat 15000 gtcttgtttt aagaaaacac ctgttattgc tgaacctgat gcttgtgctt atgagcacag 15060 gagttttttg tggcccagca ataaccaaca actcaggtag gccagttgcc tcatttaatg 15120 agcttcttgg tttctgaata caacagaggc aaagagagta agttttacga ggacttgggt 15180 ttccttaatt agacacaagc tttttatttg gttgggggaa ctaatggaga aagggagaca 15240 ctagcggcat ttgtaacttg ttaagactaa ttgaaaatct taggaccaaa gctttctgtg 15300 aagagagtgc tctaatgaga ataaatgtga tgattattta cctaattgag cagtaatgac 15360 tgaggtgtga gccacttccc caggattaat aaagagccgg ggagttgaca gtttagacca 15420 ttaggcttag ctggtacttc atcttggcga aggacacagt gccagaatca tattaatatt 15480 gtaaaatgag cccaaaacat agacatatac ttttggagaa ataattttaa ttggctaagt 15540 acctgacatc aggttgggcc attcagtttt atcattaaac aaagtttcac acaagttctt 15600 caagacttgt gccatttaca gtgttctcag cattcagtgt ttaaaaaaga aaagtagaag 15660 agggaccttt atcaatatca aaaatagttt tttgtgcaac caaaagcaag caagctatta 15720 ttatatatac acactcgctt taaaaacaac actaaagaca ttgagttgag ctggaagcat 15780 tgcatactct gagatacaca gttgatattg ttacccacag tgtcccttca ggaaagccag 15840 aggtcatctg caacaccaca attaaggata aaaggacctt atattatcag aaatttcaat 15900 gtcttcataa aaattgtgtt tatattcaat atctccctta tttagtgtga caaatgttca 15960 tgtacgagtc atctcaagaa aaagagttac tcagcttgct acgtattcat tattctatgg 16020 ctctgctatg caggggaaag tgcaaacagc aactgagaga aagcaggaat ctaagacatg 16080 ggactcaact tgccctttac acagggtgaa tcctacacta gtgacctttg tgttttaagg 16140 aagtttgcaa atatgtttaa ttggacaaca tttcttcctt tatctagcaa gcactgagta 16200 tcttgccagg cactatgaaa aaagataaaa ctataaacat gagcaaggca cagccactgc 16260 caatcagaag cttacaatct agcagagatc ttaaaatgca gggagctctt ttagaaatct 16320 gcttagggat caaaatttcc aatcacactt ttccttccag catctttatt ctgtaatcat 16380 tattttaatc ttcattgaac gagatgatta atgtggttcc atctgctgta tgaaatcacc 16440 catgctacag tcagccaatc aagcaacagc agtaataatg tactacttca tttaatggaa 16500 atttaccaag ctgttactat gtaatatcac agttttaggg cctggagagg tagagctgaa 16560 ctaaaaataa taatctctgt tatcccatag tatagtggaa taggaaagaa atacaaaaaa 16620 aaataatgtg ttcatgtatt ataggtacta taatagtagg gtaggaagat acacagaagt 16680 gggaataacc aagccaatct cagtactcag aaaaggtgtt ataaaggagg taaccttgaa 16740 ttaaaccttg aggaaatgga tattcttcag gtagaggtgt ataaagagct tcccacacca 16800 atggagcagc ataaagaaat ggcatggcag agtgaacagt tgggtatggc caaggaaact 16860 ctcaactgca tcttcttcac tgcctcaact gatcactcaa cgctctccat tctctcagca 16920 aacaccctga ctaactaaac tcccatgact agcaggatat tattagactt aacaaacctg 16980 tcaatttata tgctttccct ttagaaagac ttgacttttt tttagtgaac tgcaatagaa 17040 ctaagctcag gagatgcaac tatgaaagat gaaggaacat tataaaaatc tctgcaatga 17100 gattctgcct tagattgctt tgctggtatg tcaactgatt actccaattt aaagaaaccc 17160 aaactggaaa ttataaaaga taaattgtga gtgtatttta tgcaaaaaag aatcaaatca 17220 aatcaaagtc ttggctctac attaaacaaa cgacaaaggc atgtttgttt ttatcaaaat 17280 gttttagggt agatttgtat gtatgcgtta tttctttaac caatgtttta atcagttaaa 17340 cagctgctat tattaatgtg ctggttgaaa gtgtttttct taaagtacaa atttaaaata 17400 gaatgagaaa agatcagact tgagaagaag gaaagtcaca gtaggacatt tggaatttat 17460 tctctagacc agaggtctgc aaactccagc ctacaggcca aatccatcct gcagcttatt 17520 tttataaata aagttttatt ggattacagc caggcccatc cagttacaga attgtctatg 17580 gttgcttcca ctctacaatg gcagatttga gtagctgtta cagagactat acgcaagtgt 17640 gcaggagagt ttagaccaca cctacaggaa aggtatgaaa tactaccctc cttcctagac 17700 acttccccaa acaaaaaact taagtcagtg tgggaacaaa cactgttgcc ccacagagca 17760 ctaataaagg cagataaatg actgagaaaa ccctatccct tggggacgga ggccagaaat 17820 ggcaacacca ataccattgg aagtctccta cttctaggta aggacatgaa attctctcat 17880 atgcaacacc catcacagat acaaggcagg agtttgattt tcatggggag gaggaattgg 17940 aacactgaga ataccccacc cctaaggccc aggcacactg gcctatatgg gtctgtggct 18000 gaactgggac aaaagagaag ccctaaaacc accagtagca agcattgagt aacaagcagt 18060 agcagtatta cagcaaaaca ggcacagctg aaagcagaga gtggggcatt aaaacccttc 18120 agcgtctcag ctactatgct aatagaaaat ccaaagaaaa atctgaagcc cataggaggc 18180 tgaggatgac cctactaaca acaaaactca agtctagcta gactcctaag cagattgatt 18240 taatacccca ctctaacaac cttaaagaag tgtgcccatt tccatgcata aatactatgt 18300 atctcaatat ttgatatact ctacacaaaa tgtttgccat ttaatcaaaa tgcatgagac 18360 tcaaaaagaa aatgcaaccc actgttaaca gccaaagcaa tcaacagaac caaacagaga 18420 catgactcca atgttggagc tattagacac ggactttaaa taaaataatt acaatgaata 18480 agaaaaatac attaaaaata cttcatgaaa gaggatatat ggatggcaaa gaagcacctt 18540 taaaagtgtt caacagttta tacactattg atggaaatgt aaattagttc ttccactgtt 18600 ggaagcagtc tggagagttc tcaaaaaact taactaccat ttgaattagc aatcccatta 18660 ctgggcatat acccaaacag aagaaaactg ttctcccaaa aggacgcatg cactcatata 18720 ttcatcatag cactatgtat attcacaata ccaaagacat ggaatcaacc tgaatgccaa 18780 tcaatggatt ggattaaaaa atggaatact atgcagtcgt agaaaagaat gaaatcatgt 18840 ctttacagca acttggatgc atctggaggc cattatccta agtgaattaa tgcagaaaca 18900 gaaaaccaaa tgccacatgt tctcatttat aagtgggagt taaaccttgg atacacatgg 18960 acataaagat ggcaacagta gaggggaaaa ggaagaacta gagcaaggga tgaaaatcca 19020 gctattgggc attatgctca gtacctgtgt aatgggatca atcgtacccc aaatctcagc 19080 accacacaat atacccatgt aataagcctg cacatgtacc ccctgaatct aaattaaagt 19140 tgaaatcatt tctaaaaaaa gaaaagaaaa atgaacaaat tgaaaataaa aagatgttca 19200 acatgattag tcattagaga aatgaaaaat aaagccatga tgaaatatca ctacatatct 19260 agtagaacaa ctaaaagaaa acacactgac agtcctgagt gctagaaagt gtgtgcaacc 19320 acagtctctc tcatacattg ttggtgggag tacacagtgg tgcagcaaca ttggaaaact 19380 gctgggcagt tttttatgaa gttaaacata tatttactta ctctgtggcc caacaattcc 19440 acttctgagt atttgtccta gagaaatgaa aatttatatt cacacaaaaa cctgtacatg 19500 aatgtttata tcagccttgt ttgaaataac aaaaaactga aaataaccca aacatatttc 19560 agtgagtgaa taaacatatt gtaatacatt tatacaattt aaaactattc ggcaataaga 19620 acaaacaaat gatacacaca ccttagaaga atttcaaagg cattatgatg aattattttt 19680 ttttttttga gatggagtct cactctgttt cccaggctgg agtgcagtgg cgcaacctca 19740 gctcactgca agctccgcct cctgggttca cgccattctc ctgcctcagc ctcccgagta 19800 gctgggatta caggcgccag ccaccacgcc cggctaattt ttttgtattt ttagtagaga 19860 cggggtttca ctgtgttagc caggatggtc tcgatctccc gacctcgtga tccacccgcc 19920 tcggcctccc aaagtgctgg gattacaggt gtgagccacc gtgcccggcc tatgatgaat 19980 tttttaaagc taatttttaa aggttgcata ttttgtaatt ccatttacgt aagattctta 20040 aaatcacaaa actataatga taaagaacac attagtgttt gctaggaaat gggtgggtag 20100 ggagtgtggc tataaaggga tagcacaagg gaatttctcg acagttgtag aactgttctc 20160 tatcccgact gtggtgttag tgacatgacc ttatatgtat gtgagattaa atttcattga 20220 tatatgacat gcttgtaaaa attggtgatg tgcaaataat tctatagttt agttaacagt 20280 attataccaa tgtcaatttc ctggttttca tcattatact gatattgacc aggtagagcg 20340 tacatgggaa acttctgtct tatttttgca actttaatat gggtcttaaa tgatttcaaa 20400 ataaacactt taaaacattc tccctactaa ataaccatga ttaataggtt aaagtttcca 20460 ggggaaaaaa gtggacaaca tagatgaaca gttgagtgat ttcacagaaa gataaaaact 20520 ataagcaaga ttcaagtaga aatgtgtggg ggaaataaat cacaatagta attcacagat 20580 ttaattctag gaatcgtaga ctttacacag ccagaggaag aattaggtaa tctgaagata 20640 gatccataaa aattgcccaa agtgaaaatc agtaagaaaa ggacaaagaa agtggatgag 20700 gagaacaaag tatttaaaaa tgatgggaca atatcaaata gtctaaaata tatgtcattg 20760 aagttacaga aggagaagag agaatgggca aaagaaatct ctgaatgata gctggaattc 20820 tccaaaaata atgaaagcat caaatcatag atccaaaatt cttaaataac ctgaagcaga 20880 ataaatttta aaaagctagc tataacttat ccaaagtacc aaataaaggt aaagaagaaa 20940 ttgaaggaag acagtggaaa atatatgaac atattaaatc agagaaattc ttaaagaata 21000 caaaattaca gctagataga actagaataa gttctagtgt tccatattac tgtagaatta 21060 ctatagttaa caataatata tggtttcaca taactaaaag aatattgcat gatcctcaca 21120 aaaaaatgat aaatgctaga gatgatagat atgccagtta tactctgata actatatgta 21180 ctgagacatc accatgtagc cccatgaata tgtacactta ttttgtcatt ttaaaaatta 21240 aattaatata aagaggtaaa gacaagaatt atagctgact tcttatctga agcaattaaa 21300 gccagatgat aaaacatatc ttcaaagcca gctgggggga caactatcac ccagaattct 21360 acatctagca aaaatacctg tttaaaatga agatacaata aggactattc aaaatttttg 21420 taatgggaga attccttacc agcagacctg tactttaaga aacattaaag aaagttcttc 21480 tgacagagga atgtgaaacc agaccggaaa ttttatctac agagagatgt gaagaactct 21540 gaaaatagta aaaataaaga ttaatattaa aagccacatt tttcttaatg ttaaatgact 21600 ctaaaatgta attgactact tgaagaaaaa ttgtagcagt gagatttata acccatgtaa 21660 aatttaaatg tctgataaca atagcacaaa gtttatgagg aatttgaatg tctaagtctt 21720 cacaatatgt aagaatttgt ataatattat ataaaacatc taatactcag tctttacttg 21780 ctgcagggaa gatcaatttg gcaggtccag cactggaatt accatttaga ttagttagga 21840 aactgcggaa gttcaagaaa gaaatcatca gtacctagag tatgccaaat aatagtaaga 21900 atacagagag gattcaaatt tgagatctac ttaataaggt aaaataagga ggatgcggtg 21960 actgagtatt gagatgttct gaatgtgagg tagagggaag agtctactat gtattatggg 22020 ttcctggctt gggtgtccct agcagacagt ggtgctatca agtgagtctg aggagagagg 22080 aggataggat cattaatatg aaaagttaat gagtttggat tttaactggg gtttcaggca 22140 atttacatgt aatgttatta ttgatgtgtt tggattgaaa tctaccactg gtttcttgct 22200 tttatttgtt ccatctatat ttttcttcct tttttccttc tatttcagcc tggattaatt 22260 gagcttttta tgatttcatt ttgtctccac tattggctta ttaattatgc ctctttttct 22320 atttctttta atgttgtcct aggcttcaca atgtacatcc tctctacatt cctacagtta 22380 tttaacatac gtttcttcct tgaacttctg catagtttcc taattaaatg gtaattccag 22440 tattggacct aacaaattga tcctcaccac agcaactaaa gaaatctatt tataatacat 22500 gtttggagac ataaacattc aacaactctc acagtataaa aaaatacatc ctcttttaat 22560 tggcatgtga gacccagaag tctggattct tcttgtttct gcagacccat ttttgccact 22620 tcctagctcc tatttaggct tcagcaataa caaacagatg cttaatatac acaagccaag 22680 tagtttctca tctccataac tttgttcatg ctgttatatg tgcctagaat caatattctg 22740 cattcctttc tcacctgacc aatcctcact gaaaagctca gctattgccc cattcttgac 22800 ttcttccttg tccacccgct tttgtgctcc aactggaacc ccattcatgt ttacaagaaa 22860 cactcaaagg acaataaagc ctgttgtgac tctacttcgg cttttctgag tattaaaatt 22920 tcctaagatc tttcacagga caaattttta aaagcaagag taatacatgg aggtgattaa 22980 gcctttaaag tgtacccttt gttcccaagg tcttgttaat tatcatttag gagcagttta 23040 tctgcaatgt gctcaattac ttaggtaact aaatagcttt ttactgatca gcattgaaca 23100 tcatttgctt aatagcaact aacaaatgcg gtggcagaat tccactgata gtctactttc 23160 agaaataggc ttatttaaga ttgagctcca ggggaaaaat agattctaac agaatagatt 23220 attgttattt acataaccac ttaggtctag agaaacaaaa taatctttcc gttttttaaa 23280 attaaggaat cagtaagcca aaagagaata tccaagtaac tcccaagtcc attccgttca 23340 ttcatccagt ccatttgtgc catgaaaatc ttcatgacat tcctatttga tcaatcacaa 23400 ctcacagctc tcaatgactg ctcacatctg accttctcag taaggacttt tcttatagct 23460 tagaacagtc ataggatttt tcctctccaa gcttttgaca ctttggatta tagatcccat 23520 gtgcttgcca atgctttttt tgttaactgt agaaaaataa aaagcaaata cagacaggcg 23580 aaagactcag agggtcacat aacattgtat ggtgaactat accatgtgaa tggtcaagga 23640 aagcttctgg agcatgggac atattagcta ggtgttgaaa gaaaaatagg aattcaatag 23700 gctggaaaat ggggggaggg tatttcaagc agagggaaca cctatctaga tgcacaaatg 23760 tatgatcaat atggtgttca acattgaaat gccacatggg gacctgacaa gaggtagttg 23820 tattagtttg ttttgtgctg ctgtgatgga atgccacaga ctgtataatt tataaacaga 23880 aatttattag gacacagttc tggaggctgg gaagtctaag gtccaggtgc cagaaagttc 23940 agtgtctggt taggtcattc tcttccaaga tggtgccttg catgctgcct agatcctcac 24000 gtggcagaag gccaaaggga gaaagaggat gagcccattc actttttata atggcattaa 24060 tctattcatg agggctcaac ctaaatgctt cccattaggc cccactgtca cattgggaat 24120 taagtttcca acacaccaat tcttgggcac acattcaaac tgtagcagta ggcaaagcca 24180 aatagtggaa ggcttttatt ctaagctgtg ggactcagct ttattctgtt aacagtgaag 24240 atgcagaaag ggcgagatgc agtggctcat acctgtaatc ctagcacttt gagaggttga 24300 agtgagtgga tcacttgagc ccgggagttc aagaccagcc tgggcaacat agtgagatcc 24360 cgtctctatg aaaattttta aaaagtaaaa gttagctagg tgtggtgtca cgtactgttc 24420 ccaactactc aggaggctga ggcaagagga tcacttgatc ctgggaagtt gaggctgcaa 24480 taagccatga tcacaccact gcactccagc ctgagtgaca gcaataccct gtaccacttc 24540 cccaccaaaa aagatgcaca aaagggagat ttatctccct agttttctaa aggagcaaaa 24600 gcaacttctg tgggtggaat agccctataa gtagaagggg ccaaaagata aaaagggcaa 24660 ccaaagaagg gaatgagggg atgagaagaa gacagggact catatctgca cattagtcta 24720 gggaataaag aagaaaagac acaacatcaa tctaaaaaga aataaatgaa aacaataaaa 24780 ggcagtgttg aaggcagtcg agcactgact tctatagtat gggttaaagc ccagcttcac 24840 ctctaacttt ctctgaaatc ttaaaatgtt ctaacctttc ttattttgtt catctataaa 24900 atggagattt tatctcagtt tgttgtgaga ttaaacaagt taatgattct aactacttag 24960 aaccttgcca aggatataat aactgcttaa taacccctca caatcatgtt ctgtgttcta 25020 gagaagtcag gttaagggta gtaattctct tttaaaccat gaagtctacc tagagttatg 25080 taggatgtca ccattggggg atgctttgcg gtaggcacat gaaacctttc tgtaccattt 25140 attgtaacat cttgtgagtc tctaattatt tcaaaataaa agttttattt tgttttgttt 25200 ttcttaaagc cttttcaaac cacaatggca attcattcaa gcatgttctc agcacttgct 25260 gcatgccata ccctgagctc cttctgttct aacattagta aacctcattt tccaatattc 25320 agaaagcaat taaccaaatg acagtgtgac tttccatttt tactattgct ctttagcaga 25380 aacatagcaa taaaaataaa ctattggaaa tgaaattatg agtatcctag attaatcccc 25440 aaagttgcag tttcttttgt tgttcagctg tttgattttc taagagcctg aacccagcca 25500 agtgcatact ctatttctga gcagagttct gcccagttct ctgtctgact agaattgcac 25560 agaaaccaca aatctctcat aaagcctaat ggtgtttctc aacagaggca tgattggaat 25620 tctgagctgg ataatttaat actagggtac agcccatggg tagtacagaa aagagtcaat 25680 acttgccttg tctttgtaca accaggatgt atgtctgcat gacaataatg aagactcaat 25740 ttcagccccc attcaccctt ccacaacagc aggggcaggg caccctagag cataaataat 25800 ctgaacaacc ctgtgttggg ggcctgctga agatgcttaa catccctggc cccatccact 25860 aattgtctgc catcaatcac aacttgacag ttacaagtaa attgcctgtg ttctccccat 25920 atgcctgcct ttctcattgt gtaaaaacag ctctacctcc atctgctagt cactaccaat 25980 cactcttgcc aagatggtga ctcctcttct tgcctgctag tccctagaca caaagagtcc 26040 aaagtgccct ggtggcagcc atagctttta gttcaatggt acctttgcta tgttccctgg 26100 cagaagtaca cttcctttgg tgaccaggac ctccaagttg aagagcacag aggtgcagat 26160 gaagaagtgc aaagcccgtt agtgggtcaa tgggagtgat gttaacttag gccatttctt 26220 cctgtacccc ttgattctaa gacctatgta tacttcctgt tagggaccca acaccatgaa 26280 gtgggctctg atttaacaca tatgctgcac tttaaaggat gggaccctaa actttcagag 26340 cattaccttt aagtggcact tcatatgttc cttcagtagt tcattctagg gctctaaaag 26400 tacagctact tctgtctggt gaagtatgta atacaaacag taggttctag gatcaagagc 26460 tatcctacac ccccttcaca attaagtggg tcccctgatc acatactatg ttgtgggatt 26520 tccattcttg tttggtaatc taaaagcccc cagataacag ttagctgtgt tgactatgac 26580 tcagagatca ggaaaggaaa gcttataccc agaataagtg catcattgga aggatggaca 26640 gctggctgat gcaggacaga ggggaaccaa tgtagtcaac ttgccacaaa tcaaccagtc 26700 gaatctcctg aagacctagt aacctattga gggctccttg ttggtctctc ttgttagcaa 26760 gttggacatt caaaatcagc agtagctaga tttaccagga taattggtag tccattttat 26820 tggctaatga gtagtcttgc tctctgccac tgtggccact cgattcatgt gcccatcatg 26880 ccagtactta atccaaagac aaagcctgga taatgtcaac tggacaagtt atcttgtcta 26940 tttgtttttt cagtgcttct tgtgtacttg atgctttcca attagtgtta aacgcatgac 27000 acaaaaatct tcacacattg tgcccactcc catagtccca accacatgtc tctgtctcag 27060 actcttgttt ccaatctcca agtccctttc attcaggtcc ctgtccacac agctagacta 27120 ttggctactg tgcagaaacc tatacatata ttcacacctt aggccaattt ttcttccaca 27180 cgaatagata accatattca ttgcttgcag cttcattcat tgggaagacc ttccttctcc 27240 actgtcttcc aaggctaccc cataattcag ctgtacttca gtgatcatct atttttgctt 27300 tacagctact taaggaacta acccattgtc agccaggatt ggccttttac ctccctttca 27360 gctagtcata gagaaccccc atatagccat aagtgtgagc tatgcaaggg cactggtaca 27420 accctggtgg gtgacatgga ggcatctgtg ctacttgctc atgcagcctc ttcatgccag 27480 tctagtccca tatgggtttg atcccagatg tgccatttcc attttccaat agaaggctgt 27540 gggacacgtc tgagtgtatg acttagtgca ttggcaataa tctagctcat aatggtcagt 27600 tccaaataca tttggtgccc cattatcagc tgttccatct tgaccaaggc tcagcaacat 27660 tctaggaagg gtttctcaaa aggtgtataa ctttgtactg aaaatggatg gcattgcttc 27720 agagccctag gggcctgcat tctgattctt tcgcttgggc atccatcaac tccaaactgt 27780 atctttcccc actaacacat tcagcaccat ggggtccacc agatcatatg cctcaagtag 27840 tagggttgct tatactgcag cccatacatg ctgcagagcc ctttcttgct ttcttgctcc 27900 aggcccactc aaagctgtga gacttctatg tagttcagta tatgggacca aaaatattcc 27960 tagatgtgga atgtgttgcc tccaaaacac aaagaggcct accaggtatc ttgctctatt 28020 tattgagatt gagaatgtaa gatacagcaa tttaactttt acttgaaaat gcagtggtgg 28080 gagtggtatt ctagcagact ttcactactg aaccactaaa aactttaccg atgtggcatg 28140 ttcctgaatt ttcacagggt ttgtctctca ccctccagag tgtatgtgtc ctaccaatgc 28200 ctctaatgta ttagacactt cttgttgact cttaatgaca tctttgatgt aaatggatca 28260 atgtgatatt ctacagaatg ttcagatggt ccatgtctct tcagacctta ttatgacaga 28320 tgtttgaaga ggtaacatag ccatgggcaa agcagaaaac gaatattatt gtctgtttca 28380 tgtgaataca gactctgatt ttttggatgt gtctttgtct ggttttggta tcaggataat 28440 attggcctcg tagaatgagt ttggaagtat tccctcctcc tctatttttc agaatagttt 28500 gagtaagatg atattagttc ttcattaaat gtttggtata attcagcaga gaagccatca 28560 gttcctgaac ttttctttat tggaagacat tttattataa gttcttgtta tttgttattg 28620 gtcatagttc aatcttggta cattgtatgc atctaggaat ttgttccttt cttctgtaat 28680 ttccaattta tttacaattt atttatttga gtcttctctc ttctttatta gtctggctaa 28740 aggtttgtca attttgcatg acatttcaaa aatccaactt tttgtttcat tgatattttg 28800 tattgttttc ttcatctcaa tttcatttat ttctgctctg atatttatta tttattttct 28860 gctactaatt ttgagtttgt tatgctcttc cttttctagt tctttaagat gcatcattaa 28920 gttgtttatt taaagtttat cttctttttc aatgaaggta ctaatagcca taaacttccc 28980 tcttagtgat tttgctgtat cccatagatt ttggtatgtt gtgtttctat tatcatttgt 29040 ttcaagaaac ttttaaattt tcttcttaat ttcttcattg acccaccagt cattcaggag 29100 catatggttt gatttccatg tatttgtata gtttccaaaa ttcctcttgt tattgatttc 29160 tagttttatt ccattatggt cagagatgat gcttcatatt atattatttt attttgtttt 29220 aatgttttca ggctttttag tgatttaaca tatagtctac tcttgagaat gacccatgtg 29280 ctgtggaaaa taatgtgtat tctacagctg ttgtttggtc tatagcgcag attaactctc 29340 gtgtttcttt accaattttc tgtctggaag atctgtccaa tggtgaaatt gtggtgttga 29400 agtctccagc tattattgta tggggtctat atctctcttt agctctaaca atatttaatt 29460 tatatgtctg ggtgttccag tgttgggtgc atatatattt acaattgtta tattctcttg 29520 ctgaattgac ccctttttca ctatatagta accttcttta tctcttccta tagtttttgt 29580 cttgaaatct attttgcctg atataagcat aactagccct gctcttttgt ggtttccatt 29640 gacatggaat atcttttccc atccctttat tttccgccta catatgcctt atgtctttat 29700 tggtgaagtg tgtttcttgt aagcaacaga tcattgaatc ccttttgttt tttcaatccg 29760 ttcagccact tggtgacttt tgattggcaa gtctcagagt ctcatccaaa gtcttcaatg 29820 tacctgggta ttgctgctgg ttattctgag cccagggact ctttagttag caggtgatga 29880 atgttgccag gactatgtcc ttcccttcaa ggcagtagtt tcccttctgg cctagggcat 29940 gtctagaaat gccatccagg agctagagct tggaaaggcg gcctctcaga gctgactagt 30000 gccctctcct gttgtgactg tgctggtatc caagatgtaa gacaaaatcc ttcctactcc 30060 ttccttctcc ttcttctcct ttccttaagt ggaagaaaga gacctctttt ggagctgtga 30120 gaattgcagc ctggggttag gggaggggta gtgccagaac tcccttagcc acccaagctg 30180 gtatctcagt agtccatgtg cctccccagt gtactggctc tgggcccagt tcagaactag 30240 aacttgcttg aaagttgcac tccttgtggc ctagactgac tttcaagtgt atttagagcc 30300 ctagagcact ttagcttgca gtggtaaggc ttgtgggaac tcaagttctg accaccagga 30360 ttggtgattt ccttttggct agagctaata taaatgctgt ctccatgggg tggggcatca 30420 gctgagtttg gcccagtttt cttttatgct ataataggac agcactaagt tcaatgcctc 30480 acaattgctg tgcttttctc ccctggcacc taggaatgct ctccacaccc tgctgccatt 30540 ggtgggggat gggagagggg tggcgtcaga gatttaaaac tgtttttttt ttttttctac 30600 ttcttcagtg cctctttcag caatatgaag ttaaaaccaa gcactatgag agctcacctg 30660 atttttggtg cttacaaagc tacttttttt gtgtgtagat agttgctaaa ttagtgtcct 30720 tgctgaggga ggaagaggga acgatcagtg gaaccttcta ttctgcaacc ttgcctgcag 30780 cactcttttg agaaagattc tggattacgt gataaattag tgatgtctgt catggagggg 30840 tgaggggcag tttttagaca tatagcctat cttgccattt ctgctataaa catctgcaca 30900 gcttgtacaa tctgtaacta tagaattgag tacagatgac ctgcccacaa gaggaaaaat 30960 gtcctgatct tggccttagt gcctctgtaa ttcaaccaag tatattaatt aaatggatag 31020 atcatacact tgctgtttcc caagtgtaga ggttgaaagt ggaaaggaga agaaagcaaa 31080 gaaaactggg aggaggggca ctaagactgg gcataaggag aaacaagagg tccaatttgc 31140 aaaataatgg gtgtagtaag gggaattttg aagtattctc caaagataac gattttgctt 31200 ttctcaattt tgtcctcttg attctcacac agtgctttct ttagtacaga cctacatacc 31260 ccgaaaactt ctgttctgtg acttaaaaag tcaactctat gattagcatg attcctcttc 31320 agtcattact gaaattcttc ctaggtggtt acatttaagt ggtaagaagc ttcagtaata 31380 taagtcaaag aactcctacc ttgctttgca tttcctcagt ggccatctga taaagcagga 31440 aggaaaaaaa ttaaaaatga acctccccag gatttcattt ctattgtggc ttagctgcaa 31500 atttgaaaaa taaaaataaa aataaaccct gaatgtaagc acttgtacgt ttttgttaga 31560 ttctttcaca ggactggtca acatcttgac agatattaat tggcgattca ctggagactt 31620 cacggcacct gacctggttt gccgagtggt ccgctatttg caggtatgtc acaccttcca 31680 aatgtgatga gacaaactga taccagagtt agcttttaga tttatctaag gaaaatcata 31740 taaaaccttg cattcctatg catcaaactg cccgctttct cctgggtaga agggcaatga 31800 aaatttgatt tttaatgtat ttcctttgct aaaaatagta tctatataaa gaaaacacaa 31860 acgagccaca aatgagcaat gctaaggaca taaagcattc atatttcaaa tgttaaataa 31920 aatgtctggg tcaatattaa ggattttggc atattgtgga taatctccaa aaagtttgtt 31980 aattatattt acctttcact tctcaaatga actcaacgct ggctactgct cttttttgta 32040 aaccaagggg aatttgttgg aacataacca ttaactattg aattactgcc taaattatac 32100 tttttaaagt atctattggc atttgaattt cttcctctca aatttcctat tttccttttt 32160 gaatgatttt ataactgaga gactttttag tttttctaag atctattttt agattaaaga 32220 tattgatgct tcaaatgtca atctgcttca ttgtaagcca tatttatgta tcatatgtat 32280 atttgattta aaatattaca tatatacata tttacatata tacatacttg ttaatatgca 32340 ttagatgttt ataatataga tttagacact tcaactaagt ctggaaggaa tggattattt 32400 cataactggt attaggtttg atgtgctgtt tctgagttct taagattatt ttttattaat 32460 atatttttat tctgatgcta gtacttcagg tctaaattat tatagcttta tgtatatata 32520 atgcatttct agaaagcttt atcctgctag attccatttg ttagtagact cttttaggat 32580 ctttgtatat atattcataa gtaaaatttt aatttttttc attggtttta ttattttcag 32640 gtcatggtaa tgaagttatt ccatattcag aaaatgaata tggaatagtt acaatcttct 32700 tttgtgctct gaatataacc ttgaaagttt ggtatgtctg aaagagcctt ttctattatg 32760 tacggctagt attttctcag gggaaatttt taaaaacata tttcaatttc tttctgagga 32820 tatttgcttc cttgtaaata aatgctttca attgcttatt atattagcaa tcaattgctg 32880 atacacaaat tatgacaaaa catggtggct taaaacaata aacatttatt atctcacagt 32940 ttctattagt caagaattca ggaacagctt ggctaggcag atctggataa aggcttatca 33000 aaaggttcgg tcagatgctt tgtggtactg tagtcatcag aacgcttggc tgggactgga 33060 caagatggat cactcacata ggtggtaaat tagtactggc tttagtggaa tactcagttc 33120 tccacatggg cctctctata ggtacatttt agtgtcctca caacatagta gctggctttt 33180 ccaagaataa cctattcaag tgactgaggt ggaagtggca acatatttat gaactagtct 33240 caaaggtcat acaccatcac tttcatatga ttattttggt tgtacaaatc aacttggatt 33300 cagtatggga aaagaagaac cacaaaacta ggaagtaagg attattttcg acatgttgga 33360 ggttggcaac cacactatct tcatattttt ccaaagcatt tgataaccta tggtttctcc 33420 caattgttaa ctttaaaatg tcttcttgat ttagaaatat tcatgtcagt aaaatttttt 33480 ctaactgtat ctacaataaa tgttaagact atatataaaa tatatctttt gacataggga 33540 aaacgataga gaaagaaatt ctgataattc tctcttctat aaaggaagca agaaaattgg 33600 caaaaaatat cagaatcaaa tttgtaaaac tctggaaatt aaccaaacac ttgcaattac 33660 tcagggagca tttattcagg aaaatggctg aatctcagtg agaaaaatga gctttgcggt 33720 gctttggctt gcattattct cagcccccag tatccaactc tgtaacagcc ttaaaaagta 33780 atagctctca ttcatagtga aaacaaattg tctggcagcc actgtagaaa gcaaaacagg 33840 gacagagccc tttcaaattc ccaagaaatt gccattattt gacatgtctg gcagttctct 33900 ggaagactcc acttgcaagg ctgtctttat tttacttaaa tcagaactca cccactgtga 33960 aaaacgtttc tcctctgggc attcgtcaaa acagttacag gcaattgatt aactttgctt 34020 atgacaaagg tattggataa tagtcaggga aaacaacaga ctaaccaaag cttaagaaca 34080 tacgctgagt aatgagatat ccatagggga tttgaaaatc tctgacatac tcccaaaaat 34140 ctagaagacc aggtatatgc ccaggactat gctcatccta aggaaaaaat agagaaggca 34200 ctgagctgta acctgtgaat gatcttgagg ctttgtgcaa gcaggaagtg agggcaaaga 34260 cagaattgta agttgcctgg ctaagtgtca aaatcatgct ccaacattca cacagacttc 34320 ctctgcaatg aatgggggaa ttaatagttt ctagaatgta agaaaatctc tgtttaggac 34380 ctatcaccaa gatcatggag taggagatat tcatccctcc aaagcattca agtatagaca 34440 gctattcaca aactaaaata gcccagagag gactcaaggg cccattaaag aatttgcagc 34500 aacatcgtga aggaaaaaat ggagaataac cacatagaaa gaattgctgg tgtgattggc 34560 acacctaaga ggccatgatt tggctaggaa caaagaagaa aggtggaagc tatcagtatt 34620 agacacagaa aggaccaaca ttgtctctag tggcctgctc cacaggagac actagcatct 34680 tttcccactg agtaaccaac agtcattcct gcaagagaac cccagagggg gagatgtggc 34740 tataccttcc tcctatcccc caagaagcag ttgctgtcga gctgctttgg gaatggggtc 34800 accacctctc ccaaccatgt gtaagctcca gccctggagc catggccacc ctgggaatgc 34860 ccacactcca gactgatagt ctgactacac tgggctcacc catgttttta acatcacagc 34920 cagcaccata gtaagctagt taacactcca agccccagtg ttaaactctg cctgcatgtg 34980 tccacactcc agacactgac ttaaccacca tagagagcta gccccatcca ggcctcagag 35040 ccattataat tctgtgcata cctgtgctct cattcttgtc tccttgacta atttatacgt 35100 atactattac caacattaca gcaggggcac ctgtgccctg ggcaacagct cagccataga 35160 aagctacgcc ttgccccaac cctgaagcca ctgaaagact gtgttctcag ctcccacact 35220 actttgcatg tgcactcatg cctcacatac tataccatgc agcagaaggg gcatctgcac 35280 cttgagcacc aatgtcatta ccattctaat cccagagcca taatctctcc atgtgagccc 35340 atgcatcaga cctcagtttc atggctactc catgagtgtc acccatcaga cactggtgat 35400 actgccacta agagaggccc tacaagccag atctagtacc aagagaaatc ttctcagctc 35460 cagcttccct ggtgggggga aagatcagaa gaaccttagc agccatcacc actgaagacc 35520 ctatcaattc ttgctgctac tgccaatatc cactgctttg gccactgagg atccttatga 35580 tctttatcaa ctctgacctg agctgaaaaa gctacacaga gactacaaat ctgcaccatc 35640 actgatgcta ccccacccaa caaaccctcc ctcatagggc atggtctttc catagtgaac 35700 tagttcataa aatctggaag gtgattcttt ttggttttgt tgatgtttat ctttccctta 35760 tattgatgtg tgtgcatttg actgctttac caaacgcaca cacatcaaca taaggcaaaa 35820 ataaacataa aaaaacagac ataacatcat caaaagaaca cagtaatttt acagtaactg 35880 gccccaatga aatagagata tatgcaatgc ttgaccaaaa aaatcaaaat aattttttta 35940 ggaaagctta gtgaacttaa agtacagaga agcaattcaa tgaaatcagt aaaacagtac 36000 aaccaaaaca aagaattaaa gagagagact gaaattattt tttaattaaa tagaaattct 36060 ggagctaaaa aacattataa atgaaataat aaatgcacta gacagcatcc agcagaaatt 36120 atcaagtaga caaagaattt gtgaagtgaa aaacaggtta tttgaaaata tacaactaaa 36180 gaaaaagaaa gaaaaaagaa tgagaaaaga tgaagaaagc ttaagagatt tatgaggcag 36240 catcaaaaga gaaaatgtgc aatgcattag tccattctca tactgctata agaatgtatt 36300 caagactggg taatttataa gggaaagagc tttagttgac tcacagttct acagggttgg 36360 ggaggcctca ggaaacttat aatcatggtg gaagggaaag caaacatgtc cttcacaagg 36420 tggcaggaga gagaagaatg agaactgagc aaaaggggaa gccccttata aaaccatcag 36480 atctcatgag aacttactat catgagaata ccatggggga aaccacctcc atgatttaat 36540 tacctcccac tgaattcctc ccatgacatg tagggattat ggcaactaaa attcaagatg 36600 agatttgggt aggaacatag ccaaactata ttatacaagt tataggagtt atagaaggag 36660 atgagagaga caaaaaaaat atagattatt taaagaaata atagcagaat agtttgcaaa 36720 tctggggaaa gatacaaata tccaggtgta caagaaggtc agaagtttct aatcagattt 36780 aatgaaaata agactacacc aagacatatt ataatcaaac tgtcaaaaat caaaaacaga 36840 gaaaatcctg ataacagcaa gagagaagag gcaaatcaca tataagagag ttataacaag 36900 gctagcagaa aatttctcag caaaaacctt gcagaacagg agagactaga agaacatatg 36960 taaggaagga aaaacaaact gccaaccaaa aatatttacc caacaaagct gtcctttagg 37020 aatcaagtag agagaaagat ttccccagac aaacaaaagc tgaaagagtt catcaccacc 37080 aaacctattt tccaaaaatt ctacacagaa tcttcaagct aaaggaaaaa aaaaagagcg 37140 agctaattag tgacatgaaa atatataaaa gtgattttgg gctgagacaa tggggttttc 37200 tagatataca atcatgtcat ctgcaaacag ggacaatttg acttcctctt ttcctaattg 37260 aatacccttc atttccttct cctgcctaat ggccctggcc agaacttcca acactctgtt 37320 gaataggagt ggtgagagag ggcatccctg tcttgtgcca gttttcaaag ggaatgcttc 37380 cagtttttgc ccattcagta tgatattggc tgtgggtttg tcatagatag ctcttattat 37440 tttgagatac atcccatcaa taccgaattt attgagagtt tttagcatga agggttgttg 37500 aattttgtca aaggcctttt ctgcatctat tgagataatc atgtggtttt tgtctttggt 37560 tctgtttata tgctggatta catttattga tttgcatata ttgaaccagc cttgcatgcc 37620 agggatgaag cccacttgat catggtggat aagctttttg atgtgctgct ggattcggtt 37680 tgccagtatt ttattgagga tttttccatc aatgttcatc aaggatattg gtctaaaatt 37740 ctcttttttt tgttgtgtct ctgccaggct ttggtatcag gatgatgctg gcctcataaa 37800 atgagttagg gaggattccc tctttttcta ttgattggaa tagtttcaga aggaatggta 37860 ccagttcctc agaaaaaatg ctcaccatca ctggccatca gagaaatgca aatcaaaacc 37920 acaatgagat accatctcac accagttaga atggcaatca ttaaaaagtc aggaaacaac 37980 aggtgctgga gaggatgtgg agaaatagga acacttttac actgttggca gaactgtaaa 38040 ctagatcaac cattgtggaa gtcagtgtgg cgattcctca gggatctaga actagaaata 38100 ccatttgacc cagccatccc attactgggt atttacccaa aggactataa atcatgctgc 38160 tataaagaca catgcacacg tatgtttatt gtggcactat tcacaatagc aaagacttgg 38220 aaccaaccca aatgtccaac aatgatagac gggattaaga aaatgtggca catatacacc 38280 acggaatact atgcagccat aaaaaaggat gagttcatgt cctttgtagg gacacggatg 38340 aaattggaaa tcatcattct cagtaaacta ttgcaaggac aaaaagccaa acatcgcatg 38400 ttatcacact tagatgggaa ctgaacaatg agaacacatg gacacaggaa ggggaacatc 38460 acactctggg cactgttgtg gggtgggggg aggggggagg gatagcatta ggagatatac 38520 ctaatgctaa ttgatgagtt aatgggtgca gcacaccagc atggcacatg tatacatatg 38580 taactaacct gcacattgtg cacacgtacc ctaaaactta aagtataata aaaaaagaaa 38640 gaaaatatat aaaagtatat atcactcact gttaaaagta agtacattta caatactcta 38700 ataatgtaat ggtggtgtgt aaatcactga tatcattagg ataaaggcta aaagacaaaa 38760 ctattaaaaa taataatagc tacaatagag gtatacctca gagatattgt gggttcaatt 38820 ccagaatgcc taaataaagc aaatttcaca ataaagctaa tcacaatatt tttgtttccc 38880 agtacatata aaagttatgt ttacatttta ctgtagcctt ttaaatgtgt gataatatgt 38940 ctaaaaagta tacatgttaa tttaaaaata cttaatggct aaaataaaaa gattaacagt 39000 catctgagcc ttcatcaaat attggccttt ttactgttgg aaggtcttgc tttgatgttg 39060 atgactgctg acttatcagg gtggtggttg ccaaaggttg tggtggctgt ggcaatttct 39120 taaaatcaga caacaataaa gtttgttgca tcaattgact tttccttaca tataaaaaat 39180 tatctgtagt atgcaatact gtttgatagc attttaccca gagtagaact tctttcaaaa 39240 ttggagtcaa ttctctcaaa tcttgccact gttttatcaa atatgtttat gtactagttt 39300 aaattatttg ttatcatttc agcaatgttc acagcattat caccaagagt agattccatt 39360 tcaaggaatc actttctttg ctcatccata ataagcaatt cctcatccat tctagtttta 39420 ttaagaaagt gaagcaattc agtcacatgt acacactcca cttctaattc tatttctctt 39480 gctatttcca ccactttcgc agtacctttc tccagtgaaa tcttgaaccc atcaaagtca 39540 ttcataagag ttggaatcaa ccttctacac tcctgtaaat gttgatacat tcaccttctc 39600 ccataaatca tgaatgttct taatgacatc taagtagtga gtccttctgg aaggttttca 39660 atttcccttg tcctgatcca gcagaggaat tactatctat ggcagccatg gccttacaaa 39720 atgtatttct taaataataa cactggaaag tcaaaattac tccttgatct atgggatgca 39780 aaatggatgt tgtgttagca gaaatgaaga caagtttaat ctttttgttc atcgtcatca 39840 aagctcttgg gtaacaatgt gcactgtcaa tgagcagtga tatttggaaa ggaatctttt 39900 tttctgagca gtagatatca acagggagct taaaatattc agtaaaccat gctgtgaaca 39960 gatgtgctgc cctttaggct ttgttgtttt atttatagag cacaggcaca gtagattagt 40020 ctaattgtta agggccctag gatctttaga atgatcaatg agcattggct tcaactcaaa 40080 gtcaccacct gcattagctg ttaaaaagaa tatcatgatg tcctttgaag ctttgaagcc 40140 aggcattgac ttctcctctc tagctataga agcgctagat ggcatcttct tctagtattt 40200 tactgtttgt ttccactgaa aaactatcgt ttactgtagc caccttcatc agttatctaa 40260 cctcaatatt ctggataact taatgcaact tctgtattat cacttgatgc tttaccttgc 40320 atgtttatat tacagagaca acttccatcc ttaaacctca tgaaacaaac tatgctagct 40380 tcaaactttt ctgctgcagc tttcacatct atctcagcct tcatagaggt gaagagagtt 40440 taagaacttg ttctggatta ggctttggct taatgttgca actagtttga tcatatatcc 40500 agaccactaa aactttctcc atatcagcag taagcttgtt tcattttctt gtaatttgtg 40560 tgttcactga agtagtcatt ttacttttct tcaagaaagt ttcccttaca ttcacaactt 40620 ggctaactgg cccaaaacta agcttttggt ctatcttggt ttctgacatg ctttttctcc 40680 ctaagctaag tcatttctag cttttgattt aaagtgagac atgtgtgact cttcctatca 40740 cttgaacacc taaagacaat ttcagggcta tttattggct taatttcaat attactgtgt 40800 ctcagagaat aggaacagct gaggagaggg agacagatgg aggaacaacc agttggtgga 40860 gctgtcagta tgcacacaac atttatcagt taagtttgtc accttatatg gatgtgattt 40920 acagcaccac aaaacaatta caatagtatc atcaaacatc acttgatcac agatagcctt 40980 aatggacgta ataataacaa taatgaaaaa gctcaaaata accaaaatat gacacagaca 41040 tgaaataaac acatagtgct ggaaaaatga cagacttgct caacacaggg ttgccacaaa 41100 ccttcaattt gtaaaaaaaa tgcactatct gtgaagaaca ataaagtaaa tcatgacaaa 41160 atgaggtata tttgtagtgt gttaagggat atactatata aaaaatttaa attgtgacat 41220 caaaaactaa aatgggggtg gtagagtaaa agtgtagagt ttttgtgtgt aatcagagtt 41280 aagttatcat tttaaaatcg ctcgttataa gacattcctt tgtaagtctc aaggtaacca 41340 caaagcaaaa cctgtagtag atacatgaaa gataaaaagt aaggaatcaa agcataccat 41400 tagagaaaag catcaaccac agaagaagac aggaaaaata gaagaaagga aaaaaaacac 41460 acaaagcaga aagagtggaa gacagaaaaa aaatatatga tagccagaat ataattatta 41520 aaatggcaat ttagggcaca tataactgaa agtaaaaatg gaaaaaagat attccatgca 41580 agtggaaacc aaaatagatg aggggttgct acatttacat cacatagaat agactttaag 41640 tcaataacag taaaacaggg caaataaggt cattgcataa taataaacgg attatttcat 41700 caggaagaaa taacagttat aaatatatat ggaccctaca ctggatcacc taaatatata 41760 aagcaaatat taatagacct gaagagagaa atagactgca ataaaatcat aggtcttcaa 41820 aatcccactt ttaataaaca gattatctag acagataatc agtaaagaac gattggattt 41880 aaactacact ttagaccaaa tggacctaat agacacatat agaacatttc acctagtggc 41940 agcagaatat ataatctttt gaagcaccca aggaacattc tccaggataa tcatagagta 42000 agccacaaaa caagtcacaa caaaattaag attgaaatat ataaattatt ttttcaaaaa 42060 caatgacatg aaactagtaa tcaataatat aaggaatttc aaaaatgtta caaacgtgaa 42120 aattaaacaa gagactcctc aacaatcaat aggtcaaaga agaaattaaa agcaaaaatt 42180 taaaatatct taagataaat gaaaatgaaa acacatcata acaaagctta tgggatgcaa 42240 caaaagcagg tctaagaggg gagtttatac caataaatac ctacatcaaa caaaagattt 42300 aaaataaata acctaatatt acaacttaag taactagaag aagaagaaga gtcagggttt 42360 ccctttcata aaaagggaga aataataaaa attagagaag aaagaaaaca aatggagaat 42420 agaaaaacaa tagaaaagat caatgaagag ttagttcttt gaaaagataa aattgacaaa 42480 cctttagcta gaataactag gaaaaagaag aaaactcaaa taaaattaga aatgaaagct 42540 gagacattac aactgatacc atagaaacaa aaagcatcat aacaagcgac tatgaaaaac 42600 taaatgtcag ccaggcgtag tggctcatgc ctgtaatccc agcacttcgg gaggctgagg 42660 caggcagatc acctgaggtc aggagtttga caccagcctg accaacatgc agaaaccccg 42720 tctctactaa agatacaaaa attagccagg tgtggtggcg ggcccctgta atcccaacta 42780 ctcaggaggc tgaggcaaga gaattgcttg aacccaggag gcagaagttg cagtgcgcaa 42840 aaaaaaaaaa aaaaaaaaaa aatagataac ctagaggaaa tggataagtt cctagataca 42900 caaaaactac caagactttg agtattgaag gaatggaaaa tctgaacaca ccaatactaa 42960 ggagatttaa tcagtaataa aatgtttcca ttccaagaaa agaccaggat cagatggctt 43020 cactgcaaaa ttctaccaaa cacttagaga agaactaata gcaatctttc tcaaagtctt 43080 cccccaaaaa agtgaaaaaa gtgtttactt ccaaactcat gttacaaagt cagcattact 43140 ctgataacaa agtcagacaa gatactatga gaaaattaca gggcaataac cctgatgaac 43200 ataggtttaa aaatcctcaa caaaatacta gcaaacatat ttcaatagca cacttgaaat 43260 attattcacc atgattaagt gtaatttatt cctggaatgc aacaatagtt taacatacac 43320 aaattaataa atgtgacatg ccacattaac aaaatgaaag ataaaaggca tatgatcatc 43380 ttaatagatg cagaaaaaca tcgtgacaaa attcaatatc tttttgtagt aaaaatgctc 43440 aacaaattag gtacagaaga gaagtgcttc aacaaataaa gaccacatat gacaagtcca 43500 ctgctaacat cacagtcaac agtggtaaac taaaagcttt tcttctaaga ttaggaacaa 43560 gataagaatg ctcactattg caacttctat tcaacatagt actggaagtt ctagccaaag 43620 aagtaaggca agaaaaaaag aaaagaaaaa agaaaggcat tcacatcaga aaggacaaac 43680 ttaaattttc tgtttgaaga tgacctgatc ctacatatat ataaaatata taatttatat 43740 ataatatgta ttatgttata aatatatgtt atatgttcta tgttatatat aatatatgtt 43800 ctatgttata tataatatat gttatatgtt atatgttata tataatatat gttatatgtt 43860 atatataata tatgttatat gttatatata tgttataggt tatatgttat atatgttata 43920 ggttatatgt tatgttatat atatgttata tgttatgtta tatatgttat atgttatatt 43980 atatatcata tatgttatat gttatattat atatcatata tgttatatgt tatattatat 44040 atcatatatg ttatatgtta tattatatat gttatatgtt atattatata tgttatatgt 44100 tatatgttat attatatatg ttatatgtta tatattatat tatatatgtt atatgttata 44160 tattatatta tatatgttat atgttatata tattatatat aatatgttat ataatataat 44220 atatatgtta tatattatat ataatatgtt atatattata tatgttatat attatattat 44280 atatgttata tgttatatat tatattatat atgttatatg ttatatatta tattatatat 44340 gttatatgtt atatattata tgttataagt tatatataat atagataata tataaaatat 44400 ataatatata tacacaaaac acaaaacacc accaaaaact gttaaaacta acaaatgaat 44460 ttactatagt tgcaggatac aaaatcaaca tgcaaagtca gtaatgtttc tatacactaa 44520 caatgaacta tccaaaaaaa aatagaatct atttacaata actccaaaaa gaataaaata 44580 cgtagaaatg aagttaatca agtaggtgat agacttatac aaaaaaacta taatatattg 44640 atgaaagaaa ttaaactagg caaaaattgg aaaggcatcc tgttttcata aatatacaga 44700 cttaatactt taaagtgtct ataaatcaaa gctatctaca gattcaatgc attccctatc 44760 aaaatcccaa cagcatgttt tacagaaatt aaaaaaaatc aaaaattcaa attaaatcac 44820 aaaagtccca gaattgccag tgttaacttg agaaagaaca aagctcaagg catcacactt 44880 cctgcttaca aaaatatatt atgaagctac agtaatcgaa acagtgttgt actggcatga 44940 aggcagacat atagacagat gaaacagaat aaagaagcca gaaataaatc catgtatgta 45000 tggtccactg atcttcaaca gtgatgccaa aaataaacag tggtgccaaa aataaacaat 45060 ggggaaagga cagtctcctc aacaaggtgt tggaaaactg gacatctaca tgagaagagt 45120 gcaatttaac ccttaactta tacaatacag aaaaaaatca actcaaaaca gattaaagac 45180 ttaaatgtaa gaccttaaac tataaaattc ctagataaaa acaggggaaa tgttccttga 45240 catttctctt ggcagtgatt tttttggata agacaccaaa aactcaagaa acaaaaccac 45300 aaatagacaa gtgggacaac attaaactaa ataactctgg tgcaataaag aaaacaatga 45360 atcaaatgaa aaggtgacct atggaaaggg agtaaatatt tacaagccat acatatgata 45420 aagggttaat atccaaaata tattagaaac atctacaact caatttaaaa aatagtacca 45480 ggcatggtgg ctcacgcata tagtcctagt actttgggag gttgaggctg gtgaatggat 45540 tgagcgcagg tattcaagac ccgccaggga aacatggcaa acccctatct ctacaaaaac 45600 acacacacac acacatatat atatatgtac atatatacac acacacatat atatgtacat 45660 atatatatat gtgtgtgtgt atatatatac gtatatatgt gtgtgtatat atgtgtatat 45720 gtgtgtgtgt gtgtatgtgt atatatatat gtatatatat atttatatat atgtatatat 45780 atatatgtat atatatacgt atatatatat atttatatat atatatatat attagccagg 45840 catggtgggt gtgtgtctgt agtcccagct actcaggagg ctgaggtagt aggattgctt 45900 gaacccgggg tgtcaaggct gcagtgagcc atgacagcac cattgcactt cagcctgggc 45960 aacagagaga gaccctgtct caaaacaaac aaacaaaaac ataggctgtg tgcagtggct 46020 catgcttata ataccagcac cttgggaagc caaagcagga ggatttgaga ccaggagttt 46080 gagaccagct tgggaaacat agcaagaccc tgtctctaca aaaagtaaaa ataaaaataa 46140 ataaccaggc atattggcat gagttagtag tcctagctac atgggaggct gaagtgagag 46200 gattgcttga gcccaggagt tcaagaccag cctgggcaac atagtgagac ccccatctag 46260 gaaaacaaaa agcacaggca acaaaagcaa aagtatacaa atgggattgc aggaaactaa 46320 aaagcttctg cacagcaaaa gaactatcaa cagagtaaag atacagttta cagaatggga 46380 gactattggc aaactatgca tctgatgagg agttaatatc cagaatatat gagaaactca 46440 aacaactcaa tagcaaaaaa caaaaaataa acccaatcca aaaaatgggc aaatgacctg 46500 aatagacatt tctcaaaaaa tatatataca aaagaagaca tacaaatggg caacatgtat 46560 acgaaaatat gcttaacatc cctagtcatc agggaaatac aaatccaaac cacagtaaga 46620 taccacctca gtctagttag aatggctact acagaaagac aaatgataac aagtgttggc 46680 aaggatgtgg agaaaggaaa ctcttacata ttgttggtgg gaatgtaaat tagaacagtc 46740 actataaaaa cagtatggaa gttccttgaa aaattaaaaa ttgaactgcc atatgatcca 46800 gcaatcccac taatgggtat aaacccaaaa gtaatgaaat cagtatgtca aagagacatc 46860 tgctgtcctg tgtttattac agcactattc ataatagcca agatatggca acaatctatg 46920 tccatcaatg gatgaatgaa tttaaaaatc ttggtatata cataatatgc aatactattc 46980 attcataaaa aagaaagaaa ttgtttcatc tgtgacaaca tagatgaacc tggagaacat 47040 tgtgtcaagt gaaataagct acacacagaa agaaaactac tgcatgattt cactgatatg 47100 tggaatctta aaaagttgat ctcatagaag ctgagagtag aatggtggtt agcagaagct 47160 ggtgagggta agtgaaagag ggtatgggag aacactggtc aatgagtaca atgttaaagt 47220 taaatagagg aacgggttct agtgttctat tgcacatcag ggtgaatata aaaaacaata 47280 gtgtattata tatttcaaaa taacttgaag aaaggatttt aaatgttctc accataaaga 47340 aatgataaat gtttaagatg atggatattc taattaccct gatttgagca ttacacaata 47400 tatacacata tcaaaacatc atatcgtacc acataaatat gtacgattat tctggctcaa 47460 ttgaaaataa aataaaattt tagaaacgtt aagaaaggaa tattatgaac aatcttatct 47520 cacagatttt ataacctagt taagatggac caattccttg aaagatacag tctattataa 47580 ctcatacagg gagaaatagg caatctaaat actgttaatt gtattaaagg aattaattat 47640 tgaataaact tccaaaacag aaagcatcaa gcccagatgg gttcactgga gtattccacc 47700 aaacatttag gaaagaaaac tacaccaagt ctctacagtt gcattgaaaa tatagaagca 47760 gaggcaatat tttctaactc attgtataag gtcagcatta cactaatacc aaaagcagac 47820 aaaaatattg caaggaaaaa aacacatcaa tatatctgat gaatatagat gcaatatttc 47880 tcaagaaata ttagcaagtc aatccaacaa atttataaaa ataattctac acttgagata 47940 agcctgggca acatagcaag acactgtacc tacaataaat acaaaaatta gccaagcatg 48000 gtggtgcata cctgtactcc tagctacttg ggaggttgag gcaggaggat tatttgagcc 48060 caggggttag aggctacagt gagctatgat tgtgccactg cactccagcc tgggtgacag 48120 agtgagaccc tatctcttaa aaaaagaaaa aagaattata caccacaaac aagtaaggct 48180 tatcccaaaa aagtaagact ggttcaacac tggatatcag ttaatgtaac ccattatatc 48240 aataggctaa agaagaaaag tcacaagatt ataacaacag atttttaaaa agtgtttaac 48300 aaattacaac acctattatg atttcaaaaa aaattcagta aactaggaat agaaagtaat 48360 cttcctcaac ttgaaaaata acatctacaa aacagccttc atctgacatc ttatttaata 48420 gtgagaaact atgagctttc ttgctaagat taggaagaaa acaaggattt ccctctcaca 48480 ttccttttca tcattgtaca gtaagtccta gctagtgcaa tgagacaaaa aaggaaataa 48540 aagacacact aattggagga gagaaataaa atgttgcagg tgacatgatt gtctatgcag 48600 acaatctaaa ataattaacc aaaaaaactc tcccagaact aataggcaat taaagcaaga 48660 ttacagaata tgttaatata caaaagttca ttgctttcct atataaccgc aataaacaag 48720 tataatttga tattaaaaaa caatattatc tgcattagca cacctgaaaa tgaaataatt 48780 aggtataaat ttaataaaat atgtgcaaga tctatacaag gaaaactacg aaacttgaat 48840 gaaagtaatc aaagaaaaac taaataaaga gttattccat gtatacatag gaagattcaa 48900 tattgtcaag gtgtcagatc ttctcaactt actctatgta gattcaacac agtcccagtc 48960 agtaacccag caagttattt tgtggatatc aacaaactga ttctaaactt tatgtgaaag 49020 acaaaacatg cagaatggtc agcataatat tgaaggtgaa gaacaaattt gaaggactga 49080 tacttcccaa aatcaatatt tactataaag ctatagtaat taagacagtg tgctattagt 49140 gaaagaacaa acaggtcaat ggaacagaat agcaagccca gaaatagtct ggcaaaaata 49200 tagtcaacca atatttacaa aaaagcaaaa tacaatggag aaaaggtcat aattttaaca 49260 aatggtgctg aaacaagaag acatccacac gcctaataat aaatctaaac acagatctta 49320 tatccatgac aaaaacgaac ataaaagaaa acctagatga ccttgagtat ggtgatgact 49380 ttttagatac aacaccaaag gcatgatcca tgaaaaaaag aactgataag ctggcattta 49440 ttaaaattaa aattaaaatt tctgctctgc aaaaggcaaa tgagaagcaa accacagact 49500 aaagagaata tatttgcaaa aggcatacct gataaaagat tgttattcaa aatatgcaga 49560 agagctctta aagcacaata ggtaaatgaa caatctgatt ttaaaatggt caaaaaaaca 49620 gacacctcac caaaaaatta cacagaaggc aaataagtaa atgaaaagat gctcatatac 49680 ttatgaatat ctttgttatt agggaattgc aaattaaaac aatgatatag cactgcatat 49740 ttattagaat aatcaaaatc taaaacatta acaacacaaa atgctattga gaatgtgaag 49800 caacaggaac gttcactcat tgctagtggg aatacaaaat agcacagcca cttcagcgac 49860 agtttagtgg tttattccaa aattacattc ttaccatgca ttccagcaat tgtgctcctg 49920 ggtatttacc caaataagtt gaaaacatat attcccacaa acacctgcat acaaacgttt 49980 atatcatgtt tattcctatt ttccaaactt ggaagcaacc aagatgtcct ttggtaggta 50040 aatggagaaa taagctgtgg tacatccata caatgaaata ttattcagtg ctaaaaagaa 50100 atgagctgtc aagcttattt aaaggttacg tgtctcatgc aaagacatgg aagaaattta 50160 tgcatattag taagcaaaag tgacagtctg agaagctaca tactgtagat tccaacttta 50220 tgacattctg gaaaaggcaa aactctggag aaagtgaaaa cattagtggt tgccagggct 50280 tggggagagg gaggcagagc acagaggggg aacaaagggc agtagaacta ctctgtacta 50340 tactataaca gtggacacat gtctatactt ttgtcaaaat acaatgtata acaccaagag 50400 tgaatcctaa tgtaaactat gaactttggg tgataatgat gtgtcaatgt aggttcatcc 50460 actgtaacaa atataccact cttgcatgga agcgtgatgg tgagtgaggc tctgtgtatg 50520 ggggacaggg ggtttatggg aaatctgtaa cttctgctca attatgttat taatctaaaa 50580 ctgctctaat aataaaatct acttttaaac atgtaataga attcccaaga actgtgggac 50640 aattacacaa agtgtagcac acacatataa cagaaatacc aaaaaaagaa aagagcagaa 50700 gaagtatttg aagaaataaa agatgaaaaa ttttctaaat taatggcaaa caccaatcca 50760 gagatccagg aagctcagag aacaccaaag caaaataaat gtcagaaaaa atgtacctct 50820 aggcatatca tattcaaact gcagaaaacc aaagacaaag ataaaatcct gatagaagtt 50880 gagggggaaa cttacagata aataaacaat aataagaatt tcctctgact tatcagaaat 50940 cagccaagta agaagatagt ataataaaat atttaaagtg ggaaaagaat acaaatcccc 51000 ctgacctaga attctctatc aagtgaaatt attcttcaaa agtgaagaag aaataaagac 51060 tttctcagac atacaaaaac aggaaatttc tcaaaagtaa acttttctta caaaaaatgc 51120 taaaagaagt tcttcagata aaggggaaaa tgataaaata ataagcacaa atcaatataa 51180 aggaagagca attgagaagg aataaatgaa ggcaaattaa agctactttt cttactctta 51240 attgacctat agatagttgc tcgacacaaa aatagcaata atgcattggt aatcattatt 51300 accacttatt aggataagtg aactgaatga caatattaaa agagatgcag cccaggcacg 51360 ggtggcccat gcctgtaatc ccagaacttt gggaggccga ggcaggtgga tcacttgagg 51420 tcaggagctt gtggccagcc tgaccaacat ggtgaaaccc cgtgtctact aaaaatacaa 51480 aaataggcca gatgtggtgg cacgcacctg taatcccagc tactcgggag gctgaagcag 51540 gagaatctct tgaacccgga aggcgaaggt tgcagtgatc caagattgta ccactacact 51600 ccagcctggg tgacagagtg agactctgtc taagaaaaag gggcgggggg ttgaatgcaa 51660 agagaaatac aatttaactg aacagctatc agttaaagtg aactgaacta ttaattaaat 51720 ggatctaatt ggcatttgta gaatacttca tccagtaata gcagaatata tcttcttatc 51780 aaacttatat gcgatttcca tcaagagaaa cttcatatgg accataaaac acattttaac 51840 aatgtaaaaa aatagaaatt acacaaagta tactctcaga acacacagaa tagaactaaa 51900 aatcagtaac agaaggatag ctgaaaattt tcaaactgtt tggagattga acaacacact 51960 tctaagtaat aagtgaattg aagaagatat ctcaagaaat attttgaaat aaatgaaaat 52020 gtaacatcat agtttgtagg atgcagtaaa agcagttctt tgagtgaaat ttataacact 52080 gaatggatat attagaaaat aaaaaaatgt gatattaata aactaatctt aggccttagg 52140 aaactagaga aagaaaagaa atgtaggcct aaagaaagca gaataaaaga aatgataaaa 52200 attggagcat aaattattaa attgaagtag aatttaaatt ttctctgcag agtaagtatg 52260 tgaggtaatg aatatgttaa ttagctttac ttagccattc cacatgtata cataaacacg 52320 ttatacagca taaacgtata ttattttgtt tttcaattaa aaatttaatt aaaatcagaa 52380 aaaattaata attaaattta aaacaggaat tcaatactga aaaatcaatg aaaccaaaag 52440 ctgtttcttt aaaaagataa taaaattgat aaatttctag ccaggctaat caagaaaaga 52500 agaggattca acattcttaa agaaaacaat tttcaaccca gaatttcata tccagccaaa 52560 ctaagcatca taagtgaagg agaaataaaa tattttacag acaagcaaat gctgagagac 52620 ttttgtcacc accaggcctg ccctaaaaga gctcctgaag gaagcactaa acatgcaaag 52680 gaacaaccgg taccagccac tgcaaaacca tgacaaaatg taaagaccat cgagagtagg 52740 aagaaactgc atcaactaac gagcaaaata accagctaac atcataatga caggatcaaa 52800 tttacacata acaatattaa ccttaaatgt aaatgggcta aatgctccaa ttaaaagaca 52860 cacactggca aattggataa agagtcagga cccatcagtg tgctgtattc aggagactca 52920 tctcatgtgc agagatacac ataggctcaa aataaaggga tggaggaaga tctaccaaga 52980 aaatggaaag caaaaaaaag caggggttgc aatcctagtg tctgataaaa tagactttaa 53040 accaacaaag atcaaaagag tcaaagaagg ccactgcata atggtaaagg gatcaattca 53100 acaagaagag ccaactatcc taaatatata tgcacccaac acaggagcac ccagattcat 53160 aaagcaagtc cttagagacc tacagagaga cttagactcc aacacaataa taatgggaga 53220 ctttaacacc ccactgtcaa tattagacag atcaacgaga cagaaggtta acaaggatat 53280 tcaggacttg aactcagctc agcaccaagc agacttaata gacatctaca gaactcttca 53340 ccccaaaaca acagaatata cattcttttc agcaccgcat tgcacttatt ccaaaattga 53400 ctacataatt ggaagtaaag cactcctcag caagtgtaaa agaacagcaa tcacaacaaa 53460 ctgtctctca gaccacagtg ctatcaaatt agacctcagg attaagaaac tcactcaaaa 53520 ccgcacaact acatggaaac tgaataacct gctcctgaat gactactggg tacatagtga 53580 aatgaaggca gaaataaaga tgttctttga aaccaataag aacaaagaca ctatgtacca 53640 gattctctgg gacacattta aagtagtgtg tagagggaaa tttatagcac taaatgccca 53700 caagagaaag caggagagat ctaaaattga caccctaaca tcacaattaa aagaactaga 53760 gaagcaagag caaacaaatt caaaagctag cagaaggcaa gaaataacta agatcagagc 53820 agaactgaag gagatagaga cacaaaaacc cttcgaaaag tcaatgaatc caggagctgg 53880 ttttctgaaa agatcaacaa aattgataga ctgctagcaa gactaataaa gaagaaaaga 53940 gggaagaatc aaatagatgc aataaaaaat aataatgtgg atatcactac caatcccgca 54000 gaaatacaaa ctaccatcag agaatactat aaacacctcc atgcaaataa actagaaaat 54060 ctagaagaaa tggataaatt cctggacaca tacaccctcc caagactaaa ccaggaagaa 54120 gttgaatctc tgaatagacc attaacaggc tccaaaattg aggcaataat taataggcta 54180 ccaaccaaaa aaagtccagg accagaccaa ttcacaactg aattctacca aaggtacaaa 54240 gaggagttgg taccattcct tctgaaacta ttccaatcaa tagaaaaaga gggaatcctc 54300 cctaactcat tttataaggc cagcatcatc ctgataccaa agcctggcag agacaaaaca 54360 aaaaaaagag aattttagac caatatcctt gatgaacatc gatgtgaaaa tcctcaataa 54420 agtactggca aactgaatcc tgcagcacat caaaaagctt atccaccatg atcaagtcgg 54480 cttcatcccc gggatggaag gctggttcaa catatgcaaa tcaataaatg taatccagta 54540 tataaacaga accaaagaca aaaaccacat gattatctca atagatgcag aaaaggcctt 54600 tgacaaaatt caacaaccct tcatgctaaa aacactcaat aaattaggta ttgatgggac 54660 atatctcaaa ataataagag ctatctatga caaacccaca gccaatatca tattgaatgg 54720 gcaaaaactg gaagcattcc ctttgaaaac tggcacaaga cagggatgcc ctctctcacc 54780 actcctattc aacatagtgt tggaagttct ggccagggca attaggcagg agaaggaaat 54840 aaagagtatt caattaggaa aagaggaagt caaattgtcc ctgtttgcag atgacatgat 54900 tgtatatcta gccccatcat ctcagcccca aatctcctta agctgatagg caacttcagc 54960 aaagtctcag gatacaaaat caatgtacaa aaatcacaag cattcttata caccaataac 55020 agacaatcag agagccaaat catgagggaa cacccattca caattgcttc aaagagaata 55080 aaatacctag gaatccaact tacaagtgac gtgaaggacc tcttcaagga gaactacaaa 55140 ccactgctca atgaaataaa agaggataca aagaaatgga agaacattcc atgctcatgg 55200 gtaggaagaa tcaatatcgt gaaaatgccc atactgccca aggtatttta tagattcaat 55260 gccatcccca tcaagctaca aatgactttc ttcacagaat tggaaaaaac tactttaaac 55320 ttcatatgga accaaaaaag agctcacatc gcgaagtcaa tcctaagcca aaagaacaaa 55380 gctggaggca tcacactacc tgacttcaaa ctatactaca aggctacaat aaccaaaaca 55440 gcatggtact ggtaccaaaa cagagatata gatcaatgga acagaacaga gccctcagaa 55500 ataacgccgc atatctacaa ctatctgatc tttgacaaac ctgagaaaaa caagcaatgg 55560 ggaaaggatt ccctatttaa taaacggtgc tgggaaaact ggatagccat atgtagaaag 55620 ctgaaactgg atcccttcct tacacctcat acaaaaatca attcaagatg gattaaagac 55680 taaattgtta gacctaaaac cataaaaacc ctagaagaaa acctaagcat taccattcag 55740 gacataggca tgggcaagga cttcatgtct aaaacaccaa aagcaatggc aacaaaagcc 55800 ataattgaca aatgggatct aattaaacta aagagcttct gcacagcaaa ggaaactacc 55860 atcagagtga acaggcaacc tacaaaatgg gagacaattt ttgcaaccta ctcatctgac 55920 aaagggctaa tatccagaat ctacaatgaa ctcaaacaaa tttacaagaa aaaaacaaac 55980 aaccccatca aaaagtgggc gaaggacaag aacagacact tctcaaaaga agtcatttat 56040 gcaggcaaaa aacacatgaa aaaatgctca ccaccactgg ccatcagaga aatgcaaatc 56100 aaaaccacaa tgagctacca tctcacacca gttagaatgg caatcattaa aaagtcagga 56160 aacaacaggt gctggagagg atgtggagaa ataggaacac ttttacactg ttggtgggac 56220 tgtaaactag ttcaaccctt gtggaagtca gtgtggcgat tcctcaggga tctagaacta 56280 gaaataccat ttgacccagc catcccatta ctgggtattt acccaaagga ctataaatca 56340 tgctgctata aagacacatg cacacgtatg tttattgcgg cactattcac aatagcaaag 56400 acttggaacc aacccaaatg tccaacagtg atagactgga ttaagaaaat gtggcacata 56460 tacaccatgg aatactatgc aaccataaaa aaggatgagt tcatgtcctt tgtagggaca 56520 tggatgaaat tggaaatcat cattctcagt aaactatcgc aaggacaaaa aatcaaacac 56580 cgcaggttcg cactcatagg tgggaattgg acaatgagaa cacatggaca caggaagggg 56640 aacatcacac tctggggact gttgtggggt gggaggaggg gggagggata gcattaggag 56700 atatacctaa tgctaaatga caagttagtg ggtgcaccac accagcatgg cacacgtata 56760 catatgtaac taacctgcac attgtgtaca tgtaccctaa aacttaaagt ataatagtaa 56820 taaaataaaa tttaaaaaaa gatagcatga gtagaaaaaa aaaaaagaag agggaagcca 56880 caagttacta atatcagaaa tgaaagaggg gtcatcacta ctgattctgt ggacattaaa 56940 agaatgataa ataaatacca taaacaactc tatgcccaca agtttgatag cttagatgaa 57000 atgaacctat tccttgaaaa gctcaatctg ccaaaactca cataaagtga aatagataat 57060 ttgaataggc ctatacctac taaagaaact gaattaataa ttaataatct tccacaaaag 57120 aaaacaccag gcccagatgg gttcattagt gaattctgtc aatcatttaa aaaaaaaatg 57180 gtaacaatta tctgcagtct tctctagaaa acagatgaaa agggaaccat tcctaattca 57240 tatacttgct gacttgttcc atgaggccag aaatgcccta attctaaaac caatgatatt 57300 aaaagaaagg aaaactacag aacaatatcc ctcatgaaca taaatgcaaa aattctcaat 57360 aaatattagc aacttaaatt tttgtttaaa ggtataatca tgtatagaaa gaattatagt 57420 ccgtggccaa gtgagattta ttccaggcat gaaaatctgg ttaaatattt aaaaatcaat 57480 taatataatc tatcacacaa acaagataaa gaaggaaaat tatgtgattt ttccatcaat 57540 ggacacagga aaagcattta acaaaattca acatccattt ataataaaaa ctcagcaaac 57600 tggaaacaaa gagaaactgc ctcaacttca ttaacagcat ctaaaaaaac catacagtta 57660 acctcatatt taatggcaag aaattaggtg cttttgtcct aagactggga acaaggtaaa 57720 gatgtcctct ctcgccactc ccattcaaca ctgaactaga tgtcttagat aatttaacag 57780 gacaagaaaa gtaaataaaa agtttataca ttggaaaaga tgaaataaaa atgtctttgt 57840 taataaattt gtaattttct atattaaaat ctgaaagaat agacaagaaa aataaaaaca 57900 aacaaaaaag aaacttccag acctagtagg caaaaaaatg gcaacactga agaatagaag 57960 gttaatatac aaaagtcagt tgtttttttc cagcaattac caagttgaga ttgaaattaa 58020 aaacacaata ccatttatgt gaacaccaaa aaatgaaact taggtgtaaa tctaacaaaa 58080 tatatacaag atctattgaa gacgactaca aaactgatgg aaaaaaaagc aaatatctaa 58140 ataaatgaag agatgttcca tgttcatgaa taggaagact taatattgtt aagatgtcta 58200 ttctgcccaa cgtgatctat aaattcaata caattccaat caaagtccca acgagatatt 58260 ttatcaatat aaacaaactc taaaatcata tggaaaggca agagacacag aataaccaat 58320 gcaatattaa agaaaaagag caagtttgaa caaccaacac tacctgattt taagacttac 58380 tataaagctt cataatcaag acagcatggt attggtaaaa gaatcaacaa gtagattgat 58440 gaaacagaac agagagccca gaaatagaca tacaaaaaga tagtcaacta gtctttgaca 58500 aatgagcaaa ggcattgaga gatagccttt tcaagaatgg ctgtcttagt tgaaagagtg 58560 gttgaatatc cacatgcaaa aaaaaaaaaa aaaaaaaaac ttaatgtaga ccttatgcct 58620 ttcacaaaaa ccaactcagt ttagatcata gatataacat aatgctcaat actattatat 58680 aaaacgacta gaagataaca taggagaaga tttaagggac ctactctttg tctatgagtt 58740 tttagataca acaccagaag cataatccat gaaaaatgat tgaaatgttg gacattatga 58800 aaatttacaa ctttgcaaag gacactgttt aagagaatga aaagacagcc ctcagaatgg 58860 gagaaaatat ctgcagaata tatatttcat aaaggatttg tatccaaata tgtacaaaga 58920 actcttaaaa ctcaacaata agaaaacaac tcatttcaaa aacggccaaa agatctgaat 58980 aaacccttca ccaagaagat ggcaagtaaa cagatagaaa gaagctcaaa atcatatgcc 59040 attagggaat tgcaaattaa aacaacagtg agacaacact acacatctat tagataatca 59100 ctaaaattca aaaaaaactg aaaataccaa tggctgatga ggatgaatat taacaggaac 59160 tttcattcat tgctgctggg aattcaaaat agtacagtca ctttggaaga taatttagca 59220 gtttcttaca aaactaagca tggtcttacc atacaaccca gcaattgtaa ggctatgtat 59280 ttactcagtt gagttgacaa cttatatcca cagaagaatg tttattgtag ctttattcat 59340 aatcaccaaa aactggaagc aaacaagagg ttcctcaaaa gctgaatgga taagctgcgg 59400 tacatccatt aaatgggata ttattcaatg atataacaaa atgggctatc cagccatgaa 59460 aagacatgga ggaatcttaa atgcccattg ctaagtgaaa gaagccagtc tgaaaaagct 59520 acatactaaa tgattcaact atattacatt ctcaaaaagg caaaactgta gaagagcaag 59580 aaaccagtgt tgccagagat ttggagtagg aaagagatga atagataaaa gcagtggatt 59640 tttaggacag tgaaactctt ctgatattat aatggtgggt acataacatt atgcaatggt 59700 caaaacccat agaactgtcc aacacagagt gaaccttaat ataaacaatg gactttagtt 59760 aatgataata tatccatatt ggttcatcag ttttaacaaa tgaactacaa gatgttaatg 59820 acaaggaaaa gtatatagat gggagggagt catagggaaa ccctctgtgt tgtttgcaat 59880 tttttgtaaa tataaaattg ttctgaaaaa taaagtctat tttcttaaag tcagtccagg 59940 gatcctcctt tatatgaata caatctggca ttttgctaag taaaatttct ctgtttccag 60000 catttaagtc tcacttctct gtgcaagatt ttctttagtt ttatatttcc taggtcattt 60060 ctgtcagaat taaggggtgg ggtagtgaga attcagacat atgtcctcaa gctgccatct 60120 gttctccaaa tggtatccca tatgttgttg atgtgtagag ttttcattgt tgacatttat 60180 gaattgacta taattgtact ttgatttcct tcttgactcg agttaattat gagggtgttt 60240 aaatttccaa gtggtatttt ttaaaaaaac atgttactaa tttctgcttc attgctcatt 60300 gttttaaata tgtgatttgc gtaagtctta ctttttagag ctattgagag ggtttttttt 60360 cttggtagtt tagtatatcg ccaatttttg aaatgtctag atattttata gcaatgtgta 60420 ctattcttat gttatgaagt ctattttttt ctatctgtat atttttgttt attcttctgt 60480 aaaactttga acggtttcat tatatattta gcattatgtt acttgttaca tataactttg 60540 tgaatatcct attgccatca tgtgttgtat cttttatcaa tataaataat cctttatcac 60600 atgaaatgct gtttgctttg aatttaattt gtctaatagc aatgttgtaa tgaatgcctt 60660 ctttaatttt tactttcttg atataccttt ggccatccct ctatttccac acttagatat 60720 ctaagtgatg tggtttaaaa tttttctctt ttaaacagca tagaattaga ttttagggaa 60780 gttttaaaat aagttatttt cttaatgaaa gaccttaagt cattcacatg tattgcgaca 60840 aatagtgttt tggtttggtg taatttcagt tccttatttt agtctttcta tattaagggt 60900 tttttgtttg tttgttgcta tttacttgtt ttttcttttt atttgattat caattgtggt 60960 aggcttgaaa aaagctcccc gcccctaccc cccaccacca ccaccaccac aaaatccgta 61020 tcctaatccc tggaacctgt gatgttacct tatataagaa aagggaactt cacaaatgta 61080 atcaaattaa agatcttaaa actgggagat tattctggtt tatcccagtg attcccacat 61140 gtaatcataa cagggtggta gaagggagtg tgacacacag acagaagagg aaaaggcaga 61200 gcttgggccg atatggtcac acgccaagga ctgctggcag tcacccgaag ccagaagagg 61260 caaggggcag attctcccct agagtctctg gaggactcat gggcttgcca aacttttatt 61320 tttgcccagt agaactaatt ttggacttct ggtctccaga gctgtgcgag aataaattta 61380 tgttgtttta agccataaag tttgtagtag tttgttacag ccaccatagg aaactaatta 61440 aaatttctcc atttttattt tactctatca tagcttatct ttaactttta gctttaatat 61500 atctctatca aggttaaaaa acaaaagaga gacccaaaat acataacaaa attgaacatg 61560 atgtctttct ttgtactctg tcccttcact caactccctt aagtttttcc tgaaatgttc 61620 catagtcata tttataatta ttttgtaagc atttcatgtg tttctaactt cattgcttac 61680 catagttgtt attattctat gctcttccct cttcttgaat tcttaatttt aattcaattc 61740 tcaattagct gaagtatgcc aggaagacta taaaatatta tattttcttc cttcttatat 61800 atctgagaaa actgttctgt gccttggcac agaaatcata tttacaaagt tcttgaatca 61860 caattttttt tcaaaactct gaacatgttg ttatagtgtt ttctggcatt actttttgtg 61920 ggaaagaggt atgataattt aagatgcatt tcttttaggt aacttttaaa tttttttacc 61980 ctgccttaaa tgcctgaaga tggttaatct ctgaaattaa atactctttt gattgtatct 62040 caaagtcagc atctttttat caacattgac tgctcttctg gacactctta tttatggctc 62100 ttcctcctgc tccagattct gaactgtgcc tgtcacctcc ctcaagacag ccacagagcc 62160 ccaagatcct tataacctca ccatgatgtt ccactccaca gggttctgcc attgtgtgct 62220 ttctttttca tccttctctg atgccacctc ctcctctgtt tgttgccagc cttaataatt 62280 ttaaattcat ggatcacagg tagaaacccc agttttgtct aagtagacga tcgatttttt 62340 ttttcttaaa gctagtcttc catttttctc tttctctatt tgtcaccttt tcccaagaga 62400 taattttttc ttttagtttt cagaggagcc ttcaatttct ttttttaaac cttttttcta 62460 acttttattt taagttgagg ggtacatgtg caggtttctt atacaggtaa acttgtgtca 62520 tgggggtttg ttgtacagat tatttaatca cccaggtatt tttttttttt tttttttttg 62580 agacggagtc tcgctctgtc gcccaggctg gagtgcagtg gcgcaatctc ggctcactgc 62640 aagctctgcc tcccgggttc acgccattct cctgcctcag cctcccgagt agctgggact 62700 acaggcgccc gccactacgc ccggctaatt ttttgtattt ttagtagaga cggggtttca 62760 ccgttttagc cgggatggtc tggatctcct gacctcgtga tccacccgcc tcggcctccc 62820 aaagtgctgg gattaagctt catattcatt agttattttt cctgatccta accctcctcc 62880 caccctacac cctcctatag gccccagtgt gttttgttcc cctctatgta tctgtgtgtt 62940 ctcatcagtt agcttccact tataagtgag aatatacagt attttgtttt ctgttcttgc 63000 attagtttgc tgaagataat gccctccatc catgtccatc catgtccctg caaagcacat 63060 tatctcattc tttcttacga gccttcaatt tctaatcatt cctcagaacc tcctccctat 63120 ggtggctttc acaacattag tgctgagatg catttgtaga aataacaaat cataaagaac 63180 cacaatgtgc ttgattgtta tttgtctgag ccagagaaag aacaaaaagg cacgaattca 63240 gaacaaagat aactgccaag aagaaagtga agtaaatgct ctccattaga cttcaatcta 63300 caagttactc ttctactccc tctggatttg aacctaatgt tacaaagtgg agatacagcc 63360 agactcttga tagaaatgag gctccaagtt acctgaaaaa tgtccacctt gatcatccct 63420 tcaaatatat ttcatttaat cacattctaa atatgctctt cacataagag aaattaactt 63480 cttaaatccc aatttccctt tctgctaatt atgcaaaaaa agattgtaca cagataatta 63540 aaaggtgtgg gtaaagttaa taaaagagac agtgggaagg aagaggagac ccagatcctg 63600 agcctaatga agtggatgaa aaaggggagc tctctgatgg tgtcagtgct gatgatgata 63660 aatgattcaa caccgcacat aggctcccta aaaccggaac ccttctatca tctcttgact 63720 cccactgata aaaagcaaat gaacttttgt ttctaattat tctggaatgt caattgtggc 63780 agaaaaaatt agtttagctt taaaagtcaa ttccaaacaa atgtaccatg caaatgtcaa 63840 ggactgatcc tgaaatatgg agtttccaag aggccaaggg aataagtgag caagaaagaa 63900 ctgaagcatt gtcactcatc atggccagca gtacaaattc tagcaccagg aaccaaactc 63960 tgcttcctgg tgtggagatg aaaagggaga gttccctggt ccatccatca caggacatgg 64020 gacaggggta tggctctctg ttcagcttcc tcaagctcaa actccttata ggagggggag 64080 catgcagaag ggtaggtgca ggagccaggg caagtgcatt gaactccggc cccacagtag 64140 tgtctggggt gggtgcctgt gactcctgaa gccccagtgt tatagtgctg ttttaactct 64200 gccatctgca gatggcttaa gtggtaacca gctcagtgcc ctcttggtgg ccatgtcctc 64260 gtccataggc caggaagagt caggtcacac acagacttga aggatgaatg caggagtttt 64320 attgagtggt ggaggtggtt ctcagtggga tggatgggga actggaaggg ggatggagtg 64380 ggaagatgat cttcccctgg agtttggctg tccagggcca ttctcctgtc tgattgtccc 64440 cagctgaact cttcttagtg ttcagaccct ccttctcttc tctccttctc tgccatgctg 64500 ttctgccatt cgtctgctca tctcctcctg gagcctggga tttggggttt atatgggtac 64560 aggatagggg catgtagctg gccaaaaggc aactttttgg gcacaaaaac aggaatacct 64620 gttctcattt aagaccactg gtttccaggc ttgagggtgg ggtctttgct gggaaactgc 64680 cctctttcac ccagtatttc cctttctctt gtccatgtaa gagagttatt tcccttccta 64740 atccaacact caccccttct ttggttcacc tctcagattt ctaaataaca caaggtgcta 64800 ttctttccat tatgtgcctt ccctcacctc tctgaagtca taagcttcct ctcatttctg 64860 tctttaggtt gtgctgctct acgcctctac ctacgtcctg gtgtccctca gcatagacag 64920 ataccatgcc atcgtctacc ccatgaagtt ccttcaagga ggtgagctgg ctttaccagg 64980 tgctctttca taaagaactg tccttgagtg agggtaggat cattttcact aatattttac 65040 tcttaataat agtgatcttc ctcctctttc cttctctttc ttctctcttc attctcctct 65100 tccacctctt tcctcacttc atgggtctga ttgtctaaaa agatgtacaa aagaaaactt 65160 agatgcctgg aaaaatgccg atggttccca tggacagccc agagccacta aggaaggtgg 65220 gtggctgacc cactttgtga ccattcagct tgatgctgat gcttccatct ttttcctcta 65280 gagcagtgtt gacatgcata cctgtccaaa gaaatgaact ctcccacact aacttctcat 65340 tttccagaaa caaacacctt gttctcctta tccaaaacca tagaaataat tggaaagatg 65400 tttttaattg atcatcgtat tgggaaaaaa aaataaggaa actctctttg atccagaaat 65460 ggttagggat ccctaagaaa aggaagcaga tgggtcagag ggaaggctga gaccacacag 65520 cccacaaaac ccctaggaga tgctgaagtg ggatgggagg ccttaggagc acttcctgaa 65580 caggctgcat caatgtggag tgtaggagag gacccgaggc aactgacaag gtgatttctg 65640 aagtacaaca cagaggatta atcacagcaa gtttccctgg atttgaagag gcagagaggg 65700 gccctgggga gcagtaatgc cctagaggaa gggtgagtac atattcacaa gactagctgc 65760 ctactgctct gcccacaatc agagaccact ctcctccata caccctgaaa gcaaatacaa 65820 agccattgtt tagcaacctg ttctcccttc ctccagataa cttcgaaaac tgataaagaa 65880 cctaacaaaa aatcttgacc acaaaaatga gtgcaatcaa atattattta aaaagtgaca 65940 aaatccaaac tgtagaaaac agataatacc tttaaaatct cattccacac aatttggatc 66000 tagggaagca aatttaatag aagtagcaga attttaggat aaatataatt aacgtcatca 66060 aggatctaca agaagtggag tgaaataggg taatttcatt tactattgac aggggtataa 66120 gtaaacacat cttattgaaa tataaaatgt gcagcccttt gatatgactt cttggtatct 66180 gctctggaga aacacccaca cgtgtgcatg tatacatatg tgatgtatat tgtggcactg 66240 cctacaatag caggaattca tcgctaacct tggtgtgtct cagtggagga atggctaact 66300 agtctatgga agaagtttca gtaccttctg tttattgatt gcatactagg tgtcattcat 66360 gattctaact gattcataca tattaaatat tttaatattc ataatatctc tgtgaggtgg 66420 gctctattat tatctgcatt ttacaggtaa ggcaatcgtt gttccaagag tgaaagtaat 66480 ttgcccaagg tcacagctag taagtgcagg aacaggattt gaacccacac agtctgggtc 66540 tagctccagc gccctcaaat gctatatagc ctgcctctca atgtggaagt ggtagagcca 66600 tgggcagtaa tatgcatcaa catgaacata tccatattgt atgctgagtg acaaaaacaa 66660 tatgcacaaa aatccatgtg aacgataaca ttaaagtcaa aaactcaaaa caatgctaga 66720 tattgtgtac agaaagacag agaggagcag aaagagagaa cacacaaaag aaaactccag 66780 gaaaaataaa aaactatttg caaaaacaca caaaacttga catttgacct cacttctagt 66840 tatgggagtt agaccagtgg tgtgaccacc acaggaactt atatgcaagg tggtaatttt 66900 tacatgaaga acatatcaat gtgttgtgtg caattaaaat gaatttattt tgatcatgct 66960 tgttatgcct actgtacagc ataagacata tgagtaaaaa tactaaattg tatacttaag 67020 aatttgctgg ggatctgttc caagatggcc aaataggaac agctctggtc tgcagctccc 67080 agcatgatcg atgcagaaga caggtgattt ctgcatttcc aactgaggtg cctggttcat 67140 ctcactggga ctggttggac agtgggtgca gcccatggag ggtgagccaa agcagggcag 67200 ggcatcgcct cacctgggga gcacaaaggg ttgggggatg tccctttcct agccaaggga 67260 agctggggca cactgtacct gggacactcc tgccaaatac tgcacttttc ccaaggattt 67320 agaaacgagc agacaaggag attctctccc atgcctggct caggaggtct ggagccttgc 67380 tcactgctag cacagcagtc tgaaattgaa ctgtgaggca gcagcctggc taggggagga 67440 gcgtccacca ttgctgaggc atgagtaggt aaacaaagtg gcccggcagc tcaaactggg 67500 tggagcccac tgcagctcag caaggcctac tgcctctata ggctccacct ctgtgggcag 67560 gacatagctg aacaaaaggc agcagacagc ttctgcagac ttaaacgtcc ctgttcgaca 67620 gctctgaaga gcacagtggt tcttccagca tggcgtttga gctctgagaa tggacagact 67680 gcctcctcaa gtgggtccct gacacctgtg tatgctaact gggagacatc tcccagtagg 67740 ggccaacaga cacctcatat aggtgggtgc ccctctggga caaagcttcc agaggaagga 67800 tcaggcagca atgtttgctg ttctgcaata tttgctgttc acagcctctg ctagtgatac 67860 ccaggcaaac agggtctgga gtggatctcc agtaaactcc aacagacctg cagctgaggg 67920 acctgactgt tacaacggaa actaacaaac agaaaggaat agcaccaaca tcaacaaaaa 67980 ggacatctac accaaaaccc catctgtagg tcaccaatat caaagaccaa aggtagataa 68040 aaccacaaag atggggagaa accagagcgg aaaagctgaa aattctaaaa atcagagcgc 68100 ctcttctcct ccaaaggact gcaactcccc gccagcaatg gaacaaagct ggatagagaa 68160 tgactttgac gagttgacag aagtaggctt cagaaggtcg gtaataacaa actactcctc 68220 cgagctaaag gagcatgttc aaacccattg caaggaagct aaaaaccttg aaaaatggtt 68280 agacgaatgg ctaaatagaa taaacagtgt agagaagacc ttaaatgacc tgaaggagct 68340 gaaaaccatg gcacaagaac ttcgtgaggc atgcacaagc ttcaatagcc aattcaatca 68400 agtggaagaa agggtgtcag tgattgaaga tcaaattaat gaaataaagc gagaagacat 68460 ggttagagaa aaaagattaa aaagaaacaa acaaagcctc caagaaatat ggtactatgt 68520 gaaaagacca aatctacatt tgattagtgt acctgaaact gatggggcga acagaaccaa 68580 gttggaacac actcttcatg atattatcca gaacttgccc aaaatagcaa ggcaggccaa 68640 cactcaaatt caggaaatac agagaacacc acaaagatac tcctcgagaa tagcaacccc 68700 aagacatgta gtcagattca ccaaggttaa aatgaaggaa aaaatgttaa cggcagccag 68760 agagaaaggt caggttaccc acaaagggaa gcccatcaga ctaacagcag atctcttggc 68820 agaaacccta caagccagaa gacagtgggg gccaatattc aacattctta aagagaagaa 68880 ttttcaatcc agaattccat atccagccaa actaagtttc ataagtgaag gagaaataaa 68940 atcctttaca gaaaaacaaa tgctgagaga ttttgtcacc accaggcctg ccttacaaga 69000 gctcctgaag gaagcactaa atatggaaag gaacaaccag taccagccac tacaaaaaca 69060 tgccaaattg taaagaccat tgatgctagg aagaaactgc atcaactaac gggcaaaata 69120 accagctaac atcataatga taggatcaaa ttcacatata acaatattaa ccttaaatgt 69180 aaatgggcta aatgctccaa ttaaaagaca cacactggca aattggataa agagtcagga 69240 cccatcagtg tgctgtattc aggagactca tctcatgtgc agagatacac ataggctcaa 69300 aataaaggga tggaggaaga tctaccaaga aaatggaaag caaaaaaaag caggggttgc 69360 aatcctagtg tctgataaaa tagactttaa accaacaaag atcaaaagag tcaaagaagg 69420 ccactgcata atggtaaagg gatcaattca acaagaagag ccaactatcc taaatatata 69480 tgcacccaac acaggagcac ccagattcat aaagcaagtc cttagagacc tacagagaga 69540 cttagactcc aacacaataa taatgggaga ctttaacacc ccactgtcaa tattagacag 69600 atcaacgaga cagaaggtta acaaggatat tcaggacttg aactcagctc agcaccaagc 69660 agacttaata gacatctaca gaactcttca ccccaaaaca acagaatata cattcttttc 69720 agcaccgcat tgcacttatt ccaaaattga ctacataatt ggaagtaaag cactcctcag 69780 caagtgtaaa agaacagcaa tcacaacaaa ctgtctctca gaccacagtg ctatcaaatt 69840 agacctcagg attaagaaac tcactcaaaa ccgcacaact acatggaaac tgaataacct 69900 gctcctgaat gactactggg tacatagtga aatgaaggca gaaataaaga tgttctttga 69960 aaccaataag aacaaagaca ctatgtacca gattctctgg gacacattta aagtagtgtg 70020 tagagggaaa tttatagcac taaatgccca caagagaaag caggagagat ctaaaattga 70080 caccctaaca tcacaattaa aagaactaga gaagcaagag caaacaaatt caaaagctag 70140 cagaaggcaa gaaataacta agatcagagc agaactgaag gagatagaga cacaaaaacc 70200 cttcgaaaag tcaatgaatc caggagctgg ttttctgaaa agatcaacaa aattgataga 70260 ctgctagcaa gactaataaa gaagaaaaga gggaagaatc aaatagatgc aataaaaaat 70320 aataatgtgg atatcactac caatcccgca gaaatacaaa ctaccatcag agaatactat 70380 aaacacctcc atgcaaataa actagaaaat ctagaagaaa tggataaatt cctggacaca 70440 tacaccctcc caagactaaa ccaggaagaa gttgaatctc tgaatagacc attaacaggc 70500 tccaaaattg aggcaataat taataggcta ccaaccaaaa aaagtccagg accagaccaa 70560 ttcacaactg aattctacca aaggtacaaa gaggagttgg taccattcct tctgaaacta 70620 ttccaatcaa tagaaaaaga gggaatcctc cctaactcat tttataaggc cagcatcatc 70680 ctgataccaa agcctggcag agacaaaaca aaaaaaagag aattttagac caatatcctt 70740 gatgaacatc gatgtgaaaa tcctcaataa agtactggca aactgaatcc tgcagcacat 70800 caaaaagctt atccaccatg atcaagtcgg cttcatcccc gggatggaag gctggttcaa 70860 catatgcaaa ttgataaacg taatccatca cataaacaga accaatgaca aaaatcacat 70920 gattatctca atagatacaa aaaaggcctt caacaaaatc caacgccctt catgctaaaa 70980 actgtcaata aactaggtat tgattgaaca tatctcaaaa taataagagc tatttatgac 71040 aaactcacat ccaatatcat actgaatggg caaaaactgg aagcattccc tttgaaaacc 71100 ggcacaagac aaggatgccc tctctcacca ctcctattca acatagtgtt ggaagttctg 71160 gccagggcaa tcaggcaaaa ggaagcaata aagcgtattc aattaggaaa agaagaagtc 71220 aaattgtccc tatttgtaga ccacatgatt gtatatttag aaaaccccat tgtctcagcc 71280 caaaatctcc ttaagctgat aagcaacttc accaaagtct caggatacaa aatcaatgcg 71340 caaaaatcac aagcattcct atacatgaat aagagacaaa cagagagcca aatcatgagt 71400 gaattcccat tcacaattgc tacaaagaga ataaaatacc taagaatcca acttacaagg 71460 gatgtgaagg accttttcaa ggagaactac aaaccactgc gcaaggaaat aaaagaggac 71520 acaaacaaat ggaagaacat tccatgctca tggataggaa gaatccatat agtgaaaatg 71580 gccatactgc ccaaggtatt ttatagattc agtgccatcc ccatcaagct accaatgact 71640 ttcttcacag aattggaaaa aactacttta aagttcatat ggagccataa aagagcctgc 71700 attgccaaga caatcctaag caaaaagaac aaagctggag acatcaagct acctgacttc 71760 aaactgtagt acaaggccac agtaaccaaa acagcaaggt acttgtacca aaacagagat 71820 atagaccaat ggaacagaac agagccctca gacataacac cacacttcta caaccatctg 71880 atctttgaca aacctgacaa aaacaagaaa tggggaaacg attccctatt taataaatgg 71940 tgctgggaaa cctggctagc catatggaga aagctgacac tggatccctt ccttacacct 72000 tatacgaaaa ttaactcaag atggattaaa gacttaaatg ttaaacctaa aaccataaaa 72060 accctagaag aaaacctagg caataccatt caggacatag gcatgggcaa agacttcatg 72120 actaaaacac caaaagcaat ggcaacaaaa gccaaaattg acaaatggga tctaattaaa 72180 ctaaagagct tctgcacagc aaaagaaact accatcagag tgaatgggca gcctacagaa 72240 tgggagaaaa tttttgcaat ctacccatct gaaaagggct aatatccaga atctacaaag 72300 aactcaaaca aatttacaag agaaaaaaca accccatcaa aaagtgggca aaggatatga 72360 acagacactt ctgaaaagaa gacatctatg cagccaacag acacatgaaa aaatgctcat 72420 catcactgat catcagagaa atgcaaatca aaaccacaat gaaaaaccat ctcatgccag 72480 ttagaatagt gaccattaaa aagtcaggaa acaacaggtg ctggagagga tgtggagaaa 72540 taggaacact tttacactgt tggtgggagt gtacattagt tcaaccattg tggaacacag 72600 tgtggcgatt cctcaaggat ctagaactag aaatactatt tgacccagca atcttattac 72660 tggtatatac ccaaaggatt ataaatcatg ctactataaa gacacatgca cacgtatgtt 72720 tattgctatt gcagcactat tcacaatagc aaagacttgg aaccaaccca aatgtccatc 72780 aatgatagac tggattaaga aaatatggca catatacacc atggaatact atgcagccat 72840 aaaaaaggat gagtttgtgt cctttgcagg gacatggatg aagctagaaa ccatcattct 72900 cagcaaactg tcacaaagac agaaaaccaa acactgcatg ttctcactca taggtgggaa 72960 ctgaacaacg aaaacacttg gacgcagggt ggggaacatc agacaccggg gcctgtcagg 73020 gagtgagggg ctgggggagg gatagcgtta gcagaaatag ctaatgtaaa tgacaagttg 73080 atgggtgcag caaaccaaca tggcacatgt atacctatgt atccaacctg cacattgttc 73140 acatgtacaa tgataattta aaaaaaagaa tttgctaaca agataaacct tatgttaagt 73200 gctcttgcca caaaaggaaa aaactaaaca aaacaatact aaagggggac aggaagaagc 73260 ctttggaggt gatggataca tttatggcat tgcttgtaat gatggttaca ggaatgtata 73320 catatctcca gacacattaa gtggtatgca ttggatatgt atagcttttt atatgccaat 73380 tatacatcaa taaagtggtt tagaagttaa ttttaaaaat agaaaatata cttgtttcct 73440 gggtttcttc tcggtcattt ggtgtgtctg ttttgtgaag ggttgagacc tgtaccaagt 73500 tttctgggca ctgtaaagcc ctagttatta tgatagggga ggcaggaaat tgatgaggca 73560 ggggagatag gagagacatt tcgtgacata ggtatgcaaa aatgtgtcaa tgaagcatca 73620 aattctgtaa aatatttgta gagatttatt ctgagtgaaa tatcagtgac aatggacaaa 73680 gccctcagga ggtcatgaga atatgtgccc aaggtggtca gggtgcagct tggttttata 73740 cattttaggg cgacatgaac cttcaatcaa acacatttaa gaaatacata gggttggtcc 73800 gaaatggcag ggttgggtag tgggggatgg ggtgggcgaa gcttccagat tatagttaga 73860 tttaaatttt ttctggttga caattggttg agtttatcta aagacctggg atcaacaaaa 73920 aggaatgtct gagttaagac aaagaattgt ggagaccaaa cttcttattt gcaggggaaa 73980 cttttaggtt tcctcttcag ggagactatg ttgtaaaatg tttctcatca gacttaaagt 74040 ctgtgttgat gttaacgctg gagaggtata atgagacaca cctgaacccg cactgcccat 74100 catggcttgg aacagcctct caggttaaat cttaaaagag ccttggctga ggaggaaatc 74160 cattcggaag gttggggggc cttataactt tatttttggt ttacattcat ggatttgtga 74220 tacacttttt tttttttttt tttttttttt tagacagagt ctcactctgt cgcccgggct 74280 agagcgcagt ggcgcgatct cagctcactg caacttctgc ctcccaggtt caagtgattc 74340 ttgtgcctca gcctcccgag tagctgggat tacaggtgtg catcaccacg cctaattttt 74400 gtattttagt agagatgggg tttcaccgtg ttggccaggc tggtctcaaa ctcctgggct 74460 caagcaatcc accttggcct tccaaagtgc tgggattata ggcatgagac actgcacctg 74520 gcccgtgata cacttattta tccatctatt tgtttatgcc tagccgactt tagaaagggt 74580 tgaatgtggt ggacaaaagg acatcgacgc caaagtattt taaggtgaag aaatataagt 74640 gaaggaaaaa taagtatagg aaattgcagg agggaagtcc caggaaactt gttagaggta 74700 cagacttgag acccatagcc agagggtgac atgatgaatt acatgtttca ccatattcac 74760 taggttaaaa aattagctgt ttgctcgtgg aaaatatgtc tagttctggg agacactgtg 74820 taatatcatc aagagtgtcc taaattatca gaaaggcagc aattaatatt atagtgcttt 74880 tctaaagatg taaaacaact tattccctca ctacaaaatt aagagaggct caacataagg 74940 tgcttggaaa atcctcatca tcagtagctt ctgggaaaga tgaaagctta gaaacacatt 75000 agccagctgc cttcctctgc ccaggcccaa cgaaagtcac tgaagaaatc taaaaacagg 75060 gggagacctg catctggaat gagagccaag gaaagaagcc atccaaatac cagaaacttc 75120 taagaattcc cagcacacga gggagcagat gaaacacgga agccaagtgt ataatgtata 75180 attcagcccc cgggagaact ccctggcctt gtagaggatg aactgatact cacaagttta 75240 tagggtgagg gcagccggtg agaacgcgac acgagaggtt ccaggaagcc caacgcggga 75300 gtcattttag taccgcagct tgtcagaatt taagggcagc tgagaggcag ggttcggagt 75360 ttatgcggct cagctgagag aaagccgtag aaagaagaga ttccccgaga gtggcagggc 75420 tctctgggag agtcatggag cagggagaaa ccaggaggga gtcaaatgta gctgtgcagg 75480 cacaaggcaa tggccgctta actgagggga ggccatattt tatttatttt ttactgctat 75540 ttactgaagc agtatttttc ttagccagca actccagaaa agttgacaat tttaaaggtc 75600 ttcaccaaaa atgaatatga gaataattag aaaaatatca aaataataaa gagaaatatg 75660 cagtgttata ttaaaatgta atataaaact ttgataatta aaacaatgct ggaaccagaa 75720 taacacatat aaatcataca aaatttcaaa tcagttggca aaaaatgaat tagtatacgg 75780 tgttgaaata gctgtctggc cttttttcag aatattagat caccacccac catagctaat 75840 aacaaagtaa attttagttg gattgaaaaa attaacactt caaacataaa aggagtaaaa 75900 gaatatttgg gtaacacctt cataatttca gtgaaggaaa ggcctttcca ggaaccatat 75960 caaaagcaga agcaagaagg aaaatatagt tttttactac ataaaaattt aaattattta 76020 tgtaaataat aaatatccat aaacaaactt aaaaagcaaa attataaatg gaaaatattt 76080 ttatgtaaca ggcaaagaaa aatatccttt ttataaagaa gtctggcaaa gaaataaaaa 76140 cattctaatt gagtaaatgg gcaaagggca tgaacagact aacaagaaac aaagaaacat 76200 aaatgagacc aggcgctgtg gcccacgccg gtaatcccag cacttcggga ggctgaggtg 76260 ggtggatcac ttgaggtcac aagtttgaga ccagcctggc caacatagtg aaaccctgtc 76320 tctactaaaa aaatacaaaa attagctggg catggtggca tgcacctgta atcccgctac 76380 tcaagaggct gaggcacaag aatcgcttga acctgggaag cggaggttgc ggtgagtgga 76440 gatggcacca ctgcactcta gccctctagc attggcaaca gagcaagact tcaccagaaa 76500 aaaaaaaaaa aaaacaacac cataaatgaa tagaaaatgt atagaaatat tcattttgac 76560 tactaattaa agaattgcaa aattgaacat ttggatacaa aattttacca accacataac 76620 aagattaaaa ggaagaatta tccaactatt aggagagtat aaggaaattg gtacttttgt 76680 tgttacagtg agagccataa atagtaggca cttttgaggg aaatgtaaca atatttgtca 76740 aaatttataa atcttctgtt tctaagagtt tatcctaagg aataacaaga actgagaaaa 76800 atagatgaat ataaattatt tataataaaa aatggaaaac aacttagata ataatcggct 76860 attgataaaa ttggagtaca gtataaccac cggaaaaaat gttatttatc agtgcttttc 76920 caattgcact tcccacagtg acccccagag ggctcatttt gctggcctgc tccagggcag 76980 atctgggagc tgctggctgt ctcagtttca accaaagata cctgagcttt caacactttc 77040 ctatactggg ttcgagataa aattatattt gaagaaagga tcttactacc tgaaaaaaaa 77100 tgccacttgt acaagttcat atttcttaac aggaaaagat ggtcataaca ggcttttcag 77160 aggaaaaaaa ttaggttaca aggtaggatc tgtatcatga tctcatttct aaatgtgtaa 77220 tctatgtatt atatatgcat gcgttatcaa aatttaagct tgacgtttct ggttggtgcc 77280 actatggatt tttttccttt tcgcttattt ttatttgcta gtgtttctat aatcaatgtg 77340 tgtaacttat acgattttat aaaaaggtaa atgagttaca tggaaaagag gaaggctaag 77400 cggcagagaa gtacagaaat ggacaagagc acatggaaga gggagtctga ctttccgggg 77460 gtgagaaaca tgagacagtc taccttatat gcaaacctgc atttcatctg ttcgatcctg 77520 gatccttcag ccctgagaag tcactcttca tggcaaatgg gctcagctgc ctggaaggcc 77580 atcagtctcc ctgctgtggc agctgcgtca cagcctaaga gagtggggct ttcacagtgt 77640 agccccagca ccagtaagag aaaaacagct ccaagcctat accctgctgg gcctttgggg 77700 aaacatcttc ggagaccttg gtagaattga ttctaaagta tgattctata ctctcttccc 77760 tgtccatccc tctcaaaagt gaatgcactg ttcatccatc aagtggaaac tttgtggggc 77820 ccaggagtca cacgttgccc ttaagagtgc cctggaacct atagaagaag atgacattag 77880 aattctaacc attgaaagaa caagagcaca gggggcagct actaatgtca cccaggacca 77940 tagaaaccca tcaggcttca cacccccacc atcaagaaga accccctcca gtcctattac 78000 ctgccctctt catcccaccc tgcttctttc ttaatctgaa ctcccactgc ttctctccac 78060 gcctggtttt tctctgttcc tttagggacc agctccccta tgccatcaaa ctcctaatgg 78120 gaggctccct ccacctcctg cctcctgagg tggctgattc ccttaagaca tctcaagagg 78180 atgctcctca accttccttt ttaggtacct catggcctgg tggtggtgaa gacattttcc 78240 taccgttcta gaccacctcc aggccttttc tccttcagta ttgcatacgc atgccctctc 78300 tgtttctctg atgctcatgc tatcagtcta gactaccttc tacaacacct ccccatatgt 78360 ctgtgcccat atggccatgg ccctcatcca gtgaagatgt tgacactatt ctcagtctct 78420 cacctttcat actgtcctaa tcacaggtga ctcgatgtct acataaacta agtctagtga 78480 gagggcttca catgatgact cacagagctt gacatgttcc ctgcatttga aagcattgtg 78540 gaccaatgac tacatcacac ctgagaatgt tgaagagaag ctggctggcg ctgtggtcct 78600 agcccagggg gctgatgtaa aacctgcatc atgaagtttg cctgaggctg tgttaaaaaa 78660 gatcctgccc cagacatttc tgccagagaa agaggcctcc ctgaaggtca ccagggaggg 78720 tggaaggtca ctgcccaagt caaggaagtg gccaccagca agaccccaca ggataatttc 78780 caaaggaccc agaaaagttc ctcaggggac caagaatcag ctttggatgc agccaggcac 78840 agagagcaca aagccctctg atgacagcag cagtcaagca agaactctgt cttcttcctc 78900 ctcctggttc cctgtacccc agctccagag agaccccaat gtggatagca acctggggga 78960 ggaggaggaa tagcagacaa ggatagaaag cagaagggct ggtacctctg ctggacttcc 79020 tacttgaagc aagcccacct agggagaaaa gacttaactt gaaatcttct tgggaatttg 79080 gggttttttt attgttatct aggattttaa ttactaattt tcatgtaatt attaaattga 79140 ccaatgttta ccacttaatg tgtcagtcac ctgtgagtca tcactaacat caagggactc 79200 gagtttccaa atgcaggcag gaaaacctct ccccctgtcc ccagtggatt accggttgca 79260 tgtaaggaac aggaaagacc ttaatcagat tgctattata attctacccc aagactcctg 79320 cttgctcagt gggccaataa caactctttt ctacatgaat ctaatatctc ttttcagtgc 79380 atacaattca ggaagaacag aaccctagat attattctcc taaatatttt gggtttggat 79440 tttaatagag tccctagttt cctctagatt tttctcactt cttgtagctc gaccacagtc 79500 aacacactgt cgaacaacac cacctgactc tacattccaa ccccacccaa agacacacac 79560 ctgctttcca agttgaaagt aggggagcaa ggtggcctct tatttctgga agaaggtccc 79620 agagccaatg agcacagaaa gcccagctag gtgagggatt aagatgagag tttcaacaac 79680 agcttgacag aaagcatcac atcataacaa cgggtgtatt ttaaaggtac ttgcttatgt 79740 attaattgtc tctctccagc cccatcataa ccagctgagg tggccagagc aggtattttt 79800 tataccaatt taaagaaaag atgaggctga gactgcatgg tttagccaag gtcagaatat 79860 tgcaactaaa gtccagtgtg cagacatagc taccaggttt ctgggctggt tttgaatgca 79920 ccctactctc cagaacgaag ttcagtgttc tttctctgcc ttgtaagtcc acccatgttc 79980 ctaccaaaaa aaaaaaaaaa gaaagaagtt tccttcccat ttggcaaata actctcaaaa 80040 actgtcccag tgctttgcag tgctgggtac agtgaaaaga tgccacgtgg accaaaggct 80100 ctagccctgc ctggtaacaa gagactgcat atgggtagac acaactcagc atttgcaccg 80160 caacttacca aatgtacatg gtacaaactg agctccctaa tactgcagga atggatgcgt 80220 cagcatctca agtcagatgg gtaaatcagg aaagaaaaag caccaacctt aggccaggca 80280 atgtgctggc ttctgttcaa gcttcccttt gtaatcttca cattgacaat gtatggagat 80340 actgtatccc tgtttacaga gaaggaaact gaggctctgg gaggttcttt gaggtccagg 80400 gtggctgccc cacagtgatc cttttctata gcagactcca ttgtgctccc aaaaatggtt 80460 gccacatacc cagacattcc tctcttttct ttgggcagaa aagcaagcca gggtcctcat 80520 tgtgatcgcc tggagcctgt cttttctgtt ctccattccc accctgatca tatttgggaa 80580 gaggacactg tccaacggtg aagtgcagtg ctgggccctg tggcctgacg actcctactg 80640 gaccccatac atgaccatcg tggccttcct ggtgtacttc atccctctga caatcatcag 80700 gtaagaagcc gtcaggacag gaccacacgg gggggtgggg cggggggggc tttcctgttt 80760 ctccagctgt tgctctcctc cccaacagac ccatttttcc tagtgccctt gagggaactg 80820 accaggccac aagattttat gtgtagctac cataggctaa gcccaatttc ttcaaagtag 80880 agtaaggaga agggaattaa caattactgg gtatataggg caggcattgt gctaaatagc 80940 taacaattat cacattagcc acagtataac cctgtgaaat aatttccatt gccccaattt 81000 aatgaatgat gaaactcaag ctcagagtga ttaagtaact tattcaacat caaacaggat 81060 tgatatccag gtttttctga aatcatacca tattatttct tttatatctc gcagccttcc 81120 aaatataagg caaattacca gtttcaggga ttttgtaaat gaaaagatag acatacttga 81180 aacaaactga acacaaaact cagtatgcac taatatgcta aactgtctat gcagtggagt 81240 cagataatgg cagggaatat attttggaag ccaccattga aggaggaaat gattcaggta 81300 ggataaggga gaagtgggga ggaagcagag tctgtgatga ccagaaatca gagtgagtgt 81360 agaggcagag tggacaggta cacagtgcca gtgggacaga agttggcagt gagctcctcc 81420 cagtgactgg gggaggctca gttgtgaatg accttggcaa aaaagtcata ggaagtcctt 81480 tgtcctgcag ccaatggtga gctgtagagg gtctttcaac agagattagc acaacaacct 81540 ggtcaaggta gggtctcact tggccatgcc atgtggcagg atcaccctct gaaatgggct 81600 ctgcatgtgt agatggggtg ggagactaca ggaagagacc tggcacattg tgtgtatcct 81660 tgagccatga tgatgctgca ccttttgggt aggtctaagc ctgccatagt gtgtcatata 81720 acacattgta agcaaaggaa gattatcagc ctttgttttt gatagtgtaa agagagctgt 81780 gataaaaatc cttgtactta aaactgtaca tgagtctctg gttatttcct cataactcat 81840 tcttgtggaa ttactagatc aaaggtatag atcaaagatg atgcacattt taaaactttt 81900 gatgcagagt cacaagctgc ccttgagaaa agctgtattg cttcttggcc tgttagctaa 81960 gatcacttgt agaaaaggta tattctgggc aataccatac aagggctctt gttttctgct 82020 cccctgaccc aatggaaggt agcactatta ccttactaaa tctttgccaa cctaagagtt 82080 taaaaagtat ttcattgttt taatatgcat ttctttaatt actaagctgg tggcatgttt 82140 ttcaagtgtt ttctgataca gtgggagtca ccttttcctg ctcattattc atctttagtc 82200 taataaaata ctatagctgg gagaaacgtt atccatcata tggtcaaacc cctgaatttt 82260 tcataagagt agaattaaga ctaaaagaag ttaactgcct tgcccccgcc ccctcatcag 82320 agattgagat gggcaagcac atagtgacct caaaagccaa cccagcagcc tttccaaaat 82380 ggggtgttgt ccagtcatct ctgctgaatg gacaacttaa caccaacact ttattttgac 82440 ttattgccct ccactccatc aagctgagct tgagagaaag tttgaaggag aaaaggttat 82500 ttagacaact atccaaggta agtcacagcg catgggaagg ggcccatggc agaggagaca 82560 ggcaagtgag ccacagcggt cagagagcat ttggaagaaa gtggcttgtg tcatcctgag 82620 caactgaggc atcgatttca gtggcagcac atgtcctggc ttcactgctg attgatttcc 82680 catcaactca agaaatgaac tccagtcaaa gtccccgctc agcagagtgg atgctgcagc 82740 acatggacca cgcagctcag gttatcctgt atctatgatt tccccattaa tttgggctgc 82800 tttttccacc aggacttctc ctcaaacttg cctgtgggct agctagtgtg tctttttcgt 82860 gtccttgaaa gggcaaaata caatgtgttt gctgattgag ggaaatgatt tcaaaaactg 82920 gtttccctca gctctcacca agctaaagcc tctggaaggc cagatcctag ctccttgctt 82980 ccagcccgtg acggtcatga aaactcagcc atgacctcca gccatccttg agcttctctg 83040 aagcatttcc tacctgacaa gaggctcctc ttccatcacc ttccctcttt cgtggctccc 83100 tgctgctgaa gaaacaactt ctctcttggg gactaacatc ctctacctcc ttcagcaaca 83160 actatcttct caaacaagac caggccctgg gggggcgagt tttgtgagga acttgtttcc 83220 aactagtacc tggcataggt gctacaattt catctcagat ataaggttca actcttattc 83280 tgtctttatt acctatattc tggccccctg ggctcaattc tctgagtaag gttaaattct 83340 tcatttcaag cttaaataga caaggaaaac agctcaagga aagtgttcac tcgtgttcac 83400 catgcctcat tctccttcat gcatgctata tatgctacat ttaccaaatt gacagaaaaa 83460 aaaacatatc ttagttgttt tattttgcat ttctttcatt acaaatgaga ttgaatatat 83520 tttatatgct ttttgccatt tttgtttttt ttaaagtact tattaggttg gtgcaaaagt 83580 aattgcggac tttgccattg aaagtaatgc cacttttctt gtttaaatgt ttttattttc 83640 tctattctct atctttagaa attattcata caataacctt tttctttttg catatgttgc 83700 aaatatttct cctaatttgt catttgcctc tctattgagt atggttttat tttgtttttg 83760 attattaaaa gtagtgattg acgtaattaa gaaaaaaaga aaaagcacaa ataactaact 83820 cagtggcttt tctgccacaa atacctcatt gttttactta ttgcccagct tcgtatgcat 83880 ttaagtatct gctaggacaa gatctacttg ttttttttca aagattccct ggctgcttca 83940 tggtgagctg ctgatgcctc acctgcactc ccagctccag ccatggaaca aacacccctc 84000 tggcccatgt gcatcactcc catgcctgaa cactctgcca agctcacctt gccttgtttc 84060 acccaactag ttcacatccc ttgtgtctca tttccaatac caactccaca gtagagcttc 84120 ccttgccaac cctggaccaa gaggcacctc aggtcctcac tccctaacct ccaacctcac 84180 tttgtccatg tcgtcatcta gacttcatgg cagtttgact gtatctcatg agtgcaggga 84240 ctgtggcctc ttcatttctg gatttcacat ccagcacaca ctaaacagtt ggtgaatatt 84300 agattgaatg aataacgcaa taaattgcac cgaacaacag atgtgtcatg tcactctctc 84360 tactctttct ctccctctct cattctctct ctctctgtct ctcacacaca tcacacacac 84420 acacacacac acacacacaa acacacgtgt acacatactg ctaatataga aatttctggc 84480 tatctaatgc ctagatcagt ttttggcata tgatagctcc tccataaata tatgtgagag 84540 gaaagaagaa agggagaaaa gaaaggaggg gggaagaaag ggagggaggg aaagagagag 84600 agagagaggc agttgtattg ttggtggcaa actctcatga gagctgcgta tgaataaaga 84660 tgtagctgtt ccatcatcca ctaaatcagg ctcccaggag ttgaaaccat agtgactgac 84720 agcaaaggca atacattgtt tttctgggtc aaaacaacag gagttgtttt gaaattcact 84780 tgacataact gtctaattgt tgctggggag gttattagcc ctggtgtaat tgctttactt 84840 tagctgtgct tattttcttg ctacctaatt gatttttcat tctcttatca ttttcatctc 84900 tgtaagataa agatagaagc agaagagatt cacaaccgac aattgcaaaa aaaaaaagtg 84960 gaaaaagcac attagtcatg gatcattgat ttgtcatatg tgagaaaaat tcatttattt 85020 tgcttaggaa atgggatcac attgtgggaa agccccatgc caggttggtg cagccctgtg 85080 gatagaatac atggccatgg tgggtaaaag cgccccaggg acctggccag cactggccat 85140 gggcataagg tccaaggtca aagaggatca cagggcccac aataaaagta gtcatcaaaa 85200 tgaataaaga gagattgtaa gggtctccac taatgctgaa aacctggatg gagaggaagg 85260 tacagattat ggagtcattt tgcagggaca atccacaaaa cttatctgca atctgattga 85320 tcagataaag gaaaaaggaa aagagacaaa gccaagtgtg gtgactcaca cctgtaatct 85380 cagcactctg ggaggcctag gcaggtggac ctcttgggcc cgggagttca agaccagcct 85440 ggcagcatgg tgaaaccctg tctctataaa atatacaaaa attagccggg catagtggcg 85500 cacactggta gttccagcta ttcaggtggc tgaggtggga ggtcaaggct gcagtgaact 85560 atgatcctga cactgtactc cagcctgggt gagagagcaa aaccctgtgt ccaaaaaaaa 85620 atggggacac acagcaacgc agatgtctct ttgatgcttg atcactaagc tccaagaagt 85680 agtctgattt ggcaataata ccctagttat taggtgttcg ccatgctaac agaaaagctg 85740 gtactggttc tcactcatct gattggccct aagtaaaaag aggggtgact taggcccaaa 85800 tccctaaagc ataagacatt tcttaacttt tcccctgtgt acatggttga taaccataaa 85860 tatttgaatt attggtcaat taaatactgg ggttgcaatt gacataacca ttaactttcc 85920 atggtgagtg taaccttacc ttgcacagta tttcactttc tggggaagaa gtttccctgt 85980 tctagcaaat agtcaactta gggttgaact cactaataac atttttctca ttttttcttt 86040 actgcaggca tacaaattgc aaaaatagtc cctgggcaat tatataagaa agaatggaga 86100 tgctccaaaa aagtccctga gctttcctgg agcacttgga ggggttcact cagcaagaat 86160 gggaaaaggc agtaagaagc agagatttta acattgccat taattaagtt atattctaaa 86220 gatcattaaa agcaattagt gctttgtcgg ctactgcaaa ctgaagctct gattttttaa 86280 aataattctc aagagggaag atacacagtt ttaaaataaa gcattgcttt gtcccaaagt 86340 ttttagtcaa gatgcttaat gtagtcaaaa tatcaagtaa tattaaagaa gagtagtttt 86400 tatatttatc aaagagtacc taggatagaa aacttgctga cacttttgaa tccttaacac 86460 tttgttttcc tgttaggcac agattaaatc atgtaagaat tggtgtgata tagtataaaa 86520 aataggcaaa aaagaggaga aaggaaatta gtctctacta attttccagc accgtacttg 86580 gcactttaaa tattgtcaca tctgatactc aaaaagttcg agaggtctgt attgttaaca 86640 ccattttgta gaacctcaac tgaggctcag tgtagtagtt atctattact gcattacaaa 86700 tcaccacaaa cctagtgact taaatcaaga tacatttgtt atctcacagt ttctgtgggt 86760 caagaatttg gccgtggctt aaccgggtcc tctgctcatg caaggcagcc attcaagttg 86820 tttatccagg gcaggggtca tcagaggctg gactgggaga ggctcttttc caagctccct 86880 caggtcctta gcagaattca ttttcttgca gctgtgggat tcatggcacc ttgcttcttc 86940 aaagccagca atgcatagag acaccaacaa gacaggcact acattctatg taatcagtcc 87000 catccccttt gccacattgc attgattaga ggcaagtcac ctgctcttcc cacactaaag 87060 gggtgaggat caacaaagcc atgaatgcca gaatcaggga tcatagatgt catttaaaag 87120 actgtctaaa gtcaggactg tacaacagac aagtagagga gacccaagtt tttctgactc 87180 taaggcctgt ttttggattc taatcacagc tctccctcaa accatttggg ctaccttgag 87240 gaaactgcat aactttacca ggtcttagcc tcctcactta agaaagaagt aactccatcc 87300 agtggatcct catggtcact ttcagttgca attctatgaa cagcaagtat aagggggcag 87360 gcatggttaa aagatctgtc ccttcacacc ttgcactcgg ggaggtggga gtggtcttct 87420 ctgtgtcctc acagtaggga tccaccagtc actttaatac tacctttggt tctttctgca 87480 gcatcatgta tggcattgtg atccgaacta tttggattaa aagcaaaacc tacgaaacag 87540 tgatttccaa ctgctcaggt aagtctctac tctgcatggc ccaattcttg gctaatttgc 87600 ttctccagag gttttcttct agcaaatgtg agctagggac tccttgatac acaagcatac 87660 aggatcatat caggacccag ccggcagacc agacccacca aaggctgtca caggcgggct 87720 ctgtcttccc ccatgtgacc tccctgaaat ctaggagaag gaagggggca ctttggacct 87780 ggtcaagcta tgccagcaga gagttagcct ttgacctagg atccaagggt taccccagcc 87840 tcagatctag caaagaagca ccttggagga cacagataag aaaagacaga ctgtccaagg 87900 aggacatcac accttcagca aagatgagca taggcttttc tgattggctt gaattttcag 87960 atacataaag ctgccatctg tccatagaac aatcttggac ccttagccag taaaggcacg 88020 gtagtccatg ctttcccaac tgacacacca attcaaacca gatgaagcct aagaccacct 88080 actacaactc ttccccacat tccttctcag taaacctgaa tgcagagcct ctcgtatgca 88140 atagactctg agccctggaa gcctaccctg cttcccagga aaacattact ggacctgacc 88200 aaggtcaacc tggagaaaac acagcaaacc aaggggccaa aagaagaaag ggcttctagt 88260 tttctgttgc tataatgtga taggtctgca gaagaagact ggctccgctc agcttccaca 88320 cccctcccat tccttgtgca cacacataca cacaatgtag gctcatatac acaaatacac 88380 acaccttcac acactcagtc tcacacacac taacaatgca tactcacact tatatgcact 88440 cacacaagga caacaagcta taccacaaat atctggaata agaagagcta ctttctgttc 88500 cagatgtacc actaagagct gtgccacctg gcaaagttat ctaatccctg ggctccaaga 88560 ggttaaaata aggggataga ctggattctc cctaagccct cctcttttca gactgtgagc 88620 taaacttttg ttggaccaag acagagcttg ttttctccct cttaaagcta ctttttccaa 88680 taagactgtg aggccaccaa gaggatgcac aagtattatc gggcactgat aacttgtgtc 88740 tctttcccta gaagtatgag tggagataca taagtctggg ttcttcacct gaattcagtt 88800 caattcttct gtactcttct gcatgtcagg agtggtacag ggactggaaa tgacaaagaa 88860 tgaatagcat ggttcctgac tataggcagc ttacagtcta gggccttggg tcttggccct 88920 ggctacacag tagaatcgcc tggggaggtt ttacaatgca ccgaaaccca gacaccattc 88980 cctgagagat tctgattcac tccatctgga gtggggcatg gattttatta tttcggaaaa 89040 gctcttcagg catttttaat gttcaaccag gtttgacaat ctggtccagt gagacacaga 89100 gtcataggtg gctgaccttc acactgactg accagtgtaa ccaagagatg tgcttaggct 89160 gcttggaaat tttcaaccca cgaagaccca gtcattcagc ttggggctaa ttccagcccc 89220 catgcagatc ctagtgcttc ccttccactg gtgcagtctc cacaccctgg tttttctgga 89280 agagcaaaag caatcagaga gaataaacac aagtgaattc attctattca gtgcagttgg 89340 ctttggttaa aagttagaat atttgtccaa aaaaaaaatt ggatgaagac atccttcctc 89400 tatcagatat caaataaatg cagtaagtac tataattata atactaaaat cattgaaaga 89460 gaattatatg gacagggaaa tccaacagaa cagaaatgcc aaaggaaacc tcaggaattt 89520 agaatgtgat gaagtatttt aaactgatag agaaatagaa actgtttaat tactaatgtt 89580 gagacaactg cccatatgga aacaatcata tattagattg ttgtatcata tgctacaagg 89640 aaatacactc cttatgaaac gaagaacaaa agatagaatg agggagaaag aaagagtgag 89700 agagaaagag tgaggaaaga aaagaagaaa gaaagaaaga aagagaaaga aagacagaaa 89760 gaagaaagaa agagagagag ggagggaggg agaaaggaag gaaggaagga aaagaaagaa 89820 aggaaaggaa agatgggtag aagaagagag gcggggggga agaaagagaa agaaaaaaat 89880 ataggaaata ttgtttatat tcatgaaaaa ctgaaaagat ctgaatatcc tacaatgagg 89940 gaactgagca taataattat atagccatac aattaaatgc tacagctcta aaaattatta 90000 tagagagtgt acttattgcc atagaaatat ttctccaata tagtacatta agaaaaagaa 90060 agcagtatgg tatccctttt atagatatgt gcacatattt ttacttagcg gaatatatat 90120 gtgcctgtat agacagatga tagctagaga gagagggaga tggaaaatat caagaagcta 90180 aatgttatca atgttattgc agttatctct gagtggtcga attttaggtg atttttgttt 90240 tcttctgttt tccacttagc catgtgttaa aattctctac agttacctaa atcatacaat 90300 tgaaacaatt gccctgtggc cctttagcct gagtaaacag ccaatattat cctagatgta 90360 tatatgtata ttcatttttt aaaaccatca agtcaggccc cacaaaacat atatttgcca 90420 tgcacttctc tgtataaatg tcatgcttag accctctaag gcccactcaa agccatcgtc 90480 cactcatctc aacacagaca gacaagtcag agggacagat ggagcagctc ctgtctgcca 90540 ctgctaggtc ctttccttgt gttcttccct ttaactcatt tcctgtttgc cccatttcac 90600 ccatggccca ttgcccattt cccatttaac ccatttcccg tttgagaata ctgcacaggc 90660 agtgagttgc actttttttt ctaaacagta aatgggttaa tccacaactc tttgaggtgg 90720 tgttattaac tgtctctcac agacagaaga caggctctaa ggttaagcag tttgcttgtt 90780 ttcacaggta gcatgtgaca caactggtat tcaaatgcac acatatcgaa tgcacacata 90840 aagacaagac tttttaaaaa ttaaaaacac aaactcaggg tcttgggtgt ggcttccttt 90900 cctggacact ccctccagag ctctgccttc agagagctat tcctacctca tctcttgaag 90960 gttttgtttt gatatattta aaatctaaag gctgagtcat gactggcagt gtggagacca 91020 attttgtgga ggtagccaag gtcttcctgt actttcagac gaatcagatt ggtgtaaacc 91080 cctgtcttgt ggtttctgcc aattccatgg gtctgacatg ctcctccctg cttgtccctc 91140 tgagcactca ctctcactgt ctcacctcct acagctctcc tgttccctcc acagcagcac 91200 cgcccttgct caccaccttc ctcagcatgc ctccccccag ggaggctgac ttcctggctc 91260 tctccaaagt tcccatgtct cctgctacta catatgccag tccttgcact cttgggctcc 91320 cctgacttcc agtccttgaa actgtacaaa gccacttgga ggtctgtttc ccactgatat 91380 agagtatgcc attactccct cccaaaggtg gaaatggcta ccgccacttt ttattcttta 91440 atatagtttt atatctccat tatatctatt tttcagttac cattagtgac ctcatcccga 91500 aatgagggca gctggtattc tcagaagctt atatgctctc tatatcttat tcgtaaaagg 91560 aacacagttg atttcccatc tgtcattaca gccaagcagc tctggagttg gcaggtaaat 91620 cggatctcca gctgggtccg catgccagga ttattgctca tcaacaaggg gacattagcc 91680 atgattagtg tgaacagaag ctcactttgt aaacactggc taaaaagctc aagccatcct 91740 tagtgcgaga accactcttc ttactggcaa atatgtctat tttctcccag tcaaaggctg 91800 acagaaagga aaagaaaaag aactgtatca taaattatct aaagactttc ccataaacaa 91860 gcatggaggg caagacgtgg aggagatggg gtttccaatc ctgtatgtta tctttcataa 91920 atgagcatat tattgatgtc caggaggatt tacttgtaca aactagaaca tttactgcat 91980 gggcaagtgt acccatggaa cagacaaatt tctcgttata actatgtcta gctatcatgg 92040 cttggtggat atgatccatg ctatatccaa attccatgtt tttaattaaa tgaggcatac 92100 tagagtgaag aaaaaaagct atggattagg aattgggtta gagccctatt cactttctag 92160 cttaaaaaat ttaagagaag cccattaact gctgtccata tcagcttctt catcagtaac 92220 tgtgaataaa atggcttctc tacaattaac tacatttaat aaaagatgtg acagaaaaac 92280 ataaagatac aaataaatga agattatgac atgttcgtgg atagtaaggt tcaatatcat 92340 aaagacgttg aatctcccca gctgatctac aagttaataa atttccaatc aaaattgaat 92400 tgaaacattt tattgagctt cacaagccta ttttaaaata gacaaggaaa attcaagaga 92460 catgagtagc ctagacattc ctagagatgc agaacaaggt agagaaagtt cggtttacca 92520 aatattgaaa tgcattgtaa agtcagagtg cggtattggc acaatagaca aatggaaacc 92580 tcagtttcct tgctacctgc tgcctgccca caaatccaat gctacatgtt tcaggttttc 92640 attaagacag cactgcatat gaggtaccaa tctctacttt agaagggaaa cactagcagc 92700 tgtgtaaacc caaaatatca gtagccttaa ccacatagaa gtttatgtct taattaaaat 92760 ccagttggca ataaagacca gagggaaagg cattgttcca cacagtcatt cagaaattca 92820 agcaggtgga gattctgcca cgcttaacag agggctgcta aggtactcct cagcacctcc 92880 ctccagcaag caggggcagg ggaagagaga gagtggagga ctgctcagga gaggtatctg 92940 agcaaggttt ggggtggtag acattgactc ttcccagcgt cccttaggca gatcttagtc 93000 acatgactac acactgctgg aaggcaggct gggaattgta gtctagttgt gtgccctggg 93060 gaaacaggaa tgggttttgt gaacagctcg tctgtctttg cataattatt ttaggttgtc 93120 agggctcctg cttctgcttg agctgaggtg ctgaggtata gaaagggcta tctggtgggt 93180 taggtgaaat cttctcatat ctagctacaa tttacagttg gctctgggct aaaaacctcc 93240 tgaaagggaa tgcaaaatac tttcctactt gaaggttcag agatatgcag ccatgcccag 93300 ctaatgggga gagagggagc acctcagatg acaagaaagg gacaataaga tccctgaatg 93360 tgaaaacatt ctggagaata cagagtcagg cacaacgagt gccttaaggt caaagggaaa 93420 tgtaagttct gggtcacaga agaacattcc cacctaacca gtctagccac ttgtcagcat 93480 ctagggagga aaacgctgtg tggtgggcta aagaagctga aactcttggg agttcaagag 93540 agtctgctgc aagctcctgg aatagcacag cacagaggag agaggccatt cccttgcttc 93600 ctggcagaag aacttggaga gcaggtatcc ccgggaagag cagcagtgct gaataaccca 93660 cagcccaggg acagaactga ggccctgaga ggtggagcag aagagcaaag caactgctca 93720 gggtcaagag caataatgaa gaggactcac aatgtggctt tgaagtgact gtggctgtgg 93780 agcatctgct gcccagccgg agcccctcaa gaggcagtca ttggcaaaga agaggtctgg 93840 gtgaagtgac ctggggcagc ccagggcagc tgcagcgagc ctagaaagca ggatccagag 93900 agcgtcacca tagaggcaca ggcggtggcc tgggtggatc ctggaacact gagacacctc 93960 cttgggtctc tcagaaaaac tagagggaca aagacaccct gggaagaaac tgactgcagt 94020 cctgcagcta aacagatgag acctaatgtg cttaaaatac tgaactgatg agttcagggg 94080 gtattcaagc tatattagta aagagaatgt tactgttcaa aatgaatttc aagtttcaag 94140 aattttagaa atcaggaaaa actgctaaaa ataatgttga agtttttaaa aatcaaccta 94200 acatacacaa agtttctaat ataggaagca tatttatttt aaaatattgc cagttagact 94260 tccatgtttc taaacaaatc acctgcactc tttataggtc cacagatgaa ttccccccac 94320 tacctcccag gaaacaattc tgcttccatt tgaaatccca aggtaccaat tgctcccact 94380 tcaggtgctc agcctgcatg aagaatgggt tcccagtggc tctgtaagag gcctgtggtc 94440 ttgggaaggt gaagagccag aaatggccat ttggagacta aattttcagc atgtgtcccc 94500 attagggata tactgtggaa ctaaaacagt ccacatcagt gtgcttctcc cagtcccaaa 94560 tcgaatggac gtgccacttt caggctaccc aagcccgatt aatgcacagt gacagctgaa 94620 tttaactgct tttcactgca gctcagcacc aaggcctgag tagaaataat ccttttatct 94680 cccaataaag gagaattacc agcatttcgt agctcagctc tctctgaagg gccatcttta 94740 gaagctagag gctttgcatt tcctggaatg gtcagattaa agatgctttt cactgatctc 94800 tgggcaggta gatgattata ctgtcaccca gttgccctgt gggaagcact gcgggtttcc 94860 attttaaagg gatttcagag cacaaatgtc attctcgaaa acttttctga aagaccaact 94920 tagtcttcag agccatactg tttaggggcc agctgttgcc taggaacagc cagtggggac 94980 actttgaaag aatataattt ggtctgctgt cttctttact tgcagcccat gggtataatc 95040 tcacccagat cattttctgc tgtacataat tcttacacag ataacaacct tgtataatag 95100 acaatcaaac gtaataatac cttctgttca ctttcataaa gatggctcac cttccacctg 95160 aaatactgtt aaaactgcat tcatctcaac tgataagata tccaacatcc aagcttgggg 95220 cttggttcct tgaatatatt attttatgtt aatcttcaaa gtaactctgt gagttaggtg 95280 ttctacacct caatttttaa atgggagaac tgaagccggg aactttagac gatttgccta 95340 agtttacaaa gttttagtaa ttggtagaga cggaggatgc attccagtct gatcttaaag 95400 cctgtgtcct tcccaagatc ccatcctaga aatcaaggtt tctcaccttt gacacctttg 95460 gcattttgga ctggataatt ctttgttgtg gaggctgccc tgtgcattga aggatgttta 95520 gcaacattcc tggtctctac ccactagacg ccagtagcac acatgcacac acaattgtga 95580 caattaaaaa tgtgtccagg ctttgccaaa agttccctgt aaagcaagat cacccccaat 95640 ggagaatcac tgctctaaat gttctgaagc atttgctttc ttacaaggcg gaggttcgtg 95700 gtcccatgaa acgcacagaa taatttgaag accctaatag tagttaggag tggccttaca 95760 gggtatgctt taagaactat gaattaatta taattagcag ttttcctttg tacttaaaga 95820 gcccctattc ctgttactct tgaaaatcat ttgtcctctg caatgagtaa atgttcacac 95880 tacaaaaaca ctcagaaact tcaatggcct gcggccgcct caggagttca gcccaagctc 95940 ctcagaaaga cattcaaggc ctccccagtt tgccttcagt tctctcctcc actctccacg 96000 catttgtagg ctacagccaa gcaatatgac tcactgtggt taaaacgcat cctacatttt 96060 cttgttccat gtcttggctg aggatgttca ctctctgcct cccacctctc ctattcccac 96120 gctgcacccc gcctttgtct tggaatcctt cttatgtcat ttgagttcac ttgatgctct 96180 ctgcatctcc cacacagcct ccccagcaca gtggtggaag gatgggtctc tcctctgtcc 96240 acagttggtt tctatctgtc ttagtccatt ttctgctgct ataacagaat accacagact 96300 gggaaattta tttttaaaaa aagagattta tttggcttat ggttctagag gctgggaaat 96360 ccaagagcag ggcacttgca actggcaaag gtcatcccat ggcagaaaac agagggcgaa 96420 agcgagcaca caagacagag agaacgtcaa gccaaactcg tccattccat cagaagccca 96480 cttccacaat aacacaataa tagcaataat ccattcataa gggccaagcc ctggtggcct 96540 aatcacctct caaaggctcc acctcccaat actgttacaa tgacaattaa atttacacat 96600 gagttttcgc agggacattc aaaccatagc agcatctcgc tcatctcaac cagttttatg 96660 gagagtgtgt gatctttcat gctggattga aaattcttag agaacaagta ctatatttca 96720 gcccttctag tcagccctta tctcttagca gatgtgctat acttgtgggg ttggactaga 96780 tcagattgga ggtgggattg aatgaatatt gcaaaggtaa acatctgact ggtttccatg 96840 ggcattaaaa taaatttcaa acgtgagagc tgggcagtgc agtgaagaca atggagcaca 96900 gcagtttgcc tttctagtgc acagctgccc tactccatgt gacttcgacg cactgagtgg 96960 gcctctgacc agggccacca ctagggttgt gcccattgag ccccactggg tggctcctgg 97020 ctgagagttg tgtggggctg gcattctctt catatttccc tcactgaatg tgtgctctag 97080 gcaggcctgt gcttatcaga gcaagggccc cttttccaaa acttcacaaa ggtggcatat 97140 gggctggtgg aagccctgac agtagaaact cttccatgag gaaagggaca ccacatctga 97200 catttttatc cccaaattta taggtaatca ctactttaac taagacctat tgcactggat 97260 cctgcctagc ctaatcttat ctctttgttt taccactgct cgactaatga gacgtggtta 97320 ttgattcatt caacatattt gtgttagtca ttgaatatgt gtttaggcta caggagtgcg 97380 aaaaacaaag cccctgtcct catcaatcta gtagattctt atatttaccc ctcagtgttc 97440 accatcagac aacagtctac atgaaaaaaa tgtatatcca agctcctatt ttggagagtt 97500 ctgatacccc tggcttgagc ttttcttgag agcgtttttt tgtttttgtt tttttgtttt 97560 ttttttgatg aatgtatttg tctggggcaa ccattttaga aagtaacttt gcctaggttg 97620 ctaaagtggc cacatgggtg tctcagcata gccagggctt agagagtagc actcctcagg 97680 gaagccctca gctcctgcat ggtcacatag tctaatttca gctgcagctg ttcaggccat 97740 ctgaccaagt ctcttgagag agtctgagca ttccatacca ttttcatata atattaaggt 97800 gtaaactgag cattctccag aaaccagccc agaaccaact ttaatctaaa aatttccaag 97860 gaaggccatc tgggcataaa tgcacaggat ataagtgaaa actggagtct aacctttaat 97920 gttcctattg gctgaaacag aaactgtcac atcttgaaca cttcatctta ctattcccct 97980 cttgtatcta cagatgggaa actgtgcagc agctataacc gaggactcat ctcaaaggca 98040 aaaatcaagg ctatcaagta tagcatcatc atcattcttg gtaagcaatg tccctccttg 98100 agctgtaaag tggtatgaac gtcccaaaag caagtttgct cctgggacct ggtgacagaa 98160 aggaatttgc cagcaggcac ttctacatcg gtctgcttag aaaggaatgt gtgaaactca 98220 tcagcccatt catggttcct tcaagggctg acatttggtt cctaatccct ctccttatga 98280 atacagctgc ctgccaaggc tatgggttga ataatttgga gaaaatctga ttaggaccta 98340 actagctgaa gtggatgctc acatcaccag ctaactcagt cacttccttt aagacacact 98400 gttccccagg gctggggttc acaaggaaaa agaagataga agtgactttc caccttatct 98460 gaatatttga tgttaggttc actacaaatt tcccccttat ggcaccttac ctgtccttcc 98520 accctcctgt cttctgccct ttccttttcc tttctctcta ctcttaagac tcataaagtc 98580 accttgtact atttcctgtc tgaaatgctc tgctctccgg tggtgccccg gcttacttcc 98640 taatctcatt tgttccccaa caacgccacc tccctgaggg ctccttgata agtcttttta 98700 aatatccttt ttctagtctt tactctgcct tatttttctt cttggttcta cctcacacta 98760 caggatatag attgattttc ttatagtctg tctcccctgt tggagtaata aatctatgag 98820 ggcaatgact ttggcttttg tgttacttat attatcacca agacctaaaa tagggtctcc 98880 tacacactgc tcaattaaca tttgtcgaat gaatgaatga atgaatgaat gaaactatgc 98940 aagaaggaaa gggatttgtg ctattttctt ttttatttag cttaaatacc ccctccttgc 99000 ccctctggca gctcttgaag ctccaaggaa gtatagatct cccattagct gcatgtcaaa 99060 gcaccagaac agtcttctca cctttctgaa acgcaactgc aaaatgccaa acagaccaca 99120 tgcagcatga ctcagccagc aggacgtagg cacaaaacaa cactgcaggc ggaactggga 99180 taaaacatat acaacccacc agggctcaaa aactttctga gaggcttctg aagtggatca 99240 aagactcctc tgtcttctca gatagtcaga agcacagatg caccttccct ggatgttgag 99300 ttggaaaatg tatgtttaca agtgtgtccc agagcctgca tagcccttta tcatcagcaa 99360 ccatactcca aggccctgtg ggatcccttc agtcagcaag caggaacacc ctctagaggg 99420 tcagcaaata ttgacagccc taccagacca aaagggccct ttctatagca aacactttgt 99480 aatgtccctt tcccaccttg aaataaaatg cctacttata ctacctacca tgatcattta 99540 aacattaata tattgcccaa aaaataatat aaaagaggaa taagaaaata atctaaaatg 99600 aaacaatact atttttatta attaaaatgt ataccaattt taatgtgtaa aaacataagc 99660 acagctacac tagaagaata atgaagtagt cacacctaca ccgtgacata ataacagcca 99720 caatgaaaac caatacaggt gtattttcat ggagacataa aaaaatgtaa gcggtattac 99780 tgtcagtgac ttgattttct cagccggcaa aaagaaaaaa tccttgtaaa attttgaatt 99840 aaacaaagta atctttcctc catttacaac agaattgcat ttctacaaat ttcaatattt 99900 atttaaaata cctgtgttta tgtgtaaaac aaagtcaggg ataactatat agagggttct 99960 cctctacatg aatggacatt caaagtagat acaaatcttt gctggctggg ctgcgtgtac 100020 catgccagag gactggtatc cctgtgaaaa cttgaatcct ccaacccaac ttacacacac 100080 atggaaacac ccaagcacac aaggccattt gcccccttag tgccccaaat actgttcagc 100140 gccagtgttt gggttaatta atcaggatcc agaacactta gtgggttttg tgtttgaatt 100200 gctcctcttt aatacattgc caaggtctgg ggtcgagagg ggaaacatga gtcagtttat 100260 cattccaaaa ttcccaacaa gttacagaat ccacattaca cagttatgac ggaaagcttg 100320 tccctgcatg cagacagcca aggaagccaa acttctactc cgagaaaaaa ttctatggat 100380 gagaaagtgg gagaaggaga gtggagaatt tatggtgaga aaatgagaga tgcgtgtatt 100440 tccagtcaac ttaggagtgt ttagctctgt gtcgtagtct gtgctttcca gaggaaaatg 100500 agagagagag agagagaggt ttattagaag gaattggctc aggtgattac tgaggctgag 100560 aattcccaag ctgcagttgg aagctggaga cccaggaaag ccaatggtgt aggttctagt 100620 ccaagtctga gtccaaaggc ctgaaaacca ggagaatgga tggggtacat ttcagtttga 100680 ttccaagtgt gaaggcagga gaagaccaac gtcctagctc gaagacaggc aagcagagtg 100740 aatcttctct tacttaacct ttttctatga ctcaggcctt caacagattg gatgcggccc 100800 acaaacaggg gagggcaatc tgcttttctt actctaccag atcaaatgtt actctcctcc 100860 agaaacgtct tcatacacag ccagaatagc gtttaaccga atatctgagc actccgcagc 100920 ccagtcaagt agtctcaaaa ttaaccatca cacctgaatc cccacctttc atccatttct 100980 tttgagaatt tggggccaaa taaactggtg tctcacacat actaatggat ttagagaagg 101040 gcatagtgtg ggtgttttct ggagaggcca acttaggggt gaaagagaac actgtcatta 101100 aactggggtg tgcttagaaa atattgtgat caccccttct ccctgacata acctaaaacc 101160 agtagtcact acgtggtcaa aatgcttcct gttcttctgt cttttcctag agagtcttca 101220 aagtattttg ctgttttttc ctgatccctg tgtttgatga gaggctatgg ccatagtcac 101280 ttgttcctgg ggtttctata aagaatccac agcagtagaa atttgaccct tctttacaga 101340 tagagaagct ctacaacctt tgctcagttt taggaacatg tctgtaagat gtgtccatat 101400 atatgtgtgt atgtgtttaa gtgaatatga catcaatgct ccaaacaaca tcaaactcca 101460 atatttctga gaaattccag gtcccaaaga acctctcagg taaaagtcca gtcaggacca 101520 accaaaagag acccctcaac tgctacctgc tgtgatgcta atggctctct tctcccccag 101580 ccttcatctg ctgttggagt ccatacttcc tgtttgacat tttggacaat ttcaacctcc 101640 ttccagacac ccaggagcgt ttctatgcct ctgtgatcat tcagaacctg ccagcattga 101700 atagtgccat caaccccctc atctactgtg tcttcagcag ctccatctct ttcccctgca 101760 ggtaagggga gctcttgcat gggtcagaca cactgatggc cattgcactg ggattctgcc 101820 aacatgtggg tttctcatgt ccaaactctc cagcaggtta caggatcccc cttttataga 101880 tgagaggctt gagagtcaga aagattccac taacatggct gattcaaacc ctggcccagg 101940 ccacagctga tgtgcttttt cctataccac aacacctcct atagaaaccg ccttaatcat 102000 gacacatcta gaagaccttg cttttattca aagcatcttc acatgaattg cctcaataca 102060 attctatgac aataatagga catggagcct tattaccatt ttacagataa acaaagtaaa 102120 tcttacatgg ttaatagcat cattgagttt atatgaataa ttagcagagc tgaaattaaa 102180 tccctcccac agttattgtc attcttctgt ttttctgctg tttttcagct gttttcctgc 102240 ataagccaca gagggtaggt ggagaattcc ataggagata caagaggaga atgatttaag 102300 tcttgggctt aatgccagtg gttgaagttt atatcttgcc attgtttatt cgtagcgatg 102360 tgtgaccttg ggcaagttat ttaacatctg taaacctcag cttcttcatc tgtaaaacag 102420 ggctaatagc agtgtctacc tgttggcctg tgatgtctct gtcctctggg ctctggtgct 102480 gaccagtgag aaggagagct gtgagtcatg gagaaggaag gtcagggtat tacatgtaaa 102540 gtgcctggca cagttgtctg acatttaata catttttcat aactattgtc tcttaacatg 102600 tctacttgcc ttttcattag gtcaaattat ttccctccct gctttatttt gactttctcc 102660 agggagcaaa gatcacagga ttccagaatg acgttccggg agagaactga gaggcatgag 102720 atgcagattc tgtccaagcc agaattcatc tagaccctag ggcagtgcca gtgctaggct 102780 gagcaccatc agctctccca ggtccttgtc acctgcttgg gcacgtgcat ggaacccgag 102840 ccaacttcac cccaccctcg tcattacctg ggagatgcac aagacaaatg ttctaatgac 102900 tgcatgcact gcttaagtat tggccaacac gaactcccca gttattcatg ccagccagga 102960 aggaaacgcc ttccttcccc accattccca gccctccttc ccactggcca gcacctgaac 103020 ccagtgaaca caggcattag tggtccaggg tcctggcttg gagccagtga gtagacaggc 103080 aagcagaggg gacaaaggta gctgggttat acatgaatat tctcattaca atagaagaaa 103140 ataaaagact taattaagcc catatttttc ccccagtttt ggattggagg ttcagtgctt 103200 gtagccaaga aagtgtttgt ccttgaaatg ccaacaaatt catttccagg cattggtgct 103260 ttgcacctct tctgcagata gcctcggttt gcagatgggt gtgctggcag cagccaagtg 103320 catctcctat tccatcaaca aatgatttgt ggaaagggca tgctgttggc cctccaaaac 103380 aaggtgaaat gaagggatac tggttctgat agaaaacaag ttgtgttaaa aagccatggg 103440 cccctgactt ccagcctctg agagctggtc cctagaacac acatgtcctt gaggcctttt 103500 tttttttttt ttttttttga cagagtctcg ctctgtcgcc caggctggag tgcagtggca 103560 cgatctcggc tcactgcgag ctccacctcc cgggttcatg ccattctcct gcctcagcct 103620 cccgagtagc tgcgaccaca ggtgcccgcc accacgcctg gctaattttt tgtattttta 103680 gtagagacgg agtttcaccg tgttagccag gatggtctca atctcctgac ctcgtgatct 103740 gcctgccttg gcctcccaaa gtgctgggat tacaggcatg agccaccgcg cccggcctgt 103800 ccttgaggct ttctgagacc tctcactctg tatttaacac ttgggccact ctgggctcca 103860 ttcctcacac ctcaaggaca agtcttcccg tttttaaatc cctgaacact ctctttagtt 103920 aggagctagg ttcctgcggc ttttccaggc ttaatgtttc tctaagatct ttatcgtttt 103980 tgcctgtcac agcctttgtc tagcacctcg gccaggaagt gctggtgggg cttattttga 104040 cagatctgga gtttggtact tatgagcata atccaagtga aatatgacta aatgttttct 104100 agtcaatttc tcctatcaga tttttccaca agtggaagtg aaataatttc atttgatcat 104160 atatacatcc cacccacggc tccggtatgc acgtgaacac cttattttag cttcacgtat 104220 attcttgaca ttaaaatctc cttggcaaaa tcctccttcc cagaattatt cagagcttaa 104280 atcttttttt ttttttttgg catactgcta gtggagtcat taaattgttc agtatatttt 104340 aatagcactc cattcctcat tatggtgtca actcaaagtc tgcgtgttta aggtcatgtg 104400 ggcttttttt ttttttttca taaactcttt tcaattcgat ctgaccttag ggaaagtatc 104460 tctttaggag gaaatcagac tcctcactca ccatctctcg gagaattatt ctctgaattt 104520 gaggagcctg aataatctag ttttatttct acacaacagt tttgaaggct gcctccctct 104580 ctgtccaatc agctaaactt gagcaaccct ggaagctttg agcatttgag aaatgctttt 104640 caacatttca ctttaaatca agatgtgcca cagaagaccc acggaactgt tgctaaaata 104700 gctggctgca taggagccaa ttaacagagc aaaatctggc agatgtccta catggcaaaa 104760 caggaggacc aggttctctt gacagatgct ttaattcttt gtcaagtctg gtctgcaaaa 104820 tacattacat gcctacctca tccatcagta gagtctcaaa gtgaaggaga gagtggagtg 104880 aggggcgttg tgatctgtag aaactgtgaa catgattttt tagttgtgat gctgtctctc 104940 tcatttcccg agaagactgg agatcaataa gataatggta caggttgctg caggataatc 105000 taccatttaa atgaaacttg ctttatattg gtaaggattc tggaattgtc atttccatgt 105060 atttgctgag cttggagaaa catgatttaa gcattatgaa aatactggta attggccggg 105120 cacagtggct cacacctgta atcccagcac tttgggaggc tgaggtgggc ggatcgtgag 105180 gccaggagat cgagaccatt ctggctaaca cacggtgaaa ccctgtctct actaaaaata 105240 caaaaagatt agccaggcat ggtggctggc gcctgtagtc ccagctactc aggaggctga 105300 ggcaagagaa tggcatgaac ctgggaggcg gagcttgcag tgagccgaga tcacgtcact 105360 gcactgcggc ctgggcgaga gagcgagaat ccgtctcaag gaaagagaga aagagagaaa 105420 gagagagaga gaggaaggga ggaagggagg aaggaaggaa agaagaactg gtaattaata 105480 gtcttgtgac cttgaacaaa tcatttcaca cctctgggca ttgatggtct catctgcaag 105540 atggggacaa aatcaggctg gagcagagga tcttggtggt tcctcccaga cacagggagg 105600 aatctctgag attgtgtcca gagactgaga gcttctggaa ttctttcccc aggggaccaa 105660 tgactcagtg acttaatgct gagtcatttg ccctttagag gtgtgacttc cctatctatc 105720 actatgaatg cagagaaata tcatttccca actgagaaat gcagtttgag ctcttggaga 105780 aaattagaag cttagtgctg tgacgttact gtttgtagcc tttgatgccc atgtggaatc 105840 agagaagcca gcaggacgat acctaaaata aaggtgctta cttcctgcac caagatgtca 105900 aaaagtctac ggttacatta ttgcatggca tcagggacag gagaaaattt aggagagcca 105960 gagtaggtgt gcttactata ttcagccata ctatagaaaa taagtgactc tactttactg 106020 aactaaatta aatatgaatg gtaaaaactt ctctacttgc agggtgcatg tggaacataa 106080 tttagttgaa gtttactttc actaagcaac atctcccacc ttttccccca gaaaatgata 106140 acaccttttt aatgactttc atttgtggat aatcatgaga aaaaagtggc ccttttaaat 106200 cagcccaaca cgcagcttaa acttcctagc ttcatttgga aaattctgta tactcatata 106260 cagaaatgac cttgcctctt ccaactgcat tcacagtgtc aatcagaaaa ggccacaagc 106320 ctgagtctga gagaaaaaag gaaaacaaaa atatctttag caggaaataa agtgattctg 106380 ctcttctaga attatcttag gtgagctaca gacctgctgg caactccaat tttctcgtca 106440 tcatttgaat gtacctcatc ttatatgcag atcgactagt gtcccctgaa gctttccaat 106500 tgcatttaat tgaagggaga aggccgtaac tgtttaggtg ccaatctctg tgtttttgga 106560 aacatgaaaa acccatgcct catttctctg caattgcatt ttaagaatac attatccgca 106620 acaggctggt tcagttaaca ttttaaaagt gcaattccag gcttacagaa tgttaaagtg 106680 gatggagtct tatatcagct ggtctcatgg ttttcagatt gctcggagac tccaaagctg 106740 ttccaaggag gtgactcaat attaatattt ttacacggcc gggcatggtg gctcacgcct 106800 gtaatcccag cactttggga ggccgaggag ggcggatcac ctgagttcga acaggagttc 106860 gagaccatcc cagtcaatat ggtgaaaacc cgtctgtact aaaaatacaa aaattagccg 106920 ggtatggtgg cgggccgcct gtaatctcag ctacttggga ggctgaggca ggagaatcac 106980 ttaaacctgg gaggaggagg ttgcagtgag ccgagatcgc accattgcac tctggcctgg 107040 gcaacaagaa ggaaactctg cctggaaaaa aaaaaaacaa aaaacaaaaa aaacattatt 107100 acgcacaaca atagcataga aatcgagagg caattaaatg tagttagttt caagttcctt 107160 gaattatctt gcatgcaaaa tgtggattat tagtcattga tacaccaaga atgcatgtta 107220 caatttcagg gtcatcacta aaatagtaga aatgcaaaaa catacatctt tcagagtaaa 107280 agagaaggaa agctgagtga taagtcactc aaacaatttg aaagaaagca agaaaagaga 107340 gaaacaggga cataaaacag ctgggataaa cagaaaacac ataggaagat ggtggttttt 107400 ttatccaaac ttactagtaa ttataagtgc aaagagatta aatgccccag ttaataatca 107460 aagactatca gactgatttt ttaaaaaata aataactgtc tgctgtttac aaaagacatg 107520 cctaaaacac aaggatacag aaagtttgaa aatcaaagaa tggatcaagg tagtccatgg 107580 aaactgtagc taaaagaaag ctggtaaggc tatattaata aagactaaat accttttaag 107640 gcaaaaagta ttagtagagt taaacaggga cacttcgtaa tgataaagat tttagtttaa 107700 taagatgaag taataattct aaatttccag gcatttaaaa acatggcctc aaaatatata 107760 cttttaaaag ttgtcagaac tatgaaacaa atagaaaaat tcacaaccct aatggggaat 107820 tttatcacac ttaatgccag tcattaaagc agacaaaaat caggaatgat ctggataatt 107880 tgagcaacat gaataacaca ggaagagcac tttaccttac cacccctgaa cagacatttt 107940 tttcaagcac acatgaagca gttaccaaag ttgaccacat gctaggccat aaaacaagct 108000 tcaacacttc cacgagattg aattcatata gtctagtttt tctgatcatg ttataattat 108060 gctggaactc aagagtaaga ggataactag aaaattcaaa taggtttgga agttaggaaa 108120 tacacttccg aacaacttat tgccaaagaa gaaagcatat gaaaattaga aaacaattgt 108180 actgaatgtt aatgaaagta ttatgtatta aatgtatagg atacaaataa aacaatactt 108240 aaagaaaaaa gagaaggatt aaaaatcaat aaacaaatta tctatcttat gaagttagaa 108300 acatttacca aattaaactc aagggaagta gaaagaataa aataataaga ataggagtaa 108360 aattaatgaa ataagaaaca aacataataa aaagcctcaa caaagatcaa attctgttct 108420 tgaaaaaaat taaattaata aacctctggt gagactgatc aaaggaagaa aaagagagaa 108480 ggcacaaata aacagtattc tttaaatgat atcactatag atcctagagt caatcaaaag 108540 ataataaaag gatattatga tcaagcttat gtcaaaacaa attgaaaata tagatgaatg 108600 ggaaaacata taattgaccc aagaagaaac aaaatcagaa tagtagcata actgctaaag 108660 aaagagaatg tcttcattgg tgagctgtac taaaatttaa ggacaaagca acaccaattt 108720 tatagtcttc agtaaaatag aaaaagtgtg acttttcaga ttatttatga ggctaaaaaa 108780 acctcaatat caaatgctac aaaggcatta caagaaaaaa attgcaagtc aattttgccg 108840 cagaaataca tgcaaaaatt ccaaaaaaaa attaccaatc aagtccagca aaatataaca 108900 aggctaacat atgtgacaaa actggtttca ttccaggaat gcaatgttgg cttactatta 108960 gaaaatcact caactcgtta cattaataga ttacaggata aaacaatata taaactcaac 109020 agatgcagaa aaaaatgttt gataaaaatt tttgagctcc aattataaga tattcacaaa 109080 cttgggatag aagacaattt cttaaacctt aaagtttatc tgcaagaaag ctacaggaaa 109140 cctatactta atggtgaagc tttgaagatg ttccttttga aataaagaat gagtgaagaa 109200 tgccagcatc aacacttctg ttcaacattg taagaaatcc tagtcaatgt agtaaaacaa 109260 gaaaaaaaaa taagataaaa ggtatatgga ttcataataa ataataaaaa ctgacaatat 109320 agatataaat atatagctga atatccaaaa taatatacag ataaattatt agaattaatc 109380 acaaggttta ataaggttgc aggatacaaa aatcaatatt atttccacat agcagcaata 109440 aataaaaaat ttaattttta aagttttgta gcaatgaagg gaaagcttcc tttttgccct 109500 tggaggcttc actgaaaaat caagtcataa aaaggcagaa aaataagaga aaaagcataa 109560 aatttattac tcctatgcac acggggaaaa tcggagtgat tggccaatac ttcaatgggt 109620 acagatgctt gtagagcctt cttcttaggg gaaagagaga tggggaagcg tggatgattt 109680 taggggaata ataaatgatt tttaggaatt tggtgtgctt gaagaaaaca atggtccagg 109740 acagagtctg ttggactcac agagcagact tttgtttgtg acaaaagtct gtccaggttt 109800 gttgatagac tttagtcttc cttcttgtga tatgggttca gttaatgaaa actcggggaa 109860 gggaccgcaa gtcattgttt tcttctttgg taagtctaga attaggcaga taaggaaact 109920 tcatgattga gaggcaggag gagggagagg agaaacaatt gttctccctg gtaagagaac 109980 tgaaaactgg tccagtcttt atgtagatgg ggggggaaat ctcttctagc atctgctgat 110040 ctctaagggc cttttaattc aaaatatatt ataatgccat gaagccatat tttagggtaa 110100 agttccatga gctcctgcat tcgttattta caatagcctt aaaaaatgaa attcgtagga 110160 gtaaatttat aaaaaggtat gtaaatctct atggagaaat tataatacta ttgagatata 110220 ttctaaaaac taatgaaatg cagaaatata tcatgactat tgttcagaaa ctgaatatcc 110280 taagataatc aattttcaaa ttgatctctg aagattcagt agaatgccaa gaggaatttg 110340 gtagaacttg gtaagttgtc tctaaaattt atatggaaat gcaaagggcc aaaaatagcc 110400 acgacactgt tgactaaaaa ggaaaaaaat gggagagctt aactaaccac atatcaaact 110460 tatcatgaaa gaataataat gaaagctgtg gtatgggcgc taaagtagac aacttagcaa 110520 atggaataga aaaggagtcc agggaaagat gcccacatat aggtaaacga tttgtttcag 110580 tggtaacatt gcaaagcagt aaggaaaggg tgttcttttc aattatataa aaaattggac 110640 atttatgtgg gagaaaattt actgaaaacc tactggatta tatgtcaaat tggttccagg 110700 tggattatag acctaaattc acaagacaat aggacgctga aaaaataatg tgacaaaaca 110760 caaaacactg tactcatgaa ggaaaatatt gatacattta attatttaaa agtagaaatt 110820 tctgttcatc aaaatatatt aaaaatgtga aaagacaagc tatagaatgg aaaatgacat 110880 ttgcaaaata tataactgac caagatctag tatttgtaat atataaaaac tactgcaaat 110940 cagtaagaaa aagattttaa aagacagtag aagacataga aaaatgggca agaattaact 111000 tcagaaaaga agttatccaa atggacaaaa aactatgaaa aggtgtttaa tctcattaaa 111060 aagcaaggga aagtaaatta aatcacaatg atatatgagt atgcatattg gcctaactta 111120 aaacctttga caatatcaaa tgttgctgag gatgtacagc atcagaaatg cttatcttgt 111180 gtgaactgga gaataattag tacaactatt ctggaaaatt atgtgcctta aactagtaaa 111240 actaaggatt tgtgtttccc gtgaccttga aattccacac tgagtacaca ccctacagaa 111300 gtgtgaatta tgtgcaccat aatagatatg aaaaatattt gtaatagcac taattataag 111360 agcctcaaat tggaggcaaa acaaatgctt attagcagta gaatagataa ataaattatg 111420 gtgtatttca tacaatggaa tactttacag caacaaaaaa atgaagaaac tgcatatgct 111480 tgcagcaaca taaaaaaact ttaaaaacat aatataaagg tcaaagacag agacattaaa 111540 gataacatat gatctcattt atatgaaatt caaaactaac caaaattaaa ttatcatatt 111600 tagcaatgca cacataggta attgtattag tccgtttttc acactgctga taaagacata 111660 cctgagactg gacaatttac aaaagaaaga ggtttattgg acttacagtt ccacattgct 111720 ggggaggttt cacaatcatg gcagaaggca aggaggagca agtcacatct tacatggatg 111780 gcagcagtca aagagcaagc ttatgcaaag aaactcccat ttttaaaacc atcagatctc 111840 gtaagaccca ttcactatca caagaacagc acaggaaaga cctgtcccca tgattcagtc 111900 atctcccact gggtcccttc cacaacatgt gggaattatg ggagctacag gatgagatct 111960 ggggggggga cacagatcca aaccatatca gtgacaaaac tctaaagcaa agcaggaaat 112020 cactttttat aagagtccag attgaaatat ctttgtgggg agagggagga gatgtacaga 112080 gagaggctgg cagagtctct tttttgctct aggtggcagg ttcaagggtg ttcagtttat 112140 tttggaagca gtgcagagaa gggagccaga ctagaaacag ggaggtgatc 112190 <210> 17 <211> 23 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: synthetic DNA <400> 17 cgtgaagtct ccagtgaatc gcc 23 <210> 18 <211> 22 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: synthetic DNA <400> 18 gatggtgctc agcctagcac tg 22 <210> 19 <211> 880 <212> DNA <213> Homo sapiens <400> 19 agcacgtaga tcctccctgt catcaggcag agctcttcag tgaggtgggc tcagggaggg 60 ctctgtgcct ccgttcagca gagctgcagc tgctgcccag ctctcaggag gcaagctgga 120 ctccctcact cggctgcagg agcaaggaca gtgaggctca accccgcctg agcc atg 177 Met 1 cca gcc aac ttc aca gag ggc agc ttc gat tcc agt ggg acc ggg cag 225 Pro Ala Asn Phe Thr Glu Gly Ser Phe Asp Ser Ser Gly Thr Gly Gln 5 10 15 acg ctg gat tct tcc cca gtg gct tgc act gaa aca gtg act ttt act 273 Thr Leu Asp Ser Ser Pro Val Ala Cys Thr Glu Thr Val Thr Phe Thr 20 25 30 gaa gtg gtg gaa gga aag gaa tgg ggt tcc ttc tac tac tcc ttt aag 321 Glu Val Val Glu Gly Lys Glu Trp Gly Ser Phe Tyr Tyr Ser Phe Lys 35 40 45 act gag caa ttg ata act ctg tgg gtc ctc ttt gtt ttt acc att gtt 369 Thr Glu Gln Leu Ile Thr Leu Trp Val Leu Phe Val Phe Thr Ile Val 50 55 60 65 gga aac tcc gtt gtg ctt ttt tcc aca tgg agg aga aag aag aag tca 417 Gly Asn Ser Val Val Leu Phe Ser Thr Trp Arg Arg Lys Lys Lys Ser 70 75 80 aga atg acc ttc ttt gtg act cag ctg gcc atc aca gat tct ttc aca 465 Arg Met Thr Phe Phe Val Thr Gln Leu Ala Ile Thr Asp Ser Phe Thr 85 90 95 gga ctg gtc aac atc ttg aca gat att att tgg cga ttc act gga gac 513 Gly Leu Val Asn Ile Leu Thr Asp Ile Ile Trp Arg Phe Thr Gly Asp 100 105 110 ttc acg gca cct gac ctg gtt tgc cga gtg gtc cgc tat ttg cag gtc 561 Phe Thr Ala Pro Asp Leu Val Cys Arg Val Val Arg Tyr Leu Gln Val 115 120 125 atg gta atg aag tta ttc cat att cag aaa atg aat atg gaa tagttacaat 613 Met Val Met Lys Leu Phe His Ile Gln Lys Met Asn Met Glu 130 135 140 cttcttttgt gctctgaata taaccttgaa agtttggtat gtctgaaaga gccttttcta 673 ttatgtacgg ctagtatttt ctcaggggaa atttttaaaa acatatttca atttctttct 733 gaggatattt gcttccttgt aaataaatgc tttcaattgc ttattatatt agcaatcaat 793 tgctgataca caaattatga caaaacatgg tggcttaaaa caataaacat ttattatctc 853 acaaaaaaaa aaaaaaaaaa aaaaaaa 880 [Sequence List] SEQUENCE LISTING <110> KYOWA HAKKO KOGYO CO., LTD <120> Novel Polypeptides <130> H11-1931A4 <140> <141> <160> 18 <170> PatentIn Ver. 2.0 <210> 1 <211> 371 <212> PRT <213> Homo sapiens <400> 1 Met Pro Ala Asn Phe Thr Glu Gly Ser Phe Asp Ser Ser Gly Thr Gly 1 5 10 15 Gln Thr Leu Asp Ser Ser Pro Val Ala Cys Thr Glu Thr Val Val Thr Phe 20 25 30 Thr Glu Val Val Glu Gly Lys Glu Trp Gly Ser Phe Tyr Tyr Ser Phe 35 40 45 Lys Thr Glu Gln Leu Ile Thr Leu Trp Val Leu Phe Val Phe Thr Ile 50 55 60 Val Gly Asn Ser Val Val Leu Phe Ser Thr Trp Arg Arg Lys Lys Lys 65 70 75 80 Ser Arg Met Thr Phe Phe Val Thr Gln Leu Ala Ile Thr Asp Ser Phe 85 90 95 Thr Gly Leu Val Asn Ile Leu Thr Asp Ile Asn Trp Arg Phe Thr Gly 100 105 110 Asp Phe Thr Ala Pro Asp Leu Val Cys Arg Val Val Arg Tyr Leu Gln 115 120 125 Val Val Leu Leu Tyr Ala Ser Thr Tyr Val Leu Val Ser Leu Ser Ile 130 135 140 Asp Arg Tyr His Ala Ile Val Tyr Pro Met Lys Phe Leu Gln Gly Glu 145 150 155 160 Lys Gln Ala Arg Val Leu Ile Val Ile Ala Trp Ser Leu Ser Phe Leu 165 170 175 Phe Ser Ile Pro Thr Leu Ile Ile Phe Gly Lys Arg Thr Leu Ser Asn 180 185 190 Gly Glu Val Gln Cys Trp Ala Leu Trp Pro Asp Asp Ser Tyr Trp Thr 195 200 205 Pro Tyr Met T hr Ile Val Ala Phe Leu Val Tyr Phe Ile Pro Leu Thr 210 215 220 Ile Ile Ser Ile Met Tyr Gly Ile Val Ile Arg Thr Ile Trp Ile Lys 225 230 235 240 Ser Lys Thr Tyr Glu Thr Val Ile Ser Asn Cys Ser Asp Gly Lys Leu 245 250 255 Cys Ser Ser Tyr Asn Arg Gly Leu Ile Ser Lys Ala Lys Ile Lys Ala 260 265 270 Ile Lys Tyr Ser Ile Ile Ile Ile Leu Ala Phe Ile Cys Cys Trp Ser 275 280 285 285 Pro Tyr Phe Leu Phe Asp Ile Leu Asp Asn Phe Asn Leu Leu Pro Asp 290 295 300 Thr Gln Glu Arg Phe Tyr Ala Ser Val Ile Ile Gln Asn Leu Pro Ala 305 310 315 320 Leu Asn Ser Ala Ile Asn Pro Leu Ile Tyr Cys Val Phe Ser Ser Ser 325 330 335 Ile Ser Phe Pro Cys Arg Glu Gln Arg Ser Gln Asp Ser Arg Met Thr 340 345 350 Phe Arg Glu Arg Thr Glu Arg His Glu Met Gln Ile Leu Ser Lys Pro 355 360 365 Glu Phe Ile 370 <210> 2 <211> 1714 <212> DNA <213> Homo sapiens <400> 2 agcacgtaga tcctccctgt catcaggcag agctcttcag tgaggtgggc tcagggaggg 60 ctctgtgcct ccgttcagca gagctgcagc tgctgcccag ctctcaggag gcaagctgga 120 ctccctcact cggctgcagg agcaaggaca gtgaggctca accccgcctg agcc atg 177 Met 1 cca gcc aac ttc aca gag ggc agc ttc gat tcc agt ggg acc ggg cag 225 Pro Ala Asn Phe Thr Glu Gly Ser Phe Asp Ser Ser Gly Thr Gly Gln 5 10 15 acg ctg gat tct tcc cca gtg gct tgc act gaa aca gtg act ttt act 273 Thr Leu Asp Ser Ser Pro Val Ala Cys Thr Glu Thr Val Thr Phe Thr 20 25 30 gaa gtg gtg gaa gga aag gaa tgg ggt tcc ttc tac tac tcc ttt aag 321 Glu Val Val Glu Gly Lys Glu Trp Gly Ser Phe Tyr Tyr Ser Phe Lys 35 40 45 act gag caa ttg ata act ctg ctg tgg gtc ttc ttt gtt att gtt 369 Thr Glu Gln Leu Ile Thr Leu Trp Val Leu Phe Val Phe Thr Ile Val 50 55 60 65 gga aac tcc gtt gtg ctt ttt tcc aca tgg agg aga aag aag aag tca 417 Gly Asn Ser Val Val Leu Phe Ser Thr Trp Arg Arg Lys Lys Lys Ser 70 75 80 aga atg acc ttc ttt gtg act cag ctg gcc atc aca gat tct ttc aca 465 Arg Met Thr Phe Phe Val Thr Gln Leu Ala Ile Thr Asp Ser Phe Thr 85 90 95 gga ctg gtc aac atc ttg aca gat att aat tgg cga ttc act gga gac 513 Gly Leu Val Asn Ile Leu Thr Asp Ile Asn Trp Arg Phe Thr Gly Asp 100 105 110 ttc acg gca cct gac ctg gtt tgc cga gtg gtc cgc tat ttg cag gtt 561 Phe Thr Ala Pro Asp Leu Val Cys Arg Val Val Arg Tyr Leu Gln Val 115 120 125 gtg ctg ctc tac gcc tct acc tac gtc gtg tcc ctc agc ata gac 609 Val Leu Leu Tyr Ala Ser Thr Tyr Val Leu Val Ser Leu Ser Ile Asp 130 135 140 145 aga tac cat gcc atc gtc tac ccc atg aag ttc ctt caa gga gaa aag 657 Arg Tyr His Ala Ile Val Tyr Pro Met Lys Phe Leu Gln Gly Glu Lys 150 155 160 caa gcc agg gtc ctc att gtg atc gcc tgg agc ctg tct ttt ctg ttc 705 Gln Ala Arg Val Leu Ile Val Ile Ala Trp Ser Leu Ser Phe Leu Pcc 165 170 175 att ccc acc ctg atc ata ttt ggg aag agg aca ctg tcc aac ggt 753 Ser Ile Pro Thr Leu Ile Ile Phe Gly Lys Arg Thr Leu Ser Asn Gly 180 185 190 gaa gtg cag tgc tgg gcc ctg tgg cct gac gac tcc tac tgg acc cca 801 Glu Val Gln Cys Trp Ala Leu Trp Pro Asp Asp Ser Tyr Trp Thr Pro 195 200 205 tac atg acc atc gtg gcc ttc ctg gtg tac ttc atc cct ctg aca atc 849 Tyr Met Thr Ile Val Ala Phe Leu Val Tyr Phe Ile Pro Leu Thr Ile 210 215 220 225 atc agc atc atg tat ggc att gtg atc cga act att tgg att aaa agc 897 Ile Ser Ile Met Tyr Gly Ile Val Ile Arg Thr Ile Trp Ile Lys Ser 230 235 240 aaa acc tac gaa aca gtg att tcc aac tgc tca gat ggg aaa ctg tgc 945 Lys Thr Tyr Glu Thr Val Ile Ser Asn Cys Ser Asp Gly Lys Leu Cys 245 250 255 agc agc tat aac cga gga ctc atc tca aag gca aaa atc aag gct atc 993 Ser Ser Tyr Asn Arg Gly Leu Ile Ser Lys Ala Lys Ile Lys Ala Ile 260 265 270 aag tat agc atc atc atc att ctt gcc ttc atc tgc tgt tgg agt cca 1041 Lys Tyr Ser Ile Ile Ile Ile Leu Ala Phe Ile Cys Cys Trp Ser Pro 280 285 tac ttc ctg ttt gac att ttg gac aat ttc aac ctc ctt cca gac acc 1089 Tyr Phe Leu Phe Asp Ile Leu Asp Asn Phe Asn Leu Leu Pro Asp Thr 290 295 300 305 cag gag cgt ttc tat gcc att tgt g atc ac ctg cca gca ttg 1137 Gln Glu Arg Phe Tyr Ala Ser Val Ile Ile Gln Asn Leu Pro Ala Leu 310 315 320 aat agt gcc atc aac ccc ctc atc tac tgt gtc ttc agc agc tcc atc 1185 Asn Ser Ala Ile Asle Pro Leu Tyr Cys Val Phe Ser Ser Ser Ile 325 330 335 tct ttc ccc tgc agg gag caa aga tca cag gat tcc aga atg acg ttc 1233 Ser Phe Pro Cys Arg Glu Gln Arg Ser Gln Asp Ser Arg Met Thr Phe 340 345 350 cgg gag aga act gag agg cat gag atg cag att ctg tcc aag cca gaa 1281 Arg Glu Arg Thr Glu Arg His Glu Met Gln Ile Leu Ser Lys Pro Glu 355 360 365 ttc atc tagaccctag ggcagtgcca gtgctaggcacct gtgccct gagcaccatcgc gctccctcgc gtgctaggc 1397 tcattacctg ggagatgcac aagacaaatg ttctaatgac tgcatgcact gcttaagtat 1457 tggccaacac gaactcccca gttattcatg ccagccagga aggaaacgcc ttccttcccc 1517 accattccca gccctccttc ccactggcca gcacctgaac ccagtgaaca caggcatcag 1577 tggtccaggg tcctggcttg gagccagtga gtagacaggc aagcagaggg gacaaaggta 1637 gctgggttat acatgaatat tctcatta ca ataggagaaa ataaaagact taattaagcc 1697 caaaaaaaaa aaaaaaa 1714 <210> 3 <211> 30 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: synthetic DNA <400> 3 agcaucgagu cggccuuguu ggccuacugg 30 <210> 4 <211> 42 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: synthetic DNA <400> 4 gcggctgaag acggcctatg tggccttttt tttttttttt tt 42 <210> 5 <211> 21 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: synthetic DNA <400> 5 agcatcgagt cggccttgtt g 21 <210> 6 <211> 21 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: synthetic DNA <400> 6 gcggctgaag acggcctatg t 21 <210> 7 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: synthetic DNA <400> 7 cttctgctct aaaagctgcg 20 <210> 8 <211> 30 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: synthetic DNA <400> 8 tgtgggaggt tttttctcta 20 <210> 9 <211> 23 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: synthetic DNA <400> 9 agagggcagc ttcgattcca gtg 23 <210> 10 <211> 24 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: synthetic DNA <400> 10 gaatggggtt ccttctacta ctcc 24 <210> 11 <211> 22 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: synthetic DNA <400> 11 ggctgcagga gcaaggacag tg 22 <210> 12 <211> 23 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: synthetic DNA <400> 12 aacccagcta cctttgtccc ctc 23 <210> 13 <211> 33 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: synthetic DNA <400> 13 tgacaagctt accccgcctg agccatgcca gcc 33 <210> 14 <211> 33 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: synthetic DNA <400> 14 tagtgcggcc gctggcactg ccctagggtc tag 33 <210> 15 <211> 80578 <212> DNA <213> Homo sapiens <220> <221> exon <222> (25203) .. (25523) <220> <221> exon <222> (51516) .. (51648) <400> Fifteen gatctttgac aaacctgaca aaaacaagaa atggggaaag gattccctat ttaataaatg 60 gtgctgggaa aactggctag ccatatgtag aaagctgaaa ctggatccct tccttacacc 120 ttatataaaa attaattcaa gatggattaa agacttaaac gttagaccta aaaccataaa 180 aaccctagaa gaaaatctag gcaataccat tcaggacata ggcatgggca aggacttcat 240 gtctaaaaca ccaaaagcaa tggcaacaaa agccaaaatt gacaaatggg atctaatcaa 300 actaaagagc ttctgcacag caaaagaaac taccatcaga gtgaacaggc aacctacaga 360 atgggagaaa agttttgcaa tctactcatc tgacaaaggg ctaatatcca gaatctacaa 420 tgaactccaa caaatttaca agaaaaaaac aaacaacccc atcaacaagt gggcaaagga 480 catgaacaga cacttctcaa aagaagacat ttatgcagcc aaaagacaca tgaaaaaatg 540 ctcatcatca atggccatca aagaaatgca aatcaaaact acaatgagat accatctcac 600 accagttaga atggcaatca ttaaaaagtc aggaaacaac aggtgctgga gaggatgtgg 660 agaaatagga acacttttac actgttggtg ggactgtaaa ctagttcaac cattgtggaa 720 gtcagtgtgg cgattcctca gggatctaga actagaaata ccatttgacc cagcaatccc 780 attactgggt atacacccaa aggattataa atcaagctgc tataaagaca catgcacatg 840 tatgtttatt gtggcactat tcacgatagc aaagacttgg aaccaaccca aatctccaac 900 aatggtagac tggattaaga aaatgtggta catatacacc atggaatact atgcagccat 960 aaaaaatgat gagttcatgc cctttgtagg gacacggatg aagatggaaa ccatcactct 1020 cagcaaacta tcgcaaggac aaaaatccaa acactgtatg ttctcactca taggtgggaa 1080 ttgaacaatg agaacacatg gacacaggaa ggggaacatc acacacaggg gcctgttgtg 1140 gggtgtgggg aggtggggag ggatagcatt tggagatata cctaatgtta aatgacgagt 1200 tactgggtgc agcacaccaa catggcatat gtatacatat gtaactaacc tgcacattgt 1260 gcacatgtac cctaaaactt aaagtataat aaataacaaa aaaaaaaaaa gaaaaggaac 1320 aaacaaatcc tctgagaaat atagaactat gtgaaaagac caaatctacg tttgatgggt 1380 gtacctgaaa gtgatgggga gaatggaacc aagttggaaa acattcttca ggatatgatc 1440 caggagaact tccccaacct actaagacag gccaatattc aaattcagga agtacatgga 1500 acaccacaaa gatactcctc gagaagagca accccaaaac acataatcat cagattcacc 1560 aagtttgaaa tgaaggaaaa aatattaaca gcagctagag agaaaggtcg ggttacccac 1620 aaaagggagc ctatcagact aacagtggat ctctctgcag aaaccctaca agccagaaga 1680 gagtaggggc caatattcaa cattcttaaa gaaaataatt ttcaacccag aatttcatat 1740 ccagtcatac taagcttcat aagcaaagga gaaacaaaat cctttacaga caagcaaatg 1800 ctgagagatt ttgtcaccac cagacctgac ttaaaagagc tcctgaagga agcactaaat 1860 atgaaaagga aaaacccata ctagccactg caaaaacata ccaaattgta aagaccatca 1920 acactatgaa gaaactgcat caactaatga gcaaaataac cagctagcat cacaatgaca 1980 ggatcaaatt cacactaaca atattaacct caaatgtaaa caaactaaat gccccaatta 2040 aaagacacag actggcaaat tggataagca gtgaagaacc actggtgtgc tgtattcagg 2100 agacccatct cacagacaaa gacatacaca ggctcaaaat gaagggatgg aggagaattt 2160 accaagaaaa tggaaagcaa aaaaaagcag gggttgcaat cctagtctct gataaaacag 2220 actttaaacc aacaaagatc aaaaaagaca aagaagagca ttacataatg gtaaagggat 2280 caaagcaaca agaagagcta actatcctaa atatatatgc acccaataca ggagcaccca 2340 gattcataaa gcaagttctt agagaactac aaagagactt agaatctcac acaataatag 2400 tgggagactt taacaaccca ctgtcaatat tagacagatc aacaagacag aaaattaaca 2460 aggatattca ggacttgaac tcagctctgg attgagcaga cctaatagac atctccaccc 2520 caaattaaca gaatatacct tcttctcagc acctcatggc acttattcta aaattgacca 2580 cataattgga agtgaaacac tcctcagcaa atgcaaaaga acggaaatca taacagtctc 2640 tcagaccaca gtgcaatcaa attagaaccc aagattaaga aactcattca aaactgcaca 2700 accacaagga aactgaacaa cctgcccctg aatgactact gggtacataa tgaaatcaag 2760 gcagaaataa ataagttctt tgaaaccaat gagaacaaag acacagtgta ccagaatctc 2820 tgggacacag ctaaagcagt gtttagagga aaatttatag cactaaatgc ccacaggaga 2880 aagtagaaaa gatctaaaat caacacccta acatcagaat taaaagaact agagaagcaa 2940 gggcaaagaa attcaaaagc tagcagaagg caagaaataa ctaagatcag agcagaactg 3000 aaggagatag agacatgaaa aacccttaaa aatatcaacg aacccaggag ctggtgtttt 3060 gaaaagatta acaaaataga tagaccgcta gccagactaa taaagaagaa aatagagaaa 3120 aatcaaatag acacaataaa aaatgataaa gggataccat cactgatccc acagaaagac 3180 aaaccaccat cagagaatac tataaacatc tctatgcaaa taaactagaa catctagaag 3240 aaatggataa attcctggac acatacacac tcccaagacc aaaccaggaa gaagttgatc 3300 cctgaataga ccagtaacaa gttctgaaat tgaggcagta attaatagcc taccaaccaa 3360 aaaaaccaca ggaccagatg gattcactgc caaattctac cagaggtaca aagaggagct 3420 ggtactattc cttctgaaat ttttccaaac aacaaaaaaa gagggactcc tccctaactc 3480 attttaagag accagcatca tcctgatact aaaacctggc agagacacaa caaaaaaaga 3540 aattttaggc caatatccct gatgaacatc aatgtgaaaa tcctcaataa aatactggca 3600 aaccaaatcc agcagcacat caaatagctt atccaccaca atcaagttgg cttcatacct 3660 gggctgcaag gctagtttaa cttatggaaa tcaataaacg taatccatca cataaacaga 3720 accaatgaca gaaaccacat gattatctca atagatgcag aaaaggcctt tgacaaaatt 3780 caacacccct tcatgctaaa aactctcaat aaactaggta ttgatggaac atatctcaaa 3840 ataataagag ctatttatga caaacccaca gccagtatca cactgaacgg gcaaaagctg 3900 gaagcattcc ctttgaaaac cagcacaaga caaggatgcc ctctctctcc actcctattc 3960 aacatagaat tggaagttct ggccagggca atcaggcaag agaaagaaat aaagcgtatt 4020 caaaaagaaa ggaaatccaa ctgtctctgt ttgcagatga catgactgta tacctagaaa 4080 accccattgt ctcagcccaa aatctccttc agctgataag caacttcagc caagtctcag 4140 gatacaaaat caatgtgcaa aaatcagaag aattcctatg caccaatcat acacaaaaag 4200 agagaaagat tatgagtgaa ctcccattca caatggctac aagagaataa atacctagga 4260 atccaactta cttacaaggg atgtgaagga cctcttcaag aactacaaac cactgctcaa 4320 ggaaataaaa gaggacacaa acacatggaa aaacattcca tgctcatgga taggaagaat 4380 caatatcgtg aaaatggcca tactgcccaa agtaatttag agattcaatg ctatccccat 4440 caagctacca ttaactttct tcacagaatt agaaaaaaac tactttaaat ttgatacgga 4500 accaaaaatg aggctgtata gccaagaaaa tcctaagcaa aaataacaaa gctggaggca 4560 tcacactacc tgacttcaaa ctatactaca aacagcatgg tactggtacc aagacagata 4620 tatagaccaa tggaacagaa cagaggcctc agaaataatg acatatatct acaatcatct 4680 gatctttgac aaacctgaca aaacaagcaa tgaggaaagg attccctgtt taataaatgg 4740 tgctgggcaa actggctagc catatgcaaa aaacacagaa actggacccc ttccttacac 4800 cttatacaaa aattaagcca agatggatta aagacttaag tgtaagacct aaagccataa 4860 aaaccctaga agaaaacctg ggcaatacca ttcaggacat aggcatgggc aaagacttca 4920 tgactaaaac accaaaagca aaggcaacaa aagccaaaat tgacaaatgg gatctaatta 4980 aactaaagag cttctgcaca gcaaaataaa ctatcatcag agtaaacagg caacctacag 5040 aatgggaaaa aaattttgca aactattcat ctgaaaaagg gctaatatcc agaatctaca 5100 aagaacttaa agaaatttac aagaaaaaaa atcccatcaa aaagtgggtg aaggatatga 5160 atagacactt ctcaaaagaa gatatttatg tggtcaaaaa acatatgaaa aaaagctcat 5220 catcactggt cattagagaa atgcagatca aaaccacaat gagataccgt ctcatgccag 5280 ttagaatggc gatcattaca aagtcaggaa acaacagatg ctggagagga tgtggagaaa 5340 taggaaagct tttacactac tggtgggagt gtaaattagt tcaaccattg tggaagacag 5400 tgtggcgatt cctcaaggat ctagaaccag aaataccatt tgacccagcc atcccattac 5460 tgggtatata cccaaaggat tataaatcat tctactataa agatgcatgc atacgtaggt 5520 ttattgcagc actagtcaca atagtaaaca cttggaacca acccaaatgc ccatcagtaa 5580 tagactggat aaagcaaatg tggcacatat acaccatggg atactatgca cctataaaaa 5640 aggatgggtt catgtccttt gcagggatgt gaatgaagct ggaaaccatc attctcagca 5700 aactaacaca gaaacagaaa accaaacact gcatgttctc actcataagt gggagttgaa 5760 caatgagaac agatggacac agggaggaca tcacacacca tggcctgcca gggggttaga 5820 ggctagggga gagatagcat tcaagaaata cctaatgtag atgacaggtt gatgggtgca 5880 gcaaaccaac atggcatgtc catacctatg taacaaacct gcacattctg cacatgtatc 5940 ccagaactta aagtataatt ttaaaaaagt aggttggaga ttcatattta aagtgaaact 6000 aagccaaaat ttgtattatt tttcttaata atttccaaaa tgcaatctaa gttttacctt 6060 ttaagccaat ctgatcaact tctcatggca ctaccttgag aaaaactcta aggtatacta 6120 agacacagtg gttctcagtg ccataatcca tcagtgaatg tggggacagg cagcaggcac 6180 agagagtggg gagtgtgccc agctctgaca taaagaacaa caatatgttg atgcaacatc 6240 aagaagttgc ttctctcctg ggcttccttg tagccgttat cagctattac ccaactcagc 6300 tactctacag tcattttcaa cacttttctt cctttctgtg tcccattgcc aagtctttaa 6360 aagccaggca ctcatttttc aagacccctt tcataaggcc aggggttgct gtataaccta 6420 gttattgcca gtaggatgta aagagataat tgtcatcatc ttcataagca tcatgaaaat 6480 attttcctct ctgaacagag aaacagatga agaagaatgt cttcctctac caccagcatc 6540 ctcccccacc ctccgaccta ttttgttgtt gttgattttt gtttcttgtt tgagacggag 6600 tctcgctctg tcgcccaggc tggagtgcag tggcgcaatc ttggctcact gcaacctctg 6660 cctcccaggt tcaagcgatt ctcctgcctc agcctcccga gtagttggga ttacaggcac 6720 cctgccccca cgcctggcta atttttgtat ttttagtaga gatgaggttt caccatgttg 6780 gccaggctgg tctcctaacc tcaagtgatc ctcttaacct caagtgatct gcctgtcttg 6840 gcctcccaaa gtgctgggat tatatgcatg agccaccacg cctagcctcc tccccgcctt 6900 tttttaaacc cattaccatc cttgctttct gatttggact ggcattgaag atatgattat 6960 taggaatctg actgccaact tgtgatcgtg aaggaagaca ttggcaacat gataaaaata 7020 gcatagagga ggatgaaagg agtctggatg tcctggggac ttgttgagct accaaaccca 7080 ccctgatact gcccagcttc tgttctttgt ggtataaaca atacatggct tggcggtttc 7140 atctactgtg agttaagtct tctgctcctt gctatcgagt gtatcctaaa accaatacac 7200 cagcaaatga gatgcaagaa taactgcctg tttgctctgt catttttgca atgtagacac 7260 cacctagaac aagaaaatta ctgaatctct gaatgacatt tttgtaaagc catagaagca 7320 aaaacacaag tttaaaagac ctagatttta attattagag tcagattctt gagaaaattt 7380 ctgatggcct tgaagccagc agtttataca gtgaggcagg acaaggagaa atctatttga 7440 gtgttgtttc ctccccgcac acagataaaa tcagaacatt ttctagagag gattgggaat 7500 ggagaagaca gcagatgcta atgttgggct ctgcttcctg gctttccctt cctacagggt 7560 tgacccattg atggggtgga taaaataggc ttggagatct gaatgtagaa aggacttgcc 7620 ccacacttcc tgcctcgaac tcagagagga gatggccttc aagaatgcct tgcagcaacg 7680 tgggtagaca gcattgggct cagaataggg gcacagcata gcaaaaccaa ctcatctcag 7740 gtcttggaag agacttcaaa aagctcccaa gcttccccca aaaaggagct caaaggacag 7800 cagagaatga agagctggaa tgcatcagga attcacatcc gcatatcaga gactcagaaa 7860 gtgattatgt cagataaatg gaagaaaaat aagtagaaag agaatcattc aggcagacta 7920 aattttaaaa taaattactc tgaaatgaga agttaagagt cttttgggtc ttgtcccata 7980 tagaacaaaa gagctatgtt aatttatctt gtaaagaaag ttttgtttca tgcatccgag 8040 ttgataatgt aaaatttaaa gttgcttcag ataatgtgac aaccctggag tataatacat 8100 taggactcat ctctctgaac gaacagcaac tttgcaaaag aggaaacggg gctgcctgtt 8160 ctgttactgt cacatctgat ttttatttgt atatgacttg accagccttt atagctctca 8220 ccacacagca cttccatgtt ccataatgga cctgttcaaa ggaagccata tcactccact 8280 tgatttgctt ctgataccag ttccaggggt attgatctgt cttgagtaat gtgttattgt 8340 tgacagagag gtttcttgac tcactgtagg tgacttttta tgccctttaa agttctgaaa 8400 agcccataaa gataatgttt aaattacaag tcatacacaa cagaagagag tctggagcag 8460 ccacacaggc aactgcatag taccagaagg actgtggaca tggaatcaga ctacacagtt 8520 ccatagctga ctgggtatat tactctttcc tcaatttcct catatgtgaa atggtaaggc 8580 taatatctac ctagcatagt tttctgaaga ttttataaga gatcacatat ataaagcacc 8640 taaccttgtt aatccataga agaaatgtaa taaatatcag aaaaagaaga gatttttttt 8700 ctcccttctt ttgttatttc atgctataaa ttttaccatt ttctgggttt aagtacaatg 8760 cgtttatgct aaggtttaac acggtggctt catcttttag tcattctaat taatttcagc 8820 attgactgaa cccagtggcc cctgtagata aaaacaggac caaccactaa acattaaact 8880 ctcaagcacc cacctgtaat cacttaaaca gctagaggtg gctccactga tacttattaa 8940 acagatgttc actctgtaac aaaagtgtac caatctcatc ctgaagccca gaaaatagaa 9000 aagaagatag gacagcctct gttaccaatg gcagaaatat gacagggcta tatgaggcta 9060 agataaagga tatcaaactc aaaaccaaga gtgataagca aggagactgt gttagactgt 9120 ttcaataatt aaggtgagaa atgatggcag cctgaagtgt gattttcatg atggagatgg 9180 ggagaaatag atagtttaaa aactgttaaa aaggagcatt ggcagaactc attaattgaa 9240 cagatgcaga tagcaggtag gctgggggag ggaggtgtta catatgacaa catgacatat 9300 tctgttaata ctaattgaag gcctctatgg tggaatcact tacttaggtg acttgggaat 9360 acagggaggt aaagtcacat tcctggctcc caagaaatgt atagtacatt taaagggata 9420 agacataaca acatcttttt agtatctgct ctagtttatt attttatttt ttagggccct 9480 attctgttct caaaaaaaaa aaaaaaaaaa gtagtaagga tgaaaagggg tagggcatct 9540 ggaaaaaact ttggagaagc ctcaggaaca tcccgcttga aacctccagc caattatttc 9600 agtcttatag agagagtgga ttaaatgaat aggttgtgtc actatttttg agaagcctga 9660 gtgcctcttc taagagctat tctcatttcc acaaaaagga agggaaattg cggtatctaa 9720 aagtagtgtt tgaaagtcac ttcttaagaa ttatatcgag tcaaaacact ttcatttaaa 9780 gcccttaata tttgaacatt gttatttatt tttgctgttt ggatttttat gtgtgtgttt 9840 gtgtacctat gaaaaactat tcatgtctca aatgaaataa aagaaggtgg ctgtgatgta 9900 ttagtatagg ttctcaattt ctgtcctagg taagatgaaa agcatgaaga tgcctccttc 9960 aatcccgtca tggccacagt ctccttgtca tacccatata ggctctacct caagttgtgg 10020 gcaaacttct ttacccacct gtcatgaaac tgtgcttttt ctatgctatc tctagggccc 10080 caagactgta tggatagctg cagaccacca cattcaggaa gaggggccag atccattagg 10140 gagtatattt ggcattgagc tgatagagaa taaaggagaa aaacttcctg agtagctcca 10200 gtcttaccaa cccagcttct gtttcaaagt gagttcatga tcaacggtgg tctcgcctgg 10260 agtcattagt ccagagaaca tcccaacaaa gaaggtgtag gaagttttcc taaacctaat 10320 ttttaggtca aaaaaacaag acagagagag aacaagatta ggaaataaat gggaagttgg 10380 aggagcccgg atcaagcaga agtaagccca agaatgcaag ggaaaggtct gaggtataat 10440 ggtataggtc tgagacagga agagctacgg aataagcaga gcaagaaagt gcagagggca 10500 ataaggaatc ctttcagatg cttttcttct actccaaccc caattagata cacatgggca 10560 ttggtaattt tgccttctga atctctggga taatacatca accacgtcat ttgccctggg 10620 gagagggtct ttgaaattag cacaatagct ctgatttcct gccaaatggt taatcagaag 10680 gggacctaat acataaagag caggaatcta ttgttttcat agactcctta tgccttgggt 10740 aagacataat tctaacttgc tattaccccc ttctctgatt ttacactaac tagggatata 10800 acagccacct caaatgtccc cagatagtcc acatcccagc aacagccgac ttcgccaaat 10860 tggggcagcg atttcacctt catctcacag agttcaatga gtatgttgcc aagggacatt 10920 ttgagtgcca attcactaat tttacagaaa ctctgtaatt ggttggaatt gctaaggtca 10980 gggattgtac atttcttgtc accttccttc agagggctaa tttctgtttt ctctctcgga 11040 tgcattctat agctcaaaca gcagatgcat tctcttgcag tggtgaataa aggccattct 11100 tggacaggcc caattgctct actaagttag aaggaacctc ctttttagct gacatataat 11160 caatcagcat gcattcggtt tagagcaatg aatcttctgt aagtgacaag agactggatt 11220 tgttaatttt gctttcagca aatgtacctt aatatggata tttctaagat tcttggcagc 11280 aatataattt aaaacatggt ttagtgtgac aatacaagag catgatgttc tgattctgat 11340 aaaattttgt cacatatgag agaaggaaga aaaaaaaggt tagtagttca gataagagaa 11400 aataattggc tgaaaagctt ttatatttga gaatgatata aaagtggaaa gtgaaatcat 11460 tgacatgaac tgagaacttt gacggacctt tactctggaa ccgcaattgc ccagctgtgc 11520 ctgacatgat cccatttgaa gtcaggggtc atgatataaa cctctcatct ctgattttcc 11580 cctaaccagg gctccaatgg acatctcaga attcctcaga acccccacac tctccaacag 11640 ctgactttga tagtttgcct gttacgaatc agggcagcaa tttgatcact tctcatatgg 11700 tccaatacat atgttgtcaa gtaaagtaaa aagatagcac aagaaatttt tactagatat 11760 aattgcattt gaatcacatc caactatgca tgaaaacagc atagatatca cctaagactc 11820 ttactaacga aagttcccca caaaatatct tagtgcagtg attctcaaag ttgtggtata 11880 tatcggaatc accaggggga acttgttaaa atgcagaagc ccaggctttt gtctacttga 11940 tgaatctgag cccctattct ttattaactc ccccaggtaa ttctaaaaca cttctgagtt 12000 tgagaaccac tgatgtagtg ttatagaaag taagtagaga aaaggatgag ctatagataa 12060 gagggcaaca ctttctgccc cttttcccac tgcatgtagg acatgttgag gagtggttta 12120 gctggatggg aaagcaagtg tcttttttca tcacttttca ctgagcaggc agtttctcaa 12180 ttgcagcgcc ttctccctct gactccatgc ccatacacac attatgaatc cgagggccgg 12240 tgcccatgca gccatacaat agagacaagg accaatttac ttgccaacta aacatgtagg 12300 gacatgctgt ctatcctcaa cacagataaa acctgcaggt gctcttcctt tgttgagccc 12360 agtgcttctc aaccttggtt gcacattaca attgaagaat gtttcaaact ccccattgcc 12420 caagctgtaa cacagtctag ttacagctaa attgggagga gagcacaggt tttggtggtt 12480 tataaggctt cccaggtgat tcaacatcta accaaaattg aaaacaactg tctctaattc 12540 agattctcac gaatgaggca gattcatcct gcatttaaga gagcaacctg taactctaag 12600 gttacttctt ctattgtata gtctcatgat ttggtatcag attaagtagt ttaaaatatg 12660 agaaaatgtg cacgaagaaa agtcccagag atctgattgc ccattccttc tcctttccta 12720 cagtcttcag tctaggtgac aatgcaaata taaacctgct cttttcagga agaaaatacc 12780 caccacacca acatatggaa atagaaagac tgtgtaaacc tgattctttt ataaggcgtg 12840 taaagagaga aatgagaaca gcacatttga aattcagatt taatcaagaa gtcttaaact 12900 caataaaaag acaactcaat ttttaaatgg acagaagatt ttagtagata tttttatcaa 12960 agaagatata caaataacta ataagcacct gaaaaaaagc tcaacattat tggctattag 13020 gaaatgcaaa tcaaaaccac atgaaataac acttactcat cactgaaatg gctataatca 13080 aaaaaacaga caataaaagt gatgtcaatg atgtggaaaa actaaaacgc tcattaatac 13140 attgctggtg ggaatgtaaa atggtgtggc cactttggaa agcagtatgc caatttctta 13200 aaaattaaac acaaagttac catgcaaatc agcaattcta ctcctagtag tctctccaag 13260 agagatgaaa atgaaagatg gccacacaaa gacttgtatg tgaatgttta ttatggataa 13320 tacccccaaa gtggaaacaa cgcaaatgtc tttcaactgg taaatggata aacaaaatgt 13380 gatatagcca caaaatggaa taatttacaa caataaaaag taatacagta ctgatatagg 13440 ccacactatg catgaacttc agaaaattat gctgcacaaa agaaatccaa cacaaagtcc 13500 acatatttta tgatttaatt tctacaaaat gtctagaaaa gataaatctg cagagacaaa 13560 aagctgatta gtggttgccg gggactggag tggatataaa gaatgactac aaatgggcct 13620 gagagatact atttgcgtga gagaaatgtt ctaaaattgg attgtggcga tggttgcaca 13680 actctgtaaa tttactagaa gttaattaag ttgtgtactt aaaatgggtg aattttatga 13740 tatatatatt ataataaagc tatttagaaa aacatgtaga attgacttta caattctgca 13800 aaaataatgt aaaaatttaa gtagatataa catgcaaaaa taaagcttat tactttggaa 13860 aaaattactt caaaaatatg aaaatagttt aagctgcagg aattttttta aaaaaacaaa 13920 ctctaaaatg ataatattga gcattgacta tattccaggc attattctaa gtgctttata 13980 tcattttgtc ctataaatga gcctctaagt ttgatgttat gttccattgt actagtattg 14040 aaactgaggt ctaactagag ataaaagact gatgctagaa taagaagaca gattaaaagg 14100 aagatggtag tactaaagaa ataatttgag taatttatag tgcgtttgca taattgtaac 14160 tggtattaaa aagaatgaaa aagagaatag agacccaaat ctagtgttga tcagatgaag 14220 attaaagaca tcacagacaa tgcagagaaa aaggagaaag agattaaggt gatcagagaa 14280 tagatgatag atagatacag atgacataaa atgaggaaca gagtagggat aattagtgtt 14340 cttggggtgc agaggagaat caacataaaa atattaaaga tattatttaa aatgtctttt 14400 tagctgaaga gaattctaaa cataaataat actatcatta gcaagaataa atatcaggca 14460 ataatgtacc acaactgcac tgagcacaca tcagctcctt gaaccatcac aacaacccta 14520 ggaagcatga actataattt ccattttaca aaggatccct agagctaaga tgactagata 14580 tcttgtttgc ttaggacaat tctggtttac tgcatgtaaa ctacctaaaa tacccatttt 14640 attctcaaat ttatgagtct ggacaataaa ttacatgatc accctatttt gagtctaaga 14700 actacaggtg gtaaactgca gaaccaaaac ttattggaga agtctccaaa gcctttgttc 14760 ttaaccattt tgttatacta aatctgcaga gctaaagtgt tcatcacaaa gcgacacaac 14820 ttgtaaaaaa taagtgatta taccaagaaa ttctgcattt caaagataaa taaacaactc 14880 tatatgcatt cagtagaagt aagtcattta aaaaggaaaa agatattaat taatttcata 14940 agtaaatgaa aaatagtacc ctggatttct tctttacaac attaaatgcc agaaaacaat 15000 gtctacaaag tcaagttaga attaatggaa gctctcaaat atacaagtag ctaagaatca 15060 agaagtcaag caactactta aagacattgt ccagctaatt taggtagaaa tcaaaattta 15120 gacttcacaa acacataagt aagatacaga agtacttata gtgggcaatg aatccacttt 15180 aatatcaaat tatgtaacag ttgatctggt aaatatcatg tctagacaaa gtatacatgt 15240 gatatttctt ggaagacaat atgcaccata tctaacttcg atcctgcatc aaaaattcca 15300 ctggtttgag aagaggccga gggagcagtg tgggaagaaa tgcatatgag ctgcttttcc 15360 cattttcaca aggggaatcc aataaataat gtcttattcc tgttgttgat aaactagcag 15420 tctgaaattt agtcaaaatt tttaagttgt aaaaatatac atcagtagag caaaaaaaat 15480 tgtattatct ttcatgttgc agaagaaaat agaattaaag aaaaccttag aaagataaca 15540 taaagaaaaa atgcaaaggt aatactaaaa ctaaagaaaa tattttaaat agcagtaaaa 15600 gacagaaaac aaaggtaaaa atcaggaagt atatagagag accaaacaca ggatgtttaa 15660 tactaaatac aaatggttaa atcactctct tattaaaaga aagatagcct catattaaac 15720 aaaacaataa gtaaaatata tttacaagag acaccaaatg ccaatgatta cagaatgtag 15780 agaataaaag aatcagtaaa gatatgcaaa agaaactaaa atataataca aatttaaaaa 15840 tacagtataa cagctattta cctagcattt acattgtatt taattaatct agagatgatt 15900 ttaagtatat gtaaggatat gcataggtta tatgcaaata ctacaccgtt ttatataagc 15960 gacttgagca tcttggattt ggcatccacg ggagtcttac aacaaatcct ccatgcatac 16020 caagggattt gtctgcttat ctgacttact taaagaatcc tgattttata gagcgtgacc 16080 atattctcag cctcccttgc aaataggaga agctatgtga ctaagttctg accagtgaaa 16140 tataagtgga agttactggg agggcttcca ggaaaattcc tttaaaaaga gctgagctcc 16200 cttttgtctt tcccctttcc ttcttccatt ggctggaatg caaacacgat gaagctgaaa 16260 tgtatatctt acaaccatat ggtgacctta aagatggaag cacttcatca aggaaaacag 16320 agcaagaaga tacgatgagc ctgggtcact aatgatatcc tggaaccact tcaccacccc 16380 ttgattcatg ttaccactaa ttccccattg ctttcctaca ttaattcaaa cttgactttg 16440 taaaaattat tttctggcat ataatgttgt aaagaaaaaa ttcaagatac tgttttttta 16500 tttacttact aaattaatat agtatttctt tattagtgac tcacttttac tgaatgcatg 16560 taaaacttgt ttatccttga aatacaggat tccttggtac aaccactttt ttttctaaaa 16620 ctagtttgtt tctttatgat gaacactata atagctctgc agatttagtg taataaaagg 16680 gttaagaaca atagctttgg agacttccat gactgaaagt tttggttctg caacttacca 16740 actctagttc ttaggcccaa agtaaggtga tcatgttatt taccttgtgt cttcaccaca 16800 ataccttgac tctatctttc ttgagggaaa gacaaacaag cattctgttt tgttcaaatt 16860 gctctttttt taagatctct gtacttggac taaaaagcaa ttattaactg atatcagcac 16920 ataaaattag tttataacaa atcaaaatcc aaggtgaaaa aattatatga gagtcttttt 16980 acttgatggt tgacaaattc aacataatca cgtgtgtcat gaatcttttt atgacaacaa 17040 tacagcatca aaatgtacag tgtagaccta gaggaaatac aaagagaaac acagggcccc 17100 aataataatg gaaaacataa acaaaccttt ctgtgccttt gacaaattag gtagacaaaa 17160 gctaaaaggt aaagaaatga gattctagag acttcagtag aactaagagt acctaataaa 17220 atgcttctaa aaatatgtgt gtgtgcgtgc gcacatgtgc acacacacag gcatttgtga 17280 aattatctta taaatagaat tccaggtatt ttttcaaaaa ctgaacatat atatataatg 17340 ttttaaaata tttcaaaaga tagaacttgc cttcaaaata taattcaaga aataaacaaa 17400 acttgaaatt aaactgaaca aaaatataaa catttagaag tcacttccaa gtaattcttt 17460 ggtctaagaa gaaatcagac acacattgta tttattgtag aaaataatga aaatgaaaat 17520 accacatatc agactctcca ggtcacagct aaaagcagat tcagaggaaa attcgttgcc 17580 ttaaatgctt caattataaa tatgaatgaa tgaaaataaa cgttaagtat ttaatccaag 17640 cattcagatt ttttaaagac agcaaaatta agaaagaaaa agaaggaatt gatgaagatg 17700 tagtaatagc aattgtactt caataaaata ttttgaggaa ataatcagac aagagctcaa 17760 gaatgtttgt tcggtgctgt ttctggaaac tcagaaaaaa ctttaatctt tattataggg 17820 atgattgaat aaatcataac acatttcatg ttagcagaac aaagagacac taaaatatat 17880 accttaatac aaaaatctac aacaagtgga attaaaaagc agaatgcaga gctgaatata 17940 agaatcacaa ttgggcactg aggaatacat tagcagttaa tataagttgt gtctttacat 18000 cttcaggtat ttatttaaag gaactacagt ttggtgttat aattagaaaa atacaaccct 18060 aaaagtatgg actgtgaaat catatttatt ctagtgtcct cctttaagta gaacattgca 18120 ttccatttct ttagggactg tatttcttaa tcattgtaac aggtataacc tcttgtaccc 18180 attacagcaa gcaattacta aatataatat accacatttg tcttttctgc aggatcccaa 18240 gaatttctct gccctcaaag caattttctg tttaatgcta tgctgaggat actcttattt 18300 catactaatg atttagaacc ctcaccacca tatcagaatt ccaagccaaa actaaggtac 18360 tatgaaaagt taactggtgt ggaaagtcaa tggtcatttc ttatcttatt tctctacttg 18420 aagagttatt ccttaccaag agctctccgc accttcacta tggggaaata tgcacctact 18480 ttaaggaaat attatgggaa ttaaatgttg tgacatcttt caggcaccca gcacagtggt 18540 gagatggagt tcccccttta ccttctccca tattctttcc tgatcctatc tgagtaatta 18600 caactcttcc aaccaatcca cttttacaca gtttttttta tagaataaac atccaaatgc 18660 agcatctgtg atatatctga attaaatagt gggtgcaaca acatggctat ttcaagctta 18720 aatgtcagct aatttttttg aaagcaaagt catgggagtg agtgtctgtt tacacctaat 18780 gctgagaaat ttaatctctg caggctgtga cacattctga tatcagagga tcaaaatccc 18840 actggtggaa gttaatttcc tttgctctac aatccacact taccattctg cactcaggtg 18900 ggaaaataaa acttgtgttc ttcatccaaa gttactaaaa acacccaagc ccaaatttaa 18960 acctcaaaac tatgagctct gcttccttgg aactcaaaag aataattctc tttgctactc 19020 agagattaat cacactgcct ttatcaccta ctatgcttgt gttattttac tcttcttttg 19080 ttatttaact gagagcattt gtgtctattc tacccaacca aaccatgaat ttgcatgtgt 19140 cagggaagct ctggcaaaat ctgatacaac ttattcctca tatattaatt gcttaataca 19200 gtttttgtga ttgaattttg agctaataac atattttaat tcaatacagc atgcattttt 19260 aaacactctg agaatgtcca aaaacaattt ggcacttagg taagaagaga ctttattcag 19320 gctgggtgcg gtgggtggct cacgcctgta atcccagccc ttcgggaggc cgaggcgggc 19380 ggatcacaag gtcaagaaat cgagaccatc ctggacaaaa tggtgaaacc cagtctctac 19440 taaaaataca aaaattagct gggcgtggtg ccatgggcct gtagtcccag ctactgggga 19500 ggctgagaca ggagaattcc ttgaacccgg gaggcggaga ttgcaataag ctgagatcac 19560 gccagtgcac tccagcctgg caacagagca agactccatc ttaaaataga ataaaataaa 19620 ataaagagac tttattcgaa aggattagtg caagagggag actggaccat tacagtaagg 19680 agaaaggggc tgttgtagtt tggagaacat tcttatcatg agatctggaa gtatctcaag 19740 ggttaggaaa aaagagattc tctttcatag gaaagaatag acaaggctag aaagaaccag 19800 gtgtggagaa gtaccatgac aggagtgaca cgatctgcca gtagatgagg gaatatttta 19860 ccctgaactc tgcagcgtac tccagggaga ggctgtggag gaggagctgt gtgctggctg 19920 aggctgaggg cgggacaaag ttcagcctag gagaagcaaa gaatcttaac caaagttggt 19980 ttagcctgca tttttttctg attgatcagt ggggacaaaa cagcttagct aatatcattt 20040 atgagacaaa caaaaggaat ttagagggtc tgcgtctggc cttgttataa gtgttgatgg 20100 ctatttactc tgtgttgcta caaaaatata tgtgaaattg ggtaatttaa aaagaacaga 20160 ggttcatttg gttcacagtt ctgcaggctg tacaagaagc atagtgtcag catttgcttc 20220 tggtgagggc cttgggaagc ttacaatcat ggcagaaggc aaagtaggaa caggcacgcc 20280 acatggcaag agagggagca agagagaaag gaggaggtgc caggctcttt gaacaaccag 20340 atctcatgag aactaaaatc aagaactcac tcattactgc aagaacagca ccaagccctt 20400 catgagggat ccacccccat gatcgaaaca cctcccacca ggccccacct ccaacattag 20460 aggtcacatt tcaacatgag atttgaaggg gacaaaacat ttgaaccata tcaatgccca 20520 caaggcagca ttggtgaatc tgatttaagt cacatgggga ataatggtta gctgcacaaa 20580 gccctttctg gaacacaaag cagtgggggc atttattaac cttttctgtt ttccaggatc 20640 acagggttct ggtaaagttc aaacttgtca gaggatacaa ggagaaaagg tgcagtgtct 20700 ccattcagga atttggagac taaagaaaga gtcaaggaaa aattgttcac atttttaaaa 20760 atagtaacga ttaagcagaa gacaagaagg aagacaatta gatctcattt gatttccaat 20820 accttcatga tgcaggcacc acagtctctc agttaacaga tgagaagaaa gaggcttaga 20880 actgttaagt aaataatcca gggactcaca gacaggacat agcagagcca agtttgaatc 20940 cagatcattt tgacagccca gggcacagtt catatatgaa aaggccaact aacaaaatgt 21000 tagctaacaa atgcatcact gtggacagtc aggaaatacc tgcaagctcc agaactttct 21060 catttacata gcactaacag aaacttttgg actttccctg caatgaggca gagtgtcaat 21120 ccctactgag atggacccca ataaccatta aaaatacata tataaaaaac aagtttaaat 21180 attttgccta taacttttat tccaaagctt atgaactctt ctcttttagc attacaggaa 21240 aatgatgtat ttgttcaagg atataaaaat tgtggccagg gctcccatag tgaatgtatg 21300 aagcaggaag ctggggggat ccatggaacc ttgagcattc tcttccagaa ctctccatcc 21360 ctgctaaagc taaaatgcct gtatcatggg caaagcttgt cacactagaa aggtcaaaac 21420 ttaaaaatgt tcttaccaag tatctcccag tagtatgtgg ctgatatgag actgaggcaa 21480 agcttctcct agcagaaaag aagggactca gtaacctggg aaaggtgacc ttcatctaga 21540 aaaggaagag acagaatttc tacaaatgag ttcaggtaag aatgtgtatt agagttctcc 21600 agagaaacag aaatagaact aataggaggg gtgtgtgtgt gtgtgtgtgt gtgtgtgtgt 21660 gtgtgtgtgt gtagggaggg gggagagaga gaaacagaga gagaaattta ttatagggaa 21720 tacaatatga aataatcatt cacacaatta atagagacta agaagtccca agatctgcaa 21780 gcagcaagtg tcaggcctct gagcccaagc caagccatcg catcccctgt gacttgcacg 21840 tatacgccca gatggcctga agtaactgaa gaatcacaag agaagtgaaa aggccctgcc 21900 ccgccttaac tgatgacatt ccaccattgt gatttgttcc tgccccaccc taactgatca 21960 aggtactttg taatctcccc cacccttaag aaggttcttt gtaattctcc ccacccttga 22020 gaatgtactt tgtgagatcc acccctgccc gcaaaacatt gctcttaact tcaccgccta 22080 tcccaaaacg tataagaact aatgataatc caccaccctt tgctgactct cttttcagac 22140 tcagcccacc tgcacccagg tgaaataaac agccatgttg ctcacacaaa gcctgtttgg 22200 tgctctcttc acacggacgc gcatgaaagc aagctggaga cccaggagag ctgatgtgta 22260 gttccagtct gagtatgaag gcctgagaac caggagagcc aatggtgtag ttccagtctg 22320 aaagctggca ggcttgagac ccaggaagaa ctgatgtttc agttcaagcc caaaagccag 22380 aaaaaaaaca atgtcccagc tcaaagaagt caggcaagag gagttccccg cttttcacag 22440 aagaattagc ctatttattc tattcaggcc tttaattgaa tggatgagag ccattcacat 22500 tagggagggc aatctgcttt actcagtctg ccaattcaaa tgctaatctc atccagagcc 22560 acctcacaga cacacccaga ataatgttta actatttggg cactccatgg cccagtcaaa 22620 ctgacacata cagttaatca ttataccatg ttagtttgtc ttcttgtcca ctcaactttc 22680 ttctaactac tgtatagtat tccattgtgt tatatacatg cacagttata ctttataaag 22740 atgaaagggc tgggcacagt ggctcacacc tgtaatccca gcactttggg aggccgaggc 22800 aggtggatca cgaggtcagg agatcaagac catcctggct aacatggtga aaccctgtct 22860 ctactaaaaa tacaaaaaat tagccaggcg tggtggcagg cgcctgtagt cccagctact 22920 tgggaggttg aggcaggaga atggcgtgaa cccaggaggc agaacttgca gtaagccgag 22980 atcgtgccat tgcactccag cctgggcaac agaaaaagac tccatctcaa aaaaaaaaaa 23040 aaaaaaaaag gaaacaacca tatttattat tttgcttaat attatgtttg taagttccat 23100 ttatgttatt tttggctaca gatcattttc ttattgctat atagtatttc attgtgtgac 23160 tacatgaaaa tttattcatc cagttgatgg acatttgggt ggtttccagt ttgggatgat 23220 tcattgattt tgacatcatg aatatttagg ttgcttctga tacgtttctt taatactttg 23280 cgaaggcatc attttgcatg actgcttgta tagatacata aatgtttctc ttgggtggcc 23340 acaggttaaa caatggtcta tctggatcat gaatggagag aaaaggaaac aaccagaaag 23400 ctctctctcc ccacctattc tctgtccatg gcatctgcca ctttctctca ctctgcccct 23460 accacactgt gacctaacca gcttctacct tctcccagga gttcctcaca gattttgtct 23520 tataaacatt ttcttgaagt aaaacatacc tacagaaaag tgcatatgtt ttaagtatgt 23580 agtgcaaaga atttatgtga attgagcata tgtaagtaac ccagatagag atgaaaaatt 23640 attagcatct agaaatggaa caatgcatta gaggatatgt aattccagct ttactaaata 23700 ctgctgaatt gcttttcaaa aattaccaca tcaactaact ctcaccagaa gtaaagatgt 23760 acacccgttt cccttcaatc ttgtcagcac ttggggatag ccacacgcta gctttcacta 23820 taataatagg taaacattct tactggtttt agttattttc cttaattttt aatatggttg 23880 agcctatctt catactcatt tgttagttgg aatatgctgc acttgttttg ctattgagtt 23940 gttgtcctgt tttgaacctt tccttaagag tccacagctt atccagtttt ctacacaact 24000 cacttctgtt tgctgccctt cattatagac tcaatgcctt ctcattgcta gagcactgtg 24060 ccctccttgg ggctcgatgg tttataataa agcttcccca ggagatctca tgggggccag 24120 gttctttagt ggtggccact aaagctacta cctcttattc caggtgccat aaaccagtgg 24180 ctggacctgg ttggttcaca gagtgttctc aatgtgagga atcaggtatt gtgcttggtt 24240 gtcatataag cagcttagtt cccattgttt tatacctggc ctgctaccct cattcatgtt 24300 accttcatgc cccatagaca tttgagattt gatgcaaacc agtctgttac agtaaaagca 24360 ccactgtcta ggaagttctg gagatgggtt atcagctcat ttacatcagc agctgcggga 24420 tcttgggcaa gtcatttcac ctattggagc cactctctgc tagcataaag gagaacataa 24480 agataccttc cctgcctatc tcacaaggtt gtttgggaaa ctgaatgaaa gaacgtgtaa 24540 atgtgctttg caggtttttt gtgaaacagg aatagctgtt agtattctcg cctagccctg 24600 tctgtggtgc ccaggatgct gcattacctc ctttctaccc tcgccctgag tattggtcct 24660 aggtagaagc tgaggtgaat atactgaaag cagtaagaat cttcaccagg cccctcccag 24720 tcatatcaca aggtgttgta gcttattgac aaacacagac ctcatgtttc tctgagaacc 24780 gccctgtgaa cacctagata gaactaaggg tgtgaaatac aaacgtacta tttgcctaca 24840 cttacggaaa taagagcaca tgacacagta gatggcaagg tgaggcttta agtcagaaag 24900 caacctcagc tgaaacaaat gcataattat aatttgattt cagaagtgga aacatgaccc 24960 gaattcatgc acctactgat tagtccaaat tcctttattg ttgaagctgg agcagaagtg 25020 ggggtccacc gtggaagtaa ggaaaagcaa aacagaacag gggtctcatc cagggagcca 25080 tgtcgatggc tatggggagc tccaccttgc tcttggggtg gggccctggc cctgggtggg 25140 actgtggggt gatgagggtt gtgctatgct ggctacctgg tggtaattgc caaggagaga 25200 gcagcacgta gatcctccct gtcatcaggc agagctcttc agtgaggtgg gctcagggag 25260 ggctctgtgc ctccgttcag cagagctgca gctgctgccc agctctcagg aggcaagctg 25320 gactccctca ctcagctgca ggagcaagga cagtgaggct caaccccgcc tgagccatgc 25380 cagccaactt cacagagggc agcttcgatt ccagtgggac cgggcagacg ctggattctt 25440 ccccagtggc ttgcactgaa acagtgactt ttactgaagt ggtggaagga aaggaatggg 25500 gttccttcta ctactccttt aaggtaagtt tcttgcctgc gactctgaac actgacttat 25560 aacaatgaga ctgctggaac ttaagagtgt caattgaagt atcatagcca gtattgtgaa 25620 tgagtgttat tttctttact aaaaaggatt tttaaaagtc tgaagtgcta aaacaacaag 25680 ctgtagtgtg cagagaccta gattgtagtt tcttaggaat acaggtgacg tttttctttc 25740 tgatgctgct ggaaatgtgt gaatcgtgag taacatttat gagtggatga tttttacttt 25800 ccccctttcc ttaggtgaaa gcacttttaa ttaatcctat agcagtactt gaaatgtctg 25860 tttctagtag gggttagagc tatgagtttt ttgctaggaa caccagagat gcggaaagct 25920 cacaatcccc aggacagtga ctgatatgat gagaaacaac attgaataag gcaggaagga 25980 cgacactttc tttgatgatc cttttcatta aacatcagtg aggaatatat ttctttgagg 26040 gtagttgatg atgccaccat ttgcaacaaa ttacctccta gaacaaatga aggacagaga 26100 gtttggtgag tttcaccttc aaagtatcca agggccacac tgaggaagga tcttcattaa 26160 gctaatactg tattgtttct tattccgcaa caagatcttg tggacagaaa tgaaccgcac 26220 atttgggaaa agaacagttt cctgcttctt gcctcagaat gctgggttgt caggttattt 26280 cacacctgtc taacgatatg tttagtcatt gcaataattc acaggtctca aactggtcct 26340 ttccactgaa gaaaaaatac ttcaaaaaga ttctagttgt tgctttgttg ggttttgttg 26400 ttgttgttgt tgttaatcct ctgtatgttc ttgaaatgat ttggttttta cacaatgaga 26460 tagcattact gtaacatcca cctccctact ggaagttcac ttcttttgca aatattcaga 26520 ataaaacttt cagcagggtg ctgtcccagg agtcagactt aaacttccag ggccctaatg 26580 atcctgcagc aaagcagaac ctgagcaaac tactcctcca ctggcttcag tgaaaccctg 26640 tcccttggaa tcacctccta atgcatatgc acatacgcag cccagctgca cagctccacg 26700 atgtagctta gaaagtaaaa ttagagtttg ttgccactta atgtcgactg aataatcccc 26760 tttatgaaat cagcctgcag acccagagag tctgtcttgg caggctgtgt gcacccagga 26820 agcacaggac tccactcagt attgctgcct gtgtagcctc tttgatattc ttagaacatg 26880 atagcaagca gaatgaagag aggccctcca ttgcaaaggg aataaaatca gcaataaggt 26940 ggttattctg agactctggc aagaatcaat ctcagctgaa atctcatttg ccattttttg 27000 aatatagcac ctacagggat atttggaata tgtgaagaaa caaatcccac cttgctctct 27060 atgagtgttt gtcctctcta tcctagcaac atcatcgcca gacactaaag agaatcacag 27120 catctctagc tgattcctat tgatatgttt gcagcaaaac ggctggacca ctggacaagg 27180 agaaaagcag aaagacagga attgtgtttg gccaggagct tagaatgctc agattcatta 27240 tttgagagat acgtgtattg actaaaaccc tgtgattttt agttacacag tgattactgg 27300 tggtatttgt gagaacttag cttatatttc ttagtgtaac tttttttcta tgatcccctt 27360 tgggcacaag caattctaat gcattgttga tacagaaata gttccaatgc aagcccttgt 27420 tcactgcaat tcattttatc tgacatactt ctagagaaga aattcgaaac catgctccct 27480 ttactgtctc ccagatgtat cccctttaat ccccattgcc ttcatcaaaa gcagtaaaaa 27540 aaatagcatg aaaataaaaa tagcagcagc agtaaaagtc acagaaataa cagcaacaac 27600 catacgtctc atttactttg ggcattcttg gtgccaagag tcatagcaag actcacttag 27660 caagtgactt ctgtgaagta tctcatttaa ttctcacaat ccatggtgta tctttccttc 27720 cggtcctgcc ttccatcttc atctgtttat ctcaatttta cccagtctat aaagctcagc 27780 ttgggttgct tcctccatga agccctcctt gactcatccc tccctgactc atccctccct 27840 gagcttcatt agtgtcacgg actgtacctc tcttcttgcc acttaatgca gttctgtctt 27900 aaactgctat ttccatatgt gttggctgaa tgtgttacag tcctcaagct ccttgagtaa 27960 aatgaatgcc ttatatttgt ttcatatttt ctcccaggac ctaccactat gttagtcata 28020 ctcaataaac attgactgca taaacaaatt gtgatgtgtt ttttcttcca attaccaaca 28080 ttttgtcaaa taagcaacag aaagcatgta ttccctgtga cagaggtggg tgggggctct 28140 cattaaccaa gtttccaccc atcagcccct accctgcctg gtctctatac tcacccaggt 28200 ccctttctgc aagcatgttc agcttgtccc tattccattt ctaagccaat gagaccaaag 28260 tcggttctag attccagtgg gtggggtatg gaattagctg aggcaccatg agctggtacc 28320 aagtacctgg tccagccctg gggaatccat ctctattgca tggcagcctt acctagtctc 28380 agctgtcttg ctccgtccac ttacctaggc tcctgacttc gtttcccatc tcacattcta 28440 gttcttatcc tctgaactcc aaagctcttt caggaggaga caaagcaccc cgtctagatc 28500 ttactggcac ttccttcaca ggcttagagt ctgttccttc ctcccacctc cacccttgaa 28560 ttctggcttc tgcttccacc cctctaacct actctacctt cctaagcatg tgaggctctt 28620 ggaaatgagc agggaggtct agggtgggtt cacccatccc atcttccacc atgggccttg 28680 tgtaactaac cctacgtggt cttgggttca agattctcag ctcagaccct ggctcccttc 28740 acagtttcca gttttgtgtg cttttaagat cacatccagc tcacctcttc aagacctagg 28800 tcttggcact aaggaattat atgcgtttca agaatctacc agaagttttc aaggggaaat 28860 gggaaccagc tcatcagaaa ataaatgagg tatctgaata taaggctgtc caaatgcaaa 28920 acaaatacaa aactcttcac acagaaagcc cttaattttg ctggtgaatt caccagcaat 28980 gtttcctgaa tctctgatac ttaatgagaa acctaattag aagtaactgg gagggagacc 29040 tgtcttgatt agtgaattat ctaaattata aaataatgta aatgaaactt agttttatta 29100 ctcataggtg agcacagaaa catgaactaa gactgctaaa tatcacctaa taacaatctt 29160 ttattgcgcc tccttcggtg gatagttaca agtgatacac aattagtcta ttgtttatat 29220 gtaaatggtt gcttctaagt gcttgagggt gatttgacac agtttgttcc ctttgtttgt 29280 acaccctccc tgccacgctg ccttactgtt aattttctta acacactctt cctccattaa 29340 tataacaaaa gcaaatttca actcaacgca tgtcccaatt atctcacgct atgcttttgc 29400 aagggagctc cttcctgccc tggccccagg acagtgtcag ggatgtcctt cctggaatcc 29460 agaatccctc atgtcccaac ccccaaatgt atctcctgca atttgtaacg agaggtcttg 29520 catttacatc atgcattttt tattcttttc taattagtct cgctcagtat gttcaatttg 29580 agtttctaca gttgaatact gtggctgctc ctaaggaaat tactaccagt tttgctcggt 29640 taaatcatta ttaaacatat tattccttcc tgccagttct gctacccaga cctagtgctc 29700 tgctttccaa tccctgaccc tgggtaaact ctaccgtgca gtgtgtccaa tttcacttca 29760 cacaaatgag aaaggctgag gatggcacac aatttccaaa ctatagacgc tagtatttga 29820 aaaggaaatc ttcctcagct aaatttctct ttgcattact aatacatttg atggcaggaa 29880 gcataatctt agctaattca gaataaacct agtcattgca gagcttttca gcccaggaag 29940 agttttcaca ttttctggct tcgggaaggc atctaactcc aggggcagtg cttctgtagt 30000 gcatttctct ctctctctct ctctctctct ctgtgtgtgt gtgtgtatgt gtgtgtggcg 30060 ggggggagtg ggggtagagg atggatggtg aagagagtct gatctactga gggatctgag 30120 caagttggca tcagctgaaa caagacctgt ctgtccctca gatgtggtca tcctcgttct 30180 ggactttcat ctgggttccc atccgacctg tgtcaggccc acattgcttt ctggggtaat 30240 gtcccttggc cacattctct cctggtacag ggtgcttgaa tccctgtctc tcaatcccag 30300 cgataatttc tgcctccttc ctaagaatag aaagtttgac tgctaccaac tttgggctgc 30360 agaaaacaaa atggagcatc tctggccctc tctcatccca catagccacc tacgctatac 30420 aacttccacc tcatgataga tgggaaaatc tgggagactg tacttccctg gtccctacac 30480 agtaagtgga cctcagcgcc cttccaatcc tgtgctcccc aaatgtagca aatgttctct 30540 cttcctccgc tttttcctgc taacccttgg aggggggcaa tccaataccc tcttgtcatt 30600 gtctcagttg cctcgcatct ccccagcatc tgacaccact gctgcgccat caaactcttc 30660 catcgccctc agcgaccccc ctgtcatggg gaaattgatg acacagtgtt cttccgaatt 30720 tattattcca ggctctctgt tctgaatgct caaaagtcac accctcttgc aacagaaaaa 30780 acccatttct cttccagctg tttaagatat cctcactgag gtattttgaa agcccagtgc 30840 tgacttgttt ctgtccatct gcattgataa agagtgcagt ctgaggacag tggggctgcc 30900 tgggctggtg gacagtgtat caaagaagtg gaaagaagca catccattca tgcttgacaa 30960 tgtcattctg ccatccttca aataatttcc tgttgatgaa gtaagaatgt ttcaagccat 31020 gcactcaggt agataagaaa tctaacacta tttttcttaa ataaactgag cttctctctg 31080 gacctctcag tcccccaagt aaactcaggc ttttgagctt tctccatcat ttcaatgagg 31140 cagtgtggct cagagagcag gctttagagc cagacttctg gggtcaaatc ccagtgccac 31200 accatctagc agagtgactt tgggcacttt acttccaccg gtgtctcagt ttcctcatcc 31260 aacaaacaaa gctaataatt gcatgtcctg tagagagttg ttgtgaatag ttaagtgaga 31320 gaatgcttgt atagccttaa agaacagcaa gcggccccca ggagtgttca ttattcataa 31380 ttagagtccc aggaattcgt cattccactc ttttctcaag acaactactg agaggtgagg 31440 aggcagcatt agctgtaagg aagaagtttc ggaagatgct gagagagacc actgcaggtg 31500 gaagcacttc aggacagctt cgatatgcag gtggtcctca aacaatggtc atgaattaag 31560 ctgtttcttt tctttttttt aaaaaaaaaa aatgagacca tgaaaatgta gaataagata 31620 tagatataga gggaaaattt ccatttctta ctttgtcatc ctgatattat gtctagctat 31680 tatctaagca aacttaatgg cccactacat gaaaggctat ttgcagaaag agcaaattat 31740 gccctatctg gagaaagaaa gaaatggctt cttctctgct gtgaagattt tccaggccac 31800 agatggcaaa atcacccaag gtcatgagga agttgtaagg aataatcaag tttcttgttt 31860 tcccacttag gcaatattga tggctgccta aaaatgatag atctattact cttgtcagca 31920 ctttacagtt tgcaatatga tttcacaata tcacctttga acctcccatc agctctaggg 31980 ggatttaaaa tagcattctt tttctttgag cagatatgaa actaaagtct gagggaagtt 32040 aaaggtgtaa acttcctaaa agttaagata aggtaaaaat aaaataagaa agaaaagaaa 32100 gagaattctg agctgatttt ggtctggata ggttaagctc tccaacagta aaaaacaaac 32160 cctaaatctc cgtgatttaa cacaccagag gtttattgtt ccctcatatc acagtagcaa 32220 acaggtcaac ttgtagctac accttctaga acaagtggct tccaggggtg atggtaaatt 32280 ttctcttgct gtctttggcc tgaaatgaca catgactttg actgaattcc attggcaaga 32340 attaattacc tcaataggca acagaaacgc ccccagggtc gagggtataa tgcatggctt 32400 taaagatttg atccttacct tctggcagat aaaacccaaa tccttgggcc tggcctactg 32460 gcctttcaca ttctgaccca atcaccttct ctactcctct cttcacatcc tggaccacgt 32520 tgtactgact gtcttaccat agtctgagga tacagggtcc tgtttacctt ttctggatat 32580 gcctttctca cacctttttc ttctgatatc acgctaacct caattgcctt ctcttctagg 32640 aaggcttcag aattgttcag tagtccagca tcatcacatc actacccttc tgctcctaaa 32700 gcacttagaa tctctgtgca atatggttcc tctcttgaca tgcatgttca cctacataca 32760 cacacacaca cgcatacaca cacacccatg agcacataca catggacaca tacaaataca 32820 cagtgacaga cacacatgcc cacacacaca cagactagat gtcagttatt tagggacacc 32880 tttagatcct actattccta gtacagtgac tgacacacag cagataaaag gtcagtaaat 32940 attttgttga gtgaaagagt atatcaagaa ataatctgta aaacaagttt actgctaata 33000 tctcaataag ctcatgtgaa tgaatttggg tagataaagt cttaatcctt attcaccaac 33060 catttggctt gaatttatag gtgtcataat ttgggaggga ttcgtgacat cacagtaagc 33120 catgttctat attatttagt aatgatgagg aataatgatg atgctatcgg attttgggaa 33180 aaatccgtag gattggtgag tagaggcact acacaagcct ggaaaaggga aaggaaaaga 33240 gaacaggttt ctgtaaccca ggatgacatt tggttgaaac aatacttagt ttcaacctcc 33300 tcctcacttt cccagctaag tactcactct cctagtctcc cttgcagtta aaggtagcac 33360 agtttgggaa gcttaattgg aagtctctga gatttctaat aaagattttt ccttttctga 33420 tgaaagcgga aagatattgc tggcattctg atgtccccct gacttgaatt cagacataat 33480 gcatggagcc gcagcagcca ttttgtgacc acaggaaaaa aaagccaagg gaatcttagc 33540 aaattgagtt cagcagcaac atatcttcag atttcttatt atatgaaaaa aaataaatct 33600 ttgtttaagc cactgctaag ctgaatactt tcctaattga tataaatact aagtgtaata 33660 cgacattgac agtattgaag ccaagatctt aaaacatggc ccccagagag tcaagcagac 33720 attgcattat tacacatttg gagggtacag aggctggatc tgcccatggt ttttgtcttg 33780 ttattatcta cattacaaag agattgaata gattcttata aaaactgatt cagactagat 33840 tgtatggttt tgagtaacca agaaagtaaa agtttctccc cctcctcaaa gaaaagggcc 33900 ttacattttt caaatgattc tctacattcc agataataac aatgccattc acttatgtaa 33960 ttctatgaaa aaatactaaa accattctga aaacatcagc tcaaaaaact acccaaaaca 34020 tttgctcatt ttttcatgat ggctcaataa gaagattttt ttattctcct ccaaaaagca 34080 taaggaatca catcctttcc tgacagctta aaacatccaa gcaaaatgtg agctggagcc 34140 atgggctctg gacctggcag gcaggtgtgg accttcagca caccacaggg ctgctctagc 34200 cccaggcatt tctgccctgg gtacagaaca ataaccacca tccctgcctg gatggtgaag 34260 taggaatgga gccagttctc atgtgggagg aagagttttg agagacagga gaaagggggg 34320 tagtcatgga ggagttctgc ttactaatct gtgacaatcc tctccaagcc cagagaaggt 34380 gggaggtagg ggaggaccga tgctcttccc catcaaaggc cagcctccta gactctccat 34440 tcatccagct tcttcaccct cctggcctct ccactttccc cgcctttcca cttactcaga 34500 ttctccacct ttccagacac tccatcctca aagactctcc acccacccag gctagtcatg 34560 cattgctaaa gataaataaa aaagaaactt cctgggactc tttcctcctt ctaaagacag 34620 gagtaggtgg ttggaaagga ataagatgca atcataactt tgacaagact cacaagaacc 34680 ctcatgaaga ttccctgccc tctcacaagc ctctcttttc ccagccttaa ctgcttgccc 34740 tcatccttac cagggcattc agcttggact ttgcacgctc agtttttaaa aaacagttct 34800 gtctccccct ttctcaccat ccctctttta tctcatcaga acttctttct tcaataaact 34860 gattccaagt attagcaaaa aaaaccattc taagtaaaag agttctgagt tccatccctc 34920 aagtgtctct tcttataacc cccctaacat atgttagggg ggttaatatt aatgtaaaat 34980 aaactcttac tcctcatgcc ctctggacag agtctaaagg attcttggag ttccttaaag 35040 aagccaaaac tcttttgctg ggctacagcc acgattcacc caggcctctg aatcagaccc 35100 aagatatccc cacagcactc agaattccat tcacataaag atattgaacg aaggtgttca 35160 cacaaggagc attattcaca agtcataatt taataaaaaa tgtcagggaa tattgtgagt 35220 gctcaaatgc aggtttctca tctttcacgt attattgtag actctaaccc ttagcaacac 35280 agagcaaccc atgcagatag aagatattct tttggctaag aatacattta ttccttttcc 35340 aatgtattta gtcccttttc aggatttttg gtctaggtta agattaaaat gcaaagagta 35400 ttcaagaaca cagaaactat cagcctaaaa taaaacttag aataatgtaa tgaatgcaat 35460 tctatcaggc cactcagtct tttctattga tcatttcatt catcaatcag gttaagcaag 35520 cttatgctga ggaaacaaat aactggatat tctcagtggg ttaaaatcat aatattttaa 35580 tgtttgtttc ctactcatgt cccatgtcca tcacaggtta acagggtgac tccgtgtatt 35640 gtaatctctc agggaaccag ttgatggaag ccccatgtca acaaaggctt ccataatact 35700 gaagtcagaa gagcaagagc tagagagata cagagtaacg aaccttgccc tggctctcat 35760 aagcttctgc ccagaaataa cacatatgac ttccactcac tattcattgg ccaaagtaag 35820 ttcatggtca cgtctggtat cagtggagca gagaaatgta atcctcctgc tcggaaaggc 35880 agggaatctt ggtgctcggt aatgtctaat gcaactccta aagctctgag acaggcatta 35940 tcctctttga tttagagaga agaaaagtga ggctctgaga agataagttc acataatagt 36000 taataatcca aaaactttta cccagatatt ggttaaaatt ataacccaga taaggcgcat 36060 gctctttcca ccatatcaga acttcccaaa agttgttcca cagaactcta attatgagag 36120 ttcttaagca gttgtcaggg gaatatgaaa taaagaattt tggaagcacc acatattata 36180 caccattata tacttagagg atgcattcac catttaactc tctgagaagt cttacagtaa 36240 ggaaacttgt ttatggtggc tcacgcctgt aatcccagca ctttgggaga tcaaagcggg 36300 tggatcattt gaggtcagga gtttgagacc agcctggcca acatgataaa accccatctc 36360 tactaaaaat acaaaaatta gccaggcgtg gtggcaggtg cctgcagtcc cagccactca 36420 ggaggctgag gctgaggcag gagaattgct tgatcccggg aggcagagga tgcagtgagc 36480 caagatcaca ccattacact ccagcctggg cgacagagcg agactctgtt tcaaaaaaaa 36540 aaaaagaaag aaagaaaaga aacttgttta attctttaat atgcattttc caagtctatt 36600 tgaccacaga gcattacaat attacctcta ataatgacca ctggcacaca cttcagaaaa 36660 cactctgtta tgtgttttcc tgaaagagcc taccagacaa ccaaacagaa ctagctcttt 36720 gagcagatga ggcccagaga agtaaagtga ccttcccaag gttacatagc tggtagatgg 36780 tagagtcagg acaagaactg caatctctaa ctatccaagt tggagcttct gctcagctgt 36840 cgagaggatc gtgaaaaaac gagagtgttt tataaactgg aaagcgctat tcgaatttaa 36900 gatagcatta attctctagg tgaagcatta ctgaaatata tagaatacat ggaaggacat 36960 gaggtgcttc aagataggat gattaaattt ggtgaagatg tcaattctcc ccaaattagc 37020 atataatgtt tgaaataatt ttaatcaaaa cttcaatgtg attgttttaa attgattaaa 37080 taatttgaaa tttttattta aaaaataggt gagaaaagct cagaaatttg aacacaaaca 37140 actatgggga agaaagatgt ttccctatta gttattaata aatgtatatc cacagtaagc 37200 aaaacattac agaactagca aaataattga cagatggatc aataataaga aatattttgc 37260 actgaaaata aagtcctggt acatatatga acttaatgtt acaaagaaac taccacagtt 37320 agtaaaaaag gaactagtat ttttgcaaca aaagtagtgg gtgaataatg gttcttatat 37380 aaagttgtaa atctcagcta gattgcggaa ctaaattttt acaaaatagc tagaaaaatt 37440 atataatgat gacactaatt tcaggactag caagcattat tcaagcctaa aaacaaaaat 37500 ttaaagggaa acaacaaact aagaaaatta tttgcaataa aaataaatat ataatattat 37560 agctaatagt atatacatta attatataaa aatataacat ggttaaagtc cttaatatgt 37620 aaagagccct tgagggaaaa taaataatat ttctaatgga aaagtgggca tgggaaataa 37680 aaacaatttt agattaaata cagagttaaa agaatgtgtg aaaaaatatt gtttattagt 37740 ggtctgaaca atacaaactc aataattcac cataatatga gatatatcaa ataaagatca 37800 aagcaaaata atatataaag cacagaacag ttctgtaaaa ctgtttgtgg gagagtaaat 37860 cagaacaact taacccaatt tttctggaga acaatttagt aatatacagc aaacttaaat 37920 gatgtattca ggcactgctt agtaattcta cttgtaggat tataccataa gtatactaaa 37980 gaaacattca aagacagaaa caaagactgc attaagttgt tttattaaaa agtaagtttc 38040 tagcaatgga ataataaaat tgtgatataa ccatagaatg gaatattaag gaatattatg 38100 caactataat aaccatttct ctttgtgcaa tgttaaaggt ttttaaaagc acaataaata 38160 taatatattt caagttttat atacactcat aaaatataga agaaacaaat accaagatgg 38220 aaaagtaaga aattctctct gaaagttact ttgcagatgg tttttatttt atctttgtgt 38280 aaaagcttac tgtattttct agagtgagca catattatat ttattattct aaacgacaaa 38340 ataaccatgt aagatacacc atgccacctc tcaaataaat tgtgtgcatt gtatttccat 38400 gacagtaaat aggaagaatc tatttactct gcagaagccc agaaatgaac ccaagcaagc 38460 gaggcttgca tgacccagag agcacattaa aggatccaga aatgcaggca agggaacaag 38520 acagccaatg aaaaccaagg cagatgactg gctgtatgaa ttgagtgcac accaactcat 38580 tagcctttta cattttgcta cccaaccacc caacttagat gcacagaaaa caaagcttgc 38640 aagagtagca attccagact ctgtagcagg aatccttctg ctgagcctct ctcatgcccc 38700 ctcccctact gttctcatct cccaggatgt tcaaatccat tccctggtcc ttacatctgc 38760 ttctgcccat gcatgtgttc gctcctcctg gtttcttttg gctacttgat tttgagtctc 38820 ccggatggat tttaaatacc aggtccaagc caaagtgggc cctccagggg aaagtttctc 38880 agacactttc cctttttatt agcacctcca gaacagaaaa caaattcctg aaggtttatt 38940 attttaatta cgtggatcat caggaataat acattctggg tatttttatt atatagtaat 39000 tactttggtt cctacgacat tgtagagatt tggacttaat ttgctcaaat gttagttttc 39060 catatttcaa gagtctagtg cttaaatagc aatttaaatg ttaatctcag ttcttgttat 39120 gtagctgaca tttcattcgt ttattcagca aatattaatt actacataga cttgaagccc 39180 agtgggtttc caaatgattt ctaacatctg tggtttgcta tattatggga attcagatgg 39240 aatctcagaa tttaattgtt tcaaagcttt caatacatgc tattagtggt taatttggaa 39300 gtcctcttgc gatccaagaa caaattgcaa gaagagattc acgttaaaat gattgcagaa 39360 cattggcatt tctgtttctg gtgaaattca aggattcacc agtaaccaga aaactgaatt 39420 cgaaagtaac gcaagtgcag tcccacatgc caagccctga tcgaaatgag aacgtttagg 39480 atgtgggaga ttaacattgt taataaagca tgatctacgg cccatggtac tgatgataaa 39540 aactccaaac caatgactat gtctttctgg tcagagtaga aatgactaat gcagttattc 39600 aacatgtcct ggagactaaa ctaagaaatc aatgtcaggc agtaatccag agtccactga 39660 atcactttcc tgtacagtcc cagtctgaag gtgctagtat tacattctgt cacttgtaat 39720 catggtgttg agaggtaagg caaaggcaat tcaggtgaag acaactgagg aagatcgcag 39780 atggacaaga atctctcctc ctgacagcag attcttctaa ctccggacaa tgacacaggc 39840 cctggacctt gtcccattat tgaaataatt ggctttcaga ccgagctcca gcttgctcat 39900 tgtaaacctt tctctgctgt tactacctca aaagtgcctg aatggccact atctgtcctc 39960 actaacctgc agttctcact ctctgccttc acttacgctg ttgccaggca ccctacttct 40020 tagcttggct acttctactc attgtttcag actcagctca cataacagtc tctctaggct 40080 atacctgctg accaaccatg accagctcct ccccaggttc tattacatgt tccttatttg 40140 ggtttctaca acatctttat catagaagtt cacattgaaa attctggttg acgtacctgc 40200 ctccaccatc agactataag ctccttgtct tcgcctccct tttatcccca aagtatgttg 40260 aactttgata ctagattctc agaaatgttt atggaatttg attgtacaga ttacaaacca 40320 gtataatcat gtctccagct ccatgatttt caggagagtt tcccacttcc ggcctgagtg 40380 tcatttctac accaacatgt aagccaaggc tctctcctct ggataaatgc ctttccctct 40440 gccatactac atgggagttc acagaatgac tctcagttca caactacttg gaacaatcgt 40500 ggtccacagc cccactctcc aattcaacag gcctaggctt caactgcacc tcccatccca 40560 ttcacattcc ctattcttca tgaagaaggc ctctgtcagc ttgtcttgcc agtctccaga 40620 caagtctaga ggcattgcag agggtgtaat ctctctccat ccctgttcta gacccttgtt 40680 aaagtgatat gagaagcctt acaaaggtat taaaacttga gctaacaacc acatttatat 40740 gtagctgtat acagatttct tacttttttg tgaatattta aaaaatttta tcatacatat 40800 tttcataatt gagtgttgta actgatgaca atcctgggta atccaggata gaatccccat 40860 agttcatggt aaagcagtta gaaaacgtaa atgccaacag gaggtcgtga tgacaataat 40920 tcaactgtat ttgcaagcag gcctcccagt tgggttactc aggggttgat agcaggggag 40980 tggaggagag acagatttta aaaaggggca tcatcggaag gagatggctg tcagggagaa 41040 aaatggcagg ccctcctgaa ctagcccagt cctagcttca ggcctccttg ttgaccttga 41100 ctggttattg accacctggc attgcttctg tagcagcagg tagggtgaga tgtgggaaga 41160 agttgggatg acctcctgaa tgacagatta ccaactgtcc agctactgcc caggggtcac 41220 cacatcctca cattgtgtct cattctccaa gtctaattaa gcagcttcag gaacacagaa 41280 ctttgctatc tgctcctacc tgtttcactt aaaatcaggt gcccatgtat gtctctgtgt 41340 tacactgtga ctgatcccta ataaaattag agattttcaa tctttgcact tgatattgcc 41400 aactcaccta agcaaattaa tgaggctttg agtaggcctc agagcctggt gctgtgaatg 41460 atggaagcca cacaagtctc agggacaggg cagtagaatt tcattgtctt ctcactgaga 41520 agtgacacca aatcattgaa accttttttc ttatacttta tttcctgtat tggaaaatgg 41580 cagatatttg ctccttcctg tgttagagat attcatcttc aacatcacat acataacaac 41640 cttcctaaaa caaaccctga aaacatgagg ggcacggaaa gctttgtgac tcccaggaca 41700 gctgatgtag ctgcatcttg tgtgacattt atcactactg ttgtgtggag gccacatgtt 41760 gccatagagt ccctccattc ctccaatgca tggaccttat gctcagtcct gagggagaca 41820 gtcatgaatc caacccagcc ccagaaaccc agcttcaggc aagttttggc tcagaaagaa 41880 aatgaagatt tgtctccccc ttgaaaattg aaagtaaatg aggcaacttt cactatctta 41940 aaccaaaatt ggggcagaaa actactagag taagcagggc atggtctttc cagttaagca 42000 aaactacatg caaatcccag ctgcatcacc taatgagcca gtaacccagg taagtaactt 42060 ctctgagctt catttcctta cctataagat tgaggacagt gataactcgt tggtcaggtt 42120 gttatggtta agtgagcaat atgtaagcct tcttaaatga tgcttggcac atggcaatca 42180 atcaaaaata tttattgtgc acctactaca tacattacaa actcagtaag ccatgtactg 42240 gattaatgtg attcactcaa attatttcat tccctttcac cctataattg ttaaagatac 42300 ttaggctttt tgtcttccag ttttcagcac ctaactgaaa aaggagatca ctattccttg 42360 gatctggata aatccagact agcctgacag atccagaatc aactagagta actaatgtct 42420 tgtatttcct gagataattc ccatttcaaa tgaccttttc tgtgattctt gtaagtagct 42480 ttgcacttgt catcaaccaa gtttccatct gacagagatt tattaagcac cttctacggg 42540 ccagacagat gccaggggtg gagttgtgac ccaggcttag tgcctgccag catgggcatc 42600 cttttggctc tggaagcatg gctcatggag ccacatccca gctatcagcc ctgtggcagc 42660 atcaccatca tcaaaggaac cctgcaattc atctttctaa atcccaattt gcaattctct 42720 aagtctgcag aaaactgatg tcactgtgta gcctgactaa cttgaggtga aaagccaatc 42780 agtcatgtgc cagcaaccat gtaattgagc tgagaacagg ccaatcttta gttattgaaa 42840 cattttaaat acatttctta tttccactca gtattggacc atctggctgg aattttgcct 42900 cacatcacca ctagggggca ttttatgccc aactatattc tgcaatagtt tgggggttgt 42960 gttgggacac catcagcaca gtgtggtggg gggtgggtag ggagaatgct tcttaggctt 43020 agtgaaattc cgatagactg gtaccgaaaa tagggtgaac agggtgaatt caagcatcac 43080 tctgaaaagg cagtgagtta gttatcaccc ctcaaatgta catatgtagt ccacaaacct 43140 aagggaggag ataaaccaat ttttattgca tatctactat gtaacaggca ctgagctaaa 43200 aatctccatc ttcatcatct tatctaccca tcacaactat cctgagatag gttttgtctt 43260 catcctcatt ttacaaataa gaggtcagag aggttatcac ttacaaccta tcacacatcc 43320 agcaagtagc aaaaactgag tccaggtcag gttgctttca aagcctatca acttttcgtc 43380 cacgaggctc acctagttgt gatattctca ctcctctgaa attgtttcct cagtccccat 43440 taccatgact ctccagatta tcctgggatt tgtgtgtgtc tctgtgtgcc tgtgggtggg 43500 gagggggaca tgcacgcata atacggctgc gaataaagga gcaagcagct gagtgttttc 43560 atacttaatg acccttgtac tagtcagtga aacaggattt aaatttgact gagtataact 43620 tacacactct acctgtttta ttctcttgta gcaccaacgc cttacactgt gtctggcata 43680 gagtaggaaa ttaatagatg ttagatgaat tcataaacag ataaatcaac atggctctta 43740 ggaagacccc aaaagcattt gcccggggag gcttcctatg tctggaagtg ttctgaagcc 43800 tatgaagtaa ggtgagatta tcttccaaca gaaaactcca aaagatgtgg aggtggggag 43860 ggtttgattt ataggatttg ctcagcctgc cctagagaca tcagccaatc aaaggaaaat 43920 agactccaac ctgtttacag agctcctcgg acttaccatc ccaaagcata gtccaagaac 43980 aaaagcccag tccaagggat cactgactca ccagcccctg ggaatgattt ccaattcact 44040 gatacatcaa accagggtga tttgatatgc agtgtttgtc actctgaact tccaacaatg 44100 cagatctgag ccccgggact actttgaaaa gactggatcc cttggctcgg attgtactct 44160 acaaagatga agaaggcagc cattttctgc ccactgggga ccagaagcct cttccattag 44220 gcagaaactt catttctgga aatgtgaact ttgctgccag agtcatcaat gccgacgctc 44280 tatgtgaaaa gcagaccatt tactcacttc agcattgatt ttctggaaac atggcctgcc 44340 tgtatttata tgaggaaagg agaacatgaa agagagatat agtctgaaaa tgtaacgttg 44400 acttccaatg caaaactacc ctgagttcac tgattttatt ctcttcctct ttccaattct 44460 catccaaaag gctatcagaa tgtaatttca gttgaaaagg cttccatatc agaagtagaa 44520 aatagggaag gtcgatgact tccctattcc cttccacctg ctggaaaact ggaggaatgc 44580 ccacaaggtg tagagtaggt aagacattct gagggagggg ccaacagatt cgtctgctct 44640 ctgacaggaa gtaaaggcct tcctggggag gtcagtagag aagagaccag ccccagggga 44700 ttccactcct cagagtccat ccactgaggc tggggccatc tccagtgagc aaatttctgt 44760 gggaggttta ctgaatgctg cagacctcac aaaaaaggat tttggccagt gccttctccc 44820 agctaaagga gtgtggacag ctggctaagt aaaacttggg cgaggccatg gatggtgcca 44880 gtgaagacag agcctcagta aggaaaacag tcctgtatct actatcttcc tcacattcca 44940 cccttgcctc cttctttggc tgctcccaga cattgttctc acctctccca ccatggagac 45000 gtggatttct gatctggcaa agaaacatca caagtgcttt aacttttctc ttccttcttc 45060 atccaagaat gaaagttcaa cagagaccaa tacagttctg gacaagtgca agaaataaac 45120 catcccccag caccatccag gctcagaaaa aatgctggat atgatacaag gctttgcaat 45180 tctttttttt tttttttttt ttttttgaca gagtctcatt ctatctccag gctggagtgc 45240 agtggcgcca tctcagctca ctgcaacctc cgcctcccgg gttcaagcga ttctcctggc 45300 tcagcctccc gagtagctgg gactacaagc acgcaccacc acgaccagct aattgcaatt 45360 tttaaagaag aaattgcttt aaggcattaa catgcttctc tttatgaaac agatccccta 45420 aaagaaacag gagtaaatct tggaaaatct cttacttgta ttctcagcag agcttgaaag 45480 gacattgcat taagaaaagg gacacagtgg ccgggcgcgg tggctcacat ctgtaatctc 45540 agcactttgg gaggcccagg agggtggatc atgaggtcag gagatcgaga ccatcttggc 45600 taacacagtg aaaccccgtc tctactaaaa atacaaaaaa ttagctgggc atggtggtgg 45660 ttgcctgcag tcccatctac tcgggaggct gaggcaggag aatggcgtga acccggcagg 45720 cggagcttgc agtgagccga gattgcgcca ctgcactcca gcctgggtga cagaactaga 45780 ctctgtctca aaaaaaagaa aaaagaaaaa aaaaagaaat tcttataaac ttcactgtaa 45840 acaatggaaa gcagaatatg atctcccgaa aagagaagta tgttatacta gaatatgcta 45900 ataatctaaa ttttaaaatc acagattatt ttaacagaac ctggggttgg ggaaataaaa 45960 tagttttaaa gcctcttaat taattttatt tctcagtgtg aagtcaaatt tgaatgattt 46020 ttaatggtta cttaaaaatt aagcattcaa tgtcttaaat tttttaaagt taacatgcga 46080 taaaagagaa taactgtttc aaattactag tgaacaaatt aaaataaaaa cacaaatgac 46140 aaagaaaata tttttaaagt acaaaaacaa actttaaaaa ccttgtaaga tcttacatat 46200 cagttacaca ataaattaca atgaatcagt gtcattatta aaaatagact gtcagtttaa 46260 gtcaaaaaca aaaattatat tctacttaca ggagaaatac ttggtagcaa atgaaacaac 46320 atagttagaa atatatagat aaacaaagat ataccattaa aatagaaata tgattcaatc 46380 aagtatggca aaattaatat taggaaatag ttcaaggcaa aaagagttat gaaagaaaag 46440 aacagtaagc cctcacttat catccgagtg ttttgataag ttctcggaaa ctgtgacttt 46500 aagcgaaact acatataata aaaccagtga tttttctttt tcttatcaat ggcataatgt 46560 tgaaggaaat gatgttattc tgggcctgct agttcgtttc acttaaagtc acagtttcca 46620 agaacctatt gatgatgata agtgaggact tactgtaagt tatgtaattg aagatgaaat 46680 agacataaaa tcacaagcca aataaaaata tttcattaaa atgtgtaaac aaaaattatt 46740 agtaataaaa ggtaaacttt aaaattagta tagaaatcat ttaaataata atatgcaaca 46800 gttttattta taagtataaa ctgaaatggt gctactacta gttagaaata aactaatcct 46860 aatactaaat acaaaatgtt aaaattgatc acaaatgaga taaaaaatat caaaaattga 46920 tcttatctag ataattcatc aacagtataa aaataattgc agaaatgtta tgtaaagaat 46980 tgcatagcaa atatttacaa agctcacatg atatgaccat aatagataaa ccaccagaga 47040 aaaccttatt gattttatgc ataacaagaa tgccttctat catattataa cctcatcatt 47100 gttctgaaac ttctaaccaa tgcaaaaaaa tgggaaatat aaataatctt tgaaagtcgg 47160 aaagaaaatt atttgccatt gatatgataa tctccactaa aaatacaaaa gacttaatga 47220 aatgacaatt aagattagtg aaacaattta tatcttggct ggcttcaaag tacatatatg 47280 aaagtaagtt atttttatat aaaccaacat tacccagtta gagaaataca atggtgtaaa 47340 tgaaatatgt catttaaaat agaaatttta aaatataaaa cacttaggaa taaaaaatgt 47400 gaagaaaact gtaaagctac ccagaaccac taaagagagc atcatggcat atcctagtca 47460 agtttaagat ttgtttctcc catgtcccag catttccata cctagaatat gtactagaga 47520 aaaaaagtac ggtaccctat agcattgttt ctgatagctt caaactggaa accacccaac 47580 tgtctatcaa atacatgaga tcaataaatc gcagcatagt cacaccatgg agtactatat 47640 aggaataaaa atgaaaaacc tgcagctctt tgcaatcaca agaacgaata ttgcaatcat 47700 aaaccaaaga gtcaagacaa aagaaacaca tagcataaaa ctactctata aagctggaaa 47760 acaggcagca ctctttttgg atgcatgtat aagtggtaac agtaaatatt aaataagtag 47820 aaatcaggtt agaggtaatt tctagaagag acagaataga gttttacatg gggcacagga 47880 agggctttct ggtgttgata aaggtttttt ttttttttaa tgatgttggt aataattata 47940 tgggctttta ctctatgatt actaagtaat gtgtatgtat atatattgtg cactttttat 48000 gttgtatatt ttgtgtcagg cagatcgtct gcatagtcct aaactcttga tttcttccac 48060 ttcttgacac aatcctttgg gaccctttca gctcttcatt ctgtaggctc aagttctgcc 48120 ctgcctccat ccccagacca agtcccaacc tgagggagag ctgggtctca atcttccctt 48180 tactaggatg ggaaatgcca acattctttt tggttaccca ttcctggagg atggttccag 48240 ctggcagggg ccatagaaga ttgatgcaca gctgtatttt cctgtcattt tgggcacagg 48300 ggtgaggatg gaactttgcc cctttgacag ttttagctcc agtcaactgc tgttaacttt 48360 gacctcagga cacccttcac cctacatcca tgaacatgtt gcaacatcag gcaactacaa 48420 ggtaagtaga ggtatgcagg gccttgtgga ttcagtttct tctcccacgt ggatgaacag 48480 cagcagcgga agagatagat agcacctctt ttccagctgg atagtgtgct gaaacacttc 48540 ctcagcctcc tagcagtgcc aaagacatgt agggtggcct tagccagaaa ggtgaggcca 48600 tcccagcctc cagcatgggg ttgcggaagt agatataggt gacccactag agctgtgaac 48660 tcctttaact ctagcgttga agtgccatat tcaatgagca cagttctgga aaggtctcca 48720 gggaccccat atcacatcat gaactaaccc aaacctctaa atcccctaaa tctttcaaag 48780 ctgagagaga gagagagaga gtaattcacc tttagggatt gatatagact gggctatgat 48840 attttgagcc cactcactgg gaaccatgga tagggtgatt atataattga ctatccaacc 48900 aaagacactt tttgagagag aaagggcaat ttaaataatt atcttgggac agcagttgac 48960 aactaggact atcctaggca aaccaggtta cataattacc ctagccatgg accatacttt 49020 gagaagcact ttccaaaggc ctctgccatg tgcagctgct catagccaag ctcatgctac 49080 acaggtggaa aagcttctgg aaaattgggg tgcttcccta gaagactcag aatgttaaca 49140 aggaataggg aagaaagaga actactgaag agcttggcac aggagggctg gcccagaacc 49200 tgtgtcacag cactgccctg ggccattcac accaaagctc attccagaga ctgaaagtat 49260 ttgatggcct tctgtcatac cttacctgcc aggccacctg cttgatgggc tctttcctga 49320 acctagacac ccccagggca ccatcgtcct ccctgataga atattatatt agaacaattt 49380 gaggaacata gacacattat ccccaaccct gtccctcaac tgtttcatct gtcagcacca 49440 tggtgtcagt gagaccttct gatggagact tccaagccac ctggctgctt aggttagtct 49500 gcaagttgtt ccagtgtttt ttaagagagg tcctccaaat tcaaatcact tgtttatgtc 49560 ccactgctgg cacaccacct gaatgggaag tgtcagtcta cgacatcaaa ggcctctcct 49620 gctgtgtctg ctactgacag cactgttgtc catctatctc aaatgggaga attctcttac 49680 aaaaactcac tccctccact cagtacggtc ctttgcataa caattagttt ttattcttga 49740 tgctttatca cccatttcaa gactgctaga gaaatgagtt atgcaggata tgacccctct 49800 agtcatcaaa gaaccagaga aaaagtgtgt ggcttgaagc tgagcaaaga tgctgcctcc 49860 aagtgggaag tgacatatgt atgctggaca cgatatatct gcagagctct ccaaccctgt 49920 catcctccca ctctagttgt acagccctca tcctcccccc acatcaccac aatgcctatc 49980 ctcatttcca cagttctgca gttccaaggc cctgacctcc acctaggatc tcagaaactg 50040 atctgtaaat ccaggatgga gagcctaaat atcagattga taaagtgtag gactcatgaa 50100 gatgctcata aaaaatttct tagaaggcca ggtgcggtgg ctcacaccta taatcccagc 50160 actttgggag gctgaggcag gtggatcact aggtcaggag attgagacca tcctggctaa 50220 cacggtgaaa ccctgtgtct actaaaaaat acaaaaaaaa attcgccggg cgtggtggtg 50280 ggtgcctgta gtcccagcta cttgggaggc tgaggcagga gaatggcatg aacctgggag 50340 gcagagcttg cagtgagcta aggtcatgcc actgcactcc agcctgggtg acagagtgag 50400 actctgtcac aaaaaaaaaa aaaatatttc ttagaaggac tgtcagattc atagcattct 50460 cgcttttttc ttttttacta attaatcatt tatcttaatc tgtttcatgc tgctatgaca 50520 gaatacccaa gactgagtaa tttataaaga aaagtaattt atttctacag tgccagggtc 50580 tgggaaggtg ctggtatctg gtgagggctt tcttgctgca tcattccatg gcagaaagtg 50640 agagggtgag agagggacaa gggaggggaa ctgaactcat tcctttatca gtaacccact 50700 cctgcaataa ctaatccact cccacaataa caacattaat ctattcatga gggcacagcc 50760 ttcatgacct agtcacttct taaaggttct accttaactc cattgctttg gggattaaat 50820 ttcaacatat aaacccttgg aggacacatt caaaccacag aaacattctt cagtagaact 50880 ttaatattac tgtcttataa aattctgtca aatgaacaaa agataaccca taattacacc 50940 ctaatatgac tgcttttaac attttactgt atttcagcct ttttgctatg tatataattt 51000 tacagagttg taatcatacc cagtatatga ttttatcatg ttttcccact taccattata 51060 ggtattttta atattgctac atagtcttca tggttgtcat tgttaatagc tatgctgtaa 51120 tagttcactg aattgaagtg ctttatttac ttagctaccc tattatcttt aaacaatttc 51180 taatttcttt ttataataaa catggacata tttctgacag gggtgttctt tttcacatct 51240 tgacctactt ttcacatagt gttacaatta cctgaccaaa gaatacaaac tttttgtctc 51300 ttgacgtata tttccaaaag atttttaaaa ggtgcattaa tttactctgc agctggtgta 51360 aatgaagacc attttgtcat tgttttcttg agagtagagc ttccaaaagt agggatatgt 51420 ggctaggagg aagaaatcca gcctggggca ggcattctgt aaagaactcc agttctcact 51480 ggtacactgg ttttattttt ctctgtttct tgcagactga gcaattgata actctgtggg 51540 tcctctttgt ttttaccatt gttggaaact ccgttgtgct tttttccaca tggaggagaa 51600 agaagaagtc aagaatgacc ttctttgtga ctcagctggc catcacaggt aagtaactat 51660 gcaagtgaga ggcaggaagc tatatgtgaa gtccctatgg cttcctgctt ttaatgaatt 51720 ttatcaaaaa aaaaaaaatg taacgcatcg gtcaatttgg gaataatttc tgaaagaata 51780 taaaacctat atttgaatat ttcctctggc atacttaaca catatgaatg cctctaagat 51840 ttcattataa aagtaactca ctacactaat ggaaatatca ttatcagtat caccaaatgg 51900 ttctataggg tttccctgtt tttatacaca gtagcctcca tagttcacta aggtgatatt 51960 accatatcat cctgcattat aagcttaagg aatacatccc agaaaatgta ccagcactat 52020 ctctattaaa ttattaatgt taagtcttga gtactttgca gattaaagcc tgtggacatt 52080 gcttttgaaa tgcaaatgat gtgtaacacc actactgggg gtagtataat gaagtaatat 52140 aatctcaagg atcgggatgc ttaagtgtag actttggaaa tgaccattca gtagaagagt 52200 gagcacagca cacctagtag aggaatggtg aaatattctc aaggaagaaa atgatctgtg 52260 aaagttaggg ccccaaagac atgagtagag ctcatgttca aaaggaaaag aaaaacacaa 52320 ccagggaaag agtcctgttc tacaggccag aaagaaagtg agaaaatgag attcacagaa 52380 ggtccagcat aagccacact tggagtccta agctctggga gcaagatggc tgttatatta 52440 gcttaatttg gatcagacta tagaaaaaaa aatgcaaaag gaaaaattta aatattaaat 52500 gcttacaagg agtgacggca aatgactttc agaaagggct atttggtaca tttcaacctg 52560 tactgttatc tcagctgtag taatggtagt ggagctcttt agaatttagt cttgagccat 52620 aatatttcaa aaatttatga cactgtaact tacaagagaa tcttagccat acattgttag 52680 taacctgaaa ttcccctttt tctttctaac aaagtataac aagcccacct gcttgagctg 52740 ggctgcagtg gccagggtaa acatccaagg caccagtgaa aaatacagag aaggtaaaag 52800 gagcaagagt tctgaagatg gaacctggga tgggggaaag tttcttcaat ctttcctacc 52860 aacaagaact ccaatttttc actcctataa ccgtagaagt agaggtaatt aggatcatcc 52920 agcaaatgct tagaggcaaa tatccctgga tgaggatgcc acagcttatt ttcattatat 52980 ttcttcgatt acagtgtggt aatgcatgtt gtatggaact acatattctt tcagaatgaa 53040 aggatttaga ggtggcaaga atatcagctt gaaatttaaa gttttttcat aaacaataaa 53100 caaatgataa ttgaaaattc actacatatt atcaaagaca aaagttgtat gttctaattc 53160 atcatcgttg tattaatctg ggcttaattt catgtacatc tcctggacag tgtttttatt 53220 tgttaattgt ttctagaaaa actctagggg tcaggtcaga agcattttaa atgaagaatt 53280 cctgaaatga aaaacattgc caaaggtcta agactgaagc tcaatggtct gagattgaat 53340 ttatatatta ttgaaatttc cttcatacac attttagcat gatcacagat cctttggtaa 53400 aggaggtgag aatacatacc tgagtcttga gtatgcatat agaagttacc caggcatcaa 53460 ctgaggggcc ctgtgctttg agacatatat aaaaatgtgg tttgagtccc ccatcatatg 53520 tcaatgtcct ccttaagatt tcttcaaatt ctgtggaatt tatattttta cttctctttt 53580 gcttcttgct tcctccttcc actaaattct tgctctctct caccagtatc tcatctttct 53640 gagctcctct ttttttgcgg ttgtttcatg ctgtccctaa cgaggcactc aaagcaccct 53700 cctttccttt attttcttta aaatcatcca caaaagtatg actttctttg tttaaaggac 53760 ttttctgaat atttcaggta atataatgat attgtatcac agaaaagtaa atatcttaag 53820 agcaaatatt tcattttctc agaacattca gctgacatca gaaatgtttc attttgatca 53880 tgccactgca ctccagcctg ggcgacagag tgagactccg tctcaaaaaa aaaaaaaaaa 53940 aaaaagaaat gtctcagttt taccttgctt cagcctcact attctgctct ctcttctaaa 54000 tgtctagtat cttgtgccaa aaaattttaa tactttcctc tgtttttgtt ttgctttgtt 54060 cttaccacta ccaaaccgtg atctcagaga ccccacaact tccaaaaaac aagtatcagg 54120 cttttttttt ttttaacaaa ggaagttgct ccctaaaaaa gaaccctgga actagttaca 54180 atgataaaca gacaaagaaa aatacacatt catatttata gttacatatg tcatggctaa 54240 aaataaatta ttctaaattg tataaaacca taagatatac agtgataact caatagtatg 54300 ttgtattagt ctgttctcac actgctatga agaaattctc gagactgggt aatttataaa 54360 ggaaagaggt ttagttgact cagagttctg cattgctagg gagacctgag gaaacttatt 54420 aatacaatca tggcagaagg caaaggagaa gcaggtacct tcttcacaag gcagcaaggt 54480 ggagtgaggg caagcagggg gaatgccaga tgcttataaa acatcagatc ttgtgagact 54540 cactcattat cacaacaaca gcatagggaa accgccctca tgatccaatt acctccacct 54600 ggtcctgccc ttgacacatg ggggttatta caattcaagg tgagttttgg gtggggacat 54660 agagtcaaac catatcatat attatgtgct gtgcttgcaa aaattttgaa gtggttttag 54720 gccaatacgc ctacctacaa taattagaaa agctggacaa aatttaaaca tttgttagaa 54780 ggtatcacat agctgccaaa gacaattaag acttgagggg ccaagatttc atagagcaga 54840 aaattttatg agataaatac attatttgac accactatcc ccttaaagta ttagctgatt 54900 taaaagcaga aactggaagg ctgaaaacct gagtagagct ttgggcagtt tcactggact 54960 gatggggcaa aaattaattt gccaaagcat actggctttg ataaacattc cagggtttcc 55020 attggtactg ctgaaaagat acaacctaca agtaagagtg aactaaaaat ggatcagccc 55080 tcaccaaaaa attaaataca acccaaaacc tgaatgaaat cagatgatct acctctgcat 55140 gcacacaaac catctgccag tgcaaaaata aatcttcttt ggaggaagaa ggcattatcc 55200 catcatcaaa ttaactataa ttttccatgc acaacgttca gcacttgatt aaaaaataac 55260 caggaaggca acaatacaat aattgatgaa aaacgaggag aaaaatagat aacgaagagt 55320 tgcacaagag atccatctat tggcattatc aagatacaga atttataact gttgctcatc 55380 tgtttagaag ctacaaaata agattgaagg ttgaatgtcc tatctccagg cttttggtgc 55440 acctgccccc ttaacagtgg agcttgagca cacaaagaac tccctttcca cacaaagaac 55500 ttggtgtagt ggcagttcct ccactccaca cctggatgta attccagcca tttaacacac 55560 ctgccccaat ggactaggag tttgagccac ctcttcctcc catgcaaaga ccttgtggct 55620 gcagtttctc tgctctttcc ccagacatat cacccaactc gaggtgcacc tgctcctcca 55680 gatcaggagc ttgagctact cctacattcc ccaggaaaac tttgtggcag tagtggtctc 55740 tctccacctt gctggggcat atttccaggc atttgacaca cctgattgtc taaattagaa 55800 gcatgacctg cccctccgtg cagagatctt ggtagagcaa agctctctgc actcgatgcc 55860 cagacatatt tccaggcatt tgaagcacca actcttctag attaggaatt taagcttccc 55920 ccacttcctg tgcagagaac ttgggacagt ggaggtttcc agactctatg cctaggcaca 55980 tctccaggca cttggcagct gcccaccaga ccctgcctca gagctaatgc ttctgcctgc 56040 cattgggaga actgtaggag agcttgctta gtctagccca cccatcttgg cccccactcc 56100 agaactaagc agggagctca gaccactgtg catttcacag atcagcccat tgcccaagtc 56160 agcagaactt ctcccagtaa acaagaatca agtatatatc catttgagtc agctgcagct 56220 gaactttatc cataagcttc acctactggc ctggaggttg aactgcacaa tacaataaga 56280 aatctggggc caggcacagt ggctcacgcc tgtaatccca gcactttggg aggccaaggc 56340 gggcagatca caaggtcagg agatcgagac catcctggct aatacggtga tacccggttt 56400 ctactaaaaa tgcaaaaaat tagctgggtg tggtggtgga cgcctgtagt cacagctact 56460 cgggaggctg aggcaggaga atggcatgac cccaggaggt ggagcttgca gtgagccgag 56520 attgtgccac tgcactccag cctggatgac agagccagac tctgtctcaa aaaaaaaaaa 56580 aaaaaaaaaa aaaaaaaaga aaagaaaaga aagaaagaaa tctaggcagg gcatggtggt 56640 ttatgcctgt agtcccagca ctttgggatg ctaaggccgg caaatcactt gagcttagga 56700 attcgtaacc aacctgggca acatagtgag acccccatct ctgcaaaaaa tttttaaaat 56760 tagccaggca tggtgatgca cacctgtagt cccagttgcc agggaggctg aggtgggaga 56820 attattggtg cccagaaggt caaggcagca gtgagccaag atcatgccac tgcactccca 56880 tctgggtaac aaagtgggac cctgtctcta aaaaaaatta aaaaaaaaaa aaggaaaaga 56940 aaagaaatct gatgacataa ctgcacagca ctggaaaatg taataagcct cctgagacct 57000 ctgccaccca gccttatagg aggcagtgag cctcctcaca tacccagtac acggctacta 57060 caaccagcat ttgggaaagc caccatacaa agactaccca ttaccaagaa acgcttatac 57120 agactcgttg ccactgaaag cacccagaac caaatccaaa ggaccttaca caacataaac 57180 tatagacatc tcctcagatg aggaaaaaag tcacatccaa ataaaagcaa atttaaaaaa 57240 aaataagaag agatagctta tctggatgag aaggaaccag agaaataact cggaatgtat 57300 gaataaaata gagtgctaca acacccccaa aggatcacac taactctcca gtaatggatt 57360 ctaaccaaga tgaaatattt gaaatatcag gtaaagagct caaaatattg atttttaaaa 57420 agctcaatga gatccaagaa aaaattgaaa accaacacaa agaaaacaat tcaggacatg 57480 caagaagaga tagataccac taaaataaaa gaaacggaca tttaaaaatt attgaaggaa 57540 aaacaaaata aaagtgaaag cttcaacaat aggctagacc aagtggaaga aagactttca 57600 gaactagaag acatcttttg aattaaacca gtaagaaaaa tatacagaaa aatgaatttt 57660 aagaaatgcc tagtgccttt gataaatacg ggattatgta aagcacccaa acctacaatt 57720 tataggtatt tcaaagggtg aagaagaaaa agtatggaaa acctatttga ggaaataatt 57780 cagaaaagct tctttggttt tgggagagat ttagaaaccc agatacaaga aactcaaaaa 57840 actcctagaa gacacatcgt gagaagaaca tcaccaagac gtatagtcat cagactatcc 57900 aaagtcaaca tgaaggaaaa aatcctaaga gtgcccagag agaagtgtct aatcacctat 57960 aaaggaaatt tcataagact aatagtggac ttctcagcag aaaccctaca tgccagaaga 58020 gatcaggggc ctatttttag cctccttaaa gaacaaatgt gccagccaag attttcacat 58080 cctgccatgc taagctttat aaatgaagaa gaaatcaagt cttaaccaga caaataaatg 58140 ctaagggaat ttgtcaatac tagaccagac ttacaagata tgctcaaagg agttctaaac 58200 atggaaacaa aagaacaata ctcatcatca taaaaggaca cacagataca aagctcacag 58260 atcctgtaaa ccaacaacac aattgaaact ccaagtaaca acactgtgac aggaacacaa 58320 cctcacatat taatattaat cttgaatgca aatggcctaa atattccact taaaatatag 58380 agtggaaaat tggattaaaa agagactcaa ctatctgcta cctacaagat atccacttac 58440 tgactaaaga cagctataga ctcaaagtaa aggggtggga aaatatatat catgcaaatg 58500 ggaaaaaaag caagcaggag tagccattct tatattagat aaaacagaca tcaaaccacc 58560 aacaataaaa aaacaagaca aagaatggca tcatataatg ataaaaggtt caaacgacaa 58620 gaagattgaa ctattgtaaa gtatacacga ccaacactgg agagcccaga tttacaaaaa 58680 ttacgactac atataagaac aaagatgaat agaaaaaaaa tagtggtctt caatactcca 58740 ctgacatcag tagacagatc atcaaggcag gaaatcaaca aaaaatctct ggacttattc 58800 tgggtacagt aactgactct tgtaatccca gcactttgag gggctgaggt ggtaggattg 58860 tttgaggcca gttgttcaag accagcttgg gcaatatact gagacccaat tccacaaaat 58920 aaataaatga ataaataaat aaaaattaat taagcatagt agcacatgcc tgtagtctaa 58980 gcaacttgca aggctgagct ggaaggattg tgtgagtgca ggagtttgag gttacagtaa 59040 gcaccactgc aatccagcct gggcaaaaga gtgagaccct gtctcctaaa aaaacaaaac 59100 aaaacgaaac aaaataaaaa gaaagaaaga aactctggac ttaaactata tatagaccaa 59160 atggacctaa tagacattta tagaacattt catttaataa ctgtaaaata tacattcttc 59220 tcatctgtac atggaacatt ctcccaaatt gactttattc ttagccataa agcaattctc 59280 aataaattaa aaaaaactga aatcatatca agtgttttct taaaccacag tggaataaaa 59340 ttataaatca aaccaacggg caccttcaaa aatacacaag aacatgaaaa ctaagcaatt 59400 tgctcctgaa tggccttttg gtaaacaata aaattaagac aaaaataaaa aacatttcaa 59460 aatgaatgaa agtagagata caacatacca aaacctctgg gatatagtga aaacagttct 59520 aagagaaaag tttatagaat tcaatgctta cactaaaaga tagaaagatt tcaaattaac 59580 aacctaacat tacacctcta aggaacaagg aaagcgagaa caagccaaat ccaaagtaag 59640 cagaaaaaaa agaaatataa taacaaagat cagagcacaa tgacatgaga ttgagattta 59700 aaaaaagata caaaaagtca acaaaacaaa atgttggatc tttgaaaaga taaatgaaat 59760 tggcagcctt ctagctagat gaaacaagaa acaggagaga tgattcaatt aagtacaatc 59820 agaaatgata aagatgattg acatagtttg gatgtgtgtc ctagaccaaa tcgcatgttg 59880 aaatacaatc cccccgtgtt ggaggtaggg cctggtggaa agtgattata tcatggaggc 59940 agatttctca ttaatggttt aggaccatcc cccttgggca ccagcctact gccctcatga 60000 tagtgaatga gcttttgtga gatctggtgt tgcacccccc tgctctctct ctcttgattc 60060 ttctctggcc atgtgatgtg cctgctccct cttcgctttg ccttccatta tgattgtaag 60120 cttcctgagc ccctccaaga agccaagcag atgccagcat catacttcct gcacagcctg 60180 cagaactatg agccaattaa acctcttttc tttataaatt acccagtctc agttacttct 60240 ttatagcctt gtgagaatgg actaatgcag tgaaattaca actgatacta tagaaataaa 60300 aaaaaatcat cagagatgac tatgaacacc tctgtgcaca caaactagaa aacctggagg 60360 aaatggataa atcccagaaa catacaaccc cctaagattg aaccaggaaa gagtagaaat 60420 cctgaataga ccaatagcaa gtaataaaat cacatcagta ataaaaaatc ttccaacaaa 60480 aaaaatctca agaccagaca gattcacagc tgaattttat cagatgtaca aagaaaagct 60540 ggtaccaatc ttactgaatc tattccaaaa catgaatgtg aagcaattcc taactgttcc 60600 tataaaacca gtatcaccct gataccaaaa tcatacaagg acacaacaac aacaatacaa 60660 aaaaacccac tacaggccaa taaccctgat ggacatagtt gcaaaatttc tcatcaagat 60720 accagcaaac caaatccaac agcatgttaa aaagataata catcacaatc aagtgagttt 60780 tattccatgg atgcaaggat gattcaacat atgcaaatca ataaaatcaa tagacatgat 60840 tcaccacatt aacaaaacta aaaacaaaaa ccatatgatc atctcaatac aataaggcgt 60900 caataaaatc caacatcttt tgataataaa aaccctcaac aaattaggca tctaaggaac 60960 atacctcaaa ataagagcca tctattacaa acctacagcc aacattatac tgaatgagga 61020 aaaattgaaa gcattatccc taaaaactgg aacacaatga ggatgtccac attcaccact 61080 cctattcaac atagcactga aagtcctagc tagagcaatc aggcaagaaa aagaaatgaa 61140 aggaatccac actagaaaaa aaagtcaaat taccaaatta tctctgttca gtaatgacat 61200 gactgtatac ttagaaaaca ctctacagac tccaaaagac tcctagactt aacaaacaac 61260 ttcaataaat tttcaggata caaaatcaac atataaaaat cagtagcatg tctatacacc 61320 agtagtcttc aggctgagaa ccaaatcaag aacttgatct taacaatagc cacaaaaaat 61380 aaaataaaat aaaataataa aacacctagg aatactttta accaaggaga tgaaatatct 61440 ctacaaggac aactacaaaa agtgatgaaa gaaattgtag ataacacaca tgactggaaa 61500 aacatcccat gctcatggat tggaaaattt aatatcatta aaatgaccat acttcccaaa 61560 gcaatctaca gattcaacac aatccctatc atattacaaa tgccattttt cagagaatta 61620 gtaaaacaag attaaagttt atatagaatt ttaaaagacc ctgaatagcc aaagtaattc 61680 ttttcttttt ttgaaatgga gtctcgctct gtcaccaggc tggagtgcat tggcacgatc 61740 ttggctcact gcaacctaca cctcctgggt tcaagagatt ctcctgcctc agcctcctga 61800 gtagctggga ctacaggtgc gcatcaccat gcccagctaa tttttgtatt tttagtagag 61860 acggggtttc accatgttgg ccaggatggt cttgatctct tgaccttgtg atctgccagc 61920 ctcagcctct caaagtgctg ggattacagg tgtgaaccac cgtgcctagc atagccaaag 61980 taattctaag caaaagaaaa aatccagagg caccacattg cctgacttta tacaacaagg 62040 ctgtagtaac taaaacagca tgatactggt acaaaaatag acacacagat caatgaaaca 62100 gaatagagaa agcagttaaa atgccacata cctgcaacca acccatcttt aacaaagctg 62160 acaaaaataa acaatatgga aaggacacct tattcaataa atggtgctgg gaaaattggc 62220 tagccatatg cagaagaatg aaaccctacc tatgacaata tacaaacatt aactcaagat 62280 agatcaaaga cttaaatgta agatctgaaa ctaaaaatct tagggaaaaa aacctgggaa 62340 aactctactg gacattagac taggcaaaga atttatgaca aagaccccca aaacaaatgg 62400 aacagaaaca aaaataggca agtggaactt atttaaatta aaaagcttct gtacaacaaa 62460 agaaataatc aacaaataga cagcctattt ggagaggaag tatttgcaga ttatttctcc 62520 aacaaatgac taatatccaa aatatacaag gaactaagac aaatcaacaa gaaagaacaa 62580 acaaccccat taaaaactgg gcaaaagaca tgaacagaca tttctcaaaa ttagaaatac 62640 tagcagccaa caaacacatg aaaaaaggct caatatcact aatcatcaga gaaattaaaa 62700 gtaataccac aatgagatat catcttacac cagtcagaat ggctattatt aaaaaatcaa 62760 aaaacaatag atgctggcaa ggctgtgaag aaaagggtag acttacacac ttttgaggga 62820 atgtaaatta gttcaaccac tatagaaaac agtatagaga tttctcagaa gacttgaaac 62880 agatcttcca tttcaccaag caatctcact actgagtatc tacccaaagg aaatgaaatc 62940 actatataaa aaagacattt gccctcatat gttcattgca gcactattca cactagcaaa 63000 gtcaggcaat gaagctcagt ctccagcaat ggttgatttg ataaaaaaaa aaaaaaaaaa 63060 aactgcggta tatatacacc atagaatact atgcagctat aaaaaagaat gaaatcatgt 63120 cctttacaga aacatagata aagctagaag ccattatact aagtaaaata actcagaagc 63180 aaataaaata acatatgttc tccttcataa gggggagcta aatatccatc catagataaa 63240 aagatggaaa taatagacac tagggactcc aaaagagaga aaggtgggag gtgaataaga 63300 gttgaaaagt tacctattgg ttacagtgtt cactatttag gtaatgggta cactggaatc 63360 acaatctcca ctagttacaa tatgttacaa tacacctgtg tattacaata tgcctgtgta 63420 aaaaactgca cacatatgcc tggaatctaa aattttaaaa taatgaagat tgaatgtcct 63480 agaaaggaat aaaacaaaac atttaggaac tgacaattac aactgaagct tacaatacaa 63540 tagttaaact tagcggcaaa ttaaatgtag ctaaagaaga aatcattgaa ctggaatata 63600 ggtccaaaga aaataattag attgaagcat gaaaaaagaa aggacaaaaa atacaaaaag 63660 aaaataaaaa gcatatggaa gtagtgaaaa ggactcccag aaaaagataa agcccagact 63720 ggatagaaac aacacttata gtggccaata attttcccaa actctttaaa gacatcaaaa 63780 cacaaataca taaagcacca taaaggacaa cagcaagcaa acaaacaaat ataaagagaa 63840 ttaaaacaca tgaaatgata agactaagta aaagccccat aatcttgaat ttgaaatgaa 63900 aatatttatg ctagctcatg atgtatttta tgcttcagga gtttttaagg atacatacca 63960 aaatgtttat aggtaaactg ataacatgtc tgggatttac ttcaaaataa tttgaggctg 64020 ggggtgggtt gagatgtata gatgtacaaa attgatattg ataactgttg gaggttggtg 64080 gtgagtacat tggattcttt atttttttta tactattctc tctactttta tgtaagttta 64140 agattttttt cataataaaa ttcaaaacaa aattatgcat gattataatg aaacaaaata 64200 aagagatctg ggtagttaaa gatgttaaag tccttggatt gcctggatgt agtaaaagta 64260 ctaatttcta ttagatttta atgtcaagga ggtgtgttaa aatctctaaa gtaatcctcc 64320 caaattatga aaactgacat tactagcaag ctaaagaagg tataaaatgc agtatttgaa 64380 tatgcaaata tatatgttta tatatagagt tattccccag tatccatgga ggattagttc 64440 cagaatcccc tgccaataca aaaattcgag gatgcttaag tcccttacat aaaatagata 64500 gtatttgcat ataacctaca tacaccctcc tgtatacttt aagtcatctc taaattactt 64560 ataatttcta atgcaatgta aattctatat aaaaattttt atactatatt cttaaaattt 64620 gtatcatttt attattgtat tgttatttta tactttctta atatttttaa tctgcagttg 64680 atagaatcca tggatgtgga acccacagat aaaaagggcc aattataata catacatatt 64740 atataaaatc aatctaagtt aagacaggag agaaaaaata ttagaattat tagaacaagt 64800 aagaagaata ggccagtaca cttaacctca aatgtatcag taattgcatt aattgtaaat 64860 ggactaaata ttcccattaa aataacaaga ttgtcagagt agatttttaa attacctatt 64920 ttaatttgtt tataaaaggt gtacaccata aataaaatga tgcaggttaa aattaaaagg 64980 aaaaggatgg taaagtaaaa tgataaaaaa taatgaaaca aaacaaaaca caaagtaaaa 65040 gtaagccaat gcagctacat atgtgtatca aaagtttata aatttgctgt gattcttgga 65100 atcacttgta gctttatctg tgtcttagaa tttgctttga aaggaataca aagacaggag 65160 ggcttctaaa gctagtaatg ttctatttct tgatcttgct tgtagttacg tgggcgtgtt 65220 cctcttgtaa taattcacca aattatatac ttatgatttt gtatactttt ctttatgtgt 65280 tttatttcaa tacaaagttt atttacaaaa tatatcacat taatccaggg caggggttgc 65340 aatctcaaat ggctttagga atcaagcagg caatgaatgt aaacatgtaa aagagccaag 65400 gggaagagac agaatgaaaa cagagataaa aaccagagaa tgaatgccct gcctaaagac 65460 attaaaatca atttttgtca aacactgtgc tgatcaaaca aatcacacat gcaggccaga 65520 tttgacccaa gggtgacttt cttacaacaa ctgatatata aaatttaaac atcagaattt 65580 gaaaagtgtg ccactataaa attctagccc acctctgaag tatgaaccca ccttcaattt 65640 gtgaggtaga atattaatct ttactggtgg attgtgagaa gtgaggccaa gaagttgggg 65700 aggttaacat ttacaatggt ttagacaaat catatgtttg acaaggttta aaatcccttc 65760 tgttcaaaga atatcttata ttaggatttt cttctcctaa tgtgtttatt attgttttta 65820 ttagtataat ttttaaagaa atctgaacta ttgcacgcct cagagaccat aacagtgaga 65880 acaaaaatat aaaggaaaat tttcaaatga tggaaagtgt aacccatata acccgaaatc 65940 ttcatgattt tcagatgacc atctgattaa ggagaaaagt caagataagc acatattcat 66000 atctgcttat ttctagaatt gttctatcag aagaccatga attggtcata tgaggggaag 66060 aaacactgac atgatactgg ctctattagg atgatattaa aagaggctgc tggctcaagc 66120 ttagcatgga tgagttgttc tcacataaag atgctgttat tgaccaggtg tggtggctca 66180 cgcctataat cccagcactt tgggaggctt tggtgagtag atcccctgtg tccaggagtt 66240 caagaccagc ctgagcaaca tagtgagacc ctgtctctac taaaaaattt tttaaattaa 66300 aagttaaaaa attaaatgat gttgctattg ttaatgcatt cctgcaatgc taacatgctt 66360 tcataaatat acttatgatt ttataggtgt tttcctctta gcctcaagaa gggagatgtt 66420 ttagtctagg gactgtcata acaaaataat ataaactgtg tggctcaaac aacagaaatt 66480 tatttcctcg cagtcctgta ggctgaaagt ttaacattag ggtgccagca tggtgtggct 66540 ctcttcctgg gttgcagatg tcaccgtctc actgcatcct catgtggcct ttgtgcaatg 66600 cctctgcaca aagagagaga aacagcaagt tatgtgccgt ctcttcttgt aggctcacta 66660 atcctatgga atcagggccc cacccttgtt aaccttaatt atttccacag aggtcatatg 66720 ttcaaataca gtcacattgg gagttagaga ttcaacatat aaattttagg ggaatacaaa 66780 ccttcagtct gtaacaggga acagaggtgc tagaagaaat gtagtagtag caaaaggtgg 66840 ggtggggaga taataggagc ttcatatgtc ttgctaagaa gttcaggctt tgcttttagc 66900 acagcccctc ttctgctagc tttgttcagg ccaccatcac ctttgatgca gattactaca 66960 aaagccaccc aaggtgtatg aaatgagaaa acacatactt aaattaaccc atggccaggt 67020 tttgctggta acttgggaac acagtaaggg aaggaaaata actttgttgt ggagagggca 67080 aaccaaggaa ggtcagaaag acatagagac agtggaagct caaggaaccg gaggttgtcc 67140 caaagtcata aggcggatgt aacgagagca ccagaacaac agagctggaa ggaaggaagg 67200 aaggaaggat atgtttagaa agcaagatgt tcccagatga atactgcaga ggtagtataa 67260 ctcagtgcaa cgattgtact gggtaggcaa ggtagggtgg cagggaaagt cactagcaaa 67320 catggccaca ataatggaaa ctaaactttg tgtttaccat gcaccaggct ctgtgctaca 67380 tgctttctgt agatcatctc atttaatcct cacacaggga tttaagcctg aagttttttt 67440 cagagaagac atacaaatcc caagtaagag catgaaaaga tgttcattag cattagtcat 67500 tagaggaaat gcaaatccaa agatcaggga gatacgactt cacaccttca agaatggcta 67560 ttcccctata aaataatata ctaaatcact ctttgaaaca taacattttc cacaaactca 67620 cctctttgaa ttcacatttt gctttgccag tgttttatgt tattcagaca tgagtttgaa 67680 tctcagcatt tctacttctg agccctatga cctatgaaaa gtgacaattt ctctgaatat 67740 caatttccca atccaaaaaa tgggaatacc tcttggagtt gtggtgagga ttaaataaga 67800 taatgaatat aaagtgccta gtatagtaag aggcatatta ttgttcaata aatgctagct 67860 gtgaatgcta ctgctatagt tatttcattc actgtagaaa tgattaattt aaactccttc 67920 aagtaactta ctaaagagtg aaagttctcc aaaaggcttg aatttcactg caaacctctt 67980 tccttgtttt gctcttttat tcaggacaat acactttgct caggtgtgtc tttgactctc 68040 aagcattgct ttaaagaatg accagacttt gtcatatacc attcttaaag gagttcagga 68100 catgccaccc caaaatatgc tgctttcata tattgattat tttgagctga tagcacttca 68160 acagcaaatg caagagagac tttttcggaa ctcagctgcc taaaaacaga tcctccaaaa 68220 gaaattcaat tgccatatat cctctccctg ggagttttat taatcagcaa agatacactt 68280 ttatcacaaa acaggaaact ggaagtcaac accacctaca gaaaaacttt ttcataaact 68340 gttatatctc ccattgattc ttctaaaaac ccattcatct ttccccagaa tcatttactc 68400 caccctaagt gacttacatc acccctcccc atcccctgtt aacacagtat gtaagctctc 68460 aaatctcttt taggagtatt cattattttc ctgtggcacc ccatgaacat aatattaaaa 68520 tgaatatgcc ttctctctta ttaatctgcc tgttgtcagt ttatttcata gacacagcta 68580 tcgaacctag gagagtacag ggaaattctt tcctccccta tatgcttaaa tcataagatt 68640 caactgacat cagcaatgaa acaaacattc agaaaactaa attcagagac attatatctg 68700 gcttttctga gggagaataa taagaactaa taggcattgt caggtaaggc aatacagatg 68760 tttttaatta aatgatgttt tttcaccatg acccacatct tgaaaacacc ttcctaatta 68820 aagaccagta gtcttgagtg attctttgaa gaacattttt acttccattt ggtcttttct 68880 ttattgagtt gatgaatctg ctggaattag attcagcgca cataacataa aatccaaata 68940 atgctggctt aagttcataa ggatttattt ttatcttatg taaagaagtc cggacgtagg 69000 taatccaggg ctcgtgctgc attttcttac cattgggaac ccaggctcct ctgtatttct 69060 actgtattaa aggactgtca ccctcaagtt cagctcatgg tacagatggc ggttggttca 69120 agatgactgc tagaacatct gtcatcatgc ccaaattcta gccagcagga aggaagaagg 69180 gaggaaggac agaggggctc atatcagctc tttgtcctcc tcttaattgg cattgccaga 69240 attcccaccc attagttttt ccttgcatct caatggtaac gtctaagtga aaaaaagcct 69300 gggaaatatt ttcatttatt attatttttt taacccaggc ccattggcca gaataaaacc 69360 agcttccttt tcctaaggaa gaaggagaaa tagaattaag gaacagtctc tggcatagct 69420 tgttctccat acttttactt ccatccagaa ctgagaagtt tagacaacaa atctcttttt 69480 gtccacccat tgcctgcttt gagaatgctt cttccagagt gctacgctct cttctaatga 69540 cttattatct tggcagactg cacttttcac accctccata ggctgcagtg atccattgga 69600 tgattgtccc attatgtaga taagttccta ttgctggctg tttatgcttt tctcccattt 69660 ttaggctatt agcaatcctg caataaacat tctcataatt aaatttgtat gagaattctg 69720 tattatttat ttagaaaaag tttatagaag tggacttact gcatcaaaga aaggcacttt 69780 tgtggctttt gaattggcta atgtcttttt tggttaccca agttaaaaga tgatggaaaa 69840 tgtcggggga caaatgctct agaacccgct agcatagacc tacactaagt cttattcaaa 69900 aaggtccctg taaacaaaac cctagttgac ttgcagtagc tacagaatca taactggttt 69960 tttgagagca gagattctct ccgttcctcc cttagtgata cttagccagc tactggtaat 70020 ttgcttatta tcaaaaggag cggccaggcg cggtggctca tgcctgtaat cccaccactt 70080 tgggaggcca aggcgggcgg atcacgaggt caggagatcg agaccatcct ggctaacacg 70140 gtgaaacccc gtctctacta aaaatacaaa aaatcagcca ggcgtggtgg cgggcgcgat 70200 ggcaggcgcc tgtagtccca gctactccag aggctgaggc gggagaatgg cgtgaacccg 70260 ggaagcggag ctcgcagtga gccgagatcg cgccactgcc ctccagcctg ggtgacagag 70320 caagactccg tctcaaaata aataaataaa taaataaata aataaataaa gcattttttt 70380 tttcacttta gccagcgcat cagagaagaa cccacacttg attgtcttat ttttccccct 70440 acaatgccca gagcagtatt cacacattca tgaaaagaaa acacatcact tagaacattc 70500 gaatagagca cgtgttttta ttttgctctt ctatgtttta cctccacttc tccacaattt 70560 tgatcccttc aaaaaaaaat cttaactaat tattctctat atattctatt aggaatcttg 70620 gctgtagact taatcttgag gttagaaaga aaatagatct tgaagccact attttggcac 70680 attctgtaat tcttagaatt tccattctaa caattttctg gatgaattta ataaccgttt 70740 atattttatg agctaaagtg ccaattaaaa ttattcattt accatcttta agacttactt 70800 gtctgtttta ttcaaatgca ataaaaatgc ggaactaata agagtaactc ccgatgagtg 70860 ttcaacaaag aaaagaaaga aaacatattt tttggcgcac attcaaatca tttccttttt 70920 ctggtagggc caaatcttct catattggga aaggaaatta gctttgcttc aaagcacttt 70980 ctgaagagca atttactaat gagcttagga attctctgcc ctcataaccc tcctatacat 71040 tacctgaacg cagagaaact tgagacgttc agcaagggag gtaaggccag gagtgttgag 71100 gcgtccaggt ccgtctgtgg agttcactgc caccttcctg tgtggatttc agtccttgtt 71160 ttcctggatt ttgagttgca ttctcaatac attattttta tttttattca tagtgaaaat 71220 attgaagact gaattttttc tgaattcata caatttatat gacatgttat tttttatttt 71280 ctaaatattt tactgttgaa gtagttcctc tttcacccaa aaaaactaat agtttttgct 71340 gtcttttttt aatttctacg tgaccatttc tttaatattt tgtaattcac atttaatttt 71400 attgccttgt agtcaaggaa tatttctgaa aggacttctg ctctttggaa cttattaaga 71460 gtgtctttga ggtttaatat gtaattatta tcttaaaaat atttaatgta tactaaaatg 71520 taagacacaa tttattgctg tggaattaaa caaagaccat ccaaatgaga acaagcaatg 71580 gctatttact cagagtttgg gagtcagccc acagtttctt gtgttgacag agactcaaaa 71640 ggctgagtgg aaaagctttg caagggggaa aaaaaggcag ggtctcagct atgccctgat 71700 tggaggctgc tggcctaggg aagttgacct gaagcacagc atcttatcgg attgcttaag 71760 ggtgcatatt tacctttctc ctattggtcc taagttagaa gcaagggaaa caattaaagg 71820 agctatcagt tatgaaccaa gttctgggtt tgttgggcta attgctatgg tggtattgtt 71880 tggcttcctg agctggttgc tgcaggttgt ggataagagt tctattttat gtatatggtc 71940 tggccattgt ctatatgttc agtctctcaa tgcattattt gtacttattc ttttgaattt 72000 gcctttacta attatggtct ctatattgtc tctttttata tacatatttt ttgcctgttt 72060 aacgtatgat agatgactaa aagtgctatt aaaaactttc acacttttgg ttggacgtgg 72120 tggctcatgc ttgtaatccc agcactttgg gaggctgagg cgggcagatc actggaggtc 72180 aggagttcaa gatcagcctg gtcaatatgg tgaaaccccg tctctattaa aaatataaaa 72240 atcagttggg catgatggtg cacgcccgta ataccagcta ctcaggaggc tgaggtggga 72300 ggatcgcttg aatccaggag gtggaggttg cagtgagcag ggatcacgcc actgcactcc 72360 tgcactccag cctgggcagc agaatgagac tccatatcaa aaaaaaaaaa aaaaaagaga 72420 gaaaagaaaa gcctttcaca ctttctctca tcttttagta tttttgatca atgtttgttt 72480 tatacatttc aatggtttat tatttggttc ctaaaggctc ctgattagca tatctttaat 72540 gtatgtttgt gtatgtatgt tgatctctct ctctctctct ctctctctca tacacacaca 72600 taagtctttt catttattag ctttgcttta aactttgcta atgtgatatt aatattatgt 72660 ttatctatct tctttttatt gcacttgttt gccaagcacc gaactaagca ttttaaataa 72720 tatcacattt ttgtaactgt tttggcattt atcttcttca ttgtgacttt acttgaaata 72780 attatcaatg tgtatttcta tatttgagtg tttcaatact tatcaagagt tttcttcccc 72840 attcttggtt cctgtgtttc gacacagctc tcaactttct gtagtacttt gggtagtatt 72900 ttttttttca agaagtcatt ggataagatt ataaacacct ggcatttctt tatgagcctt 72960 tttcttcact ccacaacaat aatgatttag atgggtatag aaatcttgaa ttcataactc 73020 aaatctccat agatgttgct ccatttaatt ctggtatttt gtgttaccaa aaaaaaatct 73080 aaagtcagtc caagatttct ttcttgatag gttatccaat tttgtctttt gtttctgatt 73140 tttttttttt tagatttcat gctttcacca ggttatgtct attttttggt cgtctgttat 73200 gtgagttctc tgagctgcca tatgctcttt tgatctgctg attaatgtga attcgtaggt 73260 tattttcttt atgtctttga atacagatta cttaccattt attttaatct tatcttcagg 73320 aactctaact gtctgtctat atgttagtaa ttttggcctt tctgtcatca tttaaatatc 73380 ttggtcctat tcttctacgt gggaagaata atttatactt tattaatcaa taatttgatt 73440 ttgattcaat gattagcagt gctaattcta ctttttattg tttctgaagt atcttaaagg 73500 ttgctttgtc tatgaaaagt tttaaaacat tcttcctttg tattatctgg tgccttttta 73560 tttctgtcag cttcttggtg tttcccttct cacaacctat ctaatgtctt attatctcgt 73620 ctttcacctt taattccata ctgtcaaagt gtccccaaaa tgtaaaaaga atgcaaaata 73680 tgcgctaaaa tttcagggtt tcttgagcta aagttttttt gaatatatat tctttttctg 73740 atatttttgt gctcttttta actcaatgct aggaaatctc tctctgtctc atatgtttca 73800 cccatctact gaaagttttt taattggcta acatctgaat aaatgcacat atcttttatt 73860 tggattattc ctacactagc tgcacaatgc catcattgtt tcctccacca agaagagctg 73920 ggtgggccat gttcattgag aaaatcagtt tctctcaaac aggagaaaaa atggcattgt 73980 cctatcgcta tgtgaataat tcaactaaaa agaataactg ttctcccagt aaagcttttt 74040 ctttcttaga aaaattgggt ttctttatat tccatgcctt tgcttcagag cacaatatgt 74100 gacctgggaa aggcatttac ccttgttaaa ccttcatttt ctcatttcta aaattacaag 74160 ggttatctcc atgatcttta ggaagccaga actgatctgg ttctaatggt cctttgattc 74220 taattagaaa tttccaactg caaaagttga gggggattct tacatcttca gaagccaact 74280 aattaaacaa cttttgctgt aatgagtgtc agtcaccttt atgaatcagc ttgtcactta 74340 ataatagaaa tagctggctt ctggcccatg cagaaggaat gtagaaaata gactatagta 74400 acaagctgac tcccattctc ctgttgttcc ctgcctcact cagtttccac agtcaactta 74460 ggacaattcc atactgtgat tatttactcc tgctttgctt tcgtaattca acaaacagta 74520 ttaaccactt actatggcga ggcatggttc caggtgctaa ggacccacag tggatttgat 74580 tacaaattac aggtaaaata ataaagcaat aaaaaggata attttgcttt catcatcgaa 74640 agctcagtga tagagtaagc tttagacttt atttgcctca gcaatgcagc agtggtagag 74700 ggcagaggag aagtctcatc ctaagccttg ctcccaaggc tggttatagg atgctgtatt 74760 agtttgctgg gactgccgta acaaatacca aagattgggc agcttaaaca acagaaattt 74820 actttctcac agttctagaa gctagaagtc ctctatcaaa gtgttggcta attttatttt 74880 gaggcctttc tcattggatt gtagatggct gtcttctccg tttttttcac atggcttttt 74940 ttctgtccat gtctgtatcc taatcttctc ttcttatgag gacaccacca gttatactgg 75000 attagggccc acccagaatt acctcatctt tttttcttca ttatctcttt aaagtcccta 75060 tctctaagca tgtcacattg tgaaggactg gaggttagga ctttaacata tgaatttagg 75120 ggagatgcaa ttcagcccat aacaaatgcc tgctagtaac tcatgggaac tctcttccac 75180 atgcaaagag ataaaatgtg atttctgcaa gttttattag aaatatagga aggaaccctt 75240 cccagcaggg cttgacaagc ctgtgcatgt gcctcactga cataactaag ttatagggtc 75300 atatttgaac taatccatgg aacaagacat gcaattacac tgatgagctt aggctgaagt 75360 caaatgtctc actcctgaaa attcagactt ccccaaaaca catgggctga acaggtaaga 75420 tggatacttc aactgaaagc cagggtactt aacaaaagca ggagaaatag atgctgggga 75480 ggtaatccca acgtccagtg caaatgctat gagggaaaac gacagagtcc caaacatgct 75540 ggagcttata gttagaggaa ggaaaaatta gatttttctc agggctttgg gattggggca 75600 cctggcagtc agcgcctaga ttccaaagca ggtcagaaga tgcctctgcc caagtattgg 75660 aaaccttttg aatatctttg agtattaaaa acattttaac actgcctgag aaaagtagta 75720 gttatgaagt tatacattta gcctatccca ttcaactcag gggattgtac acagatcaaa 75780 taaattgcaa ttgtgtttcc ctccctgata ttcacatagg aaggtgagtg gtgagcagta 75840 aacttcagga cctttaaagt tatcattgct ttcacccttg caccagcttt ttgaggtaaa 75900 tattcccatt ttctaggaga ggataatgag gctcagagag ggtaagtggc ctccccaggg 75960 tcttctagct gaattgtaac cagcttgatc ttccttttga attccaccat cttgcctgtg 76020 agggaaaaag gaataaggag ccaggagttg cagggtcatt cttctcctca agaggcttga 76080 gagtaactaa gtatctgttc aaaacacttt tgagaatttg gcggcctcat tacgtttctc 76140 aggagtccct gggggaggtt acacttttag gatccccagg aatagagtga caaaatacag 76200 ctaccacaac ttggtcctgt gcaactgtgc ccttgctcag caattactga ctccattctg 76260 actgaactct gccaaaaact cttaacatta ataattatta cctgttctca attttaataa 76320 ttaagagttt tacaacttcc agtgactctt aattcaggtt tctttggctt actgttcttg 76380 gacaataaca gtatggtcac tgttgcacag acagaagcta gacatagtct gtatagctaa 76440 ctccctcatg tccttcaaat ctttcttcaa atgtcagttt cttttggggc cttctgtgac 76500 caacctgatg aatagagccc accagcccca gaccacagcg ttcctgactt cctttactct 76560 gcttcacttt tccctttttc acagcaattg tcacattcta ttctactata acttacttat 76620 ttattgaatt taccactgat tgtttgccta acctcactat aagacaggga tctttgtttt 76680 attctccaag aacttagaac agtagttatt caattaatat ttgttgaagc aatgaatgaa 76740 ccaaatgaat gaatgaaaga tgaatataaa aatatttata tgtcctaaca ctctactaag 76800 cattatgaca gaatatccac caaaaaaaaa agatgagaag gagaaaccat tattcttctg 76860 tagcagggct aacagaacat gagcagatgg caaacgtgag attatcagca ccttctgggc 76920 tagttcctgg aaatcagctg atttcctgct gcttccaaaa attcttaaag ctttcagact 76980 cctgagcaag ctcctgcaaa acacctattt tggtgctgca agcacctgca gtagctctct 77040 agtcattcag gtacttgttg accttaggaa ctcaagccat agcttccacg attttcaatc 77100 cctgatccct cttcagtctc aaattgctgt atccaaaacc cttcctactt gcaatatatt 77160 agaaaggcca ccttctgacc aaatctgaaa agttgggtag gtttgtagag gatgagtttt 77220 tggattattc ccaattcttt tgatcctcac cccaacctcc taagactaaa gctacagtgg 77280 cctcccttta gggaagaaag cagaggaaag gagcagagga attattttct gtgaattaac 77340 tgtttctaga ttctaatatt agtgactaaa ctgccatttg tacttcctat attcctgttt 77400 tagcaagagc taaaagagtt tcaaagaagg taaattgtat tctaagaaga gaattcagaa 77460 agtcctttcc agaatagatg aatcttaaat gatgggcagg tttcccacag agataggtgg 77520 ggaagccatt ctaacctaga aaacaggatg cctagaagta tgcagtgttt tcagaaaatg 77580 gcagacacag gcttccttgg ctagagaaca aagacttcat acaggagtag gttcataaat 77640 acaagcacaa gagaccttta tagcattggg gtctagtgat tctcaattat tctgcctata 77700 agcatcaact gcaagaatag ttaaaattct attgaagaga agaaatgttt cctgctgtgc 77760 cagaaaccct taagaaaaag caaaggaatt tcacagagct gaagatcaag cacctgagaa 77820 acaagtttgc ctcaagagat gcttccaaag gcaagttgga agcttattga tgaaaaagtg 77880 aaacactatc acaaggagta caggcagatg ggacagaact gaaattcaaa tggctaggat 77940 ggcaagaaaa gctgaccact tctatgtacc tgcagaacgc aaattggcat ttgtcatcag 78000 gatcagagat atcaatgatg tgagcccaaa ggtccaaaag gtgttgtagc ttcttcgcct 78060 ttgtcagatc ttcaatggaa gctttgttaa gctcaacaag cttagcatgc tgaggattgt 78120 agaaccatat attgcacgag ggtacccaaa cctgaagtca ttaaatgaac taatctacaa 78180 gcattgttat ggcaagatca ataagaagag aactgccatg atagatacca atttgattgc 78240 ttgatctggc ttcatctgcg tggaggatct gattcatgaa atttgtactg ctggaaacac 78300 ttcaaagaag caaataactt cctgtacccc ttcaaattat cctctctatg agatggaatg 78360 aagagaaaaa ccactcattt tatagaggtg gagatgttgg caacagggaa gaccagatta 78420 atgggctcat tagaaggata aaataaggtg tctgccatga ttatttttgt aatcttgtca 78480 gttaataaac agtgactgct ttcgatttga aaaaaaaata catagttaaa atacacctac 78540 acattcacac caaagattct gatttaattg gtatgaagcc aaaccaagac attagtactt 78600 ttccagagct tcccaggtga ttttaatttg cagccagtgc tgagaaacac tgagacgatg 78660 cacataaaat gcctagccca gagcctgctc aagaaatgtt agctgttgct ctctactgtc 78720 actgtttggg tggttgagac ttgtgcccag gcttcctagg ggagtgttcc tcccattgcc 78780 ccacagttcc ctgtaagtgg tggaaaagga gaccctatag cagcacttct caacaccggc 78840 tacacatttg aatcaataga ggagccttgc caaggtttgc aaaagatggc tgggtctgtc 78900 tctaaccaat tagaatctct gaaggtggga cccaggtatc cccattattt actttcccca 78960 ttaactattc cacaaatatc ctcatatgat ctgatctcta tttccccata atgattgact 79020 ggtatttctc tttgccattt cagtattcac aatctgcttt gtattaaagc tgcttattta 79080 cgttatctct cccactgtga accactgcag atcagggact ggatttgttt tgttttgttt 79140 tagtttttat acaattgctt tccccttgca ctcagcatac agcaaagctc taacacatga 79200 tatatactta cataatatta atttaattaa ttgtcagaaa ccatagatac tcaactataa 79260 gactttcctg ccttctccac tctacttttc catttttcat gttttctttg ttgttgtgct 79320 tttctatgcc ttcttcacac tgtagccaaa gttattttat tcaaaattca aattaattta 79380 attatggaag ctgggtaatg agcctaataa tataaacaca gtggtgcagt gagcatgcag 79440 ttagttacaa tgttccatct atttttctgt tgtgtgaagg catccacaat ttataaagta 79500 cctggtgatt caaaaattaa gaaccactat tctaagagta ggtggaggcc agactatgga 79560 atcttccaac aaccaggagc aggagttgga atggaataaa ttagagcact ggatcatccc 79620 tgaaatccct gagcagagga acaaccgaaa cagagatgta tttaagctta taagtctaaa 79680 taaaagttgg gggtttaaaa aggctactta attacttctg agaaaaaata ttttattcat 79740 ttctcactgg gcttctataa tcacctcagc tctgtctgca gtttcctttc ttctgtaatt 79800 atttttctct ccattttctt gccctgatag ccacgtgctc atttgggtat ccatcaaaag 79860 actacatttc agtatattaa ttctctcact ggatggtaca gcttgaattt ccttctgcta 79920 gtttcattaa aatctaaatg gggggaaaag tcctctacat tatctaggag atccatgtga 79980 gctgcccagc tccattagct gttgtctgtt agaggtggat tacaagcagg tgtaatctta 80040 aggacaccgc ccttctgtga ttgttaagaa ggaacacaga ctgagcagag cggctactgt 80100 tctgatcagg agccaccacc actggttcct acagtataca gaatttcaat tgtcagatct 80160 gtcctggagg aacaatagaa tacaactgtg aattaaataa tttagaaacc aaggacataa 80220 tctcactttt ctaaatgagt ttgcctcttt taggagtcag tatattcgta gttttgctag 80280 cacagtcctg tgatgtagga ggaaaatgcc caaaaatatt ctagaaaaaa cattgagaat 80340 tcaagttaaa atgtcagatg gagcagcctc tagaattcct cctttgtagg ccatcagtaa 80400 tctcactgaa aattagacat gtattattta taaataataa tataatatta tgcatatttt 80460 aaatattaat gatttaggtc aaacgcagaa ggtgaaattt gtaggtgtca gaaatgaagg 80520 ccaaatcttt agtgggaagg ctgtgggagc tgaagctctg cagagcacag tggggatc 80578 <210> 16 <211> 112 190 <212> DNA <213> Homo sapiens <220> <221> exon <222> (31560) .. (31663) <220> <221> exon <222> (64868) .. (64961) <220> <221> exon <222> (80499) .. (80700) <220> <221> exon <222> (87482) .. (87558) <220> <221> exon <222> (97994) .. (98080) <220> <221> exon <222> (101581) .. (101761) <220> <221> exon <222> (102663) .. (103161) <400> 16 gatcacgagg tcaagagatc gagaccattc tggccaacgt ggtgaaaccc cgtgtctatt 60 aaaaatacaa aaattagctg tgcatggtgg aacgcacctg cagtcctagc tactcaggag 120 actgaggcag gggagtcact tgaacctggg aggtggaggt tgcagtgagc cgagactgcg 180 ccactgcact ccagcctggc gacagagcaa gactccacca aaaaaacaaa aaaaaaaaaa 240 aaaaagaggc atttctaaga gagagacctt aaccctaagg cagacactga agaggatttg 300 gggcatgaaa taggagctgc aggttggaga acatcacaag caagggcatc tgtaacccac 360 cctacccact ttctcaagag acagtccaga gagcgagtaa ggcacagggg ccctcttctg 420 catattgaaa gtgagaagaa atgcctatgc gagtgtctag gcagagagct tgaaacagcc 480 acttgtgggt ctctgcacct gcagcctggt gcagggatca gaagaatgta cttattctgt 540 gcaacaagag ccatgccttt gtgacaaagc ccgtggccca agaaggccct gcatttggaa 600 caaggaggca ccactttgat ctgctgacag ctaagtgcaa ggtggaatca gagatatctt 660 aatagatgtc aatgataaca gatgatacca agaaccaggc atcttagaca cacacacaca 720 tacacacaca cacacacgtg cacgagcacc cacgcacgca tgtgactgga taccgcatga 780 gttttctaaa gcttaaagat gactacaagg acaaagagta aacacttaat tgactgcaat 840 taagtttttg atatccagca gagtaggagt ttttactagc aattaacttc agttttagaa 900 cacgacaaat cttattttta ttatacaact acaaacaaat atataatgaa tgctcagatt 960 ccaggaccct atacctgggg tgatgggtgg gacgagttaa agaagggatc tggacactgc 1020 tgcctctctg ccttctttat atggggaccg tatcacaaat gaggctcact gtgcctccag 1080 tcatgtttac tgtgcagcaa ggcttttggc cagagaacat aattgacatg cacagagctg 1140 gagctcttgc cagctcacag caaaagggcc tctaattcag agaaaaagga gttggacctc 1200 tgccagtcat gtacctgtta tgctttcata taggcatcag ttagaccctg atctcagtct 1260 gacaaaccag aaaatataaa accatcagga tcaaggcata ctttttactg ggagtgttag 1320 cctggtaatg gagaggaatg ttattgctct aagcattcgc ataatatcta ttgatcaaac 1380 ctctgtgaag ctgctattct tcatgccagc gtctggcggc aagggaggac tatttcaggt 1440 ctcaccatca cagccacttc acactcaggc catgccacag tcaccagcac agcttgggat 1500 tggggcagga agtccccagg gtgaccagac agaaagcagc ctcaggacgg ggccagagca 1560 tgagactagg ggtggtggca gctgggtttt atttactctg ggctgtgtga ccttgggcaa 1620 gctgccagcc cattctgttc ctctctgcat gccatacaac cgggaattcc tacattactg 1680 agtcactcct gggccaaggt ttgatgtccc tattaaaatg ctgttgagag agtaagtggc 1740 ttcagtcact agccctggag aatgagttca ccagtttgat ttgtttacaa ctgagaactc 1800 tttcagtttg tgtgcgtgag gtgctggggg agcaggtgga agaggctttg ctggagtggg 1860 ggaaatatcc tgcctgggag tgggattggc ggaagggggc atatttgtca atcacaatag 1920 aatcctagac acttatgtct gggaggcata gcataggcca ttgcattcat cttcccccca 1980 gtacctgaat ctgtgaccaa tggaactgag gatctttact taacaacctc tagtgatggg 2040 ataatcacct ccttctaagg caagctactt ggaaactcta agatattact gagaaaagac 2100 cctgagccca gccttgaatt agtccaaagt ctaatgcttc tcccaggtga cagcccttga 2160 aagagtgtgt gacaggcgcc atgccccctg aatggtctct tctcccaaat aaataatacc 2220 tgattctccc tctgcaatgt tcatgaccca aacaaagctg agcctctgtg tggccactct 2280 cagtttgatg ttgtacccca aaccttcaac ctcagtctta atgcctggga atgggggaat 2340 gtgtggaaaa aggcatgaaa cacagtacac agcaaaatgt cttaacattt ctcttgattc 2400 tctagctcct tatccctttt cctaaaaatc tctttctaaa tctttcaagg ataaagggaa 2460 gggggtagaa aggggaagtg aggagaggta aaggaagatg ttcattattg ggagcctata 2520 atgttccaaa cacgtgggac atttaatctt cacaaagtaa gtatacccac cctaatttta 2580 taaggtagaa actaagaccc aagatatcta agtaagttgc ccaaagtcac aaagcaatta 2640 cctggcaaac aatggattca gataatgact atatcatagg ccaagcccaa ttacactcaa 2700 aataattcac atcttcctaa gaggcaagcc ctgggggccc aagagggggt tgttgagtaa 2760 gggcagaaag tacaagggag acaagttgcc aatcacagct tggccctgat tattgtaata 2820 actgacacaa ttaaagttca atttcgtatc cttagaaggt ttccgtcata ttccaaggct 2880 gatgagaaat ttccattcta agaatgggga tctgttgaat gttttaaatt caggcactta 2940 attaaatctt ttaagatgac tctttctgtg tttgccctta gtcttttatt tctatccaat 3000 attgttcctg gaccaaatag ggtcgggctg ctgtttcttg tagcccaata atgagatgca 3060 gatgaactgg ggaggaagag agtttttttt ttaagtatat aaaaacattt attcattaga 3120 aaacaaggag actggcaaac atatattcca aagtgaaagc agctcaatgc agttcagtta 3180 ggctaattta agagaaaggc cttgcatttt aaagatcgtg tatgtatttt tttttttttt 3240 caaaaaagga gacaggcaaa tattctacaa ggggaacaga attagaattc taggtcaccc 3300 tacaagttac cctgcacagg gaggaaagga acaggcaaga tgacttctca ggatctgtgc 3360 ctgcgagctg atgctctgag aatgggggtt attttcttgg gtgtcctgtc ttctgtcatc 3420 taggctaaaa aatcttcctc acttgactca tcacttgaga agacaacttt tggtttcttt 3480 tcggaagctc gctgctgggt gttcggatgc cgatgggtag tacgacgggg ctctggtgtg 3540 acgaagtcat tgtctgaggc tgcagaagcc agaggctggt gcctacaaac agtggatggt 3600 ttcttggctg ttggggctct ctggctacct gcttggttaa tctcaagctc ctcaatccca 3660 tccaaacctc tggcatgaca ggcctgaagc ttttgctcaa attcatctat tatagccttg 3720 ccctcaggct tggccccatg ttgtagcttg cccataactg acaaaaaaga actgaagatg 3780 gactcatctg acagtttatc tccaaaacag tcaaaattgc caagcatctt gcaagggcct 3840 tgctctgtga ggggcagctg tgacacacag taggccaggt cctgctgcac ctgctcagtt 3900 taggctgtgt ggaaccgctg acacagcttt tccaccaggc tttgtctgct tgtctttggt 3960 gatgatgtag gagaagaact gcttcataat ggtgtgaaaa ggcacttcct ccacccccag 4020 ctcggggtct gacaggtggc tgatgatatc tggaaggaga ctatagattg cattgccctt 4080 gtggaagagc tcattgaaga acttcttggc cagggcagca atttgagact cagggttgat 4140 gagcagcatg gccatctcac tcacctgccc ctttaccttc accatgtcct tgaggatcag 4200 gtggagtcat caccagcccc actgttttcc acactggctg agcagggtcc tgaaggtgag 4260 catatagatg aggagtccag gggtccacca gattgggaaa gtggatggcc agatccccag 4320 tggcaacgat gagattagac cggacaatgg gaagtggaga cttttctagc atggtgaaca 4380 gaagatgagg ctgggagttg cagaaagtgg tactgatcat gcagaacttg ccaagggtag 4440 gtgaagcagc tgcagagagg tctgggttgc tatagaggcc tgagttgttg tagactttaa 4500 gcaagagtgg aacaaaggca gccagtgtct gtttgccatc caacagttcc atcttgcaga 4560 agccgcggat tagttctgcc tccgtgtcat ctgctgcccc aaccagcccc agctcctcct 4620 ccatagtggt ctcgaaactt gtattcttct ccttgggatc tttggtcttg tgctcctgtt 4680 cttcccggag aactcggcgc tgacagagct ctccactcac tgcctgctcc aagtggacca 4740 gctgctgcag agccacatcc ccagccaggg acaagaggtt catcaacagg aaagtgggga 4800 gcattgtggg agactccttc gggtccccct gactggttct cttctcttct agcttctcca 4860 gggcctgttt tgcacagccc tgccatatct gggcacagat cactgtggga ctctctgcca 4920 gttggtaaat gagggtcact gccacctctt tgaatgggat ccagagtggg tctggtggac 4980 aaagcctttc gggaccgtct cccgcagtca ctcaaacaac ttgtgttcct gaggcaactg 5040 gaagtggggg tgacgtttgc ccagagaagt ctttctactg tcagagatgt tggcgatggc 5100 atggcacacc tgctgggcca gccggtagtc ctgtggaaac ttcggaagag agttttattt 5160 tctgcaaccg gtgacgggga gaaggcctgg aaattattgc cagaccaact taaaattaca 5220 aagttttcca gagcttatat accttccaaa ctatatgtct acgtgtaagg tatgcattca 5280 tctaaagatg taaatggtta acttctttta atctataacc aaggtctgag tcctaaatac 5340 cttcctctgg agcctcagta aatttactta atctaaatgg gtccaggtgc tggggggatt 5400 acccttatct tgtctcctgc taaattacag aggttttggg agttccttca gacctccaat 5460 aaacttgttt gtggaggcct aaggagtttc cttagacccc cagtgaaact tgtttaatcc 5520 taaatgggtc ctgttaagaa ttcctttgtt attttgtcat gccttaagtc ccaggaaagg 5580 cctaggtaaa actcttgatg ggcttttgtt acattccagc cttcgtacag gggcactggc 5640 ttttaatatt taacttaacc actcagtcag tactgaaaga gttgtcagtg acacctggcc 5700 tgccacaatt atgagtgtcc agaattttac tagatgtttg ggggaagggg aatgagaagc 5760 ctgaattagg aatattctcc acgagtctct cacaatctag ttggaaagac tagtaaactc 5820 aatgacatat taaatgataa gtaaatgaca acctgtggtc cttacttcat gcctttgcac 5880 acactgctct ctctacctgg atgcccttct ctcacctgat ctctccagca aagcactact 5940 cattcctcaa gacacaaagc tgaacaggca ctctgtgaag cctgcctagt ccgcttgctt 6000 ccttcccaga agattttgcc aatcatccct cttttggaca aatatcgtgc aacactgtat 6060 tttaattatt tcccaactcc ctgaaacact agaatgtgag caatttgaag ataggaatgg 6120 agtttccttc cttgcattct cagcacatag cattgtgtct gaaaccaaat agtcagcaat 6180 caatagtaat tgatgagtgt ttaaagaagc actacaggaa gtggcaaaaa tcagggtcct 6240 ccagggcaac acgatgggga cttcacagag tgggtggagc ttgtattggg ccttagagga 6300 tgactaacat ttggagatgc tgatgctgcc aaaagtagaa agatcaggag gaataaaagc 6360 ccagaaatac gagactgtct tccccagtgt tttatggtgg tcctagattc aaatatccca 6420 tcatgtcaca actttgaaat gaggaaaata ctttcaccaa gaagttgaat gctattctga 6480 attacaaacc caggtgagtg ctcatcaaga acagaagacc agccaggtgt ggtggtgcac 6540 gcctgtagtc ccagctattc aggaggctga ggtgggagta tcacttgagc ccaggagctc 6600 atagtgcgct atgtggatcg gatgtttgta ctaagtttgg catcagtatg gttaccccta 6660 tcccaggagc aggtgaccac tagattgcct aaggaagcat gaaccagccc aagttggaaa 6720 cagagcaagt caaaattccc atgctgatca gcagtgggat tatgccagtg aacagccact 6780 gcactacaat gtgagcaaca taaagagacg cccctgtcca aaaaaacaaa gaaggaaacc 6840 tgcaatccga gcactttggg aggctgggga aggaggattg cttgaagcca ggagtccaag 6900 accagccagg gcaacatggc gagaccctgt ctctacaaaa ataaaaataa gttaaacata 6960 aataaaaaat tctaaatgaa ttttaaaaag aaagaaaaaa taatagaagg ctttggggat 7020 cagggcagcc caaagggatt cctggagttt caaacacaaa atagacatga gagacttaat 7080 ctggatgtca gaccagcact agaagaaaac ctggacattt tgaagccctt aaattcataa 7140 aactttgaca gtttcatgaa catttgttga aaccttgcca tgtccaagaa ggtcacctag 7200 gatcagaact tccacccatc tcctcttctc cccctgtcct tttctgaggt ctacaccccc 7260 tttgtagtag gtggtcaact ggacacagga ctaggtttat caaaacttgc tctcgggaaa 7320 taaaaataag acaagaaata caatatacac aagaacacat gttcttgtac ctcagtctct 7380 gaatagcctg tctctagact ctgtttgatg taagagtggt tgcttctgaa aaaagaactg 7440 agtgactaac aatggttgga gaagggtgcc tttcttaatt ttagttttta ttatttttat 7500 tgaagtatga agttcaatcc ggtgcacgca agtatcagct gatgaatttt cacaaacaga 7560 agataccagt gtaactagca cccaaatcaa gaaatgttac catctgcctc tatgccccct 7620 cctaccaatt cccagtacca cctcttcccc ccaccaagag taagccctga ggcccagaca 7680 ggcttcacct aattttatat tttatttttt ctttttatga acagctttat taaaatattc 7740 acataacaat acagttcacc cattaaaagt ataaaactga gtggctttta atatattcac 7800 agatatgtat aaccatcacc aaagtcaatt ttaaaatatt ttcatcacct caaaaagaag 7860 gcaaatacct tttagctata actcccacct cacatcctcc gtaaccctag ccaactgcca 7920 atctacttcc tatgtctatg aaattgccag ttctccacat ttcatataaa tggaatcatg 7980 taatatatta tcttttgtga ctggtttatt tcacttaaca ctttcaaggt tcatttttgt 8040 tgtagcacgt atccatattt cattttttat ggctaaataa tattctatca tatggatata 8100 gcacattttg tttatccgtt catcagttga tgattatttc agtggttttt accttttggc 8160 tcttaggaat aaaatgctgc tataaacatt catgtacaac tttctgtgtg gacagttttt 8220 tctcttgggt atgtaactag aagcagaatt gctgggtcat atggtaacac tgtggttagc 8280 attctaagca actacagttt tatattccca ccagcagtgt acaaaggttt caattcctcc 8340 tcatcctcac caacatttgt tgtttgggga ttgttcatta caaatacatg aaacagtggt 8400 taccagagtc agtcagggtg ggagggagga atgcagagat ttaggtcaag gatacaaagt 8460 agcaaatacg tagaatgatt taattcttta cataaataga accttacagt atgtgtgctt 8520 ttgtttctga cttcttttgc tcagcattag attcaggaga ttcatcaaca ttgctgcgta 8580 tagttgcaga cagtttacta tccttattga atggtgttct actgtgtgaa catactacag 8640 ttgctttttt cattccacta gtggtgggca tttgggtcat ttccagttta gggctactat 8700 gaatactgct gccttgaaca gtccaggata catcattttg tgagctgctt atttttatta 8760 tttgtgctac ctgaattttg tattatgtgc aggtattact ttttttaaat gtcctaaaaa 8820 cacctttaag ggcttttaaa ctaggatcag aaacttagct ccttccctac tgacaagcag 8880 gcagaaaaaa aaaataatag taatagctag tatttactga atgctcattg agccacctct 8940 ttagggaaaa aaatcttttc atatatgttt gcttttaatc ctccaaatta ctcaaagcca 9000 taggtattct cattatgccc atgttagacc tgcagaaact gagaccgaag gaggttaaat 9060 aacttgtgca aaaccataca actagcaagt agggaatcac agtacaaata caggtctctg 9120 aatataaagc ctgtgcattc accctccaat tacacagcct ctgattacac tcagctggga 9180 gttcagggag cctgctagac atggggagga gaagctgaaa tgagagcacc tgaaactgcc 9240 agctcagtcc agctcaacag ctcggattgt tctccccacc gcccccctac ttcctgtcct 9300 aattaatcaa atgctcttga acatgaaaga gagtgagatt ggatttttgt taagatgaaa 9360 gaaaggaatc tgttcccatc tggcaccttc aaaactctcc tattcaagcc agcagggagc 9420 atttatgcaa cctacatggc agtttaataa ttccccaaga atgccaggag attaagcaat 9480 gtcacaaccg atctggatcc accggcactt gagaataatg gaaagagcag gggtctaagg 9540 tctaggacag gggtcaacca aatttctctg taaaggccca gatattaaat attttaggct 9600 ttgcaggtcc tatgatctct gtgtcaacta cccaactctg gcattgtaac atgaaagcag 9660 ccatgagcaa acaggcatgg ctgtgtaact aaaacttctt ttatggcaca gatatttgaa 9720 tttcatataa ttttcatgtg cctgggcata tatttctttt ttaaaaaata ttttctaacc 9780 agtaaaatat gtaaaagtta ttcttagttt gaaagctgca caaaaatgga ggacaaagtc 9840 tagcgacctg aattcaaatc ctctctctgc catttgttat ttctgtggct ttcgacatat 9900 tacttacatt cactaagctt catttctctc ttgagaaaat gagcagagca ggtgccatgc 9960 attcagggcc tcccttgtgg ctggcactga gccacatgct ttatatgctt tactgaatta 10020 aatcctacaa taaccacaaa aggctgaaat tatatgattg ccttcttcag atagttacga 10080 tgattaagaa attatgtcta taattgtgcc tgagctggcc tccatagttc attgagtttg 10140 atgcttcctg ttgtacgcaa aaattgccat gttggttcga tgagagcatg cctgcttttt 10200 ctactacctg tggtgttttg agtacctata tttgtattgc acttacagtg aaaattatct 10260 aattatatta ttctatttaa ttacaattgc atcaagctcc aataaacaat ccaaatttca 10320 ctgaactgaa agttgagtgc acactttgaa tagtcactcc ttctgttagg ttggtgcaaa 10380 agtaattgcc attactttta gtagcaaaaa cagcaattac tttcgcacca acctaatata 10440 tatgtgcaca gtaggcagtt tggctcaggt acacttattc aaaacattgc attaagtaag 10500 ataatacatg ttaaatacct agcacacagc ctgggatgca ggtgtcggcc agtgtttgtt 10560 ccccacttcc ttagtgacaa agattaggct tagctacttt ttgggaaagg tgagtgccac 10620 cagaaagatg aggccaaggc cttatcagac acactggaac acagccttcc caaggaataa 10680 atccagaata ttttgtgtat gagttctggc tctgaagccc agcctgttct tacactgacc 10740 ccccagtttc tgccttgatc agccacccac taggctgggc attgcttcct ctcactctgc 10800 tatctagtga cccaacctcg gcccaaccct ccagctttct tctggccatg cgactgttct 10860 gctagtctgc tccgcatatc tgctcctacc ttccgatgcc tcctctgagc tttggctcca 10920 ctccccactc agcacaaaca acttactttg ccccagtatg gggtacaaca gctcagactc 10980 ttctagaggt ctaatcctgg acacctcgtt tgctttataa gcacaatctg gaaagaagag 11040 tttcattgct cagagcccct caggaagcag aagaggagag tggtgaagag agcattcatc 11100 ctctggaatg accataactg gtgtttcaat cccagctccc ctccatacta atacttgggt 11160 gagttactca ccaggtctat gcttcagttt cttcatctgt aaaatggagg ttgtaaaaat 11220 atcatctacc ccatagggtt atggtgatga ttaaattagt tcttctatag aaagtgcctg 11280 cagcagtggt tagcatgtgg taggcacttt gtatgtgtta tctgttatgt ctgtttgctc 11340 ttactaacat ctatatttct gagtcctaga cctccccaga gagtgtgaag ttcatggtgt 11400 ttcatgggaa cagatgtaag cccacttgct gaatctctct ctgagctaat aattaacaaa 11460 tacattgcac agtagcttac caggaaagcc tatactggtc tgaacaagaa gaaacttgct 11520 gaacaattct aaagctcact tctcaatata acagcagccc ttgctcaaca tgttgcccat 11580 atcttcagta ccgtgcagag gtcacagcca tcatattctg ccagctcttc ccctatgggt 11640 tgagcaacca tatgtgtctt cccaaccagg acatttttca tttttagctt cttgttttga 11700 cataatttca ggtttacaga aaatcttcaa gagtagtaca aataccccca tgtaccctgt 11760 acacatattc ctgaaatgtt aatatttttc atatttgctt tatcatttcc tctatcagtc 11820 tatctataat acctacctat ctacctatcc atccatctaa aaatgtccca ggtaatcagc 11880 aaacctgctt taaatgtcac caattatccc aagaacatcc tttttagcac aaaaaacccc 11940 gaatcatgta ttgtattcag ttgccatgta cgtttagtgt tctttaactt agaacagttc 12000 cttggtcttt ctttgtatct tatgacatca acatttttaa atagcatagg ttagatattt 12060 tgtggagttt ctctcacttt gggtttgtgt gatgtttcct tctgaataga ttaaggttat 12120 gtgcttttga gagttataca ccaggaatga tgctatgttc ctcttagtat atagtatcag 12180 cagacacagt atatcaattt gtcccattac tagtgatgtt attgtcagat ttctccactg 12240 taaagatact atttttcctt ttgcaactga caagtatttt aagagtacat agccatcctg 12300 atactcctta aactttcact cacagcactt accatacagt gtagattcct gtctgaatca 12360 atgctataaa ggtttccaaa tgatgatttt ctaatttcat tatttcttct atacttatta 12420 gcagtctctc tactttaagg aagaaatttc ccttctctcc catttttaaa tttacatcat 12480 aggttcttct tttattctgt gggttataat ttgttgccat agttatttct ttttatgcct 12540 agattgctga ctggggtcag caagagccct acaatttggt gcgtgtttct gttgacatgt 12600 ttctcagcat ttttgggcat gtcctcactt gccagcacaa catgatgttc caggcttatc 12660 ttgtcctttt cccagcccca ggccaggaat cagccatctc caatgagcca agtaaaacca 12720 tggcatattt aagagaaagg gccacaggca taatcatggc gggtataaac tgaaactgac 12780 ctagaaatgc tgggtcatat tcccaatcta ccactagatg tccttccaca cctcaatagt 12840 tcttcacagg aagcagtcct ggggcatttg gaaatggtgg gatatttgga gttatcacaa 12900 agactggggc agcaggggtt acttctggca tttagtaagc acagcccagg catgccaaat 12960 ttcctgcaca ggaccatcta tcctaacaca gaattgcccc ataagtagca atcctgttaa 13020 taaatagtgg cccaatccct gaactaatct atcttgtgtt ctagtctctc aaggattggc 13080 ttagttcttt tcaccttatc cgccatcagt taatttaatc accactgttt ccatagtgag 13140 aatctaatat attagactga tcaagtgtgt taatcaaata tattggatta gctggcatgc 13200 attatagcaa ataaaatagc cagtcttcat tttagatcta gtttaaagaa agcctctact 13260 tcttatgtgt caatttttgc agaaaacatt attctagcaa gttggcaagg agtctaggac 13320 ttatgttaag acacaccatc tcatccccag ttcttgcagc tctctgtcta gttattggcc 13380 ctattcattg catcagcacc aacaacagct acccaggttt tatagggcaa gcattttact 13440 aaacatttta cataaactat ctcatttaac cttcacagta gccctataaa tcaggcattc 13500 ttattacaat tttacaaaga gccctggatt ccgtgtggtc agtagcaagc ccaagatagc 13560 acagctgtca tgtagcagag ccaacattca aaatcccaca gtcgggctcc agtagccatg 13620 ctgtgtactg cccatgcatg taagaacata cccaacacaa tgaaaaataa gaaatgaaat 13680 agaaagggca tggaaaatat caaatcataa ctgcagagga aaaaagtcaa atttaagctt 13740 agagttactg caaagttact gcaacccatc atattttatt ttgtgcttcc tagttagtgg 13800 ctaaaactaa gggcaaaact gactaaatat aatttgttgt aatcttgagg gaaatgcaca 13860 gcaagatgtt tcttgatcaa gaaaactgat actacggagc tttatattca gtactttgat 13920 gaaacagcac taaaatgtcc tcaataacat ctctacaaag aatcagtgat tcttagacct 13980 ctaagaggag ccagtgtgat gcctaaacat aggcatgtag gctacttgac agacagactc 14040 agcatagcag tcatcatcac gtagtaattt ctagcatcct agtagctttc tcactggctt 14100 tagttttgaa taaatgggat ttttgctaag atcttacatt atgcaacaga ggcaaccaca 14160 aagaccaccc ctagaaaatg aaatgatctt gggccccttc ctcccttacc tcctgcttca 14220 cactgcattc tttgggaagc ggatgctgaa acagagtcag gtatacaaaa atctggggag 14280 aagtcactcc tgtgaaagca aagggaagaa gtaagattgg gctggaggac ccatcagagc 14340 ctgacattaa cctgacagtc tctggcagct caggaatcct ttaggatttc catgttgggt 14400 ataaatgatt agactcttct actataactt agtcattggt agaggttgta ccaagaatag 14460 catgatccca gctaaaaagc tgaggcaaac cctgaggaat ctaacagctg gaggatgtca 14520 gcaaaccata tacctcacag ctggacagca aggtctttct tgaaggggga tctgagcagc 14580 atatctctat gtctgcctca tttccctatg tacaagcgtg tacctgattg cagcagaatg 14640 agatgagaaa caaatatttt tttgttacaa tttaccactt ccatctcagc ctgctacccc 14700 ttagctctcc ttgggcaaag ggaaaaagac atttgaagag cctgcctctt ggataagtga 14760 aaatggaact ctcctctcct tctcttggat ttctaaacat cccagatcat ttctgtgaat 14820 tctttttatt aggaaaatag catcctttaa aagagaaaac aagttgtcta tgtcttatat 14880 tcagagtcag tttgagcccc atgttgtgca atgatcttgt gcaatgataa ttacatgcta 14940 ccatgcctca agaaatttcc ccttaagtgg agtgaggagg agaaatagtg gaggctcaat 15000 gtcttgtttt aagaaaacac ctgttattgc tgaacctgat gcttgtgctt atgagcacag 15060 gagttttttg tggcccagca ataaccaaca actcaggtag gccagttgcc tcatttaatg 15120 agcttcttgg tttctgaata caacagaggc aaagagagta agttttacga ggacttgggt 15180 ttccttaatt agacacaagc tttttatttg gttgggggaa ctaatggaga aagggagaca 15240 ctagcggcat ttgtaacttg ttaagactaa ttgaaaatct taggaccaaa gctttctgtg 15300 aagagagtgc tctaatgaga ataaatgtga tgattattta cctaattgag cagtaatgac 15360 tgaggtgtga gccacttccc caggattaat aaagagccgg ggagttgaca gtttagacca 15420 ttaggcttag ctggtacttc atcttggcga aggacacagt gccagaatca tattaatatt 15480 gtaaaatgag cccaaaacat agacatatac ttttggagaa ataattttaa ttggctaagt 15540 acctgacatc aggttgggcc attcagtttt atcattaaac aaagtttcac acaagttctt 15600 caagacttgt gccatttaca gtgttctcag cattcagtgt ttaaaaaaga aaagtagaag 15660 agggaccttt atcaatatca aaaatagttt tttgtgcaac caaaagcaag caagctatta 15720 ttatatatac acactcgctt taaaaacaac actaaagaca ttgagttgag ctggaagcat 15780 tgcatactct gagatacaca gttgatattg ttacccacag tgtcccttca ggaaagccag 15840 aggtcatctg caacaccaca attaaggata aaaggacctt atattatcag aaatttcaat 15900 gtcttcataa aaattgtgtt tatattcaat atctccctta tttagtgtga caaatgttca 15960 tgtacgagtc atctcaagaa aaagagttac tcagcttgct acgtattcat tattctatgg 16020 ctctgctatg caggggaaag tgcaaacagc aactgagaga aagcaggaat ctaagacatg 16080 ggactcaact tgccctttac acagggtgaa tcctacacta gtgacctttg tgttttaagg 16140 aagtttgcaa atatgtttaa ttggacaaca tttcttcctt tatctagcaa gcactgagta 16200 tcttgccagg cactatgaaa aaagataaaa ctataaacat gagcaaggca cagccactgc 16260 caatcagaag cttacaatct agcagagatc ttaaaatgca gggagctctt ttagaaatct 16320 gcttagggat caaaatttcc aatcacactt ttccttccag catctttatt ctgtaatcat 16380 tattttaatc ttcattgaac gagatgatta atgtggttcc atctgctgta tgaaatcacc 16440 catgctacag tcagccaatc aagcaacagc agtaataatg tactacttca tttaatggaa 16500 atttaccaag ctgttactat gtaatatcac agttttaggg cctggagagg tagagctgaa 16560 ctaaaaataa taatctctgt tatcccatag tatagtggaa taggaaagaa atacaaaaaa 16620 aaataatgtg ttcatgtatt ataggtacta taatagtagg gtaggaagat acacagaagt 16680 gggaataacc aagccaatct cagtactcag aaaaggtgtt ataaaggagg taaccttgaa 16740 ttaaaccttg aggaaatgga tattcttcag gtagaggtgt ataaagagct tcccacacca 16800 atggagcagc ataaagaaat ggcatggcag agtgaacagt tgggtatggc caaggaaact 16860 ctcaactgca tcttcttcac tgcctcaact gatcactcaa cgctctccat tctctcagca 16920 aacaccctga ctaactaaac tcccatgact agcaggatat tattagactt aacaaacctg 16980 tcaatttata tgctttccct ttagaaagac ttgacttttt tttagtgaac tgcaatagaa 17040 ctaagctcag gagatgcaac tatgaaagat gaaggaacat tataaaaatc tctgcaatga 17100 gattctgcct tagattgctt tgctggtatg tcaactgatt actccaattt aaagaaaccc 17160 aaactggaaa ttataaaaga taaattgtga gtgtatttta tgcaaaaaag aatcaaatca 17220 aatcaaagtc ttggctctac attaaacaaa cgacaaaggc atgtttgttt ttatcaaaat 17280 gttttagggt agatttgtat gtatgcgtta tttctttaac caatgtttta atcagttaaa 17340 cagctgctat tattaatgtg ctggttgaaa gtgtttttct taaagtacaa atttaaaata 17400 gaatgagaaa agatcagact tgagaagaag gaaagtcaca gtaggacatt tggaatttat 17460 tctctagacc agaggtctgc aaactccagc ctacaggcca aatccatcct gcagcttatt 17520 tttataaata aagttttatt ggattacagc caggcccatc cagttacaga attgtctatg 17580 gttgcttcca ctctacaatg gcagatttga gtagctgtta cagagactat acgcaagtgt 17640 gcaggagagt ttagaccaca cctacaggaa aggtatgaaa tactaccctc cttcctagac 17700 acttccccaa acaaaaaact taagtcagtg tgggaacaaa cactgttgcc ccacagagca 17760 ctaataaagg cagataaatg actgagaaaa ccctatccct tggggacgga ggccagaaat 17820 ggcaacacca ataccattgg aagtctccta cttctaggta aggacatgaa attctctcat 17880 atgcaacacc catcacagat acaaggcagg agtttgattt tcatggggag gaggaattgg 17940 aacactgaga ataccccacc cctaaggccc aggcacactg gcctatatgg gtctgtggct 18000 gaactgggac aaaagagaag ccctaaaacc accagtagca agcattgagt aacaagcagt 18060 agcagtatta cagcaaaaca ggcacagctg aaagcagaga gtggggcatt aaaacccttc 18120 agcgtctcag ctactatgct aatagaaaat ccaaagaaaa atctgaagcc cataggaggc 18180 tgaggatgac cctactaaca acaaaactca agtctagcta gactcctaag cagattgatt 18240 taatacccca ctctaacaac cttaaagaag tgtgcccatt tccatgcata aatactatgt 18300 atctcaatat ttgatatact ctacacaaaa tgtttgccat ttaatcaaaa tgcatgagac 18360 tcaaaaagaa aatgcaaccc actgttaaca gccaaagcaa tcaacagaac caaacagaga 18420 catgactcca atgttggagc tattagacac ggactttaaa taaaataatt acaatgaata 18480 agaaaaatac attaaaaata cttcatgaaa gaggatatat ggatggcaaa gaagcacctt 18540 taaaagtgtt caacagttta tacactattg atggaaatgt aaattagttc ttccactgtt 18600 ggaagcagtc tggagagttc tcaaaaaact taactaccat ttgaattagc aatcccatta 18660 ctgggcatat acccaaacag aagaaaactg ttctcccaaa aggacgcatg cactcatata 18720 ttcatcatag cactatgtat attcacaata ccaaagacat ggaatcaacc tgaatgccaa 18780 tcaatggatt ggattaaaaa atggaatact atgcagtcgt agaaaagaat gaaatcatgt 18840 ctttacagca acttggatgc atctggaggc cattatccta agtgaattaa tgcagaaaca 18900 gaaaaccaaa tgccacatgt tctcatttat aagtgggagt taaaccttgg atacacatgg 18960 acataaagat ggcaacagta gaggggaaaa ggaagaacta gagcaaggga tgaaaatcca 19020 gctattgggc attatgctca gtacctgtgt aatgggatca atcgtacccc aaatctcagc 19080 accacacaat atacccatgt aataagcctg cacatgtacc ccctgaatct aaattaaagt 19140 tgaaatcatt tctaaaaaaa gaaaagaaaa atgaacaaat tgaaaataaa aagatgttca 19200 acatgattag tcattagaga aatgaaaaat aaagccatga tgaaatatca ctacatatct 19260 agtagaacaa ctaaaagaaa acacactgac agtcctgagt gctagaaagt gtgtgcaacc 19320 acagtctctc tcatacattg ttggtgggag tacacagtgg tgcagcaaca ttggaaaact 19380 gctgggcagt tttttatgaa gttaaacata tatttactta ctctgtggcc caacaattcc 19440 acttctgagt atttgtccta gagaaatgaa aatttatatt cacacaaaaa cctgtacatg 19500 aatgtttata tcagccttgt ttgaaataac aaaaaactga aaataaccca aacatatttc 19560 agtgagtgaa taaacatatt gtaatacatt tatacaattt aaaactattc ggcaataaga 19620 acaaacaaat gatacacaca ccttagaaga atttcaaagg cattatgatg aattattttt 19680 ttttttttga gatggagtct cactctgttt cccaggctgg agtgcagtgg cgcaacctca 19740 gctcactgca agctccgcct cctgggttca cgccattctc ctgcctcagc ctcccgagta 19800 gctgggatta caggcgccag ccaccacgcc cggctaattt ttttgtattt ttagtagaga 19860 cggggtttca ctgtgttagc caggatggtc tcgatctccc gacctcgtga tccacccgcc 19920 tcggcctccc aaagtgctgg gattacaggt gtgagccacc gtgcccggcc tatgatgaat 19980 tttttaaagc taatttttaa aggttgcata ttttgtaatt ccatttacgt aagattctta 20040 aaatcacaaa actataatga taaagaacac attagtgttt gctaggaaat gggtgggtag 20100 ggagtgtggc tataaaggga tagcacaagg gaatttctcg acagttgtag aactgttctc 20160 tatcccgact gtggtgttag tgacatgacc ttatatgtat gtgagattaa atttcattga 20220 tatatgacat gcttgtaaaa attggtgatg tgcaaataat tctatagttt agttaacagt 20280 attataccaa tgtcaatttc ctggttttca tcattatact gatattgacc aggtagagcg 20340 tacatgggaa acttctgtct tatttttgca actttaatat gggtcttaaa tgatttcaaa 20400 ataaacactt taaaacattc tccctactaa ataaccatga ttaataggtt aaagtttcca 20460 ggggaaaaaa gtggacaaca tagatgaaca gttgagtgat ttcacagaaa gataaaaact 20520 ataagcaaga ttcaagtaga aatgtgtggg ggaaataaat cacaatagta attcacagat 20580 ttaattctag gaatcgtaga ctttacacag ccagaggaag aattaggtaa tctgaagata 20640 gatccataaa aattgcccaa agtgaaaatc agtaagaaaa ggacaaagaa agtggatgag 20700 gagaacaaag tatttaaaaa tgatgggaca atatcaaata gtctaaaata tatgtcattg 20760 aagttacaga aggagaagag agaatgggca aaagaaatct ctgaatgata gctggaattc 20820 tccaaaaata atgaaagcat caaatcatag atccaaaatt cttaaataac ctgaagcaga 20880 ataaatttta aaaagctagc tataacttat ccaaagtacc aaataaaggt aaagaagaaa 20940 ttgaaggaag acagtggaaa atatatgaac atattaaatc agagaaattc ttaaagaata 21000 caaaattaca gctagataga actagaataa gttctagtgt tccatattac tgtagaatta 21060 ctatagttaa caataatata tggtttcaca taactaaaag aatattgcat gatcctcaca 21120 aaaaaatgat aaatgctaga gatgatagat atgccagtta tactctgata actatatgta 21180 ctgagacatc accatgtagc cccatgaata tgtacactta ttttgtcatt ttaaaaatta 21240 aattaatata aagaggtaaa gacaagaatt atagctgact tcttatctga agcaattaaa 21300 gccagatgat aaaacatatc ttcaaagcca gctgggggga caactatcac ccagaattct 21360 acatctagca aaaatacctg tttaaaatga agatacaata aggactattc aaaatttttg 21420 taatgggaga attccttacc agcagacctg tactttaaga aacattaaag aaagttcttc 21480 tgacagagga atgtgaaacc agaccggaaa ttttatctac agagagatgt gaagaactct 21540 gaaaatagta aaaataaaga ttaatattaa aagccacatt tttcttaatg ttaaatgact 21600 ctaaaatgta attgactact tgaagaaaaa ttgtagcagt gagatttata acccatgtaa 21660 aatttaaatg tctgataaca atagcacaaa gtttatgagg aatttgaatg tctaagtctt 21720 cacaatatgt aagaatttgt ataatattat ataaaacatc taatactcag tctttacttg 21780 ctgcagggaa gatcaatttg gcaggtccag cactggaatt accatttaga ttagttagga 21840 aactgcggaa gttcaagaaa gaaatcatca gtacctagag tatgccaaat aatagtaaga 21900 atacagagag gattcaaatt tgagatctac ttaataaggt aaaataagga ggatgcggtg 21960 actgagtatt gagatgttct gaatgtgagg tagagggaag agtctactat gtattatggg 22020 ttcctggctt gggtgtccct agcagacagt ggtgctatca agtgagtctg aggagagagg 22080 aggataggat cattaatatg aaaagttaat gagtttggat tttaactggg gtttcaggca 22140 atttacatgt aatgttatta ttgatgtgtt tggattgaaa tctaccactg gtttcttgct 22200 tttatttgtt ccatctatat ttttcttcct tttttccttc tatttcagcc tggattaatt 22260 gagcttttta tgatttcatt ttgtctccac tattggctta ttaattatgc ctctttttct 22320 atttctttta atgttgtcct aggcttcaca atgtacatcc tctctacatt cctacagtta 22380 tttaacatac gtttcttcct tgaacttctg catagtttcc taattaaatg gtaattccag 22440 tattggacct aacaaattga tcctcaccac agcaactaaa gaaatctatt tataatacat 22500 gtttggagac ataaacattc aacaactctc acagtataaa aaaatacatc ctcttttaat 22560 tggcatgtga gacccagaag tctggattct tcttgtttct gcagacccat ttttgccact 22620 tcctagctcc tatttaggct tcagcaataa caaacagatg cttaatatac acaagccaag 22680 tagtttctca tctccataac tttgttcatg ctgttatatg tgcctagaat caatattctg 22740 cattcctttc tcacctgacc aatcctcact gaaaagctca gctattgccc cattcttgac 22800 ttcttccttg tccacccgct tttgtgctcc aactggaacc ccattcatgt ttacaagaaa 22860 cactcaaagg acaataaagc ctgttgtgac tctacttcgg cttttctgag tattaaaatt 22920 tcctaagatc tttcacagga caaattttta aaagcaagag taatacatgg aggtgattaa 22980 gcctttaaag tgtacccttt gttcccaagg tcttgttaat tatcatttag gagcagttta 23040 tctgcaatgt gctcaattac ttaggtaact aaatagcttt ttactgatca gcattgaaca 23100 tcatttgctt aatagcaact aacaaatgcg gtggcagaat tccactgata gtctactttc 23160 agaaataggc ttatttaaga ttgagctcca ggggaaaaat agattctaac agaatagatt 23220 attgttattt acataaccac ttaggtctag agaaacaaaa taatctttcc gttttttaaa 23280 attaaggaat cagtaagcca aaagagaata tccaagtaac tcccaagtcc attccgttca 23340 ttcatccagt ccatttgtgc catgaaaatc ttcatgacat tcctatttga tcaatcacaa 23400 ctcacagctc tcaatgactg ctcacatctg accttctcag taaggacttt tcttatagct 23460 tagaacagtc ataggatttt tcctctccaa gcttttgaca ctttggatta tagatcccat 23520 gtgcttgcca atgctttttt tgttaactgt agaaaaataa aaagcaaata cagacaggcg 23580 aaagactcag agggtcacat aacattgtat ggtgaactat accatgtgaa tggtcaagga 23640 aagcttctgg agcatgggac atattagcta ggtgttgaaa gaaaaatagg aattcaatag 23700 gctggaaaat ggggggaggg tatttcaagc agagggaaca cctatctaga tgcacaaatg 23760 tatgatcaat atggtgttca acattgaaat gccacatggg gacctgacaa gaggtagttg 23820 tattagtttg ttttgtgctg ctgtgatgga atgccacaga ctgtataatt tataaacaga 23880 aatttattag gacacagttc tggaggctgg gaagtctaag gtccaggtgc cagaaagttc 23940 agtgtctggt taggtcattc tcttccaaga tggtgccttg catgctgcct agatcctcac 24000 gtggcagaag gccaaaggga gaaagaggat gagcccattc actttttata atggcattaa 24060 tctattcatg agggctcaac ctaaatgctt cccattaggc cccactgtca cattgggaat 24120 taagtttcca acacaccaat tcttgggcac acattcaaac tgtagcagta ggcaaagcca 24180 aatagtggaa ggcttttatt ctaagctgtg ggactcagct ttattctgtt aacagtgaag 24240 atgcagaaag ggcgagatgc agtggctcat acctgtaatc ctagcacttt gagaggttga 24300 agtgagtgga tcacttgagc ccgggagttc aagaccagcc tgggcaacat agtgagatcc 24360 cgtctctatg aaaattttta aaaagtaaaa gttagctagg tgtggtgtca cgtactgttc 24420 ccaactactc aggaggctga ggcaagagga tcacttgatc ctgggaagtt gaggctgcaa 24480 taagccatga tcacaccact gcactccagc ctgagtgaca gcaataccct gtaccacttc 24540 cccaccaaaa aagatgcaca aaagggagat ttatctccct agttttctaa aggagcaaaa 24600 gcaacttctg tgggtggaat agccctataa gtagaagggg ccaaaagata aaaagggcaa 24660 ccaaagaagg gaatgagggg atgagaagaa gacagggact catatctgca cattagtcta 24720 gggaataaag aagaaaagac acaacatcaa tctaaaaaga aataaatgaa aacaataaaa 24780 ggcagtgttg aaggcagtcg agcactgact tctatagtat gggttaaagc ccagcttcac 24840 ctctaacttt ctctgaaatc ttaaaatgtt ctaacctttc ttattttgtt catctataaa 24900 atggagattt tatctcagtt tgttgtgaga ttaaacaagt taatgattct aactacttag 24960 aaccttgcca aggatataat aactgcttaa taacccctca caatcatgtt ctgtgttcta 25020 gagaagtcag gttaagggta gtaattctct tttaaaccat gaagtctacc tagagttatg 25080 taggatgtca ccattggggg atgctttgcg gtaggcacat gaaacctttc tgtaccattt 25140 attgtaacat cttgtgagtc tctaattatt tcaaaataaa agttttattt tgttttgttt 25200 ttcttaaagc cttttcaaac cacaatggca attcattcaa gcatgttctc agcacttgct 25260 gcatgccata ccctgagctc cttctgttct aacattagta aacctcattt tccaatattc 25320 agaaagcaat taaccaaatg acagtgtgac tttccatttt tactattgct ctttagcaga 25380 aacatagcaa taaaaataaa ctattggaaa tgaaattatg agtatcctag attaatcccc 25440 aaagttgcag tttcttttgt tgttcagctg tttgattttc taagagcctg aacccagcca 25500 agtgcatact ctatttctga gcagagttct gcccagttct ctgtctgact agaattgcac 25560 agaaaccaca aatctctcat aaagcctaat ggtgtttctc aacagaggca tgattggaat 25620 tctgagctgg ataatttaat actagggtac agcccatggg tagtacagaa aagagtcaat 25680 acttgccttg tctttgtaca accaggatgt atgtctgcat gacaataatg aagactcaat 25740 ttcagccccc attcaccctt ccacaacagc aggggcaggg caccctagag cataaataat 25800 ctgaacaacc ctgtgttggg ggcctgctga agatgcttaa catccctggc cccatccact 25860 aattgtctgc catcaatcac aacttgacag ttacaagtaa attgcctgtg ttctccccat 25920 atgcctgcct ttctcattgt gtaaaaacag ctctacctcc atctgctagt cactaccaat 25980 cactcttgcc aagatggtga ctcctcttct tgcctgctag tccctagaca caaagagtcc 26040 aaagtgccct ggtggcagcc atagctttta gttcaatggt acctttgcta tgttccctgg 26100 cagaagtaca cttcctttgg tgaccaggac ctccaagttg aagagcacag aggtgcagat 26160 gaagaagtgc aaagcccgtt agtgggtcaa tgggagtgat gttaacttag gccatttctt 26220 cctgtacccc ttgattctaa gacctatgta tacttcctgt tagggaccca acaccatgaa 26280 gtgggctctg atttaacaca tatgctgcac tttaaaggat gggaccctaa actttcagag 26340 cattaccttt aagtggcact tcatatgttc cttcagtagt tcattctagg gctctaaaag 26400 tacagctact tctgtctggt gaagtatgta atacaaacag taggttctag gatcaagagc 26460 tatcctacac ccccttcaca attaagtggg tcccctgatc acatactatg ttgtgggatt 26520 tccattcttg tttggtaatc taaaagcccc cagataacag ttagctgtgt tgactatgac 26580 tcagagatca ggaaaggaaa gcttataccc agaataagtg catcattgga aggatggaca 26640 gctggctgat gcaggacaga ggggaaccaa tgtagtcaac ttgccacaaa tcaaccagtc 26700 gaatctcctg aagacctagt aacctattga gggctccttg ttggtctctc ttgttagcaa 26760 gttggacatt caaaatcagc agtagctaga tttaccagga taattggtag tccattttat 26820 tggctaatga gtagtcttgc tctctgccac tgtggccact cgattcatgt gcccatcatg 26880 ccagtactta atccaaagac aaagcctgga taatgtcaac tggacaagtt atcttgtcta 26940 tttgtttttt cagtgcttct tgtgtacttg atgctttcca attagtgtta aacgcatgac 27000 acaaaaatct tcacacattg tgcccactcc catagtccca accacatgtc tctgtctcag 27060 actcttgttt ccaatctcca agtccctttc attcaggtcc ctgtccacac agctagacta 27120 ttggctactg tgcagaaacc tatacatata ttcacacctt aggccaattt ttcttccaca 27180 cgaatagata accatattca ttgcttgcag cttcattcat tgggaagacc ttccttctcc 27240 actgtcttcc aaggctaccc cataattcag ctgtacttca gtgatcatct atttttgctt 27300 tacagctact taaggaacta acccattgtc agccaggatt ggccttttac ctccctttca 27360 gctagtcata gagaaccccc atatagccat aagtgtgagc tatgcaaggg cactggtaca 27420 accctggtgg gtgacatgga ggcatctgtg ctacttgctc atgcagcctc ttcatgccag 27480 tctagtccca tatgggtttg atcccagatg tgccatttcc attttccaat agaaggctgt 27540 gggacacgtc tgagtgtatg acttagtgca ttggcaataa tctagctcat aatggtcagt 27600 tccaaataca tttggtgccc cattatcagc tgttccatct tgaccaaggc tcagcaacat 27660 tctaggaagg gtttctcaaa aggtgtataa ctttgtactg aaaatggatg gcattgcttc 27720 agagccctag gggcctgcat tctgattctt tcgcttgggc atccatcaac tccaaactgt 27780 atctttcccc actaacacat tcagcaccat ggggtccacc agatcatatg cctcaagtag 27840 tagggttgct tatactgcag cccatacatg ctgcagagcc ctttcttgct ttcttgctcc 27900 aggcccactc aaagctgtga gacttctatg tagttcagta tatgggacca aaaatattcc 27960 tagatgtgga atgtgttgcc tccaaaacac aaagaggcct accaggtatc ttgctctatt 28020 tattgagatt gagaatgtaa gatacagcaa tttaactttt acttgaaaat gcagtggtgg 28080 gagtggtatt ctagcagact ttcactactg aaccactaaa aactttaccg atgtggcatg 28140 ttcctgaatt ttcacagggt ttgtctctca ccctccagag tgtatgtgtc ctaccaatgc 28200 ctctaatgta ttagacactt cttgttgact cttaatgaca tctttgatgt aaatggatca 28260 atgtgatatt ctacagaatg ttcagatggt ccatgtctct tcagacctta ttatgacaga 28320 tgtttgaaga ggtaacatag ccatgggcaa agcagaaaac gaatattatt gtctgtttca 28380 tgtgaataca gactctgatt ttttggatgt gtctttgtct ggttttggta tcaggataat 28440 attggcctcg tagaatgagt ttggaagtat tccctcctcc tctatttttc agaatagttt 28500 gagtaagatg atattagttc ttcattaaat gtttggtata attcagcaga gaagccatca 28560 gttcctgaac ttttctttat tggaagacat tttattataa gttcttgtta tttgttattg 28620 gtcatagttc aatcttggta cattgtatgc atctaggaat ttgttccttt cttctgtaat 28680 ttccaattta tttacaattt atttatttga gtcttctctc ttctttatta gtctggctaa 28740 aggtttgtca attttgcatg acatttcaaa aatccaactt tttgtttcat tgatattttg 28800 tattgttttc ttcatctcaa tttcatttat ttctgctctg atatttatta tttattttct 28860 gctactaatt ttgagtttgt tatgctcttc cttttctagt tctttaagat gcatcattaa 28920 gttgtttatt taaagtttat cttctttttc aatgaaggta ctaatagcca taaacttccc 28980 tcttagtgat tttgctgtat cccatagatt ttggtatgtt gtgtttctat tatcatttgt 29040 ttcaagaaac ttttaaattt tcttcttaat ttcttcattg acccaccagt cattcaggag 29100 catatggttt gatttccatg tatttgtata gtttccaaaa ttcctcttgt tattgatttc 29160 tagttttatt ccattatggt cagagatgat gcttcatatt atattatttt attttgtttt 29220 aatgttttca ggctttttag tgatttaaca tatagtctac tcttgagaat gacccatgtg 29280 ctgtggaaaa taatgtgtat tctacagctg ttgtttggtc tatagcgcag attaactctc 29340 gtgtttcttt accaattttc tgtctggaag atctgtccaa tggtgaaatt gtggtgttga 29400 agtctccagc tattattgta tggggtctat atctctcttt agctctaaca atatttaatt 29460 tatatgtctg ggtgttccag tgttgggtgc atatatattt acaattgtta tattctcttg 29520 ctgaattgac ccctttttca ctatatagta accttcttta tctcttccta tagtttttgt 29580 cttgaaatct attttgcctg atataagcat aactagccct gctcttttgt ggtttccatt 29640 gacatggaat atcttttccc atccctttat tttccgccta catatgcctt atgtctttat 29700 tggtgaagtg tgtttcttgt aagcaacaga tcattgaatc ccttttgttt tttcaatccg 29760 ttcagccact tggtgacttt tgattggcaa gtctcagagt ctcatccaaa gtcttcaatg 29820 tacctgggta ttgctgctgg ttattctgag cccagggact ctttagttag caggtgatga 29880 atgttgccag gactatgtcc ttcccttcaa ggcagtagtt tcccttctgg cctagggcat 29940 gtctagaaat gccatccagg agctagagct tggaaaggcg gcctctcaga gctgactagt 30000 gccctctcct gttgtgactg tgctggtatc caagatgtaa gacaaaatcc ttcctactcc 30060 ttccttctcc ttcttctcct ttccttaagt ggaagaaaga gacctctttt ggagctgtga 30120 gaattgcagc ctggggttag gggaggggta gtgccagaac tcccttagcc acccaagctg 30180 gtatctcagt agtccatgtg cctccccagt gtactggctc tgggcccagt tcagaactag 30240 aacttgcttg aaagttgcac tccttgtggc ctagactgac tttcaagtgt atttagagcc 30300 ctagagcact ttagcttgca gtggtaaggc ttgtgggaac tcaagttctg accaccagga 30360 ttggtgattt ccttttggct agagctaata taaatgctgt ctccatgggg tggggcatca 30420 gctgagtttg gcccagtttt cttttatgct ataataggac agcactaagt tcaatgcctc 30480 acaattgctg tgcttttctc ccctggcacc taggaatgct ctccacaccc tgctgccatt 30540 ggtgggggat gggagagggg tggcgtcaga gatttaaaac tgtttttttt ttttttctac 30600 ttcttcagtg cctctttcag caatatgaag ttaaaaccaa gcactatgag agctcacctg 30660 atttttggtg cttacaaagc tacttttttt gtgtgtagat agttgctaaa ttagtgtcct 30720 tgctgaggga ggaagaggga acgatcagtg gaaccttcta ttctgcaacc ttgcctgcag 30780 cactcttttg agaaagattc tggattacgt gataaattag tgatgtctgt catggagggg 30840 tgaggggcag tttttagaca tatagcctat cttgccattt ctgctataaa catctgcaca 30900 gcttgtacaa tctgtaacta tagaattgag tacagatgac ctgcccacaa gaggaaaaat 30960 gtcctgatct tggccttagt gcctctgtaa ttcaaccaag tatattaatt aaatggatag 31020 atcatacact tgctgtttcc caagtgtaga ggttgaaagt ggaaaggaga agaaagcaaa 31080 gaaaactggg aggaggggca ctaagactgg gcataaggag aaacaagagg tccaatttgc 31140 aaaataatgg gtgtagtaag gggaattttg aagtattctc caaagataac gattttgctt 31200 ttctcaattt tgtcctcttg attctcacac agtgctttct ttagtacaga cctacatacc 31260 ccgaaaactt ctgttctgtg acttaaaaag tcaactctat gattagcatg attcctcttc 31320 agtcattact gaaattcttc ctaggtggtt acatttaagt ggtaagaagc ttcagtaata 31380 taagtcaaag aactcctacc ttgctttgca tttcctcagt ggccatctga taaagcagga 31440 aggaaaaaaa ttaaaaatga acctccccag gatttcattt ctattgtggc ttagctgcaa 31500 atttgaaaaa taaaaataaa aataaaccct gaatgtaagc acttgtacgt ttttgttaga 31560 ttctttcaca ggactggtca acatcttgac agatattaat tggcgattca ctggagactt 31620 cacggcacct gacctggttt gccgagtggt ccgctatttg caggtatgtc acaccttcca 31680 aatgtgatga gacaaactga taccagagtt agcttttaga tttatctaag gaaaatcata 31740 taaaaccttg cattcctatg catcaaactg cccgctttct cctgggtaga agggcaatga 31800 aaatttgatt tttaatgtat ttcctttgct aaaaatagta tctatataaa gaaaacacaa 31860 acgagccaca aatgagcaat gctaaggaca taaagcattc atatttcaaa tgttaaataa 31920 aatgtctggg tcaatattaa ggattttggc atattgtgga taatctccaa aaagtttgtt 31980 aattatattt acctttcact tctcaaatga actcaacgct ggctactgct cttttttgta 32040 aaccaagggg aatttgttgg aacataacca ttaactattg aattactgcc taaattatac 32100 tttttaaagt atctattggc atttgaattt cttcctctca aatttcctat tttccttttt 32160 gaatgatttt ataactgaga gactttttag tttttctaag atctattttt agattaaaga 32220 tattgatgct tcaaatgtca atctgcttca ttgtaagcca tatttatgta tcatatgtat 32280 atttgattta aaatattaca tatatacata tttacatata tacatacttg ttaatatgca 32340 ttagatgttt ataatataga tttagacact tcaactaagt ctggaaggaa tggattattt 32400 cataactggt attaggtttg atgtgctgtt tctgagttct taagattatt ttttattaat 32460 atatttttat tctgatgcta gtacttcagg tctaaattat tatagcttta tgtatatata 32520 atgcatttct agaaagcttt atcctgctag attccatttg ttagtagact cttttaggat 32580 ctttgtatat atattcataa gtaaaatttt aatttttttc attggtttta ttattttcag 32640 gtcatggtaa tgaagttatt ccatattcag aaaatgaata tggaatagtt acaatcttct 32700 tttgtgctct gaatataacc ttgaaagttt ggtatgtctg aaagagcctt ttctattatg 32760 tacggctagt attttctcag gggaaatttt taaaaacata tttcaatttc tttctgagga 32820 tatttgcttc cttgtaaata aatgctttca attgcttatt atattagcaa tcaattgctg 32880 atacacaaat tatgacaaaa catggtggct taaaacaata aacatttatt atctcacagt 32940 ttctattagt caagaattca ggaacagctt ggctaggcag atctggataa aggcttatca 33000 aaaggttcgg tcagatgctt tgtggtactg tagtcatcag aacgcttggc tgggactgga 33060 caagatggat cactcacata ggtggtaaat tagtactggc tttagtggaa tactcagttc 33120 tccacatggg cctctctata ggtacatttt agtgtcctca caacatagta gctggctttt 33180 ccaagaataa cctattcaag tgactgaggt ggaagtggca acatatttat gaactagtct 33240 caaaggtcat acaccatcac tttcatatga ttattttggt tgtacaaatc aacttggatt 33300 cagtatggga aaagaagaac cacaaaacta ggaagtaagg attattttcg acatgttgga 33360 ggttggcaac cacactatct tcatattttt ccaaagcatt tgataaccta tggtttctcc 33420 caattgttaa ctttaaaatg tcttcttgat ttagaaatat tcatgtcagt aaaatttttt 33480 ctaactgtat ctacaataaa tgttaagact atatataaaa tatatctttt gacataggga 33540 aaacgataga gaaagaaatt ctgataattc tctcttctat aaaggaagca agaaaattgg 33600 caaaaaatat cagaatcaaa tttgtaaaac tctggaaatt aaccaaacac ttgcaattac 33660 tcagggagca tttattcagg aaaatggctg aatctcagtg agaaaaatga gctttgcggt 33720 gctttggctt gcattattct cagcccccag tatccaactc tgtaacagcc ttaaaaagta 33780 atagctctca ttcatagtga aaacaaattg tctggcagcc actgtagaaa gcaaaacagg 33840 gacagagccc tttcaaattc ccaagaaatt gccattattt gacatgtctg gcagttctct 33900 ggaagactcc acttgcaagg ctgtctttat tttacttaaa tcagaactca cccactgtga 33960 aaaacgtttc tcctctgggc attcgtcaaa acagttacag gcaattgatt aactttgctt 34020 atgacaaagg tattggataa tagtcaggga aaacaacaga ctaaccaaag cttaagaaca 34080 tacgctgagt aatgagatat ccatagggga tttgaaaatc tctgacatac tcccaaaaat 34140 ctagaagacc aggtatatgc ccaggactat gctcatccta aggaaaaaat agagaaggca 34200 ctgagctgta acctgtgaat gatcttgagg ctttgtgcaa gcaggaagtg agggcaaaga 34260 cagaattgta agttgcctgg ctaagtgtca aaatcatgct ccaacattca cacagacttc 34320 ctctgcaatg aatgggggaa ttaatagttt ctagaatgta agaaaatctc tgtttaggac 34380 ctatcaccaa gatcatggag taggagatat tcatccctcc aaagcattca agtatagaca 34440 gctattcaca aactaaaata gcccagagag gactcaaggg cccattaaag aatttgcagc 34500 aacatcgtga aggaaaaaat ggagaataac cacatagaaa gaattgctgg tgtgattggc 34560 acacctaaga ggccatgatt tggctaggaa caaagaagaa aggtggaagc tatcagtatt 34620 agacacagaa aggaccaaca ttgtctctag tggcctgctc cacaggagac actagcatct 34680 tttcccactg agtaaccaac agtcattcct gcaagagaac cccagagggg gagatgtggc 34740 tataccttcc tcctatcccc caagaagcag ttgctgtcga gctgctttgg gaatggggtc 34800 accacctctc ccaaccatgt gtaagctcca gccctggagc catggccacc ctgggaatgc 34860 ccacactcca gactgatagt ctgactacac tgggctcacc catgttttta acatcacagc 34920 cagcaccata gtaagctagt taacactcca agccccagtg ttaaactctg cctgcatgtg 34980 tccacactcc agacactgac ttaaccacca tagagagcta gccccatcca ggcctcagag 35040 ccattataat tctgtgcata cctgtgctct cattcttgtc tccttgacta atttatacgt 35100 atactattac caacattaca gcaggggcac ctgtgccctg ggcaacagct cagccataga 35160 aagctacgcc ttgccccaac cctgaagcca ctgaaagact gtgttctcag ctcccacact 35220 actttgcatg tgcactcatg cctcacatac tataccatgc agcagaaggg gcatctgcac 35280 cttgagcacc aatgtcatta ccattctaat cccagagcca taatctctcc atgtgagccc 35340 atgcatcaga cctcagtttc atggctactc catgagtgtc acccatcaga cactggtgat 35400 actgccacta agagaggccc tacaagccag atctagtacc aagagaaatc ttctcagctc 35460 cagcttccct ggtgggggga aagatcagaa gaaccttagc agccatcacc actgaagacc 35520 ctatcaattc ttgctgctac tgccaatatc cactgctttg gccactgagg atccttatga 35580 tctttatcaa ctctgacctg agctgaaaaa gctacacaga gactacaaat ctgcaccatc 35640 actgatgcta ccccacccaa caaaccctcc ctcatagggc atggtctttc catagtgaac 35700 tagttcataa aatctggaag gtgattcttt ttggttttgt tgatgtttat ctttccctta 35760 tattgatgtg tgtgcatttg actgctttac caaacgcaca cacatcaaca taaggcaaaa 35820 ataaacataa aaaaacagac ataacatcat caaaagaaca cagtaatttt acagtaactg 35880 gccccaatga aatagagata tatgcaatgc ttgaccaaaa aaatcaaaat aattttttta 35940 ggaaagctta gtgaacttaa agtacagaga agcaattcaa tgaaatcagt aaaacagtac 36000 aaccaaaaca aagaattaaa gagagagact gaaattattt tttaattaaa tagaaattct 36060 ggagctaaaa aacattataa atgaaataat aaatgcacta gacagcatcc agcagaaatt 36120 atcaagtaga caaagaattt gtgaagtgaa aaacaggtta tttgaaaata tacaactaaa 36180 gaaaaagaaa gaaaaaagaa tgagaaaaga tgaagaaagc ttaagagatt tatgaggcag 36240 catcaaaaga gaaaatgtgc aatgcattag tccattctca tactgctata agaatgtatt 36300 caagactggg taatttataa gggaaagagc tttagttgac tcacagttct acagggttgg 36360 ggaggcctca ggaaacttat aatcatggtg gaagggaaag caaacatgtc cttcacaagg 36420 tggcaggaga gagaagaatg agaactgagc aaaaggggaa gccccttata aaaccatcag 36480 atctcatgag aacttactat catgagaata ccatggggga aaccacctcc atgatttaat 36540 tacctcccac tgaattcctc ccatgacatg tagggattat ggcaactaaa attcaagatg 36600 agatttgggt aggaacatag ccaaactata ttatacaagt tataggagtt atagaaggag 36660 atgagagaga caaaaaaaat atagattatt taaagaaata atagcagaat agtttgcaaa 36720 tctggggaaa gatacaaata tccaggtgta caagaaggtc agaagtttct aatcagattt 36780 aatgaaaata agactacacc aagacatatt ataatcaaac tgtcaaaaat caaaaacaga 36840 gaaaatcctg ataacagcaa gagagaagag gcaaatcaca tataagagag ttataacaag 36900 gctagcagaa aatttctcag caaaaacctt gcagaacagg agagactaga agaacatatg 36960 taaggaagga aaaacaaact gccaaccaaa aatatttacc caacaaagct gtcctttagg 37020 aatcaagtag agagaaagat ttccccagac aaacaaaagc tgaaagagtt catcaccacc 37080 aaacctattt tccaaaaatt ctacacagaa tcttcaagct aaaggaaaaa aaaaagagcg 37140 agctaattag tgacatgaaa atatataaaa gtgattttgg gctgagacaa tggggttttc 37200 tagatataca atcatgtcat ctgcaaacag ggacaatttg acttcctctt ttcctaattg 37260 aatacccttc atttccttct cctgcctaat ggccctggcc agaacttcca acactctgtt 37320 gaataggagt ggtgagagag ggcatccctg tcttgtgcca gttttcaaag ggaatgcttc 37380 cagtttttgc ccattcagta tgatattggc tgtgggtttg tcatagatag ctcttattat 37440 tttgagatac atcccatcaa taccgaattt attgagagtt tttagcatga agggttgttg 37500 aattttgtca aaggcctttt ctgcatctat tgagataatc atgtggtttt tgtctttggt 37560 tctgtttata tgctggatta catttattga tttgcatata ttgaaccagc cttgcatgcc 37620 agggatgaag cccacttgat catggtggat aagctttttg atgtgctgct ggattcggtt 37680 tgccagtatt ttattgagga tttttccatc aatgttcatc aaggatattg gtctaaaatt 37740 ctcttttttt tgttgtgtct ctgccaggct ttggtatcag gatgatgctg gcctcataaa 37800 atgagttagg gaggattccc tctttttcta ttgattggaa tagtttcaga aggaatggta 37860 ccagttcctc agaaaaaatg ctcaccatca ctggccatca gagaaatgca aatcaaaacc 37920 acaatgagat accatctcac accagttaga atggcaatca ttaaaaagtc aggaaacaac 37980 aggtgctgga gaggatgtgg agaaatagga acacttttac actgttggca gaactgtaaa 38040 ctagatcaac cattgtggaa gtcagtgtgg cgattcctca gggatctaga actagaaata 38100 ccatttgacc cagccatccc attactgggt atttacccaa aggactataa atcatgctgc 38160 tataaagaca catgcacacg tatgtttatt gtggcactat tcacaatagc aaagacttgg 38220 aaccaaccca aatgtccaac aatgatagac gggattaaga aaatgtggca catatacacc 38280 acggaatact atgcagccat aaaaaaggat gagttcatgt cctttgtagg gacacggatg 38340 aaattggaaa tcatcattct cagtaaacta ttgcaaggac aaaaagccaa acatcgcatg 38400 ttatcacact tagatgggaa ctgaacaatg agaacacatg gacacaggaa ggggaacatc 38460 acactctggg cactgttgtg gggtgggggg aggggggagg gatagcatta ggagatatac 38520 ctaatgctaa ttgatgagtt aatgggtgca gcacaccagc atggcacatg tatacatatg 38580 taactaacct gcacattgtg cacacgtacc ctaaaactta aagtataata aaaaaagaaa 38640 gaaaatatat aaaagtatat atcactcact gttaaaagta agtacattta caatactcta 38700 ataatgtaat ggtggtgtgt aaatcactga tatcattagg ataaaggcta aaagacaaaa 38760 ctattaaaaa taataatagc tacaatagag gtatacctca gagatattgt gggttcaatt 38820 ccagaatgcc taaataaagc aaatttcaca ataaagctaa tcacaatatt tttgtttccc 38880 agtacatata aaagttatgt ttacatttta ctgtagcctt ttaaatgtgt gataatatgt 38940 ctaaaaagta tacatgttaa tttaaaaata cttaatggct aaaataaaaa gattaacagt 39000 catctgagcc ttcatcaaat attggccttt ttactgttgg aaggtcttgc tttgatgttg 39060 atgactgctg acttatcagg gtggtggttg ccaaaggttg tggtggctgt ggcaatttct 39120 taaaatcaga caacaataaa gtttgttgca tcaattgact tttccttaca tataaaaaat 39180 tatctgtagt atgcaatact gtttgatagc attttaccca gagtagaact tctttcaaaa 39240 ttggagtcaa ttctctcaaa tcttgccact gttttatcaa atatgtttat gtactagttt 39300 aaattatttg ttatcatttc agcaatgttc acagcattat caccaagagt agattccatt 39360 tcaaggaatc actttctttg ctcatccata ataagcaatt cctcatccat tctagtttta 39420 ttaagaaagt gaagcaattc agtcacatgt acacactcca cttctaattc tatttctctt 39480 gctatttcca ccactttcgc agtacctttc tccagtgaaa tcttgaaccc atcaaagtca 39540 ttcataagag ttggaatcaa ccttctacac tcctgtaaat gttgatacat tcaccttctc 39600 ccataaatca tgaatgttct taatgacatc taagtagtga gtccttctgg aaggttttca 39660 atttcccttg tcctgatcca gcagaggaat tactatctat ggcagccatg gccttacaaa 39720 atgtatttct taaataataa cactggaaag tcaaaattac tccttgatct atgggatgca 39780 aaatggatgt tgtgttagca gaaatgaaga caagtttaat ctttttgttc atcgtcatca 39840 aagctcttgg gtaacaatgt gcactgtcaa tgagcagtga tatttggaaa ggaatctttt 39900 tttctgagca gtagatatca acagggagct taaaatattc agtaaaccat gctgtgaaca 39960 gatgtgctgc cctttaggct ttgttgtttt atttatagag cacaggcaca gtagattagt 40020 ctaattgtta agggccctag gatctttaga atgatcaatg agcattggct tcaactcaaa 40080 gtcaccacct gcattagctg ttaaaaagaa tatcatgatg tcctttgaag ctttgaagcc 40140 aggcattgac ttctcctctc tagctataga agcgctagat ggcatcttct tctagtattt 40200 tactgtttgt ttccactgaa aaactatcgt ttactgtagc caccttcatc agttatctaa 40260 cctcaatatt ctggataact taatgcaact tctgtattat cacttgatgc tttaccttgc 40320 atgtttatat tacagagaca acttccatcc ttaaacctca tgaaacaaac tatgctagct 40380 tcaaactttt ctgctgcagc tttcacatct atctcagcct tcatagaggt gaagagagtt 40440 taagaacttg ttctggatta ggctttggct taatgttgca actagtttga tcatatatcc 40500 agaccactaa aactttctcc atatcagcag taagcttgtt tcattttctt gtaatttgtg 40560 tgttcactga agtagtcatt ttacttttct tcaagaaagt ttcccttaca ttcacaactt 40620 ggctaactgg cccaaaacta agcttttggt ctatcttggt ttctgacatg ctttttctcc 40680 ctaagctaag tcatttctag cttttgattt aaagtgagac atgtgtgact cttcctatca 40740 cttgaacacc taaagacaat ttcagggcta tttattggct taatttcaat attactgtgt 40800 ctcagagaat aggaacagct gaggagaggg agacagatgg aggaacaacc agttggtgga 40860 gctgtcagta tgcacacaac atttatcagt taagtttgtc accttatatg gatgtgattt 40920 acagcaccac aaaacaatta caatagtatc atcaaacatc acttgatcac agatagcctt 40980 aatggacgta ataataacaa taatgaaaaa gctcaaaata accaaaatat gacacagaca 41040 tgaaataaac acatagtgct ggaaaaatga cagacttgct caacacaggg ttgccacaaa 41100 ccttcaattt gtaaaaaaaa tgcactatct gtgaagaaca ataaagtaaa tcatgacaaa 41160 atgaggtata tttgtagtgt gttaagggat atactatata aaaaatttaa attgtgacat 41220 caaaaactaa aatgggggtg gtagagtaaa agtgtagagt ttttgtgtgt aatcagagtt 41280 aagttatcat tttaaaatcg ctcgttataa gacattcctt tgtaagtctc aaggtaacca 41340 caaagcaaaa cctgtagtag atacatgaaa gataaaaagt aaggaatcaa agcataccat 41400 tagagaaaag catcaaccac agaagaagac aggaaaaata gaagaaagga aaaaaaacac 41460 acaaagcaga aagagtggaa gacagaaaaa aaatatatga tagccagaat ataattatta 41520 aaatggcaat ttagggcaca tataactgaa agtaaaaatg gaaaaaagat attccatgca 41580 agtggaaacc aaaatagatg aggggttgct acatttacat cacatagaat agactttaag 41640 tcaataacag taaaacaggg caaataaggt cattgcataa taataaacgg attatttcat 41700 caggaagaaa taacagttat aaatatatat ggaccctaca ctggatcacc taaatatata 41760 aagcaaatat taatagacct gaagagagaa atagactgca ataaaatcat aggtcttcaa 41820 aatcccactt ttaataaaca gattatctag acagataatc agtaaagaac gattggattt 41880 aaactacact ttagaccaaa tggacctaat agacacatat agaacatttc acctagtggc 41940 agcagaatat ataatctttt gaagcaccca aggaacattc tccaggataa tcatagagta 42000 agccacaaaa caagtcacaa caaaattaag attgaaatat ataaattatt ttttcaaaaa 42060 caatgacatg aaactagtaa tcaataatat aaggaatttc aaaaatgtta caaacgtgaa 42120 aattaaacaa gagactcctc aacaatcaat aggtcaaaga agaaattaaa agcaaaaatt 42180 taaaatatct taagataaat gaaaatgaaa acacatcata acaaagctta tgggatgcaa 42240 caaaagcagg tctaagaggg gagtttatac caataaatac ctacatcaaa caaaagattt 42300 aaaataaata acctaatatt acaacttaag taactagaag aagaagaaga gtcagggttt 42360 ccctttcata aaaagggaga aataataaaa attagagaag aaagaaaaca aatggagaat 42420 agaaaaacaa tagaaaagat caatgaagag ttagttcttt gaaaagataa aattgacaaa 42480 cctttagcta gaataactag gaaaaagaag aaaactcaaa taaaattaga aatgaaagct 42540 gagacattac aactgatacc atagaaacaa aaagcatcat aacaagcgac tatgaaaaac 42600 taaatgtcag ccaggcgtag tggctcatgc ctgtaatccc agcacttcgg gaggctgagg 42660 caggcagatc acctgaggtc aggagtttga caccagcctg accaacatgc agaaaccccg 42720 tctctactaa agatacaaaa attagccagg tgtggtggcg ggcccctgta atcccaacta 42780 ctcaggaggc tgaggcaaga gaattgcttg aacccaggag gcagaagttg cagtgcgcaa 42840 aaaaaaaaaa aaaaaaaaaa aatagataac ctagaggaaa tggataagtt cctagataca 42900 caaaaactac caagactttg agtattgaag gaatggaaaa tctgaacaca ccaatactaa 42960 ggagatttaa tcagtaataa aatgtttcca ttccaagaaa agaccaggat cagatggctt 43020 cactgcaaaa ttctaccaaa cacttagaga agaactaata gcaatctttc tcaaagtctt 43080 cccccaaaaa agtgaaaaaa gtgtttactt ccaaactcat gttacaaagt cagcattact 43140 ctgataacaa agtcagacaa gatactatga gaaaattaca gggcaataac cctgatgaac 43200 ataggtttaa aaatcctcaa caaaatacta gcaaacatat ttcaatagca cacttgaaat 43260 attattcacc atgattaagt gtaatttatt cctggaatgc aacaatagtt taacatacac 43320 aaattaataa atgtgacatg ccacattaac aaaatgaaag ataaaaggca tatgatcatc 43380 ttaatagatg cagaaaaaca tcgtgacaaa attcaatatc tttttgtagt aaaaatgctc 43440 aacaaattag gtacagaaga gaagtgcttc aacaaataaa gaccacatat gacaagtcca 43500 ctgctaacat cacagtcaac agtggtaaac taaaagcttt tcttctaaga ttaggaacaa 43560 gataagaatg ctcactattg caacttctat tcaacatagt actggaagtt ctagccaaag 43620 aagtaaggca agaaaaaaag aaaagaaaaa agaaaggcat tcacatcaga aaggacaaac 43680 ttaaattttc tgtttgaaga tgacctgatc ctacatatat ataaaatata taatttatat 43740 ataatatgta ttatgttata aatatatgtt atatgttcta tgttatatat aatatatgtt 43800 ctatgttata tataatatat gttatatgtt atatgttata tataatatat gttatatgtt 43860 atatataata tatgttatat gttatatata tgttataggt tatatgttat atatgttata 43920 ggttatatgt tatgttatat atatgttata tgttatgtta tatatgttat atgttatatt 43980 atatatcata tatgttatat gttatattat atatcatata tgttatatgt tatattatat 44040 atcatatatg ttatatgtta tattatatat gttatatgtt atattatata tgttatatgt 44100 tatatgttat attatatatg ttatatgtta tatattatat tatatatgtt atatgttata 44160 tattatatta tatatgttat atgttatata tattatatat aatatgttat ataatataat 44220 atatatgtta tatattatat ataatatgtt atatattata tatgttatat attatattat 44280 atatgttata tgttatatat tatattatat atgttatatg ttatatatta tattatatat 44340 gttatatgtt atatattata tgttataagt tatatataat atagataata tataaaatat 44400 ataatatata tacacaaaac acaaaacacc accaaaaact gttaaaacta acaaatgaat 44460 ttactatagt tgcaggatac aaaatcaaca tgcaaagtca gtaatgtttc tatacactaa 44520 caatgaacta tccaaaaaaa aatagaatct atttacaata actccaaaaa gaataaaata 44580 cgtagaaatg aagttaatca agtaggtgat agacttatac aaaaaaacta taatatattg 44640 atgaaagaaa ttaaactagg caaaaattgg aaaggcatcc tgttttcata aatatacaga 44700 cttaatactt taaagtgtct ataaatcaaa gctatctaca gattcaatgc attccctatc 44760 aaaatcccaa cagcatgttt tacagaaatt aaaaaaaatc aaaaattcaa attaaatcac 44820 aaaagtccca gaattgccag tgttaacttg agaaagaaca aagctcaagg catcacactt 44880 cctgcttaca aaaatatatt atgaagctac agtaatcgaa acagtgttgt actggcatga 44940 aggcagacat atagacagat gaaacagaat aaagaagcca gaaataaatc catgtatgta 45000 tggtccactg atcttcaaca gtgatgccaa aaataaacag tggtgccaaa aataaacaat 45060 ggggaaagga cagtctcctc aacaaggtgt tggaaaactg gacatctaca tgagaagagt 45120 gcaatttaac ccttaactta tacaatacag aaaaaaatca actcaaaaca gattaaagac 45180 ttaaatgtaa gaccttaaac tataaaattc ctagataaaa acaggggaaa tgttccttga 45240 catttctctt ggcagtgatt tttttggata agacaccaaa aactcaagaa acaaaaccac 45300 aaatagacaa gtgggacaac attaaactaa ataactctgg tgcaataaag aaaacaatga 45360 atcaaatgaa aaggtgacct atggaaaggg agtaaatatt tacaagccat acatatgata 45420 aagggttaat atccaaaata tattagaaac atctacaact caatttaaaa aatagtacca 45480 ggcatggtgg ctcacgcata tagtcctagt actttgggag gttgaggctg gtgaatggat 45540 tgagcgcagg tattcaagac ccgccaggga aacatggcaa acccctatct ctacaaaaac 45600 acacacacac acacatatat atatatgtac atatatacac acacacatat atatgtacat 45660 atatatatat gtgtgtgtgt atatatatac gtatatatgt gtgtgtatat atgtgtatat 45720 gtgtgtgtgt gtgtatgtgt atatatatat gtatatatat atttatatat atgtatatat 45780 atatatgtat atatatacgt atatatatat atttatatat atatatatat attagccagg 45840 catggtgggt gtgtgtctgt agtcccagct actcaggagg ctgaggtagt aggattgctt 45900 gaacccgggg tgtcaaggct gcagtgagcc atgacagcac cattgcactt cagcctgggc 45960 aacagagaga gaccctgtct caaaacaaac aaacaaaaac ataggctgtg tgcagtggct 46020 catgcttata ataccagcac cttgggaagc caaagcagga ggatttgaga ccaggagttt 46080 gagaccagct tgggaaacat agcaagaccc tgtctctaca aaaagtaaaa ataaaaataa 46140 ataaccaggc atattggcat gagttagtag tcctagctac atgggaggct gaagtgagag 46200 gattgcttga gcccaggagt tcaagaccag cctgggcaac atagtgagac ccccatctag 46260 gaaaacaaaa agcacaggca acaaaagcaa aagtatacaa atgggattgc aggaaactaa 46320 aaagcttctg cacagcaaaa gaactatcaa cagagtaaag atacagttta cagaatggga 46380 gactattggc aaactatgca tctgatgagg agttaatatc cagaatatat gagaaactca 46440 aacaactcaa tagcaaaaaa caaaaaataa acccaatcca aaaaatgggc aaatgacctg 46500 aatagacatt tctcaaaaaa tatatataca aaagaagaca tacaaatggg caacatgtat 46560 acgaaaatat gcttaacatc cctagtcatc agggaaatac aaatccaaac cacagtaaga 46620 taccacctca gtctagttag aatggctact acagaaagac aaatgataac aagtgttggc 46680 aaggatgtgg agaaaggaaa ctcttacata ttgttggtgg gaatgtaaat tagaacagtc 46740 actataaaaa cagtatggaa gttccttgaa aaattaaaaa ttgaactgcc atatgatcca 46800 gcaatcccac taatgggtat aaacccaaaa gtaatgaaat cagtatgtca aagagacatc 46860 tgctgtcctg tgtttattac agcactattc ataatagcca agatatggca acaatctatg 46920 tccatcaatg gatgaatgaa tttaaaaatc ttggtatata cataatatgc aatactattc 46980 attcataaaa aagaaagaaa ttgtttcatc tgtgacaaca tagatgaacc tggagaacat 47040 tgtgtcaagt gaaataagct acacacagaa agaaaactac tgcatgattt cactgatatg 47100 tggaatctta aaaagttgat ctcatagaag ctgagagtag aatggtggtt agcagaagct 47160 ggtgagggta agtgaaagag ggtatgggag aacactggtc aatgagtaca atgttaaagt 47220 taaatagagg aacgggttct agtgttctat tgcacatcag ggtgaatata aaaaacaata 47280 gtgtattata tatttcaaaa taacttgaag aaaggatttt aaatgttctc accataaaga 47340 aatgataaat gtttaagatg atggatattc taattaccct gatttgagca ttacacaata 47400 tatacacata tcaaaacatc atatcgtacc acataaatat gtacgattat tctggctcaa 47460 ttgaaaataa aataaaattt tagaaacgtt aagaaaggaa tattatgaac aatcttatct 47520 cacagatttt ataacctagt taagatggac caattccttg aaagatacag tctattataa 47580 ctcatacagg gagaaatagg caatctaaat actgttaatt gtattaaagg aattaattat 47640 tgaataaact tccaaaacag aaagcatcaa gcccagatgg gttcactgga gtattccacc 47700 aaacatttag gaaagaaaac tacaccaagt ctctacagtt gcattgaaaa tatagaagca 47760 gaggcaatat tttctaactc attgtataag gtcagcatta cactaatacc aaaagcagac 47820 aaaaatattg caaggaaaaa aacacatcaa tatatctgat gaatatagat gcaatatttc 47880 tcaagaaata ttagcaagtc aatccaacaa atttataaaa ataattctac acttgagata 47940 agcctgggca acatagcaag acactgtacc tacaataaat acaaaaatta gccaagcatg 48000 gtggtgcata cctgtactcc tagctacttg ggaggttgag gcaggaggat tatttgagcc 48060 caggggttag aggctacagt gagctatgat tgtgccactg cactccagcc tgggtgacag 48120 agtgagaccc tatctcttaa aaaaagaaaa aagaattata caccacaaac aagtaaggct 48180 tatcccaaaa aagtaagact ggttcaacac tggatatcag ttaatgtaac ccattatatc 48240 aataggctaa agaagaaaag tcacaagatt ataacaacag atttttaaaa agtgtttaac 48300 aaattacaac acctattatg atttcaaaaa aaattcagta aactaggaat agaaagtaat 48360 cttcctcaac ttgaaaaata acatctacaa aacagccttc atctgacatc ttatttaata 48420 gtgagaaact atgagctttc ttgctaagat taggaagaaa acaaggattt ccctctcaca 48480 ttccttttca tcattgtaca gtaagtccta gctagtgcaa tgagacaaaa aaggaaataa 48540 aagacacact aattggagga gagaaataaa atgttgcagg tgacatgatt gtctatgcag 48600 acaatctaaa ataattaacc aaaaaaactc tcccagaact aataggcaat taaagcaaga 48660 ttacagaata tgttaatata caaaagttca ttgctttcct atataaccgc aataaacaag 48720 tataatttga tattaaaaaa caatattatc tgcattagca cacctgaaaa tgaaataatt 48780 aggtataaat ttaataaaat atgtgcaaga tctatacaag gaaaactacg aaacttgaat 48840 gaaagtaatc aaagaaaaac taaataaaga gttattccat gtatacatag gaagattcaa 48900 tattgtcaag gtgtcagatc ttctcaactt actctatgta gattcaacac agtcccagtc 48960 agtaacccag caagttattt tgtggatatc aacaaactga ttctaaactt tatgtgaaag 49020 acaaaacatg cagaatggtc agcataatat tgaaggtgaa gaacaaattt gaaggactga 49080 tacttcccaa aatcaatatt tactataaag ctatagtaat taagacagtg tgctattagt 49140 gaaagaacaa acaggtcaat ggaacagaat agcaagccca gaaatagtct ggcaaaaata 49200 tagtcaacca atatttacaa aaaagcaaaa tacaatggag aaaaggtcat aattttaaca 49260 aatggtgctg aaacaagaag acatccacac gcctaataat aaatctaaac acagatctta 49320 tatccatgac aaaaacgaac ataaaagaaa acctagatga ccttgagtat ggtgatgact 49380 ttttagatac aacaccaaag gcatgatcca tgaaaaaaag aactgataag ctggcattta 49440 ttaaaattaa aattaaaatt tctgctctgc aaaaggcaaa tgagaagcaa accacagact 49500 aaagagaata tatttgcaaa aggcatacct gataaaagat tgttattcaa aatatgcaga 49560 agagctctta aagcacaata ggtaaatgaa caatctgatt ttaaaatggt caaaaaaaca 49620 gacacctcac caaaaaatta cacagaaggc aaataagtaa atgaaaagat gctcatatac 49680 ttatgaatat ctttgttatt agggaattgc aaattaaaac aatgatatag cactgcatat 49740 ttattagaat aatcaaaatc taaaacatta acaacacaaa atgctattga gaatgtgaag 49800 caacaggaac gttcactcat tgctagtggg aatacaaaat agcacagcca cttcagcgac 49860 agtttagtgg tttattccaa aattacattc ttaccatgca ttccagcaat tgtgctcctg 49920 ggtatttacc caaataagtt gaaaacatat attcccacaa acacctgcat acaaacgttt 49980 atatcatgtt tattcctatt ttccaaactt ggaagcaacc aagatgtcct ttggtaggta 50040 aatggagaaa taagctgtgg tacatccata caatgaaata ttattcagtg ctaaaaagaa 50100 atgagctgtc aagcttattt aaaggttacg tgtctcatgc aaagacatgg aagaaattta 50160 tgcatattag taagcaaaag tgacagtctg agaagctaca tactgtagat tccaacttta 50220 tgacattctg gaaaaggcaa aactctggag aaagtgaaaa cattagtggt tgccagggct 50280 tggggagagg gaggcagagc acagaggggg aacaaagggc agtagaacta ctctgtacta 50340 tactataaca gtggacacat gtctatactt ttgtcaaaat acaatgtata acaccaagag 50400 tgaatcctaa tgtaaactat gaactttggg tgataatgat gtgtcaatgt aggttcatcc 50460 actgtaacaa atataccact cttgcatgga agcgtgatgg tgagtgaggc tctgtgtatg 50520 ggggacaggg ggtttatggg aaatctgtaa cttctgctca attatgttat taatctaaaa 50580 ctgctctaat aataaaatct acttttaaac atgtaataga attcccaaga actgtgggac 50640 aattacacaa agtgtagcac acacatataa cagaaatacc aaaaaaagaa aagagcagaa 50700 gaagtatttg aagaaataaa agatgaaaaa ttttctaaat taatggcaaa caccaatcca 50760 gagatccagg aagctcagag aacaccaaag caaaataaat gtcagaaaaa atgtacctct 50820 aggcatatca tattcaaact gcagaaaacc aaagacaaag ataaaatcct gatagaagtt 50880 gagggggaaa cttacagata aataaacaat aataagaatt tcctctgact tatcagaaat 50940 cagccaagta agaagatagt ataataaaat atttaaagtg ggaaaagaat acaaatcccc 51000 ctgacctaga attctctatc aagtgaaatt attcttcaaa agtgaagaag aaataaagac 51060 tttctcagac atacaaaaac aggaaatttc tcaaaagtaa acttttctta caaaaaatgc 51120 taaaagaagt tcttcagata aaggggaaaa tgataaaata ataagcacaa atcaatataa 51180 aggaagagca attgagaagg aataaatgaa ggcaaattaa agctactttt cttactctta 51240 attgacctat agatagttgc tcgacacaaa aatagcaata atgcattggt aatcattatt 51300 accacttatt aggataagtg aactgaatga caatattaaa agagatgcag cccaggcacg 51360 ggtggcccat gcctgtaatc ccagaacttt gggaggccga ggcaggtgga tcacttgagg 51420 tcaggagctt gtggccagcc tgaccaacat ggtgaaaccc cgtgtctact aaaaatacaa 51480 aaataggcca gatgtggtgg cacgcacctg taatcccagc tactcgggag gctgaagcag 51540 gagaatctct tgaacccgga aggcgaaggt tgcagtgatc caagattgta ccactacact 51600 ccagcctggg tgacagagtg agactctgtc taagaaaaag gggcgggggg ttgaatgcaa 51660 agagaaatac aatttaactg aacagctatc agttaaagtg aactgaacta ttaattaaat 51720 ggatctaatt ggcatttgta gaatacttca tccagtaata gcagaatata tcttcttatc 51780 aaacttatat gcgatttcca tcaagagaaa cttcatatgg accataaaac acattttaac 51840 aatgtaaaaa aatagaaatt acacaaagta tactctcaga acacacagaa tagaactaaa 51900 aatcagtaac agaaggatag ctgaaaattt tcaaactgtt tggagattga acaacacact 51960 tctaagtaat aagtgaattg aagaagatat ctcaagaaat attttgaaat aaatgaaaat 52020 gtaacatcat agtttgtagg atgcagtaaa agcagttctt tgagtgaaat ttataacact 52080 gaatggatat attagaaaat aaaaaaatgt gatattaata aactaatctt aggccttagg 52140 aaactagaga aagaaaagaa atgtaggcct aaagaaagca gaataaaaga aatgataaaa 52200 attggagcat aaattattaa attgaagtag aatttaaatt ttctctgcag agtaagtatg 52260 tgaggtaatg aatatgttaa ttagctttac ttagccattc cacatgtata cataaacacg 52320 ttatacagca taaacgtata ttattttgtt tttcaattaa aaatttaatt aaaatcagaa 52380 aaaattaata attaaattta aaacaggaat tcaatactga aaaatcaatg aaaccaaaag 52440 ctgtttcttt aaaaagataa taaaattgat aaatttctag ccaggctaat caagaaaaga 52500 agaggattca acattcttaa agaaaacaat tttcaaccca gaatttcata tccagccaaa 52560 ctaagcatca taagtgaagg agaaataaaa tattttacag acaagcaaat gctgagagac 52620 ttttgtcacc accaggcctg ccctaaaaga gctcctgaag gaagcactaa acatgcaaag 52680 gaacaaccgg taccagccac tgcaaaacca tgacaaaatg taaagaccat cgagagtagg 52740 aagaaactgc atcaactaac gagcaaaata accagctaac atcataatga caggatcaaa 52800 tttacacata acaatattaa ccttaaatgt aaatgggcta aatgctccaa ttaaaagaca 52860 cacactggca aattggataa agagtcagga cccatcagtg tgctgtattc aggagactca 52920 tctcatgtgc agagatacac ataggctcaa aataaaggga tggaggaaga tctaccaaga 52980 aaatggaaag caaaaaaaag caggggttgc aatcctagtg tctgataaaa tagactttaa 53040 accaacaaag atcaaaagag tcaaagaagg ccactgcata atggtaaagg gatcaattca 53100 acaagaagag ccaactatcc taaatatata tgcacccaac acaggagcac ccagattcat 53160 aaagcaagtc cttagagacc tacagagaga cttagactcc aacacaataa taatgggaga 53220 ctttaacacc ccactgtcaa tattagacag atcaacgaga cagaaggtta acaaggatat 53280 tcaggacttg aactcagctc agcaccaagc agacttaata gacatctaca gaactcttca 53340 ccccaaaaca acagaatata cattcttttc agcaccgcat tgcacttatt ccaaaattga 53400 ctacataatt ggaagtaaag cactcctcag caagtgtaaa agaacagcaa tcacaacaaa 53460 ctgtctctca gaccacagtg ctatcaaatt agacctcagg attaagaaac tcactcaaaa 53520 ccgcacaact acatggaaac tgaataacct gctcctgaat gactactggg tacatagtga 53580 aatgaaggca gaaataaaga tgttctttga aaccaataag aacaaagaca ctatgtacca 53640 gattctctgg gacacattta aagtagtgtg tagagggaaa tttatagcac taaatgccca 53700 caagagaaag caggagagat ctaaaattga caccctaaca tcacaattaa aagaactaga 53760 gaagcaagag caaacaaatt caaaagctag cagaaggcaa gaaataacta agatcagagc 53820 agaactgaag gagatagaga cacaaaaacc cttcgaaaag tcaatgaatc caggagctgg 53880 ttttctgaaa agatcaacaa aattgataga ctgctagcaa gactaataaa gaagaaaaga 53940 gggaagaatc aaatagatgc aataaaaaat aataatgtgg atatcactac caatcccgca 54000 gaaatacaaa ctaccatcag agaatactat aaacacctcc atgcaaataa actagaaaat 54060 ctagaagaaa tggataaatt cctggacaca tacaccctcc caagactaaa ccaggaagaa 54120 gttgaatctc tgaatagacc attaacaggc tccaaaattg aggcaataat taataggcta 54180 ccaaccaaaa aaagtccagg accagaccaa ttcacaactg aattctacca aaggtacaaa 54240 gaggagttgg taccattcct tctgaaacta ttccaatcaa tagaaaaaga gggaatcctc 54300 cctaactcat tttataaggc cagcatcatc ctgataccaa agcctggcag agacaaaaca 54360 aaaaaaagag aattttagac caatatcctt gatgaacatc gatgtgaaaa tcctcaataa 54420 agtactggca aactgaatcc tgcagcacat caaaaagctt atccaccatg atcaagtcgg 54480 cttcatcccc gggatggaag gctggttcaa catatgcaaa tcaataaatg taatccagta 54540 tataaacaga accaaagaca aaaaccacat gattatctca atagatgcag aaaaggcctt 54600 tgacaaaatt caacaaccct tcatgctaaa aacactcaat aaattaggta ttgatgggac 54660 atatctcaaa ataataagag ctatctatga caaacccaca gccaatatca tattgaatgg 54720 gcaaaaactg gaagcattcc ctttgaaaac tggcacaaga cagggatgcc ctctctcacc 54780 actcctattc aacatagtgt tggaagttct ggccagggca attaggcagg agaaggaaat 54840 aaagagtatt caattaggaa aagaggaagt caaattgtcc ctgtttgcag atgacatgat 54900 tgtatatcta gccccatcat ctcagcccca aatctcctta agctgatagg caacttcagc 54960 aaagtctcag gatacaaaat caatgtacaa aaatcacaag cattcttata caccaataac 55020 agacaatcag agagccaaat catgagggaa cacccattca caattgcttc aaagagaata 55080 aaatacctag gaatccaact tacaagtgac gtgaaggacc tcttcaagga gaactacaaa 55140 ccactgctca atgaaataaa agaggataca aagaaatgga agaacattcc atgctcatgg 55200 gtaggaagaa tcaatatcgt gaaaatgccc atactgccca aggtatttta tagattcaat 55260 gccatcccca tcaagctaca aatgactttc ttcacagaat tggaaaaaac tactttaaac 55320 ttcatatgga accaaaaaag agctcacatc gcgaagtcaa tcctaagcca aaagaacaaa 55380 gctggaggca tcacactacc tgacttcaaa ctatactaca aggctacaat aaccaaaaca 55440 gcatggtact ggtaccaaaa cagagatata gatcaatgga acagaacaga gccctcagaa 55500 ataacgccgc atatctacaa ctatctgatc tttgacaaac ctgagaaaaa caagcaatgg 55560 ggaaaggatt ccctatttaa taaacggtgc tgggaaaact ggatagccat atgtagaaag 55620 ctgaaactgg atcccttcct tacacctcat acaaaaatca attcaagatg gattaaagac 55680 taaattgtta gacctaaaac cataaaaacc ctagaagaaa acctaagcat taccattcag 55740 gacataggca tgggcaagga cttcatgtct aaaacaccaa aagcaatggc aacaaaagcc 55800 ataattgaca aatgggatct aattaaacta aagagcttct gcacagcaaa ggaaactacc 55860 atcagagtga acaggcaacc tacaaaatgg gagacaattt ttgcaaccta ctcatctgac 55920 aaagggctaa tatccagaat ctacaatgaa ctcaaacaaa tttacaagaa aaaaacaaac 55980 aaccccatca aaaagtgggc gaaggacaag aacagacact tctcaaaaga agtcatttat 56040 gcaggcaaaa aacacatgaa aaaatgctca ccaccactgg ccatcagaga aatgcaaatc 56100 aaaaccacaa tgagctacca tctcacacca gttagaatgg caatcattaa aaagtcagga 56160 aacaacaggt gctggagagg atgtggagaa ataggaacac ttttacactg ttggtgggac 56220 tgtaaactag ttcaaccctt gtggaagtca gtgtggcgat tcctcaggga tctagaacta 56280 gaaataccat ttgacccagc catcccatta ctgggtattt acccaaagga ctataaatca 56340 tgctgctata aagacacatg cacacgtatg tttattgcgg cactattcac aatagcaaag 56400 acttggaacc aacccaaatg tccaacagtg atagactgga ttaagaaaat gtggcacata 56460 tacaccatgg aatactatgc aaccataaaa aaggatgagt tcatgtcctt tgtagggaca 56520 tggatgaaat tggaaatcat cattctcagt aaactatcgc aaggacaaaa aatcaaacac 56580 cgcaggttcg cactcatagg tgggaattgg acaatgagaa cacatggaca caggaagggg 56640 aacatcacac tctggggact gttgtggggt gggaggaggg gggagggata gcattaggag 56700 atatacctaa tgctaaatga caagttagtg ggtgcaccac accagcatgg cacacgtata 56760 catatgtaac taacctgcac attgtgtaca tgtaccctaa aacttaaagt ataatagtaa 56820 taaaataaaa tttaaaaaaa gatagcatga gtagaaaaaa aaaaaagaag agggaagcca 56880 caagttacta atatcagaaa tgaaagaggg gtcatcacta ctgattctgt ggacattaaa 56940 agaatgataa ataaatacca taaacaactc tatgcccaca agtttgatag cttagatgaa 57000 atgaacctat tccttgaaaa gctcaatctg ccaaaactca cataaagtga aatagataat 57060 ttgaataggc ctatacctac taaagaaact gaattaataa ttaataatct tccacaaaag 57120 aaaacaccag gcccagatgg gttcattagt gaattctgtc aatcatttaa aaaaaaaatg 57180 gtaacaatta tctgcagtct tctctagaaa acagatgaaa agggaaccat tcctaattca 57240 tatacttgct gacttgttcc atgaggccag aaatgcccta attctaaaac caatgatatt 57300 aaaagaaagg aaaactacag aacaatatcc ctcatgaaca taaatgcaaa aattctcaat 57360 aaatattagc aacttaaatt tttgtttaaa ggtataatca tgtatagaaa gaattatagt 57420 ccgtggccaa gtgagattta ttccaggcat gaaaatctgg ttaaatattt aaaaatcaat 57480 taatataatc tatcacacaa acaagataaa gaaggaaaat tatgtgattt ttccatcaat 57540 ggacacagga aaagcattta acaaaattca acatccattt ataataaaaa ctcagcaaac 57600 tggaaacaaa gagaaactgc ctcaacttca ttaacagcat ctaaaaaaac catacagtta 57660 acctcatatt taatggcaag aaattaggtg cttttgtcct aagactggga acaaggtaaa 57720 gatgtcctct ctcgccactc ccattcaaca ctgaactaga tgtcttagat aatttaacag 57780 gacaagaaaa gtaaataaaa agtttataca ttggaaaaga tgaaataaaa atgtctttgt 57840 taataaattt gtaattttct atattaaaat ctgaaagaat agacaagaaa aataaaaaca 57900 aacaaaaaag aaacttccag acctagtagg caaaaaaatg gcaacactga agaatagaag 57960 gttaatatac aaaagtcagt tgtttttttc cagcaattac caagttgaga ttgaaattaa 58020 aaacacaata ccatttatgt gaacaccaaa aaatgaaact taggtgtaaa tctaacaaaa 58080 tatatacaag atctattgaa gacgactaca aaactgatgg aaaaaaaagc aaatatctaa 58140 ataaatgaag agatgttcca tgttcatgaa taggaagact taatattgtt aagatgtcta 58200 ttctgcccaa cgtgatctat aaattcaata caattccaat caaagtccca acgagatatt 58260 ttatcaatat aaacaaactc taaaatcata tggaaaggca agagacacag aataaccaat 58320 gcaatattaa agaaaaagag caagtttgaa caaccaacac tacctgattt taagacttac 58380 tataaagctt cataatcaag acagcatggt attggtaaaa gaatcaacaa gtagattgat 58440 gaaacagaac agagagccca gaaatagaca tacaaaaaga tagtcaacta gtctttgaca 58500 aatgagcaaa ggcattgaga gatagccttt tcaagaatgg ctgtcttagt tgaaagagtg 58560 gttgaatatc cacatgcaaa aaaaaaaaaa aaaaaaaaac ttaatgtaga ccttatgcct 58620 ttcacaaaaa ccaactcagt ttagatcata gatataacat aatgctcaat actattatat 58680 aaaacgacta gaagataaca taggagaaga tttaagggac ctactctttg tctatgagtt 58740 tttagataca acaccagaag cataatccat gaaaaatgat tgaaatgttg gacattatga 58800 aaatttacaa ctttgcaaag gacactgttt aagagaatga aaagacagcc ctcagaatgg 58860 gagaaaatat ctgcagaata tatatttcat aaaggatttg tatccaaata tgtacaaaga 58920 actcttaaaa ctcaacaata agaaaacaac tcatttcaaa aacggccaaa agatctgaat 58980 aaacccttca ccaagaagat ggcaagtaaa cagatagaaa gaagctcaaa atcatatgcc 59040 attagggaat tgcaaattaa aacaacagtg agacaacact acacatctat tagataatca 59100 ctaaaattca aaaaaaactg aaaataccaa tggctgatga ggatgaatat taacaggaac 59160 tttcattcat tgctgctggg aattcaaaat agtacagtca ctttggaaga taatttagca 59220 gtttcttaca aaactaagca tggtcttacc atacaaccca gcaattgtaa ggctatgtat 59280 ttactcagtt gagttgacaa cttatatcca cagaagaatg tttattgtag ctttattcat 59340 aatcaccaaa aactggaagc aaacaagagg ttcctcaaaa gctgaatgga taagctgcgg 59400 tacatccatt aaatgggata ttattcaatg atataacaaa atgggctatc cagccatgaa 59460 aagacatgga ggaatcttaa atgcccattg ctaagtgaaa gaagccagtc tgaaaaagct 59520 acatactaaa tgattcaact atattacatt ctcaaaaagg caaaactgta gaagagcaag 59580 aaaccagtgt tgccagagat ttggagtagg aaagagatga atagataaaa gcagtggatt 59640 tttaggacag tgaaactctt ctgatattat aatggtgggt acataacatt atgcaatggt 59700 caaaacccat agaactgtcc aacacagagt gaaccttaat ataaacaatg gactttagtt 59760 aatgataata tatccatatt ggttcatcag ttttaacaaa tgaactacaa gatgttaatg 59820 acaaggaaaa gtatatagat gggagggagt catagggaaa ccctctgtgt tgtttgcaat 59880 tttttgtaaa tataaaattg ttctgaaaaa taaagtctat tttcttaaag tcagtccagg 59940 gatcctcctt tatatgaata caatctggca ttttgctaag taaaatttct ctgtttccag 60000 catttaagtc tcacttctct gtgcaagatt ttctttagtt ttatatttcc taggtcattt 60060 ctgtcagaat taaggggtgg ggtagtgaga attcagacat atgtcctcaa gctgccatct 60120 gttctccaaa tggtatccca tatgttgttg atgtgtagag ttttcattgt tgacatttat 60180 gaattgacta taattgtact ttgatttcct tcttgactcg agttaattat gagggtgttt 60240 aaatttccaa gtggtatttt ttaaaaaaac atgttactaa tttctgcttc attgctcatt 60300 gttttaaata tgtgatttgc gtaagtctta ctttttagag ctattgagag ggtttttttt 60360 cttggtagtt tagtatatcg ccaatttttg aaatgtctag atattttata gcaatgtgta 60420 ctattcttat gttatgaagt ctattttttt ctatctgtat atttttgttt attcttctgt 60480 aaaactttga acggtttcat tatatattta gcattatgtt acttgttaca tataactttg 60540 tgaatatcct attgccatca tgtgttgtat cttttatcaa tataaataat cctttatcac 60600 atgaaatgct gtttgctttg aatttaattt gtctaatagc aatgttgtaa tgaatgcctt 60660 ctttaatttt tactttcttg atataccttt ggccatccct ctatttccac acttagatat 60720 ctaagtgatg tggtttaaaa tttttctctt ttaaacagca tagaattaga ttttagggaa 60780 gttttaaaat aagttatttt cttaatgaaa gaccttaagt cattcacatg tattgcgaca 60840 aatagtgttt tggtttggtg taatttcagt tccttatttt agtctttcta tattaagggt 60900 tttttgtttg tttgttgcta tttacttgtt ttttcttttt atttgattat caattgtggt 60960 aggcttgaaa aaagctcccc gcccctaccc cccaccacca ccaccaccac aaaatccgta 61020 tcctaatccc tggaacctgt gatgttacct tatataagaa aagggaactt cacaaatgta 61080 atcaaattaa agatcttaaa actgggagat tattctggtt tatcccagtg attcccacat 61140 gtaatcataa cagggtggta gaagggagtg tgacacacag acagaagagg aaaaggcaga 61200 gcttgggccg atatggtcac acgccaagga ctgctggcag tcacccgaag ccagaagagg 61260 caaggggcag attctcccct agagtctctg gaggactcat gggcttgcca aacttttatt 61320 tttgcccagt agaactaatt ttggacttct ggtctccaga gctgtgcgag aataaattta 61380 tgttgtttta agccataaag tttgtagtag tttgttacag ccaccatagg aaactaatta 61440 aaatttctcc atttttattt tactctatca tagcttatct ttaactttta gctttaatat 61500 atctctatca aggttaaaaa acaaaagaga gacccaaaat acataacaaa attgaacatg 61560 atgtctttct ttgtactctg tcccttcact caactccctt aagtttttcc tgaaatgttc 61620 catagtcata tttataatta ttttgtaagc atttcatgtg tttctaactt cattgcttac 61680 catagttgtt attattctat gctcttccct cttcttgaat tcttaatttt aattcaattc 61740 tcaattagct gaagtatgcc aggaagacta taaaatatta tattttcttc cttcttatat 61800 atctgagaaa actgttctgt gccttggcac agaaatcata tttacaaagt tcttgaatca 61860 caattttttt tcaaaactct gaacatgttg ttatagtgtt ttctggcatt actttttgtg 61920 ggaaagaggt atgataattt aagatgcatt tcttttaggt aacttttaaa tttttttacc 61980 ctgccttaaa tgcctgaaga tggttaatct ctgaaattaa atactctttt gattgtatct 62040 caaagtcagc atctttttat caacattgac tgctcttctg gacactctta tttatggctc 62100 ttcctcctgc tccagattct gaactgtgcc tgtcacctcc ctcaagacag ccacagagcc 62160 ccaagatcct tataacctca ccatgatgtt ccactccaca gggttctgcc attgtgtgct 62220 ttctttttca tccttctctg atgccacctc ctcctctgtt tgttgccagc cttaataatt 62280 ttaaattcat ggatcacagg tagaaacccc agttttgtct aagtagacga tcgatttttt 62340 ttttcttaaa gctagtcttc catttttctc tttctctatt tgtcaccttt tcccaagaga 62400 taattttttc ttttagtttt cagaggagcc ttcaatttct ttttttaaac cttttttcta 62460 acttttattt taagttgagg ggtacatgtg caggtttctt atacaggtaa acttgtgtca 62520 tgggggtttg ttgtacagat tatttaatca cccaggtatt tttttttttt tttttttttg 62580 agacggagtc tcgctctgtc gcccaggctg gagtgcagtg gcgcaatctc ggctcactgc 62640 aagctctgcc tcccgggttc acgccattct cctgcctcag cctcccgagt agctgggact 62700 acaggcgccc gccactacgc ccggctaatt ttttgtattt ttagtagaga cggggtttca 62760 ccgttttagc cgggatggtc tggatctcct gacctcgtga tccacccgcc tcggcctccc 62820 aaagtgctgg gattaagctt catattcatt agttattttt cctgatccta accctcctcc 62880 caccctacac cctcctatag gccccagtgt gttttgttcc cctctatgta tctgtgtgtt 62940 ctcatcagtt agcttccact tataagtgag aatatacagt attttgtttt ctgttcttgc 63000 attagtttgc tgaagataat gccctccatc catgtccatc catgtccctg caaagcacat 63060 tatctcattc tttcttacga gccttcaatt tctaatcatt cctcagaacc tcctccctat 63120 ggtggctttc acaacattag tgctgagatg catttgtaga aataacaaat cataaagaac 63180 cacaatgtgc ttgattgtta tttgtctgag ccagagaaag aacaaaaagg cacgaattca 63240 gaacaaagat aactgccaag aagaaagtga agtaaatgct ctccattaga cttcaatcta 63300 caagttactc ttctactccc tctggatttg aacctaatgt tacaaagtgg agatacagcc 63360 agactcttga tagaaatgag gctccaagtt acctgaaaaa tgtccacctt gatcatccct 63420 tcaaatatat ttcatttaat cacattctaa atatgctctt cacataagag aaattaactt 63480 cttaaatccc aatttccctt tctgctaatt atgcaaaaaa agattgtaca cagataatta 63540 aaaggtgtgg gtaaagttaa taaaagagac agtgggaagg aagaggagac ccagatcctg 63600 agcctaatga agtggatgaa aaaggggagc tctctgatgg tgtcagtgct gatgatgata 63660 aatgattcaa caccgcacat aggctcccta aaaccggaac ccttctatca tctcttgact 63720 cccactgata aaaagcaaat gaacttttgt ttctaattat tctggaatgt caattgtggc 63780 agaaaaaatt agtttagctt taaaagtcaa ttccaaacaa atgtaccatg caaatgtcaa 63840 ggactgatcc tgaaatatgg agtttccaag aggccaaggg aataagtgag caagaaagaa 63900 ctgaagcatt gtcactcatc atggccagca gtacaaattc tagcaccagg aaccaaactc 63960 tgcttcctgg tgtggagatg aaaagggaga gttccctggt ccatccatca caggacatgg 64020 gacaggggta tggctctctg ttcagcttcc tcaagctcaa actccttata ggagggggag 64080 catgcagaag ggtaggtgca ggagccaggg caagtgcatt gaactccggc cccacagtag 64140 tgtctggggt gggtgcctgt gactcctgaa gccccagtgt tatagtgctg ttttaactct 64200 gccatctgca gatggcttaa gtggtaacca gctcagtgcc ctcttggtgg ccatgtcctc 64260 gtccataggc caggaagagt caggtcacac acagacttga aggatgaatg caggagtttt 64320 attgagtggt ggaggtggtt ctcagtggga tggatgggga actggaaggg ggatggagtg 64380 ggaagatgat cttcccctgg agtttggctg tccagggcca ttctcctgtc tgattgtccc 64440 cagctgaact cttcttagtg ttcagaccct ccttctcttc tctccttctc tgccatgctg 64500 ttctgccatt cgtctgctca tctcctcctg gagcctggga tttggggttt atatgggtac 64560 aggatagggg catgtagctg gccaaaaggc aactttttgg gcacaaaaac aggaatacct 64620 gttctcattt aagaccactg gtttccaggc ttgagggtgg ggtctttgct gggaaactgc 64680 cctctttcac ccagtatttc cctttctctt gtccatgtaa gagagttatt tcccttccta 64740 atccaacact caccccttct ttggttcacc tctcagattt ctaaataaca caaggtgcta 64800 ttctttccat tatgtgcctt ccctcacctc tctgaagtca taagcttcct ctcatttctg 64860 tctttaggtt gtgctgctct acgcctctac ctacgtcctg gtgtccctca gcatagacag 64920 ataccatgcc atcgtctacc ccatgaagtt ccttcaagga ggtgagctgg ctttaccagg 64980 tgctctttca taaagaactg tccttgagtg agggtaggat cattttcact aatattttac 65040 tcttaataat agtgatcttc ctcctctttc cttctctttc ttctctcttc attctcctct 65100 tccacctctt tcctcacttc atgggtctga ttgtctaaaa agatgtacaa aagaaaactt 65160 agatgcctgg aaaaatgccg atggttccca tggacagccc agagccacta aggaaggtgg 65220 gtggctgacc cactttgtga ccattcagct tgatgctgat gcttccatct ttttcctcta 65280 gagcagtgtt gacatgcata cctgtccaaa gaaatgaact ctcccacact aacttctcat 65340 tttccagaaa caaacacctt gttctcctta tccaaaacca tagaaataat tggaaagatg 65400 tttttaattg atcatcgtat tgggaaaaaa aaataaggaa actctctttg atccagaaat 65460 ggttagggat ccctaagaaa aggaagcaga tgggtcagag ggaaggctga gaccacacag 65520 cccacaaaac ccctaggaga tgctgaagtg ggatgggagg ccttaggagc acttcctgaa 65580 caggctgcat caatgtggag tgtaggagag gacccgaggc aactgacaag gtgatttctg 65640 aagtacaaca cagaggatta atcacagcaa gtttccctgg atttgaagag gcagagaggg 65700 gccctgggga gcagtaatgc cctagaggaa gggtgagtac atattcacaa gactagctgc 65760 ctactgctct gcccacaatc agagaccact ctcctccata caccctgaaa gcaaatacaa 65820 agccattgtt tagcaacctg ttctcccttc ctccagataa cttcgaaaac tgataaagaa 65880 cctaacaaaa aatcttgacc acaaaaatga gtgcaatcaa atattattta aaaagtgaca 65940 aaatccaaac tgtagaaaac agataatacc tttaaaatct cattccacac aatttggatc 66000 tagggaagca aatttaatag aagtagcaga attttaggat aaatataatt aacgtcatca 66060 aggatctaca agaagtggag tgaaataggg taatttcatt tactattgac aggggtataa 66120 gtaaacacat cttattgaaa tataaaatgt gcagcccttt gatatgactt cttggtatct 66180 gctctggaga aacacccaca cgtgtgcatg tatacatatg tgatgtatat tgtggcactg 66240 cctacaatag caggaattca tcgctaacct tggtgtgtct cagtggagga atggctaact 66300 agtctatgga agaagtttca gtaccttctg tttattgatt gcatactagg tgtcattcat 66360 gattctaact gattcataca tattaaatat tttaatattc ataatatctc tgtgaggtgg 66420 gctctattat tatctgcatt ttacaggtaa ggcaatcgtt gttccaagag tgaaagtaat 66480 ttgcccaagg tcacagctag taagtgcagg aacaggattt gaacccacac agtctgggtc 66540 tagctccagc gccctcaaat gctatatagc ctgcctctca atgtggaagt ggtagagcca 66600 tgggcagtaa tatgcatcaa catgaacata tccatattgt atgctgagtg acaaaaacaa 66660 tatgcacaaa aatccatgtg aacgataaca ttaaagtcaa aaactcaaaa caatgctaga 66720 tattgtgtac agaaagacag agaggagcag aaagagagaa cacacaaaag aaaactccag 66780 gaaaaataaa aaactatttg caaaaacaca caaaacttga catttgacct cacttctagt 66840 tatgggagtt agaccagtgg tgtgaccacc acaggaactt atatgcaagg tggtaatttt 66900 tacatgaaga acatatcaat gtgttgtgtg caattaaaat gaatttattt tgatcatgct 66960 tgttatgcct actgtacagc ataagacata tgagtaaaaa tactaaattg tatacttaag 67020 aatttgctgg ggatctgttc caagatggcc aaataggaac agctctggtc tgcagctccc 67080 agcatgatcg atgcagaaga caggtgattt ctgcatttcc aactgaggtg cctggttcat 67140 ctcactggga ctggttggac agtgggtgca gcccatggag ggtgagccaa agcagggcag 67200 ggcatcgcct cacctgggga gcacaaaggg ttgggggatg tccctttcct agccaaggga 67260 agctggggca cactgtacct gggacactcc tgccaaatac tgcacttttc ccaaggattt 67320 agaaacgagc agacaaggag attctctccc atgcctggct caggaggtct ggagccttgc 67380 tcactgctag cacagcagtc tgaaattgaa ctgtgaggca gcagcctggc taggggagga 67440 gcgtccacca ttgctgaggc atgagtaggt aaacaaagtg gcccggcagc tcaaactggg 67500 tggagcccac tgcagctcag caaggcctac tgcctctata ggctccacct ctgtgggcag 67560 gacatagctg aacaaaaggc agcagacagc ttctgcagac ttaaacgtcc ctgttcgaca 67620 gctctgaaga gcacagtggt tcttccagca tggcgtttga gctctgagaa tggacagact 67680 gcctcctcaa gtgggtccct gacacctgtg tatgctaact gggagacatc tcccagtagg 67740 ggccaacaga cacctcatat aggtgggtgc ccctctggga caaagcttcc agaggaagga 67800 tcaggcagca atgtttgctg ttctgcaata tttgctgttc acagcctctg ctagtgatac 67860 ccaggcaaac agggtctgga gtggatctcc agtaaactcc aacagacctg cagctgaggg 67920 acctgactgt tacaacggaa actaacaaac agaaaggaat agcaccaaca tcaacaaaaa 67980 ggacatctac accaaaaccc catctgtagg tcaccaatat caaagaccaa aggtagataa 68040 aaccacaaag atggggagaa accagagcgg aaaagctgaa aattctaaaa atcagagcgc 68100 ctcttctcct ccaaaggact gcaactcccc gccagcaatg gaacaaagct ggatagagaa 68160 tgactttgac gagttgacag aagtaggctt cagaaggtcg gtaataacaa actactcctc 68220 cgagctaaag gagcatgttc aaacccattg caaggaagct aaaaaccttg aaaaatggtt 68280 agacgaatgg ctaaatagaa taaacagtgt agagaagacc ttaaatgacc tgaaggagct 68340 gaaaaccatg gcacaagaac ttcgtgaggc atgcacaagc ttcaatagcc aattcaatca 68400 agtggaagaa agggtgtcag tgattgaaga tcaaattaat gaaataaagc gagaagacat 68460 ggttagagaa aaaagattaa aaagaaacaa acaaagcctc caagaaatat ggtactatgt 68520 gaaaagacca aatctacatt tgattagtgt acctgaaact gatggggcga acagaaccaa 68580 gttggaacac actcttcatg atattatcca gaacttgccc aaaatagcaa ggcaggccaa 68640 cactcaaatt caggaaatac agagaacacc acaaagatac tcctcgagaa tagcaacccc 68700 aagacatgta gtcagattca ccaaggttaa aatgaaggaa aaaatgttaa cggcagccag 68760 agagaaaggt caggttaccc acaaagggaa gcccatcaga ctaacagcag atctcttggc 68820 agaaacccta caagccagaa gacagtgggg gccaatattc aacattctta aagagaagaa 68880 ttttcaatcc agaattccat atccagccaa actaagtttc ataagtgaag gagaaataaa 68940 atcctttaca gaaaaacaaa tgctgagaga ttttgtcacc accaggcctg ccttacaaga 69000 gctcctgaag gaagcactaa atatggaaag gaacaaccag taccagccac tacaaaaaca 69060 tgccaaattg taaagaccat tgatgctagg aagaaactgc atcaactaac gggcaaaata 69120 accagctaac atcataatga taggatcaaa ttcacatata acaatattaa ccttaaatgt 69180 aaatgggcta aatgctccaa ttaaaagaca cacactggca aattggataa agagtcagga 69240 cccatcagtg tgctgtattc aggagactca tctcatgtgc agagatacac ataggctcaa 69300 aataaaggga tggaggaaga tctaccaaga aaatggaaag caaaaaaaag caggggttgc 69360 aatcctagtg tctgataaaa tagactttaa accaacaaag atcaaaagag tcaaagaagg 69420 ccactgcata atggtaaagg gatcaattca acaagaagag ccaactatcc taaatatata 69480 tgcacccaac acaggagcac ccagattcat aaagcaagtc cttagagacc tacagagaga 69540 cttagactcc aacacaataa taatgggaga ctttaacacc ccactgtcaa tattagacag 69600 atcaacgaga cagaaggtta acaaggatat tcaggacttg aactcagctc agcaccaagc 69660 agacttaata gacatctaca gaactcttca ccccaaaaca acagaatata cattcttttc 69720 agcaccgcat tgcacttatt ccaaaattga ctacataatt ggaagtaaag cactcctcag 69780 caagtgtaaa agaacagcaa tcacaacaaa ctgtctctca gaccacagtg ctatcaaatt 69840 agacctcagg attaagaaac tcactcaaaa ccgcacaact acatggaaac tgaataacct 69900 gctcctgaat gactactggg tacatagtga aatgaaggca gaaataaaga tgttctttga 69960 aaccaataag aacaaagaca ctatgtacca gattctctgg gacacattta aagtagtgtg 70020 tagagggaaa tttatagcac taaatgccca caagagaaag caggagagat ctaaaattga 70080 caccctaaca tcacaattaa aagaactaga gaagcaagag caaacaaatt caaaagctag 70140 cagaaggcaa gaaataacta agatcagagc agaactgaag gagatagaga cacaaaaacc 70200 cttcgaaaag tcaatgaatc caggagctgg ttttctgaaa agatcaacaa aattgataga 70260 ctgctagcaa gactaataaa gaagaaaaga gggaagaatc aaatagatgc aataaaaaat 70320 aataatgtgg atatcactac caatcccgca gaaatacaaa ctaccatcag agaatactat 70380 aaacacctcc atgcaaataa actagaaaat ctagaagaaa tggataaatt cctggacaca 70440 tacaccctcc caagactaaa ccaggaagaa gttgaatctc tgaatagacc attaacaggc 70500 tccaaaattg aggcaataat taataggcta ccaaccaaaa aaagtccagg accagaccaa 70560 ttcacaactg aattctacca aaggtacaaa gaggagttgg taccattcct tctgaaacta 70620 ttccaatcaa tagaaaaaga gggaatcctc cctaactcat tttataaggc cagcatcatc 70680 ctgataccaa agcctggcag agacaaaaca aaaaaaagag aattttagac caatatcctt 70740 gatgaacatc gatgtgaaaa tcctcaataa agtactggca aactgaatcc tgcagcacat 70800 caaaaagctt atccaccatg atcaagtcgg cttcatcccc gggatggaag gctggttcaa 70860 catatgcaaa ttgataaacg taatccatca cataaacaga accaatgaca aaaatcacat 70920 gattatctca atagatacaa aaaaggcctt caacaaaatc caacgccctt catgctaaaa 70980 actgtcaata aactaggtat tgattgaaca tatctcaaaa taataagagc tatttatgac 71040 aaactcacat ccaatatcat actgaatggg caaaaactgg aagcattccc tttgaaaacc 71100 ggcacaagac aaggatgccc tctctcacca ctcctattca acatagtgtt ggaagttctg 71160 gccagggcaa tcaggcaaaa ggaagcaata aagcgtattc aattaggaaa agaagaagtc 71220 aaattgtccc tatttgtaga ccacatgatt gtatatttag aaaaccccat tgtctcagcc 71280 caaaatctcc ttaagctgat aagcaacttc accaaagtct caggatacaa aatcaatgcg 71340 caaaaatcac aagcattcct atacatgaat aagagacaaa cagagagcca aatcatgagt 71400 gaattcccat tcacaattgc tacaaagaga ataaaatacc taagaatcca acttacaagg 71460 gatgtgaagg accttttcaa ggagaactac aaaccactgc gcaaggaaat aaaagaggac 71520 acaaacaaat ggaagaacat tccatgctca tggataggaa gaatccatat agtgaaaatg 71580 gccatactgc ccaaggtatt ttatagattc agtgccatcc ccatcaagct accaatgact 71640 ttcttcacag aattggaaaa aactacttta aagttcatat ggagccataa aagagcctgc 71700 attgccaaga caatcctaag caaaaagaac aaagctggag acatcaagct acctgacttc 71760 aaactgtagt acaaggccac agtaaccaaa acagcaaggt acttgtacca aaacagagat 71820 atagaccaat ggaacagaac agagccctca gacataacac cacacttcta caaccatctg 71880 atctttgaca aacctgacaa aaacaagaaa tggggaaacg attccctatt taataaatgg 71940 tgctgggaaa cctggctagc catatggaga aagctgacac tggatccctt ccttacacct 72000 tatacgaaaa ttaactcaag atggattaaa gacttaaatg ttaaacctaa aaccataaaa 72060 accctagaag aaaacctagg caataccatt caggacatag gcatgggcaa agacttcatg 72120 actaaaacac caaaagcaat ggcaacaaaa gccaaaattg acaaatggga tctaattaaa 72180 ctaaagagct tctgcacagc aaaagaaact accatcagag tgaatgggca gcctacagaa 72240 tgggagaaaa tttttgcaat ctacccatct gaaaagggct aatatccaga atctacaaag 72300 aactcaaaca aatttacaag agaaaaaaca accccatcaa aaagtgggca aaggatatga 72360 acagacactt ctgaaaagaa gacatctatg cagccaacag acacatgaaa aaatgctcat 72420 catcactgat catcagagaa atgcaaatca aaaccacaat gaaaaaccat ctcatgccag 72480 ttagaatagt gaccattaaa aagtcaggaa acaacaggtg ctggagagga tgtggagaaa 72540 taggaacact tttacactgt tggtgggagt gtacattagt tcaaccattg tggaacacag 72600 tgtggcgatt cctcaaggat ctagaactag aaatactatt tgacccagca atcttattac 72660 tggtatatac ccaaaggatt ataaatcatg ctactataaa gacacatgca cacgtatgtt 72720 tattgctatt gcagcactat tcacaatagc aaagacttgg aaccaaccca aatgtccatc 72780 aatgatagac tggattaaga aaatatggca catatacacc atggaatact atgcagccat 72840 aaaaaaggat gagtttgtgt cctttgcagg gacatggatg aagctagaaa ccatcattct 72900 cagcaaactg tcacaaagac agaaaaccaa acactgcatg ttctcactca taggtgggaa 72960 ctgaacaacg aaaacacttg gacgcagggt ggggaacatc agacaccggg gcctgtcagg 73020 gagtgagggg ctgggggagg gatagcgtta gcagaaatag ctaatgtaaa tgacaagttg 73080 atgggtgcag caaaccaaca tggcacatgt atacctatgt atccaacctg cacattgttc 73140 acatgtacaa tgataattta aaaaaaagaa tttgctaaca agataaacct tatgttaagt 73200 gctcttgcca caaaaggaaa aaactaaaca aaacaatact aaagggggac aggaagaagc 73260 ctttggaggt gatggataca tttatggcat tgcttgtaat gatggttaca ggaatgtata 73320 catatctcca gacacattaa gtggtatgca ttggatatgt atagcttttt atatgccaat 73380 tatacatcaa taaagtggtt tagaagttaa ttttaaaaat agaaaatata cttgtttcct 73440 gggtttcttc tcggtcattt ggtgtgtctg ttttgtgaag ggttgagacc tgtaccaagt 73500 tttctgggca ctgtaaagcc ctagttatta tgatagggga ggcaggaaat tgatgaggca 73560 ggggagatag gagagacatt tcgtgacata ggtatgcaaa aatgtgtcaa tgaagcatca 73620 aattctgtaa aatatttgta gagatttatt ctgagtgaaa tatcagtgac aatggacaaa 73680 gccctcagga ggtcatgaga atatgtgccc aaggtggtca gggtgcagct tggttttata 73740 cattttaggg cgacatgaac cttcaatcaa acacatttaa gaaatacata gggttggtcc 73800 gaaatggcag ggttgggtag tgggggatgg ggtgggcgaa gcttccagat tatagttaga 73860 tttaaatttt ttctggttga caattggttg agtttatcta aagacctggg atcaacaaaa 73920 aggaatgtct gagttaagac aaagaattgt ggagaccaaa cttcttattt gcaggggaaa 73980 cttttaggtt tcctcttcag ggagactatg ttgtaaaatg tttctcatca gacttaaagt 74040 ctgtgttgat gttaacgctg gagaggtata atgagacaca cctgaacccg cactgcccat 74100 catggcttgg aacagcctct caggttaaat cttaaaagag ccttggctga ggaggaaatc 74160 cattcggaag gttggggggc cttataactt tatttttggt ttacattcat ggatttgtga 74220 tacacttttt tttttttttt tttttttttt tagacagagt ctcactctgt cgcccgggct 74280 agagcgcagt ggcgcgatct cagctcactg caacttctgc ctcccaggtt caagtgattc 74340 ttgtgcctca gcctcccgag tagctgggat tacaggtgtg catcaccacg cctaattttt 74400 gtattttagt agagatgggg tttcaccgtg ttggccaggc tggtctcaaa ctcctgggct 74460 caagcaatcc accttggcct tccaaagtgc tgggattata ggcatgagac actgcacctg 74520 gcccgtgata cacttattta tccatctatt tgtttatgcc tagccgactt tagaaagggt 74580 tgaatgtggt ggacaaaagg acatcgacgc caaagtattt taaggtgaag aaatataagt 74640 gaaggaaaaa taagtatagg aaattgcagg agggaagtcc caggaaactt gttagaggta 74700 cagacttgag acccatagcc agagggtgac atgatgaatt acatgtttca ccatattcac 74760 taggttaaaa aattagctgt ttgctcgtgg aaaatatgtc tagttctggg agacactgtg 74820 taatatcatc aagagtgtcc taaattatca gaaaggcagc aattaatatt atagtgcttt 74880 tctaaagatg taaaacaact tattccctca ctacaaaatt aagagaggct caacataagg 74940 tgcttggaaa atcctcatca tcagtagctt ctgggaaaga tgaaagctta gaaacacatt 75000 agccagctgc cttcctctgc ccaggcccaa cgaaagtcac tgaagaaatc taaaaacagg 75060 gggagacctg catctggaat gagagccaag gaaagaagcc atccaaatac cagaaacttc 75120 taagaattcc cagcacacga gggagcagat gaaacacgga agccaagtgt ataatgtata 75180 attcagcccc cgggagaact ccctggcctt gtagaggatg aactgatact cacaagttta 75240 tagggtgagg gcagccggtg agaacgcgac acgagaggtt ccaggaagcc caacgcggga 75300 gtcattttag taccgcagct tgtcagaatt taagggcagc tgagaggcag ggttcggagt 75360 ttatgcggct cagctgagag aaagccgtag aaagaagaga ttccccgaga gtggcagggc 75420 tctctgggag agtcatggag cagggagaaa ccaggaggga gtcaaatgta gctgtgcagg 75480 cacaaggcaa tggccgctta actgagggga ggccatattt tatttatttt ttactgctat 75540 ttactgaagc agtatttttc ttagccagca actccagaaa agttgacaat tttaaaggtc 75600 ttcaccaaaa atgaatatga gaataattag aaaaatatca aaataataaa gagaaatatg 75660 cagtgttata ttaaaatgta atataaaact ttgataatta aaacaatgct ggaaccagaa 75720 taacacatat aaatcataca aaatttcaaa tcagttggca aaaaatgaat tagtatacgg 75780 tgttgaaata gctgtctggc cttttttcag aatattagat caccacccac catagctaat 75840 aacaaagtaa attttagttg gattgaaaaa attaacactt caaacataaa aggagtaaaa 75900 gaatatttgg gtaacacctt cataatttca gtgaaggaaa ggcctttcca ggaaccatat 75960 caaaagcaga agcaagaagg aaaatatagt tttttactac ataaaaattt aaattattta 76020 tgtaaataat aaatatccat aaacaaactt aaaaagcaaa attataaatg gaaaatattt 76080 ttatgtaaca ggcaaagaaa aatatccttt ttataaagaa gtctggcaaa gaaataaaaa 76140 cattctaatt gagtaaatgg gcaaagggca tgaacagact aacaagaaac aaagaaacat 76200 aaatgagacc aggcgctgtg gcccacgccg gtaatcccag cacttcggga ggctgaggtg 76260 ggtggatcac ttgaggtcac aagtttgaga ccagcctggc caacatagtg aaaccctgtc 76320 tctactaaaa aaatacaaaa attagctggg catggtggca tgcacctgta atcccgctac 76380 tcaagaggct gaggcacaag aatcgcttga acctgggaag cggaggttgc ggtgagtgga 76440 gatggcacca ctgcactcta gccctctagc attggcaaca gagcaagact tcaccagaaa 76500 aaaaaaaaaa aaaacaacac cataaatgaa tagaaaatgt atagaaatat tcattttgac 76560 tactaattaa agaattgcaa aattgaacat ttggatacaa aattttacca accacataac 76620 aagattaaaa ggaagaatta tccaactatt aggagagtat aaggaaattg gtacttttgt 76680 tgttacagtg agagccataa atagtaggca cttttgaggg aaatgtaaca atatttgtca 76740 aaatttataa atcttctgtt tctaagagtt tatcctaagg aataacaaga actgagaaaa 76800 atagatgaat ataaattatt tataataaaa aatggaaaac aacttagata ataatcggct 76860 attgataaaa ttggagtaca gtataaccac cggaaaaaat gttatttatc agtgcttttc 76920 caattgcact tcccacagtg acccccagag ggctcatttt gctggcctgc tccagggcag 76980 atctgggagc tgctggctgt ctcagtttca accaaagata cctgagcttt caacactttc 77040 ctatactggg ttcgagataa aattatattt gaagaaagga tcttactacc tgaaaaaaaa 77100 tgccacttgt acaagttcat atttcttaac aggaaaagat ggtcataaca ggcttttcag 77160 aggaaaaaaa ttaggttaca aggtaggatc tgtatcatga tctcatttct aaatgtgtaa 77220 tctatgtatt atatatgcat gcgttatcaa aatttaagct tgacgtttct ggttggtgcc 77280 actatggatt tttttccttt tcgcttattt ttatttgcta gtgtttctat aatcaatgtg 77340 tgtaacttat acgattttat aaaaaggtaa atgagttaca tggaaaagag gaaggctaag 77400 cggcagagaa gtacagaaat ggacaagagc acatggaaga gggagtctga ctttccgggg 77460 gtgagaaaca tgagacagtc taccttatat gcaaacctgc atttcatctg ttcgatcctg 77520 gatccttcag ccctgagaag tcactcttca tggcaaatgg gctcagctgc ctggaaggcc 77580 atcagtctcc ctgctgtggc agctgcgtca cagcctaaga gagtggggct ttcacagtgt 77640 agccccagca ccagtaagag aaaaacagct ccaagcctat accctgctgg gcctttgggg 77700 aaacatcttc ggagaccttg gtagaattga ttctaaagta tgattctata ctctcttccc 77760 tgtccatccc tctcaaaagt gaatgcactg ttcatccatc aagtggaaac tttgtggggc 77820 ccaggagtca cacgttgccc ttaagagtgc cctggaacct atagaagaag atgacattag 77880 aattctaacc attgaaagaa caagagcaca gggggcagct actaatgtca cccaggacca 77940 tagaaaccca tcaggcttca cacccccacc atcaagaaga accccctcca gtcctattac 78000 ctgccctctt catcccaccc tgcttctttc ttaatctgaa ctcccactgc ttctctccac 78060 gcctggtttt tctctgttcc tttagggacc agctccccta tgccatcaaa ctcctaatgg 78120 gaggctccct ccacctcctg cctcctgagg tggctgattc ccttaagaca tctcaagagg 78180 atgctcctca accttccttt ttaggtacct catggcctgg tggtggtgaa gacattttcc 78240 taccgttcta gaccacctcc aggccttttc tccttcagta ttgcatacgc atgccctctc 78300 tgtttctctg atgctcatgc tatcagtcta gactaccttc tacaacacct ccccatatgt 78360 ctgtgcccat atggccatgg ccctcatcca gtgaagatgt tgacactatt ctcagtctct 78420 cacctttcat actgtcctaa tcacaggtga ctcgatgtct acataaacta agtctagtga 78480 gagggcttca catgatgact cacagagctt gacatgttcc ctgcatttga aagcattgtg 78540 gaccaatgac tacatcacac ctgagaatgt tgaagagaag ctggctggcg ctgtggtcct 78600 agcccagggg gctgatgtaa aacctgcatc atgaagtttg cctgaggctg tgttaaaaaa 78660 gatcctgccc cagacatttc tgccagagaa agaggcctcc ctgaaggtca ccagggaggg 78720 tggaaggtca ctgcccaagt caaggaagtg gccaccagca agaccccaca ggataatttc 78780 caaaggaccc agaaaagttc ctcaggggac caagaatcag ctttggatgc agccaggcac 78840 agagagcaca aagccctctg atgacagcag cagtcaagca agaactctgt cttcttcctc 78900 ctcctggttc cctgtacccc agctccagag agaccccaat gtggatagca acctggggga 78960 ggaggaggaa tagcagacaa ggatagaaag cagaagggct ggtacctctg ctggacttcc 79020 tacttgaagc aagcccacct agggagaaaa gacttaactt gaaatcttct tgggaatttg 79080 gggttttttt attgttatct aggattttaa ttactaattt tcatgtaatt attaaattga 79140 ccaatgttta ccacttaatg tgtcagtcac ctgtgagtca tcactaacat caagggactc 79200 gagtttccaa atgcaggcag gaaaacctct ccccctgtcc ccagtggatt accggttgca 79260 tgtaaggaac aggaaagacc ttaatcagat tgctattata attctacccc aagactcctg 79320 cttgctcagt gggccaataa caactctttt ctacatgaat ctaatatctc ttttcagtgc 79380 atacaattca ggaagaacag aaccctagat attattctcc taaatatttt gggtttggat 79440 tttaatagag tccctagttt cctctagatt tttctcactt cttgtagctc gaccacagtc 79500 aacacactgt cgaacaacac cacctgactc tacattccaa ccccacccaa agacacacac 79560 ctgctttcca agttgaaagt aggggagcaa ggtggcctct tatttctgga agaaggtccc 79620 agagccaatg agcacagaaa gcccagctag gtgagggatt aagatgagag tttcaacaac 79680 agcttgacag aaagcatcac atcataacaa cgggtgtatt ttaaaggtac ttgcttatgt 79740 attaattgtc tctctccagc cccatcataa ccagctgagg tggccagagc aggtattttt 79800 tataccaatt taaagaaaag atgaggctga gactgcatgg tttagccaag gtcagaatat 79860 tgcaactaaa gtccagtgtg cagacatagc taccaggttt ctgggctggt tttgaatgca 79920 ccctactctc cagaacgaag ttcagtgttc tttctctgcc ttgtaagtcc acccatgttc 79980 ctaccaaaaa aaaaaaaaaa gaaagaagtt tccttcccat ttggcaaata actctcaaaa 80040 actgtcccag tgctttgcag tgctgggtac agtgaaaaga tgccacgtgg accaaaggct 80100 ctagccctgc ctggtaacaa gagactgcat atgggtagac acaactcagc atttgcaccg 80160 caacttacca aatgtacatg gtacaaactg agctccctaa tactgcagga atggatgcgt 80220 cagcatctca agtcagatgg gtaaatcagg aaagaaaaag caccaacctt aggccaggca 80280 atgtgctggc ttctgttcaa gcttcccttt gtaatcttca cattgacaat gtatggagat 80340 actgtatccc tgtttacaga gaaggaaact gaggctctgg gaggttcttt gaggtccagg 80400 gtggctgccc cacagtgatc cttttctata gcagactcca ttgtgctccc aaaaatggtt 80460 gccacatacc cagacattcc tctcttttct ttgggcagaa aagcaagcca gggtcctcat 80520 tgtgatcgcc tggagcctgt cttttctgtt ctccattccc accctgatca tatttgggaa 80580 gaggacactg tccaacggtg aagtgcagtg ctgggccctg tggcctgacg actcctactg 80640 gaccccatac atgaccatcg tggccttcct ggtgtacttc atccctctga caatcatcag 80700 gtaagaagcc gtcaggacag gaccacacgg gggggtgggg cggggggggc tttcctgttt 80760 ctccagctgt tgctctcctc cccaacagac ccatttttcc tagtgccctt gagggaactg 80820 accaggccac aagattttat gtgtagctac cataggctaa gcccaatttc ttcaaagtag 80880 agtaaggaga agggaattaa caattactgg gtatataggg caggcattgt gctaaatagc 80940 taacaattat cacattagcc acagtataac cctgtgaaat aatttccatt gccccaattt 81000 aatgaatgat gaaactcaag ctcagagtga ttaagtaact tattcaacat caaacaggat 81060 tgatatccag gtttttctga aatcatacca tattatttct tttatatctc gcagccttcc 81120 aaatataagg caaattacca gtttcaggga ttttgtaaat gaaaagatag acatacttga 81180 aacaaactga acacaaaact cagtatgcac taatatgcta aactgtctat gcagtggagt 81240 cagataatgg cagggaatat attttggaag ccaccattga aggaggaaat gattcaggta 81300 ggataaggga gaagtgggga ggaagcagag tctgtgatga ccagaaatca gagtgagtgt 81360 agaggcagag tggacaggta cacagtgcca gtgggacaga agttggcagt gagctcctcc 81420 cagtgactgg gggaggctca gttgtgaatg accttggcaa aaaagtcata ggaagtcctt 81480 tgtcctgcag ccaatggtga gctgtagagg gtctttcaac agagattagc acaacaacct 81540 ggtcaaggta gggtctcact tggccatgcc atgtggcagg atcaccctct gaaatgggct 81600 ctgcatgtgt agatggggtg ggagactaca ggaagagacc tggcacattg tgtgtatcct 81660 tgagccatga tgatgctgca ccttttgggt aggtctaagc ctgccatagt gtgtcatata 81720 acacattgta agcaaaggaa gattatcagc ctttgttttt gatagtgtaa agagagctgt 81780 gataaaaatc cttgtactta aaactgtaca tgagtctctg gttatttcct cataactcat 81840 tcttgtggaa ttactagatc aaaggtatag atcaaagatg atgcacattt taaaactttt 81900 gatgcagagt cacaagctgc ccttgagaaa agctgtattg cttcttggcc tgttagctaa 81960 gatcacttgt agaaaaggta tattctgggc aataccatac aagggctctt gttttctgct 82020 cccctgaccc aatggaaggt agcactatta ccttactaaa tctttgccaa cctaagagtt 82080 taaaaagtat ttcattgttt taatatgcat ttctttaatt actaagctgg tggcatgttt 82140 ttcaagtgtt ttctgataca gtgggagtca ccttttcctg ctcattattc atctttagtc 82200 taataaaata ctatagctgg gagaaacgtt atccatcata tggtcaaacc cctgaatttt 82260 tcataagagt agaattaaga ctaaaagaag ttaactgcct tgcccccgcc ccctcatcag 82320 agattgagat gggcaagcac atagtgacct caaaagccaa cccagcagcc tttccaaaat 82380 ggggtgttgt ccagtcatct ctgctgaatg gacaacttaa caccaacact ttattttgac 82440 ttattgccct ccactccatc aagctgagct tgagagaaag tttgaaggag aaaaggttat 82500 ttagacaact atccaaggta agtcacagcg catgggaagg ggcccatggc agaggagaca 82560 ggcaagtgag ccacagcggt cagagagcat ttggaagaaa gtggcttgtg tcatcctgag 82620 caactgaggc atcgatttca gtggcagcac atgtcctggc ttcactgctg attgatttcc 82680 catcaactca agaaatgaac tccagtcaaa gtccccgctc agcagagtgg atgctgcagc 82740 acatggacca cgcagctcag gttatcctgt atctatgatt tccccattaa tttgggctgc 82800 tttttccacc aggacttctc ctcaaacttg cctgtgggct agctagtgtg tctttttcgt 82860 gtccttgaaa gggcaaaata caatgtgttt gctgattgag ggaaatgatt tcaaaaactg 82920 gtttccctca gctctcacca agctaaagcc tctggaaggc cagatcctag ctccttgctt 82980 ccagcccgtg acggtcatga aaactcagcc atgacctcca gccatccttg agcttctctg 83040 aagcatttcc tacctgacaa gaggctcctc ttccatcacc ttccctcttt cgtggctccc 83100 tgctgctgaa gaaacaactt ctctcttggg gactaacatc ctctacctcc ttcagcaaca 83160 actatcttct caaacaagac caggccctgg gggggcgagt tttgtgagga acttgtttcc 83220 aactagtacc tggcataggt gctacaattt catctcagat ataaggttca actcttattc 83280 tgtctttatt acctatattc tggccccctg ggctcaattc tctgagtaag gttaaattct 83340 tcatttcaag cttaaataga caaggaaaac agctcaagga aagtgttcac tcgtgttcac 83400 catgcctcat tctccttcat gcatgctata tatgctacat ttaccaaatt gacagaaaaa 83460 aaaacatatc ttagttgttt tattttgcat ttctttcatt acaaatgaga ttgaatatat 83520 tttatatgct ttttgccatt tttgtttttt ttaaagtact tattaggttg gtgcaaaagt 83580 aattgcggac tttgccattg aaagtaatgc cacttttctt gtttaaatgt ttttattttc 83640 tctattctct atctttagaa attattcata caataacctt tttctttttg catatgttgc 83700 aaatatttct cctaatttgt catttgcctc tctattgagt atggttttat tttgtttttg 83760 attattaaaa gtagtgattg acgtaattaa gaaaaaaaga aaaagcacaa ataactaact 83820 cagtggcttt tctgccacaa atacctcatt gttttactta ttgcccagct tcgtatgcat 83880 ttaagtatct gctaggacaa gatctacttg ttttttttca aagattccct ggctgcttca 83940 tggtgagctg ctgatgcctc acctgcactc ccagctccag ccatggaaca aacacccctc 84000 tggcccatgt gcatcactcc catgcctgaa cactctgcca agctcacctt gccttgtttc 84060 acccaactag ttcacatccc ttgtgtctca tttccaatac caactccaca gtagagcttc 84120 ccttgccaac cctggaccaa gaggcacctc aggtcctcac tccctaacct ccaacctcac 84180 tttgtccatg tcgtcatcta gacttcatgg cagtttgact gtatctcatg agtgcaggga 84240 ctgtggcctc ttcatttctg gatttcacat ccagcacaca ctaaacagtt ggtgaatatt 84300 agattgaatg aataacgcaa taaattgcac cgaacaacag atgtgtcatg tcactctctc 84360 tactctttct ctccctctct cattctctct ctctctgtct ctcacacaca tcacacacac 84420 acacacacac acacacacaa acacacgtgt acacatactg ctaatataga aatttctggc 84480 tatctaatgc ctagatcagt ttttggcata tgatagctcc tccataaata tatgtgagag 84540 gaaagaagaa agggagaaaa gaaaggaggg gggaagaaag ggagggaggg aaagagagag 84600 agagagaggc agttgtattg ttggtggcaa actctcatga gagctgcgta tgaataaaga 84660 tgtagctgtt ccatcatcca ctaaatcagg ctcccaggag ttgaaaccat agtgactgac 84720 agcaaaggca atacattgtt tttctgggtc aaaacaacag gagttgtttt gaaattcact 84780 tgacataact gtctaattgt tgctggggag gttattagcc ctggtgtaat tgctttactt 84840 tagctgtgct tattttcttg ctacctaatt gatttttcat tctcttatca ttttcatctc 84900 tgtaagataa agatagaagc agaagagatt cacaaccgac aattgcaaaa aaaaaaagtg 84960 gaaaaagcac attagtcatg gatcattgat ttgtcatatg tgagaaaaat tcatttattt 85020 tgcttaggaa atgggatcac attgtgggaa agccccatgc caggttggtg cagccctgtg 85080 gatagaatac atggccatgg tgggtaaaag cgccccaggg acctggccag cactggccat 85140 gggcataagg tccaaggtca aagaggatca cagggcccac aataaaagta gtcatcaaaa 85200 tgaataaaga gagattgtaa gggtctccac taatgctgaa aacctggatg gagaggaagg 85260 tacagattat ggagtcattt tgcagggaca atccacaaaa cttatctgca atctgattga 85320 tcagataaag gaaaaaggaa aagagacaaa gccaagtgtg gtgactcaca cctgtaatct 85380 cagcactctg ggaggcctag gcaggtggac ctcttgggcc cgggagttca agaccagcct 85440 ggcagcatgg tgaaaccctg tctctataaa atatacaaaa attagccggg catagtggcg 85500 cacactggta gttccagcta ttcaggtggc tgaggtggga ggtcaaggct gcagtgaact 85560 atgatcctga cactgtactc cagcctgggt gagagagcaa aaccctgtgt ccaaaaaaaa 85620 atggggacac acagcaacgc agatgtctct ttgatgcttg atcactaagc tccaagaagt 85680 agtctgattt ggcaataata ccctagttat taggtgttcg ccatgctaac agaaaagctg 85740 gtactggttc tcactcatct gattggccct aagtaaaaag aggggtgact taggcccaaa 85800 tccctaaagc ataagacatt tcttaacttt tcccctgtgt acatggttga taaccataaa 85860 tatttgaatt attggtcaat taaatactgg ggttgcaatt gacataacca ttaactttcc 85920 atggtgagtg taaccttacc ttgcacagta tttcactttc tggggaagaa gtttccctgt 85980 tctagcaaat agtcaactta gggttgaact cactaataac atttttctca ttttttcttt 86040 actgcaggca tacaaattgc aaaaatagtc cctgggcaat tatataagaa agaatggaga 86100 tgctccaaaa aagtccctga gctttcctgg agcacttgga ggggttcact cagcaagaat 86160 gggaaaaggc agtaagaagc agagatttta acattgccat taattaagtt atattctaaa 86220 gatcattaaa agcaattagt gctttgtcgg ctactgcaaa ctgaagctct gattttttaa 86280 aataattctc aagagggaag atacacagtt ttaaaataaa gcattgcttt gtcccaaagt 86340 ttttagtcaa gatgcttaat gtagtcaaaa tatcaagtaa tattaaagaa gagtagtttt 86400 tatatttatc aaagagtacc taggatagaa aacttgctga cacttttgaa tccttaacac 86460 tttgttttcc tgttaggcac agattaaatc atgtaagaat tggtgtgata tagtataaaa 86520 aataggcaaa aaagaggaga aaggaaatta gtctctacta attttccagc accgtacttg 86580 gcactttaaa tattgtcaca tctgatactc aaaaagttcg agaggtctgt attgttaaca 86640 ccattttgta gaacctcaac tgaggctcag tgtagtagtt atctattact gcattacaaa 86700 tcaccacaaa cctagtgact taaatcaaga tacatttgtt atctcacagt ttctgtgggt 86760 caagaatttg gccgtggctt aaccgggtcc tctgctcatg caaggcagcc attcaagttg 86820 tttatccagg gcaggggtca tcagaggctg gactgggaga ggctcttttc caagctccct 86880 caggtcctta gcagaattca ttttcttgca gctgtgggat tcatggcacc ttgcttcttc 86940 aaagccagca atgcatagag acaccaacaa gacaggcact acattctatg taatcagtcc 87000 catccccttt gccacattgc attgattaga ggcaagtcac ctgctcttcc cacactaaag 87060 gggtgaggat caacaaagcc atgaatgcca gaatcaggga tcatagatgt catttaaaag 87120 actgtctaaa gtcaggactg tacaacagac aagtagagga gacccaagtt tttctgactc 87180 taaggcctgt ttttggattc taatcacagc tctccctcaa accatttggg ctaccttgag 87240 gaaactgcat aactttacca ggtcttagcc tcctcactta agaaagaagt aactccatcc 87300 agtggatcct catggtcact ttcagttgca attctatgaa cagcaagtat aagggggcag 87360 gcatggttaa aagatctgtc ccttcacacc ttgcactcgg ggaggtggga gtggtcttct 87420 ctgtgtcctc acagtaggga tccaccagtc actttaatac tacctttggt tctttctgca 87480 gcatcatgta tggcattgtg atccgaacta tttggattaa aagcaaaacc tacgaaacag 87540 tgatttccaa ctgctcaggt aagtctctac tctgcatggc ccaattcttg gctaatttgc 87600 ttctccagag gttttcttct agcaaatgtg agctagggac tccttgatac acaagcatac 87660 aggatcatat caggacccag ccggcagacc agacccacca aaggctgtca caggcgggct 87720 ctgtcttccc ccatgtgacc tccctgaaat ctaggagaag gaagggggca ctttggacct 87780 ggtcaagcta tgccagcaga gagttagcct ttgacctagg atccaagggt taccccagcc 87840 tcagatctag caaagaagca ccttggagga cacagataag aaaagacaga ctgtccaagg 87900 aggacatcac accttcagca aagatgagca taggcttttc tgattggctt gaattttcag 87960 atacataaag ctgccatctg tccatagaac aatcttggac ccttagccag taaaggcacg 88020 gtagtccatg ctttcccaac tgacacacca attcaaacca gatgaagcct aagaccacct 88080 actacaactc ttccccacat tccttctcag taaacctgaa tgcagagcct ctcgtatgca 88140 atagactctg agccctggaa gcctaccctg cttcccagga aaacattact ggacctgacc 88200 aaggtcaacc tggagaaaac acagcaaacc aaggggccaa aagaagaaag ggcttctagt 88260 tttctgttgc tataatgtga taggtctgca gaagaagact ggctccgctc agcttccaca 88320 cccctcccat tccttgtgca cacacataca cacaatgtag gctcatatac acaaatacac 88380 acaccttcac acactcagtc tcacacacac taacaatgca tactcacact tatatgcact 88440 cacacaagga caacaagcta taccacaaat atctggaata agaagagcta ctttctgttc 88500 cagatgtacc actaagagct gtgccacctg gcaaagttat ctaatccctg ggctccaaga 88560 ggttaaaata aggggataga ctggattctc cctaagccct cctcttttca gactgtgagc 88620 taaacttttg ttggaccaag acagagcttg ttttctccct cttaaagcta ctttttccaa 88680 taagactgtg aggccaccaa gaggatgcac aagtattatc gggcactgat aacttgtgtc 88740 tctttcccta gaagtatgag tggagataca taagtctggg ttcttcacct gaattcagtt 88800 caattcttct gtactcttct gcatgtcagg agtggtacag ggactggaaa tgacaaagaa 88860 tgaatagcat ggttcctgac tataggcagc ttacagtcta gggccttggg tcttggccct 88920 ggctacacag tagaatcgcc tggggaggtt ttacaatgca ccgaaaccca gacaccattc 88980 cctgagagat tctgattcac tccatctgga gtggggcatg gattttatta tttcggaaaa 89040 gctcttcagg catttttaat gttcaaccag gtttgacaat ctggtccagt gagacacaga 89100 gtcataggtg gctgaccttc acactgactg accagtgtaa ccaagagatg tgcttaggct 89160 gcttggaaat tttcaaccca cgaagaccca gtcattcagc ttggggctaa ttccagcccc 89220 catgcagatc ctagtgcttc ccttccactg gtgcagtctc cacaccctgg tttttctgga 89280 agagcaaaag caatcagaga gaataaacac aagtgaattc attctattca gtgcagttgg 89340 ctttggttaa aagttagaat atttgtccaa aaaaaaaatt ggatgaagac atccttcctc 89400 tatcagatat caaataaatg cagtaagtac tataattata atactaaaat cattgaaaga 89460 gaattatatg gacagggaaa tccaacagaa cagaaatgcc aaaggaaacc tcaggaattt 89520 agaatgtgat gaagtatttt aaactgatag agaaatagaa actgtttaat tactaatgtt 89580 gagacaactg cccatatgga aacaatcata tattagattg ttgtatcata tgctacaagg 89640 aaatacactc cttatgaaac gaagaacaaa agatagaatg agggagaaag aaagagtgag 89700 agagaaagag tgaggaaaga aaagaagaaa gaaagaaaga aagagaaaga aagacagaaa 89760 gaagaaagaa agagagagag ggagggaggg agaaaggaag gaaggaagga aaagaaagaa 89820 aggaaaggaa agatgggtag aagaagagag gcggggggga agaaagagaa agaaaaaaat 89880 ataggaaata ttgtttatat tcatgaaaaa ctgaaaagat ctgaatatcc tacaatgagg 89940 gaactgagca taataattat atagccatac aattaaatgc tacagctcta aaaattatta 90000 tagagagtgt acttattgcc atagaaatat ttctccaata tagtacatta agaaaaagaa 90060 agcagtatgg tatccctttt atagatatgt gcacatattt ttacttagcg gaatatatat 90120 gtgcctgtat agacagatga tagctagaga gagagggaga tggaaaatat caagaagcta 90180 aatgttatca atgttattgc agttatctct gagtggtcga attttaggtg atttttgttt 90240 tcttctgttt tccacttagc catgtgttaa aattctctac agttacctaa atcatacaat 90300 tgaaacaatt gccctgtggc cctttagcct gagtaaacag ccaatattat cctagatgta 90360 tatatgtata ttcatttttt aaaaccatca agtcaggccc cacaaaacat atatttgcca 90420 tgcacttctc tgtataaatg tcatgcttag accctctaag gcccactcaa agccatcgtc 90480 cactcatctc aacacagaca gacaagtcag agggacagat ggagcagctc ctgtctgcca 90540 ctgctaggtc ctttccttgt gttcttccct ttaactcatt tcctgtttgc cccatttcac 90600 ccatggccca ttgcccattt cccatttaac ccatttcccg tttgagaata ctgcacaggc 90660 agtgagttgc actttttttt ctaaacagta aatgggttaa tccacaactc tttgaggtgg 90720 tgttattaac tgtctctcac agacagaaga caggctctaa ggttaagcag tttgcttgtt 90780 ttcacaggta gcatgtgaca caactggtat tcaaatgcac acatatcgaa tgcacacata 90840 aagacaagac tttttaaaaa ttaaaaacac aaactcaggg tcttgggtgt ggcttccttt 90900 cctggacact ccctccagag ctctgccttc agagagctat tcctacctca tctcttgaag 90960 gttttgtttt gatatattta aaatctaaag gctgagtcat gactggcagt gtggagacca 91020 attttgtgga ggtagccaag gtcttcctgt actttcagac gaatcagatt ggtgtaaacc 91080 cctgtcttgt ggtttctgcc aattccatgg gtctgacatg ctcctccctg cttgtccctc 91140 tgagcactca ctctcactgt ctcacctcct acagctctcc tgttccctcc acagcagcac 91200 cgcccttgct caccaccttc ctcagcatgc ctccccccag ggaggctgac ttcctggctc 91260 tctccaaagt tcccatgtct cctgctacta catatgccag tccttgcact cttgggctcc 91320 cctgacttcc agtccttgaa actgtacaaa gccacttgga ggtctgtttc ccactgatat 91380 agagtatgcc attactccct cccaaaggtg gaaatggcta ccgccacttt ttattcttta 91440 atatagtttt atatctccat tatatctatt tttcagttac cattagtgac ctcatcccga 91500 aatgagggca gctggtattc tcagaagctt atatgctctc tatatcttat tcgtaaaagg 91560 aacacagttg atttcccatc tgtcattaca gccaagcagc tctggagttg gcaggtaaat 91620 cggatctcca gctgggtccg catgccagga ttattgctca tcaacaaggg gacattagcc 91680 atgattagtg tgaacagaag ctcactttgt aaacactggc taaaaagctc aagccatcct 91740 tagtgcgaga accactcttc ttactggcaa atatgtctat tttctcccag tcaaaggctg 91800 acagaaagga aaagaaaaag aactgtatca taaattatct aaagactttc ccataaacaa 91860 gcatggaggg caagacgtgg aggagatggg gtttccaatc ctgtatgtta tctttcataa 91920 atgagcatat tattgatgtc caggaggatt tacttgtaca aactagaaca tttactgcat 91980 gggcaagtgt acccatggaa cagacaaatt tctcgttata actatgtcta gctatcatgg 92040 cttggtggat atgatccatg ctatatccaa attccatgtt tttaattaaa tgaggcatac 92100 tagagtgaag aaaaaaagct atggattagg aattgggtta gagccctatt cactttctag 92160 cttaaaaaat ttaagagaag cccattaact gctgtccata tcagcttctt catcagtaac 92220 tgtgaataaa atggcttctc tacaattaac tacatttaat aaaagatgtg acagaaaaac 92280 ataaagatac aaataaatga agattatgac atgttcgtgg atagtaaggt tcaatatcat 92340 aaagacgttg aatctcccca gctgatctac aagttaataa atttccaatc aaaattgaat 92400 tgaaacattt tattgagctt cacaagccta ttttaaaata gacaaggaaa attcaagaga 92460 catgagtagc ctagacattc ctagagatgc agaacaaggt agagaaagtt cggtttacca 92520 aatattgaaa tgcattgtaa agtcagagtg cggtattggc acaatagaca aatggaaacc 92580 tcagtttcct tgctacctgc tgcctgccca caaatccaat gctacatgtt tcaggttttc 92640 attaagacag cactgcatat gaggtaccaa tctctacttt agaagggaaa cactagcagc 92700 tgtgtaaacc caaaatatca gtagccttaa ccacatagaa gtttatgtct taattaaaat 92760 ccagttggca ataaagacca gagggaaagg cattgttcca cacagtcatt cagaaattca 92820 agcaggtgga gattctgcca cgcttaacag agggctgcta aggtactcct cagcacctcc 92880 ctccagcaag caggggcagg ggaagagaga gagtggagga ctgctcagga gaggtatctg 92940 agcaaggttt ggggtggtag acattgactc ttcccagcgt cccttaggca gatcttagtc 93000 acatgactac acactgctgg aaggcaggct gggaattgta gtctagttgt gtgccctggg 93060 gaaacaggaa tgggttttgt gaacagctcg tctgtctttg cataattatt ttaggttgtc 93120 agggctcctg cttctgcttg agctgaggtg ctgaggtata gaaagggcta tctggtgggt 93180 taggtgaaat cttctcatat ctagctacaa tttacagttg gctctgggct aaaaacctcc 93240 tgaaagggaa tgcaaaatac tttcctactt gaaggttcag agatatgcag ccatgcccag 93300 ctaatgggga gagagggagc acctcagatg acaagaaagg gacaataaga tccctgaatg 93360 tgaaaacatt ctggagaata cagagtcagg cacaacgagt gccttaaggt caaagggaaa 93420 tgtaagttct gggtcacaga agaacattcc cacctaacca gtctagccac ttgtcagcat 93480 ctagggagga aaacgctgtg tggtgggcta aagaagctga aactcttggg agttcaagag 93540 agtctgctgc aagctcctgg aatagcacag cacagaggag agaggccatt cccttgcttc 93600 ctggcagaag aacttggaga gcaggtatcc ccgggaagag cagcagtgct gaataaccca 93660 cagcccaggg acagaactga ggccctgaga ggtggagcag aagagcaaag caactgctca 93720 gggtcaagag caataatgaa gaggactcac aatgtggctt tgaagtgact gtggctgtgg 93780 agcatctgct gcccagccgg agcccctcaa gaggcagtca ttggcaaaga agaggtctgg 93840 gtgaagtgac ctggggcagc ccagggcagc tgcagcgagc ctagaaagca ggatccagag 93900 agcgtcacca tagaggcaca ggcggtggcc tgggtggatc ctggaacact gagacacctc 93960 cttgggtctc tcagaaaaac tagagggaca aagacaccct gggaagaaac tgactgcagt 94020 cctgcagcta aacagatgag acctaatgtg cttaaaatac tgaactgatg agttcagggg 94080 gtattcaagc tatattagta aagagaatgt tactgttcaa aatgaatttc aagtttcaag 94140 aattttagaa atcaggaaaa actgctaaaa ataatgttga agtttttaaa aatcaaccta 94200 acatacacaa agtttctaat ataggaagca tatttatttt aaaatattgc cagttagact 94260 tccatgtttc taaacaaatc acctgcactc tttataggtc cacagatgaa ttccccccac 94320 tacctcccag gaaacaattc tgcttccatt tgaaatccca aggtaccaat tgctcccact 94380 tcaggtgctc agcctgcatg aagaatgggt tcccagtggc tctgtaagag gcctgtggtc 94440 ttgggaaggt gaagagccag aaatggccat ttggagacta aattttcagc atgtgtcccc 94500 attagggata tactgtggaa ctaaaacagt ccacatcagt gtgcttctcc cagtcccaaa 94560 tcgaatggac gtgccacttt caggctaccc aagcccgatt aatgcacagt gacagctgaa 94620 tttaactgct tttcactgca gctcagcacc aaggcctgag tagaaataat ccttttatct 94680 cccaataaag gagaattacc agcatttcgt agctcagctc tctctgaagg gccatcttta 94740 gaagctagag gctttgcatt tcctggaatg gtcagattaa agatgctttt cactgatctc 94800 tgggcaggta gatgattata ctgtcaccca gttgccctgt gggaagcact gcgggtttcc 94860 attttaaagg gatttcagag cacaaatgtc attctcgaaa acttttctga aagaccaact 94920 tagtcttcag agccatactg tttaggggcc agctgttgcc taggaacagc cagtggggac 94980 actttgaaag aatataattt ggtctgctgt cttctttact tgcagcccat gggtataatc 95040 tcacccagat cattttctgc tgtacataat tcttacacag ataacaacct tgtataatag 95100 acaatcaaac gtaataatac cttctgttca ctttcataaa gatggctcac cttccacctg 95160 aaatactgtt aaaactgcat tcatctcaac tgataagata tccaacatcc aagcttgggg 95220 cttggttcct tgaatatatt attttatgtt aatcttcaaa gtaactctgt gagttaggtg 95280 ttctacacct caatttttaa atgggagaac tgaagccggg aactttagac gatttgccta 95340 agtttacaaa gttttagtaa ttggtagaga cggaggatgc attccagtct gatcttaaag 95400 cctgtgtcct tcccaagatc ccatcctaga aatcaaggtt tctcaccttt gacacctttg 95460 gcattttgga ctggataatt ctttgttgtg gaggctgccc tgtgcattga aggatgttta 95520 gcaacattcc tggtctctac ccactagacg ccagtagcac acatgcacac acaattgtga 95580 caattaaaaa tgtgtccagg ctttgccaaa agttccctgt aaagcaagat cacccccaat 95640 ggagaatcac tgctctaaat gttctgaagc atttgctttc ttacaaggcg gaggttcgtg 95700 gtcccatgaa acgcacagaa taatttgaag accctaatag tagttaggag tggccttaca 95760 gggtatgctt taagaactat gaattaatta taattagcag ttttcctttg tacttaaaga 95820 gcccctattc ctgttactct tgaaaatcat ttgtcctctg caatgagtaa atgttcacac 95880 tacaaaaaca ctcagaaact tcaatggcct gcggccgcct caggagttca gcccaagctc 95940 ctcagaaaga cattcaaggc ctccccagtt tgccttcagt tctctcctcc actctccacg 96000 catttgtagg ctacagccaa gcaatatgac tcactgtggt taaaacgcat cctacatttt 96060 cttgttccat gtcttggctg aggatgttca ctctctgcct cccacctctc ctattcccac 96120 gctgcacccc gcctttgtct tggaatcctt cttatgtcat ttgagttcac ttgatgctct 96180 ctgcatctcc cacacagcct ccccagcaca gtggtggaag gatgggtctc tcctctgtcc 96240 acagttggtt tctatctgtc ttagtccatt ttctgctgct ataacagaat accacagact 96300 gggaaattta tttttaaaaa aagagattta tttggcttat ggttctagag gctgggaaat 96360 ccaagagcag ggcacttgca actggcaaag gtcatcccat ggcagaaaac agagggcgaa 96420 agcgagcaca caagacagag agaacgtcaa gccaaactcg tccattccat cagaagccca 96480 cttccacaat aacacaataa tagcaataat ccattcataa gggccaagcc ctggtggcct 96540 aatcacctct caaaggctcc acctcccaat actgttacaa tgacaattaa atttacacat 96600 gagttttcgc agggacattc aaaccatagc agcatctcgc tcatctcaac cagttttatg 96660 gagagtgtgt gatctttcat gctggattga aaattcttag agaacaagta ctatatttca 96720 gcccttctag tcagccctta tctcttagca gatgtgctat acttgtgggg ttggactaga 96780 tcagattgga ggtgggattg aatgaatatt gcaaaggtaa acatctgact ggtttccatg 96840 ggcattaaaa taaatttcaa acgtgagagc tgggcagtgc agtgaagaca atggagcaca 96900 gcagtttgcc tttctagtgc acagctgccc tactccatgt gacttcgacg cactgagtgg 96960 gcctctgacc agggccacca ctagggttgt gcccattgag ccccactggg tggctcctgg 97020 ctgagagttg tgtggggctg gcattctctt catatttccc tcactgaatg tgtgctctag 97080 gcaggcctgt gcttatcaga gcaagggccc cttttccaaa acttcacaaa ggtggcatat 97140 gggctggtgg aagccctgac agtagaaact cttccatgag gaaagggaca ccacatctga 97200 catttttatc cccaaattta taggtaatca ctactttaac taagacctat tgcactggat 97260 cctgcctagc ctaatcttat ctctttgttt taccactgct cgactaatga gacgtggtta 97320 ttgattcatt caacatattt gtgttagtca ttgaatatgt gtttaggcta caggagtgcg 97380 aaaaacaaag cccctgtcct catcaatcta gtagattctt atatttaccc ctcagtgttc 97440 accatcagac aacagtctac atgaaaaaaa tgtatatcca agctcctatt ttggagagtt 97500 ctgatacccc tggcttgagc ttttcttgag agcgtttttt tgtttttgtt tttttgtttt 97560 ttttttgatg aatgtatttg tctggggcaa ccattttaga aagtaacttt gcctaggttg 97620 ctaaagtggc cacatgggtg tctcagcata gccagggctt agagagtagc actcctcagg 97680 gaagccctca gctcctgcat ggtcacatag tctaatttca gctgcagctg ttcaggccat 97740 ctgaccaagt ctcttgagag agtctgagca ttccatacca ttttcatata atattaaggt 97800 gtaaactgag cattctccag aaaccagccc agaaccaact ttaatctaaa aatttccaag 97860 gaaggccatc tgggcataaa tgcacaggat ataagtgaaa actggagtct aacctttaat 97920 gttcctattg gctgaaacag aaactgtcac atcttgaaca cttcatctta ctattcccct 97980 cttgtatcta cagatgggaa actgtgcagc agctataacc gaggactcat ctcaaaggca 98040 aaaatcaagg ctatcaagta tagcatcatc atcattcttg gtaagcaatg tccctccttg 98100 agctgtaaag tggtatgaac gtcccaaaag caagtttgct cctgggacct ggtgacagaa 98160 aggaatttgc cagcaggcac ttctacatcg gtctgcttag aaaggaatgt gtgaaactca 98220 tcagcccatt catggttcct tcaagggctg acatttggtt cctaatccct ctccttatga 98280 atacagctgc ctgccaaggc tatgggttga ataatttgga gaaaatctga ttaggaccta 98340 actagctgaa gtggatgctc acatcaccag ctaactcagt cacttccttt aagacacact 98400 gttccccagg gctggggttc acaaggaaaa agaagataga agtgactttc caccttatct 98460 gaatatttga tgttaggttc actacaaatt tcccccttat ggcaccttac ctgtccttcc 98520 accctcctgt cttctgccct ttccttttcc tttctctcta ctcttaagac tcataaagtc 98580 accttgtact atttcctgtc tgaaatgctc tgctctccgg tggtgccccg gcttacttcc 98640 taatctcatt tgttccccaa caacgccacc tccctgaggg ctccttgata agtcttttta 98700 aatatccttt ttctagtctt tactctgcct tatttttctt cttggttcta cctcacacta 98760 caggatatag attgattttc ttatagtctg tctcccctgt tggagtaata aatctatgag 98820 ggcaatgact ttggcttttg tgttacttat attatcacca agacctaaaa tagggtctcc 98880 tacacactgc tcaattaaca tttgtcgaat gaatgaatga atgaatgaat gaaactatgc 98940 aagaaggaaa gggatttgtg ctattttctt ttttatttag cttaaatacc ccctccttgc 99000 ccctctggca gctcttgaag ctccaaggaa gtatagatct cccattagct gcatgtcaaa 99060 gcaccagaac agtcttctca cctttctgaa acgcaactgc aaaatgccaa acagaccaca 99120 tgcagcatga ctcagccagc aggacgtagg cacaaaacaa cactgcaggc ggaactggga 99180 taaaacatat acaacccacc agggctcaaa aactttctga gaggcttctg aagtggatca 99240 aagactcctc tgtcttctca gatagtcaga agcacagatg caccttccct ggatgttgag 99300 ttggaaaatg tatgtttaca agtgtgtccc agagcctgca tagcccttta tcatcagcaa 99360 ccatactcca aggccctgtg ggatcccttc agtcagcaag caggaacacc ctctagaggg 99420 tcagcaaata ttgacagccc taccagacca aaagggccct ttctatagca aacactttgt 99480 aatgtccctt tcccaccttg aaataaaatg cctacttata ctacctacca tgatcattta 99540 aacattaata tattgcccaa aaaataatat aaaagaggaa taagaaaata atctaaaatg 99600 aaacaatact atttttatta attaaaatgt ataccaattt taatgtgtaa aaacataagc 99660 acagctacac tagaagaata atgaagtagt cacacctaca ccgtgacata ataacagcca 99720 caatgaaaac caatacaggt gtattttcat ggagacataa aaaaatgtaa gcggtattac 99780 tgtcagtgac ttgattttct cagccggcaa aaagaaaaaa tccttgtaaa attttgaatt 99840 aaacaaagta atctttcctc catttacaac agaattgcat ttctacaaat ttcaatattt 99900 atttaaaata cctgtgttta tgtgtaaaac aaagtcaggg ataactatat agagggttct 99960 cctctacatg aatggacatt caaagtagat acaaatcttt gctggctggg ctgcgtgtac 100020 catgccagag gactggtatc cctgtgaaaa cttgaatcct ccaacccaac ttacacacac 100080 atggaaacac ccaagcacac aaggccattt gcccccttag tgccccaaat actgttcagc 100140 gccagtgttt gggttaatta atcaggatcc agaacactta gtgggttttg tgtttgaatt 100200 gctcctcttt aatacattgc caaggtctgg ggtcgagagg ggaaacatga gtcagtttat 100260 cattccaaaa ttcccaacaa gttacagaat ccacattaca cagttatgac ggaaagcttg 100320 tccctgcatg cagacagcca aggaagccaa acttctactc cgagaaaaaa ttctatggat 100380 gagaaagtgg gagaaggaga gtggagaatt tatggtgaga aaatgagaga tgcgtgtatt 100440 tccagtcaac ttaggagtgt ttagctctgt gtcgtagtct gtgctttcca gaggaaaatg 100500 agagagagag agagagaggt ttattagaag gaattggctc aggtgattac tgaggctgag 100560 aattcccaag ctgcagttgg aagctggaga cccaggaaag ccaatggtgt aggttctagt 100620 ccaagtctga gtccaaaggc ctgaaaacca ggagaatgga tggggtacat ttcagtttga 100680 ttccaagtgt gaaggcagga gaagaccaac gtcctagctc gaagacaggc aagcagagtg 100740 aatcttctct tacttaacct ttttctatga ctcaggcctt caacagattg gatgcggccc 100800 acaaacaggg gagggcaatc tgcttttctt actctaccag atcaaatgtt actctcctcc 100860 agaaacgtct tcatacacag ccagaatagc gtttaaccga atatctgagc actccgcagc 100920 ccagtcaagt agtctcaaaa ttaaccatca cacctgaatc cccacctttc atccatttct 100980 tttgagaatt tggggccaaa taaactggtg tctcacacat actaatggat ttagagaagg 101040 gcatagtgtg ggtgttttct ggagaggcca acttaggggt gaaagagaac actgtcatta 101100 aactggggtg tgcttagaaa atattgtgat caccccttct ccctgacata acctaaaacc 101160 agtagtcact acgtggtcaa aatgcttcct gttcttctgt cttttcctag agagtcttca 101220 aagtattttg ctgttttttc ctgatccctg tgtttgatga gaggctatgg ccatagtcac 101280 ttgttcctgg ggtttctata aagaatccac agcagtagaa atttgaccct tctttacaga 101340 tagagaagct ctacaacctt tgctcagttt taggaacatg tctgtaagat gtgtccatat 101400 atatgtgtgt atgtgtttaa gtgaatatga catcaatgct ccaaacaaca tcaaactcca 101460 atatttctga gaaattccag gtcccaaaga acctctcagg taaaagtcca gtcaggacca 101520 accaaaagag acccctcaac tgctacctgc tgtgatgcta atggctctct tctcccccag 101580 ccttcatctg ctgttggagt ccatacttcc tgtttgacat tttggacaat ttcaacctcc 101640 ttccagacac ccaggagcgt ttctatgcct ctgtgatcat tcagaacctg ccagcattga 101700 atagtgccat caaccccctc atctactgtg tcttcagcag ctccatctct ttcccctgca 101760 ggtaagggga gctcttgcat gggtcagaca cactgatggc cattgcactg ggattctgcc 101820 aacatgtggg tttctcatgt ccaaactctc cagcaggtta caggatcccc cttttataga 101880 tgagaggctt gagagtcaga aagattccac taacatggct gattcaaacc ctggcccagg 101940 ccacagctga tgtgcttttt cctataccac aacacctcct atagaaaccg ccttaatcat 102000 gacacatcta gaagaccttg cttttattca aagcatcttc acatgaattg cctcaataca 102060 attctatgac aataatagga catggagcct tattaccatt ttacagataa acaaagtaaa 102120 tcttacatgg ttaatagcat cattgagttt atatgaataa ttagcagagc tgaaattaaa 102180 tccctcccac agttattgtc attcttctgt ttttctgctg tttttcagct gttttcctgc 102240 ataagccaca gagggtaggt ggagaattcc ataggagata caagaggaga atgatttaag 102300 tcttgggctt aatgccagtg gttgaagttt atatcttgcc attgtttatt cgtagcgatg 102360 tgtgaccttg ggcaagttat ttaacatctg taaacctcag cttcttcatc tgtaaaacag 102420 ggctaatagc agtgtctacc tgttggcctg tgatgtctct gtcctctggg ctctggtgct 102480 gaccagtgag aaggagagct gtgagtcatg gagaaggaag gtcagggtat tacatgtaaa 102540 gtgcctggca cagttgtctg acatttaata catttttcat aactattgtc tcttaacatg 102600 tctacttgcc ttttcattag gtcaaattat ttccctccct gctttatttt gactttctcc 102660 agggagcaaa gatcacagga ttccagaatg acgttccggg agagaactga gaggcatgag 102720 atgcagattc tgtccaagcc agaattcatc tagaccctag ggcagtgcca gtgctaggct 102780 gagcaccatc agctctccca ggtccttgtc acctgcttgg gcacgtgcat ggaacccgag 102840 ccaacttcac cccaccctcg tcattacctg ggagatgcac aagacaaatg ttctaatgac 102900 tgcatgcact gcttaagtat tggccaacac gaactcccca gttattcatg ccagccagga 102960 aggaaacgcc ttccttcccc accattccca gccctccttc ccactggcca gcacctgaac 103020 ccagtgaaca caggcattag tggtccaggg tcctggcttg gagccagtga gtagacaggc 103080 aagcagaggg gacaaaggta gctgggttat acatgaatat tctcattaca atagaagaaa 103140 ataaaagact taattaagcc catatttttc ccccagtttt ggattggagg ttcagtgctt 103200 gtagccaaga aagtgtttgt ccttgaaatg ccaacaaatt catttccagg cattggtgct 103260 ttgcacctct tctgcagata gcctcggttt gcagatgggt gtgctggcag cagccaagtg 103320 catctcctat tccatcaaca aatgatttgt ggaaagggca tgctgttggc cctccaaaac 103380 aaggtgaaat gaagggatac tggttctgat agaaaacaag ttgtgttaaa aagccatggg 103440 cccctgactt ccagcctctg agagctggtc cctagaacac acatgtcctt gaggcctttt 103500 tttttttttt ttttttttga cagagtctcg ctctgtcgcc caggctggag tgcagtggca 103560 cgatctcggc tcactgcgag ctccacctcc cgggttcatg ccattctcct gcctcagcct 103620 cccgagtagc tgcgaccaca ggtgcccgcc accacgcctg gctaattttt tgtattttta 103680 gtagagacgg agtttcaccg tgttagccag gatggtctca atctcctgac ctcgtgatct 103740 gcctgccttg gcctcccaaa gtgctgggat tacaggcatg agccaccgcg cccggcctgt 103800 ccttgaggct ttctgagacc tctcactctg tatttaacac ttgggccact ctgggctcca 103860 ttcctcacac ctcaaggaca agtcttcccg tttttaaatc cctgaacact ctctttagtt 103920 aggagctagg ttcctgcggc ttttccaggc ttaatgtttc tctaagatct ttatcgtttt 103980 tgcctgtcac agcctttgtc tagcacctcg gccaggaagt gctggtgggg cttattttga 104040 cagatctgga gtttggtact tatgagcata atccaagtga aatatgacta aatgttttct 104100 agtcaatttc tcctatcaga tttttccaca agtggaagtg aaataatttc atttgatcat 104160 atatacatcc cacccacggc tccggtatgc acgtgaacac cttattttag cttcacgtat 104220 attcttgaca ttaaaatctc cttggcaaaa tcctccttcc cagaattatt cagagcttaa 104280 atcttttttt ttttttttgg catactgcta gtggagtcat taaattgttc agtatatttt 104340 aatagcactc cattcctcat tatggtgtca actcaaagtc tgcgtgttta aggtcatgtg 104400 ggcttttttt ttttttttca taaactcttt tcaattcgat ctgaccttag ggaaagtatc 104460 tctttaggag gaaatcagac tcctcactca ccatctctcg gagaattatt ctctgaattt 104520 gaggagcctg aataatctag ttttatttct acacaacagt tttgaaggct gcctccctct 104580 ctgtccaatc agctaaactt gagcaaccct ggaagctttg agcatttgag aaatgctttt 104640 caacatttca ctttaaatca agatgtgcca cagaagaccc acggaactgt tgctaaaata 104700 gctggctgca taggagccaa ttaacagagc aaaatctggc agatgtccta catggcaaaa 104760 caggaggacc aggttctctt gacagatgct ttaattcttt gtcaagtctg gtctgcaaaa 104820 tacattacat gcctacctca tccatcagta gagtctcaaa gtgaaggaga gagtggagtg 104880 aggggcgttg tgatctgtag aaactgtgaa catgattttt tagttgtgat gctgtctctc 104940 tcatttcccg agaagactgg agatcaataa gataatggta caggttgctg caggataatc 105000 taccatttaa atgaaacttg ctttatattg gtaaggattc tggaattgtc atttccatgt 105060 atttgctgag cttggagaaa catgatttaa gcattatgaa aatactggta attggccggg 105120 cacagtggct cacacctgta atcccagcac tttgggaggc tgaggtgggc ggatcgtgag 105180 gccaggagat cgagaccatt ctggctaaca cacggtgaaa ccctgtctct actaaaaata 105240 caaaaagatt agccaggcat ggtggctggc gcctgtagtc ccagctactc aggaggctga 105300 ggcaagagaa tggcatgaac ctgggaggcg gagcttgcag tgagccgaga tcacgtcact 105360 gcactgcggc ctgggcgaga gagcgagaat ccgtctcaag gaaagagaga aagagagaaa 105420 gagagagaga gaggaaggga ggaagggagg aaggaaggaa agaagaactg gtaattaata 105480 gtcttgtgac cttgaacaaa tcatttcaca cctctgggca ttgatggtct catctgcaag 105540 atggggacaa aatcaggctg gagcagagga tcttggtggt tcctcccaga cacagggagg 105600 aatctctgag attgtgtcca gagactgaga gcttctggaa ttctttcccc aggggaccaa 105660 tgactcagtg acttaatgct gagtcatttg ccctttagag gtgtgacttc cctatctatc 105720 actatgaatg cagagaaata tcatttccca actgagaaat gcagtttgag ctcttggaga 105780 aaattagaag cttagtgctg tgacgttact gtttgtagcc tttgatgccc atgtggaatc 105840 agagaagcca gcaggacgat acctaaaata aaggtgctta cttcctgcac caagatgtca 105900 aaaagtctac ggttacatta ttgcatggca tcagggacag gagaaaattt aggagagcca 105960 gagtaggtgt gcttactata ttcagccata ctatagaaaa taagtgactc tactttactg 106020 aactaaatta aatatgaatg gtaaaaactt ctctacttgc agggtgcatg tggaacataa 106080 tttagttgaa gtttactttc actaagcaac atctcccacc ttttccccca gaaaatgata 106140 acaccttttt aatgactttc atttgtggat aatcatgaga aaaaagtggc ccttttaaat 106200 cagcccaaca cgcagcttaa acttcctagc ttcatttgga aaattctgta tactcatata 106260 cagaaatgac cttgcctctt ccaactgcat tcacagtgtc aatcagaaaa ggccacaagc 106320 ctgagtctga gagaaaaaag gaaaacaaaa atatctttag caggaaataa agtgattctg 106380 ctcttctaga attatcttag gtgagctaca gacctgctgg caactccaat tttctcgtca 106440 tcatttgaat gtacctcatc ttatatgcag atcgactagt gtcccctgaa gctttccaat 106500 tgcatttaat tgaagggaga aggccgtaac tgtttaggtg ccaatctctg tgtttttgga 106560 aacatgaaaa acccatgcct catttctctg caattgcatt ttaagaatac attatccgca 106620 acaggctggt tcagttaaca ttttaaaagt gcaattccag gcttacagaa tgttaaagtg 106680 gatggagtct tatatcagct ggtctcatgg ttttcagatt gctcggagac tccaaagctg 106740 ttccaaggag gtgactcaat attaatattt ttacacggcc gggcatggtg gctcacgcct 106800 gtaatcccag cactttggga ggccgaggag ggcggatcac ctgagttcga acaggagttc 106860 gagaccatcc cagtcaatat ggtgaaaacc cgtctgtact aaaaatacaa aaattagccg 106920 ggtatggtgg cgggccgcct gtaatctcag ctacttggga ggctgaggca ggagaatcac 106980 ttaaacctgg gaggaggagg ttgcagtgag ccgagatcgc accattgcac tctggcctgg 107040 gcaacaagaa ggaaactctg cctggaaaaa aaaaaaacaa aaaacaaaaa aaacattatt 107100 acgcacaaca atagcataga aatcgagagg caattaaatg tagttagttt caagttcctt 107160 gaattatctt gcatgcaaaa tgtggattat tagtcattga tacaccaaga atgcatgtta 107220 caatttcagg gtcatcacta aaatagtaga aatgcaaaaa catacatctt tcagagtaaa 107280 agagaaggaa agctgagtga taagtcactc aaacaatttg aaagaaagca agaaaagaga 107340 gaaacaggga cataaaacag ctgggataaa cagaaaacac ataggaagat ggtggttttt 107400 ttatccaaac ttactagtaa ttataagtgc aaagagatta aatgccccag ttaataatca 107460 aagactatca gactgatttt ttaaaaaata aataactgtc tgctgtttac aaaagacatg 107520 cctaaaacac aaggatacag aaagtttgaa aatcaaagaa tggatcaagg tagtccatgg 107580 aaactgtagc taaaagaaag ctggtaaggc tatattaata aagactaaat accttttaag 107640 gcaaaaagta ttagtagagt taaacaggga cacttcgtaa tgataaagat tttagtttaa 107700 taagatgaag taataattct aaatttccag gcatttaaaa acatggcctc aaaatatata 107760 cttttaaaag ttgtcagaac tatgaaacaa atagaaaaat tcacaaccct aatggggaat 107820 tttatcacac ttaatgccag tcattaaagc agacaaaaat caggaatgat ctggataatt 107880 tgagcaacat gaataacaca ggaagagcac tttaccttac cacccctgaa cagacatttt 107940 tttcaagcac acatgaagca gttaccaaag ttgaccacat gctaggccat aaaacaagct 108000 tcaacacttc cacgagattg aattcatata gtctagtttt tctgatcatg ttataattat 108060 gctggaactc aagagtaaga ggataactag aaaattcaaa taggtttgga agttaggaaa 108120 tacacttccg aacaacttat tgccaaagaa gaaagcatat gaaaattaga aaacaattgt 108180 actgaatgtt aatgaaagta ttatgtatta aatgtatagg atacaaataa aacaatactt 108240 aaagaaaaaa gagaaggatt aaaaatcaat aaacaaatta tctatcttat gaagttagaa 108300 acatttacca aattaaactc aagggaagta gaaagaataa aataataaga ataggagtaa 108360 aattaatgaa ataagaaaca aacataataa aaagcctcaa caaagatcaa attctgttct 108420 tgaaaaaaat taaattaata aacctctggt gagactgatc aaaggaagaa aaagagagaa 108480 ggcacaaata aacagtattc tttaaatgat atcactatag atcctagagt caatcaaaag 108540 ataataaaag gatattatga tcaagcttat gtcaaaacaa attgaaaata tagatgaatg 108600 ggaaaacata taattgaccc aagaagaaac aaaatcagaa tagtagcata actgctaaag 108660 aaagagaatg tcttcattgg tgagctgtac taaaatttaa ggacaaagca acaccaattt 108720 tatagtcttc agtaaaatag aaaaagtgtg acttttcaga ttatttatga ggctaaaaaa 108780 acctcaatat caaatgctac aaaggcatta caagaaaaaa attgcaagtc aattttgccg 108840 cagaaataca tgcaaaaatt ccaaaaaaaa attaccaatc aagtccagca aaatataaca 108900 aggctaacat atgtgacaaa actggtttca ttccaggaat gcaatgttgg cttactatta 108960 gaaaatcact caactcgtta cattaataga ttacaggata aaacaatata taaactcaac 109020 agatgcagaa aaaaatgttt gataaaaatt tttgagctcc aattataaga tattcacaaa 109080 cttgggatag aagacaattt cttaaacctt aaagtttatc tgcaagaaag ctacaggaaa 109140 cctatactta atggtgaagc tttgaagatg ttccttttga aataaagaat gagtgaagaa 109200 tgccagcatc aacacttctg ttcaacattg taagaaatcc tagtcaatgt agtaaaacaa 109260 gaaaaaaaaa taagataaaa ggtatatgga ttcataataa ataataaaaa ctgacaatat 109320 agatataaat atatagctga atatccaaaa taatatacag ataaattatt agaattaatc 109380 acaaggttta ataaggttgc aggatacaaa aatcaatatt atttccacat agcagcaata 109440 aataaaaaat ttaattttta aagttttgta gcaatgaagg gaaagcttcc tttttgccct 109500 tggaggcttc actgaaaaat caagtcataa aaaggcagaa aaataagaga aaaagcataa 109560 aatttattac tcctatgcac acggggaaaa tcggagtgat tggccaatac ttcaatgggt 109620 acagatgctt gtagagcctt cttcttaggg gaaagagaga tggggaagcg tggatgattt 109680 taggggaata ataaatgatt tttaggaatt tggtgtgctt gaagaaaaca atggtccagg 109740 acagagtctg ttggactcac agagcagact tttgtttgtg acaaaagtct gtccaggttt 109800 gttgatagac tttagtcttc cttcttgtga tatgggttca gttaatgaaa actcggggaa 109860 gggaccgcaa gtcattgttt tcttctttgg taagtctaga attaggcaga taaggaaact 109920 tcatgattga gaggcaggag gagggagagg agaaacaatt gttctccctg gtaagagaac 109980 tgaaaactgg tccagtcttt atgtagatgg ggggggaaat ctcttctagc atctgctgat 110040 ctctaagggc cttttaattc aaaatatatt ataatgccat gaagccatat tttagggtaa 110100 agttccatga gctcctgcat tcgttattta caatagcctt aaaaaatgaa attcgtagga 110160 gtaaatttat aaaaaggtat gtaaatctct atggagaaat tataatacta ttgagatata 110220 ttctaaaaac taatgaaatg cagaaatata tcatgactat tgttcagaaa ctgaatatcc 110280 taagataatc aattttcaaa ttgatctctg aagattcagt agaatgccaa gaggaatttg 110340 gtagaacttg gtaagttgtc tctaaaattt atatggaaat gcaaagggcc aaaaatagcc 110400 acgacactgt tgactaaaaa ggaaaaaaat gggagagctt aactaaccac atatcaaact 110460 tatcatgaaa gaataataat gaaagctgtg gtatgggcgc taaagtagac aacttagcaa 110520 atggaataga aaaggagtcc agggaaagat gcccacatat aggtaaacga tttgtttcag 110580 tggtaacatt gcaaagcagt aaggaaaggg tgttcttttc aattatataa aaaattggac 110640 atttatgtgg gagaaaattt actgaaaacc tactggatta tatgtcaaat tggttccagg 110700 tggattatag acctaaattc acaagacaat aggacgctga aaaaataatg tgacaaaaca 110760 caaaacactg tactcatgaa ggaaaatatt gatacattta attatttaaa agtagaaatt 110820 tctgttcatc aaaatatatt aaaaatgtga aaagacaagc tatagaatgg aaaatgacat 110880 ttgcaaaata tataactgac caagatctag tatttgtaat atataaaaac tactgcaaat 110940 cagtaagaaa aagattttaa aagacagtag aagacataga aaaatgggca agaattaact 111000 tcagaaaaga agttatccaa atggacaaaa aactatgaaa aggtgtttaa tctcattaaa 111060 aagcaaggga aagtaaatta aatcacaatg atatatgagt atgcatattg gcctaactta 111120 aaacctttga caatatcaaa tgttgctgag gatgtacagc atcagaaatg cttatcttgt 111180 gtgaactgga gaataattag tacaactatt ctggaaaatt atgtgcctta aactagtaaa 111240 actaaggatt tgtgtttccc gtgaccttga aattccacac tgagtacaca ccctacagaa 111300 gtgtgaatta tgtgcaccat aatagatatg aaaaatattt gtaatagcac taattataag 111360 agcctcaaat tggaggcaaa acaaatgctt attagcagta gaatagataa ataaattatg 111420 gtgtatttca tacaatggaa tactttacag caacaaaaaa atgaagaaac tgcatatgct 111480 tgcagcaaca taaaaaaact ttaaaaacat aatataaagg tcaaagacag agacattaaa 111540 gataacatat gatctcattt atatgaaatt caaaactaac caaaattaaa ttatcatatt 111600 tagcaatgca cacataggta attgtattag tccgtttttc acactgctga taaagacata 111660 cctgagactg gacaatttac aaaagaaaga ggtttattgg acttacagtt ccacattgct 111720 ggggaggttt cacaatcatg gcagaaggca aggaggagca agtcacatct tacatggatg 111780 gcagcagtca aagagcaagc ttatgcaaag aaactcccat ttttaaaacc atcagatctc 111840 gtaagaccca ttcactatca caagaacagc acaggaaaga cctgtcccca tgattcagtc 111900 atctcccact gggtcccttc cacaacatgt gggaattatg ggagctacag gatgagatct 111960 ggggggggga cacagatcca aaccatatca gtgacaaaac tctaaagcaa agcaggaaat 112020 cactttttat aagagtccag attgaaatat ctttgtgggg agagggagga gatgtacaga 112080 gagaggctgg cagagtctct tttttgctct aggtggcagg ttcaagggtg ttcagtttat 112140 tttggaagca gtgcagagaa gggagccaga ctagaaacag ggaggtgatc 112190 <210> 17 <211> 23 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: synthetic DNA <400> 17 cgtgaagtct ccagtgaatc gcc 23 <210> 18 <211> 22 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: synthetic DNA <400> 18 gatggtgctc agcctagcac tg 22 <210> 19 <211> 880 <212> DNA <213> Homo sapiens <400> 19 agcacgtaga tcctccctgt catcaggcag agctcttcag tgaggtgggc tcagggaggg 60 ctctgtgcct ccgttcagca gagctgcagc tgctgcccag ctctcaggag gcaagctgga 120 ctccctcact cggctgcagg agcaaggaca gtgaggctca accccgcctg agcc atg 177 Met 1 cca gcc aac ttc aca gag ggc agc ttc gat tcc agt ggg acc ggg cag 225 Pro Ala Asn Phe Thr Glu Gly Ser Phe Asp Ser Ser Gly Thr Gly Gln 5 10 15 acg ctg gat tct tcc cca gtg gct tgc act gaa aca gtg act ttt act 273 Thr Leu Asp Ser Ser Pro Val Ala Cys Thr Glu Thr Val Thr Phe Thr 20 25 30 gaa gtg gtg gaa gga aag gaa tgg ggt tcc ttc tac tac tcc ttt aag 321 Glu Val Val Glu Gly Lys Glu Trp Gly Ser Phe Tyr Tyr Ser Phe Lys 35 40 45 act gag caa ttg ata act ctg tgg gtc ttc ttt gtt att gtt 369 Thr Glu Gln Leu Ile Thr Leu Trp Val Leu Phe Val Phe Thr Ile Val 50 55 60 65 gga aac tcc gtt gtg ctt ttt tcc aca tgg agg aga aag aag aag tca 417 Gly Asn Ser Val Val Leu Phe Ser Thr Trp Arg Arg Lys Lys Lys Ser 70 75 80 aga atg acc ttc ttt gtg act cag ctg gcc atc aca gat tct ttc aca 465 Arg Met Thr Phe Phe Val Thr Gln Leu Ala Ile Thr Asp Ser Phe Thr 85 90 95 gga ctg gtc aac atc ttg aca gat att att tgg cga ttc act gga gac 513 Gly Leu Val Asn Ile Leu Thr Asp Ile Ile Trp Arg Phe Thr Gly Asp 100 105 110 ttc acg gca cct gac ctg gtt tgc cga gtg gtc cgc tat ttg cag gtc 561 Phe Thr Ala Pro Asp Leu Val Cys Arg Val Val Arg Tyr Leu Gln Val 115 120 125 atg gta atg aag tta ttc cat att cag aaa atg aat atg gaa tagttacaat 613 Met Val Met Lys Leu Phe His Ile Gln Lys Met Asn Met Glu 130 135 140 cttcttttgt gctctgaata taaccttgaa agtttggtat gtctgaaaga gccttttcta 673 ttatgtacgg ctagtatttt ctcaggggaa atttttaaaa acatatttca atttctttct 733 gaggatattt gcttccttgt aaataaatgc tttcaattgc ttattatatt agcaatcaat 793 tgctgataca caaattatga caaaacatgg tggcttaaaa caataaacat ttattatctc 853 acaaaaaaaa aaaaaaaaaa aaaaaaa 880
【図1】 KAT06734Lポリペプチドのハイドロ
パシープロットを示す図である。このプロットは解析ソ
フト(MacMolly)を用いて作成した。予想される7つの
膜貫通領域(TM1〜TM7)を図中に示す。FIG. 1 shows a hydropathy plot of KAT0673L polypeptide. This plot was created using analysis software (MacMolly). The predicted seven transmembrane regions (TM1 to TM7) are shown in the figure.
【図2】 KAT06734Lポリペプチドと既知GP
CRのアミノ酸配列をアラインメントした図である。既
知GPCRとしては、ヒトバソプレッシン1A受容体
(V1aR)、マウスバソプレッシン1A受容体(V1aR-MOU
SE)、ヒトバソプレッシン1B受容体(V1bR)、ヒトバ
ソプレッシン2受容体(V2R)、ヒトオキシトシン受容
体(OXTR)、ヒト黄体形成ホルモン放出ホルモン受容体
(GnRHR)、ホワイトサッカーのバソトシン受容体(vas
otosin)を用いた。アラインメントは、CLUSTAL X Mult
iple Sequence Alignment Program(ftp://ftp-igbmc.u
-strasbg.fr/pub/ClustalX/)を用いて作成した。KA
T06734Lポリペプチド中の予想される7つの膜貫
通領域(TM1〜TM7)を下線で示した。全てのGP
CRで保存されたアミノ酸を*で、よく保存されたアミ
ノ酸を:または・で示した。FIG. 2. KAT0673L polypeptide and known GP
It is the figure which aligned the amino acid sequence of CR. Known GPCRs include human vasopressin 1A receptor (V1aR) and mouse vasopressin 1A receptor (V1aR-MOU).
SE), human vasopressin 1B receptor (V1bR), human vasopressin 2 receptor (V2R), human oxytocin receptor (OXTR), human luteinizing hormone releasing hormone receptor (GnRHR), white soccer vasotocin receptor (vas)
otosin). Alignment is CLUSTAL X Mult
iple Sequence Alignment Program ( ftp: //ftp-igbmc.u
-strasbg.fr/pub/ClustalX/ ). KA
The seven predicted transmembrane regions (TM1-TM7) in the T0673L polypeptide are underlined. All GPs
Amino acids conserved in CR are indicated by *, and amino acids well conserved are indicated by: or.
【図3】 図2と同様な図であり、図2の続葉である。FIG. 3 is a view similar to FIG. 2 and is a continuation of FIG. 2;
【図4】 図2と同様な図であり、図3の続葉である。FIG. 4 is a view similar to FIG. 2 and is a continuation of FIG. 3;
【図5】 図2と同様な図であり、図4の続葉である。FIG. 5 is a view similar to FIG. 2, and is a continuation of FIG. 4;
【図6】 図2と同様な図であり、図5の続葉である。FIG. 6 is a view similar to FIG. 2 and is a continuation of FIG. 5;
【図7】 KAT0673L cDNAの塩基配列と該
cDNAのコードするポリペプチドのアミノ酸配列を示
した図である。実施例で使用したプライマーの位置とイ
ントロンの位置を合せて示してある。FIG. 7 shows the nucleotide sequence of KAT0673L cDNA and the amino acid sequence of the polypeptide encoded by the cDNA. The positions of the primers and the positions of the introns used in the examples are shown together.
【図8】 図7と同様の図であり、図7の続葉である。8 is a view similar to FIG. 7 and is a continuation of FIG. 7;
【図9】 図7と同様の図であり、図8の続葉である。9 is a view similar to FIG. 7 and is a continuation of FIG. 8;
【図10】 図7と同様の図であり、図9の続葉であ
る。FIG. 10 is a view similar to FIG. 7, and is a continuation of FIG. 9;
【図11】 KAT0673−3'の塩基配列と該配列か
ら予想されるアミノ酸配列を示した図である。図8で示
したイントロン3の位置を図中に示してある。FIG. 11 shows the nucleotide sequence of KAT0673-3 ′ and the amino acid sequence deduced from the nucleotide sequence. The position of the intron 3 shown in FIG. 8 is shown in the figure.
【図12】 図11と同様の図であり、図11の続葉で
ある。FIG. 12 is a view similar to FIG. 11, and is a continuation of FIG. 11;
【図13】 図11と同様の図であり、図12の続葉で
ある。FIG. 13 is a view similar to FIG. 11, which is a continuation of FIG.
【図14】 KAT06734Lポリペプチドと既知G
PCRのアミノ酸配列を用いて作成したデンドログラム
を示した図である。既知GPCRとしては、ヒトバソプ
レッシン1A受容体、マウスバソプレッシン1A受容
体、ヒトバソプレッシン1B受容体、ヒトバソプレッシ
ン2受容体、ヒトオキシトシン受容体、ヒト黄体形成ホ
ルモン放出ホルモン受容体、ホワイトサッカーのバソト
シン受容体を用いた。デンドログラムは、CLUSTAL X Mu
ltiple Sequence Alignment Program(ftp://ftp-igbm
c.u-strasbg.fr/pub/ClustalX/)を用いて作成した。FIG. 14. KAT0673L polypeptide and known G
FIG. 3 is a diagram showing a dendrogram created using the amino acid sequence of PCR. Known GPCRs include human vasopressin 1A receptor, mouse vasopressin 1A receptor, human vasopressin 1B receptor, human vasopressin 2 receptor, human oxytocin receptor, human luteinizing hormone-releasing hormone receptor, and white soccer vasotocin receptor. Using. The dendrogram is CLUSTAL X Mu
ltiple Sequence Alignment Program ( ftp: // ftp-igbm
cu-strasbg.fr/pub/ClustalX/ ).
【図15】 PCR法を用いて、35種のヒト臓器にお
けるKAT06734L転写産物の発現量を調べた結果
を示した電気泳動の図である。PCRのサイクル数は3
5である。矢印は目的の増幅断片(318bp)の位置
を示している。電気泳動図の各レーンのサンプルは以下
の通りである。 n.c.:ネガティブコントロール、1:Adrenal Grand
(副腎)、2:Brain(脳)、3:Brain,caudate nucle
us(脳、尾状核)、4:Brain,hippocampus(脳、海
馬)、5:Brain,substantia nigra(脳、黒質)、6:
Brain,thalamus(脳、視床)、7:Kidney(腎臓)、
8:Pancreas(膵臓)、9:Pituitary gland(脳下垂
体)、10:Small intestine(小腸)、11:Bone ma
rrow(骨髄)、12:Brain,amygdala(脳、扁桃体)、
13:Brain,cerebellum(脳、小脳)、14:Brain,co
rpus callosum(脳、脳梁)、15:Fetal brain(胎児
脳)、16:Fetal kidney(胎児腎臓)、17:Fetal
liver(胎児肝臓)18:Fetal lung(胎児肺)、1
9:Heart(心臓)、20:Liver(肝臓)、21:Lung
(肺)、22:Lymph node(リンパ節)、23:Mammar
y gland(乳腺)、24:Placenta(胎盤)、25:Pro
state(前立腺)、26:Salivary gland(唾液腺)、
27:Skeletal muscle(骨格筋)、28:Spinal cord
(脊髄)、29:Spleen(脾臓)、30:Stomach
(胃)、31:Testis(精巣)、32:Thymus(胸
腺)、33:Thyroid(甲状腺)、34:Trachea(気
管)、35:Uterus(子宮)、36:Standard 0.01 fg
(標準試料 0.01 fg)、37:Standard 0.1 fg、3
8:Standard 1 fg、M.:サイズマーカーFIG. 15 is an electrophoresis diagram showing the results of examining the expression level of KAT0673L transcript in 35 kinds of human organs by using the PCR method. PCR cycle number is 3
5 The arrow indicates the position of the target amplified fragment (318 bp). The samples in each lane of the electrophoretogram are as follows. nc: Negative control, 1: Adrenal Grand
(Adrenal gland), 2: Brain, 3: Brain, caudate nucle
us (brain, caudate nucleus), 4: Brain, hippocampus (brain, hippocampus), 5: Brain, substantia nigra (brain, substantia nigra), 6:
Brain, thalamus (brain, thalamus), 7: Kidney (kidney),
8: Pancreas (pancreas), 9: Pituitary gland (pituitary gland), 10: Small intestine (small intestine), 11: Bone ma
rrow (bone marrow), 12: Brain, amygdala (brain, amygdala),
13: Brain, cerebellum (brain, cerebellum), 14: Brain, co
rpus callosum (brain, corpus callosum), 15: Fetal brain (fetal brain), 16: Fetal kidney (fetal kidney), 17: Fetal
liver 18: Fetal lung, 1
9: Heart, 20: Liver, 21: Lung
(Lung), 22: Lymph node (lymph node), 23: Mammar
y gland (breast gland), 24: Placenta (placenta), 25: Pro
state (prostate), 26: Salivary gland (salivary gland),
27: Skeletal muscle (skeletal muscle), 28: Spinal cord
(Spinal cord), 29: Spleen (spleen), 30: Stomach
(Stomach), 31: Testis (testis), 32: Thymus (thymus), 33: Thyroid (thyroid), 34: Trachea (trachea), 35: Uterus (uterus), 36: Standard 0.01 fg
(Standard sample 0.01 fg), 37: Standard 0.1 fg, 3
8: Standard 1 fg, M .: Size marker
【図16】 PCR法を用いて、各種ヒト細胞株、末梢
T細胞、および活性化末梢T細胞におけるKAT067
34L転写産物の発現量を調べた結果を示した電気泳動
の図である。PCRのサイクル数は25である。矢印は
目的の増幅断片(318bp)の位置を示している。電
気泳動図の各レーンのサンプルは以下の通りである。 n.c.:ネガティブコントロール、1:Jurkat、2:Molt
−3、3:Molt-4、4:Hut78、5:Namalwa KJM−1、
6:Daudi、7:Raji、8:HL−60、9:U937、10:T
HP−1、11:IVEC、12:HUVEC、13:WM266−4、1
4:WM115、15:SK−N−MC、16:PC−9、17:HLC
−1、18:QG−90、19:PC−3、20:KATO−III、
21:Capan−1、22:Capan−2、23:Colo205、2
4:SW1116、25:LS180、26:T cell(無刺激)、
27:T cell IL-2(インターロイキン-2)+PHA(Phyt
ohemagglutinin)+TGF-β(トランスフォーミング・グ
ロース・ファクター-β) 2日間(2日間培養)、28:
T cell IL-2+PHA+TGF-β 4日間、29: T cell IL-2+
PHA+TGF-β 6日間、30: T cell IL-2+PHA+TGF-β 8
日間、31: T cell IL-2+PHA 4日間、32: T cell
IL-2+PHA 6日間、33:T cell IL-2+PHA 8日間、3
4: T cell IL-2+抗CD3抗体 2日間、35: T cell IL
-2+抗CD3抗体 4日間、36: T cell IL-2+抗CD3抗体 6
日間、37: T cell IL-2+抗CD3抗体 8日間、38:St
andard 1 fg(標準試料 1 fg)、39:Standard 10 f
g、40:Standard 50 fg、41:Standard 125 fg、
M.:サイズマーカーFIG. 16: KAT067 in various human cell lines, peripheral T cells, and activated peripheral T cells using PCR
FIG. 4 is an electrophoresis diagram showing the result of examining the expression level of a 34L transcript. The number of PCR cycles is 25. The arrow indicates the position of the target amplified fragment (318 bp). The samples in each lane of the electrophoretogram are as follows. nc: negative control, 1: Jurkat, 2: Molt
-3, 3: Molt-4, 4: Hut78, 5: Namalwa KJM-1,
6: Daudi, 7: Raji, 8: HL-60, 9: U937, 10: T
HP-1, 11: IVEC, 12: HUVEC, 13: WM266-4, 1
4: WM115, 15: SK-N-MC, 16: PC-9, 17: HLC
-1, 18: QG-90, 19: PC-3, 20: KATO-III,
21: Capan-1, 22: Capan-2, 23: Colo205, 2
4: SW1116, 25: LS180, 26: T cell (unstimulated),
27: T cell IL-2 (interleukin-2) + PHA (Phyt
ohemagglutinin) + TGF-β (transforming growth factor-β) 2 days (cultured for 2 days), 28:
T cell IL-2 + PHA + TGF-β 4 days, 29: T cell IL-2 +
PHA + TGF-β 6 days, 30: T cell IL-2 + PHA + TGF-β 8
Days, 31: T cell IL-2 + PHA 4 days, 32: T cell
IL-2 + PHA 6 days, 33: T cell IL-2 + PHA 8 days, 3
4: T cell IL-2 + anti-CD3 antibody 2 days, 35: T cell IL
-2+ anti-CD3 antibody for 4 days, 36: T cell IL-2 + anti-CD3 antibody 6
Days, 37: T cell IL-2 + anti-CD3 antibody 8 days, 38: St
andard 1 fg (standard sample 1 fg), 39: Standard 10 f
g, 40: Standard 50 fg, 41: Standard 125 fg,
M .: Size marker
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61K 45/00 101 A61P 25/00 4B065 A61P 25/00 35/00 4C084 35/00 C07K 14/705 4C085 C07K 14/705 16/28 4H045 16/28 C12N 1/15 C12N 1/15 1/19 1/19 1/21 1/21 C12P 21/02 C 5/10 C12Q 1/68 A C12P 21/02 Z C12Q 1/68 G01N 33/15 Z 33/50 Z G01N 33/15 33/53 D 33/50 M 33/53 33/566 C12P 21/08 33/566 (C12P 21/02 C // C12P 21/08 C12R 1:91) (C12P 21/02 C12N 15/00 ZNAA C12R 1:91) 5/00 A (72)発明者 河合 宏紀 東京都町田市旭町3丁目6番6号 協和醗 酵工業株式会社東京研究所内 (72)発明者 西 達也 東京都町田市旭町3丁目6番6号 協和醗 酵工業株式会社東京研究所内 (72)発明者 中村 祐輔 神奈川県横浜市青葉区あざみ野1−17−33 (72)発明者 菅野 純夫 東京都杉並区南荻窪4−8−13 Fターム(参考) 2B030 AB04 AD08 CA06 CA17 CA19 CB03 2G045 AA26 AA34 AA35 AA40 BB20 CB01 CB17 CB20 CB21 DA12 DA13 DA14 DA36 4B024 AA11 AA12 BA53 BA63 CA04 CA12 DA01 DA02 DA05 DA11 EA04 GA03 GA14 HA01 HA12 HA15 4B063 QA01 QA05 QA12 QA19 QQ08 QQ21 QQ33 QQ61 QQ62 QQ73 QQ79 QQ89 QQ91 QQ94 QR32 QR42 QR50 QR62 QR75 QR76 QR77 QR78 QR80 QS03 QS05 QS24 QS25 QS34 QX07 4B064 AG01 AG26 AG27 BA14 CA02 CA05 CA10 CA11 CA19 CA20 CC24 DA01 DA13 DA14 4B065 AA15X AA22X AA24X AA26X AA32X AA41X AA48X AA72X AA79X AA87X AA88X AA90X AA92X AA93X AA93Y AB01 AB05 AC14 BA02 BA03 CA24 CA25 CA44 CA46 4C084 AA17 ZA022 ZB262 4C085 AA13 AA14 BB50 CC03 4H045 AA10 AA11 AA20 AA30 BA10 CA40 DA50 EA20 EA50 EA51 FA72 FA73 FA74 HA05 ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat ゛ (Reference) A61K 45/00 101 A61P 25/00 4B065 A61P 25/00 35/00 4C084 35/00 C07K 14/705 4C085 C07K 14/705 16/28 4H045 16/28 C12N 1/15 C12N 1/15 1/19 1/19 1/21 1/21 C12P 21/02 C 5/10 C12Q 1/68 A C12P 21/02 Z C12Q 1 / 68 G01N 33/15 Z 33/50 Z G01N 33/15 33/53 D 33/50 M 33/53 33/566 C12P 21/08 33/566 (C12P 21/02 C // C12P 21/08 C12R 1 : 91) (C12P 21/02 C12N 15/00 ZNAA C12R 1:91) 5/00 A (72) Inventor Hiroki Kawai 3-6-6 Asahicho, Machida-shi, Tokyo Kyowa Hakko Hakko Kogyo Co., Ltd. (72) Inventor Nishi Tatsuya 3-6-6 Asahicho, Machida-shi, Tokyo Kyowa Hakko Kogyo Co., Ltd., Tokyo Research Laboratory (72) Inventor Yusuke Nakamura 1-17-33 Azamino Aoba-ku, Yokohama-shi, Kanagawa Prefecture (72) Inventor Sumio Kanno Tokyo 4B-13 Minamiogikubo, Suginami-ku F-term (reference) HA12 HA15 4B063 QA01 QA05 QA12 QA19 QQ08 QQ21 QQ33 QQ61 QQ62 QQ73 QQ79 QQ89 QQ91 QQ94 QR32 QR42 QR50 QR62 QR75 QR76 QR77 QR78 QR80 QS03 QS05 QS24 QS25 QS34 QS34 QX07 4B064 CA01 DA14 CA14 DA14 AA24X AA26X AA32X AA41X AA48X AA72X AA79X AA87X AA88X AA90X AA92X AA93X AA93Y AB01 AB05 AC14 BA02 BA03 CA24 CA25 CA44 CA46 4C084 AA17 ZA022 ZB262 4C085 AA13 AA10A50 AA30A30 AA30A30 AA14A50
Claims (35)
るG蛋白質共役型受容体ポリペプチド。1. A G protein-coupled receptor polypeptide having the amino acid sequence of SEQ ID NO: 1.
ノ酸配列において、1個以上のアミノ酸が欠失、置換若
しくは付加したアミノ酸配列を有するポリペプチドであ
り、かつ請求項1に記載のポリペプチドと実質的に同一
の活性を有するポリペプチド。2. The polypeptide according to claim 1, which has an amino acid sequence in which one or more amino acids have been deleted, substituted or added in the amino acid sequence of the polypeptide set forth in SEQ ID NO: 1. A polypeptide having substantially the same activity.
型受容体ポリペプチドの部分ペプチドであり、かつ該ポ
リペプチドのリガンド、アゴニスト、アンタゴニストま
たは機能修飾物質との結合能を有する部分ペプチド。3. A partial peptide which is a partial peptide of the G protein-coupled receptor polypeptide according to claim 1 or 2, and has a binding ability to a ligand, agonist, antagonist or functional modifier of the polypeptide.
型受容体ポリペプチドをコードするDNA。4. A DNA encoding the G protein-coupled receptor polypeptide according to claim 1 or 2.
塩基番号175〜1287番で表される塩基配列を有す
るDNA。5. In the DNA of SEQ ID NO: 2,
DNA having a base sequence represented by base numbers 175 to 1287.
ばれるDNAとストリンジェントな条件下でハイブリダ
イズするDNAであり、かつ請求項1に記載のG蛋白質
共役型受容体ポリペプチドと実質的に同一の活性を有す
るポリペプチドをコードするDNA。6. A DNA which hybridizes with a DNA selected from the DNA according to claim 4 or 5 under a stringent condition, and substantially the same as the G protein-coupled receptor polypeptide according to claim 1. DNA encoding a polypeptide having the same activity as the above.
ポリペプチドの部分ペプチドをコードするDNA。7. A DNA encoding a partial peptide of the G protein-coupled receptor polypeptide according to claim 3.
ポリペプチドの部分ペプチドをコードするDNAであ
り、かつ請求項1または2に記載のポリペプチドのリガ
ンド、アゴニスト、アンタゴニストまたは機能修飾物質
との結合能を有する部分ペプチドをコードするDNA。8. A DNA encoding a partial peptide of the polypeptide encoded by the DNA according to claim 6, and a ligand, agonist, antagonist or function modifying substance of the polypeptide according to claim 1 or 2. DNA encoding a partial peptide having the binding ability of
NAをベクターに組込んで得られる組換え体DNA。9. D according to any one of claims 4 to 8,
A recombinant DNA obtained by incorporating NA into a vector.
有する形質転換細胞、形質転換植物または形質転換非ヒ
ト動物。10. A transformed cell, transformed plant or transformed non-human animal having the recombinant DNA according to claim 9.
質転換植物または形質転換非ヒト動物を用い、(i)該
形質転換細胞を培地中で培養し該培養物中に、(ii)該
形質転換植物を栽培し該植物中に、または(iii)該形
質転換非ヒト動物を飼育し該動物中に、請求項1または
2に記載のポリペプチドまたは請求項3に記載の部分ペ
プチドを生成蓄積させ、該培養物、該植物または該動物
から該ポリペプチドまたは該部分ペプチドを採取するこ
とを特徴とする、請求項1または2に記載のポリペプチ
ドまたは請求項3に記載のペプチドの製造方法。11. Use of the transformed cell, transformed plant or transformed non-human animal according to claim 10, wherein (i) culturing the transformed cell in a medium, and (ii) culturing the transformed cell. Cultivating the transformed plant in the plant, or (iii) breeding the transformed non-human animal to produce the polypeptide of claim 1 or 2 or the partial peptide of claim 3 in the animal. The method for producing the polypeptide according to claim 1 or 2, wherein the polypeptide or the partial peptide is collected from the culture, the plant, or the animal. .
ド、または請求項3記載の部分ペプチドを認識する抗
体。12. An antibody that recognizes the polypeptide according to claim 1 or 2, or the partial peptide according to claim 3.
項1または2に記載のポリペプチド、または請求項3に
記載の部分ペプチドの免疫学的定量方法。13. A method for immunologically quantifying the polypeptide according to claim 1 or 2, or the partial peptide according to claim 3, wherein the antibody according to claim 12 is used.
癌、あるいは視床または小脳の機能異常症の判定方法。14. A method for determining cancer or dysfunction of the thalamus or cerebellum using the quantification method according to claim 13.
ドをコードするmRNA量を測定することによる癌、あ
るいは視床または小脳の機能異常症の判定方法。15. A method for determining cancer or dysfunction of the thalamus or cerebellum by measuring the amount of mRNA encoding the polypeptide according to claim 1 or 2.
ドをコードする遺伝子の欠失、置換または付加を検出す
ることによる癌、あるいは視床または小脳の機能異常症
の判定方法。16. A method for determining cancer, or dysfunction of the thalamus or cerebellum by detecting deletion, substitution or addition of the gene encoding the polypeptide according to claim 1 or 2.
ド、または請求項3に記載の部分ペプチドと、被験試料
とを接触させ、被験試料より請求項1または2に記載の
ポリペプチドのリガンド、アゴニスト、アンタゴニスト
または機能修飾物質を選択することを特徴とする、請求
項1または2に記載のポリペプチドのリガンド、アゴニ
スト、アンタゴニストまたは機能修飾物質のスクリーニ
ング方法。17. The polypeptide according to claim 1 or 2, wherein the polypeptide according to claim 1 or 2 or the partial peptide according to claim 3 is contacted with a test sample, The method for screening a ligand, agonist, antagonist or function modifying substance for a polypeptide according to claim 1 or 2, wherein an agonist, antagonist or function modifying substance is selected.
ド、または請求項3に記載の部分ペプチドを発現する細
胞と、被験試料とを接触させ、被験試料より請求項1ま
たは2に記載のポリペプチドのリガンド、アゴニスト、
アンタゴニストまたは機能修飾物質を選択することを特
徴とする、請求項1または2に記載のポリペプチドのリ
ガンド、アゴニスト、アンタゴニストまたは機能修飾物
質のスクリーニング方法。18. The test sample is contacted with a cell expressing the polypeptide according to claim 1 or 2 or the partial peptide according to claim 3, and the test sample is contacted with the polypeptide according to claim 1 or 2. Peptide ligands, agonists,
The method for screening a ligand, an agonist, an antagonist or a function modifying substance of a polypeptide according to claim 1 or 2, wherein an antagonist or a function modifying substance is selected.
ペプチド、または請求項3に記載の部分ペプチドと、リ
ガンドとを接触させた場合と(ii)請求項1または2に
記載のポリペプチド、または請求項3に記載の部分ペプ
チドと、リガンドおよび被験試料とを接触させた場合と
を比較し、被験試料より請求項1または2に記載のポリ
ペプチドのアゴニスト、アンタゴニストまたは機能修飾
物質を選択することを特徴とする、請求項1または2に
記載のポリペプチドのアゴニスト、アンタゴニストまた
は機能修飾物質のスクリーニング方法。(19) The polypeptide according to (1) or (2) or the partial peptide according to (3) and a ligand, and (ii) the polypeptide according to (1) or (2). A peptide or a partial peptide according to claim 3 is contacted with a ligand and a test sample, and the agonist, antagonist or function modifying substance of the polypeptide according to claim 1 or 2 is compared with the test sample. 3. A method for screening for an agonist, antagonist or function-modifying substance of the polypeptide according to claim 1, wherein the method is selected.
ペプチド、または請求項3に記載の部分ペプチドを発現
する細胞と、リガンドとを接触させた場合と(ii)請求
項1または2に記載のポリペプチド、または請求項3に
記載の部分ペプチドを発現する細胞と、リガンドおよび
被験試料とを接触させた場合とを比較し、被験試料より
請求項1または2に記載のポリペプチドのアゴニスト、
アンタゴニストまたは機能修飾物質を選択することを特
徴とする、請求項1または2に記載のポリペプチドのア
ゴニスト、アンタゴニストまたは機能修飾物質のスクリ
ーニング方法。20. The method according to claim 1, wherein (i) a cell that expresses the polypeptide according to claim 1 or 2 or the partial peptide according to claim 3 is brought into contact with a ligand; Or a cell expressing the partial peptide according to claim 3 and a ligand and a test sample are compared with each other, and the polypeptide of claim 1 or 2 is compared with the test sample. Agonist,
3. The method for screening an agonist, antagonist or function modifying substance of a polypeptide according to claim 1 or 2, wherein an antagonist or a function modifying substance is selected.
ド、または請求項3に記載の部分ペプチドを含有するこ
とを特徴とする、請求項1または2に記載のポリペプチ
ドのリガンド、アゴニスト、アンタゴニストまたは機能
修飾物質のスクリーニング用キット。21. A ligand, agonist or antagonist of the polypeptide according to claim 1 or 2, which comprises the polypeptide according to claim 1 or 2 or the partial peptide according to claim 3. Or a kit for screening for a functional modifier.
ング方法、または請求項21に記載のスクリーニング用
キットを用いて得られる、請求項1または2に記載のポ
リペプチドのリガンド、アゴニスト、アンタゴニストま
たは機能修飾物質、またはその薬理学的に許容される
塩。22. A ligand, agonist, antagonist or function of the polypeptide according to claim 1 or 2, obtained by using the screening method according to claim 17 or 20 or the screening kit according to claim 21. Modifiers or pharmacologically acceptable salts thereof.
に記載のリガンド、アゴニスト、アンタゴニストおよび
機能修飾物質から選ばれる物質、またはその薬理学的に
許容される塩を含有する、癌、あるいは視床または小脳
の機能異常症の治療薬。23. The antibody according to claim 12, wherein the antibody is an antibody according to claim 12.
A therapeutic agent for cancer or dysfunction of the thalamus or cerebellum, comprising a substance selected from the ligands, agonists, antagonists and function-modifying substances described in 1, or a pharmacologically acceptable salt thereof.
ペプチドを発現する細胞と、(ii)請求項1または2に
記載のポリペプチドを発現する細胞と被験試料とを接触
させた場合とを比較し、被験試料より請求項1または2
に記載のポリペプチドをコードする遺伝子の発現を変動
させる化合物を選択することを特徴とする、請求項1ま
たは2に記載のポリペプチドをコードするDNAの発現
量を変動させる化合物のスクリーニング方法。24. When a test sample is brought into contact with (i) a cell expressing the polypeptide according to claim 1 or 2 and (ii) a cell expressing the polypeptide according to claim 1 or 2 with a test sample. And claim 1 or 2 from the test sample.
3. A method for screening a compound that changes the expression level of a DNA encoding the polypeptide according to claim 1 or 2, wherein the method selects a compound that changes the expression of the gene encoding the polypeptide according to 1.
方法、または請求項1または2に記載のポリペプチドを
コードするmRNA量を定量する方法で測定することを
特徴とする、請求項24に記載のスクリーニング方法。25. The method according to claim 13, wherein the variation in the expression level is measured by the method according to claim 13 or the method according to claim 1 or 2 for quantifying the amount of mRNA encoding the polypeptide. 25. The screening method according to 24.
ドをコードする遺伝子の転写を制御する領域の下流にレ
ポーター遺伝子の連結されたDNAを含有する形質転換
体と被験試料とを接触させ、被験試料より請求項1また
は2に記載のポリペプチドをコードするDNAの発現量
を変動させる化合物を選択することを特徴とする、請求
項1または2に記載のポリペプチドをコードする遺伝子
の発現量を変動させる化合物のスクリーニング方法。A test sample is contacted with a transformant containing a reporter gene-linked DNA downstream of a region controlling transcription of the gene encoding the polypeptide according to claim 1 or 2, and 3. The method according to claim 1, wherein a compound that changes the expression level of the DNA encoding the polypeptide according to claim 1 or 2 is selected from the sample. A method for screening a compound to be varied.
の20202〜25202番目の塩基配列で表わされる
DNA中の連続する50〜5000bpの塩基配列を有
するDNAで規定される領域である、請求項26に記載
のスクリーニング方法。27. The region that controls transcription is SEQ ID NO: 15.
27. The screening method according to claim 26, which is a region defined by a DNA having a continuous 50 to 5000 bp nucleotide sequence in the DNA represented by the nucleotide sequence at positions 20202 to 25202.
載のスクリーニング方法から選ばれる方法によって得ら
れる化合物またはその薬理学的に許容される塩。28. A compound or a pharmacologically acceptable salt thereof obtained by a method selected from the screening method according to any one of claims 24 to 27.
薬理学的に許容される塩を含有する、癌、あるいは視床
または小脳の機能異常症の治療薬。29. An agent for treating cancer or dysfunction of the thalamus or cerebellum, comprising the compound according to claim 28 or a pharmacologically acceptable salt thereof.
列番号2に記載のDNAから選ばれるDNAの塩基配列
中の連続した5〜60塩基と同じ配列を有するオリゴヌ
クレオチド、該オリゴヌクレオチドと相補的な配列を有
するオリゴヌクレオチド、およびこれらオリゴヌクレオ
チドのオリゴヌクレオチド誘導体から選ばれるDNA。30. An oligonucleotide having the same sequence as 5 to 60 consecutive bases in the base sequence of a DNA selected from the DNA of claim 4 or 6 and the DNA of SEQ ID NO: 2, complementary to the oligonucleotide. Selected from oligonucleotides having specific sequences and oligonucleotide derivatives of these oligonucleotides.
Aから選ばれるDNAを用い、請求項1または2に記載
のポリペプチドをコードするDNAの転写またはmRN
Aの翻訳を抑制する方法。31. The DN according to claims 4 to 6, and 30.
A transcription or mRN of a DNA encoding the polypeptide according to claim 1 or 2, using a DNA selected from A.
A method for suppressing the translation of A.
ドをコードするDNAを含む遺伝子の全部または一部が
欠損または置換し、請求項1または2に記載のポリペプ
チドの発現量が変化した遺伝子欠失または置換非ヒト動
物。32. A gene in which the expression level of the polypeptide according to claim 1 or 2 is altered by deleting or substituting all or a part of the gene containing the DNA encoding the polypeptide according to claim 1 or 2. Deleted or substituted non-human animals.
接種、または該動物の臓器、組織あるいは細胞と、被験
試料とを接触させ、被験試料より、癌、あるいは視床ま
たは小脳の機能異常症の治療薬を選択することを特徴と
する、癌、あるいは視床または小脳の機能異常症の治療
薬のスクリーニング方法。33. An animal according to claim 32, which is inoculated with a test sample, or a test sample is brought into contact with an organ, tissue or cell of the animal, and the test sample is used to produce cancer or dysfunction of the thalamus or cerebellum. A method of screening for a therapeutic agent for cancer or dysfunction of the thalamus or cerebellum, which comprises selecting a therapeutic agent for:
法で得られる化合物またはその薬理学的に許容される
塩。34. A compound obtained by the screening method according to claim 33 or a pharmacologically acceptable salt thereof.
薬理学的に許容される塩を含有する、癌、あるいは視床
または小脳の機能異常症の治療薬。35. A therapeutic agent for cancer or dysfunction of the thalamus or cerebellum, comprising the compound according to claim 34 or a pharmacologically acceptable salt thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000060548A JP2001245666A (en) | 2000-03-06 | 2000-03-06 | New polypeptide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000060548A JP2001245666A (en) | 2000-03-06 | 2000-03-06 | New polypeptide |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2001245666A true JP2001245666A (en) | 2001-09-11 |
Family
ID=18580837
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000060548A Withdrawn JP2001245666A (en) | 2000-03-06 | 2000-03-06 | New polypeptide |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2001245666A (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002031145A1 (en) * | 2000-10-13 | 2002-04-18 | Takeda Chemical Industries, Ltd. | Novel g protein-coupled receptor protein and dna thereof |
WO2001092296A3 (en) * | 2000-05-26 | 2002-05-30 | Bayer Ag | Regulation of human isotocin-like g protein-coupled receptor |
WO2003025179A1 (en) * | 2001-09-14 | 2003-03-27 | Takeda Chemical Industries, Ltd. | Novel polypeptide, dna thereof and use of the same |
WO2003087366A1 (en) * | 2002-04-16 | 2003-10-23 | Kyowa Hakko Kogyo Co., Ltd. | Endocrine cell lines and method of using the same |
JP2003304884A (en) * | 2002-02-13 | 2003-10-28 | Japan Found Cancer Res | Method for estimating compatibility with anticancer agent |
JP2004065232A (en) * | 2001-09-14 | 2004-03-04 | Takeda Chem Ind Ltd | New polypeptide, its dna and their application |
WO2004056866A1 (en) * | 2002-12-20 | 2004-07-08 | Geneos Oy | Asthma susceptibility locus |
WO2004058959A1 (en) * | 2002-12-26 | 2004-07-15 | Nippon Shinyaku Co., Ltd. | PROCESS FOR PRODUCING PNPase |
WO2004076487A1 (en) * | 2003-02-28 | 2004-09-10 | Takeda Pharmaceutical Company Limited | Antibody and use thereof |
JPWO2005028667A1 (en) * | 2003-09-19 | 2006-11-30 | 独立行政法人理化学研究所 | Drug targeting G protein-coupled receptor expressed in human mast cells and screening method thereof |
WO2007052837A1 (en) * | 2005-11-04 | 2007-05-10 | Ajinomoto Co., Inc. | Gastrointestinal function promoter |
CN114702570A (en) * | 2022-03-23 | 2022-07-05 | 山东大学 | aGPCR antagonists |
-
2000
- 2000-03-06 JP JP2000060548A patent/JP2001245666A/en not_active Withdrawn
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001092296A3 (en) * | 2000-05-26 | 2002-05-30 | Bayer Ag | Regulation of human isotocin-like g protein-coupled receptor |
US7250272B2 (en) | 2000-10-13 | 2007-07-31 | Takeda Pharmaceutical Company Limited | G protein-coupled receptor protein and DNA thereof |
WO2002031145A1 (en) * | 2000-10-13 | 2002-04-18 | Takeda Chemical Industries, Ltd. | Novel g protein-coupled receptor protein and dna thereof |
US7323541B2 (en) | 2001-09-14 | 2008-01-29 | Takeda Pharmaceutical Company Limited | Polypeptide DNA thereof and use of the same |
JP2004065232A (en) * | 2001-09-14 | 2004-03-04 | Takeda Chem Ind Ltd | New polypeptide, its dna and their application |
JP4535670B2 (en) * | 2001-09-14 | 2010-09-01 | 武田薬品工業株式会社 | Novel polypeptides, their DNA and their uses |
WO2003025179A1 (en) * | 2001-09-14 | 2003-03-27 | Takeda Chemical Industries, Ltd. | Novel polypeptide, dna thereof and use of the same |
JP2003304884A (en) * | 2002-02-13 | 2003-10-28 | Japan Found Cancer Res | Method for estimating compatibility with anticancer agent |
WO2003087366A1 (en) * | 2002-04-16 | 2003-10-23 | Kyowa Hakko Kogyo Co., Ltd. | Endocrine cell lines and method of using the same |
EP1498483A1 (en) * | 2002-04-16 | 2005-01-19 | Kyowa Hakko Kogyo Co., Ltd. | Endocrine cell lines and method of using the same |
EP1498483A4 (en) * | 2002-04-16 | 2005-12-07 | Kyowa Hakko Kogyo Kk | Endocrine cell lines and method of using the same |
WO2004056866A1 (en) * | 2002-12-20 | 2004-07-08 | Geneos Oy | Asthma susceptibility locus |
WO2004058959A1 (en) * | 2002-12-26 | 2004-07-15 | Nippon Shinyaku Co., Ltd. | PROCESS FOR PRODUCING PNPase |
JPWO2004058959A1 (en) * | 2002-12-26 | 2006-04-27 | 日本新薬株式会社 | Production method of PNPase |
US7342105B2 (en) | 2003-02-28 | 2008-03-11 | Takeda Chemcial Industries, Ltd. | Antibody and use thereof |
WO2004076487A1 (en) * | 2003-02-28 | 2004-09-10 | Takeda Pharmaceutical Company Limited | Antibody and use thereof |
JPWO2005028667A1 (en) * | 2003-09-19 | 2006-11-30 | 独立行政法人理化学研究所 | Drug targeting G protein-coupled receptor expressed in human mast cells and screening method thereof |
WO2007052837A1 (en) * | 2005-11-04 | 2007-05-10 | Ajinomoto Co., Inc. | Gastrointestinal function promoter |
JP2009516637A (en) * | 2005-11-04 | 2009-04-23 | 味の素株式会社 | Gastrointestinal function enhancer |
CN114702570A (en) * | 2022-03-23 | 2022-07-05 | 山东大学 | aGPCR antagonists |
CN114702570B (en) * | 2022-03-23 | 2022-12-06 | 山东大学 | aGPCR antagonists |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102291355B1 (en) | Identification of patients in need of pd-l1 inhibitor cotherapy | |
KR101778036B1 (en) | Phosphodiesterase 4D7 as prostate cancer marker | |
KR20180093902A (en) | Detection of fetal chromosomal anomalies using differentially methylated diene regions between fetuses and pregnant women | |
KR20210138587A (en) | Combination Gene Targets for Improved Immunotherapy | |
CA2936612A1 (en) | Atf6 polymorphisms associated with myocardial infarction, method of detection and uses thereof | |
KR101621273B1 (en) | Use of Cathepsin C | |
KR20230034198A (en) | Methods for activating and expanding tumor-infiltrating lymphocytes | |
CN108026587A (en) | Novel biomarker and method for treating cancer | |
KR20220160053A (en) | Immunotherapy targets in multiple myeloma and methods for their identification | |
CN1423696A (en) | Human schizophrenia gene | |
CN101151371B (en) | Retrotransposon inhibition in therapy | |
JP2001245666A (en) | New polypeptide | |
US20030022217A1 (en) | Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof | |
KR20210144822A (en) | Compounds and methods for modulating UBE3A-ATS | |
CN111344408A (en) | Oligonucleotides for modulating FNDC3B expression | |
CA2474759A1 (en) | Gene for peripheral arterial occlusive disease | |
TW202227102A (en) | Method of treating fatty liver disease | |
US20040171003A1 (en) | Cancer-associated genes | |
KR102477906B1 (en) | A lncRNA FOR INDUCED PLURIPOTENT STEM CELL DIFFERENTIATION AND USES THEREOF | |
KR101804678B1 (en) | Screening markers for BIS inhibitors, screening kits containing the same, and screening methods for BIS inhibitors using the same | |
US20040002102A1 (en) | BIVM (basic, immunoglobulin-like variable motif-containing) gene, transcriptional products, and uses thereof | |
US20030170683A1 (en) | Formin-2 nucleic acids and polypeptides and uses thereof | |
KR100998272B1 (en) | Novel Genes Containing Coding Mononucleotide Repeats | |
KR100909709B1 (en) | Association of ITGA1 gene polymorphisms with bone mineral density and fracture risk | |
KR20230051519A (en) | Treatment of obesity in a subject with a variant nucleic acid molecule encoding the calcitonin receptor (CALCR) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A300 | Application deemed to be withdrawn because no request for examination was validly filed |
Free format text: JAPANESE INTERMEDIATE CODE: A300 Effective date: 20070605 |